Citrus Sinensis ID: 046892
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 519 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SFT7 | 414 | Serine/threonine-protein | yes | no | 0.712 | 0.893 | 0.665 | 1e-147 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.670 | 0.763 | 0.624 | 1e-133 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.701 | 0.860 | 0.569 | 1e-124 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.562 | 0.592 | 0.539 | 7e-89 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.570 | 0.721 | 0.527 | 4e-87 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.562 | 0.595 | 0.529 | 2e-86 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.568 | 0.692 | 0.514 | 3e-85 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.572 | 0.697 | 0.514 | 5e-84 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.658 | 0.879 | 0.441 | 4e-83 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.649 | 0.866 | 0.459 | 3e-82 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 520 bits (1340), Expect = e-147, Method: Compositional matrix adjust.
Identities = 253/380 (66%), Positives = 297/380 (78%), Gaps = 10/380 (2%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDE-- 58
MNCF CF + KK ++ + S E ++ K P P +N+ +D+
Sbjct: 1 MNCFSCFYFHEKKKVPRD-SDNSYRRNGEVTGRDNNK-THPENPKTVNEQNKNNDEDKEV 58
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN 118
T NI AQTF+FRELA ATKNFRQECL+GEGGFGRVYKG L+ G +VAVKQLDRNG+QGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 119 KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWT 178
KEF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYE+MS GS++DHLLD+ + PLDW
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
TR++IA GAA GLEYLHDKANPPVIYRDLK++NILL + KLSDFGLAKLGP G+K +
Sbjct: 179 TRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298
V+SRVMGTYGYCAPEY R+G+LT KSDVYSFGV+LLELITGRRVIDTTRP DEQNL+ WA
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWA 298
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
QP+F++P RFP++ADP L FPEK LN+AVA+AAMCLQEEA RPLMSDVVTAL FL
Sbjct: 299 QPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
Query: 359 SKE---PIP---DPIIPSDE 372
+ + +P DP PSDE
Sbjct: 359 APDGSISVPHYDDPPQPSDE 378
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 475 bits (1223), Expect = e-133, Method: Compositional matrix adjust.
Identities = 234/375 (62%), Positives = 278/375 (74%), Gaps = 27/375 (7%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAP------PATIHR---- 50
M CF CF S +K N P DE + KKQ QP P+ +
Sbjct: 1 MGCFSCFDSSDDEKLN---------PVDESNHGQ-KKQSQPTVSNNISGLPSGGEKLSSK 50
Query: 51 -NEGTKQ------DETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQ 103
N G+K+ D I A TF FRELAAAT NF + LGEGGFGRVYKG L S GQ
Sbjct: 51 TNGGSKRELLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQ 110
Query: 104 VVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDD 163
VVAVKQLDRNG+QGN+EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM GS++D
Sbjct: 111 VVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLED 170
Query: 164 HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223
HL D+ K+ LDW RMKIA+GAA+GLE+LHDKANPPVIYRD KSSNILL PKLS
Sbjct: 171 HLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLS 230
Query: 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVI 283
DFGLAKLGP G+K +V++RVMGTYGYCAPEYA +G+LTVKSDVYSFGV+ LELITGR+ I
Sbjct: 231 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 290
Query: 284 DTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR 343
D+ P EQNL+AWA+P+F D ++F +ADP L+ +FP + L +A+A+A+MC+QE+A R
Sbjct: 291 DSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATR 350
Query: 344 PLMSDVVTALSFLSN 358
PL++DVVTALS+L+N
Sbjct: 351 PLIADVVTALSYLAN 365
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1146), Expect = e-124, Method: Compositional matrix adjust.
Identities = 226/397 (56%), Positives = 286/397 (72%), Gaps = 33/397 (8%)
Query: 1 MNCFPCFQ-SQKSKKANKNYV-ERSL----------PPRDECKEPESKKQKQPPAPPATI 48
M CF C + S K + NK+ V R + RD+ +P S K P
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVN- 59
Query: 49 HRNEGT--KQDE----TKNIN---------AQTFTFRELAAATKNFRQECLLGEGGFGRV 93
NEG K+D+ K +N AQTFTF+ELA AT NFR +C LGEGGFG+V
Sbjct: 60 --NEGGVGKEDQLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKV 117
Query: 94 YKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153
+KGT++ QVVA+KQLDRNG+QG +EF+VEVL LSL HPNLV LIG+CA+GDQRLLVY
Sbjct: 118 FKGTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVY 177
Query: 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213
E+M GS++DHL + KKPLDW TRMKIA+GAA+GLEYLHD+ PPVIYRDLK SNIL
Sbjct: 178 EYMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNIL 237
Query: 214 LGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273
LG + PKLSDFGLAK+GP G+K +V++RVMGTYGYCAP+YA +G+LT KSD+YSFGV+L
Sbjct: 238 LGEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 297
Query: 274 LELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAA 333
LELITGR+ ID T+ +QNL+ WA+P+F+D + FP M DPLL+ Q+P +GL +A+AI+A
Sbjct: 298 LELITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISA 357
Query: 334 MCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPS 370
MC+QE+ RP++SDVV AL+FL++SK DP PS
Sbjct: 358 MCVQEQPTMRPVVSDVVLALNFLASSKY---DPNSPS 391
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 164/304 (53%), Positives = 206/304 (67%), Gaps = 12/304 (3%)
Query: 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQ---------VVAVKQLDRNGMQG 117
FTF +L +T+NFR E LLGEGGFG V+KG ++ NG VAVK L+ +G+QG
Sbjct: 130 FTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQG 189
Query: 118 NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
+KE+L E+ L L HPNLV L+GYC + DQRLLVYEFM GS+++HL PL W
Sbjct: 190 HKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPW 246
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237
+ RMKIA GAA+GL +LH++A PVIYRD K+SNILL A+ + KLSDFGLAK P K
Sbjct: 247 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKT 306
Query: 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297
+V++RVMGTYGY APEY +G LT KSDVYSFGV+LLE++TGRR +D RP E NL+ W
Sbjct: 307 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 366
Query: 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357
A+P D +RF + DP L F KG + +AA CL + RP MSDVV AL L
Sbjct: 367 ARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLP 426
Query: 358 NSKE 361
+ K+
Sbjct: 427 HLKD 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 4e-87, Method: Compositional matrix adjust.
Identities = 163/309 (52%), Positives = 211/309 (68%), Gaps = 13/309 (4%)
Query: 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQV------VAVKQLDRNGMQGNKE 120
FT EL TK+FR + +LGEGGFG VYKG + N +V VAVK L++ G+QG++E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 121 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTR 180
+L EV L L HPNLV LIGYC + D RLLVYEFM GS+++HL +T PL W+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF--RKTTAPLSWSRR 174
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240
M IA GAA+GL +LH+ A PVIYRD K+SNILL ++ KLSDFGLAK GPQG++ +V+
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 241 SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300
+RVMGTYGY APEY +G LT +SDVYSFGV+LLE++TGR+ +D TRP EQNL+ WA+P
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360
D ++ + DP L Q+ + +A ++A CL + ARPLMSDVV L L +
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTG 353
Query: 361 EPIPDPIIP 369
D +IP
Sbjct: 354 ----DALIP 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (820), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 161/304 (52%), Positives = 204/304 (67%), Gaps = 12/304 (3%)
Query: 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQ---------VVAVKQLDRNGMQG 117
F+F +L AT+NFR E LLGEGGFG V+KG ++ NG VAVK L+ +G+QG
Sbjct: 124 FSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQG 183
Query: 118 NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
+KE+L E+ L L HPNLV L+GYC + DQRLLVYEFM GS+++HL PL W
Sbjct: 184 HKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF---RRSLPLPW 240
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237
+ RMKIA GAA+GL +LH++A PVIYRD K+SNILL + KLSDFGLAK P K
Sbjct: 241 SIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKT 300
Query: 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297
+V++RVMGTYGY APEY +G LT KSDVYSFGV+LLE++TGRR +D RP E NL+ W
Sbjct: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
Query: 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357
A+P D +RF + DP L F KG + +AA CL ++ RP MS+VV L L
Sbjct: 361 ARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLP 420
Query: 358 NSKE 361
+ K+
Sbjct: 421 HLKD 424
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 158/307 (51%), Positives = 207/307 (67%), Gaps = 12/307 (3%)
Query: 63 NAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQS---------NGQVVAVKQLDRN 113
N + FTF EL AT+NFR + LLGEGGFG V+KG + +G VVAVK+L
Sbjct: 67 NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTE 126
Query: 114 GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKK 173
G QG+KE+L EV L L HPNLV L+GYC +G+ RLLVYEFM GS+++HL +
Sbjct: 127 GYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF--RRGAQ 184
Query: 174 PLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233
PL W RMK+A GAA+GL +LHD A VIYRD K++NILL A + KLSDFGLAK GP
Sbjct: 185 PLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPT 243
Query: 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN 293
G+K +V+++VMGT+GY APEY +G LT KSDVYSFGV+LLEL++GRR +D ++ EQ+
Sbjct: 244 GDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQS 303
Query: 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
L+ WA P D ++ + D L Q+P+KG A ++A CL +A RP MS+V+ L
Sbjct: 304 LVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKL 363
Query: 354 SFLSNSK 360
L ++K
Sbjct: 364 DQLESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 5e-84, Method: Compositional matrix adjust.
Identities = 159/309 (51%), Positives = 207/309 (66%), Gaps = 12/309 (3%)
Query: 63 NAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQ---------SNGQVVAVKQLDRN 113
N + FTF EL ATKNFRQ+ LLGEGGFG V+KG + +G VVAVKQL
Sbjct: 70 NLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPE 129
Query: 114 GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKK 173
G QG+KE+L EV L L HPNLV L+GYCA+G+ RLLVYEFM GS+++HL +
Sbjct: 130 GFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF--RRGAQ 187
Query: 174 PLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233
PL W RMK+A GAA+GL +LH+ A VIYRD K++NILL A+ + KLSDFGLAK GP
Sbjct: 188 PLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPT 246
Query: 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN 293
G+ +V+++V+GT+GY APEY +G LT KSDVYSFGV+LLELI+GRR +D + +E +
Sbjct: 247 GDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYS 306
Query: 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
L+ WA P D ++ + D L Q+P+KG A +A CL +A RP MS+V+ L
Sbjct: 307 LVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTL 366
Query: 354 SFLSNSKEP 362
L + +P
Sbjct: 367 EQLESVAKP 375
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 4e-83, Method: Compositional matrix adjust.
Identities = 163/369 (44%), Positives = 232/369 (62%), Gaps = 27/369 (7%)
Query: 6 CFQSQ-KSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINA 64
CF ++ K+ A+ ++ RD K + P R EG + +N N
Sbjct: 4 CFSNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMP-------RTEG---EILQNANL 53
Query: 65 QTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQ---------SNGQVVAVKQLDRNGM 115
+ F+ EL +AT+NFR + ++GEGGFG V+KG + G V+AVK+L++ G
Sbjct: 54 KNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGF 113
Query: 116 QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL 175
QG++E+L E+ L L HPNLV LIGYC + + RLLVYEFM+ GS+++HL +PL
Sbjct: 114 QGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPL 173
Query: 176 DWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235
W TR+++A GAA+GL +LH+ A P VIYRD K+SNILL +N + KLSDFGLA+ GP G+
Sbjct: 174 SWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGD 232
Query: 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
+V++RVMGT GY APEY +G L+VKSDVYSFGV+LLEL++GRR ID +PV E NL+
Sbjct: 233 NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLV 292
Query: 296 AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAM---CLQEEAGARPLMSDVVTA 352
WA+P + +R + DP L+ Q+ L A+ IA + C+ +A +RP M+++V
Sbjct: 293 DWARPYLTNKRRLLRVMDPRLQGQY---SLTRALKIAVLALDCISIDAKSRPTMNEIVKT 349
Query: 353 LSFLSNSKE 361
+ L KE
Sbjct: 350 MEELHIQKE 358
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 163/355 (45%), Positives = 226/355 (63%), Gaps = 18/355 (5%)
Query: 46 ATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTL------- 98
AT H+ EG T ++F+F EL AT+NFR + ++GEGGFG V++G L
Sbjct: 31 ATAHKTEGEILSST---TVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTP 87
Query: 99 --QSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156
S+G V+AVK+L+ +G QG++E+L E+ L L HPNLV LIGYC + +QRLLVYEFM
Sbjct: 88 TKSSSGLVIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFM 147
Query: 157 SGGSVDDHLL-DVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP-PVIYRDLKSSNILL 214
GS+++HL + N+ KPL W R+K+A AA+GL +LH ++P VIYRD+K+SNILL
Sbjct: 148 HKGSLENHLFANGNKDFKPLSWILRIKVALDAAKGLAFLH--SDPVKVIYRDIKASNILL 205
Query: 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILL 274
++ + KLSDFGLA+ GP GE+ V++RVMGT+GY APEY +G L +SDVYSFGV+LL
Sbjct: 206 DSDFNAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLL 265
Query: 275 ELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAM 334
EL+ GR+ +D RP EQNL+ WA+P ++ + D L Q+ +G +IA
Sbjct: 266 ELLCGRQALDHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQ 325
Query: 335 CLQEEAGARPLMSDVVTALSFLSNS--KEPIPDPIIPSDEDEYSEGYSSDGHQKN 387
CL E +RP M VV AL L +S K DP+ D + + D +Q+N
Sbjct: 326 CLSFEPKSRPTMDQVVRALVQLQDSVVKPANVDPLKVKDTKKLVGLKTEDKYQRN 380
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 519 | ||||||
| 255543082 | 534 | receptor serine-threonine protein kinase | 0.653 | 0.634 | 0.697 | 1e-147 | |
| 255560177 | 447 | receptor serine-threonine protein kinase | 0.695 | 0.807 | 0.659 | 1e-147 | |
| 18397825 | 414 | protein kinase domain-containing protein | 0.712 | 0.893 | 0.665 | 1e-145 | |
| 28416685 | 414 | At3g07070 [Arabidopsis thaliana] | 0.712 | 0.893 | 0.663 | 1e-144 | |
| 297829254 | 414 | kinase family protein [Arabidopsis lyrat | 0.701 | 0.879 | 0.660 | 1e-144 | |
| 357512441 | 610 | Protein kinase-like protein [Medicago tr | 0.753 | 0.640 | 0.635 | 1e-144 | |
| 225465457 | 427 | PREDICTED: serine/threonine-protein kina | 0.695 | 0.845 | 0.669 | 1e-141 | |
| 242087721 | 474 | hypothetical protein SORBIDRAFT_09g01850 | 0.678 | 0.742 | 0.671 | 1e-141 | |
| 242087719 | 474 | hypothetical protein SORBIDRAFT_09g01849 | 0.678 | 0.742 | 0.674 | 1e-140 | |
| 255551669 | 516 | receptor serine-threonine protein kinase | 0.666 | 0.670 | 0.643 | 1e-140 |
| >gi|255543082|ref|XP_002512604.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223548565|gb|EEF50056.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 529 bits (1363), Expect = e-147, Method: Compositional matrix adjust.
Identities = 251/360 (69%), Positives = 292/360 (81%), Gaps = 21/360 (5%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQD--- 57
MNCF CFQSQKSKK+ +K++ P+ P + ++ +D
Sbjct: 1 MNCFSCFQSQKSKKSF------------------TKREHGFPSSPREVIDSKSPDEDNDN 42
Query: 58 ETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG 117
++ I AQTFTFRE+A ATKNFRQE LLGEGGFGRV+KG L + GQVVAVKQLDR+G+Q
Sbjct: 43 KSYQIAAQTFTFREIATATKNFRQEYLLGEGGFGRVFKGILAATGQVVAVKQLDRSGLQE 102
Query: 118 NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
NKEFL EV+MLSLLHHPNLVNL+GYCADGDQRLLVY+F+ GGS+ DHLL++ +KPLDW
Sbjct: 103 NKEFLAEVMMLSLLHHPNLVNLVGYCADGDQRLLVYDFVKGGSLHDHLLELTPERKPLDW 162
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237
TRM+IA GAA+GLEYLHD+ANPPV+ ++K SNILL + +P LSDFGL KLGP G+KM
Sbjct: 163 FTRMRIAFGAAKGLEYLHDEANPPVVDGNMKPSNILLDEDFNPMLSDFGLVKLGPTGDKM 222
Query: 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297
+V SR+MGTYGY APEY R GELTVKSDVYSFGVILLELITGRR IDTT+PV+EQNL+AW
Sbjct: 223 HVHSRLMGTYGYSAPEYVRGGELTVKSDVYSFGVILLELITGRRAIDTTKPVNEQNLVAW 282
Query: 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357
AQPIFRDPKRFPDMADP+L K+FPEK LN+AVAIAAMCLQEEA ARPLMSDVVTALSFLS
Sbjct: 283 AQPIFRDPKRFPDMADPVLNKRFPEKDLNQAVAIAAMCLQEEAPARPLMSDVVTALSFLS 342
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560177|ref|XP_002521106.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223539675|gb|EEF41257.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1361), Expect = e-147, Method: Compositional matrix adjust.
Identities = 256/388 (65%), Positives = 296/388 (76%), Gaps = 27/388 (6%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLP---PRDECKEPESKKQKQP---------------P 42
M+C CF SQK K N +RS+P P ++ +++ Q P P
Sbjct: 1 MSCCSCFSSQKKKPKRTNSTKRSVPQPRPASPPRQKDAQTQVHPRPADIQNHPLHGNPKP 60
Query: 43 APPATIHR---------NEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRV 93
PP H N K+D + NI AQTFTFRELA ATKNFRQECL+GEGGFGRV
Sbjct: 61 KPPTNNHEPHVHKDATNNNNHKEDGSNNIAAQTFTFRELATATKNFRQECLIGEGGFGRV 120
Query: 94 YKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153
YKG L++ Q+VAVKQLDRNG QGN+EFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVY
Sbjct: 121 YKGKLENTNQIVAVKQLDRNGRQGNREFLVEVLMLSLLHHQNLVNLIGYCADGDQRLLVY 180
Query: 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213
E+M+ GS++DHLL++ +KPLDW RMKIA GAA+GLEYLHDKANPPVIYRDLKSSNIL
Sbjct: 181 EYMASGSLEDHLLELPPEQKPLDWFIRMKIALGAAKGLEYLHDKANPPVIYRDLKSSNIL 240
Query: 214 LGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273
L + KLSDFGLAKLGP G++ +V+SRVMGTYGYCAPEY R+G+LTVKSDVYSFGV+L
Sbjct: 241 LDEEYNAKLSDFGLAKLGPVGDRTHVSSRVMGTYGYCAPEYQRTGQLTVKSDVYSFGVVL 300
Query: 274 LELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAA 333
LELITGRR IDTTR EQ L+ WAQP+F+DP R+P++ADPLL K FP +GLN+AVA+AA
Sbjct: 301 LELITGRRAIDTTRSTHEQTLVTWAQPVFKDPNRYPELADPLLDKDFPVRGLNQAVAVAA 360
Query: 334 MCLQEEAGARPLMSDVVTALSFLSNSKE 361
MCLQEEAG RPLMSDVVTALSFL E
Sbjct: 361 MCLQEEAGVRPLMSDVVTALSFLGGDPE 388
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18397825|ref|NP_566298.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|75337179|sp|Q9SFT7.1|Y3707_ARATH RecName: Full=Serine/threonine-protein kinase At3g07070 gi|6642658|gb|AAF20239.1|AC012395_26 putative protein kinase [Arabidopsis thaliana] gi|332640974|gb|AEE74495.1| protein kinase domain-containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1340), Expect = e-145, Method: Compositional matrix adjust.
Identities = 253/380 (66%), Positives = 297/380 (78%), Gaps = 10/380 (2%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDE-- 58
MNCF CF + KK ++ + S E ++ K P P +N+ +D+
Sbjct: 1 MNCFSCFYFHEKKKVPRD-SDNSYRRNGEVTGRDNNK-THPENPKTVNEQNKNNDEDKEV 58
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN 118
T NI AQTF+FRELA ATKNFRQECL+GEGGFGRVYKG L+ G +VAVKQLDRNG+QGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 119 KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWT 178
KEF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYE+MS GS++DHLLD+ + PLDW
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
TR++IA GAA GLEYLHDKANPPVIYRDLK++NILL + KLSDFGLAKLGP G+K +
Sbjct: 179 TRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298
V+SRVMGTYGYCAPEY R+G+LT KSDVYSFGV+LLELITGRRVIDTTRP DEQNL+ WA
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWA 298
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
QP+F++P RFP++ADP L FPEK LN+AVA+AAMCLQEEA RPLMSDVVTAL FL
Sbjct: 299 QPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
Query: 359 SKE---PIP---DPIIPSDE 372
+ + +P DP PSDE
Sbjct: 359 APDGSISVPHYDDPPQPSDE 378
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|28416685|gb|AAO42873.1| At3g07070 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1338), Expect = e-144, Method: Compositional matrix adjust.
Identities = 252/380 (66%), Positives = 297/380 (78%), Gaps = 10/380 (2%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDE-- 58
MNCF CF + KK ++ + S E ++ K P P +N+ +D+
Sbjct: 1 MNCFSCFYFHEKKKVPRD-SDNSYRRNGEVTGRDNNK-THPENPKTVNEQNKNNDEDKEV 58
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN 118
T NI AQTF+FRELA ATKNFRQECL+GEGGFGRVYKG L+ G +VAVKQLDRNG+QGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 119 KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWT 178
KEF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYE+MS GS++DHLLD+ + PLDW
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
TR++IA GAA GLEYLHD+ANPPVIYRDLK++NILL + KLSDFGLAKLGP G+K +
Sbjct: 179 TRIRIALGAAMGLEYLHDRANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298
V+SRVMGTYGYCAPEY R+G+LT KSDVYSFGV+LLELITGRRVIDTTRP DEQNL+ WA
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWA 298
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
QP+F++P RFP++ADP L FPEK LN+AVA+AAMCLQEEA RPLMSDVVTAL FL
Sbjct: 299 QPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
Query: 359 SKE---PIP---DPIIPSDE 372
+ + +P DP PSDE
Sbjct: 359 APDGSISVPHYDDPPQPSDE 378
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297829254|ref|XP_002882509.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297328349|gb|EFH58768.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1334), Expect = e-144, Method: Compositional matrix adjust.
Identities = 255/386 (66%), Positives = 297/386 (76%), Gaps = 22/386 (5%)
Query: 1 MNCFPCFQSQKSKKA---NKNYVERS--LPPRDECKEPESKKQKQPPAPPATIH---RNE 52
MNCF CF + KK + N R+ L RD K P P T++ +N
Sbjct: 1 MNCFSCFYFHEKKKVPRDSDNSYRRNGELTGRD--------NNKTHPENPKTVNEQNKNN 52
Query: 53 GTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR 112
++ T NI AQTFTFRELA ATKNFRQECL+GEGGFGRVYKG L+ G +VAVKQLDR
Sbjct: 53 DEDKEVTNNIAAQTFTFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDR 112
Query: 113 NGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETK 172
NG+QGNKEF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYE+M GS++DHLLD+ +
Sbjct: 113 NGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMPRGSLEDHLLDLTPDQ 172
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232
PLDW TR++IA GAA+GLEYLHDKANPPVIYRDLK++NILL + KLSDFGLAKLGP
Sbjct: 173 IPLDWDTRIRIALGAAKGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGP 232
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292
G+K +V+SRVMGTYGYCAPEY R+G+LT KSDVYSFGV+LLELITGRRVIDTTRP EQ
Sbjct: 233 VGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKHEQ 292
Query: 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352
NL+ WAQP+F++P RFP++ADP L FPEK LN+AVA+AAMCLQEEA RPLMSDVVTA
Sbjct: 293 NLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTA 352
Query: 353 LSFLSNSKE---PIP---DPIIPSDE 372
L FL + + +P DP PSDE
Sbjct: 353 LGFLGTAPDGSISVPHYDDPPQPSDE 378
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357512441|ref|XP_003626509.1| Protein kinase-like protein [Medicago truncatula] gi|355501524|gb|AES82727.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1334), Expect = e-144, Method: Compositional matrix adjust.
Identities = 260/409 (63%), Positives = 307/409 (75%), Gaps = 18/409 (4%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDE----CKEPESKKQKQPPAPPATIHRNEGTKQ 56
MNCFPCF SQKSKK+N PP++ + P+ KK K P Q
Sbjct: 1 MNCFPCFTSQKSKKSNSRRENGVAPPQENNNLITRTPDIKKPKPADDP----------NQ 50
Query: 57 DETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ 116
+T NI AQ FTFRELA ATKNFRQECL+GEGGFGRVYKGT+ + GQVVAVKQLDRNG+Q
Sbjct: 51 VDTSNIQAQNFTFRELAIATKNFRQECLMGEGGFGRVYKGTIPATGQVVAVKQLDRNGIQ 110
Query: 117 GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD 176
G+KEFLVEVLMLSLL+H NLV L GYCADGDQRLLVYEFMSGGS++ LL+ + PLD
Sbjct: 111 GSKEFLVEVLMLSLLNHENLVKLTGYCADGDQRLLVYEFMSGGSLESCLLERKNDQDPLD 170
Query: 177 WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236
W +RMKIAS A+GL YLHDKANP +IYRDLKSSNILL +L+ KLSD+GLAKL + +
Sbjct: 171 WYSRMKIASNTAKGLWYLHDKANPSIIYRDLKSSNILLDKDLNAKLSDYGLAKLAGKDKA 230
Query: 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296
V +RVMGTYGY APEY R+G LT+KSDVYSFGV+LLELITGRR +DTTR DEQNL++
Sbjct: 231 NIVPTRVMGTYGYSAPEYVRTGNLTLKSDVYSFGVVLLELITGRRAVDTTRSHDEQNLVS 290
Query: 297 WAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356
WAQPIFRDPKR+ DMADP L K +PEK LN+ VAIAAMCLQEE+ ARPLMSDVVTALSFL
Sbjct: 291 WAQPIFRDPKRYGDMADPNLNKNYPEKDLNQVVAIAAMCLQEESAARPLMSDVVTALSFL 350
Query: 357 SNSKEP--IPDPIIPSD-EDEYSEGYSSDGHQKNEN-TYDNDNARSVRE 401
S S P +P P+ P + + S + + +++N ++ +D RSV E
Sbjct: 351 STSPPPEAVPAPLPPPNCTSQKSVATADESESEDDNDSHSSDEERSVHE 399
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225465457|ref|XP_002267569.1| PREDICTED: serine/threonine-protein kinase At3g07070 [Vitis vinifera] gi|297744352|emb|CBI37322.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1308), Expect = e-141, Method: Compositional matrix adjust.
Identities = 247/369 (66%), Positives = 292/369 (79%), Gaps = 8/369 (2%)
Query: 1 MNCFPCFQSQKSKKANKNYVERS--LPPRDECKEPESKKQKQPPAP----PATIHRNEGT 54
M+CFPCF S + K A ++ R+ LPP K+ +PP P P +I T
Sbjct: 1 MSCFPCFSSHEKKSAKRSTNTRNGDLPPAAAAVTAPIKQPVRPPQPVNPKPQSIAETTDT 60
Query: 55 KQD--ETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR 112
+ KNI +Q FTFRELA+ATKNFRQECL+GEGGFGRVY+G L+ GQ+VAVKQLDR
Sbjct: 61 NDAPADGKNIGSQIFTFRELASATKNFRQECLVGEGGFGRVYRGQLEQTGQIVAVKQLDR 120
Query: 113 NGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETK 172
NG+QGNKEFLVEVLMLSLLHH NLVNLIGYCADG+QRLLVYE+M GS++DHLLDV +
Sbjct: 121 NGLQGNKEFLVEVLMLSLLHHENLVNLIGYCADGEQRLLVYEYMQYGSLEDHLLDVPPDQ 180
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232
KPLDW TRMK+A GAA+GLEYLHDKANPPVIYRDLKSSNILL + + KLSDFGLAKLG
Sbjct: 181 KPLDWFTRMKVALGAAKGLEYLHDKANPPVIYRDLKSSNILLDKDFNAKLSDFGLAKLGT 240
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292
+K++V+SRVMGTYGYCAPEY R+G+LT+KSD+YSFGV+LLELITGRRVID T+P EQ
Sbjct: 241 GDDKIHVSSRVMGTYGYCAPEYQRTGQLTLKSDIYSFGVVLLELITGRRVIDPTKPAKEQ 300
Query: 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352
NLI WA+PIF+DP FP +ADP L+ +P +GLN+AV IAAMCLQEE RPL+SDVV+
Sbjct: 301 NLINWAEPIFKDPSSFPQLADPHLQGNYPRRGLNQAVGIAAMCLQEEPAVRPLISDVVSV 360
Query: 353 LSFLSNSKE 361
LSFLS + E
Sbjct: 361 LSFLSVAPE 369
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242087721|ref|XP_002439693.1| hypothetical protein SORBIDRAFT_09g018500 [Sorghum bicolor] gi|241944978|gb|EES18123.1| hypothetical protein SORBIDRAFT_09g018500 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1304), Expect = e-141, Method: Compositional matrix adjust.
Identities = 243/362 (67%), Positives = 284/362 (78%), Gaps = 10/362 (2%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPP----ATIHRNEGTKQ 56
M C PCF S A K + ES K K P A I R+E
Sbjct: 1 MGCLPCFGSAGEGAAKKVGARKDGSSDRRVTRVESDKSKAQGGPDSKKDAVILRDE---- 56
Query: 57 DETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ 116
++I A TFTFRELAAATKNFRQ+CLLGEGGFGRVYKG L+ NGQVVAVKQLDRNG+Q
Sbjct: 57 -NNQHIAAHTFTFRELAAATKNFRQDCLLGEGGFGRVYKGRLE-NGQVVAVKQLDRNGLQ 114
Query: 117 GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD 176
GN+EFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFM GS++DHL D+ K+PLD
Sbjct: 115 GNREFLVEVLMLSLLHHDNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDIPPEKEPLD 174
Query: 177 WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236
W TRMKIA+GAA+GLEYLHDKA+PPVIYRD KSSNILLG PKLSDFGLAKLGP G+K
Sbjct: 175 WNTRMKIAAGAAKGLEYLHDKASPPVIYRDFKSSNILLGEGFHPKLSDFGLAKLGPVGDK 234
Query: 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296
+V++RVMGTYGYCAPEYA +G+LTVKSDVYSFGV+ LELITGR+ ID T+P EQNL+A
Sbjct: 235 THVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDNTKPHGEQNLVA 294
Query: 297 WAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356
WA+P+F+D ++FP MADPLL+ +FP +GL +A+A+AAMCLQE+A RP + DVVTALS+L
Sbjct: 295 WARPLFKDRRKFPKMADPLLQGRFPMRGLYQALAVAAMCLQEQAATRPFIGDVVTALSYL 354
Query: 357 SN 358
++
Sbjct: 355 AS 356
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242087719|ref|XP_002439692.1| hypothetical protein SORBIDRAFT_09g018490 [Sorghum bicolor] gi|241944977|gb|EES18122.1| hypothetical protein SORBIDRAFT_09g018490 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 244/362 (67%), Positives = 285/362 (78%), Gaps = 10/362 (2%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPP----ATIHRNEGTKQ 56
M C PCF S A K + ES K K P A I R +G+ Q
Sbjct: 1 MGCLPCFGSAGEGAAKKVGARKDGSSDRRVTRVESDKSKAHGGPDSKKDAVILR-DGSNQ 59
Query: 57 DETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ 116
+I A TFTFRELAAATKNFRQ+CLLGEGGFGRVYKG L+ NGQVVAVKQLDRNG+Q
Sbjct: 60 ----HIAAHTFTFRELAAATKNFRQDCLLGEGGFGRVYKGRLE-NGQVVAVKQLDRNGLQ 114
Query: 117 GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD 176
GN+EFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEFM GS++DHL D+ K+PLD
Sbjct: 115 GNREFLVEVLMLSLLHHDNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDIPPEKEPLD 174
Query: 177 WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236
W TRMKIA+GAA+GLEYLHDKA+PPVIYRD KSSNILLG PKLSDFGLAKLGP G+K
Sbjct: 175 WNTRMKIAAGAAKGLEYLHDKASPPVIYRDFKSSNILLGEGFHPKLSDFGLAKLGPVGDK 234
Query: 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296
+V++RVMGTYGYCAPEYA +G+LTVKSDVYSFGV+ LELITGR+ ID T+P EQNL+A
Sbjct: 235 THVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDNTKPHGEQNLVA 294
Query: 297 WAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356
WA+P+F+D ++FP MADPLL+ +FP +GL +A+A+AAMCLQE+A RP + DVVTALS+L
Sbjct: 295 WARPLFKDRRKFPKMADPLLQGRFPMRGLYQALAVAAMCLQEQAATRPFIGDVVTALSYL 354
Query: 357 SN 358
++
Sbjct: 355 AS 356
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551669|ref|XP_002516880.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223543968|gb|EEF45494.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 242/376 (64%), Positives = 286/376 (76%), Gaps = 30/376 (7%)
Query: 3 CFPCFQSQKSKKANKNYVERSLPPRDECKEPE--------------------SKKQKQPP 42
CFPCF S + + + + +D KE S +K+P
Sbjct: 4 CFPCFGSSNKEGTDGGGAIKEVAKKDSVKEGSVAQSHHVGRVSSDKSKSRNGSDPKKEPT 63
Query: 43 APPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNG 102
P K T +I AQTFTFRELAAATKNFRQECLLGEGGFGRVYKG L+S G
Sbjct: 64 IP----------KDGPTAHIAAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGRLESTG 113
Query: 103 QVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVD 162
QVVAVKQLDRNG+QGN+EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM GS++
Sbjct: 114 QVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLE 173
Query: 163 DHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKL 222
DHL D K+PLDW TRMKIA+GAA+GLEYLHDKANPPVIYRDLKSSNILL PKL
Sbjct: 174 DHLHDFPSDKEPLDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLDEGYHPKL 233
Query: 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRV 282
SDFGLAKLGP G+K +V++RVMGTYGYCAPEYA +G+LT+KSDVYSFGV+ LELITGR+
Sbjct: 234 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKA 293
Query: 283 IDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGA 342
ID TR E NL+AWA+P+F+D ++FP MADPLL+ ++P +GL +A+A+AAMCLQE+A
Sbjct: 294 IDNTRAPGEHNLVAWARPLFKDRRKFPKMADPLLQGRYPMRGLYQALAVAAMCLQEQAAT 353
Query: 343 RPLMSDVVTALSFLSN 358
RPL+ DVVTAL++L++
Sbjct: 354 RPLIGDVVTALTYLAS 369
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 519 | ||||||
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.687 | 0.862 | 0.673 | 2.8e-128 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.685 | 0.693 | 0.654 | 1.5e-124 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.587 | 0.784 | 0.737 | 5.1e-122 | |
| TAIR|locus:2075517 | 558 | AT3G02810 [Arabidopsis thalian | 0.657 | 0.611 | 0.661 | 1.7e-121 | |
| TAIR|locus:2171342 | 636 | AT5G16500 [Arabidopsis thalian | 0.674 | 0.550 | 0.661 | 2.5e-120 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.579 | 0.829 | 0.744 | 2.9e-119 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.591 | 0.812 | 0.693 | 4.9e-117 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.689 | 0.785 | 0.616 | 5.6e-116 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.578 | 0.777 | 0.697 | 1.3e-114 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.564 | 0.769 | 0.663 | 7.5e-105 |
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
Identities = 243/361 (67%), Positives = 283/361 (78%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECXXXXXXXXXXXXXXXXTIHRNEGTKQDE-- 58
MNCF CF + KK ++ + S E +N+ +D+
Sbjct: 1 MNCFSCFYFHEKKKVPRDS-DNSYRRNGEVTGRDNNKTHPENPKTVN-EQNKNNDEDKEV 58
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN 118
T NI AQTF+FRELA ATKNFRQECL+GEGGFGRVYKG L+ G +VAVKQLDRNG+QGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 119 KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWT 178
KEF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYE+MS GS++DHLLD+ + PLDW
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
TR++IA GAA GLEYLHDKANPPVIYRDLK++NILL + KLSDFGLAKLGP G+K +
Sbjct: 179 TRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298
V+SRVMGTYGYCAPEY R+G+LT KSDVYSFGV+LLELITGRRVIDTTRP DEQNL+ WA
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWA 298
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
QP+F++P RFP++ADP L FPEK LN+AVA+AAMCLQEEA RPLMSDVVTAL FL
Sbjct: 299 QPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
Query: 359 S 359
+
Sbjct: 359 A 359
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1224 (435.9 bits), Expect = 1.5e-124, P = 1.5e-124
Identities = 235/359 (65%), Positives = 284/359 (79%)
Query: 3 CFPCFQSQKSKKANKNYVERSLPPRD-ECXXXXXXXXXXXXXXXXTIHRNEGT--KQDET 59
C PCF S A+K+ V++ L +D + E T K+ T
Sbjct: 4 CLPCFGSSAKDAASKDSVKKELSAKDGSVTQSHHISLDKSKSRRGPEQKKELTAPKEGPT 63
Query: 60 KNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK 119
+I AQTFTFRELAAATKNFR ECLLGEGGFGRVYKG L++ GQ+VAVKQLDRNG+QGN+
Sbjct: 64 AHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQGNR 123
Query: 120 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTT 179
EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M GS++DHL D+ K+PLDW+T
Sbjct: 124 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWST 183
Query: 180 RMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239
RM IA+GAA+GLEYLHDKANPPVIYRDLKSSNILLG PKLSDFGLAKLGP G+K +V
Sbjct: 184 RMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHV 243
Query: 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299
++RVMGTYGYCAPEYA +G+LT+KSDVYSFGV+ LELITGR+ ID R E NL+AWA+
Sbjct: 244 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWAR 303
Query: 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
P+F+D ++FP MADP L+ ++P +GL +A+A+AAMCLQE+A RPL+ DVVTAL++L++
Sbjct: 304 PLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLAS 362
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1200 (427.5 bits), Expect = 5.1e-122, P = 5.1e-122
Identities = 225/305 (73%), Positives = 264/305 (86%)
Query: 53 GTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR 112
GT ++ KNI A++F FRELA AT +FRQE L+GEGGFGRVYKG ++ GQVVAVKQLDR
Sbjct: 45 GTNKESPKNIKAKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVAVKQLDR 104
Query: 113 NGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETK 172
NG+QGN+EFLVE+ LSLLHHPNL NLIGYC DGDQRLLV+EFM GS++DHLLDV +
Sbjct: 105 NGLQGNREFLVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQ 164
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232
+PLDW +R++IA GAA+GLEYLH+KANPPVIYRD KSSNILL + D KLSDFGLAKLG
Sbjct: 165 QPLDWNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGS 224
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292
G+ NV+SRV+GTYGYCAPEY ++G+LTVKSDVYSFGV+LLELITG+RVIDTTRP EQ
Sbjct: 225 VGDTQNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQ 284
Query: 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352
NL+ WAQPIFR+P RFP++ADPLL+ +FPEK LN+AVAIAAMCLQEE RPL+SDVVTA
Sbjct: 285 NLVTWAQPIFREPNRFPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTA 344
Query: 353 LSFLS 357
LSF+S
Sbjct: 345 LSFMS 349
|
|
| TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1195 (425.7 bits), Expect = 1.7e-121, P = 1.7e-121
Identities = 238/360 (66%), Positives = 280/360 (77%)
Query: 1 MNCFPCFQSQKSKKANK-NYVERSLPPRDECXXXXXXXXXXXXXXXXTIHRNEGTKQDET 59
M+CFPCF S K+KK++ N + P+ + I ++EGT
Sbjct: 1 MHCFPCFSSPKNKKSSTTNETNDNNEPKPD--------DRRRAEETEEIEQSEGT----- 47
Query: 60 KNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK 119
+ + FTFRELA ATKNFRQECLLGEGGFGRVYKGTL+S GQVVAVKQLD++G+ GNK
Sbjct: 48 ---SLKIFTFRELATATKNFRQECLLGEGGFGRVYKGTLKSTGQVVAVKQLDKHGLHGNK 104
Query: 120 EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTT 179
EF EVL L L HPNLV LIGYCADGDQRLLVY+++SGGS+ DHL + P+DWTT
Sbjct: 105 EFQAEVLSLGQLDHPNLVKLIGYCADGDQRLLVYDYISGGSLQDHLHEPKADSDPMDWTT 164
Query: 180 RMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP-QGEKMN 238
RM+IA AAQGL+YLHDKANPPVIYRDLK+SNILL + PKLSDFGL KLGP G+KM
Sbjct: 165 RMQIAYAAAQGLDYLHDKANPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTGDKMM 224
Query: 239 -VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297
++SRVMGTYGY APEY R G LT+KSDVYSFGV+LLELITGRR +DTTRP DEQNL++W
Sbjct: 225 ALSSRVMGTYGYSAPEYTRGGNLTLKSDVYSFGVVLLELITGRRALDTTRPNDEQNLVSW 284
Query: 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357
AQPIFRDPKR+PDMADP+L +F E+GLN+AVAIA+MC+QEEA ARPL+SDV+ ALSFLS
Sbjct: 285 AQPIFRDPKRYPDMADPVLENKFSERGLNQAVAIASMCVQEEASARPLISDVMVALSFLS 344
|
|
| TAIR|locus:2171342 AT5G16500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
Identities = 238/360 (66%), Positives = 271/360 (75%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECXXXXXXXXXXXXXXXXTIHRNEGTKQDETK 60
MNCFPCF SQKS+ A E + D+ T R +Q K
Sbjct: 5 MNCFPCFTSQKSRNAPCTTNETN----DDNVEHDEFRPPVVATTKRTEEREPAEQQPPVK 60
Query: 61 NINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE 120
TF FRELA ATKNFRQECLLGEGGFGRVYKGTLQS GQ+VAVKQLD++G+ GNKE
Sbjct: 61 -----TFNFRELATATKNFRQECLLGEGGFGRVYKGTLQSTGQLVAVKQLDKHGLHGNKE 115
Query: 121 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTR 180
FL EVL L+ L HPNLV LIGYCADGDQRLLV+E++SGGS+ DHL + +KP+DW TR
Sbjct: 116 FLAEVLSLAKLEHPNLVKLIGYCADGDQRLLVFEYVSGGSLQDHLYEQKPGQKPMDWITR 175
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP-QGEKMNV 239
MKIA GAAQGL+YLHDK P VIYRDLK+SNILL A PKL DFGL L P G+ + +
Sbjct: 176 MKIAFGAAQGLDYLHDKVTPAVIYRDLKASNILLDAEFYPKLCDFGLHNLEPGTGDSLFL 235
Query: 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299
+SRVM TYGY APEY R +LTVKSDVYSFGV+LLELITGRR IDTT+P DEQNL+AWAQ
Sbjct: 236 SSRVMDTYGYSAPEYTRGDDLTVKSDVYSFGVVLLELITGRRAIDTTKPNDEQNLVAWAQ 295
Query: 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
PIF+DPKR+PDMADPLLRK F E+GLN+AVAI +MCLQEE ARPL+SDV+ ALSFLS S
Sbjct: 296 PIFKDPKRYPDMADPLLRKNFSERGLNQAVAITSMCLQEEPTARPLISDVMVALSFLSMS 355
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1174 (418.3 bits), Expect = 2.9e-119, P = 2.9e-119
Identities = 224/301 (74%), Positives = 257/301 (85%)
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN 118
+ N+ A+ FTFRELA ATKNFRQECL+GEGGFGRVYKG L++ QVVAVKQLDRNG+QG
Sbjct: 27 SNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQGQ 86
Query: 119 KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWT 178
+EFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYE+M GS++DHLLD+ +KPLDW
Sbjct: 87 REFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWN 146
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
TR+KIA GAA+G+EYLHD+A+PPVIYRDLKSSNILL KLSDFGLAKLGP G+ ++
Sbjct: 147 TRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLH 206
Query: 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298
V+SRVMGTYGYCAPEY R+G LT KSDVYSFGV+LLELI+GRRVIDT RP EQNL+ WA
Sbjct: 207 VSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWA 266
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
PIFRDP R+ +ADPLLR +PEK LN+A+A+AAMCL EE RPLMSDV+TALSFL
Sbjct: 267 LPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGA 326
Query: 359 S 359
S
Sbjct: 327 S 327
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1153 (410.9 bits), Expect = 4.9e-117, P = 4.9e-117
Identities = 213/307 (69%), Positives = 263/307 (85%)
Query: 54 TKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN 113
+K + +I AQTFTF ELA AT+NFR+ECL+GEGGFGRVYKG L S Q A+KQLD N
Sbjct: 48 SKSKGSDHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHN 107
Query: 114 GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKK 173
G+QGN+EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+M GS++DHL D++ K+
Sbjct: 108 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQ 167
Query: 174 PLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233
PLDW TRMKIA+GAA+GLEYLHDK PPVIYRDLK SNILL + PKLSDFGLAKLGP
Sbjct: 168 PLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPV 227
Query: 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN 293
G+K +V++RVMGTYGYCAPEYA +G+LT+KSDVYSFGV+LLE+ITGR+ ID++R EQN
Sbjct: 228 GDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQN 287
Query: 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
L+AWA+P+F+D ++F MADP+L+ Q+P +GL +A+A+AAMC+QE+ RPL++DVVTAL
Sbjct: 288 LVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTAL 347
Query: 354 SFLSNSK 360
S+L++ K
Sbjct: 348 SYLASQK 354
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1143 (407.4 bits), Expect = 5.6e-116, P = 5.6e-116
Identities = 225/365 (61%), Positives = 270/365 (73%)
Query: 1 MNCFPCFQSQKSKKANK-NYVERSLPPRDECXXXXXXXXXXXXXXXXTIHRNEGTKQ--- 56
M CF CF S +K N + + + + N G+K+
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 57 ---DETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN 113
D I A TF FRELAAAT NF + LGEGGFGRVYKG L S GQVVAVKQLDRN
Sbjct: 61 LPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRN 120
Query: 114 GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKK 173
G+QGN+EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM GS++DHL D+ K+
Sbjct: 121 GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 180
Query: 174 PLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233
LDW RMKIA+GAA+GLE+LHDKANPPVIYRD KSSNILL PKLSDFGLAKLGP
Sbjct: 181 ALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPT 240
Query: 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN 293
G+K +V++RVMGTYGYCAPEYA +G+LTVKSDVYSFGV+ LELITGR+ ID+ P EQN
Sbjct: 241 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQN 300
Query: 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
L+AWA+P+F D ++F +ADP L+ +FP + L +A+A+A+MC+QE+A RPL++DVVTAL
Sbjct: 301 LVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360
Query: 354 SFLSN 358
S+L+N
Sbjct: 361 SYLAN 365
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1130 (402.8 bits), Expect = 1.3e-114, P = 1.3e-114
Identities = 210/301 (69%), Positives = 256/301 (85%)
Query: 61 NINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE 120
NI+A FTFREL ATKNF + LGEGGFGRVYKG +++ QVVAVKQLDRNG QGN+E
Sbjct: 64 NISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNRE 123
Query: 121 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDV-NETKKPLDWTT 179
FLVEV+MLSLLHH NLVNL+GYCADGDQR+LVYE+M GS++DHLL++ KKPLDW T
Sbjct: 124 FLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDT 183
Query: 180 RMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239
RMK+A+GAA+GLEYLH+ A+PPVIYRD K+SNILL +PKLSDFGLAK+GP G + +V
Sbjct: 184 RMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHV 243
Query: 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299
++RVMGTYGYCAPEYA +G+LTVKSDVYSFGV+ LE+ITGRRVIDTT+P +EQNL+ WA
Sbjct: 244 STRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWAS 303
Query: 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
P+F+D ++F MADPLL ++P KGL +A+A+AAMCLQEEA RP+MSDVVTAL +L+ +
Sbjct: 304 PLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVT 363
Query: 360 K 360
K
Sbjct: 364 K 364
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 195/294 (66%), Positives = 239/294 (81%)
Query: 64 AQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV 123
A++FTF+ELAAAT+NFR+ LLGEGGFGRVYKG L S GQVVA+KQL+ +G+QGN+EF+V
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIV 121
Query: 124 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
EVLMLSLLHHPNLV LIGYC GDQRLLVYE+M GS++DHL D+ ++PL W TRMKI
Sbjct: 122 EVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKI 181
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
A GAA+G+EYLH ANPPVIYRDLKS+NILL PKLSDFGLAKLGP G++ +V++RV
Sbjct: 182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRV 241
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303
MGTYGYCAPEYA SG+LTVKSD+Y FGV+LLELITGR+ ID + EQNL+ W++P +
Sbjct: 242 MGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLK 301
Query: 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357
D K+F + DP LR ++P + LN A+AI AMCL EEA RP + D+V AL +L+
Sbjct: 302 DQKKFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLA 355
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SFT7 | Y3707_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6657 | 0.7129 | 0.8937 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | AT3G07070 | protein kinase family protein; protein kinase family protein; FUNCTIONS IN- protein serine/threonine kinase activity, protein kinase activity, kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- cellular_component unknown; EXPRESSED IN- male gametophyte, flower, pollen tube; EXPRESSED DURING- L mature pollen stage, M germinated pollen stage, 4 anthesis; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Serine/threonine protein kinase-related (InterPro-IPR017442), Protein k [...] (414 aa) | |||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AT3G10710 | pectinesterase family protein; pectinesterase family protein; FUNCTIONS IN- enzyme inhibitor ac [...] (561 aa) | • | 0.621 | |||||||
 | PER60 | peroxidase, putative; peroxidase, putative; FUNCTIONS IN- electron carrier activity, peroxidase [...] (331 aa) | • | 0.567 | |||||||
 | ATEXPA18 | ATEXPA18 (ARABIDOPSIS THALIANA EXPANSIN A18); Alpha-expansin 18. Naming convention from the Exp [...] (257 aa) | • | 0.537 | |||||||
 | AT1G11655 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (113 aa) | • | 0.527 | |||||||
 | XTH12 | xyloglucan-xyloglucosyl transferase, putative / xyloglucan endotransglycosylase, putative / end [...] (285 aa) | • | 0.517 | |||||||
 | AT5G05500 | pollen Ole e 1 allergen and extensin family protein; pollen Ole e 1 allergen and extensin famil [...] (183 aa) | • | 0.508 | |||||||
 | XTH26 | xyloglucan-xyloglucosyl transferase, putative / xyloglucan endotransglycosylase, putative / end [...] (292 aa) | • | 0.502 | |||||||
 | AT1G34510 | peroxidase, putative; peroxidase, putative; FUNCTIONS IN- electron carrier activity, peroxidase [...] (310 aa) | • | 0.501 | |||||||
 | MES15 | MES15 (METHYL ESTERASE 15); hydrolase; Encodes a protein predicted to act as a carboxylesterase [...] (444 aa) | • | 0.480 | |||||||
 | FLA6 | FLA6 (FASCICLIN-LIKE ARABINOGALACTAN 6); fasciclin-like arabinogalactan-protein 6 (Fla6) ; May [...] (247 aa) | • | 0.475 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 519 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-42 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-26 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-18 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd02965 | 111 | cd02965, HyaE, HyaE family; HyaE is also called Hu | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 1e-56
Identities = 78/203 (38%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPNLVNLIGYC 143
LGEGGFG VY + G+ VA+K + + E L E+ +L L+HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
D + LV E+ GGS+ D L E + L ++I +GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 204 YRDLKSSNILLGA-NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELT 261
+RDLK NILL + N KL+DFGL+KL + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYS 172
Query: 262 VKSDVYSFGVILLELITGRRVID 284
KSD++S GVIL EL + +I
Sbjct: 173 EKSDIWSLGVILYELPELKDLIR 195
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 2e-55
Identities = 81/201 (40%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
LG G FG VYK + G++VAVK L + ++ E+ +L L HPN+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
D D LV E+ GG + D+L PL KIA +GLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKL--GPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
I+RDLK NILL N K++DFGLAK ++T+ V GT Y APE G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS---SLTTFV-GTPWYMAPEVLLGGNG 175
Query: 261 -TVKSDVYSFGVILLELITGR 280
K DV+S GVIL EL+TG+
Sbjct: 176 YGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 2e-54
Identities = 87/277 (31%), Positives = 130/277 (46%), Gaps = 34/277 (12%)
Query: 85 LGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG VYKG L VAVK L + Q +EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+G C + + +V E+M GG + +L + L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRK---NRPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
I+RDL + N L+G NL K+SDFGL++ + + APE + G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRP---VDEQNLIAWAQPIFRDPKRFPDMADPLL 316
T KSDV+SFGV+L E+ T +P + + ++ + + +R P+ P P L
Sbjct: 180 FTSKSDVWSFGVLLWEIFT-----LGEQPYPGMSNEEVLEYLKNGYRLPQ--PPNCPPEL 232
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
+ C E+ RP S++V L
Sbjct: 233 YD------------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 7e-54
Identities = 74/203 (36%), Positives = 106/203 (52%), Gaps = 11/203 (5%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPNLV 137
+ LGEG FG+VY + G++VA+K + + ++ ++E L E+ +L L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
L D D+ LV E+ GG + D L + + L LEYLH K
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
+++RDLK NILL + KL+DFGLA+ GEK+ T+ V GT Y APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFV-GTPEYMAPEVLLG 170
Query: 258 GELTVKSDVYSFGVILLELITGR 280
D++S GVIL EL+TG+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 91/277 (32%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 85 LGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG VYKGTL VAVK L + Q +EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+G C + + ++V E+M GG + D+L K L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK-- 122
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
I+RDL + N L+G NL K+SDFGL++ + V + APE + G+
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRP---VDEQNLIAWAQPIFRDPKRFPDMADPLL 316
T KSDV+SFGV+L E+ T P + ++ + + +R PK
Sbjct: 181 FTSKSDVWSFGVLLWEIFT-----LGEEPYPGMSNAEVLEYLKKGYRLPK---------- 225
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
P E + C E+ RP S++V L
Sbjct: 226 ----PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 6e-51
Identities = 74/200 (37%), Positives = 106/200 (53%), Gaps = 11/200 (5%)
Query: 85 LGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNL 139
LGEG FG VYKGTL + VAVK L + + EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+G C G+ +V E+M GG + D L + L +++A A+G+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++RDL + N L+ NL K+SDFGL++ + + + APE + G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 260 LTVKSDVYSFGVILLELITG 279
T KSDV+SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 4e-49
Identities = 93/293 (31%), Positives = 133/293 (45%), Gaps = 58/293 (19%)
Query: 85 LGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLI 140
LGEG FG VYKG L+ VAVK L + + K+FL E ++ L HPN+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLD-----VNETKKPLDWTTRMKIASGAAQGLEYLH 195
G C + + LV E+M GG + D+L + K L + A A+G+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS------RVMGTYGY 249
K ++RDL + N L+G +L K+SDFGL++ + + R M
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM----- 174
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308
APE + G T KSDV+SFGV+L E+ T G A P +
Sbjct: 175 -APESLKDGIFTSKSDVWSFGVLLWEIFTLG------------------ATP-------Y 208
Query: 309 PDMAD----PLLRK----QFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
P +++ LRK PE +E + C Q + RP S++V L
Sbjct: 209 PGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVL-----MLSLLH 132
+ + LLG G FG VY + G+++AVK ++ + G+ E +E L +LS L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQ 57
Query: 133 HPNLVNLIGYC--ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ- 189
HPN+V G + + + E++SGGS+ L + L I Q
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPV---IRKYTRQI 110
Query: 190 --GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
GL YLH +++RD+K +NIL+ ++ KL+DFG AK E T V GT
Sbjct: 111 LEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRV 282
+ APE R E +D++S G ++E+ TG+
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 8e-42
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G+GGFG VYK + G+ VA+K + + ++ + E+ +L HPN+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
D+ +V EF SGGS+ D L T + L + + +GLEYLH +I+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIH 121
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
RD+K++NILL ++ + KL DFGL+ Q + ++GT + APE K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 265 DVYSFGVILLELITGR 280
D++S G+ +EL G+
Sbjct: 179 DIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 78/238 (32%), Positives = 112/238 (47%), Gaps = 22/238 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLIG 141
LG+G FG+V + G++ A+K L + + KE L E +LS ++HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 142 YCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+ A + LV E+ GG + HL E + + A+ LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFSEERARF--YAAEIVLALEYLHSLG- 113
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+IYRDLK NILL A+ KL+DFGLAK + T+ GT Y APE
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKG 169
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317
D +S GV+L E++TG+ P ++ + I +DP RFP+ P R
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK------PPFYAEDRKEIYEKILKDPLRFPEFLSPEAR 221
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 24/206 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQV-VAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
LG G FG V+ GT NG VAVK L + G + FL E ++ L H LV L C
Sbjct: 14 LGAGQFGEVWMGTW--NGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
++ + +V E+MS GS+ D L K L + +A+ A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKL-------GPQGEKMNVTSRVMGTYGYCAPEYAR 256
+RDL + NIL+G NL K++DFGLA+L +G K + + APE A
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK--------WTAPEAAN 177
Query: 257 SGELTVKSDVYSFGVILLELITGRRV 282
G T+KSDV+SFG++L E++T RV
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 27/215 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
+G+G FG V G + GQ VAVK L + FL E +++ L HPNLV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVV 69
Query: 144 ADGDQRLLVYEFMSGGSVDDHL----LDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G+ +V E+M+ GS+ D+L V ++ A +G+EYL +K
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA------QQLGFALDVCEGMEYLEEKN- 122
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAK---LGPQGEKMNVTSRVMGTYGYCAPEYAR 256
++RDL + N+L+ +L K+SDFGLAK G K+ V + APE R
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALR 172
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE 291
+ + KSDV+SFG++L E+ + RV P+ +
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-33
Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLV-EVLMLSLLHHPN 135
+ +G+G FG+VY +S+G++ +K++D + M + +E + EV +L L+HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKP------LDWTTRMKIASGAAQ 189
++ + + +V E+ GG + + + KP LDW ++ +A
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----- 115
Query: 190 GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
L+YLH + +++RD+K NI L +N KL DFG++K+ +++ V+GT Y
Sbjct: 116 -LKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYY 169
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELITGRR 281
+PE ++ KSD++S G +L EL T +
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPN 135
N++ L+G G FG VYKG G VA+KQ+ ++ K + E+ +L L HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V IG D ++ E+ GS L + + P + QGL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQGLAYLH 116
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVMGTYGYCAPEY 254
++ VI+RD+K++NIL + KL+DFG+A KL + V+GT + APE
Sbjct: 117 EQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEV 170
Query: 255 ARSGELTVKSDVYSFGVILLELITGR 280
+ SD++S G ++EL+TG
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 72/203 (35%), Positives = 110/203 (54%), Gaps = 25/203 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+GEG G VYK T ++ G+ VA+K++ + NKE ++ E+L++ HPN+V+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA------QGLEYLHDK 197
GD+ +V E+M GGS+ D ++ N RM A QGLEYLH +
Sbjct: 85 LVGDELWVVMEYMDGGSLTD-IITQNFV--------RMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
VI+RD+KS NILL + KL+DFG A+L + K N V+GT + APE +
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVIK 189
Query: 257 SGELTVKSDVYSFGVILLELITG 279
+ K D++S G++ +E+ G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVK--QLDRNGMQGNKEFLVEVLMLSLLHHPN 135
+ + +LG+G G VYK + G++ A+K +D + K+ L E+ L P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPY 60
Query: 136 LVNLIG-YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRM--KIASGAAQGLE 192
+V G + +G+ + V E+M GGS+ D L KK + IA +GL+
Sbjct: 61 VVKCYGAFYKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLD 113
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YLH K + +I+RD+K SN+L+ + + K++DFG++K+ T +GT Y +P
Sbjct: 114 YLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSP 169
Query: 253 EYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312
E + + +D++S G+ LLE G+ P + + Q I P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFL---PPGQPSFFELMQAICDGPP------ 220
Query: 313 DPLLRKQFPEKGLN-EAVAIAAMCLQEEAGARP 344
P L P + + E + CLQ++ RP
Sbjct: 221 -PSL----PAEEFSPEFRDFISACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-31
Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 23/224 (10%)
Query: 71 ELAAATKNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGM-QGNKEFLVE 124
E+ + F +E LGEG FG+VYKG L + + VA+K L N + +EF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 125 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLL------------DVNETK 172
++S L HPN+V L+G C +++E+++ G + + L+ K
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232
LD + + IA A G+EYL ++ ++RDL + N L+G L K+SDFGL++
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLEL 276
+ V S+ + + PE G+ T +SD++SFGV+L E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 70/202 (34%), Positives = 110/202 (54%), Gaps = 8/202 (3%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
+ F E LG G FG V++G L N VA+K L + + ++F EV L L H +L
Sbjct: 6 EEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
++L C+ G+ ++ E M GS+ L + L + + +A A+G+ YL +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE 122
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
+ I+RDL + NIL+G +L K++DFGLA+L E + ++S Y + APE A
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 257 SGELTVKSDVYSFGVILLELIT 278
G + KSDV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 83/271 (30%), Positives = 127/271 (46%), Gaps = 30/271 (11%)
Query: 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIG 141
++G G VY N + VA+K++D Q + + L EV +S +HPN+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIAS---GAAQGLEYLHDKA 198
GD+ LV ++SGGS LLD+ ++ P IA+ +GLEYLH
Sbjct: 67 SFVVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFG----LAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
I+RD+K+ NILLG + K++DFG LA G + K+ T +GT + APE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT--FVGTPCWMAPEV 177
Query: 255 ARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
K+D++SFG+ +EL TG P+ L + DP AD
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT-----LQNDPPSLETGAD 232
Query: 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
K++ K + + ++CLQ++ RP
Sbjct: 233 ---YKKY-SKSFRKMI---SLCLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 74/222 (33%), Positives = 110/222 (49%), Gaps = 25/222 (11%)
Query: 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSN----GQVVAVKQLDRNG-MQGNKEF 121
F R L K +Q LGEG FG+V G+ VAVK L+ +G Q +F
Sbjct: 1 FEKRHL----KFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF 53
Query: 122 LVEVLMLSLLHHPNLVNLIGYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTT 179
E+ +L L H N+V G C R L+ E++ GS+ D+L + ++
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKR 110
Query: 180 RMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239
+ +S +G++YL + I+RDL + NIL+ + K+SDFGLAK+ P+ K
Sbjct: 111 LLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPED-KDYY 166
Query: 240 TSRVMG---TYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ G + Y APE R+ + + SDV+SFGV L EL T
Sbjct: 167 YVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 2e-30
Identities = 105/374 (28%), Positives = 153/374 (40%), Gaps = 27/374 (7%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLML-SLLHH 133
++R LGEG FG VY + ++VA+K L + +KE FL E+ +L SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
PN+V L + D LV E++ GGS++D LL K PL + + I + LEY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 194 LHDKANPPVIYRDLKSSNILLGANLD-PKLSDFGLAKL----GPQGEKMNVTSRVMGTYG 248
LH K +I+RD+K NILL + KL DFGLAKL G + S +GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 249 YCAPEYARSGEL---TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305
Y APE L + SD++S G+ L EL+TG P + + + +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL------PPFEGEKNSSATSQTLKII 227
Query: 306 KRFP-DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIP 364
P L PE A + L ++ R S + + L++ K
Sbjct: 228 LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL-SHDLLAHLKLKES 286
Query: 365 DPIIPSDEDEYSEGYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERIASSRGQ 424
D D+ + S ++ L+ SN S SS
Sbjct: 287 DLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346
Query: 425 VSGNLINSKEIGPS 438
S +L+ S
Sbjct: 347 NSSSLLLSTASSKR 360
|
Length = 384 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V++G L +N VAVK L M K+FL E ++ L HP L+ L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ +V E M GS+ ++L + L + +A+ A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYARSGELTV 262
RDL + N+L+G N K++DFGLA++ + +R + + APE A ++
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 263 KSDVYSFGVILLELIT-GR 280
KSDV+SFG++L E++T GR
Sbjct: 184 KSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 68/223 (30%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQL-DRNGMQGNKEFLVEVLMLSLLHH 133
+ +LG G FG VYKG G+ VA+K L + + NKE L E +++ + H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P++V L+G C Q L+ + M G + D+ V K + + A+G+ Y
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDY---VRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
L +K +++RDL + N+L+ K++DFGLAKL EK + A E
Sbjct: 125 LEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 254 YARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLI 295
T KSDV+S+GV + EL+T G + + V+ +L+
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 65/194 (33%), Positives = 107/194 (55%), Gaps = 7/194 (3%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G +G VY+G + VAVK L + M+ +EFL E ++ + HPNLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
++ EFM+ G++ D+L + N + ++ + +A+ + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
RDL + N L+G N K++DFGL++L G+ + + APE + ++KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 265 DVYSFGVILLELIT 278
DV++FGV+L E+ T
Sbjct: 187 DVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQ-----VVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
LGEG FG+V+ G +VAVK L + K+F E +L+ H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL----------LDVNETKKPLDWTTRMKIASGAA 188
G C +GD ++V+E+M G ++ L + L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
G+ YL A+ ++RDL + N L+G +L K+ DFG+++ + V M
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ PE + T +SDV+SFGV+L E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-28
Identities = 68/197 (34%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPNLVNLIGY 142
+G+G FG VYKG L+ N +V AVK K FL E +L HPN+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
C +V E + GGS+ L + K L ++++ AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
I+RDL + N L+G N K+SDFG+++ G + APE G T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 263 KSDVYSFGVILLELITG 279
+SDV+S+G++L E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-28
Identities = 83/268 (30%), Positives = 125/268 (46%), Gaps = 34/268 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQ--LDRNGMQGN---KEFLVEVLMLSLLHHPNLVN 138
LLG G FG VY+G +G AVK+ L +G G K+ E+ +LS L HPN+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL-DWTTRMKIASGAAQGLEYLHDK 197
+G + D + E + GGS+ L +P+ TR + GLEYLHD+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY-AR 256
++RD+K +NIL+ N KL+DFG+AK Q + + G+ + APE A+
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
G + +D++S G +LE+ TG+ P + +A I R P +
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVAAVFKIGRSK------ELPPI 223
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARP 344
P+ +EA CLQ + RP
Sbjct: 224 ----PDHLSDEAKDFILKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 67/198 (33%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
LG G G V K + G+++AVK + K+ L E+ +L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ + E+M GGS+D L E + + KIA +GL YLH+K +I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMGTYGYCAPEYARSGELTV 262
+RD+K SNIL+ + KL DFG++ G+ +N + +GT Y APE + + +V
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 263 KSDVYSFGVILLELITGR 280
KSD++S G+ L+EL TGR
Sbjct: 179 KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 69/202 (34%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 84 LLGEGGFGRVYKGT-LQSNGQV--VAVKQLDRNGMQGN-KEFLVEVLMLSLLHHPNLVNL 139
LG+G FG V +G S G+V VAVK L + + +FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G ++V E GS+ D L + +T A A G+ YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESKR- 117
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS---RVMGTYGYCAPEYAR 256
I+RDL + NILL ++ K+ DFGL + PQ E V +V + +CAPE R
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 257 SGELTVKSDVYSFGVILLELIT 278
+ + SDV+ FGV L E+ T
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGMQGNK--EFLVEVLMLSLLHHPNLVNL 139
+G G FG V +G L+ G+ VA+K L + G + +FL E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G +++ E+M GS+D L E + + G A G++YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG-----YCAPEY 254
++RDL + NIL+ +NL K+SDFG L + E T G G + APE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIPIRWTAPEA 179
Query: 255 ARSGELTVKSDVYSFGVILLELIT 278
+ T SDV+SFG+++ E+++
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 71/263 (26%), Positives = 117/263 (44%), Gaps = 28/263 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGY 142
+G+G FG V+K +++ +V A+KQ+D + M +E + E +L+ L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
D + +V E+ G + H L + +PL + GL +LH K +
Sbjct: 68 FLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEYARSGELT 261
++RD+KS N+ L A + K+ D G+AK L N + ++GT Y +PE
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---NFANTIVGTPYYLSPELCEDKPYN 179
Query: 262 VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321
KSDV++ GV+L E TG+ P D N A I R FP P+
Sbjct: 180 EKSDVWALGVVLYECCTGK------HPFDANNQGALILKIIRG--VFP----PV-----S 222
Query: 322 EKGLNEAVAIAAMCLQEEAGARP 344
+ + + CL ++ RP
Sbjct: 223 QMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 80/267 (29%), Positives = 115/267 (43%), Gaps = 27/267 (10%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
F LGEG +G VYK + GQVVA+K + +E + E+ +L P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G +V E+ GSV D + T K L I +GLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDI---MKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
I+RD+K+ NILL KL+DFG++ +L K N V+GT + APE +
Sbjct: 120 ---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEVIQE 173
Query: 258 GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317
K+D++S G+ +E+ G+ P+ + IF P + P P L
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPM---------RAIFMIPNKPP----PTLS 220
Query: 318 KQFPEKGLNEAVAIAAMCLQEEAGARP 344
PEK E CL ++ RP
Sbjct: 221 D--PEKWSPEFNDFVKKCLVKDPEERP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 60/226 (26%), Positives = 94/226 (41%), Gaps = 29/226 (12%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLD-RNGMQGNKEFLV--EVLMLSLL-H 132
+F+ ++GEG F V + + A+K LD R ++ K V E +L+ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
HP ++ L D + V E+ G LL LD A+ LE
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGE----LLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL----------GPQGEKMNVTSR 242
YLH K +I+RDLK NILL ++ K++DFG AK+ ++
Sbjct: 117 YLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 243 VM--------GTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
GT Y +PE SD+++ G I+ +++TG+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 81/267 (30%), Positives = 121/267 (45%), Gaps = 30/267 (11%)
Query: 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVN 138
EC+ G+G FG VYK + QVVA+K +D + E + E+ LS P +
Sbjct: 5 LLECI-GKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G G + ++ E+ GGS D LL LD T I GLEYLH++
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLD-LLKPG----KLDETYIAFILREVLLGLEYLHEEG 118
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
I+RD+K++NILL D KL+DFG++ +L K N +GT + APE +
Sbjct: 119 ---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF---VGTPFWMAPEVIKQ 172
Query: 258 GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317
K+D++S G+ +EL G + P+ + +F PK P P L
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPM---------RVLFLIPKNNP----PSLE 219
Query: 318 KQFPEKGLNEAVAIAAMCLQEEAGARP 344
K + V ++CL ++ RP
Sbjct: 220 GNKFSKPFKDFV---SLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-26
Identities = 77/208 (37%), Positives = 116/208 (55%), Gaps = 13/208 (6%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
++ R E LG+G FG V+ GT +V A+K L + G + FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V L ++ + +V E+MS GS+ D L E K L + +A+ A G+ Y+ +
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYV-E 119
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEY 254
+ N ++RDL+++NIL+G NL K++DFGLA+L E T+R + + APE
Sbjct: 120 RMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEA 174
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRV 282
A G T+KSDV+SFG++L EL T RV
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQ--LDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
+G G FG+VY G+++AVK+ + N + KE E+ +L LL HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
++ + E+ SGG+ L ++ E + LD +GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGT----LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAK-LGPQ----GEKMNVTSRVMGTYGYCAPEYARS 257
++RD+K +NI L N KL DFG A L GE++ GT Y APE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL---AGTPAYMAPEVITG 177
Query: 258 GELTVK---SDVYSFGVILLELITGRR 281
G+ +D++S G ++LE+ TG+R
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLI-GYC 143
LG+G FG+VYK + G A K + + ++F+VE+ +LS HPN+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ +L+ EF GG++D +L E ++ L + + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIML---ELERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 204 YRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYA-----RS 257
+RDLK+ NILL + D KL+DFG+ AK +K +GT + APE +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK---RDTFIGTPYWMAPEVVACETFKD 182
Query: 258 GELTVKSDVYSFGVILLELITGR 280
K+D++S G+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 77/200 (38%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ GT N +V AVK L + G + FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ + +V E+MS GS+ D L D + L + +A+ A G+ Y+ ++ N I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYI-ERMN--YIH 125
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYARSGELTV 262
RDL+S+NIL+G L K++DFGLA+L E T+R + + APE A G T+
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 263 KSDVYSFGVILLELITGRRV 282
KSDV+SFG++L EL+T RV
Sbjct: 183 KSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 70/238 (29%), Positives = 111/238 (46%), Gaps = 17/238 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIG 141
LG+GGFG V +++ G++ A K+LD+ + +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHDKANP 200
D LV M+GG + H+ +V E P R A+ GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQRR-- 115
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
++YRDLK N+LL + + ++SD GLA G+K + R GT GY APE +
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA-GTPGYMAPEVLQGEVY 171
Query: 261 TVKSDVYSFGVILLELITGRRVI-DTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317
D ++ G L E+I GR V+++ L + +PD P +
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTLEMAVEYPDKFSPEAK 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 84 LLGEGGFGRV----YKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LG+G FG V Y + G+VVAVK+L + + ++F E+ +L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 140 IGYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
G C +R LV E++ GS+ D+L + ++ LD + AS +G+EYL K
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG-EKMNVTSRVMGTYGYCAPEYAR 256
++RDL + NIL+ + K+ DFGL K+ PQ E V + APE
Sbjct: 128 R---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 257 SGELTVKSDVYSFGVILLELIT 278
+ +V SDV+SFGV+L EL T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 41/287 (14%)
Query: 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQ-LDRNGMQGNKEF-LVEVLMLSLLHHPNLVNLI 140
++GEG +G V K ++ G++VA+K+ + + K+ L EV +L L H N+VNL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDV-NETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+ LV+E+ V+ LL++ + L Q + Y H
Sbjct: 67 EAFRRKGRLYLVFEY-----VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN- 120
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+I+RD+K NIL+ + KL DFG A+ +T Y A + R+ E
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRWYRAPE 171
Query: 260 LTVKS-------DVYSFGVILLELITGR-------------RVIDTTRPVDEQNLIAWAQ 299
L V DV++ G I+ EL+ G + P+ + ++
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231
Query: 300 -PIFRDPKRFPDMADPLLRKQFPEKGLNE-AVAIAAMCLQEEAGARP 344
P F FP+ + P ++ ++ A+ CL+ + R
Sbjct: 232 NPRFAG-VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 28/207 (13%)
Query: 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCA 144
G +GRV+ +S G + A+K + + M + L E +LS P +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 145 DGDQRL-LVYEFMSGG---SVDDHL--LDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G + L LV E++ GG S+ +++ LD + + + LEYLH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI---------YIAEIVLALEYLH--- 110
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV------TSRVMGTYGYCAP 252
+ +I+RDLK NIL+ +N KL+DFGL+K+G ++N+ R++GT Y AP
Sbjct: 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 253 EYARSGELTVKSDVYSFGVILLELITG 279
E + D +S G IL E + G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 41/215 (19%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLLHHPNLVNL 139
+GEG +G+VYK + G++VA+K++ M+ KE + E+ +L L HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 140 IGYCADGDQR--LLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMK-IASGAAQGLE 192
+ +V+E+M DH LLD E K ++K +GL+
Sbjct: 64 KEIVTSKGKGSIYMVFEYM------DHDLTGLLDSPEVKFTES---QIKCYMKQLLEGLQ 114
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YLH +++RD+K SNIL+ + KL+DFGLA+ + + T+RV+ T Y P
Sbjct: 115 YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 253 E-------YARSGELTVKSDVYSFGVILLELITGR 280
E Y + D++S G IL EL G+
Sbjct: 171 ELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
LGEG G V K L++ G + A+K + D N K+ L E+ + P +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL-QKQILRELEINKSCKSPYIVKYYGA 67
Query: 143 CADGDQRLL--VYEFMSGGSVDDHLLDVNE-----TKKPLDWTTRMKIASGAAQGLEYLH 195
D + E+ GGS+D V + +K L KIA +GL YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYLH 122
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMGTYGYCAPEY 254
+ +I+RD+K SNILL KL DFG++ GE +N + GT Y APE
Sbjct: 123 SRK---IIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174
Query: 255 ARSGELTVKSDVYSFGVILLELITGR 280
+ ++ SDV+S G+ LLE+ R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 70/208 (33%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPNLVNLIG 141
LG GGFGRV ++S + A+K + + + + E +L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 142 YCADGDQRLLVY---EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
Y D++ +Y E+ GG + L D + +T R IA EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDE---YTARFYIAC-VVLAFEYLHNRG 113
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE----- 253
+IYRDLK N+LL +N KL DFG AK G+K T GT Y APE
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILNK 167
Query: 254 -YARSGELTVKSDVYSFGVILLELITGR 280
Y S D +S G++L EL+TGR
Sbjct: 168 GYDFS------VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 70/211 (33%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 85 LGEGGFGRV-----YKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V Y + + +VAVK L + K+F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 140 IGYCADGDQRLLVYEFMSGGSVD--------DHLLDVN----ETKKPLDWTTRMKIASGA 187
G C DGD ++V+E+M G ++ D ++ V+ + K L + + IAS
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A G+ YL A+ ++RDL + N L+GANL K+ DFG+++ + V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ PE + T +SDV+SFGVIL E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 71/226 (31%), Positives = 115/226 (50%), Gaps = 23/226 (10%)
Query: 71 ELAAATKNFRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQL-DRNGMQGNKEFLVEV 125
EL + F +E LGE FG++YKG L + Q+VA+K L D N Q EF E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 126 LMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLL------DVN-------ETK 172
+++ LHHPN+V L+G +++E+++ G + + L+ DV K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232
LD + IA A G+EYL ++ +++DL + NIL+G L K+SD GL++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ V + + + PE G+ + SD++SFGV+L E+ +
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 76/208 (36%), Positives = 117/208 (56%), Gaps = 13/208 (6%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
++ R + LG+G FG V+ GT +V A+K L + G + FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V L ++ + +V EFM GS+ D L + + K L + +A+ A G+ Y+ +
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYI-E 119
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEY 254
+ N I+RDL+++NIL+G NL K++DFGLA+L E T+R + + APE
Sbjct: 120 RMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEA 174
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRV 282
A G T+KSDV+SFG++L EL+T RV
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V+ + + +VAVK L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 140 IGYCADGDQRLLVYEFMSGGSV---------DDHLLDVNETKK--PLDWTTRMKIASGAA 188
G C +G L+V+E+M G + D +L E L + IAS A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
G+ YL A+ ++RDL + N L+G L K+ DFG+++ + V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ PE + T +SD++SFGV+L E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 65/201 (32%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLIG 141
LG G FGRV + +G+ A+K L + + K+ L E +L + HP LVNL G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKA 198
D LV E++ GG + HL + P AAQ LEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFY-----AAQVVLALEYLHSLD 121
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
++YRDLK N+LL ++ K++DFG AK T + GT Y APE S
Sbjct: 122 ---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSK 173
Query: 259 ELTVKSDVYSFGVILLELITG 279
D ++ G+++ E++ G
Sbjct: 174 GYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 79/247 (31%), Positives = 126/247 (51%), Gaps = 19/247 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+G+G G VY + GQ VA+KQ++ Q KE ++ E+L++ HPN+VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
GD+ +V E+++GGS+ D V ET +D + Q LE+LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDV---VTETC--MDEGQIAAVCRECLQALEFLHSNQ---VI 137
Query: 204 YRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
+RD+KS NILLG + KL+DFG A++ P+ K S ++GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQPIFRDPKR----FPDMADPLLR 317
K D++S G++ +E++ G P+ LIA P ++P++ F D + L
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254
Query: 318 KQFPEKG 324
++G
Sbjct: 255 MDVEKRG 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 87/297 (29%), Positives = 137/297 (46%), Gaps = 53/297 (17%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQL---DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
L+GEG +G V K + GQ+VA+K+ + + M K + E+ ML L H NLVNLI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV-KKIAMREIRMLKQLRHENLVNLI 66
Query: 141 GYCADGDQRLLVYEFMSGGSVDD-----HLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+ LV+EF+ +DD + LD + +K L R G+E+ H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR---------GIEFCH 117
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEY 254
+ +I+RD+K NIL+ + KL DFG A+ L GE Y A +
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT---------DYVATRW 165
Query: 255 ARSGELTVKS-------DVYSFGVILLELITGRRVIDTTRPVDE--------QNLIAWAQ 299
R+ EL V D+++ G ++ E++TG + +D+ NLI Q
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225
Query: 300 PIF-RDP----KRFPDMADPL-LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVV 350
IF ++P R P++ + L K+FP K + +A CL+ + RP S ++
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 85 LGEGGFGRVYKGTLQS-NGQV--VAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLI 140
LG G FG V KG +G+ VAVK L + + K EFL E +++ L HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETK--KPLDWTTRMKIASGAAQGLEYLHDKA 198
G C G+ +LV E G + +L E + A A G+ YL K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESKH 115
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEYARS 257
++RDL + N+LL K+SDFG+++ LG + T+ + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 258 GELTVKSDVYSFGVILLELIT 278
G+ + KSDV+S+GV L E +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGY 142
+GEG +G VYK + G++VA+K++ K L E+ +L L+HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNET-KKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
LV+EFM D L + + ++ L + QGL + H
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG-- 118
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPE-YARSGE 259
+++RDLK N+L+ KL+DFGLA+ G T V+ T Y APE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVV-TRWYRAPELLLGDKG 175
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
+ D++S G I EL++ R + +D+ I
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 85 LGEGGFGRVYKGTLQ--SNGQV---VAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
LG+G FG VY+G + G+ VA+K + + M+ EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDV---NETKKPLDWTTRMKIASGAAQ---GLE 192
L+G + G L+V E M+ G + +L E L T K AA+ G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YL K ++RDL + N ++ +L K+ DFG+ + + + + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 253 EYARSGELTVKSDVYSFGVILLELIT 278
E + G T KSDV+SFGV+L E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQL----DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
LGEG +G VYK + G++VA+K++ + G+ L E+ +L L HPN+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKLL 64
Query: 141 GYCADGDQRLLVYEFMSGGSVD-DHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHD 196
+ LV+E+ +D LD + I S Q GL Y H
Sbjct: 65 DVIHTERKLYLVFEYCD---MDLKKYLDKRPGPLSPNL-----IKSIMYQLLRGLAYCHS 116
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEY- 254
+++RDLK NIL+ + KL+DFGLA+ G T V+ T Y APE
Sbjct: 117 HR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVV-TLWYRAPEIL 170
Query: 255 --ARSGELTVKSDVYSFGVILLELITGR 280
++ V D++S G I E+ITG+
Sbjct: 171 LGSKHYSTAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 83/285 (29%), Positives = 137/285 (48%), Gaps = 26/285 (9%)
Query: 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
++E ++ G G YKG NG VK++ D N + + E+ + L HPN+V
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNIVK 747
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
LIG C L++E++ G ++ + L + L W R KIA G A+ L +LH +
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRC 800
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+P V+ +L I++ +P L +L G + ++ + Y APE +
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHL------RLSLPG-LLCTDTKCFISSAYVAPETRETK 853
Query: 259 ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM-ADPLLR 317
++T KSD+Y FG+IL+EL+TG+ D V +++ WA+ + D DM DP +R
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHL--DMWIDPSIR 910
Query: 318 KQFP--EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360
+ + E + +A C + ARP +DV+ L S S
Sbjct: 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 29/216 (13%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLD----RNGMQG-NKEFLVEVLMLSLLH 132
+ + LGEG + VYK + G++VA+K++ + G N L E+ +L L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 133 HPNLVNLIG-YCADGDQRL-LVYEFMSGGSVD-DHLL-DVNETKKPLDWTTRMKIASGAA 188
HPN++ L+ + + LV+EFM D + ++ D + P D + M +
Sbjct: 61 HPNIIGLLDVFGHK--SNINLVFEFMET---DLEKVIKDKSIVLTPADIKSYMLMT---L 112
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTY 247
+GLEYLH +++RDLK +N+L+ ++ KL+DFGLA+ G KM T +V+ T
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM--THQVV-TR 166
Query: 248 GYCAPEY---ARSGELTVKSDVYSFGVILLELITGR 280
Y APE AR V D++S G I EL+
Sbjct: 167 WYRAPELLFGARH--YGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 35/272 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLD---RNGMQGNKEFLV---EVLMLSLLHHPNLV 137
+LG+G +G VY G L + GQ++AVKQ++ N + KE+ EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
+G C D + + EF+ GGS+ L PL K G+ YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN 121
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAK----LGPQGEKMNVTSRVMGTYGYCAPE 253
V++RD+K +N++L N KL DFG A+ +G G N+ + GT + APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQPIFRDPKRFPDMA 312
KSD++S G + E+ TG+ + + + I A + R P F
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA-- 236
Query: 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
A+ CL + RP
Sbjct: 237 --------------AAIDFVTSCLTRDQHERP 254
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 9/205 (4%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLD-RNGMQGNKEFLV-EVLMLSLLHHPN 135
+F+ LG+G +G VYK S+ Q A+K++D + Q +E V E+ +L+ ++HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+++ DG++ +V E+ G + + + +K + +I +GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
++ +++RDLKS+NILL AN K+ D G++K+ K N+ +GT Y APE
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 256 RSGELTVKSDVYSFGVILLELITGR 280
+ + KSD++S G +L E+ T
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 59/199 (29%), Positives = 85/199 (42%), Gaps = 13/199 (6%)
Query: 86 GEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
G+G FG+V + ++ A+K +++ + L E +L L+HP LVNL
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
D + LV + + GG + HL K LEYLH K +
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSKG---I 121
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
I+RD+K NILL ++DF +A TS GT GY APE +V
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQGYSV 178
Query: 263 KSDVYSFGVILLELITGRR 281
D +S GV E + G+R
Sbjct: 179 AVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 85 LGEGGFGRV----YKGTLQSNGQVVAVKQLDR-NGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V Y G++VAVK L R G Q + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 140 IGYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
G C++ + L+ E++ GS+ D+L K L+ + A +G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK-MNVTSRVMGTYGYCAPEYAR 256
I+RDL + N+LL + K+ DFGLAK P+G + V + A E +
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 257 SGELTVKSDVYSFGVILLELIT 278
+ + SDV+SFGV L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 2e-23
Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 25/233 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+G+G G V+ + GQ VA+KQ++ Q KE ++ E+L++ L +PN+VN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
GD+ +V E+++GGS+ D + T+ +D + Q LE+LH AN VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLH--AN-QVI 137
Query: 204 YRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
+RD+KS N+LLG + KL+DFG A++ P+ K S ++GT + APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-----------AQPIFRD 304
K D++S G++ +E++ G P+ LIA PIFRD
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 3e-23
Identities = 72/218 (33%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 84 LLGEGGFGRVYKGTLQ------SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNL 136
LG G FG VY+GT S VAVK L + Q KEFL E ++S +HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKP---LDWTTRMKIASGAAQGLEY 193
V L+G C + + ++ E M GG + +L D + L + I A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDP-----KLSDFGLAK-------LGPQGE-KMNVT 240
L I+RDL + N L+ K+ DFGLA+ +GE + V
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV- 177
Query: 241 SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
R M APE G+ T +SDV+SFGV++ E++T
Sbjct: 178 -RWM------APESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-23
Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ G + VA+K L + M + FL E ++ L HP LV L
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ ++ E+M GS+ D L K ++ + +A+ A+G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIERKN---YIH 125
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYARSGELTV 262
RDL+++NIL+ L K++DFGLA+L E T+R + + APE G T+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 263 KSDVYSFGVILLELITGRRV 282
KSDV+SFG++L E++T R+
Sbjct: 183 KSDVWSFGILLTEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 8/202 (3%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLV-EVLMLSLLHHPNLVNLIGY 142
+G+G FG V K +S+G+++ K++D M + K+ LV EV +L L HPN+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 143 CADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
D + L V E+ GG + + + +K ++ +I + L H++++P
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 201 P--VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
V++RDLK +NI L AN + KL DFGLAK+ +GT Y +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM 185
Query: 259 ELTVKSDVYSFGVILLELITGR 280
KSD++S G ++ EL
Sbjct: 186 SYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 83 CLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGN-KEFLVEVLMLSLL-HHPN 135
LGEG FG+V K + VAVK L + + + + + E+ M+ ++ H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHL------------LDVNETKKPLDWTTRMKI 183
++NL+G C +V E+ + G++ D L D ++ L +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
A A+G+E+L K I+RDL + N+L+ + K++DFGLA+ + T+
Sbjct: 138 AYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ APE T +SDV+SFGV+L E+ T
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKE---FLVEVLMLSLLH 132
N+R+ LLG+G FGRVY G+ +AVKQ+ D + + KE E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 133 HPNLVNLIGYCADGDQRLLVY-EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
H +V G C D+ L ++ E+M GGSV D L + L T K +G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGV 117
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT--SRVMGTYGY 249
EYLH +++RD+K +NIL + + KL DFG +K Q + T V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR-LQTICSSGTGMKSVTGTPYW 173
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELIT 278
+PE K+DV+S G ++E++T
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 67/204 (32%), Positives = 111/204 (54%), Gaps = 17/204 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQV---VAVKQLDR-NGMQGNKEFLVEVLMLSLLHHPNLVNL 139
++G+G FG VY GTL + AVK L+R ++ ++FL E +++ HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 140 IGYCADGD-QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASG--AAQGLEYLHD 196
+G C + L+V +M G + + + +ET P T + I G A+G+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIR--SETHNP---TVKDLIGFGLQVAKGMEYL-- 114
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEY 254
A+ ++RDL + N +L + K++DFGLA+ E +V + + A E
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 255 ARSGELTVKSDVYSFGVILLELIT 278
++ + T KSDV+SFGV+L EL+T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 69/198 (34%), Positives = 100/198 (50%), Gaps = 19/198 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLIG 141
+G G FG VY +VVA+K++ +G Q N+++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
LV E+ G + D +L+V+ KKPL I GA QGL YLH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASD--ILEVH--KKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS---G 258
I+RD+K+ NILL KL+DFG A L ++ + +GT + APE + G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVILAMDEG 189
Query: 259 ELTVKSDVYSFGVILLEL 276
+ K DV+S G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 15/227 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+G+G G VY + GQ VA++Q++ Q KE ++ E+L++ +PN+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
GD+ +V E+++GGS+ D + T+ +D + Q LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ---VI 138
Query: 204 YRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
+RD+KS NILLG + KL+DFG A++ P+ K S ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQPIFRDPKRF 308
K D++S G++ +E+I G P+ LIA P ++P++
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 72/227 (31%), Positives = 119/227 (52%), Gaps = 15/227 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+G+G G VY + GQ VA+KQ++ Q KE ++ E+L++ +PN+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
GD+ +V E+++GGS+ D + T+ +D + Q L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSNQ---VI 137
Query: 204 YRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
+RD+KS NILLG + KL+DFG A++ P+ K S ++GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQPIFRDPKRF 308
K D++S G++ +E++ G P+ LIA P ++P+R
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 70/193 (36%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIGY 142
LLG+G FG V+KGTL+ V AVK + Q K +FL E +L HPN+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
C +V E + GG D L + + K L +K A AA G+ YL K
Sbjct: 61 CTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
I+RDL + N L+G N K+SDFG+++ G + + + + APE G +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 263 KSDVYSFGVILLE 275
+SDV+S+G++L E
Sbjct: 174 ESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 63/196 (32%), Positives = 95/196 (48%), Gaps = 13/196 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G G +G VYK + G++VA+K + + E+ ML HPN+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
D+ +V E+ GGS+ D T+ PL + +GL YLH+ I+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIY---QVTRGPLSELQIAYVCRETLKGLAYLHETG---KIH 124
Query: 205 RDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYA---RSGEL 260
RD+K +NILL + D KL+DFG+ A+L K +GT + APE A R G
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIGTPYWMAPEVAAVERKGGY 181
Query: 261 TVKSDVYSFGVILLEL 276
K D+++ G+ +EL
Sbjct: 182 DGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 70/215 (32%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLML-SLLHHPNLVNLIG- 141
++GEG +G+VYK + GQ+VA+K +D + +E E +L +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 142 -----YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK------IASGAAQG 190
+ DQ LV E GGSV D + K R+K I +G
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRG 125
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGY 249
L YLH+ VI+RD+K NILL N + KL DFG+ A+L + N +GT +
Sbjct: 126 LAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT---FIGTPYW 179
Query: 250 CAPE-----YARSGELTVKSDVYSFGVILLELITG 279
APE +SDV+S G+ +EL G
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-22
Identities = 66/197 (33%), Positives = 107/197 (54%), Gaps = 16/197 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+GEG FG V +G + GQ VAVK + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ +V E MS G++ + L + ++ + A+G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSV--IQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
RDL + NIL+ + K+SDFGLA++G G S++ + APE + + + KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPEALKHKKFSSKS 178
Query: 265 DVYSFGVILLELIT-GR 280
DV+S+GV+L E+ + GR
Sbjct: 179 DVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
LG G FG VY+G + VAVK L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL-LDVNETKKPLDWTTR--MKIASGAAQGLEYLH 195
LIG + R ++ E M+GG + L + ++P T + + A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 196 DKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
+ I+RD+ + N LL G K++DFG+A+ + R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 253 EYARSGELTVKSDVYSFGVILLEL 276
E G T K+DV+SFGV+L E+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 69/215 (32%), Positives = 116/215 (53%), Gaps = 26/215 (12%)
Query: 82 ECLLGEGGFGRVYKGTLQSNGQVV--AVKQLDRNGMQGN-KEFLVEVLMLSLL-HHPNLV 137
E ++GEG FG+V + ++ +G + A+K L + + ++F E+ +L L HHPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHL-----LDVNE-------TKKPLDWTTRMKIAS 185
NL+G C + + E+ G++ D L L+ + T L ++ AS
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMG 245
A G++YL +K I+RDL + N+L+G NL K++DFGL++ GE++ V + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV-KKTMG 178
Query: 246 TYG--YCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ A E T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 49/286 (17%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQ--LDRNGMQGN--KEFLVEVL-----MLSLLHHP 134
L+G G FG VY G S+G+++AVKQ L K +++ L +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
N+V +G D D + E++ GGSV L + ++ L +I +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG------ 248
H++ +I+RD+K +NIL+ K+SDFG++K K+ S T G
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISK------KLEANSLSTKTNGARPSLQ 173
Query: 249 ----YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304
+ APE + T K+D++S G +++E++TG P + + Q IF+
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG------KHPFPDCTQL---QAIFK- 223
Query: 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVV 350
+ P +EA+ + + RP ++++
Sbjct: 224 -------IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G G FG V+ G +V A+K + R G ++F+ E ++ L HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ LV+EFM G + D+L + T + + +G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKL-------GPQGEKMNVTSRVMGTYGYCAPEYARS 257
RDL + N L+G N K+SDFG+ + G K V + +PE
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WSSPEVFSF 175
Query: 258 GELTVKSDVYSFGVILLELIT 278
+ + KSDV+SFGV++ E+ +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 26/213 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNG--QVVAVKQLDRNGMQGN-KEFLVEVLMLSLL-HHPNLVNL 139
++GEG FG+V K ++ +G A+K++ + + ++F E+ +L L HHPN++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHL-----LDVNE-------TKKPLDWTTRMKIASGA 187
+G C L E+ G++ D L L+ + T L + A+
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A+G++YL K I+RDL + NIL+G N K++DFGL++ G+++ V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMGRL 173
Query: 248 G--YCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ A E T SDV+S+GV+L E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 84/303 (27%), Positives = 137/303 (45%), Gaps = 45/303 (14%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQV----------------VAVKQLDRNGMQGNK-EF 121
F+++ LGEG FG V+ + + + VAVK L + + + +F
Sbjct: 9 FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66
Query: 122 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDD-----HLLDVNETKKPLD 176
L EV +LS L PN++ L+G C D D ++ E+M G ++ HL D E
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 177 ----------WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226
+++ + +A A G++YL ++ ++RDL + N L+G NL K++DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTT 286
+++ G+ + R + + A E G+ T SDV++FGV L E++ +
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 287 RPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM 346
DEQ +I A FRD R + P Q GL E + C + RP
Sbjct: 244 ELTDEQ-VIENAGEFFRDQGRQVYLFRPPPCPQ----GLYE---LMLQCWSRDCRERPSF 295
Query: 347 SDV 349
SD+
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ G + V A+K + R G +F+ E ++ L HPNLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+V E+M+ G + ++L E K L + + S + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKL-------GPQGEKMNVTSRVMGTYGYCAPEYARS 257
RDL + N L+G + K+SDFGLA+ QG K V + PE
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK--------WAPPEVFDY 175
Query: 258 GELTVKSDVYSFGVILLELITG 279
+ KSDV+SFGV++ E+ +
Sbjct: 176 SRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 5e-21
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 85 LGEGGFGRV-----YKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V Y + + +VAVK L K+F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHL-------LDVNETKKPLDWTTR--MKIASGAAQG 190
G C +GD ++V+E+M G ++ L + + E +P + T + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
+ YL A+ ++RDL + N L+G NL K+ DFG+++ + V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 251 APEYARSGELTVKSDVYSFGVILLELIT 278
PE + T +SDV+S GV+L E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 53/231 (22%)
Query: 85 LGEGGFGRVYK----GTLQSNGQ-VVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
+G+G FGRV++ G L +VAVK L + +F E +++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVN------------------ETKKPLDWTTR 180
L+G CA G L++E+M+ G +++ L + PL T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240
+ IA A G+ YL ++ ++RDL + N L+G N+ K++DFGL
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGL------------- 176
Query: 241 SRVMGTYGYC-------------APEYARSGELTVKSDVYSFGVILLELIT 278
SR + + Y PE T +SDV+++GV+L E+ +
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 7e-21
Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 36/266 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ G +N VAVK L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMG-YYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETK----KPLDWTTRMKIASGAAQGLEYLHDKANP 200
+ ++ E+M+ GS+ D L K K +D++ ++ A+G+ Y+ K
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAYIERKN-- 123
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYARSG 258
I+RDL+++N+L+ +L K++DFGLA++ E T+R + + APE G
Sbjct: 124 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFG 179
Query: 259 ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318
T+KSDV+SFG++L E++T ++ ++++ Q +R P+
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGM--SNSDVMSALQRGYRMPR------------ 225
Query: 319 QFPEKGLNEAVAIAAMCLQEEAGARP 344
E +E I C +E+A RP
Sbjct: 226 --MENCPDELYDIMKTCWKEKAEERP 249
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQL---------DRNGMQGNKEFL-VEVLMLSLLHH 133
L+G+G +GRVY + G+++AVKQ+ + + + L E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
N+V +G+ + + E++ GGS+ L T + +GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
LH K +++RDLK+ N+L+ A+ K+SDFG++K + + G+ + APE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 254 YARSGE--LTVKSDVYSFGVILLELITGRR 281
S + K D++S G ++LE+ GRR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 34/283 (12%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK---EFLVEVLMLSLLH 132
NF+ E +G+G F VYK +G+VVA+K++ M K + L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD----WTTRMKIASGAA 188
HPN++ + + ++ +V E G + + + K+ + W +++ S
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS--- 117
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
LE++H K +++RD+K +N+ + A KL D GL + + S V GT
Sbjct: 118 -ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLV-GTPY 171
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV--DEQNLIAWAQPIFRDPK 306
Y +PE KSD++S G +L E+ + P D+ NL + + I +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------SPFYGDKMNLYSLCKKI--EKC 223
Query: 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
+P PL + E+ L + V + C+ + RP +S V
Sbjct: 224 DYP----PLPADHYSEE-LRDLV---SRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 37/283 (13%)
Query: 82 ECLLGEGGFGRVYKGTLQSNG---QVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNL 136
E ++G G FG V +G L+ G VA+K L ++G + ++FL E ++ HPN+
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
++L G +++ EFM G++D L N+ + + + + G A G++YL +
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDS-FLRQNDGQFTV--IQLVGMLRGIAAGMKYLSE 124
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYG--YCAPE 253
++RDL + NIL+ +NL K+SDFGL++ L TS + G + APE
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRP---VDEQNLIAWAQPIFRDPKRFPD 310
+ T SDV+S+G+++ E+++ RP + Q++I + +R P P
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVINAIEQDYRLP---PP 233
Query: 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
M P Q + C Q++ ARP +V+ L
Sbjct: 234 MDCPTALHQ-----------LMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 72/198 (36%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPNLVNLIG 141
+G G FG VY T +VVAVK++ +G Q N ++ + EV L L HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
LV E+ G + D LL+V+ KKPL I GA QGL YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASD--LLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS---G 258
+I+RD+K+ NILL KL+DFG A K + + +GT + APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 259 ELTVKSDVYSFGVILLEL 276
+ K DV+S G+ +EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG+G FG+VYK + G + A K +D + ++++VE+ +L+ HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ ++ EF +GG+VD +L E ++PL + + L YLH+ +I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHENK---IIH 126
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY-----ARSGE 259
RDLK+ NIL + D KL+DFG++ + +GT + APE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 260 LTVKSDVYSFGVILLEL 276
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 8/199 (4%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLIG 141
LG+GGFG V +++ G++ A K+L++ ++ K + +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
LV M+GG + H+ +V+E + GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELT 261
+IYRDLK N+LL + + ++SD GLA G+ + T GT G+ APE + E
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYD 175
Query: 262 VKSDVYSFGVILLELITGR 280
D ++ GV L E+I R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 46/265 (17%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLIGY 142
+GEG G V+K + G+ VA+K++ ++G + L E+ L HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDV-NETKKPLDWTTRMKIASGAAQ---GLEYLHDKA 198
G +LV E+M L +V + ++PL ++ S G+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPL---PEAQVKSYMRMLLKGVAYMHANG 119
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY---A 255
+++RDLK +N+L+ A+ K++DFGLA+L + E + +V T Y APE A
Sbjct: 120 ---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGA 175
Query: 256 RSGELTVKSDVYSFGVILLELITGR-------------RVIDTTRPVDEQNLIAWAQPIF 302
R + V D+++ G I EL+ G V T + N W P
Sbjct: 176 RKYDPGV--DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT---LGTPNEETW--PGL 228
Query: 303 RD-PK----RFPDMADPLLRKQFPE 322
P FP+ L + FP+
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPD 253
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
NF + +GEG G V T +S G+ VAVK++D Q + EV+++ HPN+V
Sbjct: 23 NFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
+ GD+ +V EF+ GG++ D + T ++ + + L +LH +
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
VI+RD+KS +ILL ++ KLSDFG +++ ++GT + APE
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 258 GELTVKSDVYSFGVILLELITG 279
+ D++S G++++E++ G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 71/234 (30%), Positives = 116/234 (49%), Gaps = 39/234 (16%)
Query: 71 ELAAATKNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQL-DRNGMQGNKEFLVE 124
E+ +T F +E LGE FG+VYKG L Q VA+K L D+ +EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 125 VLMLSLLHHPNLVNLIG-------------YCADGDQRLLVYEFM-------SGGSVDDH 164
+M S L HPN+V L+G YC+ D ++EF+ GS DD
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD----LHEFLVMRSPHSDVGSTDDD 114
Query: 165 LLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSD 224
V T +P D+ + I + A G+E+L ++ V+++DL + N+L+ L+ K+SD
Sbjct: 115 -KTVKSTLEPADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISD 167
Query: 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
GL + + + + + +PE G+ ++ SD++S+GV+L E+ +
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIG 141
LG+GGFG V +++ G++ A K+LD+ ++ G K L+E +L ++ P +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 142 YCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
Y + L LV M+GG + H+ +V E + L+ + ++ G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
++YRD+K N+LL + +LSD GLA G+ +T R GT GY APE +
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA-GTNGYMAPEILKEEPY 171
Query: 261 TVKSDVYSFGVILLELITGR 280
+ D ++ G + E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 81 QECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNL 136
++ ++G G FG V++G L+ G+ VA+K L + + +FL E ++ H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ L G +++ E+M G++D +L D + ++ G A G++YL D
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD 125
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEYA 255
++RDL + NIL+ +NL+ K+SDFGL++ L E TS + APE
Sbjct: 126 MN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 256 RSGELTVKSDVYSFGVILLELIT-GRR 281
+ T SDV+SFG+++ E+++ G R
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM---LSLLHH--PNLVN 138
+G G G+VYK + G V+AVKQ+ R G NKE +LM + L H P +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
GY + E MS + D LL + P+ K+ + L YL +K
Sbjct: 79 CYGYFITDSDVFICMELMS--TCLDKLL--KRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY---- 254
VI+RD+K SNILL A+ + KL DFG++ G + +R G Y APE
Sbjct: 135 G--VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDSK-AKTRSAGCAAYMAPERIDPP 189
Query: 255 ARSGELTVKSDVYSFGVILLELITGR 280
+ + +++DV+S G+ L+EL TG+
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 8e-20
Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 18/211 (8%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQV----VAVKQL-DRNGMQGNKEFLVEVLMLSL 130
R+ LLG G FG V+KG G VA+K + DR+G Q +E +L +
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 131 LHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKP---LDWTTRMKIASGA 187
L H +V L+G C G LV + GS+ DH+ ++ P L+W ++
Sbjct: 66 LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------ 118
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A+G+ YL + +++R+L + NILL ++ +++DFG+A L +K S
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ A E G T +SDV+S+GV + E+++
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-20
Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 19/194 (9%)
Query: 102 GQVVAVK---QLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-VYEFMS 157
G VA+K F E + + L+HPN+V L+ L V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN 217
G ++ + L + P T R+ Q L+ L N +++RDLK NI++
Sbjct: 63 GRTLREVL--AADGALPAGETGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 218 LD---PKLSDFGLAKLGPQGEKMNV-----TSRVMGTYGYCAPEYARSGELTVKSDVYSF 269
K+ DFG+ L P +V T+ V+GT YCAPE R +T SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 270 GVILLELITGRRVI 283
G+I LE +TG+RV+
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 62/199 (31%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIG-Y 142
LG G G V K G V+A K + K+ L E+ ++ P +V+ G +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
+ + + EFM GS+D + + P+ KIA +GL YL++ +
Sbjct: 73 LNENNI-CMCMEFMDCGSLDR----IYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMGTYGYCAPEYARSGELT 261
++RD+K SNIL+ + KL DFG++ GE +N + +GT Y +PE + G+ T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYT 180
Query: 262 VKSDVYSFGVILLELITGR 280
VKSDV+S G+ ++EL G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 77/266 (28%), Positives = 120/266 (45%), Gaps = 24/266 (9%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLL-HHPNLVNL 139
+LG+G FG+V+ L+ Q A+K L ++ + + + +VE +LSL HP L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+ V E+++GG + H+ ++ D A+ GL++LH K
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++YRDLK NILL + K++DFG+ K G+ T GT Y APE +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL---IAWAQPIFRDPKRFPDMADPLL 316
D +SFGV+L E++ G+ DE+ L I P + P+ A +L
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEELFQSIRMDNPCY--PRWLTREAKDIL 227
Query: 317 RKQF---PEKGLNEAVAIAAMCLQEE 339
K F PE+ L I E
Sbjct: 228 VKLFVREPERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 93/296 (31%), Positives = 137/296 (46%), Gaps = 38/296 (12%)
Query: 63 NAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFL 122
N+ L T + +G+G +G+VYK T + +G + AVK LD ++E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIE 66
Query: 123 VEVLML-SLLHHPNLVNLIG--YCAD---GDQRLLVYEFMSGGSVDDHLLDVNETKKPLD 176
E +L SL +HPN+V G Y AD G Q LV E +GGSV + + + + LD
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126
Query: 177 WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGE 235
I GA GL++LH N +I+RD+K +NILL KL DFG+ A+L
Sbjct: 127 EAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183
Query: 236 KMNVTSRVMGTYGYCAPE-------YARSGELTVKSDVYSFGVILLELITGRRVIDTTRP 288
+ N + +GT + APE Y S + + DV+S G+ +EL G + P
Sbjct: 184 RRNTS---VGTPFWMAPEVIACEQQYDYSYD--ARCDVWSLGITAIELGDGDPPLFDMHP 238
Query: 289 VDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
V + +F+ P+ P P L PEK + CL ++ ARP
Sbjct: 239 V---------KTLFKIPRNPP----PTLLH--PEKWCRSFNHFISQCLIKDFEARP 279
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 70/198 (35%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPNLVNLIG 141
+G G FG VY N +VVA+K++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
LV E+ G + D LL+V+ KKPL + GA QGL YLH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASD--LLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS---G 258
+I+RD+K+ NILL KL DFG A + M + +GT + APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 259 ELTVKSDVYSFGVILLEL 276
+ K DV+S G+ +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVN 138
+LGEG FG V +G L + VAVK + + + +EFL E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 139 LIGYCADGDQR------LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRM--KIASGAAQG 190
LIG C + +++ FM G + LL P + K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE--------KMNVTSR 242
+EYL +N I+RDL + N +L ++ ++DFGL+K G+ KM V
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 243 VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ A E T KSDV++FGV + E+ T
Sbjct: 181 ------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 73/234 (31%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM-----LSLL-HHPNLV 137
+LG+G FG+V L+ ++ AVK L ++ + + + VE M L+L HP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 138 NLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLH 195
L C RL V E+++GG + H+ +P R + A+ GL++LH
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLH 113
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
++ +IYRDLK N+LL + K++DFG+ K G G TS GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEIL 168
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
D ++ GV+L E++ G+ + DE L Q I D R+P
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEG---DDEDELF---QSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 62/193 (32%), Positives = 93/193 (48%), Gaps = 9/193 (4%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLIGY 142
+G G FG V+ G L+++ VAVK R + + +FL E +L HPN+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
C +V E + GG D L + L +++ AA G+EYL K
Sbjct: 62 CTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
I+RDL + N L+ K+SDFG+++ G + + APE G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 263 KSDVYSFGVILLE 275
+SDV+SFG++L E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLL-HHPNLVNL 139
+LG+G FG+V L+ G+ AVK L ++ + + + +VE +L+L +P L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+ V EF++GG + H+ D K D A+ GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+IYRDLK N++L + K++DFG+ K G+ N S GT Y APE + +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLK 172
Query: 260 LTVKSDVYSFGVILLELITGR 280
T D +SFGV+L E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 78/269 (28%), Positives = 123/269 (45%), Gaps = 32/269 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+G+G FG VYKG +VVA+K +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
G + ++ E++ GGS D L PL+ T I +GL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHSERK---I 123
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK 263
+RD+K++N+LL D KL+DFG+A G + + +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 264 SDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQF--P 321
+D++S G+ +EL G P+ + +F PK P P L Q+ P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPM---------RVLFLIPKNSP----PTLEGQYSKP 228
Query: 322 EKGLNEAVAIAAMCLQEEAGARPLMSDVV 350
K EA CL ++ RP +++
Sbjct: 229 FKEFVEA------CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLH-HPNLVNL 139
+LG+G FG+V L+ +G++ AVK L ++ + + + + E +LSL HP L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 140 IGYCADGDQRLL-VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
C RL V EF++GG + H+ + + D A+ L +LHDK
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+IYRDLK N+LL KL+DFG+ K G K TS GT Y APE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEM 171
Query: 259 ELTVKSDVYSFGVILLELITG 279
D ++ GV+L E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 77/278 (27%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+G+G FG V+KG +VVA+K +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ ++ E++ GGS D L PLD T I +GL+YLH + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSEKK---I 123
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK 263
+RD+K++N+LL + + KL+DFG+A G + + +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 264 SDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEK 323
+D++S G+ +EL G P+ + +F PK P P L + K
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPM---------KVLFLIPKNNP----PTLEGNY-SK 227
Query: 324 GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKE 361
L E V CL +E RP +++ + +K+
Sbjct: 228 PLKEFV---EACLNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-19
Identities = 74/234 (31%), Positives = 111/234 (47%), Gaps = 39/234 (16%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLV----EVLMLSLLHHPNLVNL 139
+GEG +G+VYK + G++VA+K++ + KE F + E+ +L L+H N+VNL
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 140 IGYCADGDQRL----------LVYEFMSG---GSVDDHLLDVNETKKPLDWTTRMKIASG 186
D L LV+E+M G ++ L+ +E I S
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH----------IKSF 121
Query: 187 AAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
Q GL Y H K ++RD+K SNILL KL+DFGLA+L E T++V
Sbjct: 122 MKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 244 MGTYGYCAPEYARSGELTVKS-DVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296
+ T Y PE E + DV+S G IL EL T + + + + + LI+
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 58/198 (29%), Positives = 105/198 (53%), Gaps = 15/198 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIG-YC 143
LG+G FG+VYK + G + A K ++ + ++++VE+ +L+ +HP +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
DG +++ EF GG+VD +L+++ I + L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSMK---II 132
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA-----RSG 258
+RDLK+ N+LL + D KL+DFG++ + + +GT + APE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 259 ELTVKSDVYSFGVILLEL 276
K+D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 66/200 (33%), Positives = 110/200 (55%), Gaps = 13/200 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ T + +V AVK + + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ ++ EFM+ GS+ D L +K+PL + ++ A+G+ ++ + I+
Sbjct: 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYARSGELTV 262
RDL+++NIL+ A+L K++DFGLA++ E T+R + + APE G T+
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 182
Query: 263 KSDVYSFGVILLELITGRRV 282
KSDV+SFG++L+E++T R+
Sbjct: 183 KSDVWSFGILLMEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 38/288 (13%)
Query: 84 LLGEGGFGRVYKGTLQSNGQ-VVAVKQLD-------RNGMQGNKEFLVEVLMLSL----L 131
LG G FG VYK ++NGQ ++A+K+++ ++ + +K V +++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
HPN+V + D+ +V + + G + +H + E K+ I L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
YLH + +++RDL +NI+LG + ++DFGLAK + + +TS V+GT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTS-VVGTILYSC 181
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311
PE ++ K+DV++FG IL ++ T P N+++ A I +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVE------AV 229
Query: 312 ADPLLRKQFPEKGLNEAVA-IAAMCLQEEAGARPLMSDVVTALSFLSN 358
+PL PE +E V + CL +A ARP D++ + +S+
Sbjct: 230 YEPL-----PEGMYSEDVTDVITSCLTPDAEARP---DIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 43/277 (15%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLD--RNGMQGNKEFLVEVL-----MLSLLHHPNL 136
LG G F Y+ G ++AVKQ+ RN +E +VE L +++ L+HP++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 137 VNLIG-YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+ ++G C D L V E+M+GGSV L + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLH 120
Query: 196 DKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLA-KLGPQGEKMN-VTSRVMGTYGYCAP 252
+ +I+RD+K +N+L+ + +++DFG A +L +G +++GT + AP
Sbjct: 121 ENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 253 EYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR-----DPKR 307
E R + DV+S G +++E+ T + P + + IF+
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK------PPWNAEKHSNHLALIFKIASATTAPS 231
Query: 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
P+ P LR + CL+ + RP
Sbjct: 232 IPEHLSPGLRD------------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 6e-19
Identities = 65/214 (30%), Positives = 114/214 (53%), Gaps = 25/214 (11%)
Query: 85 LGEGGFGR--VYKGTLQSNGQVVAVKQLD--RNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
LG+G FG +Y+ T + +V K+++ R + ++ L E+++LSLL HPN++
Sbjct: 8 LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRM------KIASGAAQGLEYL 194
+ D + L+ E+ +GG++ D + K L + M +I S + Y+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI---VRQKGQL-FEEEMVLWYLFQIVSAVS----YI 117
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H KA +++RD+K+ NI L KL DFG++K+ G + ++ V+GT Y +PE
Sbjct: 118 H-KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPEL 172
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRP 288
+ + KSD+++ G +L EL+T +R D T P
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPN 135
FRQ +LG+GGFG V +++ G++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V+L D LV M+GG + H+ + E + + A+ GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+ ++YRDLK NILL + ++SD GLA P+G+ + RV GT GY APE
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TIKGRV-GTVGYMAPEVV 173
Query: 256 RSGELTVKSDVYSFGVILLELITGR 280
++ T D ++ G +L E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 15/223 (6%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNL 136
NF+Q LGEG + VYKG ++ G++VA+K++ + +G + E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHL---LDVNETKKPLDWTTRMKIASGAAQGLEY 193
V L ++ +LV+E+M D L +D + + LD T +G+ +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-----DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
H+ V++RDLK N+L+ + KL+DFGLA+ G +N S + T Y AP+
Sbjct: 116 CHENR---VLHRDLKPQNLLINKRGELKLADFGLAR--AFGIPVNTFSNEVVTLWYRAPD 170
Query: 254 YAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
S + D++S G I+ E+ITGR + T D+ I
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGMQGNK-EFLVEVLMLSLLHH 133
+ E ++G G FG V G L+ G+ VA+K L + + +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIAS---GAAQG 190
PN+++L G ++V E+M GS+D L +K T +++ G A G
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLRGIASG 118
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGY 249
++YL D ++RDL + NIL+ +NL K+SDFGL++ L E T +
Sbjct: 119 MKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308
APE + T SDV+S+G+++ E+++ G R + Q++I + +R P
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER---PYWEMSNQDVIKAIEEGYRLP--- 229
Query: 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356
M P Q + C Q++ RP +V+ L L
Sbjct: 230 APMDCPAALHQ-----------LMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 29/247 (11%)
Query: 85 LGEGGFGRVY------------KGTLQSNGQ--VVAVKQL--DRNGMQGNKEFLVEVLML 128
LGEG FG V+ +G + +GQ +VAVK L D N +FL E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-DFLKEIKIM 71
Query: 129 SLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL--------LDVNETKKPLDWTTR 180
S L +PN++ L+G C D ++ E+M G ++ L +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240
+ +A A G++YL A+ ++RDL + N L+G + K++DFG+++ G+ +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 241 SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300
R + + A E G+ T SDV++FGV L E+ T + + DEQ +I
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIENTGE 247
Query: 301 IFRDPKR 307
FR+ R
Sbjct: 248 FFRNQGR 254
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNG--QVVAVKQLDRNGMQGN-KEFLVEVLMLSLL-HHPNLVNL 139
++GEG FG+V K ++ +G A+K++ + + ++F E+ +L L HHPN++NL
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLD------------VNETKKPLDWTTRMKIASGA 187
+G C L E+ G++ D L N T L + A+
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A+G++YL K I+RDL + NIL+G N K++DFGL++ G+++ V + MG
Sbjct: 134 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMGRL 185
Query: 248 G--YCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ A E T SDV+S+GV+L E+++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+GEG +G V+K + GQ+VA+K+ + K L E+ ML L HPNLVNLI
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKP--LDWTTRMKIASGAAQGLEYLHDKA 198
+ LV+E+ D +L+ E K P + KI Q + + H K
Sbjct: 67 EVFRRKRKLHLVFEY-----CDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCH-KH 119
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKL--GPQGEKMNVTSRVMGTYGYCAPEYAR 256
N I+RD+K NIL+ KL DFG A++ GP + + Y A + R
Sbjct: 120 N--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD----------YVATRWYR 167
Query: 257 SGELTVKS-------DVYSFGVILLELITG 279
+ EL V DV++ G + EL+TG
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 53/214 (24%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EVLMLSLLHHPN 135
+ + ++G G FG V+ +++ ++V +KQ+ M ++ E +L LL HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD----VNETKKPLDWTTRMKIASGAAQGL 191
++ + ++V E+ GG++ +++ + + L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 192 EYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
++H K +++RDLK+ NILL + + K+ DFG++K+ K V+GT Y
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYI 168
Query: 251 APEYARSGELTVKSDVYSFGVILLELITGRRVID 284
+PE KSD+++ G +L EL + +R +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 79/274 (28%), Positives = 131/274 (47%), Gaps = 43/274 (15%)
Query: 82 ECL--LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-F----LVEVLMLSLLHHP 134
E L + EG +G VY+ + G++VA+K+L M+ KE F L E+ +L L HP
Sbjct: 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHP 64
Query: 135 NLVNL--IGYCADGDQRLLVYEFMSGGSVDDH-LLDVNETKKPLDWTTRMK-IASGAAQG 190
N+V + + ++ D+ +V E++ +H L + ET K + +K + G
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYV------EHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
+ +LHD +++RDLK+SN+LL K+ DFGLA+ G + ++++ T Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYR 173
Query: 251 APE-YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI----------AWAQ 299
APE + E + D++S G I EL+T + + +D+ N I W
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW-- 231
Query: 300 PIFRD-----PKRFPDMADPLLRKQFPEKGLNEA 328
P F + K F LRK+FP L++
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDN 265
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 64/199 (32%), Positives = 105/199 (52%), Gaps = 15/199 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G+G FG V G + G VAVK + + + FL E +++ L H NLV L+G
Sbjct: 14 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 145 DGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ L +V E+M+ GS+ D+L + + L +K + + +EYL +AN +
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL--EANN-FV 124
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK 263
+RDL + N+L+ + K+SDFGL K + T ++ + APE R + + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTK 179
Query: 264 SDVYSFGVILLELITGRRV 282
SDV+SFG++L E+ + RV
Sbjct: 180 SDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIG 141
LG G FGRV + G+ A+K L + M+ + E +L L HP +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD----WTTRMKIASGAAQGLEYLHDK 197
D ++ + EF+ GG + HL + P D + + +A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLA------FEYLHSK 137
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM---GTYGYCAPEY 254
+IYRDLK N+LL K++DFG AK V R GT Y APE
Sbjct: 138 D---IIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVPDRTFTLCGTPEYLAPEV 186
Query: 255 ARSGELTVKSDVYSFGVILLELITG 279
+S D ++ GV+L E I G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 79/295 (26%), Positives = 128/295 (43%), Gaps = 41/295 (13%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-----EVLMLSLLHH 133
+++ L+G G +G VY+G G+VVA+K ++ + + V EV +LS L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQ 58
Query: 134 ---PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
PN+ G G + ++ E+ GGSV + P+ I
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVLVA 113
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
L+Y+H VI+RD+K++NIL+ + KL DFG+A L Q T +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWM 168
Query: 251 APEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
APE G K+D++S G+ + E+ TG LI ++ P R
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-----PPRLE 223
Query: 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL-SNSKEPI 363
D L ++F A CL EE R L ++ + ++ ++SK P+
Sbjct: 224 DNGYSKLLREF-----------VAACLDEEPKER-LSAEELLKSKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQV--VAVKQLD-----RNGMQGNKEFLVEVLMLSLLHHPNLV 137
LGEG FG V +G L + + VAVK + R+ M+ +FL E + + HPN++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPNVM 63
Query: 138 NLIGYCADGDQR------LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRM--KIASGAAQ 189
LIG C + +++ FM G + LL P T+M K + A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 190 GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
G+EYL K+ I+RDL + N +L N++ ++DFGL+K G+ +
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELIT 278
A E T KSDV+SFGV + E+ T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQV-VAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
LG G FG V G + GQ VA+K + + G EF+ E ++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWR--GQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+V E+MS G + ++L E K + +++ +G+ YL K I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FI 122
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYARSGELT 261
+RDL + N L+ K+SDFGL++ E TS V + + PE + +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 262 VKSDVYSFGVILLELIT 278
KSDV++FGV++ E+ +
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGN-KEFLVEVLMLSLLHHPNLVN 138
LGEG FG+V K T ++ VAVK L N ++ L E +L ++HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL--------------------LDVNETKKPLDWT 178
L G C+ LL+ E+ GS+ L N ++ L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
+ A ++G++YL A +++RDL + N+L+ K+SDFGL++ + +
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298
S+ + A E T +SDV+SFGV+L E++T L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------------LGGNP 229
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
P P+R ++ R + PE E + C ++E RP +D+ L
Sbjct: 230 YPGIA-PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+GEG G V T + G+ VAVK++D Q + EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
GD+ +V EF+ GG++ D + T ++ + + L YLH++ VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 205 RDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK 263
RD+KS +ILL ++ KLSDFG A++ + K ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRLPYGTE 198
Query: 264 SDVYSFGVILLELITG 279
D++S G++++E+I G
Sbjct: 199 VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 12/200 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVV----AVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVN 138
+LG G FG VYKG G+ V A+K L+ G + N EF+ E L+++ + HP+LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L+G C + LV + M G + D+ V+E K + + A+G+ YL ++
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDY---VHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+++RDL + N+L+ + K++DFGLA+L EK + A E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 259 ELTVKSDVYSFGVILLELIT 278
+ T +SDV+S+GV + EL+T
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 4e-18
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 31/222 (13%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN----KEFLVEVLMLSLLHHPNLVNL 139
L+G+GG G VY + VA+K++ R + N K FL E + + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNET---KKPLDWTTRMK----IASGAAQGLE 192
C+DGD ++ G ++ L V + K L T + I +E
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE----------------K 236
Y+H K V++RDLK NILLG + + D+G A E
Sbjct: 128 YVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
M + +++GT Y APE + +D+Y+ GVIL +++T
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 4e-18
Identities = 68/198 (34%), Positives = 98/198 (49%), Gaps = 19/198 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPNLVNLIG 141
+G G FG VY +VVA+K++ +G Q N ++ + EV L + HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
LV E+ G + D LL+V+ KKPL I GA QGL YLH
Sbjct: 93 CYLREHTAWLVMEYCLGSASD--LLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS---G 258
+I+RD+K+ NILL KL+DFG A + + + +GT + APE + G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILAMDEG 199
Query: 259 ELTVKSDVYSFGVILLEL 276
+ K DV+S G+ +EL
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM--------LSL 130
FR +LG G FG+V + G++ A+K L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 131 LHHPNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHL-LDVNETKKPLDWTTRMKIASGAA 188
HP LVNL C + + V E+ +GG + H+ DV + + A+
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA------VFYAACVV 111
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM---NVTSRVMG 245
GL+YLH+ ++YRDLK N+LL K++DFGL K E M + TS G
Sbjct: 112 LGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCG 163
Query: 246 TYGYCAPEYARSGELTVKSDVYSFGVILLELITG 279
T + APE T D + GV++ E++ G
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 85 LGEGGFGRVYKGT---LQSNGQV--VAVKQLDRNGMQGNKEFLV-EVLMLSLL-HHPNLV 137
LG G FG+V + T L + V VAVK L +E L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
NL+G C G L++ E+ G + + L E+ L + + A+G+ +L K
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFLASK 160
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMG-----TYGYCAP 252
I+RDL + N+LL K+ DFGLA+ + MN ++ V+ + AP
Sbjct: 161 N---CIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAP 212
Query: 253 EYARSGELTVKSDVYSFGVILLELIT 278
E + T +SDV+S+G++L E+ +
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPN 135
FRQ +LG+GGFG V +++ G++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+VNL D LV M+GG + H+ N + + A+ GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIY--NMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+ +YRDLK NILL ++SD GLA P+GE ++ RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGRV-GTVGYMAPEVL 173
Query: 256 RSGELTVKSDVYSFGVILLELITGR 280
+ T+ D + G ++ E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 9e-18
Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 41/289 (14%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGMQGNKE--FLVEVLMLSLL 131
K+ + E +LG G FG + +G L+ + VA+ L R G + FL E L L
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQF 63
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
H N+V L G G+ ++V E+MS G++D L + + L M + G A G+
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGM 120
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG--- 248
+YL + +++ L + +L+ ++L K+S F Q +K M
Sbjct: 121 KYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL----QEDKSEAIYTTMSGKSPVL 173
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRP---VDEQNLIAWAQPIFRDP 305
+ APE + + SDV+SFG+++ E+++ RP + Q++I + FR P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE-----RPYWDMSGQDVIKAVEDGFRLP 228
Query: 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354
P LL + + C Q+E G RP S + + LS
Sbjct: 229 A--PRNCPNLLHQLMLD------------CWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 74/278 (26%), Positives = 121/278 (43%), Gaps = 28/278 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGYC 143
+G+G FG V+KG QVVA+K +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
G + ++ E++ GGS D L P D + +GL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----RAGPFDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK 263
+RD+K++N+LL D KL+DFG+A G + + +GT + APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 264 SDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEK 323
+D++S G+ +EL G P+ + +F PK P K F E
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPM---------RVLFLIPKNNPPTLTGEFSKPFKE- 231
Query: 324 GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKE 361
CL ++ RP +++ + N+K+
Sbjct: 232 -------FIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSL-LHHPNLVNL 139
+LG+G FG+V L+ + A+K L ++ + + + +VE +L+L HP L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 140 IGYCA--DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
+C + V E+++GG D + + + + + R A+ GL++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARF-YAAEIICGLQFLHKK 115
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
+IYRDLK N+LL + K++DFG+ K GE S GT Y APE +
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 258 GELTVKSDVYSFGVILLELITGR 280
+ D +SFGV+L E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 41/278 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ G ++ +V A+K + G ++F+ E ++ L HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+V EFM G + ++L + + L + + +G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 205 RDLKSSNILLGANLDPKLSDFGLAK-------LGPQGEKMNVTSRVMGTYGYCAPEYARS 257
RDL + N L+ + K+SDFG+ + G K V + PE
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK--------WSPPEVFNF 175
Query: 258 GELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
+ + KSDV+SFGV++ E+ T G+ + + +I+ ++R
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR------------- 222
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354
P+ + C E+ RP ++++ A++
Sbjct: 223 ----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 69/275 (25%), Positives = 126/275 (45%), Gaps = 22/275 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHP 134
NF+ E +G G F VY+ T + + VA+K++ M + ++ + E+ +L L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
N++ + + ++ +V E G + + + K+ + T K +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H + V++RD+K +N+ + A KL D GL + K ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
KSD++S G +L E+ + + D+ NL + Q I + +P P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMA----ALQSPFYGDKMNLFSLCQKI--EQCDYP----P 227
Query: 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
L + + EK L E V +MC+ + RP + V
Sbjct: 228 LPTEHYSEK-LRELV---SMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+GEG G V T++S+G++VAVK++D Q + EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
GD+ +V EF+ GG++ D + T ++ + + L LH + VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
RD+KS +ILL + KLSDFG +++ ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 265 DVYSFGVILLELITG 279
D++S G++++E++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL---DRNGMQGNKEFLVEVLMLSLLHHP 134
+ + +G G FGRV+ + + A+K + + ++ + E +L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 135 NLVNLIGYCADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
++ L + + DQR L + E++ GG + +L +T + AS LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL----RNSGRFSNSTGLFYASEIVCALE 115
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YLH K ++YRDLK NILL KL+DFG AK + + T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167
Query: 253 EYARSGELTVKSDVYSFGVILLELITG 279
E +S D ++ G+++ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 84 LLGEGGFGRVY----KGTLQSNG-QVVAVKQLD-RNGMQGNKEFLVEVLMLSLLHHPNLV 137
LG G FG V+ KG + G +V VK L EF E+ M L H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLL-----DVNETKKPLDWTTRMKIASGAAQGLE 192
L+G C + + ++ E+ G + L D PL ++ + + A G++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
+L +N ++RDL + N L+ + + K+S L+K E + + ++ + AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 253 EYARSGELTVKSDVYSFGVILLELIT 278
E + + + KSDV+SFGV++ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 69/248 (27%), Positives = 119/248 (47%), Gaps = 30/248 (12%)
Query: 85 LGEGGFGRVY----KGTLQ------------SNGQVVAVKQL--DRNGMQGNKEFLVEVL 126
LGEG FG V+ +G + + +VAVK L D N N +FL E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN-DFLKEIK 71
Query: 127 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD-------VNETKKPLDWTT 179
++S L PN++ L+ C D ++ E+M G ++ L + ++T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 180 RMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239
+ +A+ A G++YL ++ ++RDL + N L+G N K++DFG+++ G+ +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299
R + + + E G+ T SDV++FGV L E++T + ++ DEQ +I
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTG 247
Query: 300 PIFRDPKR 307
FRD R
Sbjct: 248 EFFRDQGR 255
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 36/211 (17%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF--------LVEVLML-SLLHHPN 135
LG+G FG VY + G++VA+K++ K+F L EV L L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V L + D+ V+E+M G + + L + KP + I QGL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR-----VMGTYGYC 250
K +RDLK N+L+ K++DFGLA+ + SR + T Y
Sbjct: 117 -KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTRWYR 165
Query: 251 APE-YARSGELTVKSDVYSFGVILLELITGR 280
APE RS + D+++ G I+ EL T R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 41/270 (15%)
Query: 78 NFRQECL-----LGEGGFGRVY-------KGTLQSNGQ---------VVAVKQLDRNG-M 115
F ++ L LGEG FG V+ + + +VAVK L +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 116 QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL-------LDV 168
++FL EV +LS L PN+ L+G C ++ E+M G ++ L +
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 169 NETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228
K L ++T + +A+ A G+ YL + ++RDL + N L+G N K++DFG++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTR 287
+ + V R + A E G+ T KSDV++FGV L E++T R +
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----Q 232
Query: 288 PVDE---QNLIAWAQPIFRDPKRFPDMADP 314
P + Q +I A FRD R + P
Sbjct: 233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRP 262
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPN 135
FR +LG+GGFG V +++ G++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V+L D LV M+GG + H+ N D + A+ GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+ ++YRDLK NILL ++SD GLA P+GE + RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVV 173
Query: 256 RSGELTVKSDVYSFGVILLELITGR 280
++ T D + G ++ E+I G+
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 85 LGEGGFGRV----YKGTLQSNGQVVAVKQLD-RNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V Y + G+ VAVK L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 140 IGYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
G C + L+ EF+ GS+ ++L K ++ ++K A +G++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEYAR 256
++RDL + N+L+ + K+ DFGL K + E V + + APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 257 SGELTVKSDVYSFGVILLELIT 278
+ + SDV+SFGV L EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 99/356 (27%), Positives = 153/356 (42%), Gaps = 93/356 (26%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL-D--RNGMQGNKEFLVEVLMLS-LLH 132
+ + LG+G +G V+K + +VVA+K++ D RN + F E++ L L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD 65
Query: 133 HPNLVNLIG-YCADGDQRL-LVYEFMSGGSVDDH-------LLDVNETKKPLDWTTRMKI 183
HPN+V L+ A+ D+ + LV+E+M D H L DV+ + I
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYME---TDLHAVIRANILEDVH----------KRYI 112
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
+ L+Y+H N VI+RDLK SNILL ++ KL+DFGLA+ + E+ N + V
Sbjct: 113 MYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE-NPENPV 168
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGV-------ILLELITGR-------------RVI 283
+ T Y A + R+ E+ + S Y+ GV IL E++ G+ ++I
Sbjct: 169 L-TD-YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226
Query: 284 DTT-RPVDEQ----------NLIAWAQPIFRDP--KRFPDMADP----LLRK--QF-PEK 323
+ P E ++ R P + P A LL+K F P K
Sbjct: 227 EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNK 285
Query: 324 GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEP-IPDPIIPS--DEDEYS 376
L EEA P ++ F + S EP +P PI D + S
Sbjct: 286 RLT----------AEEALEHPYVAQ------FHNPSDEPVLPYPITIPLDDNVKLS 325
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 76/272 (27%), Positives = 120/272 (44%), Gaps = 38/272 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM-LSLLHH---PNLVNLI 140
LG+G +G VYK + G +A+K++ R + +K +++M L +LH P +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESK--FNQIIMELDILHKAVSPYIVDFY 65
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
G + E+M GS+D L + + +I +GL++L ++ N
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+I+RD+K +N+L+ N KL DFG++ L K N+ G Y APE +SG
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177
Query: 260 L------TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR-DPKRFPDMA 312
TV+SDV+S G+ +LE+ GR P N+ A I DP P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRY---PYPPETYANIFAQLSAIVDGDPPTLPSGY 234
Query: 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
+A A CL + RP
Sbjct: 235 SD------------DAQDFVAKCLNKIPNRRP 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGY 142
+GEG FG++Y +S+ + +K++D M + + EV++L+ + HPN+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVN-------ETKKPLDWTTRMKIASGAAQGLEYLH 195
+ + +V E+ GG D + +N + L W ++ + GL+++H
Sbjct: 68 FQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH 118
Query: 196 DKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
D+ +++RD+KS NI L N + KL DFG+A+ + M + +GT Y +PE
Sbjct: 119 DRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEI 173
Query: 255 ARSGELTVKSDVYSFGVILLELIT 278
++ K+D++S G +L EL T
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 8e-17
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
+LG+G +G VY S +A+K++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 144 ADGDQRLLVYEFMSGGSVDDHL------LDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
++ + E + GGS+ L L NE + + T+ + +GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT--IIFYTKQIL-----EGLKYLHDN 127
Query: 198 ANPPVIYRDLKSSNILLGANLDP-KLSDFG----LAKLGPQGEKMNVTSRVMGTYGYCAP 252
+++RD+K N+L+ K+SDFG LA + P T GT Y AP
Sbjct: 128 Q---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAP 178
Query: 253 EYARSGE--LTVKSDVYSFGVILLELITGR 280
E G +D++S G ++E+ TG+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 18/208 (8%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQL-DRNGMQGNKEFLVEVLMLSLLHH 133
F++ +LG G FG VYKG G+ VA+K+L + + NKE L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNE---TKKPLDWTTRMKIASGAAQG 190
P++ L+G C +L + + M G + D++ + + ++ L+W ++ A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
+ YL ++ +++RDL + N+L+ K++DFGLAKL EK +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 251 APEYARSGELTVKSDVYSFGVILLELIT 278
A E T +SDV+S+GV + EL+T
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 69/223 (30%), Positives = 100/223 (44%), Gaps = 51/223 (22%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---------LVEVLMLSLLHHP 134
+G G +G V + G+ VA+K++ + F L E+ +L L H
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 135 NLVNLIGYCADGDQR-----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ 189
N++ L+ +V E M + L V ++ +PL T I Q
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPL---TDDHIQYFLYQ 111
Query: 190 ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG--PQGEKMNVTSRVM 244
GL+YLH AN VI+RDLK SNIL+ +N D K+ DFGLA+ + EK +T V+
Sbjct: 112 ILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 245 GTYGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
T Y APE Y T D++S G I EL+T +
Sbjct: 169 -TRWYRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
+LG+G FG+V + ++ A+K L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 141 GYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
C RL V E+++GG + H+ V + K+P + A+ + GL +LH +
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLHRRG- 121
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM--NVTSRVM-GTYGYCAPEYAR 256
+IYRDLK N++L + K++DFG+ K E M VT+R GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 257 SGELTVKSDVYSFGVILLELITGRRVID 284
D +++GV+L E++ G+ D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 25/202 (12%)
Query: 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLLHHPNLVNLIGYC 143
G FG VY +S G A+K L ++ M + +M+ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKK----PLDWTTRMKIASGAAQGLEYLHDKAN 199
D LV E+++GG + K P DW + + G+E LH +
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG- 117
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+I+RD+K N+L+ KL+DFGL++ G + +GT Y APE
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVG 169
Query: 260 LTVKSDVYSFGVILLELITGRR 281
SD +S G ++ E + G
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKE---FLVEVLMLSLLH 132
N+R LLG G FG VY G+ +AVKQ+ D + + +KE E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 133 HPNLVNLIGYCADGDQRLL--VYEFMSGGSVDDHL-----LDVNETKKPLDWTTRMKIAS 185
H +V G D +++ L E+M GGS+ D L L N T++ TR +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR----YTRQIL-- 116
Query: 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT--SRV 243
QG+ YLH +++RD+K +NIL + + KL DFG +K Q M+ T V
Sbjct: 117 ---QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR-IQTICMSGTGIKSV 169
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
GT + +PE K+DV+S ++E++T
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHH---PNLV 137
++G GGFG VY G++ A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHD 196
+ D+ + + M+GG + HL ++ + M+ A+ GLE++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLA----KLGPQGEKMNVTSRVMGTYGYCAP 252
+ V+YRDLK +NILL + ++SD GLA K P +GT+GY AP
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAP 164
Query: 253 EYARSG-ELTVKSDVYSFGVILLELITG 279
E + G +D +S G +L +L+ G
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPN 135
FR +LG+GGFG V +++ G++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V+L D LV M+GG + H+ ++ D + A+ GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQ 119
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+ ++YRDLK NILL ++SD GLA P+GE V RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 256 RSGELTVKSDVYSFGVILLELITGR 280
+ + T D + G ++ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVE-VLMLSLLHHPNLVNLI 140
+G+G FG+V +++G+ AVK L + + KE + E ++L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
D+ V ++++GG + HL + + R A+ A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARF-YAAEIASALGYLHSLN-- 116
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
+IYRDLK NILL + L+DFGL K G + K TS GT Y APE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPY 173
Query: 261 TVKSDVYSFGVILLELITG 279
D + G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 41/214 (19%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQ----LDRNGMQGNKEFLVEVLMLSLL---HHPNL 136
+GEG +G VYK + G+ VA+K+ L G+ + L E+ +L L HPN+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST--LREIALLKQLESFEHPNI 63
Query: 137 VNLIGYCA--DGDQRL---LVYEFMSGGSVDDHL---LDVNETKKPLDWTTRMKIASGAA 188
V L+ C D+ L LV+E VD L L K L T +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLS-KCPKPGLPPETIKDLMRQLL 117
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
+G+++LH +++RDLK NIL+ ++ K++DFGLA++ +M +TS V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVV-TLW 171
Query: 249 YCAPE------YARSGELTVKSDVYSFGVILLEL 276
Y APE YA D++S G I EL
Sbjct: 172 YRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL----DRNGMQGNKEFLVEVLMLSLLH 132
F + +GEG +G VY+ ++G++VA+K++ +R+G+ + L E+ +L L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLR 64
Query: 133 HPNLVNLIGYCADGDQR---LLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIAS 185
HPN+V L G LV E+ + LLD T P + +
Sbjct: 65 HPNIVELKEVVV-GKHLDSIFLVMEYC------EQDLASLLDNMPT--PFSESQVKCLML 115
Query: 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL-GPQGEKMNVTSRVM 244
+GL+YLH+ +I+RDLK SN+LL K++DFGLA+ G + M T +V+
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVV 170
Query: 245 GTYGYCAPEYA-RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296
T Y APE T D+++ G IL EL+ + ++ +++ +LI
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHH---PNLV 137
++G GGFG VY G++ A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHD 196
+ D+ + + M+GG + HL ++ + M+ A+ GLE++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLA----KLGPQGEKMNVTSRVMGTYGYCAP 252
+ V+YRDLK +NILL + ++SD GLA K P +GT+GY AP
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAP 164
Query: 253 EYARSGELTVKS-DVYSFGVILLELITG 279
E + G S D +S G +L +L+ G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 42/267 (15%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVA-------VKQLDRNGMQGNKEFLVEVLMLSL 130
+F + LG G G V K + +G ++A +K RN Q +E L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 131 LHHPNLVNLIGY----CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASG 186
LH N ++G+ +DG+ + + E M GGS+D L + P + ++ IA
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAG--RIPENILGKISIA-- 107
Query: 187 AAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMG 245
+GL YL +K +++RD+K SNIL+ + + KL DFG++ G+ ++ + + +G
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVG 160
Query: 246 TYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305
T Y +PE + TV+SD++S G+ L+E+ GR I P D + L + +F P
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP---PPDAKEL----EAMFGRP 213
Query: 306 KRFPDMADPLLRKQFPEKGLNEAVAIA 332
+ + + +A
Sbjct: 214 V--SEGEAKESHRPVSGHPPDSPRPMA 238
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 45/288 (15%)
Query: 85 LGEGGFGRVY----KGTLQSNGQV-VAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVN 138
LG+G FG VY KG ++ + VA+K ++ M+ EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL------LDVNETKKPLDWTTRMKIASGAAQGLE 192
L+G + G L++ E M+ G + +L ++ N + P +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YL+ AN ++RDL + N ++ + K+ DFG+ + + + + + + +P
Sbjct: 134 YLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 253 EYARSGELTVKSDVYSFGVILLELIT-------GRRVIDTTRPVDEQNLIAWAQPIFRDP 305
E + G T SDV+SFGV+L E+ T G R V E L+ P
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL-------DKP 243
Query: 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
PDM L+R MC Q RP ++++++
Sbjct: 244 DNCPDMLFELMR----------------MCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 81/261 (31%), Positives = 117/261 (44%), Gaps = 42/261 (16%)
Query: 84 LLGEGGFGRVY---KGTLQSNGQVVAVKQL--------DRNGMQGNKEFLVEVLMLSLLH 132
+LG+G FG+V+ K T GQ+ A+K L DR + ++ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 133 HPNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWT---TRMKIASGAA 188
HP +V L Y + +L L+ +F+ GG + L K + +T + +A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAE-LA 108
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
L++LH +IYRDLK NILL KL+DFGL+K EK GT
Sbjct: 109 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 163
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ---PIFRDP 305
Y APE T +D +SFGV++ E++TG + +I A+ P F P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSP 223
Query: 306 KRFPDMADPLLRKQFPEKGLN 326
+ A LLR F N
Sbjct: 224 E-----AQSLLRALFKRNPAN 239
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV---EVLMLSLLHHPNLVNLIG 141
+G G +G VYK + G++ A+K + ++ ++F V E++M+ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
D+ + EF GGS L D+ PL + ++ QGL YLH K
Sbjct: 74 SYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA---RSG 258
++RD+K +NILL N KL+DFG++ + +GT + APE A R G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 259 ELTVKSDVYSFGVILLEL 276
D+++ G+ +EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSL-LHHPNLVNL 139
+LG+G FG+V L+ +V A+K L ++ + + + + E +L+L HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
D+ V E+++GG D + + ++K D A+ L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
VIYRDLK NILL A KL+DFG+ K G T+ GT Y APE + E
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 260 LTVKSDVYSFGVILLELITGR 280
D ++ GV++ E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 68/209 (32%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGY 142
L+G G +G+VYKG GQ+ A+K +D G + +E E+ ML HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 143 CAD------GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
DQ LV EF GSV D + + +W I +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
VI+RD+K N+LL N + KL DFG+ A+L + N +GT + APE
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVI 183
Query: 256 RSGE-----LTVKSDVYSFGVILLELITG 279
E KSD++S G+ +E+ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 84 LLGEGGFGRVY---KGTLQSNGQVVAVKQLDRNGMQGNKE----FLVEVLMLSLLHHPNL 136
+LG+GG+G+V+ K T G++ A+K L + + N++ E +L + HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V+LI G + L+ E++SGG + HL E + T S + LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YA 255
+ +IYRDLK NILL A KL+DFGL K VT GT Y APE
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILM 173
Query: 256 RSGELTVKSDVYSFGVILLELITG 279
RSG D +S G ++ +++TG
Sbjct: 174 RSGH-GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 84 LLGEGGFGRVYKGTLQS---NGQVVAVKQL--DRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
+LG+G FG V + L+S + Q VAVK L D +EFL E + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 139 LIGYC--ADGDQRL----LVYEFMSGGSVDDHLL--DVNETKKPLDWTTRMKIASGAAQG 190
LIG + RL ++ FM G + LL + E L T ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
+EYL K I+RDL + N +L N+ ++DFGL+K G+ +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 251 APEYARSGELTVKSDVYSFGVILLELIT 278
A E T SDV++FGV + E++T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 84/278 (30%), Positives = 129/278 (46%), Gaps = 34/278 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLML-SLLHHPNLVNLIG-- 141
+G+G +G+V+K + NG AVK LD ++E E +L +L HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 142 YCAD---GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
Y D GDQ LV E +GGSV D + + + ++ I A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
I+RD+K +NILL KL DFG+ A+L + N + +GT + APE
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 198
Query: 258 GE-----LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312
+ + DV+S G+ +EL G + P+ + +F+ P+ P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---------RALFKIPRNPP--- 246
Query: 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVV 350
P L + PE NE CL ++ RP +SD++
Sbjct: 247 -PTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRN-GMQGNKEFLVEVLMLSLLHH 133
++ +LG G FG VYKG +G+ VA+K L N + NKE L E +++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNE---TKKPLDWTTRMKIASGAAQG 190
P + L+G C +L V + M G + D++ + + ++ L+W ++ A+G
Sbjct: 69 PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
+ YL + +++RDL + N+L+ + K++DFGLA+L E +
Sbjct: 122 MSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 251 APEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR-FP 309
A E T +SDV+S+GV + EL+T A+P P R P
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT-----------------FGAKPYDGIPAREIP 221
Query: 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357
D+ + R P + I C ++ RP ++V S ++
Sbjct: 222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 84 LLGEGGFGRVYKGTLQS-NGQV--VAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPNLVNL 139
+GEG FG VY+G S + VAVK +E FL E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
IG + + +V E G + L VN K LD + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGEL-RSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++RD+ + N+L+ + KL DFGL++ + E S+ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 260 LTVKSDVYSFGVILLELI 277
T SDV+ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+GEG G V + +G+ VAVK +D Q + EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
G++ ++ EF+ GG++ D + ++ + + Q L YLH + VI+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQG---VIH 140
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR--VMGTYGYCAPEYARSGELTV 262
RD+KS +ILL + KLSDFG Q K +V R ++GT + APE
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCA---QISK-DVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPV 289
+ D++S G++++E++ G + PV
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPV 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQ--LDRNGMQGNKEFLVEVLMLSLLHHPN 135
NF++ +GEG +G VYK + G+VVA+K+ LD + E+ +L L+HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA------- 188
+V L+ ++ LV+EF+ + KK +D + I
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH-----------QDLKKFMDASPLSGIPLPLIKSYLFQL 109
Query: 189 -QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
QGL + H V++RDLK N+L+ KL+DFGLA+ G + + + T
Sbjct: 110 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTL 164
Query: 248 GYCAPEYARSGEL-TVKSDVYSFGVILLELITGR 280
Y APE + + D++S G I E++T R
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKE---FLVEVLMLSLLH 132
N+R+ LLG+G FGRVY G+ +A KQ+ D + +KE E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 133 HPNLVNLIGYCADGDQRLLV--YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
H +V G D ++ L E+M GGSV D L + L + K +G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEG 118
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS--RVMGTYG 248
+ YLH +++RD+K +NIL + + KL DFG +K Q M+ T V GT
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR-LQTICMSGTGIRSVTGTPY 174
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGR 280
+ +PE K+DV+S G ++E++T +
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
+LG+G FG+V + ++ A+K L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 141 GYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
C RL V E+++GG + H+ V + K+P + A+ A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLHSKG- 121
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE------ 253
+IYRDLK N++L A K++DFG+ K G K T GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQP 177
Query: 254 YARSGELTVKSDVYSFGVILLELITGR 280
Y +S D ++FGV+L E++ G+
Sbjct: 178 YGKS------VDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 77/267 (28%), Positives = 115/267 (43%), Gaps = 38/267 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGY 142
++G G +G+VYKG GQ+ A+K +D + +E +E+ ML HH N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 143 ------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
DQ LV EF GSV D + + DW I +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
VI+RD+K N+LL N + KL DFG+ A+L + N +GT + APE
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVI 193
Query: 256 RSGE-----LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP----- 305
E +SD++S G+ +E+ G + P+ LI R+P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP------RNPPPKLK 247
Query: 306 -----KRFPDMADPLLRKQFPEKGLNE 327
K+F D + L K + + E
Sbjct: 248 SKKWSKKFIDFIEGCLVKNYLSRPSTE 274
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL---DRNGMQGNKEFLVEVLMLSLLHHP 134
NFR E +G G F VY+ T +G VA+K++ D + + + E+ +L L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
N++ + ++ +V E G + + + K+ + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H + V++RD+K +N+ + A KL D GL + K ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177
Query: 255 ARSGELTVKSDVYSFGVILLEL 276
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 85 LGEGGFGRVYKG-------TLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLL-HHPN 135
LGEG FG+V + + VAVK L N + L+ E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHL-----------LDVNET-KKPLDWTTRMKI 183
++NL+G C ++ E+ + G++ + L D+ + ++ L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
A A+G+EYL + I+RDL + N+L+ + K++DFGLA+ + TS
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ APE T +SDV+SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 60/206 (29%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 85 LGEGGFGRVYKG---TLQSNGQVVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+G G FG+V G S +VV VK+L FL EV L+HPN++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL-DWTTRMKIASGAAQGLEYLHDKAN 199
G C + LLV EF G + ++L + ++A A GL +LH +A+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-- 257
I+ DL N L A+L K+ D+GLA + + APE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 258 -----GELTVKSDVYSFGVILLELIT 278
+ T KS+++S GV + EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
+LG+G FG+V + ++ A+K L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 141 GYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
C RL V E+++GG + + V K+P + A+ A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHSKG- 121
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM--NVTSRVM-GTYGYCAPEYAR 256
+IYRDLK N++L + K++DFG+ K E M VT++ GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 257 SGELTVKSDVYSFGVILLELITGR 280
D ++FGV+L E++ G+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQL----DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+GEG +G VYKG + GQ+VA+K++ + G+ + E+ +L L HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 141 GYCADGDQRLLVYEFMSGGSVD-DHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+ L++EF+S +D LD + +D QG+ + H +
Sbjct: 66 DVLMQESRLYLIFEFLS---MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR-SG 258
V++RDLK N+L+ KL+DFGLA+ G + V + + T Y APE S
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 259 ELTVKSDVYSFGVILLELITGR 280
+ D++S G I E+ T +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKE---FLVEVLMLSLLH 132
N+R LLG+G FGRVY G+ +AVKQ+ D + +KE E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 133 HPNLVNLIGYCADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
H +V G D +R L E M GGS+ D L ++ L K +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK------LGPQGEKMNVTSRVM 244
+ YLH +++RD+K +NIL + + KL DFG +K L G K V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK-----SVT 170
Query: 245 GTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
GT + +PE K+D++S G ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 30/221 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDR--NGMQGNKEFLVEVLMLSLLHHPNLVNLIG- 141
+G G FG V Q GQ VA+K++ + + K E+ +L L H N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
+ + + V E + D H L T +PL+ +GL+Y+H
Sbjct: 78 FISPLEDIYFVTELLG---TDLHRL---LTSRPLEKQFIQYFLYQILRGLKYVHSAG--- 128
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE-- 259
V++RDLK SNIL+ N D K+ DFGLA+ Q +M GY + Y R+ E
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMT---------GYVSTRYYRAPEIM 177
Query: 260 LT-----VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
LT V+ D++S G I E++ G+ + V++ ++I
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 71/233 (30%), Positives = 111/233 (47%), Gaps = 20/233 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLIG 141
+G+G FG+V + + ++ A+K + + + E L E +L+ ++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ-GLEYLHDKANP 200
++ LV F++GG + HL + + D +R + + LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL----QREGRFD-LSRARFYTAELLCALENLH-KFN- 113
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
VIYRDLK NILL L DFGL KL + + T+ GT Y APE
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 261 TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
T D ++ GV+L E++TG P ++N+ + I ++P RFPD D
Sbjct: 171 TKAVDWWTLGVLLYEMLTG------LPPFYDENVNEMYRKILQEPLRFPDGFD 217
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 58/233 (24%), Positives = 95/233 (40%), Gaps = 51/233 (21%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLI 140
++G G FG V+ + GQV A+K L ++ M + E +L+ P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 141 GYCADGDQRLL--VYEFMSGGSVDDHL-----LDVNETKKPLDWTTRMKIASGAAQGLEY 193
Y + D+ L V E+M GG + + L + + + +A + L +
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF---YIAELVLALDSVHKLGF 122
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSR---------- 242
+H RD+K NIL+ A+ KL+DFGL K+ ++ +
Sbjct: 123 IH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 243 ----------------VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG 279
+GT Y APE R ++ D +S GVIL E++ G
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 70/221 (31%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRN-GMQGNKEFLVE--VLMLSLLHHPNLVNLIG 141
LG G +G V K G ++AVK++ Q K L++ + M S + P V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS-VDCPYTVTFYG 67
Query: 142 YC-ADGDQRLLVYEFMS--GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
+GD V+ M S+D V + + KIA + LEYLH K
Sbjct: 68 ALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM--GTYGYCAPEYAR 256
+ VI+RD+K SN+L+ N KL DFG++ G ++ ++ + G Y APE
Sbjct: 124 S--VIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAKTIDAGCKPYMAPERI- 175
Query: 257 SGELT-----VKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292
+ EL VKSDV+S G+ ++EL TGR D+ + +Q
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 79 FRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHH 133
LL EG FGR++ G L + V VK + + + L E +L L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 134 PNLVNLIGYCA-DGDQRLLVYEFMSGGSVDDHLLD--VNETKKPLDWTTR--MKIASGAA 188
N++ ++ C DG+ ++Y +M+ G++ L + E P +T+ + +A A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQ-----GEKMNVTSR 242
G+ YLH + VI++D+ + N ++ L K++D L++ L P G+ N +
Sbjct: 128 CGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 243 VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
M A E + E + SDV+SFGV+L EL+T
Sbjct: 185 WM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 24/201 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EVLMLSLLHHPNLVNLIGY 142
+G G +G VYK G++ AVK + G+ L+ E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
++ + E+ GGS L D+ PL + QGL YLH K
Sbjct: 75 YLSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT----SRVMGTYGYCAPEYA--- 255
++RD+K +NILL N D KL+DFG+A K+ T +GT + APE A
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA------KITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 256 RSGELTVKSDVYSFGVILLEL 276
++G D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 20/234 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLLHHPNLVNL 139
++G G + +V L+ N Q+ A+K + + + +++ + + +P LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 140 IGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
C RL LV E+++GG + H+ + ++ L A+ L +LH++
Sbjct: 62 HS-CFQTTSRLFLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAK--LGPQGEKMNVTSRVMGTYGYCAPEYAR 256
+IYRDLK N+LL A+ KL+D+G+ K LGP + TS GT Y APE R
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----DTTSTFCGTPNYIAPEILR 169
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPIFRDPKRFP 309
E D ++ GV++ E++ GR D + N + Q I P R P
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 18/234 (7%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF-LVEV---LMLSLLHHPNLVNL 139
++G G + +V L+ ++ A+K + + + +++ V+ + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 140 IGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
C + RL V EF+SGG D + + +K + R ++ + L +LH++
Sbjct: 62 HS-CFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNFLHERG 116
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+IYRDLK N+LL A KL+D+G+ K G + + TS GT Y APE R
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCGTPNYIAPEILRGE 171
Query: 259 ELTVKSDVYSFGVILLELITGRRVID--TTRPVDEQNLIAWA-QPIFRDPKRFP 309
+ D ++ GV++ E++ GR D +QN + Q I R P
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQL----DRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
++GEG FGR ++ Q A+K++ + ++ +++ E ++L+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 140 I-GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKP----LDWTTRMKIASGAAQGLEYL 194
+ ADG +V E+ GG + + P L W +M + G++++
Sbjct: 64 KESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H+K V++RD+KS NI L N KL DFG A+L +GT Y PE
Sbjct: 117 HEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYYVPPEI 171
Query: 255 ARSGELTVKSDVYSFGVILLELIT 278
+ KSD++S G IL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEV-LMLSLLHHPNLVNL 139
++G+G FG+V +S+G AVK L + + KE + E ++L L HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHDKA 198
++ V ++++GG + HL +P R + A+ A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSLN 116
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+IYRDLK NILL + L+DFGL K G + E TS GT Y APE R
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKE 171
Query: 259 ELTVKSDVYSFGVILLELITG 279
D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 85 LGEGGFGRVYKGTL-------QSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLL-HHPN 135
LGEG FG+V VAVK L + + + LV E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHL-----------LDVNE-TKKPLDWTTRMKI 183
++NL+G C ++ E+ S G++ ++L D+ + + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
A+G+EYL A+ I+RDL + N+L+ N K++DFGLA+ + T+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ APE T +SDV+SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 67/234 (28%), Positives = 97/234 (41%), Gaps = 35/234 (14%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHH 133
K+F++ LLG+G GRV+ L+ G++ A+K LD+ M + L E +L+ L H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P L L LV ++ GG + LL K + R A LEY
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLL-ALEY 118
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK------------LGPQGEKMNVTS 241
LH ++YRDLK NILL + LSDF L+K L + +V S
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 242 RV---------------MGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
+GT Y APE D ++ G++L E++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 85 LGEGGFGRVYKGTLQ--SNGQVVAVKQL--DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
LG G FG V KG + + + VAVK L D N E L E ++ L +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLL-DVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G C + + +LV E G ++ L + + T+K + ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEETN- 115
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
++RDL + N+LL K+SDFGL+K LG + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 259 ELTVKSDVYSFGVILLE 275
+ + KSDV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 73/244 (29%), Positives = 108/244 (44%), Gaps = 53/244 (21%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-F----LVEVLMLSLLHHPNLVNL 139
LGEG FG VYK G+VVA+K++ M K+ F L E+ +L L HPN+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 140 IGYCAD-----GDQRLLVY---EFMSGGSVDDH----LLDVNETK-KPLDWTTRMKIASG 186
I + +R VY +M DH LL+ K M
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENPSVKLTESQIKCYML---- 122
Query: 187 AAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL----------GPQ 233
Q G+ YLH+ +++RD+K++NIL+ K++DFGLA+ G
Sbjct: 123 --QLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 234 GEKMNVTSRVMGTYGYCAPEYARSGE--LTVKSDVYSFGVILLELITGRRVIDTTRPVDE 291
G T+ V+ T Y PE GE T D++ G + E+ T R ++ +D+
Sbjct: 178 GGTRKYTNLVV-TRWYRPPELL-LGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 292 QNLI 295
+LI
Sbjct: 236 LHLI 239
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK--EFLVEVLMLSLLHHPNLVNLIGY 142
+GEG FG+ + +G+ +K+++ + M + E EV +LS + HPN+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETK-------KPLDWTTRMKIASGAAQGLEYLH 195
+ +V ++ GG D +N + + LDW ++ +A L+++H
Sbjct: 68 FEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH 118
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
D+ +++RD+KS NI L + KL DFG+A++ + + +GT Y +PE
Sbjct: 119 DRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC 173
Query: 256 RSGELTVKSDVYSFGVILLELIT 278
+ KSD+++ G +L E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 85 LGEGGFGRVYKGTLQS--NGQV---VAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVN 138
LG+G FG VY+G + G+ VAVK ++ + ++ EFL E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDV-----NETKKPLDWTTRM-KIASGAAQGLE 192
L+G + G L+V E M+ G + +L + N +P M ++A+ A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YL+ K ++RDL + N ++ + K+ DFG+ + + + + + + AP
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 253 EYARSGELTVKSDVYSFGVILLELIT 278
E + G T SD++SFGV+L E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 67/213 (31%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 78 NFRQECLLGEGGFGRVY---KGTLQSNGQVVAVKQLDRNGM-QGNK---EFLVEVLMLSL 130
NF +LG G +G+V+ K G++ A+K L + + Q K E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 131 LHH-PNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
+ P LV L Y D +L L+ ++++GG + HL + R+ IA
Sbjct: 61 VRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAE-IV 115
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
L++LH +IYRD+K NILL + L+DFGL+K E+ S GT
Sbjct: 116 LALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIE 171
Query: 249 YCAPEYARSGELTVKS--DVYSFGVILLELITG 279
Y APE R G D +S GV+ EL+TG
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 82 ECL--LGEGGFGRVYKG-TLQSNGQVVAVK----QLDRNGMQGNKEFLVEVL-MLSLLHH 133
EC+ +GEG +G+V+K L++ G+ VA+K Q GM + V VL L H
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63
Query: 134 PNLVNLIGYCA----DGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
PN+V L C D + +L LV+E + + +L V E P + M
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ--LL 120
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
+GL++LH V++RDLK NIL+ ++ KL+DFGLA++ + V+ T
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLW 174
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE 291
Y APE D++S G I E+ + + + VD+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 79/272 (29%), Positives = 119/272 (43%), Gaps = 34/272 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQL-DRNGMQGNKEFL--VEVLMLSLLHHPNLVNLI 140
+G G FG V K + +G ++AVK++ + K L ++V+M S P +V
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFY 69
Query: 141 GYC-ADGDQRLLVYEFMSGGSVDDHLLDVNE-TKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G +GD + E M S+D V E K + KIA + L YL K
Sbjct: 70 GALFREGDC-WICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL--KE 125
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM--GTYGYCAPE--- 253
+I+RD+K SNILL N + KL DFG++ G+ ++ ++ G Y APE
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERID 180
Query: 254 -YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312
AR G V+SDV+S G+ L E+ TG+ V +Q Q + DP
Sbjct: 181 PSARDG-YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ----LTQVVKGDPPIL---- 231
Query: 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
++F V +CL ++ RP
Sbjct: 232 SNSEEREFSP----SFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 68/205 (33%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 85 LGEGGFGRVYKGTLQSN---GQVVAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+G G FG+V G + S QVV VK+L + +Q +FL E L H NL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLD--VNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G C + LLV EF G + +L E P D TT ++A A GL +LH K
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLH-KN 119
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS- 257
N I+ DL N LL A+L K+ D+GL+ + + ++ + APE
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 258 -GELTV-----KSDVYSFGVILLEL 276
G L V +S+V+S GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 63/193 (32%), Positives = 95/193 (49%), Gaps = 43/193 (22%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-F----LVEVLMLSLLHHPNLVNL 139
+G+G FG V+K + Q+VA+K++ M+ KE F L E+ +L LL H N+VNL
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 140 IGYC---ADGDQR-----LLVYEF--------MSGGSVDDHLLDVNETKKPLDWTTRMKI 183
I C A R LV+EF +S +V L ++ + K L
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML-------- 128
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK--LGPQGEKMN-VT 240
GL Y+H +++RD+K++NIL+ + KL+DFGLA+ + K N T
Sbjct: 129 ----LNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 241 SRVMGTYGYCAPE 253
+RV+ T Y PE
Sbjct: 182 NRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVK--QLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
LG G G VYK +++AVK LD ++ K+ + E+ +L P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 143 CADGDQRLLVYEFMSGGSVD------DHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
++ + EFM GGS+D +H+L +IA +GL YL
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLW- 112
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMGTYGYCAPEYA 255
+ +++RD+K SN+L+ KL DFG++ + +N + +GT Y APE
Sbjct: 113 --SLKILHRDVKPSNMLVNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERI 165
Query: 256 RSGELTVKSDVYSFGVILLELITGR 280
+ + SDV+S G+ +EL GR
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 33/210 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLLHHPNLVNL 139
+GEG +G VYK + G++VA+K++ ++ E + E+ +L L+HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 140 --IGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEY 193
+ + + +L LV+EF+ D L PL I S Q G+ Y
Sbjct: 64 LDVVHS---ENKLYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
H V++RDLK N+L+ KL+DFGLA+ G + + + T Y APE
Sbjct: 115 CHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPE 169
Query: 254 Y---ARSGELTVKSDVYSFGVILLELITGR 280
+R V D++S G I E++ R
Sbjct: 170 ILLGSRQYSTPV--DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEV-LMLSLLHHPNLVNL 139
++G+G FG+V + +G+ AVK L + + KE + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
++ V +F++GG + HL +P R A A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLH---S 114
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++YRDLK NILL + L+DFGL K G + + T+ GT Y APE R
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 260 LTVKSDVYSFGVILLELITG 279
D + G +L E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 70/236 (29%), Positives = 122/236 (51%), Gaps = 33/236 (13%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVA-------VKQLDRNGMQGNKEFLVEVLMLS 129
+F + LG G G V K + +G ++A +K RN + + E+ +L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58
Query: 130 LLHHPNLVNLIG-YCADGDQRLLVYEFMSGGSVDDHLLDVNETKK-PLDWTTRMKIASGA 187
+ P +V G + +DG+ + + E M GGS+D L E K+ P + ++ IA
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KEAKRIPEEILGKVSIA--V 112
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMGT 246
+GL YL +K +++RD+K SNIL+ + + KL DFG++ G+ ++ + + +GT
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGT 165
Query: 247 YGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPI 301
Y +PE + +V+SD++S G+ L+EL GR I P D + L A + +P+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 85 LGEGGFGRVYKGT--LQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIG 141
LG G FG V KG ++ VA+K L + + E + E ++ L +P +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
C + + +LV E SGG ++ L + K + + +++ + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTY--GYCAPEYARSG 258
++RDL + N+LL K+SDFGL+K LG + +R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 259 ELTVKSDVYSFGVILLE 275
+ + +SDV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 53/230 (23%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLD---------RNGMQGNKEFLVEVLM 127
++ +GEG +G V T + G VA+K++ R L E+ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT--------LREIKI 56
Query: 128 LSLLHHPNLVNL------IGYCADGDQRLLVYEFM---------SGGSVDDHLLDVNETK 172
L H N++ + + + D +V E M + +DH+ +
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDV-YIVQELMETDLYKLIKTQHLSNDHI------Q 109
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG- 231
L R GL+Y+H AN V++RDLK SN+LL N D K+ DFGLA++
Sbjct: 110 YFLYQILR---------GLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157
Query: 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS-DVYSFGVILLELITGR 280
P+ + + + T Y APE + + K+ D++S G IL E+++ R
Sbjct: 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 68/236 (28%), Positives = 106/236 (44%), Gaps = 21/236 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
LLG+G FG+V ++ G+ A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHDKAN 199
D+ V E+ +GG + HL +++ + R + + L+YLH + N
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM-GTYGYCAPEYARSG 258
V+YRDLK N++L + K++DFGL K +G K T + GT Y APE
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 259 ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
+ D + GV++ E++ GR P Q+ + I + RFP P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELILMEEIRFPRTLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 85 LGEGGFGRVYKGT---LQSNGQV----VAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
LG+G F +++KG + G++ V +K LD++ ++ F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
G C GD+ ++V E++ GS+D + L N+ + W ++++A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTY-LKKNKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT--YGYCAPEYA 255
+ + ++ + N+LL D K + KL G + V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 256 R-SGELTVKSDVYSFGVILLELITG 279
L++ +D +SFG L E+ +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDR--NGMQGNKEFLVEVLMLSLLHHPNLVN---- 138
+G G +G V +G+ VA+K++ + K L E+ +L H N++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLH 195
L AD +V + M D H + + +PL T I Q GL+Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLMES---DLH--HIIHSDQPL---TEEHIRYFLYQLLRGLKYIH 124
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL---GPQGEKMNVTSRVMGTYGYCAP 252
AN VI+RDLK SN+L+ + + ++ DFG+A+ P K +T V T Y AP
Sbjct: 125 -SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRWYRAP 180
Query: 253 EYARS-GELTVKSDVYSFGVILLELITGRR 281
E S E T D++S G I E++ GRR
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 85 LGEGGFGRVYKGTL-------QSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLL-HHPN 135
LGEG FG+V + VAVK L + + LV E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHL---------LDVNETKKPLDWTTRMKIASG 186
++NL+G C ++ E+ S G++ ++L + K P + T + S
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 187 A---AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
A A+G+EYL A+ I+RDL + N+L+ + K++DFGLA+ + T+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ APE T +SDV+SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQL----DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+GEG +G V+K + ++VA+K++ D G+ + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ--------GLE 192
+ LV+E+ D L KK D + I + GL
Sbjct: 66 DVLHSDKKLTLVFEY-----CDQDL------KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
+ H V++RDLK N+L+ N + KL+DFGLA+ G + S + T Y P
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPP 168
Query: 253 EYARSGELTVKS-DVYSFGVILLELITGRRVIDTTRPVDEQ 292
+ +L S D++S G I EL R + VD+Q
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 66/238 (27%), Positives = 121/238 (50%), Gaps = 31/238 (13%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVA-------VKQLDRNGMQGNKEFLVEVLMLSL 130
+F + LG G G V+K + + +G ++A +K RN + + E+ +L
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLHE 59
Query: 131 LHHPNLVNLIG-YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ 189
+ P +V G + +DG+ + + E M GGS+D L + + K++ +
Sbjct: 60 CNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIK 114
Query: 190 GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMGTYG 248
GL YL +K +++RD+K SNIL+ + + KL DFG++ G+ ++ + + +GT
Sbjct: 115 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 167
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL-IAWAQPIFRDP 305
Y +PE + +V+SD++S G+ L+E+ GR I P D + L + + P+ DP
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP---PPDAKELELMFGCPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 32/238 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLIG 141
+G+GG+G+V+ + G++VA+K++ ++ + E L E +L+ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 142 YCADGDQRLLVYEFMSGGSVDDHL-----LDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
D + L E++ GG L L + + + M A A L Y+H
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF---YMAEMFEAVDALHELGYIH- 124
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
RDLK N L+ A+ KL+DFGL+K + + V+G+ Y APE R
Sbjct: 125 --------RDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLR 171
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE--QNLIAWAQ----PIFRDPKRF 308
D +S G +L E + G + P +E +NL W + P++ DP+
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-NETWENLKYWKETLQRPVYDDPRFN 228
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 17/217 (7%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLLHHPNLVNL 139
++G G + +V L+ ++ A+K + + + +++ + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 140 IGYCADGDQRLL-VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
C + RL V E+++GG D + + +K + R A + L YLH++
Sbjct: 62 HS-CFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG 116
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+IYRDLK N+LL + KL+D+G+ K G + + TS GT Y APE R
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGE 171
Query: 259 ELTVKSDVYSFGVILLELITGRRVIDTTRPVD--EQN 293
+ D ++ GV++ E++ GR D D +QN
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFL-----VEVLMLSLLHH-PNLVN 138
+G+G FG+VY+ + ++ A+K L + + KE +L+ +LL P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L LV ++MSGG + HL E + D + IA LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ--KEGRFSED-RAKFYIAE-LVLALEHLHKY- 115
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
++YRDLK NILL A L DFGL+K T+ GT Y APE
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 259 E-LTVKSDVYSFGVILLELITG 279
+ T D +S GV++ E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQV--VAVKQLDRNGMQGN-KEFLVEVLMLSLL-HHPN 135
LGEG FG+V + +V VAVK L + + + + + E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHL---------LDVNETKKPLDWTTRMKIASG 186
++NL+G C ++ E+ S G++ ++L N T+ P + + + S
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 187 A---AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
A A+G+EYL A+ I+RDL + N+L+ + K++DFGLA+ + T+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ APE T +SDV+SFGV+L E+ T
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 78/291 (26%), Positives = 117/291 (40%), Gaps = 52/291 (17%)
Query: 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIG 141
LGEG + VYKG + GQ+VA+K++ +G + E +L L H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 142 YCADGDQRLLVYEFMS---GGSVDDH--LLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
LV+E++ +DD L ++ + L R GL Y H
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR---------GLAYCHQ 121
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG-------Y 249
+ V++RDLK N+L+ + KL+DFGLA+ +V S+ TY Y
Sbjct: 122 RR---VLHRDLKPQNLLISERGELKLADFGLAR------AKSVPSK---TYSNEVVTLWY 169
Query: 250 CAPE-YARSGELTVKSDVYSFGVILLELITGRRVI-DTTRPVDEQNLI----------AW 297
P+ S E + D++ G I E+ TGR + +T D+ + I W
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 298 ----AQPIFRDPKRFPDMADPLLRKQFPEKGL-NEAVAIAAMCLQEEAGAR 343
+ P F+ P FP L P +A LQ E R
Sbjct: 230 PGVSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 85 LGEGGFGRVY-----KGTLQSNGQV---VAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPN 135
LG+G FG VY K + +V + V +L+ N +Q N E +LS L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL------DWTTRMKIASGAAQ 189
+V + D ++ E+ G +D L ++ T K L +W ++ +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 190 GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
G+ Y+H + +++RDLK+ NI L NL K+ DFG+++L ++ + GT Y
Sbjct: 118 GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 250 CAPEYARSGELTVKSDVYSFGVILLEL 276
+PE + KSD++S G IL E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
LLG+G FG+V ++ G+ A+K L + + E + E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHDKAN 199
D+ V E+ +GG + HL +++ + R + + LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
V+YRD+K N++L + K++DFGL K G T GT Y APE +
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDND 171
Query: 260 LTVKSDVYSFGVILLELITGR 280
D + GV++ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIG 141
+G G FG V+ T +G+ VA+K++ N Q K E+ ML H N+++ +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 142 YCADGD-----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLH 195
+ +V E M D H + V + +PL + +K+ +GL+YLH
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQS---DLHKIIV--SPQPLS-SDHVKVFLYQILRGLKYLH 120
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-Y 254
A +++RD+K N+L+ +N K+ DFGLA++ E ++T V+ Y Y APE
Sbjct: 121 -SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEIL 176
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
S T D++S G I EL+ R + P+ + +LI
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGMQGNKEFLVEVLMLSLLHHPNLVNLIG 141
+G G +G+V G+ VA+K+L R + + + + E+ +L + H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 142 -YCADG-----DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+ LV M L ++ + +K D + + +GL+Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLM-----GADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIH 135
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-- 253
A +I+RDLK SNI + + + K+ DFGLA+ ++M T V T Y APE
Sbjct: 136 -SAG--IIHRDLKPSNIAVNEDCELKILDFGLARH--TDDEM--TGYV-ATRWYRAPEIM 187
Query: 254 -----YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
Y + TV D++S G I+ EL+TG+ + + +D+ I
Sbjct: 188 LNWMHYNQ----TV--DIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 49/241 (20%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRN-------------GMQG-NKEFLVEVLMLSL 130
LGEG +G+V K G++VA+K++ GM G + L E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 131 LHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK------IA 184
+ H N++ L+ +GD LV + M+ + KK +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-----------DLKKVVDRKIRLTESQVKCIL 125
Query: 185 SGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA-------------KLG 231
GL LH ++RDL +NI + + K++DFGLA K
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 232 PQGEKMNVTSRVMGTYGYCAPEYARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVD 290
+ +TS+V+ T Y APE E D++S G I EL+TG+ + +D
Sbjct: 183 TMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241
Query: 291 E 291
+
Sbjct: 242 Q 242
|
Length = 335 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
LLG+G FG+V +++G+ A+K L + + E L E +L HP L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHDKAN 199
D+ V E+++GG + HL +++ + R + + L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++YRDLK N++L + K++DFGL K G T GT Y APE +
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDND 171
Query: 260 LTVKSDVYSFGVILLELITGR 280
D + GV++ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 40/218 (18%)
Query: 86 GEGGFGRVYKGTLQSN--GQVVAVKQLDRNGMQGNKEFLV--------EVLMLSLLHHPN 135
G G +GRVYK ++ G+ A+K+ +G+KE E+ +L L H N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 136 LVNLIGYC-ADGDQRL-LVYEFMSGGSVDD--HLLDVNETKKPLDWTTRMKIASGAAQ-- 189
+V+L+ D+ + L++++ + D ++ + K + M + S Q
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSM-VKSLLWQIL 118
Query: 190 -GLEYLHDKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTS-RV 243
G+ YLH V++RDLK +NIL+ K+ D GLA+L K V
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 244 MGTYGYCAPEY---ARSGELTVKSDVYSFGVILLELIT 278
+ T Y APE AR T D+++ G I EL+T
Sbjct: 176 VVTIWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-----EVLMLSLLH---HPNL 136
+G G +G VYK +G VA+K + +Q N++ L EV +L L HPN+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 137 VNLIGYCADG--DQRL---LVYEFMSGGSVDDHLLDVNETKKP--LDWTTRMKIASGAAQ 189
V L+ CA D+ LV+E VD L + P L T + +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFE-----HVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 190 GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
GL++LH +++RDLK NIL+ + KL+DFGLA++ +M +T V+ T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI--YSCQMALTPVVV-TLWY 173
Query: 250 CAPEYARSGELTVKSDVYSFGVILLEL 276
APE D++S G I E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 76/326 (23%), Positives = 129/326 (39%), Gaps = 74/326 (22%)
Query: 42 PAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSN 101
P PP + + + + + + + EL + +G G G VYK +
Sbjct: 46 PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPT 98
Query: 102 GQVVAVKQLDRNGMQGNKEFLV------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155
G++ A+K + GN E V E+ +L ++HPN+V + ++ EF
Sbjct: 99 GRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153
Query: 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG 215
M GGS++ + + + D +A G+ YLH + +++RD+K SN+L+
Sbjct: 154 MDGGSLEGT--HIADEQFLAD------VARQILSGIAYLHRRH---IVHRDIKPSNLLIN 202
Query: 216 ANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-------------YARSGELTV 262
+ + K++DFG++++ Q M+ + +GT Y +PE YA
Sbjct: 203 SAKNVKIADFGVSRILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYA------- 253
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRFPDMADPLLRK 318
D++S GV +LE GR R D WA + P P A R
Sbjct: 254 -GDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAICMSQPPEAPATASREFRH 306
Query: 319 QFPEKGLNEAVAIAAMCLQEEAGARP 344
+ CLQ E R
Sbjct: 307 ------------FISCCLQREPAKRW 320
|
Length = 353 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM----QGNKEFLVEVLMLSLLHHPNLVNL 139
L+ G +G VY + Q A+K++++ + Q + F VE +L+ +P +V++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 140 IGYCADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
+C+ +R L V E++ GG D L N P+D RM A LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGG--DCATLLKNIGALPVD-MARMYFAE-TVLALEYLH-- 118
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR--------------- 242
N +++RDLK N+L+ + KL+DFGL+K+G M++T+
Sbjct: 119 -NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG----LMSLTTNLYEGHIEKDTREFLD 173
Query: 243 --VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG 279
V GT Y APE D ++ G+IL E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 61/201 (30%), Positives = 88/201 (43%), Gaps = 14/201 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
LLG+G FG+V ++ G+ A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
D+ V E+ +GG + HL + +I S L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LGYLHSCD-- 115
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLG-PQGEKMNVTSRVMGTYGYCAPEYARSGE 259
V+YRDLK N++L + K++DFGL K G G M GT Y APE +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLEDND 171
Query: 260 LTVKSDVYSFGVILLELITGR 280
D + GV++ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 88/320 (27%), Positives = 136/320 (42%), Gaps = 41/320 (12%)
Query: 78 NFRQECLLGEGGFGRVY---KGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHH 133
NF +LG G +G+V+ K T G++ A+K L + + Q K ++L H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 134 ----PNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
P LV L Y + +L L+ +++SGG + HL + + ++ SG
Sbjct: 61 VRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEI 114
Query: 189 -QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
LE+LH ++YRD+K NILL + L+DFGL+K EK S GT
Sbjct: 115 ILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTI 170
Query: 248 GYCAPEYARSGELTVKS-DVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306
Y APE R K+ D +S G+++ EL+TG + Q+ + ++ I +
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKCDP 228
Query: 307 RFP--------DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
FP D+ LLRK P+K L A E P L + +
Sbjct: 229 PFPSFIGPEAQDLLHKLLRKD-PKKRLGAGPQGA-----SEIKEHPFFKG----LDWEAL 278
Query: 359 SKEPIPDPIIPSDEDEYSEG 378
+ + P PS +E G
Sbjct: 279 ALRKVNPPFRPSIRNELDVG 298
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 61/200 (30%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEV-LMLSLLHHPNLVNL 139
++G+G FG+V ++ + AVK L + + KE + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
D+ V ++++GG + HL + L+ R A+ A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARF-YAAEIASALGYLHSLN- 116
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++YRDLK NILL + L+DFGL K E TS GT Y APE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 260 LTVKSDVYSFGVILLELITG 279
D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 28/224 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGMQGNKEFLVEVLMLSLLHHPNLVNLIG 141
+G G +G V + VA+K++ N + K L E+ +L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA-KRTLREIKLLRHLDHENVIAIKD 71
Query: 142 YCADGDQR-----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ +VYE M D L + + + L +GL+Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH- 125
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY----GYCAP 252
AN V++RDLK SN+LL AN D K+ DFGLA+ + M Y Y AP
Sbjct: 126 SAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT------SEKGDFMTEYVVTRWYRAP 177
Query: 253 E-YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
E E T DV+S G I EL+ + + V + LI
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLI 221
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
Q L +H + +I+RD+KS+NILL +N KL DFG +K+ +V GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308
Y APE R + K+D++S GV+L EL+T + RP D +N+ + + K
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLK------RPFDGENM----EEVMH--KTL 258
Query: 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
DPL P E I L + RP
Sbjct: 259 AGRYDPL-----PPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 74/265 (27%), Positives = 113/265 (42%), Gaps = 38/265 (14%)
Query: 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVL 126
+L ++F ++G G FG V +S+ QV A+K L + M + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 127 MLSLLHHPNLVNLIGYCADGDQRLL--VYEFMSGGSVDDHLLDVNETKK---PLDWTTRM 181
+++ + +V L + A D + L V E+M GG + VN P W R
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL------VNLMSNYDIPEKWA-RF 146
Query: 182 KIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVT 240
A L+ +H I+RD+K N+LL + KL+DFG K+ G M
Sbjct: 147 YTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG--MVRC 200
Query: 241 SRVMGTYGYCAPEYARS----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296
+GT Y +PE +S G + D +S GV L E++ G DT P +L+
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DT--PFYADSLVG 254
Query: 297 WAQPIF--RDPKRFPDMADPLLRKQ 319
I ++ FPD D + KQ
Sbjct: 255 TYSKIMDHKNSLTFPD--DIEISKQ 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 29/249 (11%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLLHHPNLVNL 139
++GEG +G V K + ++VA+K+ + + N+E L E+ ML L N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+ LV+E++ ++ LL+ P + K+ S Q ++ +H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHK 118
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+++RD+K N+L+ N KL DFG A+ +G N T V T Y +PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVD--------------EQNLIAWAQPIFRDP 305
D++S G IL EL G+ + +D EQ + ++ P F
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG- 236
Query: 306 KRFPDMADP 314
RFP + P
Sbjct: 237 LRFPAVNHP 245
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 78 NFRQECLLGEGGFGRVY---KGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHH 133
NF +LG G +G+V+ K + +G++ A+K L + + Q K +L H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 134 ----PNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA- 187
P LV L Y D +L L+ ++++GG + HL K+ ++I SG
Sbjct: 61 IRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYSGEI 114
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
LE+LH +IYRD+K NILL +N L+DFGL+K + E S GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTI 170
Query: 248 GYCAPEYARSGELTVKS--DVYSFGVILLELITG 279
Y AP+ R G+ D +S GV++ EL+TG
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 87/358 (24%), Positives = 150/358 (41%), Gaps = 54/358 (15%)
Query: 10 QKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTF 69
+K+ KANK + ++ K E ++ N G +DE K I+
Sbjct: 15 EKNHKANKGGSGKF--EMNDKKLDEEERSHN---------NNAGEDEDEEKMIDNDINR- 62
Query: 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLS 129
+ K+++ ++G G FG VY+ + VA+K++ ++ N+E L+ +
Sbjct: 63 ----SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MK 114
Query: 130 LLHHPNLVNLIGY----CADGDQRLL----VYEFMSGGSVDDHLLDVNETKKPLDWTTRM 181
L+H N++ L Y C +++ + V EF+ +V ++ L
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVK 173
Query: 182 KIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP-KLSDFGLAK--LGPQGEKMN 238
+ + L Y+H K + +RDLK N+L+ N KL DFG AK L Q
Sbjct: 174 LYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230
Query: 239 VTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE------ 291
+ SR Y APE + T D++S G I+ E+I G + VD+
Sbjct: 231 ICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
Query: 292 ------QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR 343
++ + P + D K FPD+ L+K FP+ ++A+ + L+ E R
Sbjct: 286 VLGTPTEDQLKEMNPNYADIK-FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQV----------VAVKQLDRNGMQGNKEFLVEVLMLSLLHHP 134
LG+G F +YKG L+ + V +K L + + + F ++S L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
+LV L G C D+ ++V E++ G +D L + L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPLDVF-LHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC---- 250
DK +++ ++ NIL+ A KL G + V SR
Sbjct: 118 EDKK---LVHGNVCGKNILV-ARYGLNEGYVPFIKLSDPGIPITVLSR-----EERVERI 168
Query: 251 ---APEYARSGE--LTVKSDVYSFGVILLEL 276
APE R+G+ LT+ +D +SFG LLE+
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 13/202 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQV--VAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLIG 141
+G G FG+V + ++ V V VK+L N + EFL + +L HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
C + LLV+E+ G + +L ++ ++A A G+ ++H K N
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHN-- 119
Query: 202 VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS---- 257
++ DL N L ++L K+ D+G+ + + + + APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 258 ---GELTVKSDVYSFGVILLEL 276
E T S+V++ GV L EL
Sbjct: 180 LITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIGYC 143
LGEG + V+KG + +VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 144 ADGDQRLLVYEFMSGG---SVDD--HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
LV+E++ +DD +++ ++ K L R GL Y H +
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR---------GLAYCHRRK 124
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARS 257
V++RDLK N+L+ + KL+DFGLA+ + S + T Y P+ S
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 258 GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
E + + D++ G I E+ +GR + + DE +LI
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 11/215 (5%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIGYC 143
LGEG + VYKG + NGQ+VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ V+E+M D + + L +GL Y+H + ++
Sbjct: 73 HTKETLTFVFEYMH----TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---IL 125
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARSGELTV 262
+RDLK N+L+ + KL+DFGLA+ +S V+ T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSS 183
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297
D++ G I +E++ G+ V EQ W
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR--NGMQGNKEFLVEVLMLSLLHHPNL 136
++ + ++G+G +G V G+ VA+K+++ + L E+ +L LL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 137 VNLIGYCADGDQR-----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ-- 189
V + +R +V+E M D+++ K D T Q
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES--------DLHQVIKANDDLTPEHHQFFLYQLL 113
Query: 190 -GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV--TSRVMGT 246
L+Y+H AN V +RDLK NIL A+ K+ DFGLA++ + T V T
Sbjct: 114 RALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV-AT 169
Query: 247 YGYCAPEYARS--GELTVKSDVYSFGVILLELITGR 280
Y APE S + T D++S G I E++TG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 26/240 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G G V+ + VAVK++ Q K L E+ ++ L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 145 DGDQRL--------------LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
L +V E+M + L +V E + R+ +G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARL-FMYQLLRG 126
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYG 248
L+Y+H AN V++RDLK +N+ + +L K+ DFGLA+ + P S + T
Sbjct: 127 LKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 249 YCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307
Y +P S T D+++ G I E++TG+ + +++ LI + P+ R+ R
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 43/110 (39%), Positives = 60/110 (54%), Gaps = 8/110 (7%)
Query: 190 GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK---LGPQGEKMNVTSRVMGT 246
GL+Y+H AN V++RDLK N+L+ A+ + K+ DFGLA+ P +T V T
Sbjct: 117 GLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172
Query: 247 YGYCAPEYARSGELTVKS-DVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
Y APE S + K+ DV+S G IL EL+ + V VD+ N I
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIGYC 143
LGEG + V+KG + +VA+K++ +G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA-------QGLEYLHD 196
LV+E++ ++ K+ LD + +GL Y H
Sbjct: 73 HTERCLTLVFEYLD-----------SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YA 255
+ +++RDLK N+L+ + KL+DFGLA+ K S + T Y P+
Sbjct: 122 RK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLL 176
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
S E + D++ G IL E+ TGR + + +E +LI
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 22/236 (9%)
Query: 48 IHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQS-NGQVVA 106
+ ++ D TK R+ ++F LG G FGRV T ++ + VA
Sbjct: 7 LQLHKKKDSDSTKEPK------RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVA 60
Query: 107 VKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDD 163
+K+ +++ + K+ E +L+ ++HP VNL G D LV EF+ GG
Sbjct: 61 IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT 120
Query: 164 HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223
L K A+ EYL ++YRDLK N+LL + K++
Sbjct: 121 FL----RRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMT 173
Query: 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG 279
DFG AK+ T + GT Y APE + +D ++ G+ + E++ G
Sbjct: 174 DFGFAKVVD-----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLD-RNGMQGNKEFL-VEVLMLSLLHHPNLVNLIGY 142
+G+G +G V +++G+ +K+L+ RN + ++ E +LS L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 143 CADGDQRL-LVYEFMSGGSVDDHLLDVNETKKP----LDWTTRMKIASGAAQGLEYLHDK 197
D L +V F GG + L + P ++W ++ +A L+YLH+K
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLHEK 121
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
+++RDLK+ N+ L K+ D G+A++ M S ++GT Y +PE +
Sbjct: 122 H---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM--ASTLIGTPYYMSPELFSN 176
Query: 258 GELTVKSDVYSFGVILLELIT 278
KSDV++ G + E+ T
Sbjct: 177 KPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 34/274 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIGYC 143
LGEG + VYKG + NG++VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 144 ADGDQRLLVYEFMSGG---SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
+ LV+E++ +D H ++ L ++ GL Y+H +
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY-- 123
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARSGE 259
+++RDLK N+L+ + KL+DFGLA+ + + S + T Y P+ S E
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ-----------NLIAW----AQPIFRD 304
+ D++ G I +E+I G + + +Q N W + P F+
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK- 239
Query: 305 PKRFPDMADPLLRKQFPEKG-LNEAVAIAAMCLQ 337
P+RF + LR+ + + +N A +A+ LQ
Sbjct: 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQ 273
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 21/203 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLIGYC 143
LGEG + VYKG + +VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 144 ADGDQRLLVYEFMSGG---SVDD--HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
LV+E++ +DD + ++++ K L R GL Y H +
Sbjct: 74 HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR---------GLNYCHRRK 124
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARS 257
V++RDLK N+L+ + KL+DFGLA+ K S + T Y P+ S
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGS 179
Query: 258 GELTVKSDVYSFGVILLELITGR 280
+ + + D++ G I E+ TGR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 81/292 (27%), Positives = 118/292 (40%), Gaps = 27/292 (9%)
Query: 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRD 206
D+ LL+ E+ SGG ++ + + P + L+ +H + +++RD
Sbjct: 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRD 194
Query: 207 LKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDV 266
LKS+NI L KL DFG +K ++V S GT Y APE + K+D+
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254
Query: 267 YSFGVILLELITGRRVID--TTRPVDEQNLIAWAQPIFRDP--KRFPDMADPLLRKQFPE 322
+S GVIL EL+T R + R + +Q L P F P + DPLL K
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP-FPCPVSSGMKALLDPLLSKNPAL 313
Query: 323 KGL------NEAVAIAAMCLQEEAGARPLMS--DVVTALSFLSNSKEPIPDP------II 368
+ E + A Q+ +S D L L S E P P ++
Sbjct: 314 RPTTQQLLHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQESGERAPPPSSIRYGVV 373
Query: 369 PSD--EDEYSEGYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERI 418
SD Y YSSD K Y + + SEN E N G P+ +
Sbjct: 374 TSDVTHGGYLYKYSSDMRWKKRYFYIGNGQLRISLSENPE---NDGVAPKSV 422
|
Length = 478 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 35/226 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDR--NGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
+G G +G V G VAVK+L R + K E+ +L + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 143 CADG------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ LV M L ++ + +K D + I +GL+Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGA-----DLNNIVKCQKLTDDHVQFLIYQ-ILRGLKYIH- 137
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
+ +I+RDLK SN+ + + + K+ DFGLA+ ++M GY A + R
Sbjct: 138 --SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT---------GYVATRWYR 184
Query: 257 SGEL-------TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
+ E+ D++S G I+ EL+TGR + T +D+ LI
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 18/150 (12%)
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL--DWTTRMKIASGAAQGL 191
PN+V L Y D LV + GG + H+ + W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG-LAKLGPQGEKMNVTSRVMGTYGYC 250
+ LH + ++ RDL +NILL +L+ F +++ + V + YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 251 APEYARSGELTVKSDVYSFGVILLELITGR 280
APE E T D +S G IL EL+TG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 102 GQVVAVKQLDR---NGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-------L 151
GQ VA+K+L R N + + VLM L++H N++ L+ + L L
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNHKNIIGLLN-VFTPQKSLEEFQDVYL 98
Query: 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSN 211
V E M D +L V + LD + G+++LH + +I+RDLK SN
Sbjct: 99 VMELM-----DANLCQV--IQMDLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSN 148
Query: 212 ILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGV 271
I++ ++ K+ DFGLA+ G +T V+ Y Y APE D++S G
Sbjct: 149 IVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 205
Query: 272 ILLELITGRRVIDTTRPVDEQNLI 295
I+ E+I G + T +D+ N I
Sbjct: 206 IMGEMIRGTVLFPGTDHIDQWNKI 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 23/226 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGMQGNKEFLVEVLMLSLLHH 133
K ++Q +G G G V G VAVK+L R N + + E+++L ++H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNH 79
Query: 134 PNLVNLIGY------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA 187
N+++L+ + LV E M D +L V + LD +
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHME--LDHERMSYLLYQM 132
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
G+++LH +I+RDLK SNI++ ++ K+ DFGLA+ M T V+ Y
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY 187
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN 293
Y APE D++S G I+ EL+ G + T +D+ N
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 58/266 (21%), Positives = 102/266 (38%), Gaps = 40/266 (15%)
Query: 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH 132
A+ + L G GRV+ T V +K G +G L+E ++L ++
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVN 115
Query: 133 HPNLVNLIGYCADGDQRLLV--------YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIA 184
HP+++ + G +V Y +++ S +PL + I
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------------RPLPIDQALIIE 163
Query: 185 SGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM 244
+GL YLH + +I+RD+K+ NI + + D G A+ P + +
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LA 217
Query: 245 GTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVD--------EQNLIA 296
GT APE + K+D++S G++L E++ I P +L+
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277
Query: 297 WAQPIFRDPKRFPDMADPLLRKQFPE 322
+ P+ FP L + F E
Sbjct: 278 IISTLKVHPEEFPRDPGSRLVRGFIE 303
|
Length = 357 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 18/196 (9%)
Query: 92 RVYKGTLQSNGQVVAVKQL--DRNGMQGNKE-FLVEVLMLSLLHHPNLVNLIGYCADGDQ 148
+YKG N + V ++ G + + E+ L + N++ + G+ D
Sbjct: 35 SIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 149 RL----LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
L L+ E+ + G +L +V + +K L + T++ +A +GL L+ N P Y
Sbjct: 93 DLPRLSLILEYCTRG----YLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
++L S + L+ N K+ GL K+ NV V +Y ++ E T+K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKD 203
Query: 265 DVYSFGVILLELITGR 280
D+YS GV+L E+ TG+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVL 126
R+L +++ ++G G FG V +S+ +V A+K L + M + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 127 MLSLLHHPNLVNLIGYCADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIA 184
+++ + P +V L +CA D + L V E+M GG + + + + + +K + T
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT----- 148
Query: 185 SGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV- 243
+ L+ +H +I+RD+K N+LL + KL+DFG KM+ T V
Sbjct: 149 AEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM------KMDETGMVR 199
Query: 244 ----MGTYGYCAPEYARS----GELTVKSDVYSFGVILLELITG 279
+GT Y +PE +S G + D +S GV L E++ G
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLD---RNGMQGNKEFLVEV-LMLSLLHHPNLVNLI 140
+GEG F V K + G+ A+K + ++ Q N L E+ + L HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 141 GYCADGDQ-RL-LVYEFMSGGSVDDHLLD-VNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
D RL LV+E M D +L + + K+PL + L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR-----VMGTYGYCAP 252
+ +RD+K NIL+ ++ KL+DFG + + S+ + T Y AP
Sbjct: 120 G---IFHRDIKPENILIKDDI-LKLADFGSCR--------GIYSKPPYTEYISTRWYRAP 167
Query: 253 E-YARSGELTVKSDVYSFGVILLELIT 278
E G K D+++ G + E+++
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 70/261 (26%), Positives = 109/261 (41%), Gaps = 38/261 (14%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHH 133
K+F + L+G G FG V ++ G + A+K + ++ + + F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD------WTTRMKIASGA 187
P + L D D LV E+ GG D L +N + D + + +A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
+ Y+H RD+K N+L+ KL+DFG A + +N V GT
Sbjct: 118 VHQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTP 167
Query: 248 GYCAPEYARS------GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301
Y APE + G V+ D +S GVI E+I GR P E I
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPFHEGTSAKTYNNI 221
Query: 302 --FRDPKRFPDMADPLLRKQF 320
F+ +FP+ DP + F
Sbjct: 222 MNFQRFLKFPE--DPKVSSDF 240
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 74/277 (26%), Positives = 107/277 (38%), Gaps = 104/277 (37%)
Query: 85 LGEGGFGRVYK----GTLQSNG-QVVAVKQLDRNGMQGN--KEFLVEV-LMLSLLHHPNL 136
LG G FG+V + G +S + VAVK L + G + K + E+ +++ + HH N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHHLNV 73
Query: 137 VNLIG--------------YCADGD--------------------------------QRL 150
VNL+G YC G+ QRL
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 151 LVYE-----FMSGGSVDDHLLDVNET-------KKPLDWTTRMKIASGAAQGLEYLHDKA 198
SG D L DV E K+PL + + A+G+E+L A
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+ I+RDL + NILL N K+ DFGLA+ Y P+Y R G
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLAR-----------------DIYKDPDYVRKG 233
Query: 259 E-----------------LTVKSDVYSFGVILLELIT 278
+ T +SDV+SFGV+L E+ +
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQ--LDRNGMQGNKEFLVEVLMLSLLHHPNLVNL--I 140
+GEG +G VYK + + +A+K+ L++ + E+ +L + H N+V L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 141 GYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK-----IASGAAQ---GL 191
+ ++RL LV+E++ LD+ KK +D + I + Q G+
Sbjct: 70 VHS---EKRLYLVFEYLD--------LDL---KKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDP-KLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
Y H V++RDLK N+L+ + KL+DFGLA+ G + + + T Y
Sbjct: 116 AYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYR 170
Query: 251 APE-YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE 291
APE S + D++S G I E++ + + +DE
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 52/266 (19%)
Query: 85 LGEGGFGRV---YKGTLQSNGQVVAVKQLDR--NGMQGNKEFLVEVLMLSLLHHPNLVNL 139
+G G G V Y L N VA+K+L R K E++++ ++H N+++L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 140 IGY------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
+ + LV E M D +L V + + LD + G+++
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQME--LDHERMSYLLYQMLCGIKH 134
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
LH +I+RDLK SNI++ ++ K+ DFGLA+ G +T V+ Y Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPE 188
Query: 254 YARSGELTVKSDVYSFGVILLELI------TGRRVIDTTRPVDEQ------NLIAWAQPI 301
D++S G I+ E++ GR ID V EQ + QP
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 302 FRD-------------PKRFPDMADP 314
R+ PK FPD P
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFP 274
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 83/337 (24%), Positives = 119/337 (35%), Gaps = 80/337 (23%)
Query: 84 LLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH---HPN 135
+LG G FG+V + + +S+ VAVK L + L+ L + L+H H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI-LIHIGNHLN 72
Query: 136 LVNLIGYCADGDQRLLV-YEFMSGGSVDDHLLDVNETKKPLDWTT--------------- 179
+VNL+G C + L+V EF G++ + L E P +
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 180 -RMKIASGAAQGLEYLHDK-----ANPP-------------------------------- 201
+I +G A L NPP
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 202 --VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
I+RDL + NILL N K+ DFGLA+ + + APE
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ 319
T +SDV+SFGV+L E+ + L A P + + F R +
Sbjct: 253 YTTQSDVWSFGVLLWEIFS---------------LGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 320 FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356
PE E I C Q + RP S +V L L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM----LSLLHHPNLVNLIGYC 143
G FG+VY G ++N ++ AVK + + M NK + +V L+L P +V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ LV E++ GG V L D +K S A L+YLH +I
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHRHG---II 126
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKL 230
+RDLK N+L+ KL+DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 28/255 (10%)
Query: 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVL 126
R+L +++ ++G G FG V +S +V A+K L + M + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 127 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKK-PLDWTTRMKIAS 185
+++ + P +V L D +V E+M GG + + + + + +K +T + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVM 244
A + ++H RD+K N+LL + KL+DFG K+ +G M +
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAV 204
Query: 245 GTYGYCAPEYARS----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300
GT Y +PE +S G + D +S GV L E++ G DT P +L+
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DT--PFYADSLVGTYSK 258
Query: 301 IF--RDPKRFPDMAD 313
I ++ FPD D
Sbjct: 259 IMNHKNSLTFPDDND 273
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 85 LGEGGFGRVYKGTLQ----------SNGQVVAV--KQLDRNGMQGNKEFLVEVLMLSLLH 132
LG G ++Y G L S + + V K LD + + F M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
H ++V L G C + ++V EF+ G +D L ++ L + K+A A L
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD---LFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 193 YLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKLGPQGEKMNVTSR--VMGTYGY 249
YL DK +++ ++ + NILL +D + F KL G + V SR + +
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERIPW 174
Query: 250 CAPEYAR-SGELTVKSDVYSFGVILLEL 276
APE S L++ +D +SFG L E+
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 49/212 (23%), Positives = 81/212 (38%), Gaps = 32/212 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQ--LDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
+ + K +VAVK+ LD + K E++ L HPN++ +
Sbjct: 10 FEDLMIVHLAKHK--PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
+ +V M+ GS +D LL + L I L+Y+H K
Sbjct: 68 FIVDSELYVVSPLMAYGSCED-LLK-THFPEGLPELAIAFILKDVLNALDYIHSKG---F 122
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVMGTYGYCAPEYAR----- 256
I+R +K+S+ILL + LS + + G++ V + P+ +
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV--------HDFPKSSVKNLPW 174
Query: 257 -SGEL--------TVKSDVYSFGVILLELITG 279
S E+ KSD+YS G+ EL G
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 40/127 (31%), Positives = 66/127 (51%), Gaps = 16/127 (12%)
Query: 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA 216
S S D+ + E PLD ++ +S AQG+++L K I+RD+ + N+LL
Sbjct: 194 SSDSKDE---EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTD 247
Query: 217 NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG-----YCAPEYARSGELTVKSDVYSFGV 271
K+ DFGLA+ + MN ++ V+ + APE TV+SDV+S+G+
Sbjct: 248 GRVAKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 302
Query: 272 ILLELIT 278
+L E+ +
Sbjct: 303 LLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVK----QLDRNGMQGNKEFLVEV-LMLSLLHHPNLVNL 139
+GEG +G+VYK ++ G++VA+K ++D G+ L E+ L+ L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 140 IGY----CADGDQRL-LVYEFMSGGSVDDHLLDVNETK--KPLDWTTRMKIASGAAQGLE 192
+ +G L LV+E++ S +D N +PL T +G+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLD--SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDP-KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
+ H V++RDLK N+L+ K++D GL + K + T ++ T Y A
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIV-TLWYRA 179
Query: 252 PE-YARSGELTVKSDVYSFGVILLELITG 279
PE S + D++S G I E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 85 LGEGGFGRV---YKGTLQSNGQVVAVKQLDR---NGMQGNKEFLVEVLMLSLLHHPNLVN 138
+G G G V Y L+ N VA+K+L R N + + E++++ ++H N++
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIG 87
Query: 139 LIGY------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
L+ + +V E M D +L V + + LD + G++
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQME--LDHERMSYLLYQMLCGIK 140
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
+LH +I+RDLK SNI++ ++ K+ DFGLA+ G +T V+ Y Y AP
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAP 194
Query: 253 EYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
E D++S G I+ E+I G + T +D+ N +
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 63/235 (26%), Positives = 111/235 (47%), Gaps = 30/235 (12%)
Query: 83 CLLGEGGFGRVYKGTLQ--SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
C +G G +G VYK + + + A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQ 64
Query: 141 G-YCADGDQRL-LVYEFMSGGSVDDHLLDVNET----KKPLDWTTRM--KIASGAAQGLE 192
+ + D+++ L++++ H++ + KKP+ M + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 193 YLHDKANPPVIYRDLKSSNIL-LGANLDP---KLSDFGLAKLGPQGEK-MNVTSRVMGTY 247
YLH AN V++RDLK +NIL +G + K++D G A+L K + V+ T+
Sbjct: 123 YLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 248 GYCAPEYARSGELTVKS-DVYSFGVILLELITGRRV-------IDTTRPVDEQNL 294
Y APE K+ D+++ G I EL+T + I T+ P L
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 70/268 (26%), Positives = 122/268 (45%), Gaps = 39/268 (14%)
Query: 83 CLLGEGGFGRVYKGTLQ--SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
C +G G +G VYK + + + A+KQ++ G+ + E+ +L L HPN++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQ 64
Query: 141 G-YCADGDQRL-LVYEFMSGGSVDDHLLDVNET----KKPLDWTTRM--KIASGAAQGLE 192
+ + D+++ L++++ H++ + KKP+ M + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 193 YLHDKANPPVIYRDLKSSNIL-LGANLDP---KLSDFGLAKLGPQGEK-MNVTSRVMGTY 247
YLH AN V++RDLK +NIL +G + K++D G A+L K + V+ T+
Sbjct: 123 YLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 248 GYCAPEYARSGELTVKS-DVYSFGVILLELITGRRV-------IDTTRPVDEQNLIAW-- 297
Y APE K+ D+++ G I EL+T + I T+ P L
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 298 -----AQPIFRDPKRFPDMADPLLRKQF 320
A + D ++ P+ P L+K F
Sbjct: 240 VMGFPADKDWEDIRKMPEY--PTLQKDF 265
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 66/257 (25%), Positives = 103/257 (40%), Gaps = 36/257 (14%)
Query: 96 GTLQSNGQ--VVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153
+NG+ V +K LD + F ++S + H +L + G C G + ++V
Sbjct: 36 VEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVE 95
Query: 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213
EF+ G + D L + + P+ W ++ +A A L YL DK +++ ++ + NIL
Sbjct: 96 EFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNIL 149
Query: 214 LG-ANLDPKLSDFGLAKLGPQGEKMNVTSRV--MGTYGYCAPEYARSG-ELTVKSDVYSF 269
L L S F KL G SR + + APE G L+ +D +SF
Sbjct: 150 LARLGLAEGTSPF--IKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSF 207
Query: 270 GVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ--FPEKGLNE 327
G LLE+ D P+ E R P + K+ PE E
Sbjct: 208 GTTLLEI-----CFDGEVPLKE---------------RTPSEKERFYEKKHRLPEPSCKE 247
Query: 328 AVAIAAMCLQEEAGARP 344
+ + CL E RP
Sbjct: 248 LATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLI 140
++G G FG V +++ GQV A+K L++ M E F E +L + NL
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD----WTTRMKIASGAAQGLEYLHD 196
D + LV ++ GG + LL E + P D + M +A + L Y+H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH- 125
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFG-LAKLGPQGEKMNVTSRV-MGTYGYCAPEY 254
RD+K N+LL N +L+DFG +L G V S V +GT Y +PE
Sbjct: 126 --------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG---TVQSNVAVGTPDYISPEI 174
Query: 255 ARS-----GELTVKSDVYSFGVILLELITG 279
++ G + D +S GV + E++ G
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 39/154 (25%), Positives = 60/154 (38%), Gaps = 23/154 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLV-NLIG 141
LL G RVY L + + +K ++E EV +L LL V ++
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVLA 60
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201
L+ E++ G + L +V+E +K IA A+ L LH
Sbjct: 61 SGESDGWSYLLMEWIEGET----LDEVSEEEKE-------DIAEQLAELLAKLHQLPLLV 109
Query: 202 VIYRDLKSSNILLGANLDPKLS---DFGLAKLGP 232
+ + DL NIL+ D K+ D+ A GP
Sbjct: 110 LCHGDLHPGNILVD---DGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM------LSLLHHPNL 136
+G G +G V + G+ VA+K+L R F E+ L+LL H
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-------PFQSEIFAKRAYRELTLLKHMQH 73
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVD---DHLLDVNETKKPLDWTTRMKIASGAAQ---- 189
N+IG L+ F S S D D L + + L ++ Q
Sbjct: 74 ENVIG---------LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVY 124
Query: 190 ----GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMG 245
GL+Y+H +I+RDLK N+ + + + K+ DFGLA+ +T V+
Sbjct: 125 QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV- 176
Query: 246 TYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGR 280
T Y APE + D++S G I+ E++TG+
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 65/265 (24%), Positives = 99/265 (37%), Gaps = 74/265 (27%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGNKEFLVEVL--MLSLLHHPNLV 137
LG G FG+V + + + VAVK L L+ L ++ + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 138 NLIG--------------YCADGD---------QRLLVYEFMSG---------------- 158
NL+G +C G+ + Y+
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 159 ----------------GSVDDH-LLDVNET--------KKPLDWTTRMKIASGAAQGLEY 193
G V++ L DV E KK L + + A+G+E+
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
L A+ I+RDL + NILL N K+ DFGLA+ + + APE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 254 YARSGELTVKSDVYSFGVILLELIT 278
T++SDV+SFGV+L E+ +
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 25/243 (10%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLI 140
++G G FG V L++ +V A+K L++ M E F E +L + + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD----WTTRMKIASGAAQGLEYLHD 196
D + LV ++ GG + LL E + P D + M IA + L Y+H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH- 125
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFG-LAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
RD+K NIL+ N +L+DFG KL G +S +GT Y +PE
Sbjct: 126 --------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDYISPEIL 175
Query: 256 RS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310
++ G+ + D +S GV + E++ G V+ I + F+ P + D
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235
Query: 311 MAD 313
+++
Sbjct: 236 VSE 238
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 64/244 (26%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---------QGNKEFLVEVLMLSLLHHP 134
++G G FG V + G + A+K+L ++ M + ++ L E +P
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA------DNP 61
Query: 135 NLVNLIGYCA--DGDQRLLVYEFMSGGSVDDHLLDVNE-TKKPLDWTTRMKIASGAAQGL 191
+V L Y + D + L+ E++ GG + L+ + T++ TR IA +
Sbjct: 62 WVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE----ETRFYIAE-TILAI 114
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK---------------------- 229
+ +H K I+RD+K N+LL A KLSDFGL
Sbjct: 115 DSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 230 ----LGPQGEKMNVTS-----RVM-----GTYGYCAPEYARSGELTVKSDVYSFGVILLE 275
P K + R + GT Y APE + D +S GVI+ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 276 LITG 279
++ G
Sbjct: 232 MLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 9e-06
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 35/222 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDR--NGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142
+G G +G V Q VAVK+L R + + E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 143 ------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ ++ LV M L ++ + +K D + I +GL+Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGA-----DLNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHS 136
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
+I+RDLK SN+ + + + ++ DFGLA+ ++M GY A + R
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT---------GYVATRWYR 182
Query: 257 SGELTVK-------SDVYSFGVILLELITGRRVIDTTRPVDE 291
+ E+ + D++S G I+ EL+ G+ + +D+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 48/164 (29%), Positives = 71/164 (43%), Gaps = 12/164 (7%)
Query: 124 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
EV++ HPN++ G ++ FM+ GS + LL + + I
Sbjct: 49 EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN-SLLK-TYFPEGMSEALIGNI 106
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG-LAKLGPQGEKMNVTSR 242
GA +GL YLH I+R++K+S+IL+ + LS L L G+K V
Sbjct: 107 LFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163
Query: 243 V----MGTYGYCAPEYARSG--ELTVKSDVYSFGVILLELITGR 280
+ +PE R VKSD+YS G+ EL TGR
Sbjct: 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 15/96 (15%)
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMG--- 245
+GL+Y+H +I+RDLK N+ + + + K+ DFGLA+ S + G
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVV 177
Query: 246 TYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGR 280
T Y APE + T D++S G I+ E++TG+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 62/251 (24%), Positives = 106/251 (42%), Gaps = 41/251 (16%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVE--VLM------LSLLH 132
++G G FG V ++ ++ A+K L++ M E F E VL+ ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD----WTTRMKIASGAA 188
+ D + LV ++ GG + LL E + P D + M +A +
Sbjct: 68 YA--------FQDENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG-LAKLGPQGEKMNVTSRVMGTY 247
L Y+H RD+K N+LL N +L+DFG K+ G +S +GT
Sbjct: 119 HQLHYVH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTP 167
Query: 248 GYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302
Y +PE ++ G+ + D +S GV + E++ G V+ I + F
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227
Query: 303 RDPKRFPDMAD 313
+ P D+++
Sbjct: 228 QFPSHITDVSE 238
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 18/163 (11%)
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A+G+ +L K I+RDL + NILL K+ DFGLA+ V
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307
+ APE + T +SDV+S+G++L E+ + PVD +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---------------K 325
Query: 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVV 350
F M R PE +E I C + RP +V
Sbjct: 326 FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 7/82 (8%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLL-HHPNLV 137
LG G FG+V + T + N VAVK L + +E L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 138 NLIGYCADGDQRLLVYEFMSGG 159
NL+G C G L++ E+ G
Sbjct: 106 NLLGACTHGGPVLVITEYCCYG 127
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 38/206 (18%)
Query: 112 RNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV--------YEFMSGGSVDD 163
+ G + + E+L L L+H N++ + ++ Y FM
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE---- 256
Query: 164 HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223
+ +PL TR I +EY+HDK +I+RD+K NI L + L
Sbjct: 257 ---AFDWKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLG 309
Query: 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARSGELTVKSDVYSFGVILLELITG--- 279
DFG A + + E+ +GT +PE A G + +D++S G+ILL++++
Sbjct: 310 DFGTA-MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFC 367
Query: 280 -------------RRVIDTTRPVDEQ 292
++ID+ DE+
Sbjct: 368 PIGDGGGKPGKQLLKIIDSLSVCDEE 393
|
Length = 501 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 31/113 (27%), Positives = 48/113 (42%), Gaps = 5/113 (4%)
Query: 170 ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA- 228
+ PL + I + L YLH + +I+RD+K+ NI L + L DFG A
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC 233
Query: 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRR 281
KL + GT +PE K+D++S G++L E+
Sbjct: 234 KLDAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 46/167 (27%), Positives = 71/167 (42%), Gaps = 20/167 (11%)
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A G+E+L A+ ++RDL + N+L+ K+ DFGLA+ +
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP-K 306
+ APE + T SDV+SFG++L E+ T P++EQ F + K
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---------FYNAIK 356
Query: 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
R MA P +E I C +E+ RP S +V +
Sbjct: 357 RGYRMAK-------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 32/88 (36%), Positives = 43/88 (48%), Gaps = 7/88 (7%)
Query: 85 LGEGGFGRVYKGTLQ--SNGQV---VAVKQLDRNGMQGNKEFLVEVL--MLSLLHHPNLV 137
LG G FGRV + T S+ Q VAVK L K+ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHL 165
NL+G C G ++ E+ G + D+L
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 43/169 (25%), Positives = 65/169 (38%), Gaps = 21/169 (12%)
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A+G+E+L A+ ++RDL + N+LL K+ DFGLA+
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307
+ APE T SDV+S+G++L E+ + VD
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--------------- 348
Query: 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL---MSDVVTAL 353
F + R P+ E I C E RP +SD+V +L
Sbjct: 349 FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVL----MLSLLHH 133
+F ++G+G FG V + G++ A+K L ++ M K+ L V +L+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDS 60
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P +V+L D L+ EF+ GG + L+ + + + TR +A +E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAE-CVLAIEA 116
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228
+H I+RD+K NIL+ KLSDFGL+
Sbjct: 117 VHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 29/100 (29%), Positives = 44/100 (44%), Gaps = 4/100 (4%)
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240
+ I + ++YLH+ +I+RD+K+ NI + D L DFG A P N
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKY 240
Query: 241 SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
GT APE D++S G++L E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 7/78 (8%)
Query: 85 LGEGGFGRVYKGT----LQSNGQV-VAVKQLDRNGMQGNKEFLV-EVLMLSLL-HHPNLV 137
LG G FG+V + T +S+ + VAVK L + +E L+ E+ +LS L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 138 NLIGYCADGDQRLLVYEF 155
NL+G C G L++ E+
Sbjct: 103 NLLGACTVGGPTLVITEY 120
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK--EFLVEVLMLSLLHHPNLVNLIG- 141
+G G FG V+ + + K + G++ + + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 142 YCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
+ +Q+L ++ EF G + ++ + ++ + I L Y H+ +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 201 P----VIYRDLKSSNILLGA-------------NLD----PKLSDFGLAK-LGPQGEKMN 238
P V++RDLK NI L NL+ K+ DFGL+K +G + +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----S 196
Query: 239 VTSRVMGTYGYCAPEYA--RSGELTVKSDVYSFGVILLELITGR 280
+ +GT Y +PE + KSD+++ G I+ EL +G+
Sbjct: 197 MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 42/157 (26%), Positives = 63/157 (40%), Gaps = 16/157 (10%)
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232
+PL +A ++Y+H + +I+RD+K+ N+L+ D L DFG A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLE-------LITGRRVIDT 285
+ GT APE T D++S G+++ E L + R D
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRG-DE 370
Query: 286 TRPVDEQ--NLIAWAQPIFRDPKRFPDMADPLLRKQF 320
RP D Q +I AQ FP A L Q+
Sbjct: 371 RRPYDAQILRIIRQAQV---HVDEFPQHAGSRLVSQY 404
|
Length = 461 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 55/245 (22%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---------QGNKEFLVEVLM 127
++F ++G G FG V + G V A+K L + M + ++ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 128 LSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA 187
L + V + D L+ EF+ GG + L+ + + T+ IA
Sbjct: 61 LWV------VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE---ETQFYIAE-T 110
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK----------- 236
++ +H I+RD+K N+LL + KLSDFGL + +
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 237 ------MNVTSR----------------VMGTYGYCAPEYARSGELTVKSDVYSFGVILL 274
N+ S+ +GT Y APE D +S GVI+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 275 ELITG 279
E++ G
Sbjct: 228 EMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|239263 cd02965, HyaE, HyaE family; HyaE is also called HupG and HoxO | Back alignment and domain information |
|---|
Score = 36.9 bits (86), Expect = 0.004
Identities = 24/81 (29%), Positives = 27/81 (33%), Gaps = 16/81 (19%)
Query: 288 PVDEQNLIAWAQPIF-------RDPKRFPDMAD-----PLLRKQFPEKGLNEAVAIAAMC 335
VD L W DP RFP++ D P L K FP AV A
Sbjct: 14 RVDAATLDDWLAAGGDLVLLLAGDPVRFPEVLDVAVVLPELLKAFP-GRFRAAVVGRA-- 70
Query: 336 LQEEAGARPLMSDVVTALSFL 356
E+A A AL F
Sbjct: 71 -DEQALAARFGVLRTPALLFF 90
|
They are proteins serving a critical role in the assembly of multimeric [NiFe] hydrogenases, the enzymes that catalyze the oxidation of molecular hydrogen to enable microorganisms to utilize hydrogen as the sole energy source. The E. coli HyaE protein is a chaperone that specifically interacts with the twin-arginine translocation (Tat) signal peptide of the [NiFe] hydrogenase-1 beta subunit precursor. Tat signal peptides target precursor proteins to the Tat protein export system, which facilitates the transport of fully folded proteins across the inner membrane. HyaE may be involved in regulating the traffic of [NiFe] hydrogenase-1 on the Tat transport pathway. Length = 111 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 519 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.67 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.04 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.98 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.78 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.73 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.54 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.36 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.16 | |
| PLN02236 | 344 | choline kinase | 97.11 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.84 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.59 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.29 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.28 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.21 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.08 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.92 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.88 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.6 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.5 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.86 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.71 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.66 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.56 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=426.63 Aligned_cols=290 Identities=54% Similarity=0.963 Sum_probs=253.1
Q ss_pred CCccccHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeE
Q 046892 63 NAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY 142 (519)
Q Consensus 63 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 142 (519)
....|++.++..+|++|.....||+|+||.||+|...+ |..||||++.........+|..|+.++..++|||||+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56779999999999999999999999999999999975 58999998876543314569999999999999999999999
Q ss_pred EecCC-ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcE
Q 046892 143 CADGD-QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 143 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vk 221 (519)
|.+.+ ..+||||||++|+|.++|+..... +++|..+++|+.++|.||+|||....++|||||||++|||||+++.+|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 499999999999999999764322 899999999999999999999999988999999999999999999999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
|+|||+|+...... ........||.+|+|||++..+..+.++|||||||+|+||+||+.+.+...+.....+..|..+.
T Consensus 218 lsDFGLa~~~~~~~-~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGD-TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCccc-cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999997654411 11111117999999999999999999999999999999999999999877666666788998877
Q ss_pred ccCCCCCCcccchHhh-ccCCh-hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 FRDPKRFPDMADPLLR-KQFPE-KGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+.+. .+.+++|+.+. ..++. .....+..++.+|++.+|..||+|.+|+++|..+.
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 7776 88889999887 66665 67788999999999999999999999999985443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-52 Score=428.56 Aligned_cols=316 Identities=24% Similarity=0.378 Sum_probs=273.3
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCc
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 148 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 148 (519)
....++|...++||+|+||+|+++..+.+++.+|||++++... ++.+..+.|..++...+ ||+|+.|+.+|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3345789999999999999999999999999999999988643 44566788999888775 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
+|+||||+.||++..+. ....+++..+..|+..|+.||.|||++| |||||||.+|||||.+|.+||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 99999999999954433 4467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
+...... ..+++++|||.|||||++.+..|+.++|+|||||+|||||.|..||.+.+..+. +..+..+..
T Consensus 516 Ke~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~~-- 585 (694)
T KOG0694|consen 516 KEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDEV-- 585 (694)
T ss_pred cccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCCC--
Confidence 8654222 246789999999999999999999999999999999999999999987654322 222333322
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH----HHHHHHHhhhhc------CCCCCCCCCCCCCCCCcCCC
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM----SDVVTALSFLSN------SKEPIPDPIIPSDEDEYSEG 378 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~~~~~------~~~~~~~p~~p~~~~~~~~~ 378 (519)
.||...+.+++.|+.++|..||++|..+ .+.+....|++. ....+.||+.|...+..+.+
T Consensus 586 ----------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~s 655 (694)
T KOG0694|consen 586 ----------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVS 655 (694)
T ss_pred ----------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhc
Confidence 3555667799999999999999999887 666666666665 46788999999999999999
Q ss_pred ccCCCCCCCCCCCCCCCcccccccccccCCCCCCCCCC
Q 046892 379 YSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPE 416 (519)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 416 (519)
+++..++.+.+.+++.+.+.+..+++.+|.+||+++|.
T Consensus 656 nFd~eFt~e~p~Lt~~~~~~l~~~~q~~F~~Fs~~~~~ 693 (694)
T KOG0694|consen 656 NFDEEFTSEKPALTPSDPRPLTEEEQEAFRDFSFVAEW 693 (694)
T ss_pred ccchhhhcCCCccCCCCccccchhhHHHhcCccccCCC
Confidence 99999999999999988889999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-52 Score=403.56 Aligned_cols=293 Identities=24% Similarity=0.331 Sum_probs=242.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.++||+|+||+||.++.+++++.+|+|++++... .+......|..+|..++||+||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 5689999999999999999999999999999999987543 3346678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
+||+.||.|..+|. ..+.+++..++.++.+|+.||.|||+.| ||||||||+|||||.+|+++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999994 4567999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... ..+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.....+ .+....
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~------~I~~~k------- 241 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD------KILKGK------- 241 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH------HHhcCc-------
Confidence 332 23556899999999999999999999999999999999999999998765332222 222221
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCC----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDG 383 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~ 383 (519)
....+...+.++.+++..+|+.||.+|. .+.+|-.|..|..- ....+.||+.|......+...++..
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~e 317 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNE 317 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHH
Confidence 0112333556899999999999999996 46666555544322 3566778999999888888888887
Q ss_pred CCCCCCCCCCC
Q 046892 384 HQKNENTYDND 394 (519)
Q Consensus 384 ~~~~~~~~~~~ 394 (519)
++.........
T Consensus 318 ft~~~~~~~~~ 328 (357)
T KOG0598|consen 318 FTSYTVDYSPV 328 (357)
T ss_pred HHhccccCCcc
Confidence 77665544443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=416.29 Aligned_cols=252 Identities=29% Similarity=0.464 Sum_probs=221.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.+|...++||+|||+.||.+++..+|..||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46999999999999999999999999999999998742 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|+|..++|..++. ..+++++.+++.++.||+.||.|||+++ |||||||..|+||+++.+|||+|||||+.+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999984 5678999999999999999999999999 99999999999999999999999999998765
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.... ..++||||.|.|||++....+++.+||||+||+||-||+|++||+...-.+....+....
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-------------- 234 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-------------- 234 (592)
T ss_pred cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--------------
Confidence 4322 456899999999999999999999999999999999999999998764333332222111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
-.+|...+.++.+||..+|+.||.+|||+.+|+.+.+|
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 12355667799999999999999999999999999776
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=396.69 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=218.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc-eEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~E 154 (519)
.+.+....||+|..|+||++.++.+++.+|+|.+.... ....+++.+|+++++..+||+||.+||+|..... ..|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35666789999999999999999999999999995443 2345778999999999999999999999999885 999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||++|+|.+++.. .+.+++...-.|+.+|++||.|||+ ++ ||||||||+||||+..|.|||||||.+..+..
T Consensus 159 YMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999854 3679999999999999999999996 77 99999999999999999999999999987655
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. ...+++||..|||||.+.+..|+.++||||||++|+||++|+.||....+ ...........+..++.
T Consensus 232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~pp------- 299 (364)
T KOG0581|consen 232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDEPP------- 299 (364)
T ss_pred h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcCCC-------
Confidence 4 34678999999999999999999999999999999999999999987511 11222233333332210
Q ss_pred hHhhccCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 314 PLLRKQFPEK-GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 314 ~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
..+|.. .+.++.+++..||++||.+||++.++++|.+..+..
T Consensus 300 ----P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 300 ----PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ----CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 123333 667899999999999999999999999998766543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=400.27 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=214.8
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-------hHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-------NKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+..... ...+.+|+++|+.++|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567899999999999999999999999999999997643221 233578999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CCcEEee
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN---LDPKLSD 224 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~---~~vkL~D 224 (519)
..||||||+.||+|.+++. ..+.+.+..-+.++.|++.||.|||++| |+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999994 4567888888999999999999999999 9999999999999755 7799999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhccCCC---CchhHHHHHHHHHHHHHhCCCCCCCCCCcc-hhhHHHhhch
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL---TVKSDVYSFGVILLELITGRRVIDTTRPVD-EQNLIAWAQP 300 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~---~~~sDvwSlGvll~elltG~~pf~~~~~~~-~~~~~~~~~~ 300 (519)
||+|+..+.+ ..+.++||||.|.|||++.+..+ ..++|||||||+||-+|+|.+||....... ..+.+.
T Consensus 323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~---- 395 (475)
T KOG0615|consen 323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL---- 395 (475)
T ss_pred cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh----
Confidence 9999987643 35677999999999999987543 347899999999999999999997653322 222221
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.....+. ......+++++.+||.+||..||++|||+.++++|.|+-.
T Consensus 396 --~G~y~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 396 --KGRYAFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred --cCccccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 1111110 1122456779999999999999999999999999999753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=385.33 Aligned_cols=252 Identities=29% Similarity=0.433 Sum_probs=208.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..+|...+.||.|+||+||+|+++.++..||||.+.+.. ....+.+..|+.+|+.++|||||.|++++.+++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999999999999999998763 334556789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC------CCcEEeeecc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN------LDPKLSDFGL 227 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~------~~vkL~DFGl 227 (519)
|||.||+|.+||.. .+.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999954 457999999999999999999999999 9999999999999764 4589999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
|+.+..+. ...+.+|++.|||||++....|+.|+|+||+|++||+|++|+.||+.....+....+.....
T Consensus 162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~------- 231 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE------- 231 (429)
T ss_pred hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-------
Confidence 99887544 34568999999999999999999999999999999999999999987655443332221111
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
+...++...+..+.+|+...|+.+|.+|-++.+-..+
T Consensus 232 --------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 232 --------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred --------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 1111223333455567777777888888777665544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=394.82 Aligned_cols=284 Identities=23% Similarity=0.331 Sum_probs=238.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|+++++||+|+||.||+|+-+.+|..+|+|++++.... ..+.+..|-.+|....+|+||+||..|++.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 57899999999999999999999999999999999886543 445678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||++||++..+| ...+.|++..++.++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 220 MEylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 220 MEYLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999 44678999999999999999999999999 9999999999999999999999999985321
Q ss_pred CC----------------------Ccc-----------------------ceecccccccccCchhhhccCCCCchhHHH
Q 046892 233 QG----------------------EKM-----------------------NVTSRVMGTYGYCAPEYARSGELTVKSDVY 267 (519)
Q Consensus 233 ~~----------------------~~~-----------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDvw 267 (519)
.. ... ......+|||.|||||+|.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 001136899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcch-hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-
Q 046892 268 SFGVILLELITGRRVIDTTRPVDE-QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL- 345 (519)
Q Consensus 268 SlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 345 (519)
|||||+||||.|.+||....+... ..++.|...+.. | -....+.++.+||.+||. ||..|..
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-----P----------~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-----P----------EEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-----C----------CcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999998776543 455555432211 1 112334689999999999 9999974
Q ss_pred --HHHHHHHHhhhhc---CCCCCCCCCCCCCCCCcCCCccCC
Q 046892 346 --MSDVVTALSFLSN---SKEPIPDPIIPSDEDEYSEGYSSD 382 (519)
Q Consensus 346 --~~evl~~l~~~~~---~~~~~~~p~~p~~~~~~~~~~~~~ 382 (519)
+.||-.|++|-.- .....++|+.|...+..+..||+.
T Consensus 437 ~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFdd 478 (550)
T KOG0605|consen 437 KGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDD 478 (550)
T ss_pred ccHHHHhcCCccccCCcchhhcCCCCCCCCCCCccccccccc
Confidence 8888888777543 345567899999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=372.20 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=215.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeee-EEecCCc-eEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIG-YCADGDQ-RLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~lV 152 (519)
.+|++.++||.|+||.||++.+..+|..||.|.+...... ..+.+..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4689999999999999999999999999999998855433 3456889999999999999999999 4555555 8999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA-NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||.+|+|...+.........+++..+|+++.|++.||.++|+.- +..|+||||||.||+|+.+|.|||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999998888899999999999999999999999931 123999999999999999999999999999987
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ......+|||.||+||.+.+.+|++++||||+||++|||+.-++||.+..- ......+... .++
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~KI~qg--d~~-- 246 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKKIEQG--DYP-- 246 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHHHHcC--CCC--
Confidence 6543 335568999999999999999999999999999999999999999987632 2222222111 111
Q ss_pred cchHhhccCC-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 312 ADPLLRKQFP-EKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 312 ~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
.+| +..+..+..||..|+..||..||+...++..+
T Consensus 247 -------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 247 -------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred -------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 123 45677899999999999999999965555444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=388.32 Aligned_cols=259 Identities=26% Similarity=0.343 Sum_probs=219.7
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
..-..+|...+.||+|+|++|++|+.+.+++.||||++.+... ...+.+..|-..|..| .||.|++||..|+|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4446789999999999999999999999999999999876432 2334567788888888 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
+|+|+||+++|+|.++|.. .+.+++..++.++.+|+.||+|||++| ||||||||+|||||.+|++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999955 367999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc---------ce--ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh
Q 046892 229 KLGPQGEKM---------NV--TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297 (519)
Q Consensus 229 ~~~~~~~~~---------~~--~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~ 297 (519)
+.+...... .. ...++||..|.+||+|.....++.+|||+|||+||+|+.|.+||...++.-....
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk--- 298 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK--- 298 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH---
Confidence 876543221 01 1458999999999999999999999999999999999999999987664322222
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
+..- .-.|++..++.+.+||.++|..||.+|+|..+|-+|+.|-
T Consensus 299 ---I~~l------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 299 ---IQAL------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred ---HHHh------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 2111 1234455556889999999999999999999999988763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=387.18 Aligned_cols=257 Identities=35% Similarity=0.559 Sum_probs=214.6
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeE-EEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCeeeeeeEEecCC-ceEEEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQV-VAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 154 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~-vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 154 (519)
+.+.+.||.|+||+||+|.+. |+. ||||++....... .+.|..|+.+|..++|||||+++|+|.+.. .++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 344456999999999999998 666 9999997653332 458999999999999999999999999887 7999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~~~~ 233 (519)
|+++|+|.+++... ....+++..++.|+.+|+.||.|||+++. ||||||||+||||+.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999664 46789999999999999999999999985 89999999999999998 999999999987554
Q ss_pred CCccceecccccccccCchhhhc--cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYAR--SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~--~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.. ...+...||+.|||||++. ...|+.|+|||||||+||||+||..||....+......+.
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~--------------- 259 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV--------------- 259 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------------
Confidence 32 1223368999999999999 5699999999999999999999999998765421111110
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+..++..+...+..|+..||+.||..||++.+++..|..+...
T Consensus 260 -~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 260 -VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 11223344555777899999999999999999999999999977653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.47 Aligned_cols=264 Identities=28% Similarity=0.384 Sum_probs=224.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|+..+.||.|+||.|.+++.+.+|..+|+|++.+...- ..+...+|..+|+.+.||+++++++.|.+.+.+|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 35789999999999999999999999999999999876433 334567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||++||.|..+|.. .+++++..++.++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999944 567999999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.. +-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||....+.. ..+.+......
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~KI~~~~v~----- 259 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYEKILEGKVK----- 259 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHHHHHhCccc-----
Confidence 32 456899999999999999999999999999999999999999999877632 22333333333
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCC-----CCHHHHHHHHhhhhc-----CCCCCCCCCCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR-----PLMSDVVTALSFLSN-----SKEPIPDPIIP 369 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-----Ps~~evl~~l~~~~~-----~~~~~~~p~~p 369 (519)
||...+..+.+|+..+|+.|-.+| ....+|..|.||-.- ....+.+|+.|
T Consensus 260 -------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 260 -------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred -------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 344445578889999999999999 456678777776432 33456667666
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.97 Aligned_cols=269 Identities=26% Similarity=0.366 Sum_probs=218.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
+.|+.+..+|+|+||+||+|+++++|+.||||++.....+ -.+-.++|+.+|+++.|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4588888999999999999999999999999998654332 22446899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
||+. ++.+.|.. ....++...+..++.|++.|+.|+|+++ ||||||||+||||+.+|.+||||||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9976 44444433 3456899999999999999999999999 999999999999999999999999999987632
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh--------chhccCC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA--------QPIFRDP 305 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~--------~~~~~~~ 305 (519)
. ...+..+.|.+|.|||++.+ .+|+..+||||+||++.||++|.+.|.+..+.|....+... +.++...
T Consensus 155 g--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 G--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred c--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2 23455778999999999987 78999999999999999999999999998888776655422 2222222
Q ss_pred CC-----CCcccch-HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 KR-----FPDMADP-LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ~~-----~~~~~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.. +|+.-+. .+...||. .+.-+++|+..||+.||++|++-++++.|..|
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~-~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPK-ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred CceeeeecCCCCCccchhhhccc-chHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 22 2222111 22333433 34478999999999999999999999988765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=376.48 Aligned_cols=257 Identities=28% Similarity=0.412 Sum_probs=216.8
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC----CC-cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN----GM-QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 148 (519)
....|.+.+.||+|+||.|+.|.+..++..||+|++.+. .. ...+.+.+|+.+++.+. ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999999999999999987764 11 23455678999999999 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CCcEEeeecc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGL 227 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-~~vkL~DFGl 227 (519)
+|+||||+.||+|.+++.. .+++.+..+..++.||+.||+|||++| |+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999944 567899999999999999999999999 9999999999999999 9999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCC-CC-chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE-LT-VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~-~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..... .....+....
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKIRKGE 239 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHHhcCC
Confidence 99874 1122355689999999999999866 75 7899999999999999999999873322 2222233333
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..++..+. +.++..|+.+||..||.+|+++.+++.+.|+..
T Consensus 240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 33333321 568899999999999999999999997777765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=373.66 Aligned_cols=273 Identities=27% Similarity=0.349 Sum_probs=226.5
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcC-CCCeeeeeeEEecCC-ceEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLH-HPNLVNLIGYCADGD-QRLL 151 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~~l 151 (519)
..++|.+.+.||.|+||.||+|+...+|..||||.+++.... +...-++|+..|++++ |||||+|.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 457899999999999999999999999999999998754332 3334578999999999 999999999998887 9999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||| ..+|++++.+. ...+++..++.|+.||++||+|+|.+| +.||||||+|||+..+..+||+|||+|+..
T Consensus 88 VfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999 46999999653 678999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCccceecccccccccCchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc-------
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR------- 303 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~------- 303 (519)
..... .+..+.|.+|.|||+|. .+.|+.+.||||+|||++|+.+-++.|.+..+.|+...+..+-....
T Consensus 161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 54432 34567899999999764 57899999999999999999999999999888877655543321111
Q ss_pred ------CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 304 ------DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 304 ------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
-...++.+....+...++. .+.++++||..||.+||.+|||+.+.+++..|...
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1123333333334443444 77899999999999999999999999999876543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=372.83 Aligned_cols=284 Identities=24% Similarity=0.331 Sum_probs=224.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 151 (519)
.+.|+.++.||+|+||.||+|++..+|+.||+|.+..... .......+||.+|+.|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568899999999999999999999999999999987653 3345678999999999999999999998776 68999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|+|||+. +|.-++. ...-.+++.+++.|+.||+.||.|||.+| |+|||||.+|||||.+|.+||+|||||+.+
T Consensus 196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999965 8887773 23457999999999999999999999999 999999999999999999999999999977
Q ss_pred CCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc-hhccCCC---
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ-PIFRDPK--- 306 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~--- 306 (519)
........ +..+-|.+|.|||+|.| ..|+.++|+||.||||.||++|++.|.+....++...|.-.- ....+.+
T Consensus 269 ~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 65554333 34567999999999887 579999999999999999999999999887777665553221 1111111
Q ss_pred CCCccc--------chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCCCCCCCC
Q 046892 307 RFPDMA--------DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIP 369 (519)
Q Consensus 307 ~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~p~~p 369 (519)
.++.+. ...+++. -...+..+++|+..+|..||.+|.|+.+++..-+| ...+.+..+...|
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF-~t~p~~~~p~~Lp 416 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF-TTEPLPCDPSSLP 416 (560)
T ss_pred cCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCccc-ccCCCCCCcccCC
Confidence 111110 1122221 22334578899999999999999999999988665 5555444444444
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=379.93 Aligned_cols=254 Identities=29% Similarity=0.418 Sum_probs=224.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
..|.....||+|+.|.||.|+...+++.||||++........+.+++|+.+|+..+|+|||.+++.|..++.+|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888889999999999999999999999999999887777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
+||+|.+.+.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999843 45999999999999999999999999 99999999999999999999999999987655443
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
...+.+|||.|||||++....|++++||||||++++||+-|.+||-...+.....++.-.. ..
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng---------------~P 487 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG---------------TP 487 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC---------------CC
Confidence 3456899999999999999999999999999999999999999998877766555554221 11
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.-..++.++..+.+|+.+||+.|+.+|+++.++|+|..+
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 122356677799999999999999999999999999765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=365.14 Aligned_cols=262 Identities=30% Similarity=0.469 Sum_probs=211.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC--ceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~ 153 (519)
..+|...+.||+|+||.||++.+..+|..+|||.+........+.+..|+.+|..++|||||+++|...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345778899999999999999999999999999987664333566899999999999999999999855444 689999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~~~ 232 (519)
||+++|+|.+++.... ..|++..+..++.||++||+|||++| ||||||||+||||+. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999996532 26999999999999999999999999 999999999999999 7999999999998765
Q ss_pred C-CCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 233 Q-GEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 233 ~-~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
. .........+.||+.|||||++..+ ....++|||||||+++||+||.+||... .+.. .+...+.... ..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~---~~~~~ig~~~-~~-- 241 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEA---EALLLIGRED-SL-- 241 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchH---HHHHHHhccC-CC--
Confidence 3 1222233457899999999999853 3345999999999999999999999764 1111 1111111110 11
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..+|...+.++.+++..|+..||.+|||+.+++.|++....
T Consensus 242 -------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 -------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 14556677789999999999999999999999999765443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=360.12 Aligned_cols=270 Identities=26% Similarity=0.366 Sum_probs=218.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++..+||.|..++||+|+...++..||||++....-.. .+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 568999999999999999999999999999999997654433 4778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC-
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ- 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~- 233 (519)
||.+|++.+++...-. ..+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+..
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999976543 34999999999999999999999999 99999999999999999999999997754433
Q ss_pred CCcccee-cccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVT-SRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~-~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
+...... ..++||+.|||||++.. ..|+.|+||||||++..||++|..||....+....- ..+-..+....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-----~tLqn~pp~~~- 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-----LTLQNDPPTLL- 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-----HHhcCCCCCcc-
Confidence 3222223 67899999999999643 579999999999999999999999998776543221 11111111110
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...+...-.......+..++..||+.||.+|||+++++.+-+|-..
T Consensus 254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0011111112234478899999999999999999999998876443
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.81 Aligned_cols=306 Identities=26% Similarity=0.380 Sum_probs=241.1
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHh-cCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+++.||||++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999987532 1223445566666654 5899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999988843 346899999999999999999999999 9999999999999999999999999997543322 2
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.. .+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~~------------~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---SILNDR------------P 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHcCC------------C
Confidence 233467999999999999889999999999999999999999999765322 1111 111111 1
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCCCCCCCC
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLMS-DVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQKNENTYD 392 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~ 392 (519)
.++...+.++.+++..||+.||.+||++. +++.+.++... .....+++..|......+..+++..++.+.....
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLS 293 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCC
Confidence 12333455788999999999999999976 55555443221 2234556666666666667778888888888888
Q ss_pred CCCcccccccccccCCCCCCCCC
Q 046892 393 NDNARSVRESENLESSNNSGSNP 415 (519)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~s~~~~ 415 (519)
+.+.....+.++..+.++.+.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 294 PVDKKLLASMDQEQFRGFSFTNP 316 (316)
T ss_pred CccccccccccccccCCCcccCc
Confidence 88887888889999999998886
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=339.84 Aligned_cols=272 Identities=25% Similarity=0.347 Sum_probs=221.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|...+.||+|+||.||+|++..+|+.||||.+......+ .....+|+.+|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999999999999999997654332 3567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
||+ .+|...+.+ ....+....+..++.+++.||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 995 599998854 4567999999999999999999999999 999999999999999999999999999988765
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-----ccCCCCC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI-----FRDPKRF 308 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~ 308 (519)
.... ...+-|.+|.|||++.| ..|+..+||||.||++.||+.|.+.|.+..+.++...+--+-.. +.+-..+
T Consensus 155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 4332 22367999999998876 57999999999999999999999999988777666554322111 1111122
Q ss_pred CcccchH-----hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 309 PDMADPL-----LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 309 ~~~~d~~-----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+++..-. ....+-..++..+++|+..||..||.+|+++.++++|.+|..
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 2222211 111123345567799999999999999999999999987754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=367.68 Aligned_cols=277 Identities=26% Similarity=0.351 Sum_probs=216.9
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 159 (519)
+.||+|+||.||+|.+..+|+.||||++..... .....+..|+.++..++||||+++++++...+..+|||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999999999999999875421 22345778999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccce
Q 046892 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239 (519)
Q Consensus 160 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 239 (519)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 99988843 456899999999999999999999999 9999999999999999999999999987532221 12
Q ss_pred ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhcc
Q 046892 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ 319 (519)
Q Consensus 240 ~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 319 (519)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..... +..... .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~---~~~~~~------------~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL---ILMEEI------------R 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHH---HHcCCC------------C
Confidence 23467999999999999999999999999999999999999999754321 11111 111111 1
Q ss_pred CChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCC
Q 046892 320 FPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQK 386 (519)
Q Consensus 320 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~ 386 (519)
++...+.++.+|+.+||+.||.+|| ++.++++|.|+-.. ......+|..+......+..+++...+.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTA 290 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccc
Confidence 3334556889999999999999999 89999998776332 1223344445544444444444443333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=369.19 Aligned_cols=255 Identities=31% Similarity=0.452 Sum_probs=213.4
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+...+.||+|-||.||.|.+.. ...||+|.+... ....+.|.+|+.+|+.|+|++||+++++|..++.+|||||||+.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 4566789999999999999974 347999998754 34457899999999999999999999999998899999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|.++|.. ..+..+...+.+.++.|||+|++||++++ +|||||.+.||||+++..+||+|||||+...++.. .
T Consensus 286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~ 359 (468)
T KOG0197|consen 286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-T 359 (468)
T ss_pred CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-e
Confidence 999999976 35667899999999999999999999999 99999999999999999999999999995444332 2
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
......-...|.|||.+..+.++.++|||||||+||||+| |+.|+......+....+ +...+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-----------------e~GyR 422 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-----------------ERGYR 422 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-----------------hccCc
Confidence 2222233678999999999999999999999999999998 67777655433222222 22334
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...|..++.++.+|+..||+.+|++|||+..+...+..+..
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 44678889999999999999999999999999888876643
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=361.36 Aligned_cols=306 Identities=26% Similarity=0.349 Sum_probs=240.7
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHh-cCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|++..+++.||||++.... ......+..|..++.. +.||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999987542 1233456667777765 5899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 999998843 346899999999999999999999999 99999999999999999999999999875322221
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|||++|..||....... +.... .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i---~~~~------------~ 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI---RMDN------------P 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC------------C
Confidence 2234679999999999998899999999999999999999999997653221 11111 1111 1
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCCCCCCCC
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLMS-DVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQKNENTYD 392 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~ 392 (519)
.++.....++.+++.+||+.||.+||++. ++..+.++-.. ....+.++..+...+..+..+++.....+.....
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLS 293 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccC
Confidence 12223445788999999999999999997 66666554221 2234556677777777777788877777766666
Q ss_pred CCCcccccccccccCCCCCCCCC
Q 046892 393 NDNARSVRESENLESSNNSGSNP 415 (519)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~s~~~~ 415 (519)
..+...+.+.++..|.|++..+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05619 294 VTDRMLINSMDQNMFENFSFINP 316 (316)
T ss_pred CCcccccccccccccCCCcccCc
Confidence 66666777788888999988876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=374.28 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=217.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.-|+..+.||.|+.|.|-+|++..||+.+|||++.+... .....+.+|+.+|+.+.||||+++|+++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 458889999999999999999999999999999976521 22345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|.|.++|. ..+++++.++..++.||+.|+.|||..+ |+||||||+|+|||..+.+||+|||+|.+...
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999994 4678999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCccceecccccccccCchhhhccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELT-VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~-~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
+.. ..+.||.|.|.|||++.|.+|. .++||||+|||||.||||+.||+.. ++.....++......
T Consensus 165 gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~G~f~----- 230 (786)
T KOG0588|consen 165 GKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQRGVFE----- 230 (786)
T ss_pred Ccc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCccc-----
Confidence 443 3457999999999999998885 7899999999999999999999843 222333333333322
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+|..++.++.+|+.+||..||.+|.|+.+|++|+|...
T Consensus 231 -------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 231 -------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred -------CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 34455668999999999999999999999999988653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=368.92 Aligned_cols=251 Identities=30% Similarity=0.427 Sum_probs=220.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.... +.+.+.+|+.+++.++|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688889999999999999999999999999999876543 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.| +|..+|. ..+.++++.+..|+.+++.||.|||+.+ |+|||+||.|||++.+|.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9976 9999994 4567999999999999999999999999 999999999999999999999999999987654
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
..+.+.+.|||.|||||++.+.+|+..+|+||||||+|||++|++||... .+.+.+..+..++...
T Consensus 154 --t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v~~------ 219 (808)
T KOG0597|consen 154 --TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPVKP------ 219 (808)
T ss_pred --ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCCCC------
Confidence 34566789999999999999999999999999999999999999999753 3445555555555333
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
|...+..+..++..+|.+||..|.+-.+++.|..+
T Consensus 220 ------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 220 ------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred ------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 33556688999999999999999999999998764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=363.78 Aligned_cols=311 Identities=24% Similarity=0.347 Sum_probs=241.6
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..+ .||||+.+++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999999976432 2234577888888877 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 999988743 346999999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc-hhccCCCCCCcccchHhh
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ-PIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~d~~l~ 317 (519)
.....+||+.|+|||++.+..++.++|||||||+||+|++|..||.............+.. .+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------- 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------- 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----------
Confidence 2334679999999999999999999999999999999999999997543221111111111 1111111
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCC------HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCC
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPL------MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQK 386 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~ 386 (519)
.++...+..+.+++.+||+.||.+|++ +.+++.|.++-.. ......++..|...+......++..+..
T Consensus 221 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (327)
T cd05617 221 -RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTS 299 (327)
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCcccc
Confidence 123344557889999999999999998 5688887665322 2344455666666666566667666777
Q ss_pred CCCCCCCCCcccccccccccCCCCCCCC
Q 046892 387 NENTYDNDNARSVRESENLESSNNSGSN 414 (519)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 414 (519)
++...++++..........+++|+.++|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (327)
T cd05617 300 EPVQLTPDDEDVIKRIDQSEFEGFEYIN 327 (327)
T ss_pred CcccCCCCCccccccccccccCCCcCCC
Confidence 7777777777777777888999988775
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=364.23 Aligned_cols=311 Identities=23% Similarity=0.338 Sum_probs=234.6
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
++||+|+||.||+|.+..+++.||||++..... .....+..|+.++..+ +||||++++++|.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999999999999999999975422 2234577888998887 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 999988743 356999999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc--hhhHHHhh-chhccCCCCCCcccchH
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVD--EQNLIAWA-QPIFRDPKRFPDMADPL 315 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~d~~ 315 (519)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||+.....+ ......+. ..+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--------- 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------
Confidence 2334679999999999999999999999999999999999999997532211 00001111 11111111
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCC------HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCC
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPL------MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGH 384 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~ 384 (519)
.++...+..+.+++.+||+.||.+||+ +.+++.|.|+... ......++..+......+...+...+
T Consensus 223 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (329)
T cd05588 223 ---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQF 299 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCcc
Confidence 123344567899999999999999987 7899998876432 12233344455544444445555666
Q ss_pred CCCCCCCCCCCcccccccccccCCCCCCCC
Q 046892 385 QKNENTYDNDNARSVRESENLESSNNSGSN 414 (519)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 414 (519)
..+.....+.........++.++.+|.+.|
T Consensus 300 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 329 (329)
T cd05588 300 TDEPVQLTPDDPDVIARIDQSEFEGFEYIN 329 (329)
T ss_pred ccCccccCCCCccccccccccccCCCcccC
Confidence 666666666655555555666777776654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=363.15 Aligned_cols=304 Identities=25% Similarity=0.326 Sum_probs=235.1
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|++..+++.||||++.... ......+..|..++..+ +||||+++++++.+.+..||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999987542 22334567788888755 799999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 999988843 346899999999999999999999999 99999999999999999999999999875432221
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... . .+......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~---~i~~~~~~----------- 214 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---E---SILHDDVL----------- 214 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---H---HHHcCCCC-----------
Confidence 233467999999999999889999999999999999999999999865432211 1 11111111
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCC-------CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCC
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARP-------LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQK 386 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~ 386 (519)
++...+.++.+++..||+.||.+|| ++.+++++.++-.. ......+++.+......+...++..+..
T Consensus 215 -~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (321)
T cd05591 215 -YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTK 293 (321)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCcccc
Confidence 2223445788999999999999999 89999988765321 2233344555554444444455555666
Q ss_pred CCCCCCCCCcccccccccccCCCCCCC
Q 046892 387 NENTYDNDNARSVRESENLESSNNSGS 413 (519)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~s~~ 413 (519)
..+...+.+.......++.++.+|++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (321)
T cd05591 294 EEPVLTPVDPAVIKQINQEEFRGFSFF 320 (321)
T ss_pred CccccCCCCccccccccccccCCCccc
Confidence 666666677777777777778777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=361.56 Aligned_cols=310 Identities=25% Similarity=0.333 Sum_probs=231.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCC-CCeeeeeeEEecCCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~ 153 (519)
+|++.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..+.| ++|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999999999999999987542 2234567788889988876 46889999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999988843 346899999999999999999999999 99999999999999999999999999874322
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .... +....
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~---i~~~~-------- 217 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQS---IMEHN-------- 217 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH---HHcCC--------
Confidence 211 2234679999999999999999999999999999999999999997643221 1111 11111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCC
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM-----SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDG 383 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~ 383 (519)
..++...+.++.+++.+||+.||.+|++. .+++++.++... ....+.++..|......+...++..
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKF 293 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCcc
Confidence 11233445678899999999999999976 778777654321 1223344444443333344444444
Q ss_pred CCCCCCCCCCCCcccccccccccCCCCCCCC
Q 046892 384 HQKNENTYDNDNARSVRESENLESSNNSGSN 414 (519)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 414 (519)
.........+.+.....+....++.+||..|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 294 FTREPPVLTPPDKLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred cccCccccCCCCccccccccccccCCCcccC
Confidence 4444444444444444455566667666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=361.72 Aligned_cols=304 Identities=26% Similarity=0.372 Sum_probs=237.7
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+++.||||++.+.. ......+..|..++..+ +||||+++++++.+.+.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999987542 22334567788888777 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999988843 346899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+.....
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~---~i~~~~~------------ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ---SILEDEV------------ 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH---HHHcCCC------------
Confidence 1234578999999999999999999999999999999999999997543211 111 1111111
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCCCC
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLM-----SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQKNE 388 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~ 388 (519)
.++...+..+.+|+.+||+.||.+||++ .+++.+.++-.. ....+.+|..+......+...++..+..+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEK 293 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCc
Confidence 1233345678999999999999999999 999988766332 123344555555555445555666666666
Q ss_pred CCCCCCCcccccccccccCCCCCCC
Q 046892 389 NTYDNDNARSVRESENLESSNNSGS 413 (519)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~s~~ 413 (519)
..+++.......+.++.+|.+|+|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (318)
T cd05570 294 PVLTPPDEAIIRNIDQEEFRGFSYI 318 (318)
T ss_pred ccCCCCcccccccccccccCCCCCC
Confidence 6677666666777788899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=348.47 Aligned_cols=314 Identities=24% Similarity=0.307 Sum_probs=258.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|..+++||+|+||.|.+++.+.+++.+|+|++++.-.... ..-+.|-.+|+..+||.+..|-..|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4689999999999999999999999999999999987644333 3446688899999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||..||.|.-+| .....+++..++.+-.+|+.||.|||+++ ||+||||.+|+|+|.+|++||+||||++...
T Consensus 247 MeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999888 34567899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... ..+.++||||.|+|||++....|+.++|+|.+||++|||++|+.||...+......++- ...
T Consensus 320 ~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------~ed------- 384 (516)
T KOG0690|consen 320 KYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------MED------- 384 (516)
T ss_pred ccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------hhh-------
Confidence 322 34677999999999999999999999999999999999999999998754332222221 111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSD 382 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~ 382 (519)
-.||...+.++..|+..+|.+||.+|. .+.+|.++-.|..- -...+.||+.|...+..+..|++.
T Consensus 385 -----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~ 459 (516)
T KOG0690|consen 385 -----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDE 459 (516)
T ss_pred -----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhh
Confidence 236667778999999999999999994 36677666544322 356788999999999999999999
Q ss_pred CCCCCCCCCCCCCccc----ccccccccCCCCCCCCCC
Q 046892 383 GHQKNENTYDNDNARS----VRESENLESSNNSGSNPE 416 (519)
Q Consensus 383 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~~ 416 (519)
.++.+..+.++.+..- ........|..||+++..
T Consensus 460 EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~~ 497 (516)
T KOG0690|consen 460 EFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSASM 497 (516)
T ss_pred hhhcceeEecCCCCCCcccchhhhhccCCcceeeecch
Confidence 9999999988865432 222345566777776643
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=361.45 Aligned_cols=311 Identities=23% Similarity=0.352 Sum_probs=237.0
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976422 2334567788887765 799999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999888743 356899999999999999999999999 9999999999999999999999999987532211 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch--hhHHHhh-chhccCCCCCCcccchH
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE--QNLIAWA-QPIFRDPKRFPDMADPL 315 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~d~~ 315 (519)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+. ..+....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------
Confidence 22346799999999999999999999999999999999999999964322111 0011111 1111111
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCC------HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCC
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPL------MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGH 384 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~ 384 (519)
..++...+..+.+++.+||+.||.+||+ +.+++.|.++-.. ......++..|.........++....
T Consensus 222 --~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (329)
T cd05618 222 --IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQF 299 (329)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCccc
Confidence 1234445567889999999999999998 5799888765321 22334455555555555555555555
Q ss_pred CCCCCCCCCCCcccccccccccCCCCCCCC
Q 046892 385 QKNENTYDNDNARSVRESENLESSNNSGSN 414 (519)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 414 (519)
+.+....++++.+..+.....++.++.++|
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (329)
T cd05618 300 TNEPVQLTPDDDDIVRKIDQSEFEGFEYIN 329 (329)
T ss_pred ccCCccCCCCcccccccccccccCCCcccC
Confidence 666666666777777777777888877664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=358.39 Aligned_cols=318 Identities=25% Similarity=0.333 Sum_probs=266.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 151 (519)
..+|..+.+||+|+||.|.+|..+.+.+.+|||++++.... +.+--+.|-.+|... +-|.+++++.+|+..+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 45788899999999999999999999999999999876432 223345677777655 46899999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.||+|...+++. +.+.+..+..++.+|+-||-+||++| ||+||||.+|||+|.+|++||+|||+++..
T Consensus 428 VMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999765 45677788999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
..+. ..+.+++|||.|+|||++...+|+.++|+|||||+||||+.|++||++.+..... +.+...
T Consensus 501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF------~aI~eh------- 565 (683)
T KOG0696|consen 501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------QAIMEH------- 565 (683)
T ss_pred ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHHc-------
Confidence 3332 3356799999999999999999999999999999999999999999976543222 111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCC----CHHHHHHHHhhhh------cCCCCCCCCCCCCCCCCcCCCccC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP----LMSDVVTALSFLS------NSKEPIPDPIIPSDEDEYSEGYSS 381 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~l~~~~------~~~~~~~~p~~p~~~~~~~~~~~~ 381 (519)
.-.||...+.++++++...|...|.+|. ..++-+....|++ .+...++||+.|...-.-+..+++
T Consensus 566 -----nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD 640 (683)
T KOG0696|consen 566 -----NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFD 640 (683)
T ss_pred -----cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhh
Confidence 1346777888999999999999999994 3333344444443 356788999999998888999999
Q ss_pred CCCCCCCCCCCCCCcccccccccccCCCCCCCCCCCCcc
Q 046892 382 DGHQKNENTYDNDNARSVRESENLESSNNSGSNPERIAS 420 (519)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~ 420 (519)
..++.....+++.+.-...+.++.+|.+||+.||..+..
T Consensus 641 ~~Ft~~~~~lTPpD~~v~~nldq~eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 641 KFFTREPTDLTPPDKLVMMNLDQSEFEGFSFVNPEFVKP 679 (683)
T ss_pred HHHhcCCCCCCCchHHHHhcCchhhcCceeeeChhhcCC
Confidence 999999999999999888999999999999999997644
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=363.40 Aligned_cols=247 Identities=26% Similarity=0.364 Sum_probs=204.4
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 159 (519)
+.||+|+||.||++.+..+++.||||++.... ......+..|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999997542 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccce
Q 046892 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239 (519)
Q Consensus 160 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 239 (519)
+|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 99988843 356899999999999999999999999 9999999999999999999999999987532221 12
Q ss_pred ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhcc
Q 046892 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ 319 (519)
Q Consensus 240 ~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 319 (519)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ... .+..... .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~---~~~~~~~------------~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---LILMEDI------------K 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH---HhccCCc------------c
Confidence 234679999999999998899999999999999999999999997543221 111 1111111 1
Q ss_pred CChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 320 FPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 320 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
++...+.++.+|+.+||+.||.+|| ++.+++++.|+.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 255 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 2334556788999999999999997 899999987763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=364.44 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=212.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..++||||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999999999987542 223456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999843 356899999999999999999999999 99999999999999999999999999976533
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
......||+.|+|||++.+..++.++|||||||+||||++|..||......+....+......... +...+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~ 224 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR----PVYDD 224 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC----CCCCc
Confidence 223467999999999999999999999999999999999999999865433222211111111110 00000
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+ ....+.++.+++.+||+.+|.+||++.+++.+.++..
T Consensus 225 ~------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 225 P------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred c------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 0 0234568899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=359.87 Aligned_cols=306 Identities=26% Similarity=0.362 Sum_probs=228.3
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHh-cCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+|..||+|++.... ......+..|..++.. ..||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999987542 1233456667777764 5899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999988843 356899999999999999999999999 9999999999999999999999999987432221 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+... +.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~---~~~~~~------------ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFES---IRVDTP------------ 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHH---HHhCCC------------
Confidence 233467999999999999999999999999999999999999999754322 11111 111111
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCCCCCCCC
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLMS-DVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQKNENTYD 392 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~ 392 (519)
.++...+.++.+++.+||+.||.+||++. +++.|.++-.. ....+.+|..|......+...+......+.+...
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLS 293 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccC
Confidence 12233455788999999999999999985 66666554221 1233344555554444444445544444444444
Q ss_pred CCCcccccccccccCCCCCCCCC
Q 046892 393 NDNARSVRESENLESSNNSGSNP 415 (519)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~s~~~~ 415 (519)
..+.....+.....+.++++.+|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05620 294 YSDKNLIDSMDQSAFAGFSFINP 316 (316)
T ss_pred CCcccccccccccCcCCCcccCC
Confidence 44444445556667777777665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=357.85 Aligned_cols=250 Identities=26% Similarity=0.311 Sum_probs=209.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 468899999999999999999999999999999865322 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999843 356899999999999999999999999 99999999999999999999999999986533
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........... +.....
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~------i~~~~~------- 215 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK------ILAGKL------- 215 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCc-------
Confidence 2 2235789999999999988999999999999999999999999976543221111 111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~ 356 (519)
.++......+.+|+.+||+.||.+||+ +.+++.|.|+-
T Consensus 216 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 216 -----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred -----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 123334557889999999999999995 99999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=359.43 Aligned_cols=246 Identities=27% Similarity=0.362 Sum_probs=203.2
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999843 356899999999999999999999999 9999999999999999999999999997543222 1233
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+..... .++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~~------------~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEPL------------RFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC------------CCC
Confidence 467999999999999999999999999999999999999999754321 11112222211 123
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCC---CHHHHHHHHhhhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARP---LMSDVVTALSFLS 357 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~l~~~~ 357 (519)
...+..+.+++.+||+.||.+|| ++.+++.|.++-.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 34456788999999999999997 5788888877643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.41 Aligned_cols=267 Identities=28% Similarity=0.417 Sum_probs=215.8
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--------------ChHHHHHHHHHHHhcCCCCeee
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--------------GNKEFLVEVLMLSLLHHPNLVN 138 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--------------~~~~~~~E~~~l~~l~HpnIv~ 138 (519)
....++|++.+.||+|.||.|-+|++..+++.||||++.+.... ..+...+|+.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 44567899999999999999999999999999999999754221 2257889999999999999999
Q ss_pred eeeEEec--CCceEEEEEecCCCCHHHHHhhhccCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 046892 139 LIGYCAD--GDQRLLVYEFMSGGSVDDHLLDVNETKKP-LDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG 215 (519)
Q Consensus 139 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~ 215 (519)
|+.+..+ .+.+|||+|||..|.+...- ...+ +.+.+++.|+.+++.||+|||.+| ||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 9999876 46899999999988765432 2334 999999999999999999999999 99999999999999
Q ss_pred CCCCcEEeeecccccCCCCC---ccceecccccccccCchhhhccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 046892 216 ANLDPKLSDFGLAKLGPQGE---KMNVTSRVMGTYGYCAPEYARSGE----LTVKSDVYSFGVILLELITGRRVIDTTRP 288 (519)
Q Consensus 216 ~~~~vkL~DFGla~~~~~~~---~~~~~~~~~Gt~~y~APE~l~~~~----~~~~sDvwSlGvll~elltG~~pf~~~~~ 288 (519)
++|+|||+|||.+.....+. ........+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99999999999998653321 112233468999999999987632 35789999999999999999999976433
Q ss_pred cchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCC
Q 046892 289 VDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPI 363 (519)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~ 363 (519)
......+..++..++. .+++...+.+||.+||++||+.|.+..+|..|+|.......+.
T Consensus 325 ------~~l~~KIvn~pL~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~ 383 (576)
T KOG0585|consen 325 ------LELFDKIVNDPLEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQ 383 (576)
T ss_pred ------HHHHHHHhcCcccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCc
Confidence 3333344444333332 1245668899999999999999999999999999776655443
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=360.77 Aligned_cols=281 Identities=26% Similarity=0.349 Sum_probs=219.5
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 159 (519)
+.||+|+||.||++.+..+|..||+|++.... ......+..|+.++..++||||++++++|...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987542 123345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccce
Q 046892 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239 (519)
Q Consensus 160 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 239 (519)
+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988843 346899999999999999999999999 9999999999999999999999999987532221 11
Q ss_pred ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhcc
Q 046892 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ 319 (519)
Q Consensus 240 ~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 319 (519)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...........+ ..... .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~~~------------~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEEI------------R 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCCC------------C
Confidence 23457999999999999999999999999999999999999999754322111111 11111 1
Q ss_pred CChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCCCCC
Q 046892 320 FPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQKNEN 389 (519)
Q Consensus 320 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~ 389 (519)
++...+.++.+++.+||+.||.+|| ++.+++++.++... ......+|..+......+..+++...+....
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSI 293 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCCc
Confidence 2334456788999999999999998 89999998876432 1233345555555555555555554444433
Q ss_pred C
Q 046892 390 T 390 (519)
Q Consensus 390 ~ 390 (519)
+
T Consensus 294 ~ 294 (323)
T cd05595 294 T 294 (323)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.08 Aligned_cols=304 Identities=26% Similarity=0.342 Sum_probs=225.7
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+++.||||++.... ......+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999987532 22334567788888765 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 999988843 346899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~---~i~~~~~------------ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE---AILNDEV------------ 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH---HHhcCCC------------
Confidence 23346799999999999999999999999999999999999999976543221 11 1111111
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCH------HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCCC
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLM------SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQKN 387 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~~ 387 (519)
.++...+.++.+++.+||+.||.+||++ .+++.|.++-.. ......+|..|......+..+++.....+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKE 293 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccC
Confidence 1223345578899999999999999998 888888765321 12334455555554444444444433333
Q ss_pred CCCCCCCCcccccccccccCCCCCCC
Q 046892 388 ENTYDNDNARSVRESENLESSNNSGS 413 (519)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~s~~ 413 (519)
.......+...........+.+|++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (320)
T cd05590 294 DPVLTPIEESLLPMINQDEFRNFSYT 319 (320)
T ss_pred CccCCCCcccccccccccCcCCCccc
Confidence 33333333332333344555565543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=340.88 Aligned_cols=284 Identities=25% Similarity=0.321 Sum_probs=228.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 151 (519)
.+.|+.++.|++|+||.||+|+++.+++.||+|+++..... -.-.-++|+.+|..++|||||.+-.+... -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35688999999999999999999999999999999765322 22456899999999999999999998764 356999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|||||+. +|..++... .+++...+++.++.|++.||+|||... |+|||||++|+|+...|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 9999965 899988653 367899999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc-----hhccCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ-----PIFRDP 305 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~-----~~~~~~ 305 (519)
+.... ..+..+-|.+|.|||+|.+ ..|+++.|+||+|||+.||+++++.|.+....++.+.+-... .++..-
T Consensus 228 gsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 66532 2445677999999999887 579999999999999999999999999988777765553221 111111
Q ss_pred --------CCCCcccchHhhccCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCCCCCCCC
Q 046892 306 --------KRFPDMADPLLRKQFPEK-GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIP 369 (519)
Q Consensus 306 --------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~p~~p 369 (519)
..++......++..|+.. .++..++|+..+|..||.+|.|+.+.+++-+| ...+.+.+|...|
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F-~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF-RETPLPIDPSMFP 377 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc-ccCCCCCChhhcC
Confidence 122222333456666655 67889999999999999999999999998554 4455555544443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=350.88 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=211.2
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.|+..+.||+|+||.||+|.+..+++.||||.+..... .....+..|+.++..++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37788999999999999999999999999999865432 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999887542 2346899999999999999999999999 999999999999999999999999999865432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. ..+...
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~~~~~~---------- 220 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RRVKED---------- 220 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--HHhhcc----------
Confidence 21 234578999999999999999999999999999999999999998754332211111 000000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLS 357 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~ 357 (519)
...++...+..+.+|+.+||+.||.+||+ +.+++++.++-.
T Consensus 221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 11233445568899999999999999997 899999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=362.71 Aligned_cols=252 Identities=29% Similarity=0.388 Sum_probs=210.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|++..+++.||||++.... ......+..|+.++..++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986532 22345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999854 356889999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....+.... ..+......
T Consensus 170 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~~~----- 233 (329)
T PTZ00263 170 DRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------EKILAGRLK----- 233 (329)
T ss_pred CCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH------HHHhcCCcC-----
Confidence 322 2357999999999999999999999999999999999999999764332111 111111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLS 357 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~ 357 (519)
++...+..+.+|+.+||+.||.+||+ +.+++.|.++-.
T Consensus 234 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 234 -------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred -------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 22233457889999999999999997 799999987643
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=357.90 Aligned_cols=309 Identities=24% Similarity=0.321 Sum_probs=226.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
+|.+.+.||+|+||.||+|++..+++.||||++.+... .....+..|..++..+ .|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58889999999999999999999999999999875422 2233456677777766 5899999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988843 346899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||....... +... +....
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~---i~~~~-------- 217 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQS---IMEHN-------- 217 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCC--------
Confidence 21 12234679999999999999999999999999999999999999997654321 1111 11111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCC
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM-----SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDG 383 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~ 383 (519)
..++...+.++.+++.+||+.||.+|++. .+++++.++... ....+.+|..|.... .+..+.+.-
T Consensus 218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 292 (323)
T cd05616 218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKF 292 (323)
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-chhhhcCch
Confidence 11233455688999999999999999984 777766543211 223334444443221 222222222
Q ss_pred CCCCCCCCCCCCcccccccccccCCCCCCCC
Q 046892 384 HQKNENTYDNDNARSVRESENLESSNNSGSN 414 (519)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 414 (519)
+........+.....+......++.|||+.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 293 FTRHPPVLTPPDQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred hccCCccCCCCCccccccccccccCCCcccC
Confidence 2222233333344444444456777777654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=330.07 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=221.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|-||.||+|+.+.++-.||+|++.+.. .....++.+|+++.+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 468999999999999999999999999999999987653 23446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
+||..+|+|...|... ....+++.....++.|++.||.|+|..+ ||||||||+|+|++..+.+||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999653 3456889999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... ..+.+||..|++||...+..++..+|+|++|++.||++.|.+||......+...-+.
T Consensus 176 ~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---------------- 235 (281)
T KOG0580|consen 176 SNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---------------- 235 (281)
T ss_pred CCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----------------
Confidence 332 456899999999999999999999999999999999999999998765222221111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.++-.+|..++.++.++|.+||..+|.+|.+..+++.|.|..+.
T Consensus 236 --k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 236 --KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred --HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 11223456677799999999999999999999999999887653
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=356.32 Aligned_cols=250 Identities=28% Similarity=0.414 Sum_probs=202.8
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHH---HhcCCCCeeeeeeEEecCCceEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+..|+.++ ..++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999999999999999987542 22234566666554 466799999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|..++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999988873 246899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......... .+.....
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~i~~~~~------ 218 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVNDEV------ 218 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC------
Confidence 221 12234679999999999999999999999999999999999999997643221111 1111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
.++...+..+.+++.+||+.||.+|| ++.+++++.++-
T Consensus 219 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~ 261 (324)
T cd05589 219 ------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261 (324)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence 12334456788999999999999999 688888887653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=358.49 Aligned_cols=263 Identities=30% Similarity=0.429 Sum_probs=206.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecC-C
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG-D 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 147 (519)
.++|++.+.||+|+||.||+|.+. .++..||||++..... .....+..|+.++..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467999999999999999999852 3456899999875432 2345688999999999 899999999988764 4
Q ss_pred ceEEEEEecCCCCHHHHHhhhccC--------------------------------------------------------
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNET-------------------------------------------------------- 171 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 171 (519)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 588999999999999998643210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceeccccccccc
Q 046892 172 --KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249 (519)
Q Consensus 172 --~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y 249 (519)
..++++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 235888999999999999999999999 999999999999999999999999999865433222222334567889
Q ss_pred CchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHH
Q 046892 250 CAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEA 328 (519)
Q Consensus 250 ~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 328 (519)
+|||++.+..++.++|||||||+||||++ |..||........ .... ...... ...+...+..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~----~~~~~~----------~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQR----LKDGTR----------MRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHH----HhcCCC----------CCCCCCCCHHH
Confidence 99999998999999999999999999997 9999976432211 1110 011000 01223445678
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 329 VAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 329 ~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+|+.+||+.||.+|||+.+|++.|..+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.48 Aligned_cols=322 Identities=23% Similarity=0.317 Sum_probs=267.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 151 (519)
..+|..+++||+|+|..|.+++++.+.+.||+|++++.- .++......|..+..+. +||.+|.|+.+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999999999999999997643 23345566777777654 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|.||++||+|.-+++. ...|+++.++.+..+|+.||.|||++| ||+||||.+|||+|..|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999877743 456999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--cchhhHHHhhchhccCCCCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRP--VDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 309 (519)
... ...+++++|||.|.|||++.+..|++.+|+|+|||+++||+.|+.||+.... .+...--..++-+++...+
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-- 477 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-- 477 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--
Confidence 332 2346789999999999999999999999999999999999999999986432 1221112223333332222
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC------CHHHHHHHHhhh-----hcCCCCCCCCCCCCCCCCcCCC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP------LMSDVVTALSFL-----SNSKEPIPDPIIPSDEDEYSEG 378 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP------s~~evl~~l~~~-----~~~~~~~~~p~~p~~~~~~~~~ 378 (519)
+|...+-.+..++...|++||.+|. .++++..|..|- .-.+..+.||+.|...+.+.-.
T Consensus 478 ----------iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~ 547 (593)
T KOG0695|consen 478 ----------IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLD 547 (593)
T ss_pred ----------ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCcc
Confidence 3444455677899999999999994 356666554432 1246677899999999999999
Q ss_pred ccCCCCCCCCCCCCCCCcccccccccccCCCCCCCCCCCC
Q 046892 379 YSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERI 418 (519)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~ 418 (519)
+++.+++.+..++++++...+...++.+|-+|.|+||.-+
T Consensus 548 ~fd~qft~e~~qltpdd~d~i~ridqsefegfeyinpl~m 587 (593)
T KOG0695|consen 548 NFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGFEYINPLLM 587 (593)
T ss_pred ccccccccCCcccCCCCHHHHHhcchhhcCcceecchhhc
Confidence 9999999999999999999999999999999999999854
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=349.88 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=215.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHH---HHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~---~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..+|++.+.||+|+||.|-+|+....|+.||||.+++....+..+ +.+|+++|+.|+||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 457999999999999999999998889999999998876665544 57899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||..+|.|++|+ ...+.|++.+++.++.||+.|+.|+|.++ ++|||||.+|||+|.++++||+||||+.++.
T Consensus 132 MEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999 44577999999999999999999999999 9999999999999999999999999998876
Q ss_pred CCCccceecccccccccCchhhhccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELT-VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~-~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
... ...++||+|-|.+||++++.+|. +.+|.|||||+||.|+.|..||++.+. ..++..+ -
T Consensus 205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQI---s--------- 266 (668)
T KOG0611|consen 205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQI---S--------- 266 (668)
T ss_pred ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHh---h---------
Confidence 543 34678999999999999998885 789999999999999999999987532 2222211 1
Q ss_pred cchHhhccC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRKQF-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
++.| .+..+..+.-||.+||-.||++|.|+.+|..|-|.
T Consensus 267 -----~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 267 -----RGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -----cccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 1111 12233467789999999999999999999988654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.03 Aligned_cols=275 Identities=25% Similarity=0.333 Sum_probs=221.5
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEec--cCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec-----
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLD--RNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD----- 145 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 145 (519)
......|...+.||+|+||.|+.+.++.+|+.||||.+. .......++..+|+.+|+.++|+||+.+++++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344567777899999999999999999999999999987 3445566788999999999999999999999865
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
-+.+|+|+|+| +.+|...+ ..+..|+...+..++.||+.||.|+|+.+ |+||||||.|+|++.+..+||+||
T Consensus 98 f~DvYiV~elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cceeEEehhHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence 45689999999 56888888 44556999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|+|+...........+..+-|.+|.|||++. ...||.+.||||+||||.||++|++.|.+.+..++..++...-.....
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9999876432233345677899999999875 468999999999999999999999999988777766555433211110
Q ss_pred C--------------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 305 P--------------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 305 ~--------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. ..++......+...|+ .....+++|+.+||..||.+|+|+++.++|+..-
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 0 0111111111222233 5567899999999999999999999999997643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=357.30 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=214.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..|....+||+|+||.||+|.+..+++.||+|++...... ..+++..|+.+|..++++||.++|+.|..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3577778999999999999999999999999999876443 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
|.||++.+.| ..+..+.+..+..|+.+++.||.|||.++ .+|||||+.||||..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999998 34555688888899999999999999999 9999999999999999999999999998765544
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.. ..+++|||.|||||++....|+.++||||||++.+||++|.+|+....+.... +..+... .+.
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl---------flIpk~~----PP~ 230 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL---------FLIPKSA----PPR 230 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE---------EeccCCC----CCc
Confidence 33 36789999999999999889999999999999999999999999876652211 1111111 122
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+. ...+..+.+|+..||+.||+.||++.++++|-.
T Consensus 231 L~----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 231 LD----GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred cc----cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 22 234557889999999999999999999998743
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.76 Aligned_cols=257 Identities=25% Similarity=0.307 Sum_probs=204.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.|...+.||+|+||+||+|++..+++.||||++..... .....+..|+.++..++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999999999999999999975432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999853 346899999999999999999999999 999999999999999999999999997532110
Q ss_pred Cc---------------------------------------------cceecccccccccCchhhhccCCCCchhHHHHH
Q 046892 235 EK---------------------------------------------MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSF 269 (519)
Q Consensus 235 ~~---------------------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSl 269 (519)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhh-HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHH--hhhhCCCCCCCH
Q 046892 270 GVILLELITGRRVIDTTRPVDEQN-LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAM--CLQEEAGARPLM 346 (519)
Q Consensus 270 Gvll~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~ 346 (519)
||++|||++|..||....+..... ++.+.. ...++ .....+.++.+|+.+ |+..++..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~~----------~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN-----TLHIP----------PQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc-----ccCCC----------CCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 999999999999998654322211 111110 00011 011234577888887 445666679999
Q ss_pred HHHHHHHhhh
Q 046892 347 SDVVTALSFL 356 (519)
Q Consensus 347 ~evl~~l~~~ 356 (519)
.+++.|.++-
T Consensus 300 ~~~l~hp~f~ 309 (381)
T cd05626 300 DDIKAHPFFS 309 (381)
T ss_pred HHHhcCcccC
Confidence 9999998763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.56 Aligned_cols=271 Identities=22% Similarity=0.320 Sum_probs=210.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||.||+|++..+++.||||++..... .....+..|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 368999999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.++.|..+. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99887665443 22356899999999999999999999999 999999999999999999999999999865432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chh--------ccCC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPI--------FRDP 305 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~--------~~~~ 305 (519)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+... .+. ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 211 123457899999999999888999999999999999999999999865433222111111 000 0000
Q ss_pred ----CCCCccc-chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 ----KRFPDMA-DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ----~~~~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+... .......+....+..+.+|+.+||+.||.+|||+.++++|.+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000000 0001111222345679999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=353.57 Aligned_cols=247 Identities=28% Similarity=0.394 Sum_probs=201.8
Q ss_pred eeeeccCcEEEEEEEEc---CCCeEEEEEEeccCC----CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 83 CLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNG----MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+.||+|+||.||+++.. .+++.||||++.... ......+..|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999874 468899999987532 12234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.. ...+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998843 356888999999999999999999999 9999999999999999999999999987533222
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ...+.....
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~~~~~--------- 217 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKILKGKL--------- 217 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHHcCCC---------
Confidence 1 12345799999999999988899999999999999999999999976433211 111111111
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
.++...+..+.+++.+||+.+|.+|| ++.+++.+.++-
T Consensus 218 ---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~ 260 (323)
T cd05584 218 ---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260 (323)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence 12333456788999999999999999 899999887653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=358.73 Aligned_cols=257 Identities=27% Similarity=0.367 Sum_probs=210.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999999999999999987542 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999854 257899999999999999999999999 99999999999999999999999999976543
Q ss_pred CC---------------------------ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 046892 234 GE---------------------------KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTT 286 (519)
Q Consensus 234 ~~---------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~ 286 (519)
.. .........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 001123457999999999999999999999999999999999999999865
Q ss_pred CCcchhhHH-HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-HHHHHHHHhhh
Q 046892 287 RPVDEQNLI-AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-MSDVVTALSFL 356 (519)
Q Consensus 287 ~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~~~ 356 (519)
........+ .|. ....++. ....+..+.+|+..||. ||.+||+ +.+++.+.++-
T Consensus 234 ~~~~~~~~i~~~~-----~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~ 289 (350)
T cd05573 234 TLQETYNKIINWK-----ESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289 (350)
T ss_pred CHHHHHHHHhccC-----CcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence 432211111 110 1101111 11135678899999997 9999999 99999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.98 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=207.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999999999999999997532 123345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999853 346899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCccc------------------------------------eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHH
Q 046892 234 GEKMN------------------------------------VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELI 277 (519)
Q Consensus 234 ~~~~~------------------------------------~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ell 277 (519)
..... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcchhh-HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC---HHHHHHHH
Q 046892 278 TGRRVIDTTRPVDEQN-LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL---MSDVVTAL 353 (519)
Q Consensus 278 tG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l 353 (519)
+|..||.......... +..|.. ...++. ....+..+.+++.+||. +|.+|++ +.+++.+.
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~----------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKE-----TLQFPD----------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCC-----ccCCCC----------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999997654322111 111110 000000 11234578899999996 9999998 99999998
Q ss_pred hhh
Q 046892 354 SFL 356 (519)
Q Consensus 354 ~~~ 356 (519)
|+-
T Consensus 298 ~~~ 300 (364)
T cd05599 298 FFK 300 (364)
T ss_pred CcC
Confidence 763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=354.63 Aligned_cols=247 Identities=27% Similarity=0.368 Sum_probs=202.9
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 159 (519)
+.||+|+||.||++.+..++..||+|++..... .....+..|+.++..++||||+++++++.+.+..+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999999999999999999875422 23345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 160 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
+|..++.. ...+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 99988743 3568999999999999999999997 68 99999999999999999999999999875322211
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||+||+|++|..||...........+ .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~~~~~------------ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEI------------ 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------hcCCC------------
Confidence 123457999999999999999999999999999999999999999764322111111 11111
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
.++...+.++.+|+.+||+.||.+|+ ++.++++|.++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 12334456788999999999999996 899999987754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.98 Aligned_cols=257 Identities=22% Similarity=0.273 Sum_probs=208.5
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+..|+.++..++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999999999999999986532 2233457789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999998843 35788999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCccceecccccccccCchhhhccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSG----ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
..... ......+||+.|+|||++.+. .++.++|||||||+||||++|..||........... +......
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~~~~~ 265 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMDHKNS 265 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH------HHcCCCc
Confidence 43221 112346799999999998653 478999999999999999999999986543221111 1111000
Q ss_pred CCcccchHhhccCCh--hhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHhhh
Q 046892 308 FPDMADPLLRKQFPE--KGLNEAVAIAAMCLQEEAGA--RPLMSDVVTALSFL 356 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~--~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~~ 356 (519)
+ .++. ..+.++.+|+..||+.+|.+ |+++.+++.|.++-
T Consensus 266 ~----------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 266 L----------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred C----------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 0 0111 24568899999999999988 99999999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=354.73 Aligned_cols=259 Identities=23% Similarity=0.288 Sum_probs=203.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||+||+|.+..+++.||||++..... .....+..|+.++..++|+||+++++++.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999999999999999999975321 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999853 456899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcc---------------------------------ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCC
Q 046892 234 GEKM---------------------------------NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280 (519)
Q Consensus 234 ~~~~---------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~ 280 (519)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhh--hCCCCCCCHHHHHHHHhhh
Q 046892 281 RVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQ--EEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 281 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~l~~~ 356 (519)
.||...........+... .....++. ....+.++.+++.+++. .++..||++.+|++|.++-
T Consensus 234 ~Pf~~~~~~~~~~~i~~~----~~~~~~p~----------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~ 297 (363)
T cd05628 234 PPFCSETPQETYKKVMNW----KETLIFPP----------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297 (363)
T ss_pred CCCCCCCHHHHHHHHHcC----cCcccCCC----------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence 999765433222111100 00000110 01133467777777554 2344568999999997763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=358.09 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=207.0
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
...++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|+.++..++||||+++++++.++...|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999986532 123345778999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999998843 35889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSG----ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
...... ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||........... +.....
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~------i~~~~~ 264 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK------IMDHKN 264 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCc
Confidence 543221 112356799999999998753 378899999999999999999999976543221111 111000
Q ss_pred CCCcccchHhhccCC--hhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHhhhh
Q 046892 307 RFPDMADPLLRKQFP--EKGLNEAVAIAAMCLQEEAGA--RPLMSDVVTALSFLS 357 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~~~ 357 (519)
.+ .++ ...+..+.+++..||+.++.+ |+++.++++|.|+-.
T Consensus 265 ~~----------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 265 SL----------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred cc----------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 00 011 123557888999999865543 899999999987643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=344.74 Aligned_cols=271 Identities=23% Similarity=0.314 Sum_probs=208.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|.+.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 3579999999999999999999999999999999875432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+. ++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 997 489888854 2345789999999999999999999999 999999999999999999999999999754322
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch-----hcc---CC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP-----IFR---DP 305 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~-----~~~---~~ 305 (519)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... .+. ..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 TK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred Cc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 21 1233568999999998865 5689999999999999999999999976543332222111100 000 00
Q ss_pred CCCCcccchHhh----ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 KRFPDMADPLLR----KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+.....+... .........++.+|+.+||+.||.+|||+.++++|.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 000000000000 00112345678999999999999999999999988764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=368.17 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=212.2
Q ss_pred CcccceeeeccCcEEEEEEEEcCC-CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSN-GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.|.+.+.||+|+||.||+|....+ +..||+|.+..........+..|+.++..++|||||+++++|...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488999999999999999998877 7889999876554444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++|+|.++|........++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999998765555667899999999999999999999999 99999999999999999999999999987654333
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+.. .+.... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~---~~~~~~--~-------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQ---QVLYGK--Y-------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhCC--C--------
Confidence 33344567999999999999999999999999999999999999999754321 1111 111100 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
..++...+..+.+|+..||+.||.+||++.+++.+.
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~ 324 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTE 324 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCH
Confidence 012233456789999999999999999999998764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=348.89 Aligned_cols=309 Identities=23% Similarity=0.316 Sum_probs=224.4
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 153 (519)
+|+..+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999999999999999987542 223345677888888775 577889999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998843 356899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +.. .+.....
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~~~~~------- 218 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQ---SIMEHNV------- 218 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCC-------
Confidence 21 12234579999999999998899999999999999999999999997653221 111 1111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCC
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM-----SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDG 383 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~ 383 (519)
.++...+..+.+++.+||+.+|.+|++. .++.+|.++... ....+.+|..|..... ....+..-
T Consensus 219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 292 (323)
T cd05615 219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292 (323)
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCcc
Confidence 1233445678899999999999999974 677776554322 1233334444432111 12222222
Q ss_pred CCCCCCCCCCCCcccccccccccCCCCCCCC
Q 046892 384 HQKNENTYDNDNARSVRESENLESSNNSGSN 414 (519)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 414 (519)
...........+...+...+.-.+.+|++.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 293 FTRGQPVLTPPDQLVIANIDQADFEGFSYVN 323 (323)
T ss_pred ccccCCCCCCCcccccccccccccCCCcccC
Confidence 2222222222333344444555777777654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=351.11 Aligned_cols=270 Identities=23% Similarity=0.355 Sum_probs=212.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||++++..++..||+|++..... .....+.+|+.++..++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999875432 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+. |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999843 3468999999999999999999998532 999999999999999999999999998765332
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC-----
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP----- 309 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 309 (519)
. .....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+. ...........
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSISP 231 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccCc
Confidence 1 234578999999999998899999999999999999999999997543322111110 00000000000
Q ss_pred -----------------------cccchHhhc---cC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 310 -----------------------DMADPLLRK---QF-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 310 -----------------------~~~d~~l~~---~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+..... .. ....+.++.+|+.+||+.||++|||+.+++++.|+-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 306 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR 306 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence 000000000 00 1124568999999999999999999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.59 Aligned_cols=251 Identities=27% Similarity=0.337 Sum_probs=208.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC-eEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG-QVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++.... ......+..|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357999999999999999999876554 689999986532 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999843 356899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+...... +.....
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~~~~~----- 245 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------ILEGII----- 245 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------HhcCCC-----
Confidence 332 2345799999999999988899999999999999999999999976543211111 111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
.++...+..+.+++.+||+.||.+|+ ++.++++|.|+-
T Consensus 246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~ 288 (340)
T PTZ00426 246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG 288 (340)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence 12333445788999999999999995 899999997763
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.02 Aligned_cols=259 Identities=27% Similarity=0.374 Sum_probs=213.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh---HHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.+.|+.++.||.|.-|+||++....++..+|+|++.+...... .+...|.+||+.+.||.++.||..|+.+...|||
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 4568889999999999999999999999999999987655433 4456799999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||||+||+|..+.+. .....+++..++.++.+|+-||+|||-.| ||+|||||+||||-++|++.|+||.|+....
T Consensus 156 meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999998866 45667999999999999999999999999 9999999999999999999999999875321
Q ss_pred C---------------------------------CCc---------------------cceecccccccccCchhhhccC
Q 046892 233 Q---------------------------------GEK---------------------MNVTSRVMGTYGYCAPEYARSG 258 (519)
Q Consensus 233 ~---------------------------------~~~---------------------~~~~~~~~Gt~~y~APE~l~~~ 258 (519)
- ... ......++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 0012247899999999999999
Q ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhh
Q 046892 259 ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQE 338 (519)
Q Consensus 259 ~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~ 338 (519)
..+.++|||+|||+|||||.|.-||.+......... ++..+..++. ...++..+.+||.++|.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N------Iv~~~l~Fp~----------~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN------IVGQPLKFPE----------EPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH------HhcCCCcCCC----------CCcchhHHHHHHHHHhcc
Confidence 999999999999999999999999988654322211 1111112221 124567899999999999
Q ss_pred CCCCCCC----HHHHHHHHhh
Q 046892 339 EAGARPL----MSDVVTALSF 355 (519)
Q Consensus 339 dP~~RPs----~~evl~~l~~ 355 (519)
||.+|.. +.||-+|..|
T Consensus 375 dP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred ChhhhhccccchHHhhcCccc
Confidence 9999998 8888877654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=340.74 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=207.2
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
||+|+||+||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999998654322 224567899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
..++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888655445567999999999999999999999999 99999999999999999999999999976543322 123
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .......... ..++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~------------~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILNDS------------VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhcccC------------CCCc
Confidence 4578999999999999999999999999999999999999997643321111 1111111111 1223
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLS 357 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~ 357 (519)
...+..+.+++..||+.||.+|| ++.+++.|.|+-.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 34556889999999999999999 7899999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=348.95 Aligned_cols=257 Identities=26% Similarity=0.344 Sum_probs=205.6
Q ss_pred CcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCce
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGM----QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 149 (519)
+|++.+.||+|+||.||+++.. .+++.||+|++.+... ...+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5889999999999999999874 4688999999865321 2234577899999998 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+.+|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999843 356899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
........ ......||+.|+|||++.+. .++.++|||||||+||||++|..||...........+ ...+....
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~~--- 227 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKCD--- 227 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcCC---
Confidence 64332221 12346799999999999764 4788999999999999999999999754332221111 11111111
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
..++...+..+.+++.+||+.||.+|| ++.+++++.|+-
T Consensus 228 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 228 ---------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 112334456788999999999999999 788999988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=361.98 Aligned_cols=270 Identities=25% Similarity=0.338 Sum_probs=210.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--------C
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--------D 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------~ 147 (519)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999899999999885432 2345799999999999999999987432 2
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeec
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFG 226 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFG 226 (519)
.+++||||++ ++|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999996 5788877655555677999999999999999999999999 99999999999998665 69999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhchhc--
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQPIF-- 302 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~~~-- 302 (519)
+++....... .....||+.|+|||++.+ ..++.++|||||||+||||++|.+||......+....+ .......
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9986543322 223578999999999875 46899999999999999999999999875443222111 1100000
Q ss_pred -----c---CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 -----R---DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 -----~---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. ....++......+...++...+.++.+|+.+||+.||.+|||+.+++.|.++-
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 0 00122223333444455666678899999999999999999999999998864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=352.69 Aligned_cols=259 Identities=24% Similarity=0.291 Sum_probs=209.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 478999999999999999999999999999999875422 23455778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998543 346899999999999999999999999 99999999999999999999999999986544
Q ss_pred CCccceecccccccccCchhhhc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYAR------SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~------~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........... +.... .
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~------i~~~~-~ 226 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN------IMNFQ-R 226 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH------HHcCC-C
Confidence 3222 223357899999999986 45678999999999999999999999976433221111 11100 0
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+ ......+..+.+|+..||+ +|.+||++.+++.|.++..
T Consensus 227 ~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 227 FLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred ccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 0000 0011245678899999998 9999999999999987643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.91 Aligned_cols=266 Identities=28% Similarity=0.434 Sum_probs=206.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC----------------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeee
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS----------------NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVN 138 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~ 138 (519)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999998642 345799999875432 23456889999999999999999
Q ss_pred eeeEEecCCceEEEEEecCCCCHHHHHhhhcc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 046892 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNE---------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203 (519)
Q Consensus 139 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~Iv 203 (519)
+++++.+.+..++||||+.+|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999998854211 1234788899999999999999999999 99
Q ss_pred ecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh--CCC
Q 046892 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT--GRR 281 (519)
Q Consensus 204 HrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt--G~~ 281 (519)
||||||+|||++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999986544433333344556889999999988899999999999999999987 456
Q ss_pred CCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 282 VIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 282 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
||...... ..+............ ......+..++..+.+|+.+||+.||.+|||+.+|...|.
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 66643322 222211111111000 0001123344568899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=350.41 Aligned_cols=246 Identities=27% Similarity=0.372 Sum_probs=197.2
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHH-HHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999999999999999986532 122334555554 56779999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 151 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D 151 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence 99998874 3456899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~~~~~------------ 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNILHKPL------------ 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHHcCCc------------
Confidence 233467999999999999999999999999999999999999999764322111 11111110
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCHH----HHHHHHhh
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLMS----DVVTALSF 355 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~l~~ 355 (519)
.++...+..+.+++..||+.+|.+||++. +++.+.++
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 11223445788999999999999999874 77777655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=333.28 Aligned_cols=275 Identities=24% Similarity=0.315 Sum_probs=215.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCC-eeeeeeEEecCC------
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPN-LVNLIGYCADGD------ 147 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~------ 147 (519)
..|...+.||+|+||+||+|+.+.+|+.||+|++...... ......+|+.+++.++|+| ||.|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4577778899999999999999999999999999765442 3456789999999999999 999999998877
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
.++|||||+ .-+|..++.........++...++.++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 46999999765433356788899999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-----
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----- 301 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~----- 301 (519)
|+...-.. ...+..++|.+|.|||++.+. .|+...||||+|||++||+++++.|.+....+....+-.....
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99654322 224556789999999999876 7999999999999999999999999987765444333211111
Q ss_pred ccCCCCCCcccch--------HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 302 FRDPKRFPDMADP--------LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 302 ~~~~~~~~~~~d~--------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+.....++++-.. .+.... ........+++.+||+.+|.+|.|+..+++|..|...
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111111111100 011111 1112478999999999999999999999999766543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=356.73 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=204.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..++||||+++++++.+....||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999999999999999986532 122355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999843 356899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCcc---------------------------------------------ceecccccccccCchhhhccCCCCchhHHHH
Q 046892 234 GEKM---------------------------------------------NVTSRVMGTYGYCAPEYARSGELTVKSDVYS 268 (519)
Q Consensus 234 ~~~~---------------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwS 268 (519)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999899999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcchhhH-HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCC---C
Q 046892 269 FGVILLELITGRRVIDTTRPVDEQNL-IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR---P 344 (519)
Q Consensus 269 lGvll~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---P 344 (519)
|||+||||++|..||......+.... ..|.. ...++. ....+.++.+|+.+||. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~p~----------~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE-----TLYFPD----------DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC-----ccCCCC----------CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999976543222111 11110 001110 01234578899999997 67665 5
Q ss_pred CHHHHHHHHhhh
Q 046892 345 LMSDVVTALSFL 356 (519)
Q Consensus 345 s~~evl~~l~~~ 356 (519)
++.+++.+.++-
T Consensus 298 ~~~~~l~hp~~~ 309 (377)
T cd05629 298 GAHEIKSHPFFR 309 (377)
T ss_pred CHHHHhcCCCcC
Confidence 999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=342.50 Aligned_cols=271 Identities=23% Similarity=0.322 Sum_probs=207.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||.|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999999998999999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+. ++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 688887743 2356889999999999999999999999 999999999999999999999999998754322
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC--C-----
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP--K----- 306 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~----- 306 (519)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+.........+ .
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccch
Confidence 1 11233568999999999865 458899999999999999999999998653321 1111111000000 0
Q ss_pred -CCCcc--------cchHhhccCC-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 307 -RFPDM--------ADPLLRKQFP-EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 307 -~~~~~--------~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+.+ ....+...+. ......+.+|+..||+.||.+|||+.++++|.++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 00000 0000111000 112356889999999999999999999999987743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=348.58 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=203.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.+|+..+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++|+||+++++++.+.+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 457778899999999999999998999999999865432 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.... .+.+..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986532 3567788899999999999999999 9999999999999999999999999998654322
Q ss_pred ccceecccccccccCchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 236 KMNVTSRVMGTYGYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
. ......||..|+|||++.. ...+.++|||||||+||||++|+.||......+...+..... ...
T Consensus 223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~~------ 292 (353)
T PLN00034 223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MSQ------ 292 (353)
T ss_pred c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--ccC------
Confidence 1 1234579999999998743 234568999999999999999999997433322222211110 000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+.....++.+||.+||+.||.+||++.++++|.|+...
T Consensus 293 ------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 293 ------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 011223445678999999999999999999999999877654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=353.35 Aligned_cols=266 Identities=20% Similarity=0.230 Sum_probs=204.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||++++++|......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999999999999999753 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+. ++|..++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 94 688888743 346899999999999999999999999 9999999999999999999999999997533221
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch----hhHHHhhchhc-cCCCCCCc
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE----QNLIAWAQPIF-RDPKRFPD 310 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~----~~~~~~~~~~~-~~~~~~~~ 310 (519)
........||+.|+|||++.+..++.++|||||||+||||++|..||......+. ...+....... ..+..++.
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1122346799999999999999999999999999999999999988754322111 11111000000 00000000
Q ss_pred ----ccchHh----hc------c-----CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 311 ----MADPLL----RK------Q-----FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 311 ----~~d~~l----~~------~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+... .. . .....+.++.+|+.+||+.||.+|||+.+++++.++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 000000 00 0 0012345788999999999999999999999988764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=356.62 Aligned_cols=257 Identities=22% Similarity=0.224 Sum_probs=205.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
+|++.+.||+|+||.||+|++..+++.||||++.... ......+..|+.++..++|+||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999999999999999986532 1234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999844 346889999999999999999999999 999999999999999999999999997532100
Q ss_pred C-----------------------------------------ccceecccccccccCchhhhccCCCCchhHHHHHHHHH
Q 046892 235 E-----------------------------------------KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273 (519)
Q Consensus 235 ~-----------------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll 273 (519)
. ........+||+.|||||++.+..++.++|||||||+|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC---CHHHHH
Q 046892 274 LELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP---LMSDVV 350 (519)
Q Consensus 274 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl 350 (519)
|||++|..||....+......+.... ....+ ......+..+.+++.+|+ .+|.+|+ ++.+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~----~~~~~----------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWE----TTLHI----------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccC----ccccC----------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999998755432221111000 00000 011223456778888876 5999999 999999
Q ss_pred HHHhhh
Q 046892 351 TALSFL 356 (519)
Q Consensus 351 ~~l~~~ 356 (519)
.|.++-
T Consensus 300 ~h~~~~ 305 (376)
T cd05598 300 AHPFFK 305 (376)
T ss_pred CCCCcC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=358.06 Aligned_cols=256 Identities=23% Similarity=0.273 Sum_probs=203.7
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.|+..+.||+|+||.||+|++..+++.||+|++..... .....+..|+.++..++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999875422 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
||++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999843 346889999999999999999999999 999999999999999999999999997532100
Q ss_pred C---------------------------------------------ccceecccccccccCchhhhccCCCCchhHHHHH
Q 046892 235 E---------------------------------------------KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSF 269 (519)
Q Consensus 235 ~---------------------------------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSl 269 (519)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhh-HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC---
Q 046892 270 GVILLELITGRRVIDTTRPVDEQN-LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL--- 345 (519)
Q Consensus 270 Gvll~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs--- 345 (519)
||+||||++|..||....+..... +..+.. ...++ .....+.++.+++.+|+ .+|.+|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~-----~~~~p----------~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQT-----SLHIP----------PQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCC-----CcCCC----------CcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 999999999999998654332211 111100 00000 01223457778888776 59999987
Q ss_pred HHHHHHHHhhh
Q 046892 346 MSDVVTALSFL 356 (519)
Q Consensus 346 ~~evl~~l~~~ 356 (519)
+.+++.|.++-
T Consensus 299 ~~ei~~hp~f~ 309 (382)
T cd05625 299 ADEIKAHPFFK 309 (382)
T ss_pred HHHHhcCCCcC
Confidence 99999887653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.08 Aligned_cols=268 Identities=23% Similarity=0.364 Sum_probs=204.4
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----CceE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 150 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 150 (519)
+|++.+.||+|+||.||+|.+..++..||||++.... ......+..|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999999999999999986432 22345688999999999999999999988543 2479
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999999 4689888743 346899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCc-cceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC-
Q 046892 231 GPQGEK-MNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK- 306 (519)
Q Consensus 231 ~~~~~~-~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~- 306 (519)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+. .....+.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~---~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT---DLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH---HHhCCCCH
Confidence 432211 112234579999999999876 678999999999999999999999997654322211111 0000000
Q ss_pred ---------CCCccc-------chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 307 ---------RFPDMA-------DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 307 ---------~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...... ...+...+ ......+.+++.+||+.||.+||++.+++.+.++..
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 000000 00000011 123456789999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=339.42 Aligned_cols=267 Identities=24% Similarity=0.331 Sum_probs=214.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--C---ceEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--D---QRLLV 152 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~---~~~lV 152 (519)
.|...+++|.|+||.||.|....++..||||.+-.+... --+|+.+|+.+.|||||+|..+|... . ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 577789999999999999999999999999998654332 23589999999999999999988542 2 34599
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CCcEEeeecccccC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKLG 231 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-~~vkL~DFGla~~~ 231 (519)
||||+ .+|.+++......+..++.-.++-+.+||++||+|||+.+ |+||||||.|||||.+ |.+||||||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 4999999876666788999999999999999999999999 9999999999999976 89999999999988
Q ss_pred CCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc-------
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR------- 303 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~------- 303 (519)
..+... .....|..|.|||++.+ ..|+.+.||||.||++.||+-|++.|.+....++...+.-+-....
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 776643 23456889999998876 5799999999999999999999999998766665443321111100
Q ss_pred ----CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 304 ----DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 304 ----~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....++.+........+......++++|+.++|+.+|.+|.++.+++.|..|
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF 309 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF 309 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence 0122333333333233455667899999999999999999999999998765
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=353.26 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=208.9
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEec
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD 145 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 145 (519)
+.++....++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444555689999999999999999999999999999999986432 1223456789999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
+...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998843 34788999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccC----CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG----ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
|++........ ......+||+.|+|||++.+. .++.++|||||||+||||++|..||......... ..+
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i 259 (371)
T cd05622 187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKI 259 (371)
T ss_pred CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHH
Confidence 99986543221 122346799999999998753 3789999999999999999999999764332111 111
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHhhh
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGA--RPLMSDVVTALSFL 356 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~~ 356 (519)
......+. -......+..+.+++..||..++.+ |+++.++++|+++-
T Consensus 260 ~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~ 308 (371)
T cd05622 260 MNHKNSLT--------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 308 (371)
T ss_pred HcCCCccc--------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccC
Confidence 11110000 0011234567889999999844433 78999999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=347.27 Aligned_cols=246 Identities=28% Similarity=0.399 Sum_probs=198.4
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHH-HHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||+||+|.+..+|+.||||++..... .....+..|.. +++.++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999999999999999875321 22234555554 56789999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 999998843 456899999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~------------ 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNILNKPL------------ 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHHcCCC------------
Confidence 233467999999999999999999999999999999999999999764322111 11111111
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCH----HHHHHHHhh
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLM----SDVVTALSF 355 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~~ 355 (519)
.++...+..+.+++.+||+.||.+||++ .+++.+.++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 1122335678999999999999999987 588877765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=366.31 Aligned_cols=262 Identities=26% Similarity=0.314 Sum_probs=213.7
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC----
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD---- 147 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 147 (519)
...++|.+.+.||+|+||+||+|.+..+++.||||++..... .....+..|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345689999999999999999999999999999999876533 23345778999999999999999998775432
Q ss_pred ----ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 148 ----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 148 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
.+++||||+++|+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999999765555667999999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 303 (519)
|||+++...............||+.|+|||++.+..++.++|||||||+||||++|..||...... .+. .....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~---~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVM---HKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHhc
Confidence 999998654433223334567999999999999999999999999999999999999999754321 111 11111
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.. ...++...+.++.+|+..||+.||.+||++.+++.+.+.
T Consensus 260 ~~-----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~ 300 (496)
T PTZ00283 260 GR-----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300 (496)
T ss_pred CC-----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence 10 011334455688999999999999999999999987653
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=345.95 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=220.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc-eEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~lV 152 (519)
.++|..++++|+|+||.+++++++.+++.|++|.+...... .......|+.+++++.|||||.+++.|.+++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35789999999999999999999999999999998765443 33457889999999999999999999999888 9999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|+||+||+|.+.|.... +..+++..+..|+.|++.||.|||+.. |+|||||+.|||++.++.|||+|||+|+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999997643 567899999999999999999999888 9999999999999999999999999999887
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... ...+.+||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+... ++. .+..
T Consensus 158 ~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~---ki~~--------- 220 (426)
T KOG0589|consen 158 PEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL---KINR--------- 220 (426)
T ss_pred Cchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH---HHhh---------
Confidence 6542 3456899999999999999999999999999999999999999998754322 221 1111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.+-...+...+.++..++..||..+|..||++.+++.++..
T Consensus 221 --~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l 261 (426)
T KOG0589|consen 221 --GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHL 261 (426)
T ss_pred --ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhh
Confidence 11123566677899999999999999999999999988543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=326.24 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=215.6
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc----Ch----HHHHHHHHHHHhc-CCCCeeeeeeEE
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ----GN----KEFLVEVLMLSLL-HHPNLVNLIGYC 143 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----~~----~~~~~E~~~l~~l-~HpnIv~l~~~~ 143 (519)
......|...+.||.|..++|-++.++.+|..+|+|++...... .. +.-..|+.+|+++ .||+|++|.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456788889999999999999999999999999998643221 12 2345689999877 599999999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 144 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
+.+..+++|+|.|+.|.|.|+|. ..-.+++...+.|+.||++|+.|||..+ ||||||||+|||+|++.++||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 99999999999999999999993 4567999999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR------SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~------~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~ 297 (519)
|||+++.+..+... ...||||+|+|||.+. ...|+..+|+|++||+||.|+.|.+||......-...++..
T Consensus 166 DFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 166 DFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred ccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 99999998887654 3579999999999884 35788999999999999999999999975432222222222
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
....+.. .--.+.+....+||.+||+.||.+|.|+.+++.|.+++.
T Consensus 243 GkyqF~s--------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 243 GKYQFRS--------------PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cccccCC--------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 2111111 111345567889999999999999999999999999854
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=347.06 Aligned_cols=246 Identities=28% Similarity=0.406 Sum_probs=197.1
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHH-HHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
++||+|+||.||+|++..+++.||+|++.+... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999865321 22334555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 999888743 356889999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+.. .+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~~~------------~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---NILHKP------------L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---HHhcCC------------C
Confidence 233467999999999999889999999999999999999999999764321 1111 111111 1
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCH----HHHHHHHhh
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLM----SDVVTALSF 355 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~~ 355 (519)
.++......+.+++.+||+.||.+||++ .++++++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 1233445678899999999999999875 477766654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=328.99 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=214.6
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN--GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..+.|++.++||+|.|+.||++.+..+|+.+|+|+++.. ...+.+++.+|+.+.+.++|||||+|++.+......|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 357889999999999999999999999999999998643 334667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCCcEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG---ANLDPKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~---~~~~vkL~DFGla~ 229 (519)
+|+|.|++|..-|-.. ..+++..+-.++.||+++|.|+|.++ |||||+||+|+|+- ..--+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999988766443 45788899999999999999999999 99999999999994 34458999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....+. ....++|||+|||||++...+|+..+|||+.||+||-|+.|.+||.......... .+......++
T Consensus 162 ~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye------~I~~g~yd~~ 232 (355)
T KOG0033|consen 162 EVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYE------QIKAGAYDYP 232 (355)
T ss_pred EeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHH------HHhccccCCC
Confidence 776332 3456889999999999999999999999999999999999999998643332222 2222111111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+-+.+++++.+|+.+||..||.+|.|+.|.+.|.|.-
T Consensus 233 --------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 233 --------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred --------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 111234456899999999999999999999999998754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=337.27 Aligned_cols=245 Identities=22% Similarity=0.338 Sum_probs=200.3
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEec----CCceEEEEEe
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEF 155 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 155 (519)
..||+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+|..++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 48999999987654333 3567799999999999999999999876 3468899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+++|+|.+++.. ...+++...+.++.+++.||.|||+. + ++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999843 35689999999999999999999985 6 889999999999999999999999999865332
Q ss_pred CccceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|..||......+.. .. +.....
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~---i~~~~~------ 239 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DL---IINKNN------ 239 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HH---HHhcCC------
Confidence 1 23467899999999976 68999999999999999999999999865432211 11 111110
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+..++...+..+.+|+.+||+.||.+|||+.++++.|..+.
T Consensus 240 ----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 ----SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ----CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 01123345668999999999999999999999999998764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=352.37 Aligned_cols=266 Identities=29% Similarity=0.457 Sum_probs=210.6
Q ss_pred HHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 70 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
.+.....+++.+...||+|+||+||+|.+.. .||||++...... ..+.|.+|+..+++-+|.||+-+.|||..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3344455667788999999999999999974 3999999765433 4467999999999999999999999998887
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
. .||+.+|.|-+|+.+|+.. ...++....+.|+.||++|+.|||.++ |||||||..||||.+++.|||+||||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 7 9999999999999999654 356899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
+..-..-..........|...|||||+++. .+|++.+||||||||+|||++|..||... ..+. + ++.+-+.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq---I--ifmVGrG 608 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ---I--IFMVGRG 608 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh---e--EEEeccc
Confidence 975332211112233457889999999864 47899999999999999999999999832 2211 1 1111010
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.-.++.. .....+.+++.+|+..||..++++||.+.+|+..|..+..
T Consensus 609 -~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 -YLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0111111 1234566789999999999999999999999998876654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.59 Aligned_cols=261 Identities=27% Similarity=0.392 Sum_probs=206.4
Q ss_pred ccCcccceeeeccCcEEEEEEEE-----cCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||+|++ ..++..||||++.... ....+.+..|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34789999999999999999974 3456789999986543 23345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc----------------------------------------------------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE---------------------------------------------------------- 170 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 170 (519)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864221
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 171 -------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 171 -------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1225789999999999999999999999 999999999999999999999999999865443322
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....... ...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~---------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGY---------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCc----------
Confidence 22223445678999999999999999999999999999998 888886543211 1111111 100
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...+.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 011122234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=337.93 Aligned_cols=269 Identities=24% Similarity=0.338 Sum_probs=202.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcC-CCeEEEEEEeccCCCc--ChHHHHHHHHHHHhc---CCCCeeeeeeEEe-----c
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQS-NGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLL---HHPNLVNLIGYCA-----D 145 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~-----~ 145 (519)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++..+ .||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 4788999998654322 234566777776655 6999999999985 3
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999995 6899988543 2345899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|.+||......+....+....... .+
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~-~~ 230 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GE 230 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Ch
Confidence 9997654331 2334578999999999988899999999999999999999999998765433222111110000 00
Q ss_pred CCCCcc---cchHh-------hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 KRFPDM---ADPLL-------RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ~~~~~~---~d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..++.. ....+ ...+....+..+.+|+.+||+.||++|||+.++++|.+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000000 00000 001112345677899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.19 Aligned_cols=256 Identities=28% Similarity=0.354 Sum_probs=217.9
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~ 150 (519)
....|++.+.||.|.||.||+++.+.+|+.+|+|++.+..... ...+.+|+.+|+.+. |||||.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3467888899999999999999999999999999998765543 358899999999999 999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC----CCCcEEeeec
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA----NLDPKLSDFG 226 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~----~~~vkL~DFG 226 (519)
+|||+|.||.|.+.+... .+++..+..++.||+.++.|||+.| |+||||||+|+|+.. ++.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999664 2999999999999999999999999 999999999999953 3579999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
++.....+ ......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+. ....
T Consensus 185 la~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~------~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL------RGDF 255 (382)
T ss_pred CceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH------cCCC
Confidence 99987652 23566899999999999999999999999999999999999999998765443332221 1111
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.+ ....-+..+..+.+++..||..||.+|+|+.++++|+|.
T Consensus 256 ~f--------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 256 DF--------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred CC--------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 11 111223446789999999999999999999999999773
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=348.09 Aligned_cols=246 Identities=27% Similarity=0.374 Sum_probs=200.4
Q ss_pred eeeeccCcEEEEEEEE---cCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 83 CLLGEGGFGRVYKGTL---QSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~---~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
+.||+|+||.||++.. ..+|+.||+|++..... .....+..|+.++..++||||+++++++.+.+..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999886 35689999999875422 233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999998843 356899999999999999999999999 99999999999999999999999999876443321
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .+.....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~---~i~~~~~----------- 215 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MT---MILKAKL----------- 215 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HH---HHHcCCC-----------
Confidence 22346799999999999988899999999999999999999999976432211 11 1111111
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSF 355 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~ 355 (519)
.++...+..+.+|+.+||+.||.+||+ +.+++.+.++
T Consensus 216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 123334557889999999999999999 5667776654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=336.66 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=210.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.|++.+.||+|+||.||++.+..+++.||||++...... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999999988999999998654322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888542 2346899999999999999999999999 999999999999999999999999999865432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. .....|++.|+|||++.+..++.++|||||||++|||++|..||...........+. ..+....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~--------- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKEDQ--------- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--HHhhhcc---------
Confidence 21 223578999999999998899999999999999999999999998644322111111 1111110
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLS 357 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~ 357 (519)
..++...+..+.+|+..||+.||.+|| ++.+++.+.++..
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 222 ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 122334556788999999999999999 8999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.14 Aligned_cols=262 Identities=28% Similarity=0.407 Sum_probs=206.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC-----CeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN-----GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||+|++... +..||||++..... .....+..|+.+++.+ +|+||++++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35789999999999999999986433 35799999875432 2345678899999998 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc----------------------------------------------------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE---------------------------------------------------------- 170 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 170 (519)
.++||||+.+|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999854211
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecc
Q 046892 171 --------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR 242 (519)
Q Consensus 171 --------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 242 (519)
...++++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1135788999999999999999999999 99999999999999999999999999976543332222223
Q ss_pred cccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 243 VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 243 ~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
..++..|||||++.+..++.++|||||||++|+|++ |..||........ ...... .. .....+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~----~~----------~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVK----RG----------YQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHH----cc----------cCccCC
Confidence 345678999999998899999999999999999997 9999976432211 111110 00 001112
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...+.++.+++.+||+.||.+||++.+|++.|..+
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22346789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=334.55 Aligned_cols=258 Identities=31% Similarity=0.499 Sum_probs=209.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCC-----eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNG-----QVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+..... .....+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46888999999999999999986544 6899999865432 22356888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 046892 151 LVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL 218 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~ 218 (519)
++|||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 1145889999999999999999999999 99999999999999999
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAW 297 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 297 (519)
.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......+ +...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999976544332223344567889999999988899999999999999999998 999987654322 2211
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.. .. .....+..++.++.+|+.+||+.||.+||++.+|+++|.
T Consensus 239 i~---~~-----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 239 IR---SR-----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HH---cC-----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 11 00 001123455678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.72 Aligned_cols=274 Identities=20% Similarity=0.289 Sum_probs=202.8
Q ss_pred HHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC------CCeeeeeeEEe
Q 046892 71 ELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH------PNLVNLIGYCA 144 (519)
Q Consensus 71 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H------pnIv~l~~~~~ 144 (519)
++....++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+.| .+|++++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445688999999999999999999999889999999986432 223345567777666654 56899999987
Q ss_pred cC-CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCC----
Q 046892 145 DG-DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANL---- 218 (519)
Q Consensus 145 ~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~---- 218 (519)
.. ..++||||++ +++|.+++.. ...+++..++.|+.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 64 5788999988 7789888843 3569999999999999999999998 48 99999999999998765
Q ss_pred ------------CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 046892 219 ------------DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTT 286 (519)
Q Consensus 219 ------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~ 286 (519)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864322 123468999999999999999999999999999999999999999876
Q ss_pred CCcchhhHHHhhch-----------------hccCCCCCCcccchH-hhc----c-C-ChhhHHHHHHHHHHhhhhCCCC
Q 046892 287 RPVDEQNLIAWAQP-----------------IFRDPKRFPDMADPL-LRK----Q-F-PEKGLNEAVAIAAMCLQEEAGA 342 (519)
Q Consensus 287 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~d~~-l~~----~-~-~~~~~~~l~~li~~cl~~dP~~ 342 (519)
...+....+..... ++.....+....++. +.. . . .......+.+||..||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 54333222211100 000000000000000 000 0 0 0012346789999999999999
Q ss_pred CCCHHHHHHHHhhhhc
Q 046892 343 RPLMSDVVTALSFLSN 358 (519)
Q Consensus 343 RPs~~evl~~l~~~~~ 358 (519)
|||+.++++|.|+...
T Consensus 429 R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 429 RLNARQMTTHPYVLKY 444 (467)
T ss_pred CCCHHHHhcCcccccc
Confidence 9999999999887653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=373.70 Aligned_cols=319 Identities=21% Similarity=0.237 Sum_probs=251.4
Q ss_pred HHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC
Q 046892 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG 146 (519)
Q Consensus 70 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 146 (519)
.++....++|.++++||+|+||.|.+++++.+++.||+|++.+. ...+..-|..|-.+|...+.+-|+.|+.+|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 44555678999999999999999999999999999999999873 234456688899999988999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
.++|||||||+||+|..++... ..+++..+++++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999442 36999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhc----c-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYAR----S-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~----~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
.+-.+..... ......+|||.|.+||+|. + +.|+..+|+||+||++|||+.|.-||....-......|
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI------ 293 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI------ 293 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH------
Confidence 8877664433 3345678999999999985 3 67999999999999999999999999865433222222
Q ss_pred ccCCCCCCcccchHhhccCC--hhhHHHHHHHHHHhhhhCCCCCCC---HHHHHHHHhhhhcCC---CCCCCCCCCCCCC
Q 046892 302 FRDPKRFPDMADPLLRKQFP--EKGLNEAVAIAAMCLQEEAGARPL---MSDVVTALSFLSNSK---EPIPDPIIPSDED 373 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l~~~~~~~---~~~~~p~~p~~~~ 373 (519)
.... -.-.|| .+++.++.+||.+.+ -+|..|.. +.++-.|++|.-..+ ....||+.|...+
T Consensus 294 m~hk----------~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 294 MNHK----------ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred hchh----------hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence 1110 011233 346778999998877 47888888 999999887754433 3446889999888
Q ss_pred CcCCCccCCCCCC--CCCCCCCCCcccccccccccCCCCCCCC
Q 046892 374 EYSEGYSSDGHQK--NENTYDNDNARSVRESENLESSNNSGSN 414 (519)
Q Consensus 374 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 414 (519)
..+.++|+..... +..++.+ ..........+.|.||+|+.
T Consensus 363 d~DTsnFd~~~dd~~~~e~~p~-~~~~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 363 DDDTSNFDVDEDDLRDAETFPP-RIPKAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred CCccccccccccccchhhccCC-CCCCCCcCCcCCeeeeeecc
Confidence 8888888432211 1112221 11133345788999999986
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=344.15 Aligned_cols=246 Identities=27% Similarity=0.380 Sum_probs=196.0
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHH-HHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|. .+++.+.|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999999999999999875321 2223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
++|.+++.. ...+.+..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 999998843 346888999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .. +.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~---i~~~~~------------ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---DN---ILNKPL------------ 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---HH---HHhCCc------------
Confidence 233467999999999999999999999999999999999999999764332211 11 111110
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCHH----HHHHHHhh
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLMS----DVVTALSF 355 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~l~~ 355 (519)
.++...+..+.+++.+||+.||.+||++. ++++++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence 12233456788999999999999999876 55555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.34 Aligned_cols=270 Identities=24% Similarity=0.366 Sum_probs=209.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||.|+||.||+|.+..++..||+|++..... .....+..|+.++..++|+||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999999999999998875422 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|+.+++|.+++.. ...+++..+..++.||+.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999843 34689999999999999999999975 6 99999999999999999999999999875432
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc---hhccC------
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ---PIFRD------ 304 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~---~~~~~------ 304 (519)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||................ .....
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 2 1233578999999999998889999999999999999999999997643322111110000 00000
Q ss_pred ----------CCCCCc-----ccchHhhc---cCC-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 305 ----------PKRFPD-----MADPLLRK---QFP-EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 305 ----------~~~~~~-----~~d~~l~~---~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
+...+. +.+..... .++ ...+.++.+|+.+||+.||.+|||+.+++.+.++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~ 303 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence 000000 00000000 001 12346789999999999999999999999987753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.13 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=212.7
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVD 162 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 162 (519)
-+||+|+||+||.|++..+...+|||.+........+-+..|+.+.+.++|.|||+++|++.+++.+-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999999999999999998776666777899999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCcEEeeecccccCCCCCccce
Q 046892 163 DHLLDVNETKKPL--DWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDPKLSDFGLAKLGPQGEKMNV 239 (519)
Q Consensus 163 ~~l~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~ 239 (519)
++|.. ..+++ .+..+-.+..||++||.|||+.. |||||||-+||||+ -.|.+||+|||-++.+..-. ..
T Consensus 661 sLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~ 732 (1226)
T KOG4279|consen 661 SLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PC 732 (1226)
T ss_pred HHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cc
Confidence 99954 55677 78899999999999999999999 99999999999995 68999999999988764332 24
Q ss_pred ecccccccccCchhhhccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 240 TSRVMGTYGYCAPEYARSG--ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 240 ~~~~~Gt~~y~APE~l~~~--~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
+.++-||..|||||++..+ .|+.++|||||||++.||.||++||......... .+....++ ..
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---MFkVGmyK------------vH 797 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---MFKVGMYK------------VH 797 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---hhhhccee------------cC
Confidence 5678899999999999865 5889999999999999999999999764322111 11111111 12
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+|.+.+.++..+|.+|+.++|.+||++.++++....
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFl 835 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFL 835 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccc
Confidence 35678888999999999999999999999999987543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=365.71 Aligned_cols=262 Identities=31% Similarity=0.505 Sum_probs=219.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.+....+.||+|.||.||+|.... +...||||.++..... ...+|.+|++++..++|||||+|+|+|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 345566789999999999998642 3568999999876555 6788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhcc------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 151 LVYEFMSGGSVDDHLLDVNE------T----KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
+|+|||..|+|.+||..... . ..+|+..+.+.|+.|||.|+.||-++. +|||||...|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999975321 1 334899999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 299 (519)
||+||||++.....+.......-.-..+||+||.+..+.||.++|||||||+|||+++ |+.|+.+... .++++.+.
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~EVIe~i~ 719 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QEVIECIR 719 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HHHHHHHH
Confidence 9999999997666555444433445789999999999999999999999999999997 7788776543 33333221
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...+ -..|+.++.++.+|+..||+.+|.+||++++|-..|.....
T Consensus 720 -------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 720 -------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 1111 34678899999999999999999999999999988875543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.08 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=205.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..++|+||+++++++.+.+.++|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999999999999999986532 223456778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999843 356899999999999999999999999 99999999999999999999999999875422
Q ss_pred CCc---------------------------------cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCC
Q 046892 234 GEK---------------------------------MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280 (519)
Q Consensus 234 ~~~---------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~ 280 (519)
... .......+||+.|+|||++.+..++.++|||||||+||||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC---CHHHHHHHHhhh
Q 046892 281 RVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP---LMSDVVTALSFL 356 (519)
Q Consensus 281 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~l~~~ 356 (519)
.||....+......+... .....++. ....+.++.+++.+|+ .||.+|+ ++.+++.|.|+-
T Consensus 234 ~Pf~~~~~~~~~~~i~~~----~~~~~~p~----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 297 (360)
T cd05627 234 PPFCSETPQETYRKVMNW----KETLVFPP----------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE 297 (360)
T ss_pred CCCCCCCHHHHHHHHHcC----CCceecCC----------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence 999865443222111100 00000000 0113457888888876 4999998 478999887753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.07 Aligned_cols=268 Identities=24% Similarity=0.332 Sum_probs=213.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-C-----CCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-H-----PNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~~~~~ 150 (519)
-+|.+.++||+|+||.|.+|.+..+++.||||+++.. ..-..+...|+.+|..|+ | -|||+++++|...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 3789999999999999999999999999999999654 334456678999999987 4 47999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--CCcEEeeeccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN--LDPKLSDFGLA 228 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~--~~vkL~DFGla 228 (519)
||+|++ ..+|+++|... .-..++...++.|+.||+.||.+||+.+ |||+||||+||||... ..|||+|||.+
T Consensus 265 iVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999 56999999764 3445999999999999999999999999 9999999999999654 36999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-------
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI------- 301 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~------- 301 (519)
+.....-. ..+-+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.+..+.|....+..+...
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87544322 345678899999999999999999999999999999999999988877765444322111
Q ss_pred --------ccCCCCCCccc--------------ch----------------HhhccCChhhHHHHHHHHHHhhhhCCCCC
Q 046892 302 --------FRDPKRFPDMA--------------DP----------------LLRKQFPEKGLNEAVAIAAMCLQEEAGAR 343 (519)
Q Consensus 302 --------~~~~~~~~~~~--------------d~----------------~l~~~~~~~~~~~l~~li~~cl~~dP~~R 343 (519)
+.....++... .. .+...+.......+++++.+||.+||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 00000000000 00 00001112334678999999999999999
Q ss_pred CCHHHHHHHHhhh
Q 046892 344 PLMSDVVTALSFL 356 (519)
Q Consensus 344 Ps~~evl~~l~~~ 356 (519)
+|..+.+.|.|+-
T Consensus 494 ~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 494 ITPAQALNHPFLT 506 (586)
T ss_pred CCHHHHhcCcccc
Confidence 9999999998764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.99 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=220.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh--HHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..-|.+.+.||+|-|..|-+|++.-+|..||||++.+...... ..++.|+..|+.++|||||+||.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3458888999999999999999999999999999988765543 46889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-CCCCCcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL-GANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl-~~~~~vkL~DFGla~~~~ 232 (519)
|+-++|+|++||... ...+.+..+.+++.||+.|+.|+|... +|||||||+||.+ ..-|-|||+|||++..+.
T Consensus 97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999653 456999999999999999999999999 9999999999887 567889999999999887
Q ss_pred CCCccceecccccccccCchhhhccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELT-VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~-~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
++... .+.||...|-|||+|.+..|+ +++||||||||||-|++|++||...++.....++.
T Consensus 171 PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--------------- 232 (864)
T KOG4717|consen 171 PGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--------------- 232 (864)
T ss_pred Ccchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------
Confidence 77654 457999999999999999997 57999999999999999999998776554433321
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
|. .-..|..++.++.+||..||..||.+|.+.++|+...|.
T Consensus 233 -DC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 233 -DC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred -cc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence 21 113467788899999999999999999999999887663
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.34 Aligned_cols=262 Identities=28% Similarity=0.425 Sum_probs=210.7
Q ss_pred cCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
++|.+.+.||+|+||.||++.+. .++..||+|.+..........+..|+.++..++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999852 3456799999876554455678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhc---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEE
Q 046892 152 VYEFMSGGSVDDHLLDVN---------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKL 222 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL 222 (519)
||||+++++|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 12235899999999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchh
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........ ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---
Confidence 99999986543322222233446788999999998899999999999999999998 8898875543221 1111
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.... .. ..+...+..+.+|+.+||+.||.+|||+.+|+..|..+..
T Consensus 236 ~~~~--~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 TQGR--VL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HcCC--cC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1100 00 0122234578999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=346.34 Aligned_cols=240 Identities=28% Similarity=0.429 Sum_probs=205.3
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
++-||.|+.|.||+|+.. ++.||||.++. .-..+|..|++|.|+||+.+.|+|....-++||||||..|-|
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 456899999999999998 78999998752 223478899999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
...| ..+.++.......|..+||.|+.|||.+. |||||||.-||||..+..|||+|||-++..... ....
T Consensus 200 ~~VL----ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 200 YEVL----KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHH----hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 9999 45667888999999999999999999999 999999999999999999999999999865432 2344
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
.++||..|||||++...+.++|+|||||||||||||||.-||...+.. ..++.+- ...|.-..|
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwGVG----------sNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWGVG----------SNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEecc----------CCcccccCc
Confidence 689999999999999999999999999999999999999998754321 1122111 112334467
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+++.+.-|++.||+-.|..||++++++.||..+
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 78888999999999999999999999999999754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=326.02 Aligned_cols=261 Identities=22% Similarity=0.343 Sum_probs=211.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||.|+||.||+|++..+++.||||.+..... .....+..|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 578999999999999999999998999999998764322 22345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++.........+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988655444566899999999999999999999999 99999999999999999999999999886543
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ......... .. ..+.
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~---~~--~~~~--- 227 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIE---QC--DYPP--- 227 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHh---cC--CCCC---
Confidence 221 122356889999999998888999999999999999999999998653221 111111111 00 0000
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
......+..+.+++.+||+.+|.+||++.+|++.+..+
T Consensus 228 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01123446789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.27 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=206.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeE----EEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQV----VAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.+|++.+.||+|+||.||+|.+..++.. ||+|.+..... .....+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4699999999999999999998665554 89999865432 3346788899999999999999999999764 5789
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998542 345889999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
.............++..|+|||++.+..++.++|||||||++|||++ |..||....... +..... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~-- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGERL-- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----CCCCC--
Confidence 54332222222344678999999999999999999999999999998 999987543221 111111 11111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..+..+...+.+++..||..+|.+||++.+++..+..+..
T Consensus 231 --------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1122334578899999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.34 Aligned_cols=255 Identities=28% Similarity=0.415 Sum_probs=204.4
Q ss_pred cCcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.+|++.+.||+|+||.||+|.+. ..+..||+|.+..... .....+..|+.++..++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56889999999999999999875 3467899999876432 2235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999998542 346899999999999999999999999 9999999999999999999999999876532
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ...... ....
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~~---- 226 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVE----DGFR---- 226 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----CCCC----
Confidence 2211 11112345678999999999999999999999999999775 999997653322 222111 1000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+..++..+.+++..||+.+|.+||++.+|++.|..
T Consensus 227 ------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11233455678999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.81 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=208.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.++..+.|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3468888999999999999998753 3578999998765433 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhc----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC
Q 046892 150 LLVYEFMSGGSVDDHLLDVN----------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD 219 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~ 219 (519)
++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996532 12345889999999999999999999999 999999999999999999
Q ss_pred cEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 046892 220 PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 220 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~ 298 (519)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....... .....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence 99999999975433322222233456788999999999999999999999999999998 999986543322 22211
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
. .. .. ...+...+..+.+++.+||+.||.+||++.+|++.|.
T Consensus 238 ~---~~--~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T---QG--RL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H---cC--Cc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 00 00 0112234567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.08 Aligned_cols=268 Identities=27% Similarity=0.357 Sum_probs=217.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEE-ec------C
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYC-AD------G 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~-~~------~ 146 (519)
...++++.++|.+|||+.||+|.+...|..||+|++-.........+.+|+.+|+.|. |+|||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3567889999999999999999999877999999987776666778899999999997 99999999932 11 1
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
-.++|+||||.||.|-+++..+...+ |++.++++|+.++++|+++||... +||||||||-+||||..++..||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 35789999999999999998765443 999999999999999999999996 679999999999999999999999999
Q ss_pred ccccCCCCCcc-c------eecccccccccCchhhh---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 046892 227 LAKLGPQGEKM-N------VTSRVMGTYGYCAPEYA---RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296 (519)
Q Consensus 227 la~~~~~~~~~-~------~~~~~~Gt~~y~APE~l---~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~ 296 (519)
.|+........ . ......-|+.|+|||++ .+...++|+|||+|||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 98743222110 0 00113458999999976 5678999999999999999999999999865322
Q ss_pred hhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCCCC
Q 046892 297 WAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPD 365 (519)
Q Consensus 297 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~ 365 (519)
.++.....+|. .+..+..+.+||..||+.||.+||++-+|+..+..+.+.+.++.+
T Consensus 265 ---aIlng~Y~~P~----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~ 320 (738)
T KOG1989|consen 265 ---AILNGNYSFPP----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD 320 (738)
T ss_pred ---eEEeccccCCC----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence 11111111211 135677899999999999999999999999999988876655544
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.08 Aligned_cols=256 Identities=28% Similarity=0.385 Sum_probs=208.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-----ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-----GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
++|.+.+.||.|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999999888999999998654221 23457889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|+||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998853 346889999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCccce-ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNV-TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
........ .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~----~~----- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI--FKIAT----QP----- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH--HHHhc----cC-----
Confidence 33221111 12356788999999999888999999999999999999999998754322111 11000 00
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....++......+.+++..||..+|.+||++.+++.+.++
T Consensus 224 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 -----TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -----CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0112333455678899999999999999999999988763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=315.37 Aligned_cols=267 Identities=25% Similarity=0.325 Sum_probs=216.9
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC-----ce
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD-----QR 149 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~ 149 (519)
..++|.+.+.||+|||+-||++....++..||+|++.....++.+..++|+...++++||||++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4578999999999999999999999999999999998887788888999999999999999999999875543 48
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
||+++|+..|+|.+.+......+..+++.+++.|+.+|++||.+||+.. +|+.||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999988777778999999999999999999999986 469999999999999999999999999987
Q ss_pred cCCCCCcc-------ceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 046892 230 LGPQGEKM-------NVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 230 ~~~~~~~~-------~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~ 299 (519)
...-.-.. ........|..|.|||++. +...++++|||||||+||.|+.|..||+..-...+. + . .
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-l-a--L 253 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-L-A--L 253 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-E-E--E
Confidence 54321110 1111234688999999985 456789999999999999999999999764321110 0 0 0
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. +....+...-....++.+.+|+.+||+.||.+||++.+++..+..+
T Consensus 254 A----------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 A----------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred e----------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0 0011111111122566899999999999999999999999988654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=336.91 Aligned_cols=260 Identities=22% Similarity=0.252 Sum_probs=203.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||.||++++..+++.||||++.+.. ......+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999986522 223345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999854 2346899999999999999999999999 99999999999999999999999999875443
Q ss_pred CCccceecccccccccCchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
.... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||........... +......+
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~------i~~~~~~~ 227 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHKEHF 227 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH------HHcCCCcc
Confidence 2211 1223468999999999863 4578899999999999999999999976433221111 11110000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCC--CCCCHHHHHHHHhhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAG--ARPLMSDVVTALSFL 356 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~l~~~ 356 (519)
. + .......+..+.+++.+||..++. .||++.+++.|.|+.
T Consensus 228 ~-~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~ 270 (331)
T cd05597 228 Q-F------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270 (331)
T ss_pred c-C------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence 0 0 000112455778888887765443 488999999998763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=325.13 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=209.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.+|.+.+.||.|+||.||+|.+..+++.||+|.+... ......+..|+.+++.++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4588889999999999999999988999999998654 233567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998542 2346899999999999999999999999 99999999999999999999999999986543321
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ........
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~-------------- 221 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKG-------------- 221 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC--------------
Confidence 1 1112334678999999998999999999999999999998 889987543221 11111110
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.....+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01122334556899999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=333.15 Aligned_cols=271 Identities=24% Similarity=0.334 Sum_probs=209.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|.+.+.||+|+||.||+|++..++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 579999999999999999999998999999999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 964 88887744 2345889999999999999999999999 9999999999999999999999999997543322
Q ss_pred ccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh--------ccCC-
Q 046892 236 KMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI--------FRDP- 305 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~--------~~~~- 305 (519)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+...... ....
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1 1223467899999998865 46899999999999999999999999765543332222111000 0000
Q ss_pred ----CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 306 ----KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 306 ----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+......+.. .....+.++.+|+.+||+.||.+|||+.+++.+.|+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 237 EFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0000000000000 11234567889999999999999999999999988754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=328.82 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=208.7
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
|++.+.||+|+||.||+|.+..+++.||||.+....... ...+..|+.++..++|++|+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999999999999999987543222 24567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988542 2345899999999999999999999999 9999999999999999999999999987654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||................ . .
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~---~-----------~ 219 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---K-----------E 219 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh---h-----------h
Confidence 1 123478999999999998999999999999999999999999997643221111111100 0 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFL 356 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~ 356 (519)
....++......+.+|+..||+.||.+||| +.++++|.++-
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 011123344557889999999999999999 89999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=343.86 Aligned_cols=268 Identities=24% Similarity=0.367 Sum_probs=207.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC-----ceE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 150 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 150 (519)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ......+.+|+.++..++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999998899999999986432 223456888999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 57877773 3457899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc----------
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ---------- 299 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~---------- 299 (519)
....... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+.+....+....
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 5432211 12334678999999998764 57999999999999999999999998765443322221100
Q ss_pred -------hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 300 -------PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 300 -------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+.......+. .. ....+....+.++.+|+.+||+.||.+|||+.+++.+.|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 232 ACEGARAHILRGPHKPPS-LP--VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred hhHHHHHHHHhCCCCCCc-hH--HhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 00011100000 00 000122334568899999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.02 Aligned_cols=260 Identities=23% Similarity=0.424 Sum_probs=205.5
Q ss_pred hccCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
..++|++.+.||+|+||.||+|.+.. ++..||||.+..... .....+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45679999999999999999998642 356899998864322 234568889999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEE
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNET------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKL 222 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL 222 (519)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 234678899999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchh
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH--
Confidence 99999876543322222222345788999999998899999999999999999999 688886543321 111111
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.. ... ..+...+..+.+++.+||+.||.+||++.+++++|.
T Consensus 236 -~~--~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 -EG--GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -cC--CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 000 112334457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.14 Aligned_cols=251 Identities=35% Similarity=0.572 Sum_probs=197.5
Q ss_pred cceeeeccCcEEEEEEEEc----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 81 QECLLGEGGFGRVYKGTLQ----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+.+.||.|.||.||+|.+. ..+..|+||.+..... ...+.+..|+..+..++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999998 4467899999955322 2357899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++|+|.++|... ....+++..++.|+.||+.||.|||+.+ |+|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999663 2456899999999999999999999999 9999999999999999999999999998763333
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.........+...|+|||.+....++.++||||||+++|||++ |..||..... ..+........
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~------------ 222 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQ------------ 222 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTE------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccc------------
Confidence 3333334457789999999998889999999999999999999 6788765422 22222111100
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
+...+..++..+.+++..||..+|.+||++.++++.|
T Consensus 223 --~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 --RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112334556789999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.58 Aligned_cols=255 Identities=33% Similarity=0.498 Sum_probs=208.1
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChH--HHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
|++.+.||+|+||+||++.+..+++.||+|++......... ....|+.++..++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999999999999999999999876543332 2355999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++. ....+++..++.++.||++||++||+.+ |+|+||||+|||++.++.++|+|||++..... .
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--c
Confidence 9999999995 3456899999999999999999999999 99999999999999999999999999975411 1
Q ss_pred cceecccccccccCchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
........++..|+|||++. +..++.++||||||+++|+|++|..||......+.......... ..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-------------~~ 218 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-------------RP 218 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-------------TH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-------------cc
Confidence 22344567899999999998 88899999999999999999999999986522222222211110 00
Q ss_pred hhccC--ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 316 LRKQF--PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 316 l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
+.... .......+.+++..||+.||.+||++.+++++.|+
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00001 11123689999999999999999999999998764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=349.57 Aligned_cols=266 Identities=21% Similarity=0.245 Sum_probs=203.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|+.++|+|||++++++...+..+||||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36999999999999999999999999999999643 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.++|..++.. ....+++..++.|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.......
T Consensus 243 -~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 -RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred -CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 4788888743 2346999999999999999999999999 99999999999999999999999999986543322
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc-----chhhHHHhhchhccCCCCCCcc
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV-----DEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
........||+.|+|||++.+..++.++|||||||+||||++|..++...... ....+...+.........++..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22233467999999999999999999999999999999999988655332111 1111111111110000011111
Q ss_pred cchHhhc------------cCC-------hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRK------------QFP-------EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~------------~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+.. .+. ......+.+||.+||+.||.+|||+.|++++.||
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 1000000 000 0123468899999999999999999999999876
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.24 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=204.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||++.+..+++.||+|++.... ......+..|+.++..+.|+||+++++++.+.+..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 122344778899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999542 346899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCccceecccccccccCchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC--
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK-- 306 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 306 (519)
.... ......||+.|+|||++.+ +.++.++|||||||+||+|++|+.||........... +.....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~------i~~~~~~~ 227 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHEERF 227 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH------HHcCCCcc
Confidence 3221 1233579999999999875 5678999999999999999999999976443221111 111110
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHhhh
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGA--RPLMSDVVTALSFL 356 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~~ 356 (519)
.++. .....+.++.+++.+||..++.+ |+++.+++.|.++-
T Consensus 228 ~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~ 270 (331)
T cd05624 228 QFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270 (331)
T ss_pred cCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence 0111 01123567889999999876554 56899999887653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.53 Aligned_cols=284 Identities=27% Similarity=0.397 Sum_probs=231.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
+.|..-++||+|+||.||-++.+.+|+.||+|.+.+.. .......++|..+|..++.++||.+-.+|++.+.++||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56888999999999999999999999999999986542 234455788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
..|+||+|.-+|.... ...+++..++.++.+|+.||++||..+ ||+|||||+|||+|+.|+++|+|+|||..+..
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999886643 367999999999999999999999999 99999999999999999999999999998877
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
+... ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-+. ..+..+
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~~--------- 405 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLED--------- 405 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhcc---------
Confidence 6543 33489999999999999999999999999999999999999997654332221111 111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhh-----cCCCCCCCCCCCCCCCC-----cCCC
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLS-----NSKEPIPDPIIPSDEDE-----YSEG 378 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~-----~~~~~~~~p~~p~~~~~-----~~~~ 378 (519)
...|++..++++.+|+..+|+.||.+|. .+.+|-+|+.|-. -....++||+.|.+... .+.+
T Consensus 406 ---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIe 482 (591)
T KOG0986|consen 406 ---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIE 482 (591)
T ss_pred ---hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhh
Confidence 1346666778999999999999999996 4567777665422 23456678888775443 4455
Q ss_pred ccCC
Q 046892 379 YSSD 382 (519)
Q Consensus 379 ~~~~ 382 (519)
.||.
T Consensus 483 qFs~ 486 (591)
T KOG0986|consen 483 QFST 486 (591)
T ss_pred hccc
Confidence 5553
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=345.28 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=207.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC-----CeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN-----GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 148 (519)
.++|.+.+.||+|+||.||+|.+... +..||||++..... ...+.+..|+.++..+. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 56889999999999999999987432 35799999965433 23456889999999996 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc----------------------------------------------------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE---------------------------------------------------------- 170 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 170 (519)
.|||||||++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 046892 171 ----------------------------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA 216 (519)
Q Consensus 171 ----------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~ 216 (519)
....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 1235788999999999999999999999 999999999999999
Q ss_pred CCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 046892 217 NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLI 295 (519)
Q Consensus 217 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~ 295 (519)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........ ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999986543322222333457788999999998899999999999999999997 8888875422111 11
Q ss_pred HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 296 AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
... .... ....+...+..+.+++.+||+.+|++||++.+|++.|..+
T Consensus 351 ~~~----~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 NKI----KSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHH----hcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 100 0000 0112234456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=326.11 Aligned_cols=257 Identities=25% Similarity=0.335 Sum_probs=206.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|++..+++.||+|++..........+..|+.++..++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999888999999998765444556678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998843 346899999999999999999999999 9999999999999999999999999997653221
Q ss_pred ccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 236 KMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
. ......|++.|+|||.+. ...++.++|||||||++|||++|..||....+..... .... .....+
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~----~~~~~~--- 229 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSK----SNFQPP--- 229 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeec----CCCCCC---
Confidence 1 122356889999999884 3557889999999999999999999986443221110 0000 000000
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
... .....+..+.+++.+||+.+|++||++.+++++|+
T Consensus 230 --~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 --KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000 01223457889999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=330.16 Aligned_cols=262 Identities=30% Similarity=0.463 Sum_probs=211.6
Q ss_pred cCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.+|.+.+.||+|+||.||+|.+. .++..|++|.+..........+.+|+.++..++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999853 2456799999876555555678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC
Q 046892 152 VYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD 219 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~ 219 (519)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999965321 2245899999999999999999999999 999999999999999999
Q ss_pred cEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 046892 220 PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 220 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~ 298 (519)
++|+|||++................|+..|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence 99999999976544332222334557889999999998999999999999999999998 999986543322 22111
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. .. ... ..+...+..+.+++.+||+.+|.+||++.+|++.|..+..
T Consensus 239 ~----~~-~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 T----QG-RVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred h----CC-CCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1 00 000 0122234578899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=327.94 Aligned_cols=268 Identities=24% Similarity=0.307 Sum_probs=201.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhc---CCCCeeeeeeEEec-----CC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLL---HHPNLVNLIGYCAD-----GD 147 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-----~~ 147 (519)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+..|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488899999999999999999999999999998754222 223456677766654 79999999998864 34
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999996 5888887542 2345899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhchhccCC-
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN-LIAWAQPIFRDP- 305 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~- 305 (519)
+........ .....||..|+|||++.+..++.++|||||||++|+|++|.+||......+... +...........
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 986543221 233568999999999998899999999999999999999999997654332221 111110000000
Q ss_pred --------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 --------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 --------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+.......+ ..+.......+.+++.+||+.||.+|||+.+++.+.||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccccCCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000000000 01122345678899999999999999999999988664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=322.50 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=199.4
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
+.||+|+||.||+|++..+++.||+|.+..... .....+..|+.+++.++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 368999999999999998899999998764332 2345688999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999843 2346899999999999999999999999 9999999999999999999999999987644321111111
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQF 320 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 320 (519)
...++..|+|||.+.++.++.++|||||||++|+|++ |..||...........+. .. ....+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~~--------------~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---QG--------------VRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---cC--------------CCCCC
Confidence 1223467999999998899999999999999999998 888886543221111111 00 00112
Q ss_pred ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 321 PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 321 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3334568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=330.85 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=212.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|++.+.||+|+||.||+|.+..++..||+|.+..........+..|+.+++.+.|+||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999999888999999999876655667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.. ..+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998843 35789999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+.... ..+. ... .+.
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~----~~~--~~~----- 235 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA----TNG--TPE----- 235 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHh----cCC--CCC-----
Confidence 1 122346889999999999888999999999999999999999999765432111 1110 000 000
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...+......+.+++.+||..+|.+||++.+++.+.++...
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred --CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 01122344578899999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.70 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=211.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|.+.+.||.|+||.||+|.+.. +..||+|.+..........+..|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4578999999999999999999987 889999999876655567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999653 3456899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~------------ 221 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITAGY------------ 221 (261)
T ss_pred c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHhCC------------
Confidence 1 1223346778999999988899999999999999999998 88998654322 1222111100
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
+...+...+..+.+++.+||+.||.+|||+.++++.|..
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 --RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 011233445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=327.81 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=205.9
Q ss_pred cCcccceeeeccCcEEEEEEEEc----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
++|++.+.||+|+||.||+|.+. .++..||+|.+..... .....+..|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46888899999999999999853 3467899999875332 233568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhcc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 046892 152 VYEFMSGGSVDDHLLDVNE-------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL 218 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~ 218 (519)
||||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235789999999999999999999999 99999999999999999
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAW 297 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 297 (519)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....+.. +...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986544332222334456778999999988889999999999999999998 888887543221 1111
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
... .. . ...+..++..+.+++.+||+.||.+||++.+|+++|.
T Consensus 239 ~~~---~~--~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 239 VRK---RQ--L---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHc---CC--c---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 110 00 0 0122334557889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=340.99 Aligned_cols=246 Identities=26% Similarity=0.315 Sum_probs=194.7
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhc---CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
||+|+||+||+|.+..+++.||||++...... ....+..|..++... .||||+++++++.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999998653221 223344566666544 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 999988843 456899999999999999999999999 99999999999999999999999999875432221
Q ss_pred eecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 239 VTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+ ......++
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~-------- 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFGKVRFP-------- 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcCCCCCC--------
Confidence 23346799999999998754 5899999999999999999999999764322111111 11111111
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCC----CHHHHHHHHhhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARP----LMSDVVTALSFL 356 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~l~~~ 356 (519)
....+..+.+++.+||+.||.+|| ++.++++|.++.
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 012345778999999999999998 688999887764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=323.17 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=207.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|++.+.||+|+||.||+|.+..+ ...||||.+...... ....+..|+.++..++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5788999999999999999998654 458999988654322 235688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 246899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~----~~--- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDGY----RL--- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCC----CC---
Confidence 2222222222345678999999998899999999999999999998 99988654322 1222111100 00
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+..++..+.+|+.+||+.+|.+||++.+|+++|..+
T Consensus 228 -------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223456789999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=331.24 Aligned_cols=270 Identities=23% Similarity=0.334 Sum_probs=210.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|++.+.||+|+||.||++.+..++..||+|.+...... ....+..|+.++..++||||++++++|.+++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4689999999999999999999999999999998654222 235578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+++++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999854 3568999999999999999999998 57 999999999999999999999999998754322
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC-------
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR------- 307 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~------- 307 (519)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|..||........................
T Consensus 154 ~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 M----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred c----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 1 23457899999999998888999999999999999999999999754322211111110000000000
Q ss_pred ---CC------cccchHhh---ccCC-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 308 ---FP------DMADPLLR---KQFP-EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 308 ---~~------~~~d~~l~---~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.. ...+.... ...+ .....++.+|+.+||..+|++||++.+|+.+.|+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00 00000000 0011 123457899999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=337.91 Aligned_cols=262 Identities=29% Similarity=0.427 Sum_probs=205.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEec-CCc
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCAD-GDQ 148 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-~~~ 148 (519)
++|++.+.||.|+||.||+|.+.. +++.||+|++..... .....+..|+.++..+ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 579999999999999999997543 357899999875432 2234677899999999 79999999998864 457
Q ss_pred eEEEEEecCCCCHHHHHhhhccC---------------------------------------------------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNET--------------------------------------------------------- 171 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 171 (519)
++++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998542110
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCc
Q 046892 172 KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251 (519)
Q Consensus 172 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~A 251 (519)
...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++................++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999999 99999999999999999999999999986543322222233456788999
Q ss_pred hhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHH
Q 046892 252 PEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVA 330 (519)
Q Consensus 252 PE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 330 (519)
||++.+..++.++|||||||+||||++ |..||......+. ..... ... .....+.....++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~----~~~----------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRL----KEG----------TRMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHH----hcc----------CCCCCCccCCHHHHH
Confidence 999999999999999999999999998 9999876432211 11110 000 001112334467899
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 331 IAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 331 li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
|+.+||+.+|++||++.+|+++|..+-
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=337.56 Aligned_cols=269 Identities=23% Similarity=0.290 Sum_probs=204.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC-----
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD----- 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 147 (519)
..++|++.+.||+|+||.||+|.+..+|..||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986542 233456788999999999999999999986543
Q ss_pred -ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 148 -QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 148 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
..|+||||+.+ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999965 6666652 24788999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-H---------
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-A--------- 296 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~--------- 296 (519)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+ .
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 997543321 123457899999999999999999999999999999999999999865432211100 0
Q ss_pred ------hhchhccCCCCCCccc-----chHh---hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 297 ------WAQPIFRDPKRFPDMA-----DPLL---RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 297 ------~~~~~~~~~~~~~~~~-----d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
............+... .... ...........+.+|+.+||+.||.+|||+.+++.|.|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence 0000000000111000 0000 0001112345788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.33 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=198.4
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
||+|+||.||++....+|+.||+|.+..... .....+..|+.++..++||||+++++++.++...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864322 1233456799999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9888542 2345889999999999999999999999 9999999999999999999999999987654332 123
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
...|++.|+|||++.+..++.++|||||||++|+|++|..||......... .............. ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~-----------~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDEVKF-----------EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhcccccc-----------cc
Confidence 356899999999999888999999999999999999999999754322111 11111111110000 01
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCCHH----HHHHHHhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARPLMS----DVVTALSF 355 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~l~~ 355 (519)
...+.++.+|+..||+.||.+||++. +++.|.|+
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 12345789999999999999999994 45556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=325.28 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=203.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe----EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
++|++.+.||+|+||.||+|.+..++. .|++|.+..... .....+..|+.++..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 478888999999999999999977666 477777653322 223456778888899999999999998854 56789
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|+||+++|+|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999854 2346899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
.............|+..|+|||.+.++.++.++|||||||++|||++ |..||....+....+++. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~- 231 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGERLA- 231 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcCC-
Confidence 44332222334567789999999998899999999999999999998 999987653322222211 110000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+..+...+..++.+||..||.+||++.++++.+..+..
T Consensus 232 ---------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 ---------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111233467889999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=328.00 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=206.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCC-----CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSN-----GQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.+|.+.+.||+|+||.||+|.+..+ +..||+|++...... ....+..|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3577888999999999999987543 578999998754322 2355788999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 046892 151 LVYEFMSGGSVDDHLLDVN------------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL 218 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~ 218 (519)
+++||+.+++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 11245889999999999999999999999 99999999999999999
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAW 297 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 297 (519)
.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||...... .....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEM 238 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999886544332222334456789999999988899999999999999999998 77887654322 22221
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
. .... ...++...+..+.+|+..||+.+|.+||++.+|+..|.
T Consensus 239 i---~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 239 I---RNRQ-----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred H---HcCC-----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1 1110 01233455667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=342.71 Aligned_cols=269 Identities=21% Similarity=0.232 Sum_probs=207.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC--CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..+|.+.+.||+|+||.||+|.... ++..||+|.+... ....+|+.+++.++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997643 4678999987543 34567999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|++. ++|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9995 68888872 3457999999999999999999999999 99999999999999999999999999976554
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN-LIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 312 (519)
...........||+.|+|||++.+..++.++|||||||+||||++|+.||.......... +......+...+..++...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 333222335679999999999999999999999999999999999999997654332111 1111111100000011000
Q ss_pred chH-----------hhccC-------ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 313 DPL-----------LRKQF-------PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 313 d~~-----------l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... .+..+ ......++.++|.+||..||.+||++.+++.+.+|..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 000 00000 0122356788999999999999999999999988754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=320.29 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=208.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|.+.+.||+|+||.||+|.+..+++.|++|.+.... ......+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999999999999999986542 23456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998653 2456899999999999999999999999 9999999999999999999999999988654432
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ...... ... ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~~~--~~------- 218 (256)
T cd08529 156 N--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKI---IRG--VF------- 218 (256)
T ss_pred c--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HcC--CC-------
Confidence 1 223456889999999999989999999999999999999999999765421 111111 110 00
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
..++......+.+++.+||+.+|++||++.+++++.
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 219 --PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred --CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 112223445789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.43 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=212.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+..... .....+..|+.+++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 578999999999999999999998899999998864322 23457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|..++.........+++..++.++.+|+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998765455567899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ....+... .... ..
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~---~~~~--~~----- 225 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKK---IEKC--DY----- 225 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhh---hhcC--CC-----
Confidence 221 12235688999999999988899999999999999999999999865321 11111111 1000 00
Q ss_pred hHhhccCCh-hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 314 PLLRKQFPE-KGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 314 ~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+. ..+..+.+++.+||..+|.+||++.+|++.+..+.
T Consensus 226 ----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 ----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 01111 34457889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=326.72 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=205.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|++.++||+|+||.||+|.+..++..||+|.+.... ......+..|+.++..++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999999899999999986542 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|..+. .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 4688899999999999999999999 9999999999999999999999999997653321
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ-NLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||......... ............. .+
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~----- 218 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PP----- 218 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CC-----
Confidence 23457899999999999888999999999999999999999999754322111 0111111111000 00
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
. ......+.++.+++.+||+.+|.+||++.+++.+.++..
T Consensus 219 ~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 219 V---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred C---CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 0 001123457889999999999999999999999877643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=320.35 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=202.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+..|+.+++.++||||+++++++.+....++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 468888999999999999998864 5689999876443 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999988542 235899999999999999999999999 99999999999999999999999999876533221
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......++..|+|||++.+..++.++||||||+++|+|++ |+.||........ ...... .. .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~---~~-~-------- 219 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISR---GF-R-------- 219 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHC---CC-C--------
Confidence 1 1122345678999999988889999999999999999999 8899875433221 111111 00 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
...+...+..+.+|+.+||+.+|.+||++.++++.|
T Consensus 220 --~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 --LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 001222345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=329.40 Aligned_cols=261 Identities=27% Similarity=0.395 Sum_probs=208.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC-----CeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN-----GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||++.+... ...||+|.+..... .....+..|+.++..+ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 45788999999999999999998643 37899999875422 2234578899999999 79999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 046892 149 RLLVYEFMSGGSVDDHLLDVN------------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA 216 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~ 216 (519)
.++||||+++|+|..++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 999999999999999986421 23456899999999999999999999999 999999999999999
Q ss_pred CCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 046892 217 NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLI 295 (519)
Q Consensus 217 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~ 295 (519)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999999986554332222222345678999999988899999999999999999997 88888754322211111
Q ss_pred HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 296 AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. .. .....+......+.+|+.+||..||.+|||+.++++.|..+
T Consensus 248 ~-------~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 248 K-------EG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred H-------cC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1 00 00112334456889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=324.90 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=208.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC-----CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN-----GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||.||+|.+... +..||+|.+..... .....+..|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 45789999999999999999998643 47899999865432 2345688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 150 LLVYEFMSGGSVDDHLLDVNE------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865332 1234789999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHHh---
Confidence 9999876544332222233457889999999988889999999999999999998 8888865433222 11111
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
... ...++...+..+.+++.+||+.+|.+|||+.+++..|.
T Consensus 236 -~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 01123334568899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=321.93 Aligned_cols=261 Identities=23% Similarity=0.359 Sum_probs=211.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||.|+||.||+|.+..++..||||.+..... .....+..|+.+++.+.|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468888999999999999999988899999998765322 22356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998755445567899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ......... .. ..+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~---~~--~~~---- 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE---QC--DYP---- 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh---cC--CCC----
Confidence 221 122356899999999998888999999999999999999999998653221 111111110 00 000
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...+...+..+.+++.+||+.+|.+|||+.+|++.+..+
T Consensus 227 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 ----PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 001123456789999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=338.17 Aligned_cols=269 Identities=21% Similarity=0.266 Sum_probs=205.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecC------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------ 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 146 (519)
..++|.+.+.||+|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999999998999999999875432 2335677899999999999999999998643
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
...++||||+.+ +|...+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 347999999964 6766662 24789999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH-HHhh-------
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL-IAWA------- 298 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~-~~~~------- 298 (519)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.... +...
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 998653322 12345789999999999998999999999999999999999999976543221110 0000
Q ss_pred --------chhccCCCCCCcccch-----Hh---hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 --------QPIFRDPKRFPDMADP-----LL---RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 --------~~~~~~~~~~~~~~d~-----~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
............+..+ .+ ....+......+.+|+.+||+.||.+|||+.+++++.|+-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 0000000000000000 00 0011222345788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.90 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=214.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.+|++.+.||.|+||.||+|.+..+++.||+|.+..........+..|+.+++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999998899999999997665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|..++.. ..+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998842 35899999999999999999999999 99999999999999999999999999876543321
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+......+. . .... .
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~-~~~~--~--------- 234 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T-NGTP--E--------- 234 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-cCCc--c---------
Confidence 1223568899999999998889999999999999999999999997754432221111 0 0000 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
...+...+..+.+++.+||..||.+||++.+++.+.++.....
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 0112234457889999999999999999999999988765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.46 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=207.0
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
|+..+.||+|+||+||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67788999999999999999999999999998654322 224567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888543 2346999999999999999999999999 9999999999999999999999999987643322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+. .......
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~~~---------- 221 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLETE---------- 221 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhccc----------
Confidence 1 123578999999999998899999999999999999999999997643322111111 1111110
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSF 355 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~ 355 (519)
..++...+..+.+|+..||+.||.+||+ +.+++.+.++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence 1123334557889999999999999999 7888887665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.77 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=207.6
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCce
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 149 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 149 (519)
...++|.+.+.||+|+||+||+|.+..++..||+|++..... .....+..|+.++..++|||||+++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999999999999999999875432 234568889999999999999999998854 3568
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCeeeCC---------
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN----PPVIYRDLKSSNILLGA--------- 216 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~----~~IvHrDikp~NILl~~--------- 216 (519)
||||||+.+|+|.++|.........+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997655555679999999999999999999998541 23999999999999964
Q ss_pred --------CCCcEEeeecccccCCCCCccceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 046892 217 --------NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTT 286 (519)
Q Consensus 217 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~ 286 (519)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||+|++|..||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3348999999998654322 1234579999999999864 45889999999999999999999999754
Q ss_pred CCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 287 RPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.... .++.... .. ..++ ....+..+.+||..||+.+|.+||++.+++.+.++
T Consensus 247 ~~~~--qli~~lk---~~-p~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 247 NNFS--QLISELK---RG-PDLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred CcHH--HHHHHHh---cC-CCCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 3221 1111111 10 0000 01224578899999999999999999999987654
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=324.95 Aligned_cols=257 Identities=30% Similarity=0.427 Sum_probs=205.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecC------C
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG------D 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~------~ 147 (519)
+...|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888999999999999999999999999999986543 3446788899999888 699999999998753 4
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..++||||+.+++|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 579999999999999998642 2346899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
+........ ......|++.|+|||++. +..++.++|||||||++|||++|..||....+....... .
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------~ 229 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------P 229 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------h
Confidence 976533221 223467899999999986 346888999999999999999999999754322111111 0
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
... .. ...+...+..+.+|+.+||..+|.+|||+.+++.+.|+
T Consensus 230 ~~~--~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 RNP--AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCC--CC--------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000 00 00112234578899999999999999999999988653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=336.40 Aligned_cols=270 Identities=22% Similarity=0.309 Sum_probs=206.0
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecC----
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG---- 146 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 146 (519)
....++|.+.+.||.|+||.||+|.+..++..||||++..... .....+.+|+.+++.++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3456889999999999999999999998999999999865422 2335577899999999999999999988543
Q ss_pred --CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 147 --DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 147 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
...|++++++ +++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3468999998 789988773 346899999999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhchh-
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQPI- 301 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~~- 301 (519)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+ ......
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999865432 234578999999999876 57899999999999999999999999764332211111 000000
Q ss_pred -------ccC-----CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 -------FRD-----PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 -------~~~-----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... ...++......+... .......+.+|+.+||+.||.+|||+.+++.|.++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKI-FRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHh-ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 000 000000000001000 1122346789999999999999999999999988754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=338.00 Aligned_cols=265 Identities=21% Similarity=0.330 Sum_probs=200.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|.+.+.||+|+||.||+|.+..++..||+|+.... ....|+.++..++|+||+++++++......++||||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 45799999999999999999999988999999975432 235689999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+ .++|.+++.. ....+++..++.|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++.......
T Consensus 139 ~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 Y-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred c-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 9 4688888743 3456899999999999999999999999 9999999999999999999999999997533221
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh--------hHHHhhchhccCCCC
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ--------NLIAWAQPIFRDPKR 307 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~--------~~~~~~~~~~~~~~~ 307 (519)
......||+.|+|||++.+..++.++|||||||++|||+++..++....+.... .+..........+..
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 123457899999999999999999999999999999999866554332222211 111111111001111
Q ss_pred CCc-----ccchHhh------ccC-------ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 308 FPD-----MADPLLR------KQF-------PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 308 ~~~-----~~d~~l~------~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
++. .....+. ..+ .......+.+||.+||+.||.+|||+.+|++|.|+-
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 110 0000000 000 012234567799999999999999999999998763
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.52 Aligned_cols=255 Identities=29% Similarity=0.425 Sum_probs=206.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 357899999999999999999975 46779999876543 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998653 3456889999999999999999999999 9999999999999999999999999998754332
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ......... ..
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~----~~------ 223 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGY----RM------ 223 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCC----CC------
Confidence 11 1223346778999999998899999999999999999998 899987543222 112111110 00
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112234578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=340.32 Aligned_cols=250 Identities=31% Similarity=0.412 Sum_probs=209.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
-|.-++.||.|+||.||.|++..+...||||.+....... ..+++.|+..|..+.|||++.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3667788999999999999999999999999998765544 4568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|| -|+-.|+|.- ..+++.+..+..|+.+.+.||+|||+++ .||||||..|||+++.|.|||+|||.|.+..+.
T Consensus 107 YC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99 4687887743 3567999999999999999999999999 999999999999999999999999999876543
Q ss_pred CccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
..++|||.|||||++. .+.|+-++||||||++..||.-.++|+...+...... ..++ ++...+.
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY--HIAQ---NesPtLq-- 246 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ---NESPTLQ-- 246 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH--HHHh---cCCCCCC--
Confidence 3579999999999874 5899999999999999999999999876554322221 1111 1111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+.+..+..|+..||++-|.+|||..+++.|...+
T Consensus 247 ---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 247 ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred ---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 345667899999999999999999999999886544
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=325.89 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=206.3
Q ss_pred CcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
+|++.+.||+|+||.||+|.... ....||+|.+..... .....+..|+.++..++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998753 235799998865432 233568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhc--------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046892 152 VYEFMSGGSVDDHLLDVN--------------------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSN 211 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~N 211 (519)
||||+.+++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 12245889999999999999999999999 9999999999
Q ss_pred eeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 046892 212 ILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVD 290 (519)
Q Consensus 212 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~ 290 (519)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976533322111223345778999999988889999999999999999998 999987543322
Q ss_pred hhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 291 EQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+........ ....+...+..+.+++..||+.+|.+||++.++++.|..+.
T Consensus 238 ---~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 ---LFNLLKTGY--------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ---HHHHHhCCC--------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111111100 11122334567889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.66 Aligned_cols=255 Identities=29% Similarity=0.420 Sum_probs=206.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... .....+..|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4578999999999999999999764 6789999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999985432 346899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....... . ..
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~-~~------- 222 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQ---G-YR------- 222 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc---C-CC-------
Confidence 11 1111223457999999998899999999999999999999 999987543221 1111110 0 00
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 ---MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01223345678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.55 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=215.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+.|.++..||.|+||.||+|..+.++-..|.|++........++++.|+.+|..+.||+||+||+.|..++.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45788889999999999999999988899999998777777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.||.+...+.. -...|.+.++..+++|++.||.|||+.+ |||||||..|||++-+|.++|+|||.+..... .
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999988865 3567999999999999999999999999 99999999999999999999999998864322 1
Q ss_pred cceecccccccccCchhhh-----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 237 MNVTSRVMGTYGYCAPEYA-----RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l-----~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
......+.|||+|||||++ ...+|++++||||||++|.||..+.+|-....+.-- ...+.... -|.+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKiaKSe--PPTL 255 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE--PPTL 255 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHhhcC--CCcc
Confidence 2234568999999999986 457899999999999999999999998765443211 11111110 1111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
+ -|...+..+.+|+..||..||..||+++++++|.|+-
T Consensus 256 l-------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 256 L-------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred c-------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 1 2445566889999999999999999999999998753
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.97 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=203.7
Q ss_pred cccceeeeccCcEEEEEEEEcCCC---eEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc-----
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNG---QVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 148 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 148 (519)
|.+.+.||+|+||.||+|.+..++ ..||+|.+...... ....+..|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999986543 78999998754322 23568889999999999999999998866554
Q ss_pred -eEEEEEecCCCCHHHHHhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 149 -RLLVYEFMSGGSVDDHLLDVNE--TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 149 -~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.++||||+++|+|..++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865422 2346899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ........ .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~---~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRH---G 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc---C
Confidence 99986543332211222345678999999988889999999999999999999 88888654321 22221111 0
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. . ...+......+.+++.+||+.||.+||++.+|++.|..+
T Consensus 232 ~-~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N-R----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-C----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 012334456889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.39 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=205.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578999999999999999999976 6788999988654322 235688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---CcEEe
Q 046892 150 LLVYEFMSGGSVDDHLLDVNE---TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL---DPKLS 223 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~---~vkL~ 223 (519)
++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865421 1235899999999999999999999999 99999999999998755 58999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........ .....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~~~--- 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEFVT--- 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH---
Confidence 9999986533221111122334568999999998899999999999999999997 9899875433221 11111
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
... ...++...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 236 ~~~-----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGG-----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCC-----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 01123344567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=326.15 Aligned_cols=268 Identities=29% Similarity=0.400 Sum_probs=210.8
Q ss_pred ccHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEe-
Q 046892 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCA- 144 (519)
Q Consensus 67 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~- 144 (519)
+.+..+....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334555667889999999999999999999999999999999876432 2235678899999988 6999999999874
Q ss_pred ----cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 145 ----DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 145 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
.++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988654445567899999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~ 295 (519)
+|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..||....+.... .
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F 239 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence 9999999876543221 1223468999999998853 45788999999999999999999998754332111 1
Q ss_pred HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 296 AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.. . .. ..+.. ..+......+.+|+.+||+.||++||++.+|++++++
T Consensus 240 ~~-~---~~--~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 240 KI-P---RN--PPPTL-------HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hc-c---cc--CCCcc-------cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 10 0 00 00000 0122234578899999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.42 Aligned_cols=266 Identities=28% Similarity=0.423 Sum_probs=208.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC----------------eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeee
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG----------------QVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVN 138 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~----------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~ 138 (519)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+..... .....+..|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357899999999999999999876533 5689999875532 23457888999999999999999
Q ss_pred eeeEEecCCceEEEEEecCCCCHHHHHhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046892 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNE-------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSN 211 (519)
Q Consensus 139 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~N 211 (519)
+++++..+...++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999865431 1236899999999999999999999999 9999999999
Q ss_pred eeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCc
Q 046892 212 ILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT--GRRVIDTTRPV 289 (519)
Q Consensus 212 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt--G~~pf~~~~~~ 289 (519)
||++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986544333333344567889999999988889999999999999999998 6677754332
Q ss_pred chhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 290 DEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..........+...... .....+...+.++.+++.+||+.||.+|||+.+|++.|.
T Consensus 240 --~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQ-------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcccccccc-------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 22222222111111000 001112334468999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.03 Aligned_cols=259 Identities=34% Similarity=0.501 Sum_probs=210.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe---E-EEEEEeccC---CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ---V-VAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~-vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
++-...+.||+|+||.||+|.....+. . ||||..... ......+|+.|+.+|+.++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999999876422 3 899988752 234557899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
+||||+|.||+|.++|... ...++..+...++.+.+.||+|||+++ +|||||...|+|++.++.+||+||||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999653 236999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceec-ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 230 LGPQGEKMNVTS-RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 230 ~~~~~~~~~~~~-~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
...... ... ...-...|+|||.+..+.|++++|||||||++||+++ |..||.+....+.. .+ +...
T Consensus 311 ~~~~~~---~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~k---I~~~--- 378 (474)
T KOG0194|consen 311 AGSQYV---MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AK---IVKN--- 378 (474)
T ss_pred CCccee---eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HH---HHhc---
Confidence 643111 111 1123678999999999999999999999999999998 78888766443222 11 1111
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
..+...+...+.++..++..||..+|+.||+|.++.+.+..+....
T Consensus 379 -------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 379 -------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 1223344566778899999999999999999999999998776543
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=324.77 Aligned_cols=258 Identities=28% Similarity=0.457 Sum_probs=206.6
Q ss_pred cCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.+|...+.||+|+||.||+|... .++..||+|.+..........+..|+.++..++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999753 3467899998876555556678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 152 VYEFMSGGSVDDHLLDVNE-----------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 1135889999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 299 (519)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999976543322222233445788999999998999999999999999999998 889886543322211111000
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
....+..++..+.+|+.+||+.||.+||++.+|+..|.
T Consensus 242 -----------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 -----------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00112234457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=322.13 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=205.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 57888999999999999999999899999999987665444556788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999998843 356899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 237 MNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.......|++.|+|||++. ...++.++|||||||++|+|++|..||....+....... ..... ..+..
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~~~----~~~~~-- 231 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNF----QPPKL-- 231 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hccCC----CCCcc--
Confidence 1223457899999999874 456889999999999999999999998654332111111 00000 00000
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
.. ....+..+.+++.+||+.+|++||++.+|+.+.
T Consensus 232 ---~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 232 ---KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred ---cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 00 012234688999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.25 Aligned_cols=273 Identities=23% Similarity=0.315 Sum_probs=209.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+..|+.++..++|+||+++++++...+..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 3579999999999999999999998899999999875432 233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+. ++|..++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 996 588888754 2346889999999999999999999999 999999999999999999999999999754322
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chhcc--------C
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPIFR--------D 304 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~~~--------~ 304 (519)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ..... .
T Consensus 158 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 TK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 21 1223457899999998865 45788999999999999999999999765432221111100 00000 0
Q ss_pred ----CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 305 ----PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 305 ----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...++......+. ......+..+.+|+.+||+.||.+|||+.+++++.|+..-
T Consensus 236 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 236 EEFKSYNYPKYRADCLH-NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccccCccccccHH-hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0001111111110 1122345678899999999999999999999999887543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=362.20 Aligned_cols=266 Identities=31% Similarity=0.464 Sum_probs=216.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCC-C----eEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSN-G----QVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~-~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
...+..+.||+|.||.||.|..... | ..||||.+.+.. .....+|+.|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3456678999999999999998653 2 249999987653 345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 151 LVYEFMSGGSVDDHLLDVNE---TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
|++|||.+|+|..||.+... ....|.....+.++.+||+|+.||++++ +|||||...|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999976422 1456899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
|+.....+.........-...|||||.+..+.++.|+|||||||+|||+++ |..||......+-.... ....
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC-
Confidence 995544443322222223468999999999999999999999999999998 67788765543322111 1111
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCC
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEP 362 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~ 362 (519)
+-..|..++..+.+|+..||+.+|++||++..|++.+..+.+....
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 2345778888999999999999999999999999988776654433
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.29 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=206.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCe----EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.++|++.+.||.|+||+||+|.+..++. .||+|++..... .....+..|+.++..+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 4578899999999999999999876666 489999865432 234567889999999999999999999875 4578
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999854 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||....... +..+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~----~~- 230 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGE----RL- 230 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCC----cC-
Confidence 643322111122335678999999988899999999999999999998 889887543221 222211100 00
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
..+...+..+.+++..||+.||+.||++.+++..+..+...+
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ---------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 112234457889999999999999999999999987765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=320.21 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=200.5
Q ss_pred cccceeeeccCcEEEEEEEEcCCCe--EEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC------Cc
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQ--VVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------DQ 148 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~ 148 (519)
|.+.+.||+|+||.||+|.+..++. .||+|.+.... ......+..|+.++..++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466889999999999999877665 69999886542 22345688899999999999999999987432 24
Q ss_pred eEEEEEecCCCCHHHHHhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 149 RLLVYEFMSGGSVDDHLLDVN--ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
.++||||+.+|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999875322 22345899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ....... . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~-~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLR---Q-G 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---c-C
Confidence 9987644332211222346778999999998899999999999999999999 78888654322 1111111 1 1
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
... ..+......+.+++.+||+.||++|||+.+|++.|..
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 000 1122344578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=322.45 Aligned_cols=270 Identities=26% Similarity=0.338 Sum_probs=207.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|+....||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.++..++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468899999999999999999998899999998865432 233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++++|..++. ....+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999888877663 3346899999999999999999999999 999999999999999999999999999865443
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhchh-------ccCC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPI-------FRDP 305 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~~-------~~~~ 305 (519)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+. ..... +...
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223457889999999876 557899999999999999999999998655433222111 10000 0000
Q ss_pred CCCCcccchHhhc-----cCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 KRFPDMADPLLRK-----QFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+.....+.... ......+..+.+|+.+||+.+|++||++.+++.+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000000000 0011235678999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.03 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=208.3
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
|++.+.||.|+||.||+|.+..++..+++|.+..........+..|+.+++.+.|+||+++++++...+..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67888999999999999999999999999998765444556788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
++|..++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 999888743 2356899999999999999999999999 9999999999999999999999999987543221 1
Q ss_pred eecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 239 VTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
......|++.|+|||++. +..++.++|||||||++|+|++|..||........ ........ .+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~~------~~~~-- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSE------PPTL-- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhhcC------CCCC--
Confidence 223456899999999984 34578899999999999999999999876432211 11111100 0000
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..+...+..+.+|+.+||+.||.+||++.+++++.++...
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 1122334578999999999999999999999999876544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=334.39 Aligned_cols=269 Identities=21% Similarity=0.262 Sum_probs=205.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------ 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 146 (519)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999999999999999987542 22345678899999999999999999987543
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
...|+||||+. ++|..++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999996 47777663 24788999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhc------
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQ------ 299 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~------ 299 (519)
+++...... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||......+....+ ....
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998653322 123457899999999999999999999999999999999999999765432221111 0000
Q ss_pred ---------hhccCCCCCCcccchHh--------hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 300 ---------PIFRDPKRFPDMADPLL--------RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 300 ---------~~~~~~~~~~~~~d~~l--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
........+.......+ ...........+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00000000000000000 0001112345788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.81 Aligned_cols=260 Identities=21% Similarity=0.245 Sum_probs=204.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||++.+..+++.||+|++.+.. ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999999999999999986422 122344778899999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999998542 346899999999999999999999999 99999999999999999999999999875433
Q ss_pred CCccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
... .......||+.|+|||++. ...++.++|||||||+||||++|+.||........... +......+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~------i~~~~~~~ 227 (332)
T cd05623 155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHKERF 227 (332)
T ss_pred CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH------HhCCCccc
Confidence 221 1223357999999999986 34688999999999999999999999976533222111 11111000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHhhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGA--RPLMSDVVTALSFL 356 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~~ 356 (519)
. + ......++.++.+|+.+||..++.. |+++.++++|.++-
T Consensus 228 ~-~------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~ 270 (332)
T cd05623 228 Q-F------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT 270 (332)
T ss_pred c-C------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence 0 0 0011234567888999988654444 78999999997753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=323.11 Aligned_cols=270 Identities=24% Similarity=0.321 Sum_probs=206.0
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|++.+.||.|+||.||+|++..++..||||.+..... .....+..|+.++..+.||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58888999999999999999998999999999865432 2235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+. ++|.+++.... ....+++..++.++.||+.||+|||+.+ |+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 68888875432 2356899999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhchhccCC----C---
Q 046892 236 KMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN-LIAWAQPIFRDP----K--- 306 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~----~--- 306 (519)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+... ............ .
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 11223457899999998865 457899999999999999999999997654322111 111000000000 0
Q ss_pred ----CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 307 ----RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 307 ----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.++......+.. .....+.++.+++.+||+.||.+|||+.+|+.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000001111111 112345678899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=324.27 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=208.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||++.+..+++.||+|++..... .....+..|+.+++.+.||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468899999999999999999998999999999865422 23456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||+|.|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999854 356899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ... .+.....
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~~~~------- 215 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYE---KILEGKV------- 215 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHhcCCc-------
Confidence 3 234568999999999988888999999999999999999999997654211 111 1111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSF 355 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~ 355 (519)
.++......+.+++.+||+.||.+|+ ++.+++.+.++
T Consensus 216 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred -----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence 12233345788999999999999999 88999988764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=317.29 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=206.1
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+|++.+.||.|+||.||++.+..++..||+|.+.... ....+.+..|+.+++.++|+||+++++++.+.+.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999999999999999986432 233466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999988542 3446889999999999999999999999 99999999999999999999999999976543221
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .. .+.... .
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~---~~~~~~--~-------- 217 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---IL---KVCQGS--Y-------- 217 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HH---HHhcCC--C--------
Confidence 12345689999999999988899999999999999999999999975432111 11 111110 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
...+...+..+.+|+.+||+.||.+||++.+++..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01223344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=319.62 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=205.4
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh---------HHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---------KEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~---------~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
+|.+...||.|+||.||+|.+..+++.||+|.+........ +.+..|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788899999999999999988899999998865433221 457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||+|+|||++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999843 356889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc----cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 229 KLGPQGEK----MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 229 ~~~~~~~~----~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
........ ........|+..|+|||.+.+..++.++|||||||++|+|++|..||....... .+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~----- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIFKIGE----- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHHHHhc-----
Confidence 76542111 011123468899999999998889999999999999999999999997643211 1111000
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.....++...+..+.+++.+||+.||.+||++.+|+++.+
T Consensus 227 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 227 ----------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred ----------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 0011223344567889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.65 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=203.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCC--------------CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeee
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSN--------------GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIG 141 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~--------------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~ 141 (519)
++|++.+.||+|+||.||+|++..+ ...||+|.+..... .....+.+|+.++..++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5789999999999999999987542 23599999875422 23356889999999999999999999
Q ss_pred EEecCCceEEEEEecCCCCHHHHHhhhcc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 046892 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNE--------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213 (519)
Q Consensus 142 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NIL 213 (519)
++...+..++||||+.+++|.+++..... ....+++..++.++.||+.||+|||+.+ |+|+||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 1124789999999999999999999999 999999999999
Q ss_pred eCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCcch
Q 046892 214 LGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT--GRRVIDTTRPVDE 291 (519)
Q Consensus 214 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt--G~~pf~~~~~~~~ 291 (519)
++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999976543332222233455778999999998899999999999999999998 55666643321
Q ss_pred hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 292 QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..+............ ......+...+..+.+|+.+||+.||.+||++.+|++.|.
T Consensus 240 -~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111110000 0000112233458999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=326.26 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=212.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|.+.+.||.|+||.||+|.+..++..||+|.+..........+..|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36799999999999999999999888999999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998843 45789999999999999999999999 9999999999999999999999999987654332
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+...... ..... .+.
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~--~~~----- 234 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--TPE----- 234 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC--CCC-----
Confidence 1 12235688999999999988899999999999999999999999976443211100 00000 000
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...+......+.+++.+||+.+|.+||++.+++.+.++...
T Consensus 235 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 01122344567899999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=323.56 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=216.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
-|.++..||+|+||.||+|.++.+|+.||||.+... .+.+++..|+.+++++..|++|++||.|.....+|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 367788999999999999999999999999998654 456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
.|++.+.+.. .+++|.+.++..++...+.||+|||... -||||||..|||++.+|..||+|||.|..+... +
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M 183 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M 183 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence 9999999855 4578999999999999999999999998 899999999999999999999999999765432 3
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
....++.|||.|||||++..-.|+.++||||||++..||..|++|+....+.... +..+..-+ +..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------FMIPT~PP----PTF- 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------FMIPTKPP----PTF- 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------EeccCCCC----CCC-
Confidence 3345689999999999999999999999999999999999999999865543221 11111111 111
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.-|+..+.++.+++..||-++|++|-|+.++++|..
T Consensus 250 -~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 250 -KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred -CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 135667889999999999999999999999998864
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=316.11 Aligned_cols=251 Identities=34% Similarity=0.526 Sum_probs=207.0
Q ss_pred eeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+... +..||+|.+....... ...+..|+.++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3699999999999999866 8899999987654433 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 159 GSVDDHLLDVNET-----KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 159 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
++|.+++...... ...+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998654211 367999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
...........+++.|+|||.+....++.++|||||||++|+|++ |..||....... +...... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK----G------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----C-------
Confidence 432222334567899999999988899999999999999999999 589987653221 1111110 0
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
.....+...+.++.+++.+||+.+|.+||++.+++.+|
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01122334456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=319.38 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=206.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++.+.....||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 44556666789999999999999998899999999876655556778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPL--DWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~~ 231 (519)
|+++++|.+++... ...+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 86 QVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred cCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999998642 2334 78889999999999999999999 999999999999976 678999999998765
Q ss_pred CCCCccceecccccccccCchhhhccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGE--LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..... ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||......... .+.......
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~~----- 229 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFKI----- 229 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhcc-----
Confidence 33221 122345889999999986543 788999999999999999999998653221111 111101111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
...++.....++.+++.+||+.+|.+|||+.+++.+.|
T Consensus 230 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 230 -------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred -------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 11233345567889999999999999999999998865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=316.94 Aligned_cols=253 Identities=29% Similarity=0.394 Sum_probs=209.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||.|+||.||+|.+..++..|++|.+..... ...+..|+.+++.++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999998899999999865432 578899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999854 2456899999999999999999999999 99999999999999999999999999986544321
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
......|+..|+|||++.+..++.++||||||+++|+|++|..||....+......+ .. . ...
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~~----~--~~~------- 217 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PN----K--PPP------- 217 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--cc----C--CCC-------
Confidence 122345789999999999889999999999999999999999999764332211110 00 0 000
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
....+......+.+++.+||+.||.+||++.+|+.+.|
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 00112234457899999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=320.69 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=210.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|++.+.||.|+||.||+|.+..++..||+|++.... ......+..|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999999999999999987553 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999843 27899999999999999999999999 9999999999999999999999999998765432
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||....+... ..... .. ..+
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~---~~--~~~------ 216 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LFLIP---KN--NPP------ 216 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HHHhh---hc--CCC------
Confidence 122345688999999999988899999999999999999999999976542211 11110 00 000
Q ss_pred hhccCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 316 LRKQFPEK-GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 316 l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
..+.. .+..+.+++.+||..+|++||++.+++.+.++....
T Consensus 217 ---~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 217 ---SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred ---CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 01111 344788999999999999999999999988775543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.10 Aligned_cols=263 Identities=27% Similarity=0.379 Sum_probs=206.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-------NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 146 (519)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+..|+.++..+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999998643 235799999875422 2345678899999998 799999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
+..++||||+.+|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 1235899999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 9999999999999876543221111222234578999999998889999999999999999998 888886543211
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+..... .. .....+...+.++.+|+.+||..+|.+||++.+|++.|..+..
T Consensus 251 ~~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 LFKLLK----EG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHH----cC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 111111 00 0011233445688899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=316.91 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=202.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 357888999999999999998864 66899998864432 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998542 236899999999999999999999999 99999999999999999999999999876543221
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ..... .
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~---~----------- 217 (256)
T cd05059 156 T-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESVSA---G----------- 217 (256)
T ss_pred c-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHHHc---C-----------
Confidence 1 1112234567999999998899999999999999999999 78888754332211 11110 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
.....+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00112233456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.14 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=212.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|++.+.||+|+||+||++.+..+++.||+|++..... .....+..|+.++..++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 578889999999999999999998999999998865432 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+++++|.+++.. .+.+++..++.++.+++.||.|||+ .+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999988743 3468999999999999999999997 57 999999999999999999999999998654222
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc-----chhhHHHhhchhccCCCCCC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV-----DEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 309 (519)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ....+..+.........
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--- 230 (284)
T ss_pred c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence 1 22357899999999998889999999999999999999999999864432 11112222222211110
Q ss_pred cccchHhhccCC-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 310 DMADPLLRKQFP-EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 310 ~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
..++ ...+..+.+|+.+||+.||.+||++.+++.+++++...
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 231 --------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred --------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0011 12445788999999999999999999999998887643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.93 Aligned_cols=262 Identities=27% Similarity=0.378 Sum_probs=207.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 148 (519)
.++|.+.+.||+|+||.||+|++. .++..||+|++...... ....+..|+.+|..+. ||||+++++++...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346788899999999999999964 34568999999754322 2346889999999997 9999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc----------------------------------------------------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE---------------------------------------------------------- 170 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 170 (519)
.++||||+.+|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999964321
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 171 ------------------------------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 171 ------------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
....+++..++.|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 1134678889999999999999999998 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~- 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF- 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-
Confidence 9999999999999986533222222233467889999999998889999999999999999998 88888654322111
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..... .. .+...+...+.++.+|+..||+.+|.+||++.+|+..|..+
T Consensus 352 -~~~~~----~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 -YNAIK----RG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred -HHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11000 00 01112334456899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=325.75 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=208.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEc-------CCCeEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ-------SNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 146 (519)
.++|.+.+.||+|+||.||+|++. .++..||+|.+.... ......+..|+.++..+ .||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467889999999999999999753 234579999886542 23345688999999999 799999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
...++||||+.+|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999965321 1235788999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 9999999999999986544332222223446778999999988889999999999999999998 777776542211
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+.... .... . ...+..++..+.+|+.+||+.+|.+||++.+|++.|..+..
T Consensus 248 ~~~~~---~~~~-~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 LFKLL---KEGH-R----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHHH---HcCC-c----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11111 1100 0 11223445688999999999999999999999999976643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=316.69 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=202.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|.+.+.||+|+||.||+|.+.. +..||+|.+.... .....+..|+.++..++||||+++++++.+....++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 468888999999999999998764 5569999887543 33467899999999999999999999999989999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998542 236899999999999999999999999 99999999999999999999999999876543321
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .... .... .
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~---~~~~-~-------- 219 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEKV---SQGL-R-------- 219 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH---hcCC-C--------
Confidence 11122345678999999988889999999999999999998 9999875443211 1111 1100 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
...+...+..+.+++.+||+.+|.+||++.+|+..+
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 220 --LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 011122345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=322.92 Aligned_cols=265 Identities=26% Similarity=0.420 Sum_probs=204.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcC----------------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeee
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQS----------------NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNL 139 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l 139 (519)
++|++.+.||+|+||.||++.+.. ++..||+|.+..... .....+..|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468999999999999999986432 345799999875432 234578899999999999999999
Q ss_pred eeEEecCCceEEEEEecCCCCHHHHHhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046892 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNET-------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNI 212 (519)
Q Consensus 140 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NI 212 (519)
++++...+..++||||+.+++|.+++...... ...+++..++.++.||+.||+|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998653211 134788899999999999999999999 99999999999
Q ss_pred eeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCcc
Q 046892 213 LLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT--GRRVIDTTRPVD 290 (519)
Q Consensus 213 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt--G~~pf~~~~~~~ 290 (519)
|++.++.++|+|||++................+++.|+|||.+.++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543332222233345678999999888899999999999999999998 667776543221
Q ss_pred hhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 291 EQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
. +............ ......+..++..+.+|+.+||+.||.+||++.+|++.|.
T Consensus 242 ~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQGR-------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 1111111100000 0000112234467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=327.89 Aligned_cols=268 Identities=22% Similarity=0.325 Sum_probs=194.1
Q ss_pred ceeeeccCcEEEEEEEEcC--CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceEEEEEecC
Q 046892 82 ECLLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEFMS 157 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ 157 (519)
.+.||+|+||.||+|.+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 3579999999999999753 57899999986542 23567889999999999999999999854 456889999995
Q ss_pred CCCHHHHHhhhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCCcEEeeeccc
Q 046892 158 GGSVDDHLLDVN-----ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL----GANLDPKLSDFGLA 228 (519)
Q Consensus 158 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl----~~~~~vkL~DFGla 228 (519)
++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888775321 12235899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCc-cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch------hhHHHhhch
Q 046892 229 KLGPQGEK-MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDE------QNLIAWAQP 300 (519)
Q Consensus 229 ~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~------~~~~~~~~~ 300 (519)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||........ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 86543221 112234678999999999876 4589999999999999999999999975432110 001110000
Q ss_pred hccCC--------CCCCc---ccchHhhc------------cCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 301 IFRDP--------KRFPD---MADPLLRK------------QFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 301 ~~~~~--------~~~~~---~~d~~l~~------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+ ..++. ........ .........+.+|+.+||+.||.+|||+.++++|.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00000 00000 00000000 0001123468899999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=322.49 Aligned_cols=267 Identities=22% Similarity=0.268 Sum_probs=203.7
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|++.+.||.|+||.||+|++..+|..||+|.+..... .....+..|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 47888999999999999999999999999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+. ++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 578877743 2356899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc-----------
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR----------- 303 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~----------- 303 (519)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|..|+........ ..........
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhh
Confidence 1 12234678999999998764 478999999999999999999988644322111 1110000000
Q ss_pred ---CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 304 ---DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 304 ---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....++...............+.++.+++.+||+.||.+|||+.+++.+.|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0000010000000011223355688999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.36 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=207.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+.|++.+.||.|+||.||+|.+..++..||+|.+..........+..|+.+++.++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56899999999999999999999999999999997665555667888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++++|..++... ...+++..++.++.||+.+|.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999998887542 346899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 237 MNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.......|++.|+|||++. ...++.++|||||||++|+|++|..||........ ...... .. .+.
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~--~~~- 234 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK----SE--PPT- 234 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhc----CC--Ccc-
Confidence 1123356889999999884 34578899999999999999999999875432111 111111 00 000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+...+..+.+++.+||+.+|++||++.+++++.++
T Consensus 235 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 235 ------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 01122344578899999999999999999999988664
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=316.62 Aligned_cols=256 Identities=27% Similarity=0.374 Sum_probs=210.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||.|+||.||+|.+..+++.+|+|++..........+..|+.+++.++||||+++++++.+...++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999998889999999998665556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999988542 256899999999999999999999999 9999999999999999999999999987654321
Q ss_pred cceecccccccccCchhhhccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 237 MNVTSRVMGTYGYCAPEYARSG---ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~---~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.......|+..|+|||++.+. .++.++|||||||++|+|++|..||....+........ ...+ ...
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~----~~~---- 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNF----PPP---- 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccC----CCc----
Confidence 112335688899999998776 88999999999999999999999997654322211111 0000 000
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
. .......+.++.+++.+||..+|..||++.+|+.+-
T Consensus 225 -~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 225 -K--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred -c--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 0 011233456789999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.98 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=210.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||.|+||.||+|.+..++..||+|.+..........+..|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35799999999999999999999888999999998765545556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999988542 346899999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 236 KMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
. ......|++.|+|||++. ...++.++|||||||++|+|++|..||........ +..+. ... .+.
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~----~~~--~~~ 227 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKIL----KSE--PPT 227 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHh----cCC--CCC
Confidence 1 123356899999999875 34567899999999999999999999976533211 11111 100 000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+ ..+...+.++.+++..||+.+|.+||++.+++++.|+..
T Consensus 228 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 228 L-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred c-------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 0 012234457889999999999999999999999977643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=322.13 Aligned_cols=269 Identities=29% Similarity=0.420 Sum_probs=204.1
Q ss_pred cccceeeeccCcEEEEEEEE----cCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEE
Q 046892 79 FRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 151 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 151 (519)
|...+.||+|+||+||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 34678999999875432 2346688999999999999999999988653 45789
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999843 35899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ........... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM-TVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc-chhhhhh
Confidence 443221 11122345677999999988889999999999999999999999986532211 11111000000 0000011
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+.......+...+..+.+++..||+.+|.+||++.+|++.|..+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112234455678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=324.40 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=205.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe--EEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ--VVAVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... ......+..|+.++..+ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999999877665 47888876422 22345688899999888 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 153 YEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
|||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999864221 1235889999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 299 (519)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||....... +....
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~~- 231 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEKL- 231 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH-
Confidence 999999986432111 0111223557999999988889999999999999999997 999987543321 11111
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
... .....+..++..+.+|+.+||+.+|.+||++.++++.|..+....
T Consensus 232 --~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 --PQG-----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred --hcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 100 011122334567889999999999999999999999988776544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.75 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=205.7
Q ss_pred cCcccceeeeccCcEEEEEEEE-----cCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCce
Q 046892 77 KNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 149 (519)
++|.+.+.||+|+||.||+|.+ ..++..||||.+..... ...+.+..|+.+++.+ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5689999999999999999975 23456899998875432 2335688999999999 799999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+.+|+|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999998542 2234899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
...............++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ...... ...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cCC--
Confidence 6543322222233456788999999998899999999999999999998 9999875432211 111111 000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...+.++.+++.+||+.+|++||++.+|++.|..
T Consensus 262 --------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 --------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 001122334578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=314.94 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=205.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec-CCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 154 (519)
+|++.+.||.|++|.||++.+..+++.||+|.+..... .....+..|+.+++.++|+||+++++.+.. ...+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999998899999999865432 234567889999999999999999998864 446789999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++++|.+++... ....+++..++.++.+++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998652 2346899999999999999999999999 999999999999999999999999999765432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...... .... ..... .+
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~---~~~~~--~~------ 219 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLVY---RIIEG--KL------ 219 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHH---HHHhc--CC------
Confidence 21 223456899999999999889999999999999999999999998754321 1111 11110 00
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
...+...+..+.+++.+||+.+|.+||++.+++++.+
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 0122334567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=326.14 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=203.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeE--EEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQV--VAVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|++.+.||+|+||.||+|.+..++.. +|+|.+.... ......+..|+.++..+ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5788999999999999999999877754 5777765432 22345678899999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 153 YEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
|||+++++|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999865321 2236899999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 299 (519)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+. .....
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~ 237 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKLP 237 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHHHh
Confidence 999999986422111 1111234667999999988889999999999999999998 9999865433211 11110
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. .. ....+...+..+.+|+.+||+.+|.+||++.+++.++..+..
T Consensus 238 ---~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 238 ---Q-GY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred ---c-CC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 00 001122234578899999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=321.42 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=205.6
Q ss_pred hccCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... .....+..|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35689999999999999999997652 355899998764432 223457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEE
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKL 222 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL 222 (519)
.++||||+.+|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 1234577888999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchh
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~~--- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKFV--- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---
Confidence 99999876543322222223345778999999998899999999999999999998 78888654322 122111
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.... . ...+...+..+.+++.+||+.+|.+|||+.++++.+...
T Consensus 235 ~~~~-~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGG-Y----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCC-C----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1000 0 011223346899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=322.07 Aligned_cols=268 Identities=29% Similarity=0.414 Sum_probs=212.0
Q ss_pred ccHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEec
Q 046892 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCAD 145 (519)
Q Consensus 67 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 145 (519)
+...++....++|.+.+.||+|+||.||+|....+++.||+|++.... .....+..|+.++..+ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566667889999999999999999999999999999999986532 2345677899999888 79999999999865
Q ss_pred C-----CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 146 G-----DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 146 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
. +..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999988654445567899999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-----ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-----~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~ 295 (519)
||+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|+.||....+... +.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 9999999876543221 12234688999999998643 368899999999999999999999976433211 11
Q ss_pred HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 296 AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.+.. .. .+.+ ..+......+.+++.+||+.+|++||++.+++++.++
T Consensus 244 ~~~~----~~--~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 244 KIPR----NP--PPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred HHhc----CC--CCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 1110 00 0000 0122334578999999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=320.05 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=209.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEec-CCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 149 (519)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+..... .....+..|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4679999999999999999999875 257899998864422 234567889999999999999999998765 5678
Q ss_pred EEEEEecCCCCHHHHHhhhccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNET----KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
+++++|+.+++|.+++...... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 156899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||....+.. +..+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~---- 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD---- 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc----
Confidence 99986544332222233456778999999988889999999999999999998 999997654322 2221111
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+ ..+..++..+.+++.+||..+|++|||+.+++..|..+.
T Consensus 235 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1000 011223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=322.95 Aligned_cols=270 Identities=27% Similarity=0.369 Sum_probs=206.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+..|+.++..++||||+++++++.++...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688999999999999999999888999999988654322 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+++|..+.. ....+++..++.++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999988887663 2345899999999999999999999999 999999999999999999999999998765433
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhchhccC--------
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN-LIAWAQPIFRD-------- 304 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~-------- 304 (519)
.. ......|+..|+|||++.+ ..++.++|||||||++|||++|.+||......+... +..+.......
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 21 1233567899999999875 457889999999999999999999987544322111 11111100000
Q ss_pred ----CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 305 ----PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 305 ----~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...............+..+.+|+.+||+.+|.+||++.+++++.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000010000000001122345679999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=327.58 Aligned_cols=270 Identities=19% Similarity=0.250 Sum_probs=201.6
Q ss_pred cceeeecc--CcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 81 QECLLGEG--GFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 81 ~~~~LG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+.++||+| +|++||++.+..+|+.||+|++..... .....+..|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 789999999999999999999875432 22345677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC-C
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG-E 235 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~-~ 235 (519)
++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+...... .
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998543 2345899999999999999999999999 999999999999999999999999865432211 1
Q ss_pred cc----ceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc---CC-
Q 046892 236 KM----NVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR---DP- 305 (519)
Q Consensus 236 ~~----~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~---~~- 305 (519)
.. .......++..|+|||++.+ ..++.++|||||||++|||++|..||........ .......... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCcccccccc
Confidence 00 01122356788999999876 4689999999999999999999999975432111 1110000000 00
Q ss_pred -----------------CCCCcc---------cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 306 -----------------KRFPDM---------ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 306 -----------------~~~~~~---------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+... ........+.......+.+|+.+||+.||.+|||+.+++++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000000 0000001122234568899999999999999999999999988743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.72 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=206.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+|+.++..++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998754322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 154 EFMSGGSVDDHLLDVNET-------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
||++||+|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998643211 234567788999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCc----------------cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc
Q 046892 227 LAKLGPQGEK----------------MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVD 290 (519)
Q Consensus 227 la~~~~~~~~----------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~ 290 (519)
++........ .......+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9976521100 011123579999999999999999999999999999999999999997633211
Q ss_pred hhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-HHHHHHHHhhhhc
Q 046892 291 EQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-MSDVVTALSFLSN 358 (519)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~~~~~ 358 (519)
. .. .. ....+..+ .-....+..+.+++.+||+.||.+||+ +.++++.|.....
T Consensus 239 i---~~-~~-~i~~P~~~----------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 I---SY-RD-VILSPIEV----------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred h---hh-hh-hccChhhc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1 00 00 00000000 001133457889999999999999964 6667777765544
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=315.02 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=196.9
Q ss_pred eeeccCcEEEEEEEE--cCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC
Q 046892 84 LLGEGGFGRVYKGTL--QSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 159 (519)
.||+|+||.||+|.+ ..++..||+|++...... ..+.+..|+.++..+.|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 446789999998644322 2456888999999999999999999885 45678999999999
Q ss_pred CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccce
Q 046892 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239 (519)
Q Consensus 160 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 239 (519)
+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||.|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999843 346899999999999999999999999 99999999999999999999999999986543322111
Q ss_pred -ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 240 -TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 240 -~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
.....++..|+|||.+....++.++|||||||++|||++ |..||....... ...... ... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~---~~~-----------~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIE---SGE-----------R 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---CCC-----------C
Confidence 112234678999999988889999999999999999998 999997653322 222111 100 0
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+...+.++.+||.+||+.||.+||++.+|++.|..
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11233455688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.66 Aligned_cols=260 Identities=27% Similarity=0.352 Sum_probs=209.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|+..+.||+|+||.||+|.+..+++.||+|.+...... ....+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4688999999999999999999988999999998765433 3356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+++|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999988532 3356899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcc---------------------------ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 046892 234 GEKM---------------------------NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTT 286 (519)
Q Consensus 234 ~~~~---------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~ 286 (519)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 0112346899999999999888999999999999999999999999755
Q ss_pred CCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC----HHHHHHHHhhhh
Q 046892 287 RPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL----MSDVVTALSFLS 357 (519)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~l~~~~ 357 (519)
...... .. +......++. ....+..+.+++.+||+.||.+||+ +.+++.+.|+-.
T Consensus 236 ~~~~~~--~~----~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 236 NRDETF--SN----ILKKEVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred chHHHH--HH----HhcCCccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 432111 11 1111111110 1114568999999999999999999 999998876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.78 Aligned_cols=271 Identities=25% Similarity=0.367 Sum_probs=211.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999999889999999886532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.++.+..++. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 998866665542 3345899999999999999999999999 999999999999999999999999998875543
Q ss_pred CccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chh-------ccC-
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPI-------FRD- 304 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~-------~~~- 304 (519)
.. .......|+..|+|||++.+. .++.++||||||+++|+|++|..||......+........ ... ...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 32 122345688999999999887 8899999999999999999999999765433221111110 000 000
Q ss_pred ----CCCCCcccc-hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 305 ----PKRFPDMAD-PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 305 ----~~~~~~~~d-~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...++...+ ..+...++...+.++.+|+.+||..+|++||++.+++.+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 001111111 112223444557889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=320.60 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=207.2
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.|...+.||.|+||.||+|.+..++..||+|.+..... .....+..|+.+++.+.|+||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46777889999999999999988899999999875432 23456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++++|.+++. ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999873 246899999999999999999999999 99999999999999999999999999976543221
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
......|+..|+|||++.+..++.++|||||||++|||++|..||....+.... ... ... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~---~~~-----------~ 217 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLI---PKN-----------S 217 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhh---hcC-----------C
Confidence 122346889999999999888999999999999999999999998754322111 110 000 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...++...+..+.+++.+||+.+|++||++.+++.+.++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 0112233456788999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=316.13 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=205.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCe---EEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|+..+.||+|+||.||+|.+..++. .||+|.+.... ......+..|+.++..++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3468888999999999999999876554 79999886543 2234568889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999854 2356899999999999999999999999 999999999999999999999999998765
Q ss_pred CCCCcccee-cccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 232 PQGEKMNVT-SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 232 ~~~~~~~~~-~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
......... .....+..|+|||++.+..++.++|||||||++|||++ |..||....... ....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~----~~~~- 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAIND----GFRL- 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhc----CCCC-
Confidence 432211111 11223457999999988889999999999999999997 999986543221 1111110 0011
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+...+..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 230 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ---------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11223446789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=317.58 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=210.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..|+..+.||.|+||.||+|.+..++..||+|++.... ......+..|+.+++.+.|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778889999999999999998889999999987543 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998832 45889999999999999999999999 9999999999999999999999999997654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......++..|+|||++.+..++.++|||||||++|||++|..||....+......+. . .
T Consensus 156 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------~-----------~ 216 (277)
T cd06640 156 I--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------K-----------N 216 (277)
T ss_pred c--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh------c-----------C
Confidence 1 1223467889999999988889999999999999999999999987543321111110 0 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....++...+..+.+++..||+.+|.+||++.+++.+.++...
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0112334456688999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=314.00 Aligned_cols=254 Identities=31% Similarity=0.459 Sum_probs=203.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++++. ....++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 357899999999999999999876 466799999875433 3467899999999999999999999885 4568999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++... ....+++..++.++.+++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998542 2345899999999999999999999999 9999999999999999999999999997654332
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+ ...... .. .
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~~-~-------- 220 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVE---RG-Y-------- 220 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH---cC-C--------
Confidence 11 1122345678999999988889999999999999999999 888886543221 111111 00 0
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...+..+.+|+.+||+.+|.+|||+.++++.|..
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011233445678999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=321.66 Aligned_cols=266 Identities=30% Similarity=0.429 Sum_probs=203.2
Q ss_pred cCcccceeeeccCcEEEEEEEE----cCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~ 150 (519)
.+|++.+.||+|+||.||+|.. ..++..||+|.+..........+..|+.++..++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788899999999999999984 34688999999876654555678899999999999999999998754 34688
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998542 345899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccc-eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 231 GPQGEKMN-VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 231 ~~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
........ ......++..|+|||++.+..++.++|||||||++|||++|..++...... ...... .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~---~~-~~~~ 229 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMG---ND-KQGQ 229 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcc---cc-cccc
Confidence 54432211 111123345699999999889999999999999999999987765432110 000000 00 0000
Q ss_pred cccch---Hh----hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 310 DMADP---LL----RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 310 ~~~d~---~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..... .+ ....+...+..+.+|+.+||+.+|++|||+.+|+..|..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000 00 0112334556899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=319.90 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=207.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.++..++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 368889999999999999999998899999998865422 2235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+++++|..++... .....+++..++.++.||+.||.|||+ .+ |+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 9999999888542 123468999999999999999999997 47 999999999999999999999999998754322
Q ss_pred CccceecccccccccCchhhhccC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSG------ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~------~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
. .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||............. .+....
T Consensus 157 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~--- 226 (286)
T cd06622 157 L----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AIVDGD--- 226 (286)
T ss_pred c----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---HHhhcC---
Confidence 1 2234688899999998554 35889999999999999999999997543221111111 111000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...++.....++.+|+.+||+.+|.+||++.+++.+.|+...
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 227 --------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred --------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 011233455678899999999999999999999998876544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=324.49 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=207.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
.|.....||+|+||.||++.+..++..||||.+........+.+..|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 34445679999999999999988899999999876554555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+++|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 103 ~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 103 GGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 999999873 235889999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
.......|+..|+|||++.+..++.++||||||+++|||++|..||...........+ ...... .+.
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~----------~~~ 239 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPP----------RVK 239 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCC----------ccc
Confidence 1123356899999999998888999999999999999999999999764332211111 100000 000
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.....+..+.+++..||..||.+|||+.+++++.++-....
T Consensus 240 --~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 240 --DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred --cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 01123447888999999999999999999999877654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=320.10 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=205.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+..|+.++..+.||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4578999999999999999998743 578999999875432 2245688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhc------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046892 150 LLVYEFMSGGSVDDHLLDVN------------------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSN 211 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~N 211 (519)
++||||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996421 11235788999999999999999999999 9999999999
Q ss_pred eeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 046892 212 ILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVD 290 (519)
Q Consensus 212 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~ 290 (519)
||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875433322111222345678999999998899999999999999999997 87787644322
Q ss_pred hhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 291 EQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
....... .. .. ...+...+.++.+|+.+||+.+|.+||++.++++.|.
T Consensus 240 --~~~~~~~---~~--~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 --EVIYYVR---DG--NV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred --HHHHHHh---cC--CC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1111111 00 00 0112334567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=314.59 Aligned_cols=255 Identities=31% Similarity=0.450 Sum_probs=203.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|.+.+.||+|+||.||+|.+..+ ..||+|++.... .....+..|+.+++.++|+||+++++++.+ ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 35699999999999999999988754 469999987533 234678899999999999999999998754 568999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+|+|.+++... ....+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999542 2345789999999999999999999999 9999999999999999999999999997654332
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+. .. ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~------~~-~~------- 221 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------RG-YR------- 221 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh------cC-CC-------
Confidence 21 1223446778999999988899999999999999999999 788886543222111111 00 00
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...+...+..+.+|+.+||+.+|.+||++.++++.|..+
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011223455788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=318.51 Aligned_cols=266 Identities=25% Similarity=0.375 Sum_probs=208.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|++.+.||.|+||.||+|.+..+|..||+|++..... .....+..|+.+++.++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58889999999999999999998899999999876542 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998543 256999999999999999999999999 9999999999999999999999999998664432
Q ss_pred ccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC---------
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP--------- 305 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 305 (519)
. .......|+..|+|||++.+. .++.++|||||||++|+|++|.++|......... .........+
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhcc
Confidence 1 112335689999999988654 4689999999999999999998888654332111 1111100000
Q ss_pred --C-----CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 --K-----RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 --~-----~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
. .++......+.. ........+.+++.+||+.+|.+||++.+++.|.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred CcchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0 000000001111 112345789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=324.06 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=206.4
Q ss_pred cCcccceeeeccCcEEEEEEEEc-------CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCC
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ-------SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGD 147 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 147 (519)
++|.+.+.||+|+||.||+|.+. .....||+|.+..... .....+..|+.++..+ .||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999999863 2345799998875422 2345678899999988 6999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG 215 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~ 215 (519)
..++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999965321 2245899999999999999999999999 99999999999999
Q ss_pred CCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 046892 216 ANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNL 294 (519)
Q Consensus 216 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~ 294 (519)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986543221111112234567999999998899999999999999999999 8888865433222211
Q ss_pred HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 295 IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+. ... ....+..++..+.+++.+||+.+|.+||++.++++.|..+..
T Consensus 249 ~~-------~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 249 LR-------EGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH-------cCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11 000 001233445578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=329.12 Aligned_cols=263 Identities=28% Similarity=0.410 Sum_probs=203.0
Q ss_pred ccCcccceeeeccCcEEEEEEEE-----cCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEec-CC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCAD-GD 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-~~ 147 (519)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..... .....+..|+.++..+ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999984 34578999999975432 2335678899999999 68999999998865 45
Q ss_pred ceEEEEEecCCCCHHHHHhhhcc---------------------------------------------------------
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNE--------------------------------------------------------- 170 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 170 (519)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccc
Q 046892 171 ------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM 244 (519)
Q Consensus 171 ------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 244 (519)
....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124788899999999999999999999 9999999999999999999999999997653322211222334
Q ss_pred cccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChh
Q 046892 245 GTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEK 323 (519)
Q Consensus 245 Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 323 (519)
++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ..... ..... ...+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~----~~~~~----------~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRL----KEGTR----------MRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHH----hccCC----------CCCCCC
Confidence 5678999999988899999999999999999997 8888865422111 11110 00000 011122
Q ss_pred hHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 324 GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 324 ~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
....+.+++..||+.+|.+||++.+|+++|..+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3347889999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.02 Aligned_cols=257 Identities=24% Similarity=0.331 Sum_probs=208.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
.|.....||.|+||.||+|.+..++..||+|.+..........+.+|+.++..+.||||+++++++..++..++||||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 34455679999999999999988899999999876555556678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+++|..++.. ..+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 102 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 102 GGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred CCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-
Confidence 9999987732 45899999999999999999999999 99999999999999999999999999875433221
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
......|+..|+|||++.+..++.++|||||||++|||++|..||....+......+. ...... .
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~----------~- 237 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---DSPPPK----------L- 237 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---ccCCCC----------c-
Confidence 1233568999999999998889999999999999999999999997544322211111 000000 0
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.........+.+++..||+.+|.+||++.+++++.++....
T Consensus 238 -~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 238 -KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred -cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 01112345688999999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=316.68 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=204.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe---EEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.+|++.+.||+|+||.||+|.+..++. .||||.+.... ......+..|+.+++.+.||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 458889999999999999999876654 69999986542 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998542 346899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCccce-ecccc--cccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 233 QGEKMNV-TSRVM--GTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 233 ~~~~~~~-~~~~~--Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
....... ..... ++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+..... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~----~~ 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY----RL 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC----cC
Confidence 3221111 11111 2457999999998999999999999999999886 99998654322 2222221110 11
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+...+..+.+++..||+.+|.+||++.+|+..|..
T Consensus 231 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1122344578899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=312.62 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=208.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|+..+.||.|+||.||.+....++..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999999999999999986542 23446688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999986432 356899999999999999999999999 9999999999999999999999999997654332
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+ ... ...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~~--~~~------ 219 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI------VQG--NYT------ 219 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HcC--CCC------
Confidence 1 223456899999999998888899999999999999999999998764322211111 110 000
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..+...+.++.+++.+||+.+|.+||++.+++++++
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 011233457889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.12 Aligned_cols=266 Identities=26% Similarity=0.339 Sum_probs=211.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 153 (519)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||++++++|.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 468889999999999999999998999999999875433 2345688999999999999999999998653 4689999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++.........+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988655445567899999999999999999999999 99999999999999999999999999875433
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--cchhhHHHhhchhccCCCCCCcc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRP--VDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ........+...... ..+...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--PELKDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc--hhhccC
Confidence 22 1234578899999999988999999999999999999999999976532 122222222211000 000000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
. ......+..+.+++.+||..+|.+|||+.+++++.|+..
T Consensus 232 ~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 232 P------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred C------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 0 000123467899999999999999999999999988743
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.12 Aligned_cols=270 Identities=25% Similarity=0.324 Sum_probs=206.1
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-----ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-----GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
+|.+.+.||.|+||.||+|.+..+++.||||.+...... ....+..|+.++..++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999999988999999999765432 234567899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+ +++|.+++... ...+++..++.++.||++||+|||+.+ |+|+||+|+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999998432 136999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhchh----ccCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQPI----FRDPK 306 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~~----~~~~~ 306 (519)
.... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.++|....+.+....+ ...... +....
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 4321 1223456888999998864 46789999999999999999998888765433221111 100000 00000
Q ss_pred CCCcccchHhh-----ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 307 RFPDMADPLLR-----KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 307 ~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
........... .......+..+.+++.+||+.+|.+|||+.+++.+.|+-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 00000000000 011233456889999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.96 Aligned_cols=263 Identities=29% Similarity=0.421 Sum_probs=211.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|++.+.||.|+||+||+|....++..||+|++..... .....+..|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478999999999999999999988899999999865432 2456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865322 246899999999999999999999999 9999999999999999999999999987655433
Q ss_pred cc--ceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 236 KM--NVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 236 ~~--~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.. .......|+..|+|||++... .++.++|||||||++|+|++|..||........ ....... ....+....
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~~~~~~~~~ 231 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---DPPSLETGA 231 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---CCCCcCCcc
Confidence 22 122345689999999998876 789999999999999999999999976533211 1111110 100010000
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.....+..+.+++..||+.||++||++.+|+.+.++
T Consensus 232 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 232 -------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -------ccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 012345678999999999999999999999988653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.76 Aligned_cols=250 Identities=31% Similarity=0.524 Sum_probs=205.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+..|+.++..++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 357888999999999999999875 88999999976543 456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999998542 2236899999999999999999999999 9999999999999999999999999998653221
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. ...++..|+|||.+....++.++||||||+++|+|++ |..||...... .+........
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~------------ 216 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVEKGY------------ 216 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhcCC------------
Confidence 1 2334678999999988899999999999999999997 99988654322 1211111100
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...+..+.+++.+||+.+|.+||++.+++.+|..
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 001122345678999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.98 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=205.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|.+.+.||+|+||.||++.+..+++.||+|.+..... .....+..|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999875532 22346778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999843 346899999999999999999999999 99999999999999999999999999864211
Q ss_pred CCc-------------cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 234 GEK-------------MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 234 ~~~-------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
... ........|+..|+|||.+.+..++.++|||||||++|||++|..||....... +.. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~---~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG---Q 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H
Confidence 100 001122467889999999988889999999999999999999999997543221 111 1
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC---HHHHHHHHhhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL---MSDVVTALSFLS 357 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l~~~~ 357 (519)
........+. .....+..+.+|+.+||+.+|++||+ +.+++++.++..
T Consensus 228 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 228 VISDDIEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHhcccCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 1111000000 01123457899999999999999998 677777766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.93 Aligned_cols=261 Identities=28% Similarity=0.361 Sum_probs=205.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHH-HHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+..|+.+ ++.++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 478899999999999999999999999999999875432 223455556654 667789999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|++ |+|.+++.........+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 689888876544556799999999999999999999997 7 99999999999999999999999999876533
Q ss_pred CCccceecccccccccCchhhhcc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
.. ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..... .....++
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~---~~~~~~~ 229 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVE---EPSPQLP 229 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHh---cCCCCCC
Confidence 21 1223468899999998864 45688999999999999999999999653211 111111111 0000000
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+.++.+++..||..+|.+||++.+++.+.++....
T Consensus 230 -----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 -----------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred -----------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 112345789999999999999999999999998776643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=315.96 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=203.4
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc----------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ----------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
+|.+.+.||.|+||.||+|....+++.||+|.+...... ..+.+..|+.++..++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999999888999999988542111 1235678999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998542 56899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE--LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
+................|+..|+|||.+.... ++.++||||||+++|+|++|..||........ ..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~----~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLG----NKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhh----ccc
Confidence 97654322211223456889999999987654 78999999999999999999999864322111 11100 000
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
....+ . .......+..+.+++..||+.+|..||++.+|+++.+
T Consensus 229 -~~~~~-~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 229 -SAPPI-P----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred -cCCcC-C----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 00000 0 1111233568899999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=314.38 Aligned_cols=254 Identities=28% Similarity=0.417 Sum_probs=203.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
+|.+.+.||.|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788899999999999999874 6889999988644221 12457889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999843 246889999999999999999999999 999999999999999999999999998754
Q ss_pred CCCC----ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 232 PQGE----KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 232 ~~~~----~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
.... .........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.. ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA------HRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh------ccCC
Confidence 2211 11112335689999999999988899999999999999999999999975432221111100 0000
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
. ...+......+.+++.+||+.+|.+||++.+++.+.+
T Consensus 227 ~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 227 M---------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred C---------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0 1123334567899999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=313.10 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=208.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 153 (519)
+|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+..|+.+++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47888999999999999999999999999999875432 233567889999999999999999998754 45678999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH-----DKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
||+++++|.+++.........+++..++.++.||+.||.||| +.+ |+|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765555678999999999999999999999 777 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ..+..... .. ..
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~---~~--~~ 227 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIK---EG--KF 227 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHh---cC--CC
Confidence 87654332 12335689999999999988899999999999999999999999976542 12222111 00 00
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
..++...+..+.+++.+||+.+|.+||++.+|+++.
T Consensus 228 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 228 ---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 112334456889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.03 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=206.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCC-------CeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCC
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSN-------GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGD 147 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~-------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 147 (519)
.+|.+.+.||+|+||.||+|++... +..||+|.+..... .....+..|+.++..+ +|+||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 4689999999999999999986432 34799998864322 2345788999999999 7999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG 215 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~ 215 (519)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999865321 2235889999999999999999999999 99999999999999
Q ss_pred CCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 046892 216 ANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNL 294 (519)
Q Consensus 216 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~ 294 (519)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||......+ .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence 999999999999986543322211222334578999999998899999999999999999998 888886543221 1
Q ss_pred HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 295 IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..... .. . ....+...+.++.+|+.+||+.+|.+||++.+++..|..+..
T Consensus 246 ~~~~~---~~-~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 FKLLK---EG-H----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHH---cC-C----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11110 00 0 011223345578899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.81 Aligned_cols=249 Identities=31% Similarity=0.461 Sum_probs=199.0
Q ss_pred eeeeccCcEEEEEEEEcCCC---eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNG---QVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+...+ ..||+|.+...... ....+..|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999876544 78999998765442 3456889999999999999999999876 4568999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
++|.+++.. ...+++..++.++.|++.||+|||..+ |+|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999854 236899999999999999999999999 9999999999999999999999999998654433211
Q ss_pred e-ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 239 V-TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 239 ~-~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ..+........ .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~----~--------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGE----R--------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC----c---------
Confidence 1 111223567999999998899999999999999999998 9999876433 22222221110 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...+...+..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 012233456788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=312.56 Aligned_cols=255 Identities=27% Similarity=0.351 Sum_probs=194.0
Q ss_pred eeeccCcEEEEEEEEcC--CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCC
Q 046892 84 LLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 68999999999998653 456799998875532 233468889999999999999999999999999999999999999
Q ss_pred HHHHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccce
Q 046892 161 VDDHLLDVNE-TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239 (519)
Q Consensus 161 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 239 (519)
|.+++..... ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999965432 2234677888899999999999999999 99999999999999999999999999975433322222
Q ss_pred ecccccccccCchhhhccC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 240 TSRVMGTYGYCAPEYARSG-------ELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 240 ~~~~~Gt~~y~APE~l~~~-------~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.....|+..|+|||++.+. .++.++||||||+++|||++ |..||......... .... ...... +
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~~--~~~~~~---~ 230 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYTV--REQQLK---L 230 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHh--hcccCC---C
Confidence 2335678899999998642 35789999999999999996 99999764332211 1110 000000 1
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..+. ........+.+++..|| .+|++|||+.+|+..|.
T Consensus 231 ~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 11123446788999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=312.30 Aligned_cols=251 Identities=28% Similarity=0.443 Sum_probs=205.7
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-----QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
+|+..+.||+|+||.||+|....++..|++|.+..... .....+..|+.+++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778899999999999999988899999999865432 2335688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
+||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999843 345889999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCccceecccccccccCchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........ ...+.. ... .
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~--~~~---~--- 220 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIGR--SKE---L--- 220 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHHh--ccc---C---
Confidence 332 223456899999999987766 89999999999999999999999976542111 111110 000 0
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..++......+.+++.+||+.+|.+||++.+++.+.+
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 1123334567889999999999999999999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.57 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=196.7
Q ss_pred eeeccCcEEEEEEEEc--CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCC
Q 046892 84 LLGEGGFGRVYKGTLQ--SNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
.||+|+||.||+|.+. ..+..||+|++...... ..+.+..|+.+++.++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999775 34567999998654322 2356889999999999999999999885 457899999999999
Q ss_pred HHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccce-
Q 046892 161 VDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV- 239 (519)
Q Consensus 161 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 239 (519)
|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9998853 2346899999999999999999999999 99999999999999999999999999975543322111
Q ss_pred ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 240 ~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ +....... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~--------------~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIEQG--------------KRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCC--------------CCC
Confidence 111223578999999988889999999999999999996 999987653322 11111110 011
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.++..++.++.+++..||..+|++||++.+|++.|..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 2334456688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.23 Aligned_cols=267 Identities=22% Similarity=0.300 Sum_probs=193.6
Q ss_pred eeeeccCcEEEEEEEEcC--CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~ 158 (519)
..||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999754 46789999986543 23467889999999999999999999854 567899999995
Q ss_pred CCHHHHHhhhc-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCCcEEeeecccc
Q 046892 159 GSVDDHLLDVN-----ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL----GANLDPKLSDFGLAK 229 (519)
Q Consensus 159 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl----~~~~~vkL~DFGla~ 229 (519)
++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57887774321 12235889999999999999999999999 9999999999999 567789999999998
Q ss_pred cCCCCCc-cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc-------hhhHHHhhch
Q 046892 230 LGPQGEK-MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVD-------EQNLIAWAQP 300 (519)
Q Consensus 230 ~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~-------~~~~~~~~~~ 300 (519)
....... ........||+.|+|||++.+ ..++.++|||||||++|||+||.+||....... ...+......
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 6543221 112234578999999999876 458999999999999999999999997543211 1111110000
Q ss_pred hc-------c---CCCCCCcccch---------Hhh---ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 301 IF-------R---DPKRFPDMADP---------LLR---KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 301 ~~-------~---~~~~~~~~~d~---------~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.. . ....++..... .+. ..........+.+|+.+||+.||.+|||+.+++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0 00000000000 000 00111233568899999999999999999999988764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=320.81 Aligned_cols=274 Identities=22% Similarity=0.289 Sum_probs=206.2
Q ss_pred CcccceeeeccCcEEEEEEEEcC--CCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 150 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 150 (519)
.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ......+..|+.++..++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999988 78999999987643 33346678899999999999999999999988 8899
Q ss_pred EEEEecCCCCHHHHHhhhccCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC----CCCcEEeee
Q 046892 151 LVYEFMSGGSVDDHLLDVNETK-KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA----NLDPKLSDF 225 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~----~~~vkL~DF 225 (519)
+||||+. ++|.+++....... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777765433332 37899999999999999999999999 999999999999999 999999999
Q ss_pred cccccCCCCCc-cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc-------hhhHHH
Q 046892 226 GLAKLGPQGEK-MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVD-------EQNLIA 296 (519)
Q Consensus 226 Gla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~-------~~~~~~ 296 (519)
|++........ ........+++.|+|||++.+ ..++.++|||||||+||+|++|..||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112234568899999998876 457899999999999999999999997654332 001111
Q ss_pred hhchhccC-------CCCCCcccc------------hHhhccCCh--hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 297 WAQPIFRD-------PKRFPDMAD------------PLLRKQFPE--KGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 297 ~~~~~~~~-------~~~~~~~~d------------~~l~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+-.. ....+.... ..+...+.. .....+.+++.+||+.||.+|||+.+++.+.||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 10000000 000000000 011111111 345678999999999999999999999988664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.21 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=207.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|++.+.||+|+||.||++....+++.||+|.+.... ......+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999999899999999986532 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988542 2345789999999999999999999999 9999999999999999999999999997654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||......+ .. ....... .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~---~~~~~~~--~------- 218 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LV---LKIIRGS--Y------- 218 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---HH---HHHhcCC--C-------
Confidence 1 1223468899999999998889999999999999999999999987543211 11 1111100 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
...+......+.+++.+||+.+|.+||++.+|+++.+
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 0122334557899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.60 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=204.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||.|+||.||+|... +++.||+|.+..... ....+..|+.+++.++|+||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 467899999999999999999876 478899999875433 3467889999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++... ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999998542 3456899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. .......++..|+|||++....++.++||||||+++|+|++ |..||....... .........
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~------------ 220 (260)
T cd05067 157 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLERGY------------ 220 (260)
T ss_pred c-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHcCC------------
Confidence 1 11223346778999999998899999999999999999999 999997543221 111111000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...+.++.+++.+||+.+|++||++.+++..|..
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001122344579999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=316.43 Aligned_cols=259 Identities=31% Similarity=0.448 Sum_probs=207.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCC------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~------ 147 (519)
..++|++.+.||.|+||.||+|.+..++..|++|++..... ....+..|+.+++.+ .|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999988899999999875533 346788999999988 6999999999997644
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..++||||+.+++|.+++.........+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998765444567999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
+....... .......|+..|+|||++.. ..++.++|||||||+||+|++|..||........ +... .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKI----P 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHh----h
Confidence 87543322 11233568999999998753 3467889999999999999999999975432211 1111 1
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
... .+.+ ..+......+.+|+.+||..||.+|||+.+++++.|
T Consensus 232 ~~~--~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 232 RNP--PPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred ccC--CCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 100 0000 112224557889999999999999999999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=314.54 Aligned_cols=255 Identities=27% Similarity=0.362 Sum_probs=200.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-----ChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCce
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-----GNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 149 (519)
.+|...+.||+|+||.||+|.+..++..||+|.+...... ....+..|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999999989999999988654221 22457789999999999999999999875 3567
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++++||+++++|.+++.. ...+++...+.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999843 345889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc-cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEK-MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||......... .. . ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~--~~-~---~~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI--FK-I---ATQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH--HH-H---hcCC---
Confidence 5432111 11112346889999999999888999999999999999999999999754322111 11 0 0000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....++......+.+++ .||..+|.+||++.+|+.|.++
T Consensus 226 -------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 226 -------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred -------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence 00112223334566676 6888999999999999988653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=310.68 Aligned_cols=248 Identities=27% Similarity=0.436 Sum_probs=200.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEE-ecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~E~ 155 (519)
++|.+.+.||+|+||.||++... +..||+|.+... ...+.+..|+.+++.++|+||+++++++ .+++..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 47889999999999999999875 788999998643 2346788999999999999999999976 455678999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998542 2345889999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
....++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+........
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~------------ 216 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY------------ 216 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC------------
Confidence 22345678999999998899999999999999999997 8888865422 11222111100
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+..++..+.+++.+||+.+|.+|||+.++++.|..
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 011223345678899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=315.28 Aligned_cols=251 Identities=30% Similarity=0.467 Sum_probs=200.3
Q ss_pred eeeccCcEEEEEEEEcCCC------eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 84 LLGEGGFGRVYKGTLQSNG------QVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~~------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.||+|+||.||+|.+.... ..||+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 6899999999999986433 6899998865432 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-----CcEEeeeccc
Q 046892 157 SGGSVDDHLLDVNE---TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-----DPKLSDFGLA 228 (519)
Q Consensus 157 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-----~vkL~DFGla 228 (519)
++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999975332 2245789999999999999999999999 99999999999999877 8999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
................++..|+|||++.++.++.++|||||||++|+|++ |..||....... ...... . ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~---~-~~- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVT---A-GG- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHh---c-CC-
Confidence 76543322222223456788999999999999999999999999999998 999986543221 111110 0 00
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
....+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01122334567899999999999999999999998874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.88 Aligned_cols=258 Identities=23% Similarity=0.383 Sum_probs=207.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
+|+..+.||+|+||.||+|.+..++..||+|++...... ....+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999999889999999998654311 23567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeeccccc
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKL 230 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~ 230 (519)
||||+.+++|.+++.. ..++++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999853 346899999999999999999999999 99999999999998776 599999999876
Q ss_pred CCCCCc--cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 231 GPQGEK--MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 231 ~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
...... ........|+..|+|||++.+..++.++||||||+++|+|++|..||...........+.... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~---- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA---SA---- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---cc----
Confidence 543211 111233568899999999988889999999999999999999999997543322222111110 00
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.....++......+.+++.+||+.+|.+||++.+++.+.++
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 00112334455688899999999999999999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.50 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=204.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCC---eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNG---QVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+..|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57888999999999999999986443 3799998865432 2245688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998542 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccce-ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 233 QGEKMNV-TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 233 ~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. ...... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~----~~~~-- 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEE----GYRL-- 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhC----CCcC--
Confidence 3321111 112233568999999998899999999999999999886 9999875433221 111111 0011
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 --------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 1122334578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.17 Aligned_cols=248 Identities=31% Similarity=0.446 Sum_probs=200.7
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
+.||.|+||.||+|.+.. ++.||+|.+...... ....+..|+.+++.+.|+||+++++++.+....++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999987 999999998765433 446788999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++... ...+++..++.++.+++.||+|||+.+ |+||||+|+|||++.++.++|+|||++.............
T Consensus 80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9998542 346889999999999999999999999 9999999999999999999999999997654222111111
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQF 320 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 320 (519)
...++..|+|||.+.++.++.++|||||||++|+|++ |..||...........+... . ....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~-------~----------~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG-------Y----------RMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC-------C----------CCCC
Confidence 2234667999999988899999999999999999999 78888665432222211100 0 0112
Q ss_pred ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 321 PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 321 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+...+.++.+|+.+||+.+|.+||++.+|++.|.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2334568999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=317.41 Aligned_cols=263 Identities=28% Similarity=0.394 Sum_probs=206.9
Q ss_pred cHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEec-
Q 046892 68 TFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCAD- 145 (519)
Q Consensus 68 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~- 145 (519)
++.++......|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34445556678999999999999999999999899999999986543 2335677888888888 69999999999853
Q ss_pred -----CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 146 -----GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 146 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
....++||||+.+|+|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 45789999999999999998653 2345889999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~ 295 (519)
+|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|..||....+......+
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 999999987543211 1123356899999999875 346788999999999999999999999754332211111
Q ss_pred HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 296 AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 296 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.. . ... .......+..+.+|+.+||+.||.+||++.+++++.|
T Consensus 239 ~~------~--~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 239 PR------N--PPP--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred hh------C--CCC--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 00 0 000 0011234457899999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.67 Aligned_cols=250 Identities=29% Similarity=0.443 Sum_probs=201.4
Q ss_pred eeeeccCcEEEEEEEEcC-CCe--EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQS-NGQ--VVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~-~~~--~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|++|.||+|.+.. +++ .||||.+..... ...+.+..|+.+++.++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999865 333 699999987655 455678899999999999999999999988 889999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc-
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM- 237 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~- 237 (519)
++|.+++..... ..+++..++.++.|++.||+|||+.+ |+|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999865322 46899999999999999999999999 999999999999999999999999999876443221
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||......+ +...... .....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~~~-------- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGERL-------- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCCcC--------
Confidence 11223457889999999998899999999999999999998 999986543322 1111111 00000
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234467889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.74 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=209.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|+..+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.+.||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 367888899999999999999998999999999876533 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+.+++|.+++... ...+++..++.++.||+.||+|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998543 2578999999999999999999999 88 999999999999999999999999998754322
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ....|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ............. .
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~--~------ 221 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEP--P------ 221 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCC--C------
Confidence 11 125688999999999989999999999999999999999999976432111 1111111111110 0
Q ss_pred HhhccCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 315 LLRKQFPEK-GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 315 ~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...+.. .+..+.++|..||..||.+||++.+++.+.|+-
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 222 ---PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred ---CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 011111 455788999999999999999999999987763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=316.73 Aligned_cols=269 Identities=25% Similarity=0.356 Sum_probs=204.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||.|+||.||+|.+..+++.||||.+...... ....+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 46799999999999999999999988999999998754322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+. ++|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 997 4899887542 346899999999999999999999999 999999999999999999999999998754321
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC--------
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP-------- 305 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 305 (519)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ............
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhh
Confidence 11 1122356889999998875 4588999999999999999999999975432111 111010000000
Q ss_pred --------CCCCcccchHhhccCC-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 --------KRFPDMADPLLRKQFP-EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 --------~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..........+....+ ......+.+++.+||+.+|.+||++.+++.+.||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000001111111111 1112678899999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=309.46 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=212.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|++.+.||.|++|.||+|.+..+++.||||++..... .....+..|+..+..++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999999999999999876543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+++++|.+++... ..+++..++.++.||+.||+|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998542 568999999999999999999999 99 999999999999999999999999999865433
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||................ ... .
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~--~------ 220 (264)
T cd06623 154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGP--P------ 220 (264)
T ss_pred CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCC--C------
Confidence 221 123567899999999998899999999999999999999999997764322222222221 100 0
Q ss_pred HhhccCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEK-GLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+.. .+..+.+++..||..+|.+||++.+++++.++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 011222 45688999999999999999999999998664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.15 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=206.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe----EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.+|++.+.||+|+||.||+|.+..+|. .||+|.+..... .....+..|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 578889999999999999999876654 689998865543 234568889999999999999999999987 78899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999854 2345899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
.............++..|+|||.+....++.++||||||+++|||++ |..||......+ +..... .. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~-~~--- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLE---KG-ER--- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHh---CC-CC---
Confidence 53322211122234578999999988899999999999999999998 999997654322 111111 10 00
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...+......+.+++..||..+|..||++.++++.+..+..
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01122234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.42 Aligned_cols=253 Identities=31% Similarity=0.467 Sum_probs=201.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|.+...||.|+||.||+|.+..+ ..||+|.+.... .....+..|+.+++.+.|+||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 5688999999999999999988754 469999876543 33467889999999999999999999885 45689999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999998642 2345889999999999999999999999 99999999999999999999999999976543321
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... .. ..
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~---~~-~~-------- 221 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVE---RG-YR-------- 221 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---cC-CC--------
Confidence 1 1122346778999999988899999999999999999999 888887543221 111111 00 00
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+...+..+.+++.+||+.||.+||++.+|++.|..
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01223345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.55 Aligned_cols=255 Identities=32% Similarity=0.478 Sum_probs=206.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|.+.+.||.|+||.||+|.+.. +..||||.+.... .....+..|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4689999999999999999999764 5789999987543 3456789999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ....+++..++.++.+|+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999998552 2346899999999999999999999999 9999999999999999999999999987654321
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ..........
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~~------------ 221 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERGY------------ 221 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC------------
Confidence 111122334678999999998899999999999999999998 99998654321 1111111100
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011122334578999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=325.60 Aligned_cols=263 Identities=27% Similarity=0.419 Sum_probs=218.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
....+.+.||+|-||.|.+|.... +..||||.++...... ..+|..|+.+|.+++|||||.|+|+|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 456788999999999999999864 6999999998765443 47899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
|++|+|..||...... .+.-.....|+.||+.||+||.+.+ +|||||.+.|+|+|.++++||+|||+++.+..++
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999764222 2445566779999999999999999 9999999999999999999999999999888888
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT--GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
...+....+-..+|||||.+..+.++.++|||+||++|||+++ ...||... ....+++....++.....-
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~vven~~~~~~~~~~~----- 763 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQVVENAGEFFRDQGRQ----- 763 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHHHHhhhhhcCCCCcc-----
Confidence 7777777778899999999999999999999999999999865 56777643 2334444444444433211
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.....|.-++..+.+++..||..+-.+||+++++..+|..
T Consensus 764 --~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 764 --VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred --eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 1112356677889999999999999999999999887754
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.05 Aligned_cols=254 Identities=26% Similarity=0.340 Sum_probs=202.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcCCCCeeeeeeEEecC--Cce
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-----QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 149 (519)
.+|.+.+.||+|+||.||+|.+..++..||||.+..... .....+..|+.+++.+.|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578999999999999999999999999999998864321 1234677899999999999999999998763 467
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999998853 245788999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc-cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEK-MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~----~~~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFKI----ATQP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHHH----hcCC---
Confidence 5432111 1112235688999999999888899999999999999999999999975422111 1111 0000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.....+......+.+++.+||. +|.+||++.+|+++.+
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 226 -------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred -------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 0112344455678889999995 9999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=312.01 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=204.3
Q ss_pred CcccceeeeccCcEEEEEEEEcC-CCeEEEEEEeccCCC----------cChHHHHHHHHHHH-hcCCCCeeeeeeEEec
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQS-NGQVVAVKQLDRNGM----------QGNKEFLVEVLMLS-LLHHPNLVNLIGYCAD 145 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~----------~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~ 145 (519)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+..... .....+..|+.++. .++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 678999998754321 12244667888776 4799999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ |+|+||+|+|||++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986655556679999999999999999999996 66 99999999999999999999999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||........ .... ...
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~~~---~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---ATKI---VEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HHHH---hhc
Confidence 99998654432 23345689999999999988899999999999999999999999875432211 1111 000
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
. .. .......+..+.+++.+||+.||++||++.+|..++.
T Consensus 229 ~--~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 V--YE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c--CC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00 0001123457889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=318.68 Aligned_cols=259 Identities=28% Similarity=0.452 Sum_probs=204.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCe----EEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
..+|+..+.||+|+||.||+|.+..++. .||+|.+...... ....+..|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3568888999999999999999877665 4788887654322 233678899999999999999999998754 567
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999854 2345889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+.. .....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~~ 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLE----KGERLP 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCCCCC
Confidence 543332212223445778999999998899999999999999999997 889887543222 222211 110110
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+......+.+++..||..+|++||++.++++.+..+..
T Consensus 232 ----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 232 ----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112234578899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=312.47 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=196.7
Q ss_pred eeeeccCcEEEEEEEEcCCCe--EEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQ--VVAVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+..++. .+|+|.+.... ......+..|+.++..+ .||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987775 46888876432 23345688899999999 799999999999999999999999999
Q ss_pred CCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 159 GSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 159 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 1235889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||......+ ...... ..
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~---~~- 227 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP---QG- 227 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHHh---CC-
Confidence 986322111 0111223567999999988889999999999999999997 999986543211 111110 00
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.. ...+......+.+|+.+||+.+|.+||++.+++..|..+
T Consensus 228 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 00 011223345788999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.38 Aligned_cols=239 Identities=26% Similarity=0.406 Sum_probs=189.2
Q ss_pred eeeccCcEEEEEEEEcCC------------------------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeee
Q 046892 84 LLGEGGFGRVYKGTLQSN------------------------GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~------------------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 139 (519)
.||+|+||.||+|.+..+ ...||+|++..........+..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999986322 24689998865544444568889999999999999999
Q ss_pred eeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-
Q 046892 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL- 218 (519)
Q Consensus 140 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~- 218 (519)
++++.+....++||||+++|+|..++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988843 2456899999999999999999999999 99999999999997644
Q ss_pred ------CcEEeeecccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCCCcc
Q 046892 219 ------DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELI-TGRRVIDTTRPVD 290 (519)
Q Consensus 219 ------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~ell-tG~~pf~~~~~~~ 290 (519)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999988643221 12357888999998865 56899999999999999995 7888887643322
Q ss_pred hhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 291 EQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
...... ... .++......+.+++.+||+.+|.+||++.+|++.|
T Consensus 230 ~~~~~~-------~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYE-------KKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHH-------hcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 211111 000 11122234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.89 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=204.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|+..+.||.|+||.||+|.+..++..||||.+..... .....+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48889999999999999999998999999998865432 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+. ++|..++... ....+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6888888542 3456899999999999999999999999 9999999999999999999999999987654322
Q ss_pred ccceecccccccccCchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHhhchhccC---------
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ-NLIAWAQPIFRD--------- 304 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~-~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~--------- 304 (519)
. ......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||......+.. ............
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 122345788999999887644 688999999999999999999999764332211 111111000000
Q ss_pred --CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 305 --PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 305 --~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...++......+.. .......++.++|.+||+.||.+||++.+++.+.||
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00011111111111 112234577899999999999999999999988664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=311.76 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=205.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|.+.+.||+|+||.||+|.+... ...||||...... ....+.+..|+.+++.+.||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4688899999999999999987643 3479999886544 2344578899999999999999999999875 457899
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++... ...+++..++.++.+|+.||.|||+.+ ++|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999998542 335899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
..... ......++..|+|||.+....++.++||||||+++|+|++ |..||...........+. . ...
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~------~-~~~---- 226 (270)
T cd05056 159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE------N-GER---- 226 (270)
T ss_pred cccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------c-CCc----
Confidence 33211 1222334568999999988889999999999999999986 999997654322111111 0 000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
...+..++..+.+++.+||..+|.+|||+.+++..|..+...
T Consensus 227 ------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 ------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 012334456889999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=309.51 Aligned_cols=254 Identities=26% Similarity=0.329 Sum_probs=190.5
Q ss_pred eeeccCcEEEEEEEEcC--CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCC
Q 046892 84 LLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
.||+|+||.||+|.... ....+|+|.+..... .....+.+|+.+++.++|+||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 345788998764432 223467889999999999999999999999999999999999999
Q ss_pred HHHHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccce
Q 046892 161 VDDHLLDVNET-KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239 (519)
Q Consensus 161 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 239 (519)
|.+++...... ....++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999654321 233568888999999999999999999 99999999999999999999999999875433222212
Q ss_pred ecccccccccCchhhhcc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 240 TSRVMGTYGYCAPEYARS-------GELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 240 ~~~~~Gt~~y~APE~l~~-------~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||....+.+.. .... ......++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--~~~~---~~~~~~~~-- 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL--KQVV---REQDIKLP-- 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH--HHHh---hccCccCC--
Confidence 233456778999998743 356789999999999999999 77787654322111 1111 11100111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
. ...+...+..+.+++..|| .||++||++.+|++.|
T Consensus 232 -~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 -K----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -C----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 1 1122334456778888898 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=313.15 Aligned_cols=264 Identities=28% Similarity=0.445 Sum_probs=205.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcC----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCce
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQS----NGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 149 (519)
++|...+.||+|+||.||+|.+.. ++..||||.+...... ....+..|+.+++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 467788999999999999998753 3789999998765443 35678999999999999999999999877 5678
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999998542 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh--------hHHHhhch
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ--------NLIAWAQP 300 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~--------~~~~~~~~ 300 (519)
........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76533221 1111234566799999998889999999999999999999999988653221100 00000000
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..... .....+..++.++.+|+.+||+.+|.+||++.+|+++|..+
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEG----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcC----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000 00111223446789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=308.96 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=205.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|+..+.||+|+||.||+|.+..++..||+|.+..... .....+..|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58889999999999999999998999999999875432 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~~~~~ 234 (519)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999653 2345899999999999999999999999 99999999999998654 5799999999865433
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......... ... ....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~---~~~~--------- 217 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LKI---MSGT--------- 217 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HHH---HhcC---------
Confidence 21 22356889999999999888999999999999999999999998765332111 110 0000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
...++...+..+.+++..||+.+|.+|||+.+++.+.
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 0112223455788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=313.62 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=209.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...+.+..|+.+++.++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58889999999999999999998899999999875432 234678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+++|.+++.. ...+++..++.++.||++||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999843 257899999999999999999999999 999999999999999999999999998865443
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. ......|+..|+|||++.+..++.++||||||+++|+|++|..||................ .
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~----------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T----------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c-----------
Confidence 2 1234568899999999988889999999999999999999999998765432222111110 0
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCH--HHHHHHHh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM--SDVVTALS 354 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~l~ 354 (519)
....++...+..+.+++.+||+.||.+||++ .+++++.+
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence 1122333445788999999999999999999 88876644
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=306.79 Aligned_cols=247 Identities=31% Similarity=0.473 Sum_probs=197.7
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
++||+|+||.||+|... ++..||+|.+...... ....+..|+.++..++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999875 5889999988654322 234688899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ....
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~ 152 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSG 152 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCC
Confidence 998854 2345889999999999999999999999 99999999999999999999999999875433221 1111
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQF 320 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 320 (519)
...++..|+|||++.+..++.++||||||+++|+|++ |..||......... ....... ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~---~~~~~~~--------------~~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR---EQVEKGY--------------RMSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHHHcCC--------------CCCC
Confidence 2344678999999998899999999999999999998 99998754322111 1111000 0112
Q ss_pred ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 321 PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 321 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2334568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=314.10 Aligned_cols=270 Identities=24% Similarity=0.318 Sum_probs=204.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++++|.+.+.||+|+||.||+|.+..++..||+|++....... ...+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999999889999999987543322 346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 677777643 2345788899999999999999999999 99999999999999999999999999875433
Q ss_pred CCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC-------
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP------- 305 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~------- 305 (519)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ .+...+.....+
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhh
Confidence 221 1223457899999999875 4578899999999999999999999976543211 111111000000
Q ss_pred -CCCCcccchHhhccCC---------hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 -KRFPDMADPLLRKQFP---------EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 -~~~~~~~d~~l~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..++...........+ ......+.+++.+||+.||.+|||+.+++.+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0001110000000000 0124578899999999999999999999987653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=317.22 Aligned_cols=259 Identities=28% Similarity=0.410 Sum_probs=211.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|.+.+.||.|+||.||++....++..||+|.+..........+..|+.+++.++||||+++++++...+..|+|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36789999999999999999999888999999998755545556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999843 35789999999999999999999999 9999999999999999999999999887554332
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......|++.|+|||.+.+..++.++|||||||++|+|++|..||............ .... .+.
T Consensus 170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~--~~~----- 234 (293)
T cd06647 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG--TPE----- 234 (293)
T ss_pred c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCC--CCC-----
Confidence 1 123346889999999998888999999999999999999999999765432211100 0000 000
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
...+......+.+++.+||+.+|.+||++.+++.|.++....
T Consensus 235 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 001223345788999999999999999999999998775443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=314.29 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=195.4
Q ss_pred eeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHH---hcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLS---LLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
+||+|+||.||++.+..+++.||+|.+...... ....+..|..++. ...||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999989999999998654322 1223344444333 3479999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988843 346999999999999999999999999 9999999999999999999999999987543322
Q ss_pred ceecccccccccCchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 238 NVTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~-~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.....|++.|+|||.+. +..++.++|||||||++|+|++|..||..........+.... ...
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~~------------ 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTV------------ 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hcC------------
Confidence 12346899999999886 456899999999999999999999999765433222111111 000
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
...++...+.++.+++..||+.||.+|| ++.++++|.++-
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~ 259 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence 1123344556889999999999999999 699999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=315.97 Aligned_cols=270 Identities=26% Similarity=0.348 Sum_probs=208.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 152 (519)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... ....+..|+.++..++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788999999999999999999988999999998754322 223567899999999999999999999877 889999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+. ++|.+++... ...+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 5998888542 236899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhch----------
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQP---------- 300 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~---------- 300 (519)
.... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+ .....
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 4321 12334578899999998754 4689999999999999999999999865433222111 10000
Q ss_pred -hc-cCCCCCCcccchHhhccCChh-hHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 301 -IF-RDPKRFPDMADPLLRKQFPEK-GLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 301 -~~-~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
+. .............+...++.. ....+.+++..||+.+|++|||+.+++.+.||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 000111111122233334443 46778999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=310.17 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=189.5
Q ss_pred eeeeccCcEEEEEEEEcCC------------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 83 CLLGEGGFGRVYKGTLQSN------------GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
+.||+|+||.||+|+.... ...||+|.+..........+..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986422 2368999876654444557888999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC-------cEEe
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD-------PKLS 223 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~-------vkL~ 223 (519)
+||||+++++|..++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999888743 2346899999999999999999999999 999999999999987664 8999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhc-cCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCCcchhhHHHhhchh
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELI-TGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDvwSlGvll~ell-tG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|..||...........
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------- 221 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF------- 221 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------
Confidence 99998754322 2245788999999886 467899999999999999998 57777765322111110
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
.... . ........++.+|+.+||+.||.+||++.+|++++
T Consensus 222 ~~~~--~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEGQ--C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhcC--c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 0 01111235788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=314.12 Aligned_cols=240 Identities=26% Similarity=0.428 Sum_probs=191.9
Q ss_pred eeeeccCcEEEEEEEEcCCCe-------EEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQ-------VVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~-------~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+.||.|+||.||+|.+...+. .||+|.+........+.+..|+.+++.+.||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999999865443 4888988655444456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC--------cEEeeecc
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD--------PKLSDFGL 227 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~--------vkL~DFGl 227 (519)
+.+|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998542 236899999999999999999999999 999999999999987765 59999998
Q ss_pred cccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCcchhhHHHhhchhccCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGR-RVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
+...... ....++..|+|||++.+ ..++.++|||||||++|+|++|. .||......... ... ...
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~---~~~----~~~ 221 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL---QFY----EDR 221 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH---HHH----Hcc
Confidence 8654322 23467889999999976 45799999999999999999995 555443222111 110 111
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
..++.....++.+|+.+||+.||++|||+.++++.|
T Consensus 222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112333345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=313.69 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=207.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
.|...+.||.|++|.||++.+..++..|++|.+........+.+.+|+.+++.+.|+||+++++++...+..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 45556799999999999999988899999999875544555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999998843 45899999999999999999999999 99999999999999999999999998875433211
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+......+. ... .+.. .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~------~~~--~~~~-----~ 236 (285)
T cd06648 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR------DNL--PPKL-----K 236 (285)
T ss_pred -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH------hcC--CCCC-----c
Confidence 1223568999999999988889999999999999999999999987644322211111 000 0000 0
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+...+..+.+++.+||+.+|.+||++.+++++.++..
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 01123457899999999999999999999998866543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=313.84 Aligned_cols=272 Identities=20% Similarity=0.265 Sum_probs=203.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCc-----
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQ----- 148 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~----- 148 (519)
++|++.+.||.|+||.||+|.+..+++.||||.+..... .....+..|+.++..+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999999999999998865432 23356788999999995 6999999999987665
Q ss_pred eEEEEEecCCCCHHHHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeec
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNET-KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFG 226 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFG 226 (519)
.|+||||+.+ +|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||+|+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 888888654322 356899999999999999999999999 999999999999998 8899999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhchh---
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN-LIAWAQPI--- 301 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~~~--- 301 (519)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... +.......
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875432211 1122356889999998865 457899999999999999999999997644322111 11110000
Q ss_pred -ccCC------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 302 -FRDP------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 302 -~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
+... ...+......+.. ..+..+..+.++|.+||+.||.+||++.+++.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred hCcchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 0000 0000000111111 112355678999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=313.49 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=203.2
Q ss_pred cCcccceeeeccCcEEEEEEEE----cCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--Cce
Q 046892 77 KNFRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 149 (519)
..|++.+.||+|+||.||+|.+ ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999985 3468899999986443 22345688999999999999999999998775 568
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998542 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc--------hhhHHHhhch
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVD--------EQNLIAWAQP 300 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~--------~~~~~~~~~~ 300 (519)
........ .......|+..|+|||++.+..++.++|||||||++|+|++++.|+....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65443221 12234567788999999988889999999999999999999876643211000 0000000000
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..... .....+...+..+.+|+.+||+.+|.+||++.++++.+..+
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEG----------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcC----------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 00112234556899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=310.61 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=206.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
-|+..+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.++..++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 36778899999999999999988899999998865432 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999883 246899999999999999999999999 99999999999999999999999999875543221
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ..... .. ..
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~---~~--~~-------- 218 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLIP---KN--NP-------- 218 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHHh---cC--CC--------
Confidence 12234688999999999888889999999999999999999999875432211 11110 00 00
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..++...+..+.+++.+||+.+|.+||++.+++.+.++..
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 219 -PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 1122334557889999999999999999999999876654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=306.61 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=202.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.+|++.+.||.|+||.||+|.+.. +..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468888999999999999998864 6789999886443 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999998854 2345889999999999999999999999 99999999999999999999999999875533221
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.......++..|+|||++.+..++.++||||||+++|||++ |..||....... ..... .... .
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~~~-~-------- 219 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI---NAGF-R-------- 219 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH---hCCC-C--------
Confidence 11122335678999999998899999999999999999998 899987543211 11111 1000 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
...+...+..+.+|+.+||+.+|++||++.+++++|
T Consensus 220 --~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 --LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 001122345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=310.89 Aligned_cols=258 Identities=25% Similarity=0.404 Sum_probs=204.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
++|.+...||.|+||.||+|+... +.+.|++|.+...... ....+..|+.++..++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578899999999999999999753 3468999988654333 3467889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 151 LVYEFMSGGSVDDHLLDVNET-----KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
+||||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998653321 126899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... ..
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~---~~ 234 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ---AG 234 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH---cC
Confidence 99875432211 11223456788999999988888999999999999999998 778886433211 111110 00
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
. . ....+...+..+.+++.+||+.+|.+||++.+++.+|.
T Consensus 235 ~--~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 K--L--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--c--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0 0 00112234457899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=306.52 Aligned_cols=252 Identities=35% Similarity=0.538 Sum_probs=203.2
Q ss_pred cccceeeeccCcEEEEEEEEcCCC----eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNG----QVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
|++.+.||.|+||.||++.+...+ ..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356789999999999999998766 89999999765443 4567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999985422 112899999999999999999999999 99999999999999999999999999986654
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
....... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ........ ... .
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~---~~~-~----- 222 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK---KGY-R----- 222 (258)
T ss_pred ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh---cCC-C-----
Confidence 4222111 2336789999999988889999999999999999998 7788765322 22222111 100 0
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
...+...+.++.+++.+||+.+|.+|||+.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011222456789999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=306.76 Aligned_cols=238 Identities=28% Similarity=0.448 Sum_probs=191.5
Q ss_pred eeeeccCcEEEEEEEEcCCC----------eEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 83 CLLGEGGFGRVYKGTLQSNG----------QVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
+.||+|+||.||+|.+..++ ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999998766 35888887654333 5778899999999999999999999988 778999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-------CcEEeee
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-------DPKLSDF 225 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-------~vkL~DF 225 (519)
|||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998542 226899999999999999999999999 99999999999999887 7999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhc
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG--ELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.............
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------ 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------ 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh------
Confidence 99986543 1224567889999999876 78999999999999999999 567776543221111111
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
.... .+......+.+++.+||..+|.+||++.+|++.|
T Consensus 221 -~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -DQHR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -cCCC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 1111125788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=311.34 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=205.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcC---CCCeeeeeeEEecCCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.|+..+.||.|+||.||+|.+..++..||+|.+.... ......+..|+.+++.+. ||||+++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778889999999999999998899999999987543 233456888999998886 999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998743 36899999999999999999999999 99999999999999999999999999986654
Q ss_pred CCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... ......|+..|+|||.+.++ .++.++|||||||++|+|++|..||........ ...... . ..+
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~---~--~~~--- 220 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIPK---S--KPP--- 220 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcccc---C--CCC---
Confidence 331 12335689999999988654 468899999999999999999999976432211 111100 0 000
Q ss_pred chHhhccCCh-hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 313 DPLLRKQFPE-KGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 313 d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.++. ....++.+++.+||+.||.+||++.+++.+.|+..
T Consensus 221 ------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 221 ------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred ------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 0111 13457889999999999999999999999876633
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.94 Aligned_cols=270 Identities=26% Similarity=0.349 Sum_probs=207.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+|++.+.||.|++|.||+|++..+|..||||++...... ....+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588899999999999999999999999999998765332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+ +|.+++.... ....+++..++.++.||+.||+|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 74 8888875432 2346899999999999999999999999 99999999999999999999999999975433211
Q ss_pred cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh-HHHhhchhc-----------c
Q 046892 237 MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN-LIAWAQPIF-----------R 303 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~-~~~~~~~~~-----------~ 303 (519)
......++..|++||.+.+ ..++.++|||||||++|+|++|..||......+... +........ .
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1223457889999998865 357889999999999999999999997654322211 111100000 0
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....++...+... ..+.+..+..+.+++.+||+.||.+||++.+++++.||
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0011111111111 11223345678999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.35 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=190.8
Q ss_pred eeeccCcEEEEEEEEcCC--CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCC
Q 046892 84 LLGEGGFGRVYKGTLQSN--GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~--~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
.||+|+||.||+|....+ ...+++|.+..... .....+.+|+.++..++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999976433 23567777664432 344678999999999999999999999999999999999999999
Q ss_pred HHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcccee
Q 046892 161 VDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240 (519)
Q Consensus 161 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 240 (519)
|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999764333445778888999999999999999999 999999999999999999999999998643222212222
Q ss_pred cccccccccCchhhhcc-------CCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 241 SRVMGTYGYCAPEYARS-------GELTVKSDVYSFGVILLELITG-RRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 241 ~~~~Gt~~y~APE~l~~-------~~~~~~sDvwSlGvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
....|+..|+|||++.. ..++.++|||||||++|||+++ ..||...... ...... .... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~~--~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---IKDQ--QVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hhhc--ccccC
Confidence 34568899999998743 2457899999999999999974 6677543321 111111 1110 00111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
++ .++......+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~----~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KP----QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CC----ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11 112223457788999999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=314.20 Aligned_cols=273 Identities=23% Similarity=0.318 Sum_probs=202.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 147 (519)
.++|++.+.||+|+||.||+|.+..+++.||||.+...... ....+..|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999999999999999988654222 2345678999999999999999999987654
Q ss_pred --ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 148 --QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 148 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
..++||||+. ++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|||++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3499999995 588887743 2346899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCcc--ceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc
Q 046892 226 GLAKLGPQGEKM--NVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 226 Gla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999765432211 112234678899999988654 47889999999999999999999997654432222222111000
Q ss_pred c-----CCC--------CCCcccchHhhccC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 303 R-----DPK--------RFPDMADPLLRKQF-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 303 ~-----~~~--------~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
. ... .++..........+ +......+.+||.+||+.||.+|||+.+++++.||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 000 00000000000000 11123467899999999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=307.70 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=206.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|.+.+.||+|+||.||+|.+..++..||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588889999999999999999888999999998765443 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999843 345889999999999999999999999 9999999999999999999999999998754432
Q ss_pred ccce--ecccccccccCchhhhccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 236 KMNV--TSRVMGTYGYCAPEYARSGE---LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 236 ~~~~--~~~~~Gt~~y~APE~l~~~~---~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
.... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||....... ........ .....++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~~--~~~~~~~~ 229 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVGA--GHKPPIPD 229 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHhc--CCCCCCCc
Confidence 2111 12356789999999998766 8899999999999999999999997543211 11111110 11111111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.......+.+++.+||+.+|.+||++.+++.+.|
T Consensus 230 ----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 230 ----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred ----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 0122457789999999999999999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.83 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=201.1
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC----CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc--eEEEE
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN----GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ--RLLVY 153 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~lV~ 153 (519)
+...+||+|+|-+||+|.+..+|..||.-.++.. .....+.|..|+.+|+.|+|+||+++|+++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4456899999999999999999999987655432 12234679999999999999999999999988765 77999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~~~ 232 (519)
|++..|+|..|+... +.++...++.|+.||++||.|||++. +||||||||.+||||+. .|.|||+|+|||++..
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999553 45788899999999999999999985 78999999999999975 5899999999999865
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC--CCCCCc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD--PKRFPD 310 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 310 (519)
... ...+.|||.|||||++. ..|++.+||||||++|+||+|+.+||..-... ..+.. .+... +..+..
T Consensus 198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYK---KV~SGiKP~sl~k 267 (632)
T KOG0584|consen 198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYK---KVTSGIKPAALSK 267 (632)
T ss_pred ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHH---HHHcCCCHHHhhc
Confidence 433 23378999999999987 89999999999999999999999998753221 11111 11111 001111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+- ..++.+||.+||.. ..+|||+.++|.+..+-.
T Consensus 268 V~------------dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 268 VK------------DPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred cC------------CHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 11 24788899999999 999999999999876544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.58 Aligned_cols=252 Identities=30% Similarity=0.478 Sum_probs=209.0
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
+|...+.||.|++|.||++.+..++..|++|++..........+..|+.+++.++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999988899999999977655456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+++|.+++... ...+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998542 257899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||............. . . ..+....
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~---~---~~~~~~~---- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--T---N---GPPGLRN---- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h---c---CCCCcCc----
Confidence 234568899999999988889999999999999999999999987653222211111 0 0 0000000
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
+...+..+.+++.+||+.||.+|||+.+++++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~ 252 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHP 252 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 111245789999999999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=307.09 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=193.1
Q ss_pred eeeeccCcEEEEEEEEcC---CCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEe-cCCceEEEEEecC
Q 046892 83 CLLGEGGFGRVYKGTLQS---NGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEFMS 157 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~ 157 (519)
+.||+|+||.||+|.+.. +...||+|.+.... ......+..|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998753 34679999875432 233457888999999999999999999775 4556899999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc-
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK- 236 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~- 236 (519)
+++|.+++... ...+.+..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998542 234678888999999999999999999 99999999999999999999999999975433211
Q ss_pred -cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 237 -MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG-RRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 237 -~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
........++..|+|||.+.+..++.++|||||||++|||++| .+||..... ........ ... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~---~~~-~------- 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL---QGR-R------- 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh---cCC-C-------
Confidence 1111233467789999999888999999999999999999995 555654322 11221111 100 0
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+...+..+.+++..||+.+|++||++.+|+..|..+.
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0011223457889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.76 Aligned_cols=255 Identities=29% Similarity=0.397 Sum_probs=210.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 153 (519)
+|...+.||+|++|.||+|.+..++..|++|++..... ...+.+..|+.+++.++|+||+++++++.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999998899999999876543 3456788999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998542 37899999999999999999999999 99999999999999999999999999987655
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
...........++..|+|||.+.+..++.++||||||+++|+|++|..||..... .. ........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~---~~~~~~~~---------- 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PM---AALYKIGS---------- 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hH---HHHHhccc----------
Confidence 4321112345688999999999888899999999999999999999999976541 11 11111110
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
......++...+..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 00111233344568999999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.70 Aligned_cols=271 Identities=24% Similarity=0.331 Sum_probs=205.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 151 (519)
.++|++.+.||.|+||.||+|.+..+|..||+|.+...... ....+..|+.++..++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999999999999999998654322 223467899999999999999999998765 56899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+. ++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 5888887542 256899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-----ccCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI-----FRDP 305 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~-----~~~~ 305 (519)
..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....+......+...... +...
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 43321 1122345788999999865 56789999999999999999999999765443322211111000 0000
Q ss_pred CCCCc---c-----cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 306 KRFPD---M-----ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 306 ~~~~~---~-----~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..++. + ....+... ....+..+.++|.+||+.||.+|||+.+++.+.|+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred hcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 00000 0 00000000 011356788999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=304.85 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=212.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|.+.+.||.|+||.||++.+..++..||+|++..... .....+..|+.+++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 57888999999999999999998899999999876543 3456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.........+++..++.++.+|+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999765434577999999999999999999999999 9999999999999999999999999998654432
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... +... ..... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~~~--~------- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALK---ILKGQ--Y------- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHH---HhcCC--C-------
Confidence 12334578999999999988889999999999999999999999987653211 1111 11100 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..++......+.+++.+||..+|.+||++.+++++.+
T Consensus 221 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 221 --PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 1122344567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=313.23 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=202.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|...+.||+|+||.||++.+..+++.||+|.+..... .....+..|+.++..+. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 356677889999999999999999999999999875432 23456788999998886 9999999999999999999999
Q ss_pred ecCCCCHHHHHhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 155 FMSGGSVDDHLLDV-NETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 155 ~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|+. ++|.++.... ......+++..+..++.+++.||+|||+. + |+||||||+|||++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 4666554321 12335789999999999999999999975 7 9999999999999999999999999987543
Q ss_pred CCCccceecccccccccCchhhhccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSG---ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||..... ............ .+
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~--~~ 229 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGD--PP 229 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCC--CC
Confidence 322 11234688999999998766 689999999999999999999999976431 111111111100 00
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.+........+..+.+|+.+||+.+|.+|||+.+|+.+.++-
T Consensus 230 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 230 -----ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred -----cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 111112223556889999999999999999999999987763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.12 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=213.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
.+......||-|.||.||.|.|+.-...||||.++.+. ...++|+.|..+|+.+.|||+|+|+|+|..+..+|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 34556789999999999999999888899999987554 45688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
..|+|.+||..+. ...++.-..++++.||..|++||..++ +|||||...|+||.++..|||+||||++++..+.
T Consensus 346 ~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT- 419 (1157)
T KOG4278|consen 346 CYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT- 419 (1157)
T ss_pred cCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc-
Confidence 9999999998764 345777788999999999999999999 9999999999999999999999999999865432
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
........-...|.|||-|....++.|+|||+|||+|||+.| |..||.+.+ ..++.... ...
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---lSqVY~LL--------------Ekg 482 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYGLL--------------EKG 482 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHH--------------hcc
Confidence 111111222568999999999999999999999999999998 667766543 22222211 122
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.+..-|+.|+..+.+|+..||+++|.+||+++++-+.++.+
T Consensus 483 yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 483 YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 33445778888999999999999999999999998887753
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.21 Aligned_cols=269 Identities=23% Similarity=0.295 Sum_probs=205.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------ 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 146 (519)
..++|++.+.||+|+||.||+|.+..+++.||||.+.... ......+..|+.++..++|+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986432 22335677899999999999999999998643
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
...|+||||+. ++|.+.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588887732 2889999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-------
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWA------- 298 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~------- 298 (519)
++........ .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+ ...
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9986543221 23346789999999999999999999999999999999999999765432211110 000
Q ss_pred --------chhccCCC-----CCCcccchHh----hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 --------QPIFRDPK-----RFPDMADPLL----RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 --------~~~~~~~~-----~~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
........ .+.......+ ....+......+.+++.+||+.||.+|||+.+++.+.|+-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00000000 0000000000 0001223456789999999999999999999999998754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=319.25 Aligned_cols=274 Identities=21% Similarity=0.278 Sum_probs=207.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEec----CCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD----GDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~ 149 (519)
.++|++.+.||.|+||.||+|.+..++..||+|++.... ......+..|+.++..++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999999999999999987542 2334567789999999999999999998753 3568
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+. ++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 68888873 3456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc--cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 230 LGPQGEK--MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 230 ~~~~~~~--~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
....... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~-~ 234 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE-E 234 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh-H
Confidence 6433221 111234578999999998865 46889999999999999999999999765443222111110000000 0
Q ss_pred CCCcccchHh--------------hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 307 RFPDMADPLL--------------RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 307 ~~~~~~d~~l--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+.......+ ...+....+..+.+++.+||+.+|.+||++.+++.+.|+-..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0000000000 000112345689999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=308.71 Aligned_cols=265 Identities=23% Similarity=0.284 Sum_probs=200.5
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCeeeeeeEEecC--CceEEEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYE 154 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E 154 (519)
|.+.+.||+|+||.||+|.+..++..||+|++..... ........|+.++..+. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6778899999999999999998999999999875422 22234557888888775 99999999999887 88999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+. ++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 588887743 2356899999999999999999999999 999999999999999 99999999999865433
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh-hc--------hhc--
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQ--------PIF-- 302 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~~--------~~~-- 302 (519)
.. .....++..|+|||++.. ..++.++|||||||++|||++|..||......+....+.. .. ...
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 22 123467899999997654 5678899999999999999999999976543322111110 00 000
Q ss_pred -cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 303 -RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 303 -~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.....++......+. ......+..+.+|+.+||+.+|.+||++.+++++.|+
T Consensus 230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 230 RHMNYNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000011111111111 1122446789999999999999999999999988653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=336.65 Aligned_cols=276 Identities=21% Similarity=0.254 Sum_probs=196.6
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCC-eEEEEEEe--------------cc---CCCcChHHHHHHHHHHHhcCCCC
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNG-QVVAVKQL--------------DR---NGMQGNKEFLVEVLMLSLLHHPN 135 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vAvK~~--------------~~---~~~~~~~~~~~E~~~l~~l~Hpn 135 (519)
....+|++.+.||+|+||+||+|..+... ..+++|.+ .+ ........+.+|+.+|..++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998765322 22222211 00 11112345788999999999999
Q ss_pred eeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNET-KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 136 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
|+++++++.+.+..|+|++++ +++|..++...... ........++.|+.||+.||.|||+++ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999999 46777777542211 222346677889999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRV-IDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~p-f~~~~~~~~~~ 293 (519)
+.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||+||||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999986543321 122346799999999999999999999999999999999998754 43322222222
Q ss_pred HHHhhchhccCCCCCCc-------------------ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 294 LIAWAQPIFRDPKRFPD-------------------MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~-------------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+......+......++. .+...+.. ......+.+++.+||+.||.+|||+.+++.+.+
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN---LGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh---cCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 22211111000001111 01111111 112345778899999999999999999999988
Q ss_pred hhh
Q 046892 355 FLS 357 (519)
Q Consensus 355 ~~~ 357 (519)
|-.
T Consensus 457 f~~ 459 (501)
T PHA03210 457 FSA 459 (501)
T ss_pred hhc
Confidence 744
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=307.15 Aligned_cols=248 Identities=29% Similarity=0.387 Sum_probs=203.9
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
||.|+||.||+|.+..+++.||+|++..... ...+.+..|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999998899999999875432 2345688899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999843 345899999999999999999999999 9999999999999999999999999998664432 122
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
...|++.|++||.+.+..++.++|+||||+++|+|++|..||...... ...... ...... ....++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~~~~~~----------~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYN---DILKGN----------GKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHH---HHhccC----------CCCCCC
Confidence 346889999999998888999999999999999999999999765421 111111 111000 011223
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFL 356 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~ 356 (519)
...+..+.+++.+||+.+|.+||+ +.+++++.|+-
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 333568899999999999999999 89999987764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=309.10 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=202.2
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
||+|+||+||+|.+..+|+.||+|.+..... .....+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999865322 2234567899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||+|+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 99986532 246899999999999999999999999 9999999999999999999999999987654321 122
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+. ...... ...++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~------------~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLEM------------AVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hccccc------------cccCC
Confidence 3467889999999988889999999999999999999999997654321111111 111111 11123
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFL 356 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~ 356 (519)
...+..+.+++.+||+.||.+|| ++.+++.+.|+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 33456788999999999999999 888899887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=305.81 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=205.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|.+.+.||.|+||.||+|.+..+|..||+|.+..... .....+..|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47888999999999999999999999999999865422 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC-cEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD-PKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~-vkL~DFGla~~~~~~ 234 (519)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998542 2345799999999999999999999999 999999999999998864 699999999765432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... .+. ..... .+.
T Consensus 156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~~--~~~----- 220 (257)
T cd08225 156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---LVL---KICQG--YFA----- 220 (257)
T ss_pred cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH---HHhcc--cCC-----
Confidence 21 1223468999999999988889999999999999999999999987543211 111 11111 000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
......+..+.+++.+||+.+|++|||+.+++.+.|
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 112233457899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.84 Aligned_cols=271 Identities=21% Similarity=0.319 Sum_probs=204.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----Cc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 148 (519)
..++|.+.+.||+|+||.||+|.+..+|+.||||.+.... ......+..|+.+++.++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999999999999999986432 22345678899999999999999999987654 35
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++|+||+. ++|..++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 58877763 346899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc-cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 229 KLGPQGEK-MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 229 ~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
........ ........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||........ .......+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 76543221 111233578999999998754 5689999999999999999999999975432211 111111111000
Q ss_pred --CCCcccchH----hh----------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 307 --RFPDMADPL----LR----------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 307 --~~~~~~d~~----l~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+..+.+.. +. .......+.++.+++.+||+.+|.+|||+.+++++.++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 000000000 00 0011123567889999999999999999999999977653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=310.31 Aligned_cols=268 Identities=24% Similarity=0.323 Sum_probs=204.0
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
|++.+.||.|++|.||+|.+..+|..||+|++..... .....+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6778899999999999999998999999999875432 22356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
. ++|.+++.... ...+++..++.++.||+.||+|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 4 68999885422 246899999999999999999999999 99999999999999999999999999975433221
Q ss_pred cceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHhhchhccCC---------
Q 046892 237 MNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ-NLIAWAQPIFRDP--------- 305 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~--------- 305 (519)
......+++.|+|||++.+. .++.++||||||+++|+|++|..||......... .+...........
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 12223568899999987654 5789999999999999999999999765432211 1111100000000
Q ss_pred --CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 --KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 --~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..++....... .......+..+.+++.+||+.+|.+||++.+++.+.|+
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00000000000 11123344678899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.43 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=212.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..+.|+....||.|+||.||+|.+..++..||+|++..... ....+..|+.++..++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678888999999999999999998899999999976543 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+++|.+++.... ..+++..++.++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999996532 37999999999999999999999999 999999999999999999999999988754432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+......+ .. . ..+...
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~~----~--~~~~~~-- 237 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--TT----K--GIPPLK-- 237 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hh----c--CCCCCc--
Confidence 21 123345789999999998888999999999999999999999998754432211111 10 0 000000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+...+..+.+++.+||+.+|..||++.+++.+.++..
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 238 -----NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -----chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 11123457889999999999999999999999887655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=296.54 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=201.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++.+.+..||.|+.|+|++++.+.+|..+|||.+.+.. .++.+.++..+.++...+ .|+||+++|||..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34556678999999999999999999999999998754 344566777777766554 7999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
.| ...+..+|.. -.+++++..+-++...++.||.||.++.. |+|||+||+|||+|+.|.+||||||++..+...
T Consensus 172 lM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecc
Confidence 99 3455555543 24569999999999999999999998764 999999999999999999999999999766443
Q ss_pred CccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-cchhhHHHhhchhccCCCCCCc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRP-VDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
. ..+...|.+.|||||.+. ...|+-.+||||||++|+||+||+.||..... ++....+ .. .++..+
T Consensus 246 k---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv--ln---~ePP~L-- 315 (391)
T KOG0983|consen 246 K---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV--LN---EEPPLL-- 315 (391)
T ss_pred c---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH--Hh---cCCCCC--
Confidence 2 234568999999999885 35788999999999999999999999987432 2111111 11 111111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
+. ....+..+.+++..||++|+.+||...++++|....
T Consensus 316 --~~------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 316 --PG------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred --Cc------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence 11 111455889999999999999999999999986543
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.77 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=203.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++|+||+++++++.+ ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4679999999999999999998654 5679999876432 234678899999999999999999999887 778999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998542 2345789999999999999999999999 9999999999999999999999999997654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......++..|+|||++....++.++|||||||++|+|++ |..||......+ +..... .....
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~~------ 222 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE----RGYRM------ 222 (260)
T ss_pred cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----CCCCC------
Confidence 11 1222345678999999998889999999999999999998 888887543221 111111 00000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+...+..+.+++.+||+.+|++||++.+++..|..
T Consensus 223 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 ----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122344578899999999999999999999988853
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.05 Aligned_cols=253 Identities=32% Similarity=0.419 Sum_probs=203.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.+.|...+.||+|+||.||+|.+..+++.||+|.+...... ....+..|+.+++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688899999999999999999888999999998654322 234678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+. |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 577777643 2346899999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
.. ....|++.|+|||++. ...++.++||||||+++|||++|..||...........+.. ... +
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-----~~~---~ 232 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----NDS---P 232 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-----CCC---C
Confidence 32 2346788999999874 45688999999999999999999999875432221111110 000 0
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.. .+...+..+.+++.+||+.+|.+||++.+|+.+.++..
T Consensus 233 ~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 233 TL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00 01224457899999999999999999999999887654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.49 Aligned_cols=246 Identities=30% Similarity=0.473 Sum_probs=198.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|.+.+.||+|+||.||++.. +++.||+|.+.... ....+..|+.++..++||||+++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4688999999999999999875 48889999986432 345788999999999999999999998764 579999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999998653 2345899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.....+..|+|||.+.+..++.++|||||||++|+|++ |..||......... ..... ...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~----~~~-------- 215 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK---ECVEK----GYR-------- 215 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhC----CCC--------
Confidence 12334678999999988899999999999999999997 89998765432211 11110 000
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
...+...+..+.+++.+||+.+|..||++.+|++.|.
T Consensus 216 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 216 --MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 0112234467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=356.90 Aligned_cols=257 Identities=27% Similarity=0.366 Sum_probs=211.5
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
..+-+|.....||.|.||.||-|.+.++|...|+|.+.... ....+.+.+|+.++..++|||||++||+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34557888889999999999999999999999999876432 3344567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
.||||.+|+|.+++. .+...++.....+..|++.||+|||++| ||||||||.||||+.+|.+|++|||.|...
T Consensus 1312 FMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 999999999999983 3455777778889999999999999999 999999999999999999999999999876
Q ss_pred CCCC--ccceecccccccccCchhhhccC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 232 PQGE--KMNVTSRVMGTYGYCAPEYARSG---ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 232 ~~~~--~~~~~~~~~Gt~~y~APE~l~~~---~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
.... .........||+.|||||++.+. ...-++||||||||++||+||+.||...+.... +.+..
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy~V------- 1454 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMYHV------- 1454 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHhHH-------
Confidence 5432 11123357899999999999753 456789999999999999999999986543211 11100
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
-..-..++|...+.+..+++..||+.||.+|+++.+++++-
T Consensus 1455 ------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1455 ------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred ------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 01122356677888999999999999999999999998874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.96 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=206.2
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEEEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYE 154 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 154 (519)
|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+..|+.+++.+.|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677889999999999999999889999999997653 23345688899999999999999999999888 89999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|++ ++|..++.. ....+++..++.++.||+.||+|||+.+ ++|+||+|+|||+++++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 996 488888743 2257899999999999999999999999 999999999999999999999999999865443
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh-hchhccCC-CC----
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQPIFRDP-KR---- 307 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~~~~~~~~-~~---- 307 (519)
... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.. ........ ..
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 211 1223456888999997764 4678999999999999999999999976553322211111 00000000 00
Q ss_pred -------CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 308 -------FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 308 -------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
........+...+...++..+.+++.+||+.+|.+||++.+++++.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000111112222222236788999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.63 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=200.5
Q ss_pred cccceeeeccCcEEEEEEEEcC---CCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------
Q 046892 79 FRQECLLGEGGFGRVYKGTLQS---NGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 147 (519)
|.+.+.||+|+||.||+|.+.. ++..||||++..... ...+.+..|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5677899999999999998653 478999999865432 23456888999999999999999999886532
Q ss_pred ceEEEEEecCCCCHHHHHhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVN--ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
..+++++|+.+|+|.+++.... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875422 12235789999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|+++...............+++.|++||.+....++.++|||||||++|+|++ |..||..... .....+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---G 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc---C
Confidence 99986543322222223345678999999998889999999999999999999 8888865432 222221110 0
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
... ..+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 232 -~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 -NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 01123445889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.87 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=215.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
...|.+...||+|.|+.|.+|++..++..||||++.+..... ...+.+|+.+|..++|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457999999999999999999999999999999998765443 245789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+|.+.++|.. .+.+.+..+..++.|++.|++|||+++ |||||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999954 455667889999999999999999999 99999999999999999999999999998765
Q ss_pred CCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
+. ...+++|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||++..- ..+.
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k~Lr 264 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------KELR 264 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------cccc
Confidence 44 3456899999999999998776 4789999999999999999999986432 1122
Q ss_pred chHhhcc--CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 313 DPLLRKQ--FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 313 d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...++.. ++...+.++-++|+++|..+|.+|+++.++.++-|..
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 2222222 2334456788999999999999999999999887753
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.54 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=209.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|++.+.||.|+||.||++.+..++..||+|.+..... .....+..|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47888999999999999999998999999999875432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.........+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998765545567899999999999999999999999 9999999999999999999999999998765441
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... . ..++
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~---~--~~~~------ 219 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQ---R--GKYP------ 219 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh---c--CCCC------
Confidence 223467899999999998889999999999999999999999997653221 111110 0 0111
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
..+.....++.+++.+||+.+|.+||++.++++++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 12223456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.91 Aligned_cols=271 Identities=23% Similarity=0.313 Sum_probs=205.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----Cc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 148 (519)
.++|.+.+.||+|+||+||+|.+..+++.||||.+.... ......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999999999999999986532 22345677899999999999999999988654 34
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++||||+. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68888873 3456999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhchhccCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPIFRDPK 306 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 306 (519)
....... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+. ..........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 8654332 11233467899999998865 468899999999999999999999997643221111111 0000000000
Q ss_pred -------------CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 307 -------------RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 307 -------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.++......+.. .....+..+.+++.+||+.+|.+|||+.+++++.++-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000000111 12235677899999999999999999999999977643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=322.81 Aligned_cols=282 Identities=27% Similarity=0.342 Sum_probs=239.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..+++++..||-|+||.|=++........+|+|++++...- ..+.+..|-.+|.....|.||++|-.|.+...+|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 34667778899999999999998765556999998775433 345577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||-|-||.|+..|.+ .+.++...++.++..+++|++|||+++ ||+|||||+|+|+|.+|-+||.|||+|+...
T Consensus 499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999954 567889999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.+.. +-++||||.|.|||++.+...+.++|.||||+++||||+|.+||...++....+++--..
T Consensus 572 ~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------------- 635 (732)
T KOG0614|consen 572 SGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------------- 635 (732)
T ss_pred cCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-------------
Confidence 7654 346899999999999999999999999999999999999999999887765554432111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSD 382 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~ 382 (519)
-.-.+|..+...+.+||..++..+|.+|.. +.+|-.|-||.-- ....+++|+.|+..+..+.+||+.
T Consensus 636 ---d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~ 712 (732)
T KOG0614|consen 636 ---DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDN 712 (732)
T ss_pred ---hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccC
Confidence 112356667778999999999999999976 7888888887543 345678999999998888888876
Q ss_pred C
Q 046892 383 G 383 (519)
Q Consensus 383 ~ 383 (519)
-
T Consensus 713 ~ 713 (732)
T KOG0614|consen 713 F 713 (732)
T ss_pred C
Confidence 3
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=308.05 Aligned_cols=271 Identities=21% Similarity=0.274 Sum_probs=204.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+..|+.+++.++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 578999999999999999999998899999999865432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~~~~ 233 (519)
|+. ++|.+++... ....+++..++.++.||+.||+|||+.+ |+|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 5888877432 2234688889999999999999999999 999999999999985 55799999999975433
Q ss_pred CCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhch----hccCCCC
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQP----IFRDPKR 307 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~----~~~~~~~ 307 (519)
.. .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+ ..... .+.....
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 21 11223467899999998866 45789999999999999999999999765432221111 11000 0000000
Q ss_pred CCcc-------cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 308 FPDM-------ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 308 ~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
++.. ....+ .......+..+.+++.+||+.+|.+||++.+++++.++-
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 234 LPDYKSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred chhhhhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 0100 00000 011223456789999999999999999999999987654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.46 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=196.4
Q ss_pred eeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHH---HHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVL---MLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
+||+|+||.||+|.+..+++.||+|.+....... ...+..|.. ++....||+|+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999998889999999987643221 122334433 3445679999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988843 356999999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 238 NVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.....|+..|+|||++.++ .++.++|||||||++|+|++|..||.............. ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~------------ 214 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTM------------ 214 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---hhcc------------
Confidence 2235689999999998754 689999999999999999999999976533222211110 0000
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLS 357 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~ 357 (519)
...++...+..+.+++.+||..+|.+|| ++.+++++.|+-.
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 1112333456889999999999999999 9999999887644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=312.05 Aligned_cols=256 Identities=30% Similarity=0.417 Sum_probs=205.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.|...+.||+|+||.||+|.+..++..||+|.+...... ....+..|+.+++.++|+|++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477888999999999999999888999999998754322 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+. |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 996 577777643 2456899999999999999999999999 999999999999999999999999998754322
Q ss_pred CccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||.......... .+.. .. .+
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~----~~--~~-- 242 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ----NE--SP-- 242 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHh----cc--CC--
Confidence 2346889999999874 4578899999999999999999999987543221111 1110 00 00
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEP 362 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~ 362 (519)
.......+..+.+|+.+||+.+|.+||++.+++.+++.+......
T Consensus 243 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 243 ------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred ------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 001123345788999999999999999999999999887654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.39 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=204.8
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
...||+|+||.||++....++..||||.+..........+..|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 45799999999999999989999999998655444556788999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++. ...+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++....... ....
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 98773 235899999999999999999999999 9999999999999999999999999887543321 1123
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
...|++.|+|||++.+..++.++||||||+++|+|++|..||...........+. ..... .+. ..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~~~--~~~----------~~ 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNLPP--KLK----------NL 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhCCc--ccC----------Cc
Confidence 3568899999999988888999999999999999999999987543322211111 00000 000 01
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
...+..+.+++.+||+.+|.+||++.+++.+.++....
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 12344678899999999999999999999987765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=303.25 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=194.3
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHH-HHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||.|+||.||+|.+..+++.||||.+....... ...+..|..+ .....|+||+++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999999889999999986543221 1233445444 3455899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999843 346899999999999999999999999 99999999999999999999999999875432
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+. ......+ .
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~~~~--------~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL------SRRINWP--------E 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcccCCC--------C
Confidence 223568899999999988888999999999999999999999997543321111110 0000000 0
Q ss_pred cCChhhHHHHHHHHHHhhhhCCCCCCCH---HHHHHHHhhh
Q 046892 319 QFPEKGLNEAVAIAAMCLQEEAGARPLM---SDVVTALSFL 356 (519)
Q Consensus 319 ~~~~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~l~~~ 356 (519)
......+..+.+++.+||+.+|++||++ .+++.+.++.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 1112345678999999999999999955 6887777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=302.89 Aligned_cols=253 Identities=21% Similarity=0.274 Sum_probs=198.7
Q ss_pred HHHHhccCcccceee--eccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHh-cCCCCeeeeeeEEecCC
Q 046892 71 ELAAATKNFRQECLL--GEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSL-LHHPNLVNLIGYCADGD 147 (519)
Q Consensus 71 ~~~~~~~~y~~~~~L--G~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~ 147 (519)
++....++|.+.+.+ |.|+||.||++....++..+|+|.+........ |+..... .+|+||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344445677777666 999999999999999999999999865432211 2222222 26999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeec
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFG 226 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFG 226 (519)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999843 237999999999999999999999999 99999999999999988 99999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.... ...
T Consensus 156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~~- 226 (267)
T PHA03390 156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QKK- 226 (267)
T ss_pred cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-ccc-
Confidence 98765332 22468999999999998899999999999999999999999997443221 1111111111 000
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-HHHHHHHHhh
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-MSDVVTALSF 355 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~~ 355 (519)
...+...+..+.+++..||+.+|.+||+ +.+++++.|+
T Consensus 227 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 227 -----------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred -----------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 0112234567899999999999999996 6999988765
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.89 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=208.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 152 (519)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .....+..|+.++..+. |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 478899999999999999999998999999999875322 22356788999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999854 346999999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCc------------------cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 046892 233 QGEK------------------MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL 294 (519)
Q Consensus 233 ~~~~------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~ 294 (519)
.... ........|+..|+|||.+....++.++||||||+++|+|++|..||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 3221 1122345678999999999888899999999999999999999999986542111
Q ss_pred HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH----HHHHHHHh
Q 046892 295 IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM----SDVVTALS 354 (519)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~ 354 (519)
.. ..... ...++...+..+.+++..||+.+|.+||++ .+++.+.+
T Consensus 231 ~~---~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 231 FQ---KILKL------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HH---HHHhc------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 11 11111 112333345678999999999999999999 99988765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=297.60 Aligned_cols=259 Identities=24% Similarity=0.277 Sum_probs=206.8
Q ss_pred hccCcccc-eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHh-cCCCCeeeeeeEEec----CCc
Q 046892 75 ATKNFRQE-CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSL-LHHPNLVNLIGYCAD----GDQ 148 (519)
Q Consensus 75 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~~~ 148 (519)
++++|.+. ++||-|-.|.|..+.++.+|+.+|+|++.. .....+|+++.-. -.|||||.++++|+. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46677764 589999999999999999999999999853 3556778876544 469999999999854 456
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeee
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDF 225 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DF 225 (519)
+++|||.|+||.|...+.+. ....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|+.. +-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 78999999999999999774 4567999999999999999999999999 999999999999964 456899999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc----chhhHHHhhchh
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV----DEQNLIAWAQPI 301 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~----~~~~~~~~~~~~ 301 (519)
|+|+...... ...+.+-||.|.|||++....|+..+|+||+||++|-||+|.+||...... +....+...+.
T Consensus 209 GFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy- 284 (400)
T KOG0604|consen 209 GFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY- 284 (400)
T ss_pred ccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc-
Confidence 9999754322 234567899999999999999999999999999999999999999764331 11111111111
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.++. + --..+++.+.++|..+|..+|.+|.|+.+++.+.|.-....
T Consensus 285 -----~FP~---p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 285 -----EFPE---P-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred -----cCCC---h-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 1110 0 01345778899999999999999999999999988654433
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=314.89 Aligned_cols=271 Identities=25% Similarity=0.346 Sum_probs=203.9
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecC--Cce
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN--GMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG--DQR 149 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--~~~ 149 (519)
..++|++.+.||+|+||.||+|.+..++..||||.+... .......+..|+.++..+ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456899999999999999999999888999999988543 222345577899999999 999999999998653 368
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+. ++|..++.. ..+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 589888733 26889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc---ceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC-
Q 046892 230 LGPQGEKM---NVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD- 304 (519)
Q Consensus 230 ~~~~~~~~---~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~- 304 (519)
........ .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65433221 12334568999999998754 56788999999999999999999999765433221111110000000
Q ss_pred -------C------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 305 -------P------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 305 -------~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
. ..+.......+...+ ...+.++.+++.+||+.+|.+|||+.+++.+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~ 298 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence 0 000000000001111 1245688999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=299.54 Aligned_cols=250 Identities=30% Similarity=0.450 Sum_probs=207.7
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+|.+.+.||+|++|.||++.+..+++.||+|.+..... .....+..|+.++..+.|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47888999999999999999998899999999976644 3446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999844 257899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
.. .....|+..|+|||.+.+..++.++|||+||+++|+|++|..||....... ...... ....
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~~~~~~---~~~~---------- 216 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALFRIV---QDDH---------- 216 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHh---ccCC----------
Confidence 21 233568999999999988888999999999999999999999987543211 111111 0000
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
..++......+.+++.+||..+|++||++.+++.+.
T Consensus 217 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 217 --PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred --CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 112333456788999999999999999999998764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.05 Aligned_cols=269 Identities=23% Similarity=0.295 Sum_probs=200.5
Q ss_pred eeeecc--CcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEG--GFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
..||.| +||+||++.+..+|+.||+|++...... ..+.+..|+.++..++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999999989999999998754322 235678899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc-c
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK-M 237 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 237 (519)
++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++++||+.+........ .
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999886532 235899999999999999999999999 99999999999999999999999986543221110 0
Q ss_pred c----eecccccccccCchhhhccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC-----
Q 046892 238 N----VTSRVMGTYGYCAPEYARSG--ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK----- 306 (519)
Q Consensus 238 ~----~~~~~~Gt~~y~APE~l~~~--~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 306 (519)
. ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ...........+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccccc
Confidence 0 01112346679999998763 478999999999999999999999976432111 1111100000000
Q ss_pred --------------------------CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 307 --------------------------RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 307 --------------------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.........+....+......+.+|+.+||+.||.+|||+.+++++.|+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000111112222234456789999999999999999999999999987553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.61 Aligned_cols=275 Identities=24% Similarity=0.308 Sum_probs=210.7
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC-----ceE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 150 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~~ 150 (519)
+|.+.+.||.|+||.||+|.+..++..||||.+.... ....+.+..|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999998889999999987643 334467889999999999999999999988775 789
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+. ++|.+++. ....+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999996 57888873 3347999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCc-cceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chhccCC--
Q 046892 231 GPQGEK-MNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPIFRDP-- 305 (519)
Q Consensus 231 ~~~~~~-~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~~-- 305 (519)
...... ........++..|+|||++.+. .++.++||||||+++|+|++|..||...........+... .......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 554321 0112335678999999999877 8899999999999999999999999776533222111110 0000000
Q ss_pred ----CCCCcccc------hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 306 ----KRFPDMAD------PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 306 ----~~~~~~~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
......+. ..-...+....+..+.+++.+||+.+|.+||++.+++.+.|+-....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000 00000112234567899999999999999999999999987654333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=309.69 Aligned_cols=272 Identities=25% Similarity=0.325 Sum_probs=202.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 147 (519)
.++|.+.+.||.|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999999999999999998654322 2345778999999999999999999875433
Q ss_pred --ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 148 --QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 148 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.+++||||+. ++|...+.. ....+++..++.++.||++||+|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4699999995 467776643 2356999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCcc---------ceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 046892 226 GLAKLGPQGEKM---------NVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295 (519)
Q Consensus 226 Gla~~~~~~~~~---------~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~ 295 (519)
|++......... .......|++.|+|||++.+. .++.++|||||||++|+|++|.+||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754332211 111234678899999987654 5889999999999999999999999765443322221
Q ss_pred Hhhchhc-----cCCCCCCccc--------chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 296 AWAQPIF-----RDPKRFPDMA--------DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 296 ~~~~~~~-----~~~~~~~~~~--------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....... .....++... ...+...+ ......+.+++.+||+.||.+|||+.+++.+.||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 1110000 0000001000 01111111 1223578899999999999999999999988653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.18 Aligned_cols=248 Identities=28% Similarity=0.410 Sum_probs=200.5
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
||.|+||.||+|.+..+++.||+|++..... .....+..|+.++..+.|+||+++++++......++||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999875533 3445688899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc-----
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK----- 236 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~----- 236 (519)
.+++... ..+++..++.++.||++||+|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998542 36899999999999999999999999 99999999999999999999999999876443321
Q ss_pred -cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 -MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 -~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
........++..|+|||.+....++.++||||||+++|+|++|..||......... .. ........+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~~---~~~~~~~~~~~---- 223 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---QN---ILNGKIEWPED---- 223 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HH---HhcCCcCCCcc----
Confidence 11223456788999999998888999999999999999999999999765432111 11 11111111100
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCH---HHHHHHHhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLM---SDVVTALSF 355 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~l~~ 355 (519)
...+..+.+++.+||+.+|.+|||+ .+++.+.++
T Consensus 224 ------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 224 ------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred ------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 0124678999999999999999999 777776655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=305.39 Aligned_cols=266 Identities=24% Similarity=0.311 Sum_probs=206.4
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
|.+.+.||.|++|.||+|.+..+++.+++|.+...... ....+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999999888999999998754332 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
.+ +|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 64 888887542 257899999999999999999999999 9999999999999999999999999997665433
Q ss_pred cceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhchh-cc----------
Q 046892 237 MNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPI-FR---------- 303 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~~-~~---------- 303 (519)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+. ..... ..
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112234578899999998776 78999999999999999999999997654432221111 00000 00
Q ss_pred -CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 304 -DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 304 -~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
....++....... .......+.++.+++..||+.||.+||++.+++.+.|
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 232 NYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0000000000000 1112345678999999999999999999999998865
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=320.47 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=201.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 151 (519)
....|++++.||.||.+.||++...+ ...||+|.+..... ....-|..|+.+|.+++ |.+||+||+|-..++.+||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45679999999999999999998764 56677776644322 23456899999999986 9999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||= ..+|..+|... ...++.-.++.+..|++.++.++|.+| |||.||||.|+|+- .|.+||+|||+|...
T Consensus 438 vmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99997 46999998553 223343388999999999999999999 99999999999985 478999999999988
Q ss_pred CCCCccceecccccccccCchhhhccC-----------CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSG-----------ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~-----------~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
............+||+.||+||.+... ..+.++||||||||||+|+.|+.||.... +.+.-+..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl~a 584 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKLHA 584 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHHHh
Confidence 776666666778999999999988532 25678999999999999999999997542 11221111
Q ss_pred hccCCCCCCcccchHhhccCChhhH-HHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGL-NEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+.++...-.|+.... .++++++..||+.||.+||+..+||++..
T Consensus 585 ----------I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF 629 (677)
T KOG0596|consen 585 ----------ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF 629 (677)
T ss_pred ----------hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence 222222222333222 24999999999999999999999998853
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=301.77 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=202.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-----CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--Cce
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-----MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 149 (519)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999999999999999875321 12234678899999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++|+||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998843 345889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCc-cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEK-MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~----~~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIA----TQP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHHH----cCC---
Confidence 6432111 111123568999999999988889999999999999999999999997542211 111111 000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
....++......+.+++..||+ +|..||++.+++.|+
T Consensus 226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 1122344556789999999999 579999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=307.58 Aligned_cols=271 Identities=26% Similarity=0.325 Sum_probs=204.6
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC----
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD---- 147 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 147 (519)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 346789999999999999999999998899999999875432 23346778999999999999999999987655
Q ss_pred ------ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcE
Q 046892 148 ------QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 148 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vk 221 (519)
..++|+||+++ +|..++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999975 77777643 2346899999999999999999999999 99999999999999999999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...........+.....
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999986544321 11122346788999998865 4578999999999999999999999976543322221111100
Q ss_pred hccCCCCCCccc--------------chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 301 IFRDPKRFPDMA--------------DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 301 ~~~~~~~~~~~~--------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
. .....++.+. ...++.. ....+..+.+++..||+.+|.+||++.+++.+.+
T Consensus 236 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 236 S-PCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred C-CChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 0000000000 0011111 1123567899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=322.99 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=212.6
Q ss_pred cccceeeeccCcEEEEEEEEcCC-C--eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSN-G--QVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~-~--~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
....+.||+|.||.|++|.|... | ..||||.+...... ...+|++|+.+|..|+|+|+++|||+..+ ....||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34557899999999999999753 3 36999999876544 56789999999999999999999999987 77889999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+++.|+|.+.|.+ .....|.......++.||+.||.||..++ +|||||...||||-..-.|||+||||.+-+..+
T Consensus 191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999977 45567888999999999999999999999 999999999999999999999999999988877
Q ss_pred Cccceecc-cccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 235 EKMNVTSR-VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 235 ~~~~~~~~-~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
+...+... ..-...|+|||.|+...++.++|||+|||+||||++ |..||-+.....-...+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----------------- 328 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----------------- 328 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc-----------------
Confidence 66554432 223568999999999999999999999999999998 66888766543322222
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
|..-+-.-+..+++.+.+++..||..+|.+|||+..|.+.+..
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 2222233477889999999999999999999999999865543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=294.91 Aligned_cols=270 Identities=24% Similarity=0.314 Sum_probs=213.1
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCC
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGD 147 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 147 (519)
+.++...+. +.||+|+|+.|--+....+|..||||++.+........+.+|++++...+ |+||++|+++|+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 455544443 58999999999999999999999999999987777889999999999886 999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC---cEEee
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD---PKLSD 224 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~---vkL~D 224 (519)
..|||||-|.||+|..+|+. ...+++.++..+..+|+.||.|||.+| |.||||||+|||...... |||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999965 346899999999999999999999999 999999999999976544 79999
Q ss_pred ecccccCCCCC-----ccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch---
Q 046892 225 FGLAKLGPQGE-----KMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE--- 291 (519)
Q Consensus 225 FGla~~~~~~~-----~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~--- 291 (519)
|.|..-..... ......+.+|+..|||||++. ...|+.++|.||||||||-||.|.+||.+....+.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 99875322211 111233578999999999763 24689999999999999999999999987654331
Q ss_pred -hhH-----HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 292 -QNL-----IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 292 -~~~-----~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
... -..+..+-.....+|+-- -..++.++.+++..+|..++..|.++.+++.++|.-..
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFPdkd--------WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFPDKD--------WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCChhh--------hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 000 011122222222222111 12346788999999999999999999999999886543
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.80 Aligned_cols=276 Identities=23% Similarity=0.291 Sum_probs=208.0
Q ss_pred cHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec
Q 046892 68 TFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD 145 (519)
Q Consensus 68 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 145 (519)
...++....++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 445677788999999999999999999999988999999999875422 224567789999999999999999998864
Q ss_pred C------CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC
Q 046892 146 G------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD 219 (519)
Q Consensus 146 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~ 219 (519)
. ...+++++++ +++|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 3 3467888887 789988773 235899999999999999999999999 999999999999999999
Q ss_pred cEEeeecccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 220 PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 220 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
+||+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus 159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999998764322 223567899999998866 56889999999999999999999999654332211111000
Q ss_pred chhcc--CCCCCCcccchHh-h----------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 299 QPIFR--DPKRFPDMADPLL-R----------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 299 ~~~~~--~~~~~~~~~d~~l-~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..... ....+........ . .......+..+.+++.+||+.||.+||++.+++.+.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00000 0000000000000 0 0001123557889999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.87 Aligned_cols=268 Identities=23% Similarity=0.337 Sum_probs=201.9
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC-----
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD----- 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----- 147 (519)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+..|+.++..+.|+||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 35789999999999999999999988899999999865422 22345788999999999999999999986543
Q ss_pred -ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 148 -QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 148 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
..++|+||+. .+|..++ ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred ceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCC
Confidence 4689999995 4776654 235899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh----
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI---- 301 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~---- 301 (519)
++...... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 98764322 123467889999999876 46889999999999999999999999865432221111110000
Q ss_pred ----ccCC------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 302 ----FRDP------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 302 ----~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.... ...+......+...+ ......+.+|+.+||+.||.+||++.+++.+.++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000 000000000000001 1234578899999999999999999999998776443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=311.73 Aligned_cols=272 Identities=22% Similarity=0.300 Sum_probs=204.4
Q ss_pred ccCcc-cceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--------------hHHHHHHHHHHHhcCCCCeeeee
Q 046892 76 TKNFR-QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--------------NKEFLVEVLMLSLLHHPNLVNLI 140 (519)
Q Consensus 76 ~~~y~-~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~HpnIv~l~ 140 (519)
.++|. +.+.||.|+||+||+|.+..+++.||||.+....... ...+..|+.++..++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4578999999999999999889999999986543222 12467899999999999999999
Q ss_pred eEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 141 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
+++...+..++||||+. |+|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999996 689888843 456899999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCC------------ccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 046892 221 KLSDFGLAKLGPQGE------------KMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTR 287 (519)
Q Consensus 221 kL~DFGla~~~~~~~------------~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~ 287 (519)
+|+|||++....... .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997654110 01111223568899999998764 46899999999999999999999998665
Q ss_pred CcchhhHH-Hhhchhcc----CCCCCC------cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 288 PVDEQNLI-AWAQPIFR----DPKRFP------DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 288 ~~~~~~~~-~~~~~~~~----~~~~~~------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+....+ ........ ....++ ......+.. .....+..+.+++..||+.+|.+||++.+++.+.|+-
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 43222111 11100000 000000 000001111 1123356788999999999999999999999987764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.76 Aligned_cols=147 Identities=32% Similarity=0.448 Sum_probs=132.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+..|+.++..++|+||+++++++......|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999987543222 35678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
|||+.+++|.+++.. ...+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999843 345889999999999999999999999 9999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.51 Aligned_cols=203 Identities=31% Similarity=0.464 Sum_probs=177.1
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------ceEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------QRLL 151 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~~~l 151 (519)
|...+.||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++++|+|||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 556678999999999999999999999999987643 445677899999999999999999999865543 5689
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--CCCC--CcEEeeecc
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL--GANL--DPKLSDFGL 227 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl--~~~~--~vkL~DFGl 227 (519)
|||||.||+|...|....+ ...|++.+.+.++..++.||.|||+++ ||||||||.||++ .++| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999977543 446999999999999999999999999 9999999999998 3334 369999999
Q ss_pred cccCCCCCccceecccccccccCchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRP 288 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~-~~~~~~~sDvwSlGvll~elltG~~pf~~~~~ 288 (519)
|+...++. ....++||..|++||++. ...|+..+|.|||||++|+++||..||-....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99887665 356789999999999998 48899999999999999999999999976543
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.73 Aligned_cols=266 Identities=25% Similarity=0.347 Sum_probs=200.7
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhc---CCCCeeeeeeEEecCCc-----
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLL---HHPNLVNLIGYCADGDQ----- 148 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~----- 148 (519)
|++.+.||.|+||.||+|.+..+++.||+|.+....... ...+..|+.++..+ .|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 677889999999999999999889999999987543221 23456677766655 69999999999988776
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.+++|||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 58988885432 235899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhchhccC---
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL-IAWAQPIFRD--- 304 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~--- 304 (519)
........ .....++..|+|||++.+..++.++|||||||++|+|++|.+||......+.... ..........
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 77543321 1234578899999999988999999999999999999999999876443222111 1111000000
Q ss_pred ------CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 305 ------PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 305 ------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
...++....... ..........+.+++.+||+.||.+||++.+++.+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred CCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 000000000000 1112234567889999999999999999999998755
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.12 Aligned_cols=257 Identities=15% Similarity=0.150 Sum_probs=187.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCCcCh-----------HHHHHHHHHHHhcCCCCeeeeee
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGMQGN-----------KEFLVEVLMLSLLHHPNLVNLIG 141 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~HpnIv~l~~ 141 (519)
.++|.+.+.||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999999877 66778886443221111 01122334455678999999999
Q ss_pred EEecCC----ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 046892 142 YCADGD----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN 217 (519)
Q Consensus 142 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~ 217 (519)
++.... ..+++++++. .++.+.+.. ....++..++.|+.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 865543 3467788773 466666532 233578889999999999999999999 9999999999999999
Q ss_pred CCcEEeeecccccCCCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh
Q 046892 218 LDPKLSDFGLAKLGPQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292 (519)
Q Consensus 218 ~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~ 292 (519)
+.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999765322110 1122346999999999999999999999999999999999999999865322111
Q ss_pred -h--HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 293 -N--LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 293 -~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
. ...+...+.... ......+.++.+++..||+.+|.+||++.++++.+
T Consensus 243 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHEGK-------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhhhh-------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 011111111100 01123356899999999999999999999998765
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.20 Aligned_cols=272 Identities=22% Similarity=0.307 Sum_probs=203.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC---------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--------- 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--------- 146 (519)
..+|.+.+.||.|+||.||+|.+..++..||+|.+........+.+..|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999999999999999998766555667788999999999999999999876543
Q ss_pred -----CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCc
Q 046892 147 -----DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDP 220 (519)
Q Consensus 147 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~v 220 (519)
...++||||+. ++|.+++. ...+++..++.++.||++||.|||+.+ |+||||||+|||++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999996 58888773 245899999999999999999999999 99999999999997 45678
Q ss_pred EEeeecccccCCCCCc-cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 221 KLSDFGLAKLGPQGEK-MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 221 kL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
+|+|||++........ ........|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976432211 111123457889999998754 56788999999999999999999999765443222111110
Q ss_pred chhccC--CCCCCcccchHhh----------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 QPIFRD--PKRFPDMADPLLR----------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 ~~~~~~--~~~~~~~~d~~l~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.+.... ...+.......+. ..+......++.+++..||+.||.+|||+.+++.+.++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 000000 0000000000000 001123456788999999999999999999999987763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=296.86 Aligned_cols=280 Identities=22% Similarity=0.284 Sum_probs=210.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCC----eEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec-CC
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNG----QVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GD 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 147 (519)
....|+....||+|+||.||+|..+.+. +.+|+|.++.... .-.....+|+.+++.++|+||+.|..+|.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3467999999999999999999665432 3799999875422 223567899999999999999999999977 78
Q ss_pred ceEEEEEecCCCCHHHHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC----CCcEE
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNE-TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN----LDPKL 222 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~----~~vkL 222 (519)
.++|++||.+. +|+..|.-... ....++...++.|++||+.|+.|||++- |+||||||.||||..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999965 88888864332 2346899999999999999999999998 9999999999999877 89999
Q ss_pred eeecccccCCCCCcc-ceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------Ccchhh
Q 046892 223 SDFGLAKLGPQGEKM-NVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTR-------PVDEQN 293 (519)
Q Consensus 223 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~-------~~~~~~ 293 (519)
+|||+++.+...-.. .....++-|.+|.|||++.+ ..||.+.|||++|||+.||+|-.+.|.... |+....
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999987654322 23445677999999999887 579999999999999999999999986632 222222
Q ss_pred HHHhhc-------hhccCCCCCCcccch---HhhccCChh-----------hHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 294 LIAWAQ-------PIFRDPKRFPDMADP---LLRKQFPEK-----------GLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 294 ~~~~~~-------~~~~~~~~~~~~~d~---~l~~~~~~~-----------~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
+...+. ..+.+-..+++..+. .-+..+... -+....+|+..+|+.||-+|.|+.+.+++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222221 111111223332111 111111110 12237899999999999999999999999
Q ss_pred Hhhhhc
Q 046892 353 LSFLSN 358 (519)
Q Consensus 353 l~~~~~ 358 (519)
..|...
T Consensus 338 ~yF~~d 343 (438)
T KOG0666|consen 338 PYFTED 343 (438)
T ss_pred cccccC
Confidence 877654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.56 Aligned_cols=272 Identities=23% Similarity=0.313 Sum_probs=206.9
Q ss_pred HHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC--
Q 046892 72 LAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD-- 147 (519)
Q Consensus 72 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 147 (519)
+....++|.+.+.||+|+||.||+|.+..++..||||++...... ....+..|+.+++.++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344678899999999999999999999989999999998643221 2345788999999999999999999987654
Q ss_pred ----ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 148 ----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 148 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
..++||||+ +++|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 779988873 246899999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhc--
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL-IAWAQ-- 299 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~-~~~~~-- 299 (519)
|||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||........... .....
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999765332 223467899999999876 4588999999999999999999999976433211110 00000
Q ss_pred ------hhccCC-----CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 300 ------PIFRDP-----KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 300 ------~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+.... ..++......+. .+.......+.+++.+||+.||.+|||+.+++.+.++-..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000000 000001000110 1123345578899999999999999999999998776543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=300.55 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=203.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-----CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-----MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
+|.+.+.||+|+||.||++.+...+..+++|++.... ......+..|+.++..++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999998777777777665322 12234566789999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998765555677999999999999999999999999 999999999999975 569999999987654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .... ..... ..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~---~~~~~--~~---- 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVL---RIVEG--PT---- 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHH---HHHcC--CC----
Confidence 3221 223456889999999998888899999999999999999999998643221 1111 11110 00
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
...+...+..+.+++.+||+.+|++||++.+++++.|
T Consensus 223 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 223 -----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred -----CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 1123344568899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=351.24 Aligned_cols=263 Identities=30% Similarity=0.529 Sum_probs=208.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
...|....+||+|+||.||+|.+..++..||||.+...... ...|+..++.++|||||+++++|.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677788999999999999999888999999998643322 23468889999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++|+|.+++. .++|..+..|+.||+.||+|||.....+|+||||||+||+++.++..++. ||.+......
T Consensus 765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 99999999983 38999999999999999999995543449999999999999999888875 6665432211
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ...+..|........ ....+.++.
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 908 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDC-HLDMWIDPS 908 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCcc-chhheeCcc
Confidence 1236789999999999999999999999999999999999999643221 223444544332221 223334444
Q ss_pred hhc--cCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 316 LRK--QFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 316 l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+.. ..+.....++.+++.+||+.||.+||+|.+|++.|..+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 332 2334556678899999999999999999999999987654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.35 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=219.2
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCe---EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
...+.++||.|.||.|++|+++..|+ .||||.++.... ....+|+.|+.+|.++.||||++|.|+......+.||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45678999999999999999987764 799999976533 34567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||++|+|+.||... .+.+++.+...++.+|+.|+.||-+++ +|||||...||||+.+...|++||||++.+.+
T Consensus 710 EyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999653 355899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCccceeccccc--ccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVTSRVMG--TYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~~~~~G--t~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
+.. ...++..| ..+|.|||.+...++|.++|||||||+|||.++ |.+|+-.+.. ++++..+..
T Consensus 784 d~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIkaIe~---------- 849 (996)
T KOG0196|consen 784 DPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKAIEQ---------- 849 (996)
T ss_pred CCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHHHHHHh----------
Confidence 442 22222333 468999999999999999999999999999875 8898865543 333332221
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCC
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPI 363 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~ 363 (519)
..+-.-|.+++..+.+|++.||++|-.+||.+.+|+.+|..+...+..+
T Consensus 850 ----gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 850 ----GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred ----ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 2233346788889999999999999999999999999999876554444
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.95 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=203.2
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEEec
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
|.+.+.||.|+||.||+|....+++.||||.+..... .......+|+..+..+. |+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6778899999999999999988899999999865432 22234567889999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
+|+|.+++.... ...+++..++.++.||+.+|.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789998885432 346899999999999999999999999 99999999999999999999999999986543221
Q ss_pred cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhchhcc-----------
Q 046892 237 MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL-IAWAQPIFR----------- 303 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~-~~~~~~~~~----------- 303 (519)
.....|+..|+|||++.. ..++.++||||||+++|+|++|.+||......+.... .........
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 223567899999998754 4578999999999999999999999976543322211 111110000
Q ss_pred -CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 304 -DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 304 -~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
....++......+...++ .....+.+++.+||+.+|.+||++.+++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 000011111111111111 22567899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.86 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=195.4
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHHHHHh
Q 046892 89 GFGRVYKGTLQSNGQVVAVKQLDRN--GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLL 166 (519)
Q Consensus 89 ~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 166 (519)
++|.||.++...+++.||||++... .......+..|+.+++.++|+||+++++++.+.+..+++|||+.+++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4455666666668999999998764 23344678899999999999999999999999999999999999999999986
Q ss_pred hhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc-----cceec
Q 046892 167 DVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK-----MNVTS 241 (519)
Q Consensus 167 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~~~ 241 (519)
.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+........ .....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 53 2345889999999999999999999999 99999999999999999999999998864432111 11122
Q ss_pred ccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc----hhcc------CCCCCC
Q 046892 242 RVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ----PIFR------DPKRFP 309 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~----~~~~------~~~~~~ 309 (519)
...++..|+|||++.. ..++.++|||||||++|||++|..||........ ...... .... ......
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcC
Confidence 3457888999999875 3588999999999999999999999976432211 111000 0000 000000
Q ss_pred c----ccch----HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 310 D----MADP----LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 310 ~----~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. ..+. .....+......++.+|+..||+.||++|||+.+++++.++-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 0 0000 011122334456889999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.36 Aligned_cols=267 Identities=26% Similarity=0.355 Sum_probs=206.1
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
|+..+.||.|+||.||+|....+++.||+|++.... ......+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999999999999999987653 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
. ++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999986432 46899999999999999999999999 99999999999999999999999999876543221
Q ss_pred cceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhc-----------hhcc
Q 046892 237 MNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL-IAWAQ-----------PIFR 303 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~-~~~~~-----------~~~~ 303 (519)
......++..|+|||.+.+. .++.++|||||||++|||++|..||......+.... ..... ....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12234567889999998766 789999999999999999999999976543222111 11000 0000
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....++..........++ .....+.+++..||+.||.+||++.+++.+.|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 001111111111111121 225679999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.11 Aligned_cols=253 Identities=30% Similarity=0.396 Sum_probs=202.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..|...+.||+|+||.||+|.+..++..||+|.+..... .....+..|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347778899999999999999998899999999864322 22345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+. |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||+|+|||++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 688777643 2345899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
. ....|++.|+|||++. ...++.++|||||||++|+|++|..||.......... .+.. . ..+.
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~----~--~~~~ 233 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ----N--ESPA 233 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhh----c--CCCC
Confidence 2 2346889999999874 3567889999999999999999999986543221111 1110 0 0000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
......+..+.+|+.+||+.+|.+||++.+++.+.++...
T Consensus 234 --------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 234 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred --------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0112344578899999999999999999999999877654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.56 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=203.2
Q ss_pred CcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCce
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGM----QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 149 (519)
+|++.+.||.|+||.||+|... .+|..||+|++..... ...+.+..|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999874 3689999999875322 2235677899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999853 346889999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCccceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||......... ...........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~-- 228 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE-- 228 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhccC--
Confidence 6543221 11224568999999999865 34678999999999999999999999753322111 11111111111
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLS 357 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~ 357 (519)
..++......+.+++.+||+.||.+|| ++.+++.+.++-.
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 112333455788999999999999997 7888888776543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=303.44 Aligned_cols=249 Identities=31% Similarity=0.427 Sum_probs=200.1
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
|...+.||+|+||.||+|.+..++..||+|++...... ....+..|+.+++.++|+||+++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999999989999999998754332 224577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 577777643 2356899999999999999999999999 99999999999999999999999999864322
Q ss_pred ccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 236 KMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||.............. . ..+..
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~------~--~~~~~- 240 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------N--DSPTL- 240 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------c--CCCCC-
Confidence 22356899999999974 46688999999999999999999999876543222211110 0 00000
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.....+..+.+|+.+||+.+|.+||++.+++.+.++-
T Consensus 241 -------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~ 277 (313)
T cd06633 241 -------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277 (313)
T ss_pred -------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 1112234688999999999999999999999887654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.96 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=200.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|.+.+.||.|+||.||+|.+..+++.||||.+..... .....+..|+.++.... |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678899999999999999999998899999999875432 23345666777666664 999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||+. ++|.+++... ...+++..+..++.||+.||+|||+ .+ |+||||+|+||+++.++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9984 5777776442 3478999999999999999999997 47 9999999999999999999999999987654
Q ss_pred CCCccceecccccccccCchhhhccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGE----LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
.... .....|+..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ...+..... .....+
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~---~~~~~~ 239 (296)
T cd06618 167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQ---EEPPSL 239 (296)
T ss_pred CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhc---CCCCCC
Confidence 3221 12235788999999987543 788999999999999999999999653211 111111111 000011
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+. ......++.+|+.+||+.||.+||++.+++.+.++..
T Consensus 240 ~~----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 240 PP----------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred CC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 10 0123457899999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=314.54 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=211.8
Q ss_pred CcccceeeeccCcEEEEEEEEcCC----CeEEEEEEeccC-CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSN----GQVVAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.....++||.|-||.||+|.+..- .-.||||..+.+ .....+.|+.|..+|+.+.|||||+|+|+|.+ ...|||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 344567899999999999987542 336999998773 45567889999999999999999999999975 578999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||+++-|.|..||+. ....|+......++.||+.||+|||+.. +|||||...||||.....|||+||||++...
T Consensus 469 mEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999999999999965 3456889999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELI-TGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
........ ...-...|||||.++-..++.++|||-|||.+||++ .|..||.+....|-...+
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i---------------- 605 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI---------------- 605 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----------------
Confidence 65543322 233467899999999999999999999999999987 488999876543322111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...-+...|+.++..+..|+.+||..+|.+||.+.++...|..+.
T Consensus 606 -EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 606 -ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred -cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 112234568888999999999999999999999999988776543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.99 Aligned_cols=269 Identities=22% Similarity=0.336 Sum_probs=205.5
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc---
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 148 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 148 (519)
...++|.+...||.|+||.||+|.+..++..||||++.... ......+..|+.+++.+.|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999999899999999986532 2233557789999999999999999998876654
Q ss_pred ---eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 149 ---RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 149 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 6799988842 46899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhch---
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQP--- 300 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~--- 300 (519)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+ .....
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 999865432 223467889999998865 36789999999999999999999999765432211111 10000
Q ss_pred -----hccCC-----CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 301 -----IFRDP-----KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 301 -----~~~~~-----~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..... ..++......+.. .....+..+.+++.+||+.+|.+|||+.+|+.+.++-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 00000 0000000000000 01123568999999999999999999999999877654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=312.69 Aligned_cols=282 Identities=22% Similarity=0.256 Sum_probs=214.9
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
|..++.||-|+||.|.+++..++...||+|.+++...- ....+..|..||.....+-||+||..|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 67788999999999999999999999999999765432 234467799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC--
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ-- 233 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~-- 233 (519)
++||++..+|.. .+.+.+..++.++.+|..|+++.|..| +|||||||+|||||.+|++||+||||++-+..
T Consensus 711 IPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999955 456899999999999999999999999 99999999999999999999999999963211
Q ss_pred -------CCcc-------------------------------ceecccccccccCchhhhccCCCCchhHHHHHHHHHHH
Q 046892 234 -------GEKM-------------------------------NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLE 275 (519)
Q Consensus 234 -------~~~~-------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~e 275 (519)
+... ......+||+.|+|||+|....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1100 00123689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCcch-hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 046892 276 LITGRRVIDTTRPVDE-QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL---MSDVVT 351 (519)
Q Consensus 276 lltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 351 (519)
|+.|+.||....+... ..++.|-. +++ -.+....+.++.++|.+++ .+++.|.. +.+|-.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~-----------~l~----~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKa 927 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRN-----------FLH----IPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKA 927 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhh-----------ccc----cccccccCHHHHHHHHHHh-cChhhhhcccchhhhhc
Confidence 9999999987666543 33333322 111 1223344556666666532 35666642 334555
Q ss_pred HHhhhhcC----CCCCCCCCCCCCCCCcCCCccCCCC
Q 046892 352 ALSFLSNS----KEPIPDPIIPSDEDEYSEGYSSDGH 384 (519)
Q Consensus 352 ~l~~~~~~----~~~~~~p~~p~~~~~~~~~~~~~~~ 384 (519)
|.+| +.. ......|..|......+.++|+.-.
T Consensus 928 HpfF-kgIDfsslRkq~ApYIP~ItHptDTSNFdpvd 963 (1034)
T KOG0608|consen 928 HPFF-KGIDFSSLRKQRAPYIPRITHPTDTSNFDPVD 963 (1034)
T ss_pred Cccc-cccchHhhhhccCCcCccccCCCccccCCcCC
Confidence 5443 322 2334455667666666666666533
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.62 Aligned_cols=270 Identities=24% Similarity=0.273 Sum_probs=199.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCC--CeEEEEEEeccCCC--cChHHHHHHHHHHHhc-CCCCeeeeeeEEec----CCc
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSN--GQVVAVKQLDRNGM--QGNKEFLVEVLMLSLL-HHPNLVNLIGYCAD----GDQ 148 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~~~ 148 (519)
+|.+.+.||+|+||.||++.+..+ +..||+|.+..... .....+..|+.++..+ .||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478889999999999999999887 88999999864321 2245678899999988 59999999997543 245
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.+++++|+. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788889885 68888873 3456899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc--ceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc---
Q 046892 229 KLGPQGEKM--NVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF--- 302 (519)
Q Consensus 229 ~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~--- 302 (519)
......... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 765432211 11233578999999998765 468999999999999999999999997654321111100000000
Q ss_pred -----cCCC------CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 -----RDPK------RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 -----~~~~------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.... .+.......+.. ........+.+++.+||+.||.+|||+.+++.+.|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 0000 000000000000 1112346789999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=306.89 Aligned_cols=271 Identities=24% Similarity=0.303 Sum_probs=205.3
Q ss_pred HHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEec-CCc
Q 046892 72 LAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GDQ 148 (519)
Q Consensus 72 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 148 (519)
+..++++|.+.+.||.|+||.||+|.+..+++.||||++.... ......+..|+.++..++||||++++++|.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999999999999999886432 2234567889999999999999999999865 567
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++|+||+ +++|..++. ...+++..+..++.||++||.|||+.+ |+|+||+|+|||++.++.++|+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999999 568888773 245788899999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhhchh----c
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQPI----F 302 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~~----~ 302 (519)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ...... .
T Consensus 156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 754321 123467889999998765 56899999999999999999999999765432111111 110000 0
Q ss_pred ---cCCCCCCcccchHhhcc-----CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 ---RDPKRFPDMADPLLRKQ-----FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 ---~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
........+..-..... .....+..+.+++.+||+.+|.+||++.+++.+.++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 00000000000000000 1122456889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.34 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=193.6
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG----- 146 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 146 (519)
.+...+|+.+.+||+||||.||+++++-+|+.||||++.... ......+.+|+.+|..|+|||||++|..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456778999999999999999999999999999999997654 22234578899999999999999987432100
Q ss_pred --------------------------------------------------------------------------------
Q 046892 147 -------------------------------------------------------------------------------- 146 (519)
Q Consensus 147 -------------------------------------------------------------------------------- 146 (519)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHH
Q 046892 147 ----------------------------------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192 (519)
Q Consensus 147 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 192 (519)
-.+||-||||+..+|.+++....... ....+|.++.+|++||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence 11478899998877777774422111 46788999999999999
Q ss_pred HHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC----------------CCCccceecccccccccCchhhhc
Q 046892 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP----------------QGEKMNVTSRVMGTYGYCAPEYAR 256 (519)
Q Consensus 193 ~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~Gt~~y~APE~l~ 256 (519)
|+|++| ||||||||.|||++++..|||+|||+|+... .+......+..+||.-|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999999 9999999999999999999999999998611 011111234578999999999997
Q ss_pred cC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHH
Q 046892 257 SG---ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAA 333 (519)
Q Consensus 257 ~~---~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~ 333 (519)
+. .|+.|+|+|||||||+||+. ||.+... ....+ ..+. ...++.- ..|.......-..+|.
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL---~~LR--~g~iP~~------~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASIL---TNLR--KGSIPEP------ADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHH---Hhcc--cCCCCCC------cccccccchHHHHHHH
Confidence 65 49999999999999999986 4655321 11111 1111 1122211 1122222335678999
Q ss_pred HhhhhCCCCCCCHHHHHHH
Q 046892 334 MCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 334 ~cl~~dP~~RPs~~evl~~ 352 (519)
+||+.||.+|||+.+++..
T Consensus 853 ~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHhcCCCccCCCHHHHhhc
Confidence 9999999999999999864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=292.78 Aligned_cols=244 Identities=32% Similarity=0.419 Sum_probs=200.7
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
||.|+||.||++.+..+++.||+|++...... ....+..|+.+++.++|+||+++++.+..+...++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999998765332 334678899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceec
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 241 (519)
.+++.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999843 346899999999999999999999999 9999999999999999999999999997654332 1233
Q ss_pred ccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 242 ~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
...|+..|+|||.+.+...+.++|+||||+++|+|++|..||..... ...... +..... .++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~---~~~~~~------------~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEK---ILKDPL------------RFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHH---HhcCCC------------CCC
Confidence 45688999999999888889999999999999999999999975432 111111 111111 123
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCCH---HHHHHHHhh
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARPLM---SDVVTALSF 355 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~l~~ 355 (519)
...+..+.+++.+||..||++||++ .+++.+.+|
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 3335678899999999999999999 777776543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=307.37 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=206.6
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 159 (519)
.++||.|.||+||-|.++.+|+.||||++.+.. ......+.+|+.+|+.+.||.||.+.-.|+..+.+++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 478999999999999999999999999997643 3445678999999999999999999999999999999999995 5
Q ss_pred CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CCcEEeeecccccCCCCCc
Q 046892 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN---LDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 160 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~---~~vkL~DFGla~~~~~~~~ 236 (519)
+..+.|.. ...+.|++.....++.||+.||.|||.++ |+|+||||+|||+... ..+||||||+|++.+...
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 65555544 34577999999999999999999999999 9999999999999543 469999999999886643
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
....++|||.|+|||++....|+..-|+||+|||+|.-+.|..||+...+. .+.++.+...+...
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~----------- 786 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPN----------- 786 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCC-----------
Confidence 344689999999999999999999999999999999999999999864332 22222221111100
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
--.+++.++++||..+|+..-.+|-+...-+.|.|.
T Consensus 787 ---PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 787 ---PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred ---chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 012455689999999999999999999999888773
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.84 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=197.2
Q ss_pred CcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCce
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGM----QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 149 (519)
+|.+.+.||+|+||.||++.+. .++..||||.+..... .....+..|+.++..+ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788899999999999999864 3578999999865321 2335577899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||+|.||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998843 346889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCccceecccccccccCchhhhccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGE--LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
........ ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||.......... ...........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~- 229 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISRRILKSKP- 229 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHHHHHccCC-
Confidence 65433211 122356899999999987654 7889999999999999999999986432221111 11111111111
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
..+......+.+++.+||+.||++|||+.++.+.
T Consensus 230 -----------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 230 -----------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEI 263 (288)
T ss_pred -----------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHH
Confidence 1222334577899999999999999997655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.02 Aligned_cols=268 Identities=24% Similarity=0.279 Sum_probs=208.5
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.|...+.||+|+||+||+|++..+++.||+|.++..... -....++|+.+|+.+.|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999999999999999998765332 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
|. .+|..+... -++.++.+.++.++.|++.||.|+|+++ +.||||||.|+||+.+|.+||+|||+++.++-.
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 94 588887743 4567999999999999999999999999 999999999999999999999999999876543
Q ss_pred ccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcc--
Q 046892 236 KMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM-- 311 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 311 (519)
.......+-|.+|.+|.++.+ .-|+...|+||.||++.|+.. |++.|.+.+-.++...+-+......+. .++.+
T Consensus 155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed-~wps~t~ 232 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED-QWPSMTK 232 (292)
T ss_pred -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc-cCCcccc
Confidence 223344566999999999876 468999999999999999986 566666655444444443332222111 11111
Q ss_pred -cchHhhc---------cCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 -ADPLLRK---------QFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 -~d~~l~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.|-..-. ++-+.....-.+++..+|.-+|..|.++...+++..|
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 1111111 1122333445688899999999999999999988755
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=298.61 Aligned_cols=270 Identities=29% Similarity=0.410 Sum_probs=205.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHH--hcCCCCeeeeeeEEecCC----ceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLS--LLHHPNLVNLIGYCADGD----QRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~--~l~HpnIv~l~~~~~~~~----~~~ 150 (519)
...+..++||+|.||.||+|.+. ++.||||++... ..+.|..|..+.+ .+.|+||++++++-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34566778999999999999987 699999998643 4567888888776 467999999999876555 889
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA------NPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
||++|.+.|+|.++|.. ..++|....+|+.-++.||+|||+.- .++|+|||||..||||..+++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999944 56999999999999999999999753 46799999999999999999999999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhccC-CCC-----chhHHHHHHHHHHHHHhCCCCCCC--CCCcchhhH--
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELT-----VKSDVYSFGVILLELITGRRVIDT--TRPVDEQNL-- 294 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~-----~~sDvwSlGvll~elltG~~pf~~--~~~~~~~~~-- 294 (519)
||||..+..+.........+||.+|||||+|.+. .+. ...||||+|.|||||++...-++. ..+......
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 9999988877665556668999999999999753 122 358999999999999997665532 111110000
Q ss_pred ------HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 295 ------IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 295 ------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
+...+......+.-|.+.+..... ....-+.+.+..||..||+.|.|+.=|.+.++.+....
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 011111111111222222222221 23456789999999999999999999999888776544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.62 Aligned_cols=245 Identities=27% Similarity=0.342 Sum_probs=202.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHH-hcCCCCeeeeeeEEecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++.|.....+|.|+|+.|-.+.+..+++..++|++.+... +..+|+.++. .-+||||+++++++.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 35678888899999999999999999999999999976622 2334564443 457999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-CCCCCcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL-GANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl-~~~~~vkL~DFGla~~~~ 232 (519)
|++.|+-|.+.+.. .+.....+..|+.+|+.|+.|||++| ||||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988887743 22333778889999999999999999 9999999999999 689999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.. ..+.+-|..|.|||++....|++++||||||++||+||+|+.||...... ..+..
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~---------------- 524 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT---------------- 524 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----------------
Confidence 43 22345689999999999999999999999999999999999999865332 11111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
......+...++..+.+|+.+||+.||.+||+|.++..+.|+
T Consensus 525 -~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 525 -RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111123346677899999999999999999999999999887
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=290.39 Aligned_cols=228 Identities=25% Similarity=0.264 Sum_probs=183.9
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHHHHHhh
Q 046892 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD 167 (519)
Q Consensus 88 G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 167 (519)
|.||.||++.+..+++.||+|.+.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999987542 233455555556799999999999999999999999999999999854
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceeccccccc
Q 046892 168 VNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247 (519)
Q Consensus 168 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~ 247 (519)
...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 235899999999999999999999999 999999999999999999999999987654332 12234677
Q ss_pred ccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHH
Q 046892 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNE 327 (519)
Q Consensus 248 ~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 327 (519)
.|+|||.+.+..++.++||||||+++|||++|..|+....... . . .....++...+..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~-------~----------~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----N-------T----------HTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----c-------c----------ccccCCcccCCHH
Confidence 8999999988889999999999999999999998765321100 0 0 0001123334557
Q ss_pred HHHHHHHhhhhCCCCCCCH-----HHHHHHHh
Q 046892 328 AVAIAAMCLQEEAGARPLM-----SDVVTALS 354 (519)
Q Consensus 328 l~~li~~cl~~dP~~RPs~-----~evl~~l~ 354 (519)
+.+++.+||+.||.+||++ .+++.|.|
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence 8899999999999999996 66666544
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.12 Aligned_cols=261 Identities=29% Similarity=0.431 Sum_probs=216.0
Q ss_pred HHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEec----
Q 046892 71 ELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCAD---- 145 (519)
Q Consensus 71 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---- 145 (519)
.+..-++-|++..+||.|.+|.||+++...+++.+|+|+..... ...+++..|..+|+.+ .|||++.+||+|..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 33445677999999999999999999999999999999987653 4456788888888876 59999999999853
Q ss_pred -CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 146 -GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 146 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
++.+|||||||.+|++.|++.... +..+.|..+..|+..++.||.+||... ++|||||-.|||++.++.|||+|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 678999999999999999997765 678999999999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~ 299 (519)
||++..+.... ....+..|||.|||||++.- ..|+..+|+||||++..||.-|.+|+....+.-.. +
T Consensus 167 FGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-----F- 238 (953)
T KOG0587|consen 167 FGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F- 238 (953)
T ss_pred eeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----c-
Confidence 99998665433 23456789999999999853 35778899999999999999999998766543221 1
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.+.+.+ ...-.-+.....++.++|..||.+|-..||++.++++|..
T Consensus 239 ~IpRNP---------PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 239 LIPRNP---------PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred cCCCCC---------CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 111111 1111235667789999999999999999999999998754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=297.04 Aligned_cols=273 Identities=23% Similarity=0.334 Sum_probs=212.0
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--C----CeeeeeeEEecC
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH--P----NLVNLIGYCADG 146 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--p----nIv~l~~~~~~~ 146 (519)
...+.+|.+...||+|+||.|..+.+..++..||||+++.-. ...+..+.|+.+|..+.+ | -+|++.+||.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 344789999999999999999999999999999999986432 334567789999998842 2 288999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-----------
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG----------- 215 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~----------- 215 (519)
++.+||+|.+ |-++.++|.. +...+++...++.|+.||+++++|||+.+ ++|.||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence 9999999999 6799999955 34457899999999999999999999999 99999999999993
Q ss_pred ---------CCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 046892 216 ---------ANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTT 286 (519)
Q Consensus 216 ---------~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~ 286 (519)
.+..|+|+|||.|+...... ..++.|..|.|||++.+-+++..+||||+||||+||.||...|.+.
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 13458999999998754433 4467799999999999999999999999999999999999999887
Q ss_pred CCcchhhHHHhh-ch-------------hccCC-CCCCcc------------cchHh-hccCChhhHHHHHHHHHHhhhh
Q 046892 287 RPVDEQNLIAWA-QP-------------IFRDP-KRFPDM------------ADPLL-RKQFPEKGLNEAVAIAAMCLQE 338 (519)
Q Consensus 287 ~~~~~~~~~~~~-~~-------------~~~~~-~~~~~~------------~d~~l-~~~~~~~~~~~l~~li~~cl~~ 338 (519)
.......+.+.+ .+ .+... ..+++. ..+.- ...-.+.+..++++|+..||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 654433222211 00 00000 000000 00000 0011344556899999999999
Q ss_pred CCCCCCCHHHHHHHHhhhh
Q 046892 339 EAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 339 dP~~RPs~~evl~~l~~~~ 357 (519)
||.+|+|+.|++.|.+|-.
T Consensus 393 DP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFAR 411 (415)
T ss_pred CccccccHHHHhcCHHhhc
Confidence 9999999999999987643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=297.72 Aligned_cols=261 Identities=31% Similarity=0.400 Sum_probs=207.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-------hHHHHHHHHHHHhcCCCCeeeeeeEEe-cCCc
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-------NKEFLVEVLMLSLLHHPNLVNLIGYCA-DGDQ 148 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 148 (519)
++|-.+.+||+|||+.||+|.+....+.||||+-..+..+. .+...+|..+.+.|.||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 46888899999999999999999889999999865442221 234678999999999999999999985 5567
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCCcEEeee
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG---ANLDPKLSDF 225 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~---~~~~vkL~DF 225 (519)
+|-|+|||+|.+|.-||. ....+++.+++.|+.||+.||.||.... +||||-||||.||||. .-|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 889999999999999884 4567899999999999999999999985 6799999999999994 4578999999
Q ss_pred cccccCCCCC-----ccceecccccccccCchhhhcc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 046892 226 GLAKLGPQGE-----KMNVTSRVMGTYGYCAPEYARS----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296 (519)
Q Consensus 226 Gla~~~~~~~-----~~~~~~~~~Gt~~y~APE~l~~----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~ 296 (519)
||++++.... .+..+....||.+|++||.+.- ...+.++||||+|||+|.++.|+.||.... ...+++.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--sQQdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--SQQDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--hHHHHHh
Confidence 9999876543 2344566889999999997753 357889999999999999999999998642 2233332
Q ss_pred hhchhccCCCCCCcccchHhhccCC--hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 297 WAQPIFRDPKRFPDMADPLLRKQFP--EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 297 ~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...-+-.. .-.|| +.++.++.++|.+||+..-++|....++..+..++
T Consensus 696 eNTIlkAt------------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 696 ENTILKAT------------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred hhchhcce------------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 22111000 11222 24567899999999999999999988887765544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=280.81 Aligned_cols=261 Identities=26% Similarity=0.349 Sum_probs=199.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHH-HhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLML-SLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+.+-+..||.|+||+|++-.++.+|+..|||+++.... .+.++++.|.... +.-+.||||++||.+..++..|+.||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 44455689999999999999999999999999987654 4456677787654 455789999999999999999999999
Q ss_pred cCCCCHHHHHhh-hccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLD-VNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|. .+|..+... +......+++..+-.|....+.||.||...-. ||||||||+||||+..|.+||||||++..+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 566544322 12234568999999999999999999988655 999999999999999999999999998754332
Q ss_pred CccceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
...+.-+|...|||||.+.. ..|+-++||||||++|||+.||..|+..++..-+ +..+-...++ +.+.
T Consensus 222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe----ql~~Vv~gdp---p~l~ 291 (361)
T KOG1006|consen 222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE----QLCQVVIGDP---PILL 291 (361)
T ss_pred ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH----HHHHHHcCCC---Ceec
Confidence 12334578999999998853 4589999999999999999999999987754211 1111111221 1111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
. ..-....+..+..+|..||.+|-..||.+.++.++...
T Consensus 292 ~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 292 F----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred C----cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 1 01112345688999999999999999999999877543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.73 Aligned_cols=257 Identities=29% Similarity=0.434 Sum_probs=213.1
Q ss_pred cccceeeeccCcEEEEEEEEcCCCe----EEEEEEeccC-CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
....++||.|+||+||+|.+-..|+ +||+|++... ......+++.|+.+|..+.||||++|+++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3456799999999999999865554 7899988654 3445678999999999999999999999998765 88999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
+|++.|+|.+++.. .+..+-....+.|..||++||.|||.+. +|||||-..||||.....+||+|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999976 4456888999999999999999999999 99999999999999999999999999998876
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
...........-.+.|||-|.+....|+.++|||||||++|||+| |..|++.....+-.+++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------- 913 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------- 913 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-----------------
Confidence 654433333334678999999999999999999999999999997 88888765432222222
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+-..|+.+..++..++.+||-.|+..||+++++...+..+...
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 12223345777888999999999999999999999999887765543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=283.99 Aligned_cols=264 Identities=26% Similarity=0.362 Sum_probs=201.9
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHH--hcCCCCeeeeeeEEecC----Cc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLS--LLHHPNLVNLIGYCADG----DQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~--~l~HpnIv~l~~~~~~~----~~ 148 (519)
..++..+.+.||+|.||.||+|.+. |..||||++.. .++..+.+|.++.+ .|+|+||+.+++.=..+ ..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3467788899999999999999998 99999999863 34566777877776 46999999999874333 35
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-----KANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-----~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
+|||++|.+.|+|.|||.. ..++....++++.-++.||+|||. +|.+.|.|||||..||||..++...|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 7999999999999999943 579999999999999999999995 567789999999999999999999999
Q ss_pred eecccccCCCCC--ccceecccccccccCchhhhccCC----C-C-chhHHHHHHHHHHHHHhC----------CCCCCC
Q 046892 224 DFGLAKLGPQGE--KMNVTSRVMGTYGYCAPEYARSGE----L-T-VKSDVYSFGVILLELITG----------RRVIDT 285 (519)
Q Consensus 224 DFGla~~~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~----~-~-~~sDvwSlGvll~elltG----------~~pf~~ 285 (519)
|+|||....... -....+..+||.+|||||+|.... + + ..+||||||+|+||++.. +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999997654432 112234578999999999986432 1 1 249999999999999763 356655
Q ss_pred CCCcchhhHHHhhchhccCCCCCCcccchHhhcc-----CChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 286 TRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ-----FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.-+.|...--. .. .+....++.. ...++...+.+|+..||..||.-|.|+-.+-+.|..+.+.
T Consensus 439 ~Vp~DPs~eeM--rk---------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 439 VVPSDPSFEEM--RK---------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCCCHHHH--hc---------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 43332211000 00 0111122222 2345667899999999999999999999999988877653
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=275.08 Aligned_cols=274 Identities=25% Similarity=0.365 Sum_probs=205.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEec--------C
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--------G 146 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------~ 146 (519)
..|+....||+|.||.||+|+.+.+|+.||+|++-... ..-....++|+.+|..+.|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 35667788999999999999999999999999764422 2233567899999999999999999988743 2
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
..+||||.+|+. +|.-+|.+ ....++..++..++.++.+||.|+|... |+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999964 88887733 3457899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcc--ceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chh-
Q 046892 227 LAKLGPQGEKM--NVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPI- 301 (519)
Q Consensus 227 la~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~- 301 (519)
+++.+...... ...+..+-|.+|.+||.+.+ ..|+++.|||+.||++.||.||.+.+.+........++... ..+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99765433211 11223455999999998876 57999999999999999999999998876555444444322 111
Q ss_pred ---ccCCCCCCccc----chHhhccC--------ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 ---FRDPKRFPDMA----DPLLRKQF--------PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 ---~~~~~~~~~~~----d~~l~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+.+-..++-+. .+.-.+.+ +-.-.+++.+|+..+|..||.+|+.+.+++.|.+|..
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 11111111000 00000000 1111247889999999999999999999999987764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=309.92 Aligned_cols=268 Identities=20% Similarity=0.238 Sum_probs=176.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCC----CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeE------Ee
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSN----GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY------CA 144 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~------~~ 144 (519)
..++|.+.+.||+|+||.||+|++..+ +..||||++..... .+.+..+ .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999988 89999998754321 1112222 1122222223222221 24
Q ss_pred cCCceEEEEEecCCCCHHHHHhhhccC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046892 145 DGDQRLLVYEFMSGGSVDDHLLDVNET----------------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208 (519)
Q Consensus 145 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDik 208 (519)
.+...+|||||+.+++|.+++...... ........+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567889999999999999988542110 011123456689999999999999999 9999999
Q ss_pred CCCeeeCC-CCCcEEeeecccccCCCCCccceecccccccccCchhhhccC----------------------CCCchhH
Q 046892 209 SSNILLGA-NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG----------------------ELTVKSD 265 (519)
Q Consensus 209 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~----------------------~~~~~sD 265 (519)
|+|||++. ++.+||+|||+++....... .......|++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 68899999999986543321 123456789999999976432 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCcc-------hhhHHHhhchhccCCCCCCcccchHhhccC--ChhhHHHHHHHHHHhh
Q 046892 266 VYSFGVILLELITGRRVIDTTRPVD-------EQNLIAWAQPIFRDPKRFPDMADPLLRKQF--PEKGLNEAVAIAAMCL 336 (519)
Q Consensus 266 vwSlGvll~elltG~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl 336 (519)
||||||+||||+++..+++...... ......|...... .....+...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-------RASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-------ccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999765543210000 0000111110000 0000000000 1112234568999999
Q ss_pred hhCCCCCCCHHHHHHHHhhhh
Q 046892 337 QEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 337 ~~dP~~RPs~~evl~~l~~~~ 357 (519)
+.||.+|||+.++++|.++..
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCC
Confidence 999999999999999977644
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=269.65 Aligned_cols=242 Identities=31% Similarity=0.408 Sum_probs=197.1
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHHHHHhh
Q 046892 89 GFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD 167 (519)
Q Consensus 89 ~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 167 (519)
+||.||+|.+..+++.||+|++....... ...+..|+..++.++|+||+++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997665444 67889999999999999999999999999999999999999999999854
Q ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceeccccccc
Q 046892 168 VNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247 (519)
Q Consensus 168 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~ 247 (519)
. ..+++..++.++.+++.+|.|||+.+ |+|+||+|.||+++.++.++|+|||++....... ......|+.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 23899999999999999999999999 9999999999999999999999999998765432 223456889
Q ss_pred ccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHH
Q 046892 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNE 327 (519)
Q Consensus 248 ~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 327 (519)
.|++||.+.+..++.++|||+||+++|+|++|..||..... .......... ...... .........
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~---~~~~~~---------~~~~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGK---PKPPFP---------PPEWKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhc---cCCCCc---------cccccCCHH
Confidence 99999999888899999999999999999999999876321 1112221111 000000 000003457
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 328 AVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 328 l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+.+++.+||..+|++||++.+++++.+
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQHPF 243 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhCCC
Confidence 889999999999999999999998643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=280.44 Aligned_cols=269 Identities=20% Similarity=0.284 Sum_probs=203.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----C---CCeeeeeeEEec---
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-----H---PNLVNLIGYCAD--- 145 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~~~~~~--- 145 (519)
.+|.+.+.||+|-|++||+|.+.++.+.||+|+++.. ....+..+.||.+|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6899999999999999999999999999999998643 334466788999999874 3 369999999964
Q ss_pred -CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-------
Q 046892 146 -GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN------- 217 (519)
Q Consensus 146 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~------- 217 (519)
+.+++||+|++ |.+|..+|... ..+.++...++.|+.||+.||.|||..++ |||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhh
Confidence 56899999999 77899998764 34568999999999999999999999885 9999999999999200
Q ss_pred --------------------------------------------------------------------------------
Q 046892 218 -------------------------------------------------------------------------------- 217 (519)
Q Consensus 218 -------------------------------------------------------------------------------- 217 (519)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 046892 218 -------------------------------------------------------------------------------L 218 (519)
Q Consensus 218 -------------------------------------------------------------------------------~ 218 (519)
.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc----chhhH
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV----DEQNL 294 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~----~~~~~ 294 (519)
.+||+|||-|+...... +.-.-|..|.|||++.+..|++.+||||++|++|||+||...|+..... |.+.+
T Consensus 392 ~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 13555555555432211 1223477899999999999999999999999999999999999875432 22222
Q ss_pred ---HHhhc----hhccCC----------CCCCcc-------cchHhhc--cCChhhHHHHHHHHHHhhhhCCCCCCCHHH
Q 046892 295 ---IAWAQ----PIFRDP----------KRFPDM-------ADPLLRK--QFPEKGLNEAVAIAAMCLQEEAGARPLMSD 348 (519)
Q Consensus 295 ---~~~~~----~~~~~~----------~~~~~~-------~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 348 (519)
++... .+...+ +.+..+ +...|.. .++.+...++.+++.-||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 11111 111111 111111 1223333 357788899999999999999999999999
Q ss_pred HHHHHhhh
Q 046892 349 VVTALSFL 356 (519)
Q Consensus 349 vl~~l~~~ 356 (519)
.++|+|.-
T Consensus 547 cl~hPwLn 554 (590)
T KOG1290|consen 547 CLKHPWLN 554 (590)
T ss_pred HhcCcccc
Confidence 99998753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.28 Aligned_cols=260 Identities=30% Similarity=0.447 Sum_probs=206.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcC-------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCC
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQS-------NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGD 147 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 147 (519)
++..+.+.||.|.||.|++|.... ....||||.+..... ...+.+..|+.+|+.+ .|+||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 344566699999999999997531 145799999876543 3456789999999887 5999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhc---cC-------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVN---ET-------K--KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG 215 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~ 215 (519)
.+++|+||+..|+|.++|.... .- . ..++....+.++.||+.|++||++.. +|||||...|||+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLIT 452 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEec
Confidence 9999999999999999997654 00 0 23889999999999999999999999 99999999999999
Q ss_pred CCCCcEEeeecccccCCCCCccceeccccc--ccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 046892 216 ANLDPKLSDFGLAKLGPQGEKMNVTSRVMG--TYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQ 292 (519)
Q Consensus 216 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--t~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~ 292 (519)
.+..+||+|||+++............ -.| ...|||||.+....|+.++|||||||+||||++ |..|+...... .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~ 529 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--E 529 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--H
Confidence 99999999999999655443332221 122 345999999999999999999999999999998 56777653211 1
Q ss_pred hHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
++..+. ....+...|..+..++.+|+..||+.+|.+||++.++++.+...
T Consensus 530 ~l~~~l--------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ELLEFL--------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHH--------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 112211 11223345677788999999999999999999999999988763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=256.96 Aligned_cols=206 Identities=27% Similarity=0.354 Sum_probs=175.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHH-hcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++......||+|+||.|-+.++..+|+..|+|.+...- .+..+..+.|+.+.. ...+|.+|.+||.+......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 455666678999999999999999999999999987542 234456777877654 456999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|.| ..+|..+-......++.+++..+-+|+.-++.||.|||++-. |||||+||+|||++.+|.|||||||++..+.+
T Consensus 125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999 568998888888888999999999999999999999999865 99999999999999999999999999987644
Q ss_pred CCccceecccccccccCchhhhcc----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS----GELTVKSDVYSFGVILLELITGRRVIDTTR 287 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~----~~~~~~sDvwSlGvll~elltG~~pf~~~~ 287 (519)
.-. .+--.|...|||||.+.. ..|+-++||||||+++.||.+++.|++.+.
T Consensus 202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 321 222468889999998753 478999999999999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.85 Aligned_cols=267 Identities=20% Similarity=0.294 Sum_probs=186.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEc----------------CCCeEEEEEEeccCCCcChH--------------HHHHHH
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ----------------SNGQVVAVKQLDRNGMQGNK--------------EFLVEV 125 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vAvK~~~~~~~~~~~--------------~~~~E~ 125 (519)
.++|.+.++||+|+||.||+|.+. ..++.||||.+........+ ....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 23567999998654322222 234466
Q ss_pred HHHHhcCCCCe-----eeeeeEEec--------CCceEEEEEecCCCCHHHHHhhhcc--------------------CC
Q 046892 126 LMLSLLHHPNL-----VNLIGYCAD--------GDQRLLVYEFMSGGSVDDHLLDVNE--------------------TK 172 (519)
Q Consensus 126 ~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~ 172 (519)
.++..++|.++ ++++++|.. .+..+|||||+.+++|.++|..... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677777643 3568999999999999999864211 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCch
Q 046892 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252 (519)
Q Consensus 173 ~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~AP 252 (519)
..+++..++.++.||+.+|.|||+.+ |+||||||+|||++.++.+||+|||++.......... .....+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence 23567889999999999999999999 9999999999999999999999999997543322111 1112347899999
Q ss_pred hhhccCC--------------------C--CchhHHHHHHHHHHHHHhCCC-CCCCCCCcch------hhHHHhhchhcc
Q 046892 253 EYARSGE--------------------L--TVKSDVYSFGVILLELITGRR-VIDTTRPVDE------QNLIAWAQPIFR 303 (519)
Q Consensus 253 E~l~~~~--------------------~--~~~sDvwSlGvll~elltG~~-pf~~~~~~~~------~~~~~~~~~~~~ 303 (519)
|.+.... | ..+.||||+||++|+|++|.. ||........ .....|.. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcc
Confidence 9875432 1 124799999999999999875 6643221111 01111110 000
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCC---CCCCCHHHHHHHHhhhh
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEA---GARPLMSDVVTALSFLS 357 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~l~~~~ 357 (519)
....+ ...........+|+.+||..+| .+|+|+.+++.|.|+..
T Consensus 459 ~~~~~----------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDF----------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCCCc----------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00001 1122345688999999999866 68999999999988753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=269.67 Aligned_cols=267 Identities=25% Similarity=0.377 Sum_probs=208.0
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----CceE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN--GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 150 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~~ 150 (519)
+.+..+.||-|+||.||.+++..+|+.||+|.+..- .....+.+.+|+.+|..++|.|++..++...-. ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345668999999999999999999999999987542 223446788999999999999999998876543 2467
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+|+|+|. .+|...| ...+.++.+.++-+++||+.||.|||+.+ |.||||||.|+|++.+..+||||||+++.
T Consensus 134 V~TELmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8888883 4666655 56788999999999999999999999999 99999999999999999999999999998
Q ss_pred CCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch---------
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP--------- 300 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~--------- 300 (519)
-...+..+.+. .+-|..|.|||++.+ ..|+.+.||||.||++.||+..+..|....+....+++.....
T Consensus 206 ee~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 76655544433 455889999999987 4689999999999999999999999998888777666542211
Q ss_pred --------hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 301 --------IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 301 --------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+++.+..-+.+ .....-.-+.....+.+.++..+|..||++|.+..+.+.++.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~-~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDT-QRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCc-cceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111110 000011112344567888999999999999999999887765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=255.62 Aligned_cols=267 Identities=20% Similarity=0.298 Sum_probs=207.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecC--CceEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLL 151 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~l 151 (519)
..++|++.+.+|+|-|+.||.|....+.+.++||+++.- ..+.+.+|+.+|..+. ||||++|+++..+. ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999999888999999998743 3467889999999997 99999999998775 45679
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CCcEEeeeccccc
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKL 230 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-~~vkL~DFGla~~ 230 (519)
|+||+++.++..+. +.|+...+..++.+|+.||.|||++| |+|||+||.|++||.. -.++|+|+|||..
T Consensus 113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 99999998877665 45778889999999999999999999 9999999999999864 5699999999998
Q ss_pred CCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCCcchhhHHH----------hh
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDT-TRPVDEQNLIA----------WA 298 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~-~~~~~~~~~~~----------~~ 298 (519)
+.++...++ .+.+..|--||++.. ..|+.+-|+|||||+|..|+..+.||-. .+..++.-.+. ..
T Consensus 183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 877765443 345778999998865 5689999999999999999999988754 33333322221 11
Q ss_pred chh-ccCCCCCCcccchHhhcc---C-----ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 299 QPI-FRDPKRFPDMADPLLRKQ---F-----PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 299 ~~~-~~~~~~~~~~~d~~l~~~---~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... +..+..+..++....+.. | ..-...++++|+..+|..|..+|+|+.|.+.|..|..
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 100 111112222222111111 0 1123478999999999999999999999999988754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-33 Score=294.87 Aligned_cols=251 Identities=27% Similarity=0.354 Sum_probs=190.5
Q ss_pred cccceeeeccCcEE-EEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEec
Q 046892 79 FRQECLLGEGGFGR-VYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 79 y~~~~~LG~G~~g~-Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
|...+++|.|+.|+ ||+|... |+.||||++-.. ......+|+.+|+.- .|||||++|+.-.+....||..|+|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44556899999887 8999986 899999987532 234567899999876 5999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---C--CCcEEeeecccccC
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---N--LDPKLSDFGLAKLG 231 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~--~~vkL~DFGla~~~ 231 (519)
..+|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56999999652111111111445778999999999999999 999999999999965 3 46899999999987
Q ss_pred CCCCc-cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 232 PQGEK-MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG-RRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 232 ~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..+.. .....+..||-+|+|||++....-+.++||||||||+|+.++| .+||......+ .++ +.....+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI-------l~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI-------LTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh-------hcCcccee
Confidence 65442 2224557899999999999998888899999999999999987 78987532111 111 11111110
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
. +......++.+||.+|++++|..||++.+|+.|+.|
T Consensus 734 ~---------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 734 H---------LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred e---------eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 0 111111188999999999999999999999987643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=262.20 Aligned_cols=269 Identities=26% Similarity=0.375 Sum_probs=217.2
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEEcCCC-----eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeE
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTLQSNG-----QVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGY 142 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~ 142 (519)
..++.....+++...++-+|+||.||.|.+.+.+ +.|-+|.+..... -....++.|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4456666778888999999999999999776432 3466676654322 233557888899999999999999998
Q ss_pred Ee-cCCceEEEEEecCCCCHHHHHhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 046892 143 CA-DGDQRLLVYEFMSGGSVDDHLLDVNE----TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN 217 (519)
Q Consensus 143 ~~-~~~~~~lV~E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~ 217 (519)
+. +....++++.++.-|+|..||..+.. ..+.++..+...++.||+.|++|||.++ |||.||...|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 75 45678899999999999999984332 2235677788899999999999999999 9999999999999999
Q ss_pred CCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 046892 218 LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIA 296 (519)
Q Consensus 218 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~ 296 (519)
..|||+|=.+++.+-+.+.............||+||.+.+..|+.++|||||||+||||+| |+.|+...+|++....+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999998776665444444556788999999999999999999999999999997 788887766654433221
Q ss_pred hhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 297 WAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 297 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+-..|-.++++++.++.-||...|++||++++++.-|..+.
T Consensus 513 -----------------dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 513 -----------------DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -----------------ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 22233456788899999999999999999999999999887664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=278.57 Aligned_cols=197 Identities=25% Similarity=0.396 Sum_probs=172.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh--------HHHHHHHHHHHhcC---CCCeeeeeeEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--------KEFLVEVLMLSLLH---HPNLVNLIGYCAD 145 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~--------~~~~~E~~~l~~l~---HpnIv~l~~~~~~ 145 (519)
.+|..++.||.|+||.|++|.++.+...|+||.+.+...-.. -.+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468999999999999999999999999999999876532111 12456999999987 9999999999999
Q ss_pred CCceEEEEEec-CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 146 GDQRLLVYEFM-SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 146 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
.+.+||+||-. ++-+|.++| +....+++.++..|+.||+-|+++||+.| |||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999985 566888888 56678999999999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCC
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVID 284 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~ 284 (519)
||.+.....+. ...++||.+|.|||++.+..| +..-|||+||++||.++....||.
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99997765543 445789999999999999877 456899999999999999888875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-33 Score=277.71 Aligned_cols=276 Identities=22% Similarity=0.229 Sum_probs=212.6
Q ss_pred HHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC------CCCeeeeeeEE
Q 046892 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH------HPNLVNLIGYC 143 (519)
Q Consensus 70 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~~ 143 (519)
.-......+|.+....|+|-|++|.+|.+..-|..||||++..+..- .+.=+.|+++|+.|+ --++++|+-.|
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 33445567899999999999999999999988999999999866432 344567999999986 24799999999
Q ss_pred ecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEE
Q 046892 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKL 222 (519)
Q Consensus 144 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL 222 (519)
...+++|||||-+ ..+|.++|..++. .-.|....+..++.|+..||..|-..| |+|.||||+||||++.. .+||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence 9999999999998 5699999987653 456888999999999999999999999 99999999999998764 5799
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch--
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP-- 300 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~-- 300 (519)
||||.|......... ...-+..|.|||++.|.+|+...|+||+||+||||.||+..|.+....+...+...+..
T Consensus 579 CDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 579 CDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred ccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 999999876554321 22235679999999999999999999999999999999999988665544333221110
Q ss_pred ---hcc----------CCCCC----------------Ccccch------Hhhc--cCCh---hhHHHHHHHHHHhhhhCC
Q 046892 301 ---IFR----------DPKRF----------------PDMADP------LLRK--QFPE---KGLNEAVAIAAMCLQEEA 340 (519)
Q Consensus 301 ---~~~----------~~~~~----------------~~~~d~------~l~~--~~~~---~~~~~l~~li~~cl~~dP 340 (519)
++. ...++ ...+.+ .|.. .++. .....+.+|+..||..||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 000 00000 000111 1111 1333 345678899999999999
Q ss_pred CCCCCHHHHHHHHhh
Q 046892 341 GARPLMSDVVTALSF 355 (519)
Q Consensus 341 ~~RPs~~evl~~l~~ 355 (519)
++|.|..+.|.|+++
T Consensus 735 ~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 735 EKRITVNQALKHPFI 749 (752)
T ss_pred hhcCCHHHHhcCCcc
Confidence 999999999998754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=239.44 Aligned_cols=212 Identities=38% Similarity=0.582 Sum_probs=184.9
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHHH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDD 163 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 163 (519)
||.|++|.||++....+++.+++|++...... ....+.+|+..++.+.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998765332 34678899999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeecccccCCCCCccceecc
Q 046892 164 HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKLGPQGEKMNVTSR 242 (519)
Q Consensus 164 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 242 (519)
++.... ..+++..++.++.+++.+|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 985421 46899999999999999999999999 999999999999999 89999999999986544321 1223
Q ss_pred cccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCC
Q 046892 243 VMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321 (519)
Q Consensus 243 ~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 321 (519)
..+...|++||.+... .++.++|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999999877 888999999999999998
Q ss_pred hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 322 EKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 322 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
..+.+++..|++.+|.+||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2677899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=282.58 Aligned_cols=256 Identities=26% Similarity=0.361 Sum_probs=211.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|+....+|.|+||.||+++++.+++..|+|+++........-+..|+.+++..+|||||.++|.+...+.+|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46899999999999999999999999999999999988777788888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
|.+|+|.+.- ...+++++.++..++...++||+|||+.+ =+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 94 cgggslQdiy----~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 94 CGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred cCCCccccee----eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 9999998876 45678999999999999999999999999 89999999999999999999999999865433
Q ss_pred ccceecccccccccCchhhh---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 236 KMNVTSRVMGTYGYCAPEYA---RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l---~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.......+.||+.|||||+. ..+.|...+|||++|++..|+.--++|.....+.....+.. . ....-+..-
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT---k---S~~qpp~lk 238 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT---K---SGFQPPTLK 238 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh---c---cCCCCCccc
Confidence 22334568899999999976 45789999999999999999998887754433322221111 0 000111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
| .......+-+|++.||..+|.+||++..++.|.
T Consensus 239 D-------k~kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 239 D-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred C-------CccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 1 122345788999999999999999999988743
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=250.24 Aligned_cols=265 Identities=25% Similarity=0.298 Sum_probs=204.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC------C
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN--GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------D 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~ 147 (519)
..+|..++.+|.|.- .|..+.+.-.++.||+|.+... .....+...+|+.++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 467888899999999 7778888888999999987543 334556788999999999999999999998543 3
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..|+||||| ..+|...+. -.++-..+..|+.|++.|+.|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 579999999 468888875 23677889999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh---------
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA--------- 298 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~--------- 298 (519)
|+..... -..+..+.|..|.|||++.+-.|.+.+||||+||++.||++|...|.+.+..+....+...
T Consensus 165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 9865443 2345567899999999999988999999999999999999999999865544432222100
Q ss_pred -------chhccC---------CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 299 -------QPIFRD---------PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 299 -------~~~~~~---------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.-.... ...+++..-+.. ...+......+.+++.+||..||++|.++.++|.|+.+
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~-~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV-LEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCccccccc-ccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 000000 001111110000 01112334567899999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=236.66 Aligned_cols=200 Identities=36% Similarity=0.507 Sum_probs=174.1
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecC
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ....+..|+..+..++|+|++++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56678999999999999999988899999999866544 56778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+++|.+++.... ..+++..++.++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 999999985422 11889999999999999999999998 99999999999999999999999999987654320
Q ss_pred ceecccccccccCchhhh-ccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 046892 238 NVTSRVMGTYGYCAPEYA-RSGELTVKSDVYSFGVILLELITGRRVIDT 285 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l-~~~~~~~~sDvwSlGvll~elltG~~pf~~ 285 (519)
.......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112335678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=238.33 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=191.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeE-EecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGY-CADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~~~~~~~~lV~ 153 (519)
.+.|.+.+.||+|-||.+.++.++.+.+.+++|.+... .....+|.+|..---.| .|.||+.-|++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 46799999999999999999999999999999998755 34467788887654444 48999998875 77788889999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCCcEEeeecccccC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG--ANLDPKLSDFGLAKLG 231 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~--~~~~vkL~DFGla~~~ 231 (519)
||++.|+|...+.. ..+.+.....++.|++.||.|||+.+ +||||||.+||||- +...|||||||+.+..
T Consensus 102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999988733 45788899999999999999999999 99999999999993 3347999999998754
Q ss_pred CCCCccceecccccccccCchhhhcc---C--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS---G--ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~---~--~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
+..- ....-+..|.+||+... + ...+.+|||.||+++|.+|||..||... ..+......|.+..-....
T Consensus 174 g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 174 GTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred Ccee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccCc
Confidence 3321 12234677999997642 2 3467899999999999999999999843 2222223333332222222
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCC---CCHHHHHHHHh
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR---PLMSDVVTALS 354 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~l~ 354 (519)
.+|.... ..+..+..+..+-|..++.+| .+.......+|
T Consensus 248 ~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 248 ALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred cCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 2222221 123467788889999999999 55555555554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=247.64 Aligned_cols=272 Identities=23% Similarity=0.295 Sum_probs=203.5
Q ss_pred HHHhccCcccceeeeccCcEEEEEEEEcC---CCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCC
Q 046892 72 LAAATKNFRQECLLGEGGFGRVYKGTLQS---NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGD 147 (519)
Q Consensus 72 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~ 147 (519)
+....+.|.....||.|+|++||++.+.. ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34455679999999999999999999876 67899999987653 3456889999998875 899999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeec
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFG 226 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFG 226 (519)
...+|+||++.....+++. .++...+..++..++.||+++|..| ||||||||.|+|.+. .+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 9999999999999888873 3678899999999999999999999 999999999999974 5678999999
Q ss_pred ccccCCCCC-------------c-----------------------------cceecccccccccCchhhhcc-CCCCch
Q 046892 227 LAKLGPQGE-------------K-----------------------------MNVTSRVMGTYGYCAPEYARS-GELTVK 263 (519)
Q Consensus 227 la~~~~~~~-------------~-----------------------------~~~~~~~~Gt~~y~APE~l~~-~~~~~~ 263 (519)
+|....... . ........||++|.|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997210000 0 000112579999999999865 456889
Q ss_pred hHHHHHHHHHHHHHhCCCCCCCCC-Ccchh-hHHHhhc------------h--hccCCCCCCcccc----------hHhh
Q 046892 264 SDVYSFGVILLELITGRRVIDTTR-PVDEQ-NLIAWAQ------------P--IFRDPKRFPDMAD----------PLLR 317 (519)
Q Consensus 264 sDvwSlGvll~elltG~~pf~~~~-~~~~~-~~~~~~~------------~--~~~~~~~~~~~~d----------~~l~ 317 (519)
+||||.|||++-+++++.||-... +.+.. .+...+. . ++. ..+++.+.. ..+.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~-ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQ-KSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeec-cccccccHHHHhchhccChhhcc
Confidence 999999999999999999986532 22221 1111110 0 111 011111100 0000
Q ss_pred ---------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 318 ---------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 318 ---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
....+..+..+++|+.+||..||.+|.|+++.|.|..|-
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 011122345789999999999999999999999987654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=276.88 Aligned_cols=201 Identities=17% Similarity=0.230 Sum_probs=143.1
Q ss_pred cCC-CCeeeeeeEE-------ecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046892 131 LHH-PNLVNLIGYC-------ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202 (519)
Q Consensus 131 l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~I 202 (519)
++| .||+.++++| .....++++|||+ +++|.++|.. ....+++..++.|+.||+.||.|||+++ |
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 345 5888888887 2334567888988 6699999953 2356999999999999999999999999 9
Q ss_pred EecCCCCCCeeeCC-------------------CCCcEEeeecccccCCCCCc--------------cceeccccccccc
Q 046892 203 IYRDLKSSNILLGA-------------------NLDPKLSDFGLAKLGPQGEK--------------MNVTSRVMGTYGY 249 (519)
Q Consensus 203 vHrDikp~NILl~~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y 249 (519)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44556666666653211000 0001124689999
Q ss_pred CchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHH
Q 046892 250 CAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAV 329 (519)
Q Consensus 250 ~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 329 (519)
||||++.+..|+.++|||||||+||||++|..|+..... ......... ..+.. ......+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~----------~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRV----------LPPQI-----LLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhh----------cChhh-----hhcCHHHH
Confidence 999999999999999999999999999998887643211 000110000 00000 01123456
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 330 AIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 330 ~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.++.+||+.+|.+||++.+++++.++..
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 7889999999999999999999987643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=211.70 Aligned_cols=168 Identities=22% Similarity=0.190 Sum_probs=127.7
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
|+|.+++.. ....+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 689998854 2456999999999999999999999886 999999999999999 99987654321
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhc
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 318 (519)
..||+.|||||++.+..++.++|||||||++|||++|..||......... +..+........ + . ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~---~-----~-~~ 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMPADD---P-----R-DR 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhccCC---c-----c-cc
Confidence 26899999999999999999999999999999999999999754332211 111111111000 0 0 00
Q ss_pred cCChhhHH--HHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 319 QFPEKGLN--EAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 319 ~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+..... .+.+++.+||+.+|.+||++.+++++++.+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 01122222 6899999999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-24 Score=215.21 Aligned_cols=260 Identities=22% Similarity=0.253 Sum_probs=198.2
Q ss_pred CcccceeeeccCcEEEEEEEEcCCC-eEEEEEEeccCCCcChHHHHHHHHHHHhcCC----CCeeeeeeEE-ecCCceEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNG-QVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH----PNLVNLIGYC-ADGDQRLL 151 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~~~~l 151 (519)
+|.+.+.||+|+||.||+|.+..++ ..+|+|............+..|+.++..+.. .++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999988764 6799998766543333367788888887763 6899999998 57778899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-----CCcEEeeec
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-----LDPKLSDFG 226 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-----~~vkL~DFG 226 (519)
||+.+ |.+|.++..... ...++...++.|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99999 889999775433 567999999999999999999999999 9999999999999765 458999999
Q ss_pred ccc--cCCCCCc-----cce-ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-h
Q 046892 227 LAK--LGPQGEK-----MNV-TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-W 297 (519)
Q Consensus 227 la~--~~~~~~~-----~~~-~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~ 297 (519)
+++ ....... ... ...+.||..|+++....+...+.+.|+||++.++.+|+.|..||............. .
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 3221111 111 234569999999999999999999999999999999999999986654332211111 1
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
....... .+....+.++..+...+-..+...+|....+...+....
T Consensus 253 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 253 PRKLLTD--------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred hhhhccc--------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 1100000 012223345666666666789999999999988876544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-23 Score=207.97 Aligned_cols=261 Identities=32% Similarity=0.453 Sum_probs=199.4
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCC-CeeeeeeEEecCCceEEEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E 154 (519)
|.+...||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 677889999999999999987 78999998765443 256788999999999988 79999999977777899999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~~~~ 233 (519)
++.+++|.+++...... ..+.......++.|++.+|.|+|..+ ++||||||+||+++..+ .++++|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999666332111 36899999999999999999999999 99999999999999988 699999999985544
Q ss_pred CCccc----eecccccccccCchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc-chhhHHHhhchhccCC
Q 046892 234 GEKMN----VTSRVMGTYGYCAPEYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPV-DEQNLIAWAQPIFRDP 305 (519)
Q Consensus 234 ~~~~~----~~~~~~Gt~~y~APE~l~~---~~~~~~sDvwSlGvll~elltG~~pf~~~~~~-~~~~~~~~~~~~~~~~ 305 (519)
..... ......|+..|+|||.+.+ ..+....|+|++|++++++++|..||...... ...............
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP- 233 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-
Confidence 33221 2456789999999999987 57889999999999999999999997665431 011111111111000
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
.... .............+.+++..|+..+|..|.++......
T Consensus 234 -~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLAS----PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -cccc----ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000 00000002223578899999999999999999988765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=222.80 Aligned_cols=167 Identities=19% Similarity=0.172 Sum_probs=130.1
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcC-CCeEEEEEEeccCCC-----cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQS-NGQVVAVKQLDRNGM-----QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
...++|.+.+.||+|+||+||+|++.. +++.||||++..... .....+.+|+.+|..++|+||+..+..+ +
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 345789999999999999999999876 678889998753311 1235588999999999999998533322 4
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeeCCCCCcEEeeec
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDL-KSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDi-kp~NILl~~~~~vkL~DFG 226 (519)
..||||||++|++|.... . .. ...++.+++++|.|||+.| |+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~~-----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR-----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHhC-----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 579999999999996321 1 11 1457889999999999999 999999 9999999999999999999
Q ss_pred ccccCCCCCccce------ecccccccccCchhhhcc
Q 046892 227 LAKLGPQGEKMNV------TSRVMGTYGYCAPEYARS 257 (519)
Q Consensus 227 la~~~~~~~~~~~------~~~~~Gt~~y~APE~l~~ 257 (519)
+++.......... .....|++.|+|||++..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9986554321111 135678999999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=242.91 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=196.8
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC--CCcChH----HHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN--GMQGNK----EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~----~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
....++|.|++|.|+.+........++.|.+... ...... .+..|+.+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998888887766666666654311 111111 1445666777789999988888777766666669
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||++ +|..++.. ...+....+..++.||+.||.|||+.| |.|||||++|++++.+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 99999843 346888899999999999999999999 99999999999999999999999999987655
Q ss_pred CCcc--ceecccccccccCchhhhccCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKM--NVTSRVMGTYGYCAPEYARSGELTV-KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~-~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
.... .....++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+... .............
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----~~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----KTNNYSDQRNIFE 548 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----hhhcccccccccc
Confidence 4433 5566789999999999999999986 4899999999999999999997765443321 0000000000000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
-. ..+....+.+...++.+||+.||.+|.|+.+|++.-|+-.
T Consensus 549 ~~-----~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 549 GP-----NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred Ch-----HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 00 1122344557788999999999999999999999877643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=228.61 Aligned_cols=297 Identities=24% Similarity=0.320 Sum_probs=229.7
Q ss_pred eeeccCcEEEEEEEE---cCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEEecC
Q 046892 84 LLGEGGFGRVYKGTL---QSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~---~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
++|+|+||.|++++- .+.|+.+|+|++.+..... ......|..++..++ ||.+|+++.+++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999987653 3457889999887643221 123455777888777 9999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
||.|...+ .....+++.....+...++-+++++|..+ |+|||+|++||+++.+|++++.|||+++.......
T Consensus 81 gg~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99998877 34455778888889999999999999999 99999999999999999999999999986544322
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
.+||..|||||+++ .....+|+||||++++||+||..||.. +.... +.. ..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~------Il~------------~~ 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKR------ILK------------AE 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHH------Hhh------------hc
Confidence 28999999999998 667889999999999999999999986 11111 111 11
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHhhhhc------CCCCCCCCCCCCCCCCcCCCccCCCCCC
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLM-----SDVVTALSFLSN------SKEPIPDPIIPSDEDEYSEGYSSDGHQK 386 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~~~~------~~~~~~~p~~p~~~~~~~~~~~~~~~~~ 386 (519)
..+|......+.+++..++..+|..|.-. .++.++. +++. ....+++|+.|......+..+++..++.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~-f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~ 282 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE-FFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTS 282 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc-hheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhcc
Confidence 23566677788899999999999999655 3333333 3322 3456678888888888888899988888
Q ss_pred CCCCCCCCCcccccccccccCCCCCCCCCCCCcc
Q 046892 387 NENTYDNDNARSVRESENLESSNNSGSNPERIAS 420 (519)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~ 420 (519)
..+.+.+... -..++...|+++++..|+.+..
T Consensus 283 ~~P~dsp~~~--~~~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 283 QVPADSPLLS--ASGSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred CCcccCCCCC--CCccccchhcCCCccChHHhhc
Confidence 8777665443 2233557788888888887655
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=190.50 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=202.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC-CCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 154 (519)
...|.+++.||.|+||.+|.|....+|..||||+-... ....++..|..+...+++ ..|..+..+..+...-.|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46899999999999999999999999999999975433 233567889999988875 678888888889999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DFGla~~~ 231 (519)
++ |.+|.+++.-+ ...++..+++.++-|++.-++|+|.++ +|||||||+|+|..- ...+.|+|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 99 88999988654 345888999999999999999999999 999999999999964 345899999999865
Q ss_pred CCCCc-----cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 232 PQGEK-----MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 232 ~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
.+... ........||..|.+=....+...+..-|+-|+|.+|.++..|..||.+..........+-+ .+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI---~EkK- 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI---SEKK- 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH---HHhh-
Confidence 43221 12233467999999988777777788899999999999999999999987654433222211 1110
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+. ..-..|...+| .++.-.+.-|-..--++-|...-+-+....+-
T Consensus 241 -~s-~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 241 -MS-TPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred -cC-CCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 00 11123333343 46777888888888888888776665554443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=193.57 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=197.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.-.|.+.+.||+|+||.++.|.+.-+++.||||.-... ....++..|....+.|. .++|..+|.+..++-+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 44799999999999999999999999999999974432 34567888888888775 6899999999888989999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-----CcEEeeecccc
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-----DPKLSDFGLAK 229 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-----~vkL~DFGla~ 229 (519)
++ |.+|.|++.-+ +..++...+..++.|++.-++|+|++. +|.|||||+|+||...+ .+.|+|||+|+
T Consensus 105 LL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99 88999987543 356899999999999999999999999 99999999999997543 48999999998
Q ss_pred cCCCCC-----ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 230 LGPQGE-----KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 230 ~~~~~~-----~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
.+.+.. .........||.+||+=....+...+..-|+=|||-++++.|.|..||.+..........+-+. ..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG---e~ 254 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG---ET 254 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc---cc
Confidence 765433 2233456789999999998888888999999999999999999999998764433222221111 00
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
. .. .--..|...+ +.++...+.-.-..+-.+-|...-+...+
T Consensus 255 K-r~--T~i~~Lc~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 255 K-RS--TPIEVLCEGF----PEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred c-cc--CCHHHHHhcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 0 00 0011222223 34566666666666777778776554433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-23 Score=193.50 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=193.3
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
......|.+...|..|+|++. |..+++|++.... .....+|..|.-.|+.+.||||+.+++.|.....+.+|..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 344557888999999999998 5557778775432 233456888988999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe-cCCCCCCeeeCCCCCcEEe--eecccccCCC
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY-RDLKSSNILLGANLDPKLS--DFGLAKLGPQ 233 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvH-rDikp~NILl~~~~~vkL~--DFGla~~~~~ 233 (519)
+.|+|+..|+. .....++..++..++.+++.|++|||+... ++- --|....|+||++.+.+|. |--++-.
T Consensus 270 p~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred cchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccceeeee---
Confidence 99999999965 344557888999999999999999999874 444 4688899999999887764 3222211
Q ss_pred CCccceecccccccccCchhhhccCCCC---chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELT---VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~---~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
.....-.|.||+||.+...+-+ .++|+|||+++||||.|...||....+....-.
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------- 400 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------- 400 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------------
Confidence 1112336889999999765543 579999999999999999999987765433221
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
+.-+.++..+|+..+..+..|+.-|++.||.+||.+..|+-.|+.
T Consensus 401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 223456777888999999999999999999999999988877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-22 Score=191.76 Aligned_cols=173 Identities=12% Similarity=0.126 Sum_probs=134.8
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHH---------HHHHHHHHHhcCCCCeeeeeeEEe
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---------FLVEVLMLSLLHHPNLVNLIGYCA 144 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~HpnIv~l~~~~~ 144 (519)
-...+|...++||.|+||.||++.. ++..+|||++.......... +.+|+..+..+.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3467899999999999999999755 36689999997543333222 578888999999999999998866
Q ss_pred cC--------CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC
Q 046892 145 DG--------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA 216 (519)
Q Consensus 145 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~ 216 (519)
.. ...+|||||++|.+|.++.. ++. ..+.+++.+|..||+.| |+||||+|+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 43 35789999999999987741 222 24569999999999999 999999999999999
Q ss_pred CCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh
Q 046892 217 NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278 (519)
Q Consensus 217 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt 278 (519)
+| ++|+|||........... ..++....|+.++|+|+||+++..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 88 999999988754322111 114444567789999999999886654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=185.59 Aligned_cols=139 Identities=19% Similarity=0.146 Sum_probs=108.2
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--C-------h-----------------HHHHHHHHHHHhcCCCC
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--G-------N-----------------KEFLVEVLMLSLLHHPN 135 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~Hpn 135 (519)
...||+|+||.||+|.+. +|+.||||+++..... . . .....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999997 7999999998754211 1 0 11234889999998877
Q ss_pred eeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeee
Q 046892 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL-HDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 136 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~IvHrDikp~NILl 214 (519)
+.....+.. ...+|||||+++++|...+. ....+++..+..++.|++.+|.|| |+.| |+||||||+|||+
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 644333222 22389999998877665432 234688999999999999999999 6888 9999999999999
Q ss_pred CCCCCcEEeeecccccC
Q 046892 215 GANLDPKLSDFGLAKLG 231 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~ 231 (519)
+ ++.++|+|||++...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=216.96 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=169.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|+.++.|-.|+||.||.++++.+.+.+|+|+ ++.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence 4689999999999999999999999999999954 3221 11111 22222333333
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
|+...++. ..++++... +.+++|||+.+ |+|||+||+|+||+.-|++|++|||+++......
T Consensus 136 ---gDc~tllk----~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLK----NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcc----cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 44444442 223444333 77899999999 9999999999999999999999999987532211
Q ss_pred ccc-------------eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc
Q 046892 236 KMN-------------VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 236 ~~~-------------~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
... ....++||+.|.|||++....|+..+|||++|+|+||.+.|+.||.+..+..... .+.
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhh
Confidence 110 1234689999999999999999999999999999999999999998875543322 122
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC---HHHHHHHHhhhhcC-CC---CCCCCCCCCCCCCc
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL---MSDVVTALSFLSNS-KE---PIPDPIIPSDEDEY 375 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~l~~~~~~-~~---~~~~p~~p~~~~~~ 375 (519)
.+...+++- .+....++.+++..+|+.+|..|-- +-+|-+| .++... +. -....+.|......
T Consensus 272 sd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h-~ff~~LDw~~llRqkaefvpql~~ed 341 (1205)
T KOG0606|consen 272 SDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQH-GFFQLLDWKSLLRQKAEFVPQLESED 341 (1205)
T ss_pred hhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhc-cceeecccchhhhhhccccccccccc
Confidence 222222211 2334458999999999999999943 3344333 333322 22 12245666667777
Q ss_pred CCCccCCC
Q 046892 376 SEGYSSDG 383 (519)
Q Consensus 376 ~~~~~~~~ 383 (519)
+..|++..
T Consensus 342 dtsyfdTR 349 (1205)
T KOG0606|consen 342 DTSYFDTR 349 (1205)
T ss_pred cchhhccc
Confidence 77777653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=188.06 Aligned_cols=235 Identities=19% Similarity=0.250 Sum_probs=150.7
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCC----------CCeeeeeeEE-
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHH----------PNLVNLIGYC- 143 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H----------pnIv~l~~~~- 143 (519)
.+.....||.|+++.||.+++..+++.+|||++..... ...+.+.+|......+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45677899999999999999999999999998765432 223445555544433222 1222222221
Q ss_pred --------ecC---C-----ceEEEEEecCCCCHHHHHhhhccCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 046892 144 --------ADG---D-----QRLLVYEFMSGGSVDDHLLDVNETK---KPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204 (519)
Q Consensus 144 --------~~~---~-----~~~lV~E~~~~gsL~~~l~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvH 204 (519)
... . ..+++|+-+ .++|.+++....... ..+.....+.+..|++..+++||..| |||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 1 236778877 568888765322221 22445555677799999999999999 999
Q ss_pred cCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhcc--------CCCCchhHHHHHHHHHHHH
Q 046892 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS--------GELTVKSDVYSFGVILLEL 276 (519)
Q Consensus 205 rDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--------~~~~~~sDvwSlGvll~el 276 (519)
+||+|+|+|++.+|.+.|+||+.....+... .. ...+..|.+||.... -.++.+.|.|+||++||.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999999887543321 11 234578999997643 2578999999999999999
Q ss_pred HhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCC
Q 046892 277 ITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR 343 (519)
Q Consensus 277 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 343 (519)
.+|..||+...+...... .-..+. +.++.+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986533211110 111233 566788999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=179.16 Aligned_cols=141 Identities=18% Similarity=0.152 Sum_probs=111.0
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--------------------------hHHHHHHHHHHHhcCCCC
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--------------------------NKEFLVEVLMLSLLHHPN 135 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~Hpn 135 (519)
...||+|+||.||+|.+. +|+.||||++....... ...+..|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 79999999987642110 112356888899999998
Q ss_pred eeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeee
Q 046892 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILL 214 (519)
Q Consensus 136 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl 214 (519)
|.....+... ..+|||||++|+++..... ....++...+..++.|++.+|.+||+ .| |+||||||+|||+
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 7554444333 2489999998876544321 12357788999999999999999999 88 9999999999999
Q ss_pred CCCCCcEEeeecccccCCC
Q 046892 215 GANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~ 233 (519)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=211.83 Aligned_cols=197 Identities=22% Similarity=0.237 Sum_probs=159.9
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCeeeeeeEEecCCceE
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH---HPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~ 150 (519)
.....|.+.+.||+|+||.||+|...+ |+.||+|+-......+ |..-.+++.+|+ -+.|..+..++.-.+..+
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 345679999999999999999999987 9999999876554432 111222333333 345677777777778889
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-------CCCCcEEe
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-------ANLDPKLS 223 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-------~~~~vkL~ 223 (519)
||+||.+.|+|.+++. ..+.++|..++.++.|++..|++||..+ |||+||||+|.||. ....++|+
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999983 6678999999999999999999999999 99999999999994 23458999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCC
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRR 281 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~ 281 (519)
|||.+..+............++|-.+-.+|+..|..+++.+|.|.|+-+++-||.|++
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999864433222233556788999999999999999999999999999999999965
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=174.59 Aligned_cols=186 Identities=20% Similarity=0.179 Sum_probs=140.0
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh----HHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEE
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN----KEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.+...|++|+||+||.+.. .+..++.+.+........ ..+.+|+.+|..+. |++|++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3457899999999998766 477888777765443211 24788999999995 5889999886 35699999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeeCCCCCcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDL-KSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDi-kp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|+.|.+|...+.. ....++.|++.+|.+||+.| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999988754311 11347889999999999999 999999 79999999999999999999986543
Q ss_pred CCcc----c---e----ecccccccccCchhhhccC-CCC-chhHHHHHHHHHHHHHhCCCCCCC
Q 046892 234 GEKM----N---V----TSRVMGTYGYCAPEYARSG-ELT-VKSDVYSFGVILLELITGRRVIDT 285 (519)
Q Consensus 234 ~~~~----~---~----~~~~~Gt~~y~APE~l~~~-~~~-~~sDvwSlGvll~elltG~~pf~~ 285 (519)
.... . . ......++.|++|+...-. ..+ ...++++-|.-+|.++|++.++-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 3210 0 0 1112368889999854322 223 568999999999999999877644
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=212.79 Aligned_cols=248 Identities=23% Similarity=0.254 Sum_probs=181.6
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHH---HHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~---~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
+|...+.||.+.|=.|.+|++.. |. |+||++-+.. ...... .+.|+. ...++|||++.+..+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 67778899999999999999874 55 9999886543 222333 344444 56678999999999888888889999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc--C
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL--G 231 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~--~ 231 (519)
+|+.. +|+|.| ..++-+...+.+.|+.||+.||.-+|..| |+|||||.+||||+.-..+.|+||..-+- +
T Consensus 101 qyvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 99954 888887 56667888888999999999999999999 99999999999999999999999987642 2
Q ss_pred CCCCcc---ceecccccccccCchhhhccC-----------CCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 046892 232 PQGEKM---NVTSRVMGTYGYCAPEYARSG-----------ELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIA 296 (519)
Q Consensus 232 ~~~~~~---~~~~~~~Gt~~y~APE~l~~~-----------~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~ 296 (519)
..+... ....+...-..|+|||.+... ..+++-||||+||+++||++ |+++|... .+..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh
Confidence 222211 112223334579999987532 26788999999999999987 57777532 1211
Q ss_pred hhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 046892 297 WAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353 (519)
Q Consensus 297 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l 353 (519)
+.. .. .......| +.++. ..+..++..|++.||.+|.++.+.++.-
T Consensus 247 Yr~---~~----~~~~e~~L-e~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 247 YRS---GN----ADDPEQLL-EKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred Hhc---cC----ccCHHHHH-HhCcC---ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 110 00 00111111 11221 2567899999999999999999999873
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.4e-20 Score=172.76 Aligned_cols=136 Identities=18% Similarity=0.220 Sum_probs=107.7
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-----CCCCeeeeeeEEecCC---c-eE
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-----HHPNLVNLIGYCADGD---Q-RL 150 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~-~~ 150 (519)
....+||+|+||.||. +..++.. +||++..........+.+|+.++..+ .||||++++|+++++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4457899999999995 6666555 69988765445567799999999999 5799999999998864 3 33
Q ss_pred EEEEe--cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeeeCC----CCCcEEe
Q 046892 151 LVYEF--MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL-EYLHDKANPPVIYRDLKSSNILLGA----NLDPKLS 223 (519)
Q Consensus 151 lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~IvHrDikp~NILl~~----~~~vkL~ 223 (519)
+|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999943 235555 35677888777 9999999 999999999999974 3479999
Q ss_pred eeccc
Q 046892 224 DFGLA 228 (519)
Q Consensus 224 DFGla 228 (519)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=176.39 Aligned_cols=195 Identities=19% Similarity=0.229 Sum_probs=137.0
Q ss_pred CCCCeeeeeeEEecC---------------------------CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHH
Q 046892 132 HHPNLVNLIGYCADG---------------------------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIA 184 (519)
Q Consensus 132 ~HpnIv~l~~~~~~~---------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 184 (519)
.|||||.++++|.+. ..+|+||..++ .+|..++.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 599999999887542 23689998884 589999843 235556677799
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCCeee--CCCC--CcEEeeecccccCCCCC-cc---ceecccccccccCchhhhc
Q 046892 185 SGAAQGLEYLHDKANPPVIYRDLKSSNILL--GANL--DPKLSDFGLAKLGPQGE-KM---NVTSRVMGTYGYCAPEYAR 256 (519)
Q Consensus 185 ~qi~~aL~~LH~~~~~~IvHrDikp~NILl--~~~~--~vkL~DFGla~~~~~~~-~~---~~~~~~~Gt~~y~APE~l~ 256 (519)
.|+++|+.|||.+| |.|||+|.+|||| |+++ .+.|+|||++-...... .. ...-...|....||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 3343 46899999875322210 00 0112345788899999875
Q ss_pred cC--C---C-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHH
Q 046892 257 SG--E---L-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVA 330 (519)
Q Consensus 257 ~~--~---~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 330 (519)
.- + . -.++|.|+.|.+.||+++...||........ +...+ . ... -..+++.++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~Y-----q---------e~q-LPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRTY-----Q---------ESQ-LPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhhh-----h---------hhh-CCCCcccCChHHHH
Confidence 32 1 1 2489999999999999999999987322111 00000 0 001 12245566678889
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 046892 331 IAAMCLQEEAGARPLMSDVVT 351 (519)
Q Consensus 331 li~~cl~~dP~~RPs~~evl~ 351 (519)
++...|+.||.+|++..-...
T Consensus 489 lV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHHHHhcCCccccCCccHHHh
Confidence 999999999999998654433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=186.24 Aligned_cols=215 Identities=28% Similarity=0.412 Sum_probs=160.5
Q ss_pred HHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecC
Q 046892 128 LSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV-IYRD 206 (519)
Q Consensus 128 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~I-vHrD 206 (519)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++.+|+.||+|||... | +|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 3567899999999999999999999999999999999955 4567899999999999999999999887 5 9999
Q ss_pred CCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccC-------CCCchhHHHHHHHHHHHHHhC
Q 046892 207 LKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-------ELTVKSDVYSFGVILLELITG 279 (519)
Q Consensus 207 ikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-------~~~~~sDvwSlGvll~elltG 279 (519)
|+..|+++|....+||+|||+.................-..-|.|||.+.+. ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766421111111111224569999998763 146779999999999999999
Q ss_pred CCCCCCCCCcc-hhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 280 RRVIDTTRPVD-EQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 280 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..||+...... ...++..+.. .......|.+.. . .+...++..++..||..+|..||++..|-..+..+
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~----~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIEL----L---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cCccccccccCChHHHHHHHHh-cCCCCcCcchhh----h---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99998743322 2333333222 000001111110 0 03334789999999999999999999987665543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=168.27 Aligned_cols=145 Identities=17% Similarity=0.148 Sum_probs=112.5
Q ss_pred ccCcccceeeeccCcEEEEEEE-EcCCCeEEEEEEeccCCCc------------------------ChHHHHHHHHHHHh
Q 046892 76 TKNFRQECLLGEGGFGRVYKGT-LQSNGQVVAVKQLDRNGMQ------------------------GNKEFLVEVLMLSL 130 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~-~~~~~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~ 130 (519)
...|.+.+.||+|+||.||+|. +..+|+.||||++...... ....+..|+.++..
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999998 6668999999998754211 00224679999998
Q ss_pred cCCCC--eeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046892 131 LHHPN--LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208 (519)
Q Consensus 131 l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDik 208 (519)
+.+.. +.+++++ ...+|||||+.+.+|...+. ....+....+..++.||+.+|.+||+.+. |+|||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 87532 3444443 23589999999988766542 22345666778999999999999999874 9999999
Q ss_pred CCCeeeCCCCCcEEeeecccccC
Q 046892 209 SSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 209 p~NILl~~~~~vkL~DFGla~~~ 231 (519)
|+|||++ ++.++|+|||++...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-19 Score=184.45 Aligned_cols=179 Identities=27% Similarity=0.383 Sum_probs=131.1
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
.+||.|++|.-.+|.++|... ......++...+.++.|++.|+.| ++ .+|+|+||.||++..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999543 234457888999999999999999 77 89999999999999999999999999
Q ss_pred cccCCCCC----ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc
Q 046892 228 AKLGPQGE----KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303 (519)
Q Consensus 228 a~~~~~~~----~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 303 (519)
........ .....+...||..||+||.+.+..|+.++||||||+||+||+.- |..... -+... ..++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T~~e-----r~~t~-~d~r 473 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FSTQFE-----RIATL-TDIR 473 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hccHHH-----HHHhh-hhhh
Confidence 98655443 11223457899999999999999999999999999999999982 221100 00000 0011
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
+. .+++.....+| +-..|+.++|.+.|.+||++.++..+
T Consensus 474 ~g-----~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~~~ 512 (516)
T KOG1033|consen 474 DG-----IIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVALH 512 (516)
T ss_pred cC-----CCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHhhh
Confidence 10 11111111122 34579999999999999966555433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.6e-18 Score=161.28 Aligned_cols=134 Identities=21% Similarity=0.300 Sum_probs=112.6
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--------NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
+.||+|++|.||+|.+ +|..|++|+........ ...+..|+.++..+.|++|.....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 47789999765432211 1346789999999999998887777777788999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
|++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988431 12 77889999999999999999 99999999999999 78999999998874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.7e-18 Score=158.52 Aligned_cols=131 Identities=22% Similarity=0.340 Sum_probs=106.2
Q ss_pred eeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--------NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.||+|+||.||+|.+ ++..|++|......... ...+..|+.++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 47889999865432111 24567899999999988766555555666778999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
++|++|.+++... .. .++.+++.+|.+||+.+ |+|+|++|.|||++ ++.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999887331 10 68999999999999999 99999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=156.79 Aligned_cols=145 Identities=16% Similarity=0.116 Sum_probs=111.7
Q ss_pred HHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc----------------------ChHHHHHHHHHH
Q 046892 71 ELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ----------------------GNKEFLVEVLML 128 (519)
Q Consensus 71 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l 128 (519)
++......|.+.+.||.|+||.||++.+. +|+.||||++...... ....+..|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 44444445888899999999999999885 6999999987643210 011256688888
Q ss_pred HhcCCCC--eeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 046892 129 SLLHHPN--LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRD 206 (519)
Q Consensus 129 ~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrD 206 (519)
..+.|++ ++.+++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 8887774 4444442 355899999999998765410 235678899999999999999 99999
Q ss_pred CCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 207 LKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 207 ikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=179.91 Aligned_cols=144 Identities=19% Similarity=0.285 Sum_probs=114.4
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC--CC------cChHHHHHHHHHHHhcCCCCeeeee
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN--GM------QGNKEFLVEVLMLSLLHHPNLVNLI 140 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~------~~~~~~~~E~~~l~~l~HpnIv~l~ 140 (519)
|.........|...+.||+|+||.||+|.+.. ..+++|+.... .. .....+..|+.++..++|++|+..+
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~ 402 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV 402 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence 33333344556778899999999999998864 34444432211 11 1124578899999999999999888
Q ss_pred eEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 141 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
.++.+....++||||+++++|.+++. ....++.+++.+|.+||+.+ |+||||||+|||+ .++.+
T Consensus 403 ~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 403 IYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred EEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcE
Confidence 88777778899999999999999883 34678999999999999999 9999999999999 67899
Q ss_pred EEeeeccccc
Q 046892 221 KLSDFGLAKL 230 (519)
Q Consensus 221 kL~DFGla~~ 230 (519)
+|+|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-18 Score=185.91 Aligned_cols=261 Identities=21% Similarity=0.261 Sum_probs=194.4
Q ss_pred CcccceeeeccCcEEEEEEEEcC-CCeEEEEEEeccCC--CcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQS-NGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.|.+.+.||+|+|+.|-...... ....+|+|.+.... .........|..+-..+. |.|++.+++.....+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 46666779999999998887643 34467777765443 122233344777777776 999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeeeCCCC-CcEEeeecccccC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH-DKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKLG 231 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~~ 231 (519)
+|..++++.+.+.. ......+...+-.++.|+..+|.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Cccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999998887731 12224566677789999999999999 888 99999999999999999 9999999999987
Q ss_pred CC-CCccceeccccc-ccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 232 PQ-GEKMNVTSRVMG-TYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 232 ~~-~~~~~~~~~~~G-t~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
.. ..........+| ++.|+|||.+.+. ...+..|+||.|+++.-+++|..|+......+.. ...|.... ...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~----~~~ 250 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK----GRF 250 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc----ccc
Confidence 66 444445556788 9999999998874 5567899999999999999999998775443321 11111100 000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.............+++..++..+|..|.+..++....|..
T Consensus 251 --------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~ 290 (601)
T KOG0590|consen 251 --------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLS 290 (601)
T ss_pred --------ccCccccCChhhhhcccccccCCchhcccccccccccccc
Confidence 0011122334677888999999999999999987665543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=145.63 Aligned_cols=135 Identities=23% Similarity=0.199 Sum_probs=96.5
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--hHH----------------------HHHHHHHHHhcCCCC--
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKE----------------------FLVEVLMLSLLHHPN-- 135 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~Hpn-- 135 (519)
.+.||+|+||+||+|.+. +++.||||++....... ... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 78999999986532211 111 124555555544332
Q ss_pred eeeeeeEEecCCceEEEEEecCCCCHHHH-HhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCee
Q 046892 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDH-LLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNIL 213 (519)
Q Consensus 136 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NIL 213 (519)
+.+++++ ...++||||++++++... +.... .. ..+..++.+++.++.++|. .+ |+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4444443 246899999998543321 11110 11 5678899999999999999 88 999999999999
Q ss_pred eCCCCCcEEeeecccccC
Q 046892 214 LGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 214 l~~~~~vkL~DFGla~~~ 231 (519)
++ ++.++|+|||.+...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.7e-16 Score=136.37 Aligned_cols=135 Identities=21% Similarity=0.184 Sum_probs=113.0
Q ss_pred cceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--CCeeeeeeEEecCCceEEEEEecCC
Q 046892 81 QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.+.||.|.++.||++... +..+++|....... ...+..|+.++..+.| .+++++++++...+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3467999999999999986 47899998865433 4678889999999876 5899999998888889999999988
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+.+..+ +......++.+++.+|++||.....+++|+||+|.|||++..+.++++|||++..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766533 4556677899999999999996433499999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=146.72 Aligned_cols=134 Identities=22% Similarity=0.250 Sum_probs=103.9
Q ss_pred eeee-ccCcEEEEEEEEcCCCeEEEEEEeccCCC-------------cChHHHHHHHHHHHhcCCCCe--eeeeeEEecC
Q 046892 83 CLLG-EGGFGRVYKGTLQSNGQVVAVKQLDRNGM-------------QGNKEFLVEVLMLSLLHHPNL--VNLIGYCADG 146 (519)
Q Consensus 83 ~~LG-~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~ 146 (519)
..|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 8889999998775 77899998754211 122457889999999998775 6677764432
Q ss_pred C----ceEEEEEecCC-CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcE
Q 046892 147 D----QRLLVYEFMSG-GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 147 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vk 221 (519)
. ..++|||+++| .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 689888732 235543 3568999999999999 99999999999999999999
Q ss_pred Eeeeccccc
Q 046892 222 LSDFGLAKL 230 (519)
Q Consensus 222 L~DFGla~~ 230 (519)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.8e-15 Score=154.63 Aligned_cols=251 Identities=24% Similarity=0.272 Sum_probs=186.6
Q ss_pred cCcccceeeec--cCcEEEEEEEE--cCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCce
Q 046892 77 KNFRQECLLGE--GGFGRVYKGTL--QSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~--G~~g~Vy~~~~--~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 149 (519)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-.... ......-.+|+.....+. |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35677788999 99999999998 8889999999843332 233344456666666564 99999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeeeCCC-CCcEEee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ----GLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSD 224 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~IvHrDikp~NILl~~~-~~vkL~D 224 (519)
++-+|+| +.+|..+... ....++...++.++.+... ||.++|..+ |+|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999999 5677777643 3344778888888888888 999999999 9999999999999999 8899999
Q ss_pred ecccccCCCCCccce---ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 225 FGLAKLGPQGEKMNV---TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 225 FGla~~~~~~~~~~~---~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
||+...+.......+ .....|...|++||+++ +.++...|||+||.++++..+|..+....... .|.+
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~-- 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ-- 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc--
Confidence 999987766553222 22336788899999886 67899999999999999999987665432100 1110
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
+....+...|-......+...+..+++.+|-.|++.+.+..+
T Consensus 338 ---------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 ---------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ---------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 000011112222233455558899999999999988877644
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.7e-15 Score=142.34 Aligned_cols=209 Identities=24% Similarity=0.292 Sum_probs=146.6
Q ss_pred HHHHhcCCCCeeeeeeEEecC-----CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 046892 126 LMLSLLHHPNLVNLIGYCADG-----DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200 (519)
Q Consensus 126 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~ 200 (519)
.-|-.+-|.|||+++.|+.+. ....++.|||..|+|..+|.........+......+|+.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 445556799999999998653 4578999999999999999988777778888888999999999999999985 7
Q ss_pred CeEecCCCCCCeeeCCCCCcEEeeecccccCCC--CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh
Q 046892 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ--GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278 (519)
Q Consensus 201 ~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~--~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt 278 (519)
+|+|+++..+-|++..+|-+||.----...... ...........|-++|.|||.=.....+.++|||+||...++|..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 799999999999999999888753111110000 000011122346789999997666667789999999999999998
Q ss_pred CCCCC-CCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 279 GRRVI-DTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 279 G~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
|..-. ...........+..+...+. +. .-..++..|++..|..||+|.+++-|+-.+
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~le---------n~------------lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLE---------NG------------LQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred heeccCCCcceeehhhhhhhheeecc---------Cc------------cccCcCcccccCCCCCCcchhhhhcCceee
Confidence 86432 11111111111110000000 11 112477889999999999999998776543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.1e-12 Score=136.17 Aligned_cols=170 Identities=19% Similarity=0.224 Sum_probs=131.2
Q ss_pred EEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCC
Q 046892 95 KGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKP 174 (519)
Q Consensus 95 ~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~ 174 (519)
.|..+.++.+|.|...............+-+..|+.++||||+++++.++.++..|||+|.+ ..|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 57777889999999887765533455677788999999999999999999999999999998 367777743
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhh
Q 046892 175 LDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254 (519)
Q Consensus 175 l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~ 254 (519)
+....+...+.||+.||.|||+.++ ++|++|.-+.|+|++.|..||++|.++.......... ....---.|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhh
Confidence 3356677788999999999997665 9999999999999999999999999886543322100 01111223666765
Q ss_pred hccCCCCchhHHHHHHHHHHHHHhC
Q 046892 255 ARSGELTVKSDVYSFGVILLELITG 279 (519)
Q Consensus 255 l~~~~~~~~sDvwSlGvll~elltG 279 (519)
+.... -..|.|.|||+++|++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 43222 457999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.8e-13 Score=141.04 Aligned_cols=141 Identities=22% Similarity=0.176 Sum_probs=97.0
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh----------------------------------------HHHH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN----------------------------------------KEFL 122 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~----------------------------------------~~~~ 122 (519)
+.||.|++|.||+|+.. +|+.||||+.+....... -++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 68999999999999986 589999999754321100 0133
Q ss_pred HHHHHHHhc----CCCCeeeeeeEEe-cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 046892 123 VEVLMLSLL----HHPNLVNLIGYCA-DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ-GLEYLHD 196 (519)
Q Consensus 123 ~E~~~l~~l----~HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~ 196 (519)
.|+..+..+ .|.+-+.+-.++. .....+|||||++|++|.++..... ..++ ...++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 344444433 2333233333332 2345789999999999988764311 1122 3346666665 4788999
Q ss_pred cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 197 ~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
.| ++|+|++|.||+++.++.++|+|||++.....
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99 99999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.9e-14 Score=154.91 Aligned_cols=288 Identities=21% Similarity=0.205 Sum_probs=193.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.+.+.+.+.+-.|+++.++.+.-..+|...++|........ ..+....+-.++-...+|.++.....+.-....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45677777888999999999988878877777765433211 112222333333334457777666656667788999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
++|+.+++|...|+.. +..+..-++..+..+..+++|||... ++|+|++|.|+|+..++..+++|||......
T Consensus 883 ~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999988542 35666667778888999999999998 9999999999999999999999998432110
Q ss_pred CC---------------------C--------ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 046892 233 QG---------------------E--------KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVI 283 (519)
Q Consensus 233 ~~---------------------~--------~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf 283 (519)
.. . .........||+.|.+||.+.+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 0 001123467999999999999999999999999999999999999999
Q ss_pred CCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHH---HHHHHHhhhhcCC
Q 046892 284 DTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMS---DVVTALSFLSNSK 360 (519)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~---evl~~l~~~~~~~ 360 (519)
....+.... ..+......+ ..-+.....++.+++...+..+|.+|..+. ++-.+..+-...+
T Consensus 1036 na~tpq~~f------~ni~~~~~~~---------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1036 NAETPQQIF------ENILNRDIPW---------PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred CCcchhhhh------hccccCCCCC---------CCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 876553222 1111111000 112334455788899999999999998876 5544443322222
Q ss_pred CCCC---CCCCCCCCCCcCCCccCCCCC
Q 046892 361 EPIP---DPIIPSDEDEYSEGYSSDGHQ 385 (519)
Q Consensus 361 ~~~~---~p~~p~~~~~~~~~~~~~~~~ 385 (519)
..+. -++.|...+..+..|+...+.
T Consensus 1101 ~~l~~q~~~~~p~~~s~~dtS~~~~r~~ 1128 (1205)
T KOG0606|consen 1101 ENLALQKAEFVPQPESTQDTSYFESRFS 1128 (1205)
T ss_pred cccccccCccCCCCCCCCccchhhcccc
Confidence 2221 234444444444455544443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.5e-14 Score=148.27 Aligned_cols=146 Identities=20% Similarity=0.196 Sum_probs=95.8
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--------------------------C--------hH---
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--------------------------G--------NK--- 119 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--------------------------~--------~~--- 119 (519)
..|+. +.||.|++|+||+|+++.+|+.||||+++..-.. . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 7999999999999999988999999998754210 0 01
Q ss_pred ---HHHHHHHHHHhc----CCCCeeeeeeEEec-CCceEEEEEecCCCCHHHHHh--hhccCCCCCCHHHHHHHHHHHHH
Q 046892 120 ---EFLVEVLMLSLL----HHPNLVNLIGYCAD-GDQRLLVYEFMSGGSVDDHLL--DVNETKKPLDWTTRMKIASGAAQ 189 (519)
Q Consensus 120 ---~~~~E~~~l~~l----~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~--~~~~~~~~l~~~~~~~i~~qi~~ 189 (519)
++..|+..+..+ .+...+.+-.++.+ ....+|||||+.|+.|.++.. ........+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 123343333333 23333444444433 445689999999999987431 111011123333344444444
Q ss_pred HHHHHHhcCCCCeEecCCCCCCeeeCCCC----CcEEeeecccccCCC
Q 046892 190 GLEYLHDKANPPVIYRDLKSSNILLGANL----DPKLSDFGLAKLGPQ 233 (519)
Q Consensus 190 aL~~LH~~~~~~IvHrDikp~NILl~~~~----~vkL~DFGla~~~~~ 233 (519)
...| ++|+|++|.||+++.++ .++++|||++.....
T Consensus 277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3577 99999999999999888 999999999986644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=118.75 Aligned_cols=131 Identities=18% Similarity=0.098 Sum_probs=96.7
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCee-eeeeEEecCCceEEEEEecCCCC
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
.+.|+.|.++.||+++.. +..|++|+...... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 357889999999999875 78899998754421 223467788888887655544 455443 234589999999987
Q ss_pred HHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 161 VDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA--NPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 161 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+.... .....++.+++.+|+.||..+ ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus 78 l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 65420 011245778999999999987 22259999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-12 Score=136.77 Aligned_cols=250 Identities=21% Similarity=0.234 Sum_probs=179.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEc-CCCeEEEEEEeccCCCcChHH--HHHHHHHHHhc-CCCCeeeeeeEEecCCceE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQ-SNGQVVAVKQLDRNGMQGNKE--FLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 150 (519)
...+|..+..||.|.|+.|+.+... .++..|++|.+.........+ -+.|+.+...+ .|.+++..+..+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888999999999999987755 678899999876553333222 23455555444 4888888888887777888
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CCcEEeeecccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAK 229 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-~~vkL~DFGla~ 229 (519)
+-.|||.++++...+ .....+++...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||+++
T Consensus 343 ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 999999999887766 23345788889999999999999999999 9999999999999886 788999999987
Q ss_pred cCCCCCccceecccccccccC--chhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYC--APEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~--APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
.+.-.. ....+..+++ +++.+....+..++|+|+||+.+.+.++|...-.... .|.. +.. ..
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~-i~~--~~ 479 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT-IRS--GD 479 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee-eec--cc
Confidence 422111 1122333444 5556666788899999999999999999875432211 0000 000 00
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+ ..+ .....+..+...+...++..||.+.++..+..+..
T Consensus 480 ~p---------~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 480 TP---------NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cc---------CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00 011 11256777888899999999999999888776654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.6e-10 Score=118.59 Aligned_cols=171 Identities=19% Similarity=0.224 Sum_probs=134.5
Q ss_pred cEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec----CCceEEEEEecCC-CCHHHH
Q 046892 90 FGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEFMSG-GSVDDH 164 (519)
Q Consensus 90 ~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~ 164 (519)
-.+.|++....+|..|++|++.............-+++++++.|.|||++.++|.. +..++|||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45689999999999999999955444444445567889999999999999998863 4568899999875 578877
Q ss_pred Hhhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 165 LLDVNE-----------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 165 l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
.+.... .+..+++..+|.++.||..||.++|+.| +.-+-|.|.+||++.+.+++|+..|+..+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 654221 2345789999999999999999999999 88899999999999999999999888766543
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCC
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRV 282 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~p 282 (519)
+.. |.+.+ -.+-|.=.||.+|+-|.||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11111 2357999999999999999654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.7e-11 Score=111.02 Aligned_cols=136 Identities=15% Similarity=0.082 Sum_probs=97.7
Q ss_pred eeeeccCcEEEEEEEEcC------CCeEEEEEEeccCCC---------------------cC-hHHH----HHHHHHHHh
Q 046892 83 CLLGEGGFGRVYKGTLQS------NGQVVAVKQLDRNGM---------------------QG-NKEF----LVEVLMLSL 130 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~------~~~~vAvK~~~~~~~---------------------~~-~~~~----~~E~~~l~~ 130 (519)
.+||.|--+.||.|.... .+..+|||+.+.... .. ...+ ..|+..|..
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998653 357899998742210 00 1122 368888887
Q ss_pred cCC--CCeeeeeeEEecCCceEEEEEecCCCCHHH-HHhhhccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 046892 131 LHH--PNLVNLIGYCADGDQRLLVYEFMSGGSVDD-HLLDVNETKKPLDWTTRMKIASGAAQGLEYL-HDKANPPVIYRD 206 (519)
Q Consensus 131 l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~IvHrD 206 (519)
+.. -++..++++ ...+|||||+.+..+.. .+.+ ..++......++.+++.+|..| |..+ |||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 753 456666664 45689999997643322 2211 2345556677889999999999 8888 99999
Q ss_pred CCCCCeeeCCCCCcEEeeecccccC
Q 046892 207 LKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 207 ikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|++.|||+. ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=110.30 Aligned_cols=142 Identities=22% Similarity=0.282 Sum_probs=108.3
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCC--CCeeeeeeEEecC---CceEEEEEec
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHH--PNLVNLIGYCADG---DQRLLVYEFM 156 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~ 156 (519)
+.|+.|.++.||++.... |..+++|....... .....+..|+.++..+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 578999999999998753 68899998765432 134568889999998875 3467777776653 2568999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA-------------------------------------- 198 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------- 198 (519)
+|.+|.+.+.. ..++......++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99887765421 34677777778888888888888521
Q ss_pred ---------------CCCeEecCCCCCCeeeCC--CCCcEEeeeccccc
Q 046892 199 ---------------NPPVIYRDLKSSNILLGA--NLDPKLSDFGLAKL 230 (519)
Q Consensus 199 ---------------~~~IvHrDikp~NILl~~--~~~vkL~DFGla~~ 230 (519)
...++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234899999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.3e-10 Score=102.01 Aligned_cols=131 Identities=24% Similarity=0.340 Sum_probs=98.1
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEE-eccCCCc-------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQ-LDRNGMQ-------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~-~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..+++|+-+.+|.+.+. |..+++|. +.+.-.. ......+|+.++..+.--.|..-+=+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999775 55577774 2222111 11335678888887765555444445567778899999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
|++|..|.+++... ...++..+-.-+.-||..| |||+||.++||++..+. +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998998888432 2457778888899999999 99999999999998765 99999999974
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.3e-09 Score=107.75 Aligned_cols=264 Identities=17% Similarity=0.213 Sum_probs=161.4
Q ss_pred cceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHh-cCCCCeeeeeeE----E--ecCC-ceEEE
Q 046892 81 QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSL-LHHPNLVNLIGY----C--ADGD-QRLLV 152 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~----~--~~~~-~~~lV 152 (519)
..+.||+|+-+.+|-.-.- .-.+.|++.........+... .|.. -.||-+..=+.| . -+.. ...++
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4568999999999975432 124567776554333222222 2222 235543221111 1 1122 25678
Q ss_pred EEecCCCCHHHHHhh---hccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLD---VNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
|..+.+..--..+.. .........|...++++..|+.+.+.||..| .+-+|+.++|+||.+++.|.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 888876532222221 1223345789999999999999999999999 8999999999999999999999866554
Q ss_pred cCCCCCccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCc-----chhhHHHhh
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITG-RRVIDTTRPV-----DEQNLIAWA 298 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG-~~pf~~~~~~-----~~~~~~~~~ 298 (519)
+...+. .....+|...|.+||.-. +-.-+...|.|.||++|++|+.| ++||.+.... ....-|...
T Consensus 166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 432222 233467899999999754 34556789999999999999887 8999764221 111111111
Q ss_pred chhccCCCCCCcccchHhhccCC-hhhHHHHHHHHHHhhhh--CCCCCCCHHHHHHHHhhhhcC
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFP-EKGLNEAVAIAAMCLQE--EAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~l~~~~~~ 359 (519)
...+....... ...+. ...| ......+..|..+|+.. ++.-|||++.++..|..+...
T Consensus 243 ~f~ya~~~~~g-~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRRG-LKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccCC-CCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111000000 00000 0011 12234566778888876 467899999999998877653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.1e-09 Score=97.20 Aligned_cols=144 Identities=25% Similarity=0.310 Sum_probs=104.9
Q ss_pred cceeeeccCcEEEEEEEEcCCCeEEEEEEe-ccCC-------CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 81 QECLLGEGGFGRVYKGTLQSNGQVVAVKQL-DRNG-------MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~-~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
...+|-+|+-+.|+++.+. |+...||.= .+.- .-.......|+.+|.++.--.|.--.-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678899999999999886 888888842 2111 01224567788888877644554444456677778899
Q ss_pred EEecCC-CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---CcEEeeeccc
Q 046892 153 YEFMSG-GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL---DPKLSDFGLA 228 (519)
Q Consensus 153 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~---~vkL~DFGla 228 (519)
|||++| .++.+++...... .........++..|-+.+.-||..+ |||+||..+||+|..++ .+.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999976 4788888664332 1222333678899999999999999 99999999999996544 3589999998
Q ss_pred ccC
Q 046892 229 KLG 231 (519)
Q Consensus 229 ~~~ 231 (519)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-08 Score=99.69 Aligned_cols=141 Identities=17% Similarity=0.128 Sum_probs=99.0
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-----------ChHHHHHHHHHHHhcCCCCe--eeeeeEEec----
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-----------GNKEFLVEVLMLSLLHHPNL--VNLIGYCAD---- 145 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~---- 145 (519)
+.+-......|+++... |+.|.||........ ....+.+|...+..+..-+| +.++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34444444557777653 789999976433211 11136788888777743333 344445432
Q ss_pred -CCceEEEEEecCCC-CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-------
Q 046892 146 -GDQRLLVYEFMSGG-SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA------- 216 (519)
Q Consensus 146 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~------- 216 (519)
....+||||++++. +|.+++.... ....+......++.+++..+.-||..| |+|+||++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23578999999876 7888875322 234566777889999999999999999 999999999999975
Q ss_pred CCCcEEeeeccccc
Q 046892 217 NLDPKLSDFGLAKL 230 (519)
Q Consensus 217 ~~~vkL~DFGla~~ 230 (519)
++.+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46799999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-08 Score=95.21 Aligned_cols=125 Identities=22% Similarity=0.260 Sum_probs=80.0
Q ss_pred EEEEEEEcCCCeEEEEEEeccCCCc---------------------C-----hHHHHHHHHHHHhcCCC--CeeeeeeEE
Q 046892 92 RVYKGTLQSNGQVVAVKQLDRNGMQ---------------------G-----NKEFLVEVLMLSLLHHP--NLVNLIGYC 143 (519)
Q Consensus 92 ~Vy~~~~~~~~~~vAvK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~Hp--nIv~l~~~~ 143 (519)
.||.|... +|..+|||+.+..... . ......|...|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999885 4889999987432100 0 12356799999998765 466666553
Q ss_pred ecCCceEEEEEecC--CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 144 ADGDQRLLVYEFMS--GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY-LHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 144 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
..+|||||+. |..+..+. +.. +.......++.+++..+.. +|..| |||+||.+.|||++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-DVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-HCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHH-hcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4579999998 54444332 211 1123455677788885555 57888 9999999999999988 99
Q ss_pred EEeeecccccC
Q 046892 221 KLSDFGLAKLG 231 (519)
Q Consensus 221 kL~DFGla~~~ 231 (519)
.|+|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-09 Score=116.52 Aligned_cols=152 Identities=20% Similarity=0.270 Sum_probs=106.5
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc-------ceecccccccccCchhhhccC
Q 046892 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM-------NVTSRVMGTYGYCAPEYARSG 258 (519)
Q Consensus 186 qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~-------~~~~~~~Gt~~y~APE~l~~~ 258 (519)
+++.||.|+|..-. +||+.|.|++|.++.++.+||+.|+++......... ....-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44589999998764 999999999999999999999999988654331111 001112235679999999998
Q ss_pred CCCchhHHHHHHHHHHHHH-hCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhh
Q 046892 259 ELTVKSDVYSFGVILLELI-TGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQ 337 (519)
Q Consensus 259 ~~~~~sDvwSlGvll~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~ 337 (519)
..+.++|+|||||++|.+. .|+..+............. ..+..-...+...++.++.+=+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--------------~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--------------NLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--------------cccccccccccccCcHHHHHHHHHHhc
Confidence 8899999999999999999 5555554432221111110 111111223445666788889999999
Q ss_pred hCCCCCCCHHHHHHHH
Q 046892 338 EEAGARPLMSDVVTAL 353 (519)
Q Consensus 338 ~dP~~RPs~~evl~~l 353 (519)
.++.-||++..+....
T Consensus 251 ~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSIP 266 (700)
T ss_pred CCcccCcchhhhhccc
Confidence 9999999877775443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.3e-07 Score=88.11 Aligned_cols=106 Identities=23% Similarity=0.240 Sum_probs=81.3
Q ss_pred hHHHHHHHHHHHhcCCC--CeeeeeeEEecC----CceEEEEEecCCC-CHHHHHhhhccCCCCCCHHHHHHHHHHHHHH
Q 046892 118 NKEFLVEVLMLSLLHHP--NLVNLIGYCADG----DQRLLVYEFMSGG-SVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190 (519)
Q Consensus 118 ~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 190 (519)
.....+|...+..+..- .+...+++.+.. ...+||+|++++. +|.+++.... .++......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 34567787777666432 345555555442 2458999999874 7898885422 25666778899999999
Q ss_pred HHHHHhcCCCCeEecCCCCCCeeeCCCC---CcEEeeeccccc
Q 046892 191 LEYLHDKANPPVIYRDLKSSNILLGANL---DPKLSDFGLAKL 230 (519)
Q Consensus 191 L~~LH~~~~~~IvHrDikp~NILl~~~~---~vkL~DFGla~~ 230 (519)
++-||..| |+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999998887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.8e-07 Score=90.06 Aligned_cols=136 Identities=20% Similarity=0.152 Sum_probs=98.0
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC------------------c----ChHHHHHHHHHHHhcCCC-
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM------------------Q----GNKEFLVEVLMLSLLHHP- 134 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------------------~----~~~~~~~E~~~l~~l~Hp- 134 (519)
-+.+...||-|--+.||.|.+. .|..+|||.-+.... . ......+|...|..+...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3567789999999999999987 488999996421100 0 112346788888887654
Q ss_pred -CeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 046892 135 -NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213 (519)
Q Consensus 135 -nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NIL 213 (519)
.+.+.+++ +.-.+||||++|-.|...- ++....-.++..|++-+..+-..| |||+|+.+-|||
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 56666654 4568999999886554331 123344456666666666666777 999999999999
Q ss_pred eCCCCCcEEeeeccccc
Q 046892 214 LGANLDPKLSDFGLAKL 230 (519)
Q Consensus 214 l~~~~~vkL~DFGla~~ 230 (519)
++++|.+.++||--+..
T Consensus 235 V~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 235 VTEDGDIVVIDWPQAVP 251 (304)
T ss_pred EecCCCEEEEeCccccc
Confidence 99999999999986653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=7.5e-07 Score=83.73 Aligned_cols=139 Identities=17% Similarity=0.127 Sum_probs=101.7
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCC------CcChHHHHHHHHHHHhcCCCC--eeeeeeEEec----CCceEEE
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNG------MQGNKEFLVEVLMLSLLHHPN--LVNLIGYCAD----GDQRLLV 152 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~----~~~~~lV 152 (519)
-|+||.+.|+..... |+.+-+|.-...- ......|.+|+..|..+..-+ +.++..+... ....+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 467999999998775 5578899764210 235678999999988875322 4444422111 2246799
Q ss_pred EEecCC-CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC--cEEeeecccc
Q 046892 153 YEFMSG-GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD--PKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~--vkL~DFGla~ 229 (519)
+|-+.| -+|.+++.+. ...+.+......++.+|+..|+-||+.| +.|+|+-+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998753 4788887432 2234677778899999999999999999 999999999999986667 9999998765
Q ss_pred c
Q 046892 230 L 230 (519)
Q Consensus 230 ~ 230 (519)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.9e-06 Score=83.09 Aligned_cols=141 Identities=14% Similarity=0.177 Sum_probs=85.6
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eeeeeeEEecCCceEEEEEecCCCC
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
..||+|..+.||+.. +..+++|...... ......+|..++..+..-. +.+++++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 578999999999841 4457889875432 3455788999988876433 4777888877888899999998863
Q ss_pred -HHHHH------------------hhhccC-CCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEecCC
Q 046892 161 -VDDHL------------------LDVNET-KKPLDWTTRMK-IAS----------GAAQ-GLEYLHDK-ANPPVIYRDL 207 (519)
Q Consensus 161 -L~~~l------------------~~~~~~-~~~l~~~~~~~-i~~----------qi~~-aL~~LH~~-~~~~IvHrDi 207 (519)
+...+ ...+.- ........... +.. .+.. ...+|... ....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11111 111110 00111111000 000 0111 12222211 1234799999
Q ss_pred CCCCeeeCCCCCcEEeeeccccc
Q 046892 208 KSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 208 kp~NILl~~~~~vkL~DFGla~~ 230 (519)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.6e-07 Score=98.51 Aligned_cols=141 Identities=20% Similarity=0.191 Sum_probs=90.4
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--------------------------h--------------HHHH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--------------------------N--------------KEFL 122 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--------------------------~--------------~~~~ 122 (519)
..|+.++-|.||+|+..+ |+.||||+.+.+-... . -++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999986 9999999975431110 0 0123
Q ss_pred HHHHHHHhcC-----CCCeeeeeeEEe-cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 046892 123 VEVLMLSLLH-----HPNLVNLIGYCA-DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG-LEYLH 195 (519)
Q Consensus 123 ~E~~~l~~l~-----HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~a-L~~LH 195 (519)
.|...+..+. .++ +.+=.+|. -.....|+|||++|-.+.+...-.. ..++... ++..++.+ +..+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~---ia~~~~~~f~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKE---LAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHH---HHHHHHHHHHHHHH
Confidence 3443333331 233 22223332 2456789999999988888742211 2344222 22222222 33333
Q ss_pred hcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 196 ~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
..| ++|.|..|.||+++.+|.+.+.|||+.......
T Consensus 283 ~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 RDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred hcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 466 999999999999999999999999998765543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.7e-08 Score=106.40 Aligned_cols=193 Identities=18% Similarity=0.121 Sum_probs=140.8
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC-eeeeeeEEecCCceEE
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLL 151 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~l 151 (519)
+..+..|....-+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..+...++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 334445556667899999999998876654444 6665433 45566889999999999 7777777777888999
Q ss_pred EEEecCCC-CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 152 VYEFMSGG-SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 152 V~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+++++.++ +...... ...-.+...+...+...-+++|++||+.- =+|+| ||+..+ +..+..||+....
T Consensus 312 ~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred hhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence 99999877 2221110 11112333444556666678899999875 58998 777665 6889999999876
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDT 285 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~ 285 (519)
+.... ......+|+.|+|||+.....+....|+|++|+-..+|.-|-+|-..
T Consensus 381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 65443 23457799999999999999999999999999988888888776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.9e-06 Score=78.05 Aligned_cols=137 Identities=13% Similarity=0.133 Sum_probs=89.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHH---------HHHHHHHHhcC---CCCeeeeeeE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---------LVEVLMLSLLH---HPNLVNLIGY 142 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~---------~~E~~~l~~l~---HpnIv~l~~~ 142 (519)
...+|...+++-......|.+... +|..+++|............| .+++..+..+. --.++.++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 356788888888777777776655 488899998765433222222 22333232332 2223333322
Q ss_pred Ee-----cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 046892 143 CA-----DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN 217 (519)
Q Consensus 143 ~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~ 217 (519)
.+ -....+|||||++|..|.++.. +++ .++..|.++|.-||..| ++|+|+.|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 22 2234568999999988776541 222 25566778899999999 9999999999999855
Q ss_pred CCcEEeeecccc
Q 046892 218 LDPKLSDFGLAK 229 (519)
Q Consensus 218 ~~vkL~DFGla~ 229 (519)
+ ++++||+..+
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 4 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.9e-06 Score=79.46 Aligned_cols=154 Identities=21% Similarity=0.176 Sum_probs=100.7
Q ss_pred ccccHHHHHHhccCcccceeee---ccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh-----------------------
Q 046892 65 QTFTFRELAAATKNFRQECLLG---EGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN----------------------- 118 (519)
Q Consensus 65 ~~~~~~~~~~~~~~y~~~~~LG---~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~----------------------- 118 (519)
...++..+........+....| .|--+.||+|... ++..||||++........
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3455666777777776666555 5666679998874 488999999854322111
Q ss_pred -HHHHHHHHHHHhcC--CCCeeeeeeEEecCCceEEEEEecCCC-CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 046892 119 -KEFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEFMSGG-SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194 (519)
Q Consensus 119 -~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 194 (519)
.....|+.-|..+. +-.+.+-+++. ...|||||+... .-.-.|.+ -++....+..+..++++.+.-|
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHH
Confidence 11234555555543 34445555544 347999998543 11111211 1233336777888888888888
Q ss_pred Hh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 195 HD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 195 H~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
-. .+ +||+||..-|||+. ++.+.|+|||-|....
T Consensus 183 ~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 183 YKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 87 56 99999999999999 8899999999887543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.8e-06 Score=81.30 Aligned_cols=144 Identities=20% Similarity=0.211 Sum_probs=82.9
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC--CeeeeeeEEec---CCceEEEEEec
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHP--NLVNLIGYCAD---GDQRLLVYEFM 156 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~---~~~~~lV~E~~ 156 (519)
++.|+.|..+.||++.... ..+++|..... .....+..|..++..+... .+.+++.+... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3679999999999999874 48999986543 3445677888888777533 35566664422 33468999999
Q ss_pred CCCCHHH----------------HHhhhccC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 046892 157 SGGSVDD----------------HLLDVNET---KKPLDWTT---------RMKI------------ASGAAQ-GLEYLH 195 (519)
Q Consensus 157 ~~gsL~~----------------~l~~~~~~---~~~l~~~~---------~~~i------------~~qi~~-aL~~LH 195 (519)
+|..+.. .+...... ...+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 11111111 11111110 0000 111222 233333
Q ss_pred hc----CCCCeEecCCCCCCeeeC-CCCCcEEeeecccc
Q 046892 196 DK----ANPPVIYRDLKSSNILLG-ANLDPKLSDFGLAK 229 (519)
Q Consensus 196 ~~----~~~~IvHrDikp~NILl~-~~~~vkL~DFGla~ 229 (519)
.. ....++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 234499999999999999 56666899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.1e-05 Score=78.45 Aligned_cols=141 Identities=18% Similarity=0.160 Sum_probs=84.3
Q ss_pred eeccCc-EEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEEecCCCCHH
Q 046892 85 LGEGGF-GRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEFMSGGSVD 162 (519)
Q Consensus 85 LG~G~~-g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 162 (519)
|-.|.. ..||++... +..+.||+..... ...+..|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444554 779998764 4678889875432 345677888887774 344667788777766789999999988776
Q ss_pred HHHh----------------hhccC---CCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----c
Q 046892 163 DHLL----------------DVNET---KKPLDWT--TRMKIAS--------------------GAAQGLEYLHD----K 197 (519)
Q Consensus 163 ~~l~----------------~~~~~---~~~l~~~--~~~~i~~--------------------qi~~aL~~LH~----~ 197 (519)
.... ..... ..++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 11110 0011100 0000000 01111222211 1
Q ss_pred CCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 198 ~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
..+.++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124499999999999999987788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.6e-05 Score=90.88 Aligned_cols=152 Identities=15% Similarity=0.261 Sum_probs=93.5
Q ss_pred ceeeeccCcEEEEEEEEcCCC--eEEEEEEeccCC-CcChHHHHHHHHHHHhcC-CCCe--eeeeeEEecC---CceEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNG--QVVAVKQLDRNG-MQGNKEFLVEVLMLSLLH-HPNL--VNLIGYCADG---DQRLLV 152 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~~lV 152 (519)
.+.|+.|.++.+|+......+ ..+++|+..... ......+.+|+.+|+.+. |.+| .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998775432 467788765432 223456889999999885 6654 7788887664 467899
Q ss_pred EEecCCCCHHH--------------------HHhhhccC----------CCCCC--HHHHHHHHH---------------
Q 046892 153 YEFMSGGSVDD--------------------HLLDVNET----------KKPLD--WTTRMKIAS--------------- 185 (519)
Q Consensus 153 ~E~~~~gsL~~--------------------~l~~~~~~----------~~~l~--~~~~~~i~~--------------- 185 (519)
|||++|..+.+ .|...+.- ..+.. ..++..+..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 11111110 00111 111211111
Q ss_pred HHHHHHHHHHhcCC--------CCeEecCCCCCCeeeCCC-CC-cEEeeecccccCCC
Q 046892 186 GAAQGLEYLHDKAN--------PPVIYRDLKSSNILLGAN-LD-PKLSDFGLAKLGPQ 233 (519)
Q Consensus 186 qi~~aL~~LH~~~~--------~~IvHrDikp~NILl~~~-~~-vkL~DFGla~~~~~ 233 (519)
.+...+.+|..+-. +.+||+|+++.|||++.+ +. +-|.||.++....+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 12334566644321 249999999999999753 33 57999999876443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.4e-05 Score=87.04 Aligned_cols=198 Identities=21% Similarity=0.196 Sum_probs=140.1
Q ss_pred HHHHHHHHHhcCCCCeeeeeeEEecCCc----eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046892 121 FLVEVLMLSLLHHPNLVNLIGYCADGDQ----RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196 (519)
Q Consensus 121 ~~~E~~~l~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 196 (519)
...|+..+..+.|+|++.++.|...... ..+..++|...++...+. ....++....+.+..++++||+|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3456777888999999999998755332 234457888888888773 44678899999999999999999999
Q ss_pred cCCCCeEecCCCCC---CeeeCCCCCcEEe--eecccccCCCCCccceecccccccccCchhhhccCCCCch--hHHHHH
Q 046892 197 KANPPVIYRDLKSS---NILLGANLDPKLS--DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK--SDVYSF 269 (519)
Q Consensus 197 ~~~~~IvHrDikp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~--sDvwSl 269 (519)
.. ..|.-|... +..++..+.+.++ ||+.+.......... ...-+..|.++|.+....++.+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 86 666666555 5555667777777 999887655433221 1223566888888776666554 799999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHH
Q 046892 270 GVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349 (519)
Q Consensus 270 Gvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 349 (519)
|.++..+..|..+-.... .....+...+ ...+.+....|+..++++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~~-----------------------~~~~~l~~~~----~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-----------------------VPVSLLDVLS----TSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCccccccc-----------------------chhhhhcccc----chhhhhhhhhhcchhhhhccchhhh
Confidence 999999999865432210 0011111111 1156778889999999999999999
Q ss_pred HHHHhh
Q 046892 350 VTALSF 355 (519)
Q Consensus 350 l~~l~~ 355 (519)
+.+...
T Consensus 432 l~~~f~ 437 (1351)
T KOG1035|consen 432 LTHPFL 437 (1351)
T ss_pred hhchhc
Confidence 988654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2e-05 Score=71.40 Aligned_cols=130 Identities=21% Similarity=0.235 Sum_probs=92.9
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCee-eeeeEEecCCceEEEEEecC
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~ 157 (519)
....+.||+|++|.||+|.+. |..+|+|+-..+ .....+..|+.+|..+.--++. ++|.+-. .++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhc
Confidence 345678999999999999997 778999986544 3346788899999888765553 4444432 345699999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCeeeCCCCCcEEeeeccccc
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK-SSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDik-p~NILl~~~~~vkL~DFGla~~ 230 (519)
|-.|.++-.. .+ .+-+..+++.---|...| |-|+.|. |..++|..++.+.|+||..|+.
T Consensus 96 G~~L~~~~~~-------~~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIG-------GD----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhc-------cc----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8888776521 01 223445666666677777 9999995 5555555566999999999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.4e-05 Score=74.61 Aligned_cols=103 Identities=25% Similarity=0.263 Sum_probs=81.3
Q ss_pred HHHHHHHhcCC-CCeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 046892 123 VEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPP 201 (519)
Q Consensus 123 ~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 201 (519)
.|..+++.+++ +++.+++|+| ..++|.||+..+++...-.. ......-+|..+.+|+.++++.+.+|+......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888876 6999999999 34789999987665421000 011124689999999999999999999865455
Q ss_pred eEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 202 VIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 202 IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+.-.|++++|+-+++++++|++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.04 E-value=8e-05 Score=69.99 Aligned_cols=128 Identities=19% Similarity=0.238 Sum_probs=89.6
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC----------------CcChHHHHHHHHHHHhcC------CCCeeee
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG----------------MQGNKEFLVEVLMLSLLH------HPNLVNL 139 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~E~~~l~~l~------HpnIv~l 139 (519)
..+||+|+.=.||.- . .+....||+..... .....+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999964 3 24558899887654 122355666766555444 7889999
Q ss_pred eeEEecCCceEEEEEecCC------CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 046892 140 IGYCADGDQRLLVYEFMSG------GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213 (519)
Q Consensus 140 ~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NIL 213 (519)
+|+.++.-...+|+|.+.+ .+|.+++.. ..++. .. ...+-+-..||-+.+ |+.+||+|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998643 257777732 33554 33 333444566777777 999999999999
Q ss_pred eCCC--C--CcEEee
Q 046892 214 LGAN--L--DPKLSD 224 (519)
Q Consensus 214 l~~~--~--~vkL~D 224 (519)
+... + .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9532 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=3e-05 Score=82.71 Aligned_cols=140 Identities=18% Similarity=0.161 Sum_probs=86.9
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-------------------------------------hHHHHHHH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-------------------------------------NKEFLVEV 125 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-------------------------------------~~~~~~E~ 125 (519)
+.||.-+.|.||+|+.+. |+.||||+-+..-... +-+|..|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 589999999999999986 9999999854321110 01123333
Q ss_pred HHH----HhcCCCC------eeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046892 126 LML----SLLHHPN------LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195 (519)
Q Consensus 126 ~~l----~~l~Hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 195 (519)
+-. ..+.|-+ |.++|-.+ .....|+||||+|..+.|.-.- ....++...+..-+.+... .-|=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~--~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYL--EQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHH--HHHH
Confidence 222 2223444 33333322 3457899999999887765321 1223444443333333222 2222
Q ss_pred hcCCCCeEecCCCCCCeeeCC----CCCcEEeeecccccCCC
Q 046892 196 DKANPPVIYRDLKSSNILLGA----NLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 196 ~~~~~~IvHrDikp~NILl~~----~~~vkL~DFGla~~~~~ 233 (519)
..| ++|+|=.|.||+++. ++.+.+-|||+......
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 345 999999999999983 67899999999876544
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.7e-05 Score=73.14 Aligned_cols=73 Identities=16% Similarity=0.188 Sum_probs=45.3
Q ss_pred eeeeccCcE-EEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC---CeeeeeeEEecC---CceEEEEEe
Q 046892 83 CLLGEGGFG-RVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHP---NLVNLIGYCADG---DQRLLVYEF 155 (519)
Q Consensus 83 ~~LG~G~~g-~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~---~~~~lV~E~ 155 (519)
+.|+.|+.. .||+. +..+++|..... .....+..|..++..+... -+..+++..... ...++||++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 467767766 48976 234778865432 2345788899888877532 234444443322 235889999
Q ss_pred cCCCCHH
Q 046892 156 MSGGSVD 162 (519)
Q Consensus 156 ~~~gsL~ 162 (519)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=72.89 Aligned_cols=78 Identities=15% Similarity=0.109 Sum_probs=56.5
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC---CCeeeeeeEEec---CCceEEEE
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH---PNLVNLIGYCAD---GDQRLLVY 153 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~---~~~~~lV~ 153 (519)
...+.||.|..+.||...... + .+.+|..+. ......+..|...|+.+.- -.+.++++++.+ .+..+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 345689999999999986542 3 467776432 1133578889999988753 367888888754 36689999
Q ss_pred EecCCCCH
Q 046892 154 EFMSGGSV 161 (519)
Q Consensus 154 E~~~~gsL 161 (519)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0004 Score=65.02 Aligned_cols=125 Identities=26% Similarity=0.356 Sum_probs=87.6
Q ss_pred cCcccceeeeccCc-EEEEEEEEcCCCeEEEEEEecc---CCC------------------cChHHHHHHHHHHHhc---
Q 046892 77 KNFRQECLLGEGGF-GRVYKGTLQSNGQVVAVKQLDR---NGM------------------QGNKEFLVEVLMLSLL--- 131 (519)
Q Consensus 77 ~~y~~~~~LG~G~~-g~Vy~~~~~~~~~~vAvK~~~~---~~~------------------~~~~~~~~E~~~l~~l--- 131 (519)
.+++.++.||.|.- |.||++... |..||+|++.. ... ....-|..|......+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67888899999999 999999986 88999999321 100 0112356676655444
Q ss_pred CCCCe--eeeeeEEecC------------------CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHH
Q 046892 132 HHPNL--VNLIGYCADG------------------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191 (519)
Q Consensus 132 ~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 191 (519)
.+.++ |+++||..-. ....||.||++... .+.. .-+.+|.+-|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHH
Confidence 45667 9999997322 12357888775532 1222 2355677778
Q ss_pred HHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 192 ~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
..+|..| |+-+|+++.|.. .-||+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8999999 999999999986 4589999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00042 Score=72.07 Aligned_cols=77 Identities=19% Similarity=0.171 Sum_probs=53.9
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-------CcChHHHHHHHHHHHhcC---CCCeeeeeeEEecCCceEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-------MQGNKEFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 151 (519)
.+.||.|.+..||++.....++.|+||.-.... ......+..|...|..+. -..+.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 357999999999999987533689999853210 123456677887777653 3457777776 4456789
Q ss_pred EEEecCCCC
Q 046892 152 VYEFMSGGS 160 (519)
Q Consensus 152 V~E~~~~gs 160 (519)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00023 Score=71.25 Aligned_cols=144 Identities=17% Similarity=0.149 Sum_probs=84.1
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eeeeeeE------EecCCceEEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVNLIGY------CADGDQRLLVY 153 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~ 153 (519)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456777888899998654 45688998754 23345666777777664322 4444432 22345678999
Q ss_pred EecCCCCHHH-----------HHhhhc---cC-C------CCCCHHHHH----------HHHHHHHHHHHHHHhc----C
Q 046892 154 EFMSGGSVDD-----------HLLDVN---ET-K------KPLDWTTRM----------KIASGAAQGLEYLHDK----A 198 (519)
Q Consensus 154 E~~~~gsL~~-----------~l~~~~---~~-~------~~l~~~~~~----------~i~~qi~~aL~~LH~~----~ 198 (519)
+|++|..+.. .|...+ .. . ....|.... .....+..++.++... -
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876421 111100 00 0 011121110 0111223344454431 1
Q ss_pred CCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 199 ~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23499999999999999987789999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00089 Score=64.58 Aligned_cols=74 Identities=19% Similarity=0.151 Sum_probs=47.5
Q ss_pred eeeeccCcEEEEEEEEcC-CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC-CeeeeeeEEecCCceEEEEEecCCCC
Q 046892 83 CLLGEGGFGRVYKGTLQS-NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
+.|..|-...||++.... .+..|++|+...... .......|+.++..+... -.+++++.+. ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999987653 256788997654321 112334688888777533 3455555433 248999999876
Q ss_pred H
Q 046892 161 V 161 (519)
Q Consensus 161 L 161 (519)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00046 Score=67.69 Aligned_cols=139 Identities=15% Similarity=0.076 Sum_probs=78.7
Q ss_pred eeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEEEecCCCCHHH
Q 046892 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEFMSGGSVDD 163 (519)
Q Consensus 85 LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gsL~~ 163 (519)
+..|-.+.+|+... ++..+++|........-......|..+++.+....+ .+++.... .++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45677888998873 467888997654322211235678888887764333 34444432 378999998866532
Q ss_pred --------------HHhhhccC---CCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCCeEecCCCCCC
Q 046892 164 --------------HLLDVNET---KKPLDWT-TRMKIASGA---------AQGLEYLHDK-----ANPPVIYRDLKSSN 211 (519)
Q Consensus 164 --------------~l~~~~~~---~~~l~~~-~~~~i~~qi---------~~aL~~LH~~-----~~~~IvHrDikp~N 211 (519)
.+...+.. ..+++.. .+..+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11111111 1122221 111211111 1112222211 12348999999999
Q ss_pred eeeCCCCCcEEeeeccccc
Q 046892 212 ILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 212 ILl~~~~~vkL~DFGla~~ 230 (519)
||++.++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0005 Score=69.37 Aligned_cols=145 Identities=18% Similarity=0.162 Sum_probs=80.9
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eeeeeeE------EecCCceEEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVNLIGY------CADGDQRLLVY 153 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~~~~~~~lV~ 153 (519)
.+.++.|....||++... +| .+++|+..... ....+..|+.++..+.... +.+++.. ....+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 456777777899998653 34 57789765421 2344556666666664222 3444332 12245678999
Q ss_pred EecCCCCHH-----------HHHhhhccCCCC-----------CCHHHHH------------HHHHHHHHHHHHHHh---
Q 046892 154 EFMSGGSVD-----------DHLLDVNETKKP-----------LDWTTRM------------KIASGAAQGLEYLHD--- 196 (519)
Q Consensus 154 E~~~~gsL~-----------~~l~~~~~~~~~-----------l~~~~~~------------~i~~qi~~aL~~LH~--- 196 (519)
+|++|..+. ..+...+..... -.|.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 999885432 111111100000 0111110 001123334555543
Q ss_pred -cCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 197 -KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 197 -~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
.-...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1123499999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0015 Score=66.16 Aligned_cols=156 Identities=17% Similarity=0.143 Sum_probs=81.4
Q ss_pred HHHHHhccCccc-----ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eeeeee-
Q 046892 70 RELAAATKNFRQ-----ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVNLIG- 141 (519)
Q Consensus 70 ~~~~~~~~~y~~-----~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~- 141 (519)
.++......|.+ .+.|+.|....+|+.... +..+++|++.. .....+..|+.++..+...+ +.+++.
T Consensus 10 ~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 10 DELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT--QGEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred HHHHHHHHhcCCchhhccchhccccccceEEEEeC--CCcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 344444444543 345667777889998764 33688998752 22334444555555443211 333332
Q ss_pred -----EEecCCceEEEEEecCCCCHH-----------HHHhhhccCC----------CCCCH-HHHHH------------
Q 046892 142 -----YCADGDQRLLVYEFMSGGSVD-----------DHLLDVNETK----------KPLDW-TTRMK------------ 182 (519)
Q Consensus 142 -----~~~~~~~~~lV~E~~~~gsL~-----------~~l~~~~~~~----------~~l~~-~~~~~------------ 182 (519)
+....+..+++++|++|..+. ..|...+... ..+.| .....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 122345678999999887431 1111111100 01111 11111
Q ss_pred HHHH-HHHHHHHHHhc----CCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 183 IASG-AAQGLEYLHDK----ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 183 i~~q-i~~aL~~LH~~----~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
.+.+ +...+..+... -..++||+|+.|.|||++.+...-|+||+.+..
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122333211 123499999999999999766568999998863
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=1.9e-05 Score=90.73 Aligned_cols=158 Identities=13% Similarity=0.016 Sum_probs=120.5
Q ss_pred HHHHHHhcCCCCeeeeeeEEec--CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--C
Q 046892 124 EVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA--N 199 (519)
Q Consensus 124 E~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~ 199 (519)
|...++...|++++..+.-... ....|.+++|+.+|.+.+.|....+....++...+.....+.+.+..-+|+.. +
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 4444555678888777665533 34568999999999999999876666666666666555555466666666543 2
Q ss_pred CCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhC
Q 046892 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG 279 (519)
Q Consensus 200 ~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG 279 (519)
...+|++||+-|.+|..+..+|++++|+.++..+. ....+...+++.|+.|++.+.-.++.++|+|..|+.+|++..|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 33799999999999999999999999999943222 2234456788999999999988999999999999999999888
Q ss_pred CCCC
Q 046892 280 RRVI 283 (519)
Q Consensus 280 ~~pf 283 (519)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0022 Score=64.46 Aligned_cols=143 Identities=19% Similarity=0.202 Sum_probs=82.8
Q ss_pred eeeeccCcEEEEEEEEcC------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC-eeeeeeEEecCCceEEEEEe
Q 046892 83 CLLGEGGFGRVYKGTLQS------NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~ 155 (519)
+.|..|-...||++.... .+..|++|+..... ........|..++..+...+ ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899987643 25789999865432 22345567877777765333 3455655532 368999
Q ss_pred cCCCCHHHH--------------HhhhccCCC--------CCC--HHHHHH--------------------------HHH
Q 046892 156 MSGGSVDDH--------------LLDVNETKK--------PLD--WTTRMK--------------------------IAS 185 (519)
Q Consensus 156 ~~~gsL~~~--------------l~~~~~~~~--------~l~--~~~~~~--------------------------i~~ 185 (519)
++|.++... |...+.... ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765431 111111100 011 111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCCeeeCCC----CCcEEeeeccccc
Q 046892 186 GAAQGLEYLHD------KANPPVIYRDLKSSNILLGAN----LDPKLSDFGLAKL 230 (519)
Q Consensus 186 qi~~aL~~LH~------~~~~~IvHrDikp~NILl~~~----~~vkL~DFGla~~ 230 (519)
.+...+.+|-. .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 133459999999999999985 8899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0017 Score=65.31 Aligned_cols=142 Identities=18% Similarity=0.228 Sum_probs=84.1
Q ss_pred cceeeeccCcEEEEEEEEcCCCeEEEEEEecc--CCCcChHHHHHHHHHHHhcCC--CCeeeeeeEEecCC--ceEEEEE
Q 046892 81 QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR--NGMQGNKEFLVEVLMLSLLHH--PNLVNLIGYCADGD--QRLLVYE 154 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~--~~~lV~E 154 (519)
+.+.+-.|.-..+|..... ++.+++. ... ..........+|+.++..+.- --+...+++|.++. ..+.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344433333345555443 7778888 331 222334456677777776542 23455567776665 6799999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHH-HHHHHHHHHHHh-------------------------------------
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIA-SGAAQGLEYLHD------------------------------------- 196 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~qi~~aL~~LH~------------------------------------- 196 (519)
|+.|..+.+.+.. .... ..++ ..++..|+-||+
T Consensus 106 ~veGe~~~~~~~~-------~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 106 WVEGEVVWSALPP-------ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EecceeccCcCCc-------ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 9988543332210 0000 1111 244444444443
Q ss_pred -------------cC-----CCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 197 -------------KA-----NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 197 -------------~~-----~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
+- .+.++|+|+.+.||+++.++.+-|.||+++....+.
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 21 246999999999999999888999999999875543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0026 Score=63.44 Aligned_cols=75 Identities=21% Similarity=0.251 Sum_probs=48.4
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCeeeeeeEEecCCceEEEEEec
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+..+.|+.|....+|+.. .++..+.||+-. ......|..|..-|+.|. --.+.+++++....+..+|||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345678889999999887 558889999865 223456788888887773 455788899888777889999999
Q ss_pred CCC
Q 046892 157 SGG 159 (519)
Q Consensus 157 ~~g 159 (519)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0045 Score=63.57 Aligned_cols=143 Identities=16% Similarity=0.164 Sum_probs=81.9
Q ss_pred eeeeccCcEEEEEEEEcC----CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEEEecC
Q 046892 83 CLLGEGGFGRVYKGTLQS----NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 157 (519)
..|-.|-...+|++.... .++.|++|+...... ..-....|..++..+..-++ .++++.+..+ .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455557788899987542 246799998765432 22223568888877754444 4566666432 5899998
Q ss_pred CCCHHHH--------------HhhhccCC---C--CCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 046892 158 GGSVDDH--------------LLDVNETK---K--PLDWTTRMKIASGA-----------------AQGLEYL----HD- 196 (519)
Q Consensus 158 ~gsL~~~--------------l~~~~~~~---~--~l~~~~~~~i~~qi-----------------~~aL~~L----H~- 196 (519)
+.+|... +...+... . ...+..+..++.++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 11111111 1 12233333333221 1112222 21
Q ss_pred cCCCCeEecCCCCCCeeeCC-CCCcEEeeeccccc
Q 046892 197 KANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKL 230 (519)
Q Consensus 197 ~~~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~ 230 (519)
.....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234999999999999986 46899999998763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00052 Score=68.08 Aligned_cols=145 Identities=14% Similarity=0.112 Sum_probs=96.1
Q ss_pred ccHHHHHHhcc---CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---------C--------c-----ChHHH
Q 046892 67 FTFRELAAATK---NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---------M--------Q-----GNKEF 121 (519)
Q Consensus 67 ~~~~~~~~~~~---~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---------~--------~-----~~~~~ 121 (519)
+.+-.|+.... -+.+.+.||-|--+.||.+.+.. |...++|.-+... . . ..-..
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 44444444433 36778999999999999998864 8889998532110 0 0 01123
Q ss_pred HHHHHHHHhcC-CCC-eeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046892 122 LVEVLMLSLLH-HPN-LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199 (519)
Q Consensus 122 ~~E~~~l~~l~-Hpn-Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~ 199 (519)
..|+..|+.+. |-. +.+.+++ +.-++|||++.|..|...- ...+... +...+..-+.-|-.+|
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~-------~v~d~~~---ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR-------HVEDPPT---LYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee-------ecCChHH---HHHHHHHHHHHHHHcC-
Confidence 55777777765 322 4444544 4568999999887766432 1122222 3444445556677788
Q ss_pred CCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 200 ~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
+||+|+.--||+|++++.++++||--+.
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999999997554
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0071 Score=60.07 Aligned_cols=32 Identities=28% Similarity=0.444 Sum_probs=26.4
Q ss_pred CCeEecCCCCCCeeeCCCCC-cEEeeecccccC
Q 046892 200 PPVIYRDLKSSNILLGANLD-PKLSDFGLAKLG 231 (519)
Q Consensus 200 ~~IvHrDikp~NILl~~~~~-vkL~DFGla~~~ 231 (519)
+.++|+|+.|.|||++.++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 34999999999999997555 469999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.022 Score=59.35 Aligned_cols=73 Identities=12% Similarity=0.067 Sum_probs=49.9
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-------cChHHHHHHHHHHHhcC---CCCeeeeeeEEecCCceEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-------QGNKEFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 151 (519)
.+.||.|....||+.... +..|+||+-..... ........|...|..+. ...+.+++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 467899999999998874 55699998642111 12334445566665543 347888888876 45688
Q ss_pred EEEecCC
Q 046892 152 VYEFMSG 158 (519)
Q Consensus 152 V~E~~~~ 158 (519)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.019 Score=58.80 Aligned_cols=74 Identities=19% Similarity=0.129 Sum_probs=47.9
Q ss_pred eeeccCcEEEEEEEEcCCCeEEEEEEecc-------CCCcChHHHHHHHHHHHhcC--CC-CeeeeeeEEecCCceEEEE
Q 046892 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDR-------NGMQGNKEFLVEVLMLSLLH--HP-NLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 153 (519)
.||.|....||++.....++.|+||.-.. ...-...+...|...|.... -| .+.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999864346899997431 11223345556777776543 24 34555543 455677999
Q ss_pred EecCCC
Q 046892 154 EFMSGG 159 (519)
Q Consensus 154 E~~~~g 159 (519)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.031 Score=56.19 Aligned_cols=28 Identities=25% Similarity=0.258 Sum_probs=24.9
Q ss_pred CeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 201 PVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 201 ~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
.++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.13 Score=49.06 Aligned_cols=69 Identities=23% Similarity=0.247 Sum_probs=46.1
Q ss_pred EEEEEEEEcCC-CeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCeeeeeeEEecCCceEEEEEecCCCCHH
Q 046892 91 GRVYKGTLQSN-GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEFMSGGSVD 162 (519)
Q Consensus 91 g~Vy~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 162 (519)
|.|..|....+ ...+.||+-. ......|..|+.-|..|. --.+.+++.+-.+.++.|+||||++-+.+.
T Consensus 27 G~inea~~v~dg~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceeEeecCCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 44444443333 4578888633 223355777876666553 456788888888889999999999886655
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0067 Score=63.75 Aligned_cols=166 Identities=24% Similarity=0.306 Sum_probs=93.1
Q ss_pred ChHHHHHHHHHHHhcCCCCeeeeeeEEec-CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046892 117 GNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195 (519)
Q Consensus 117 ~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 195 (519)
....+.-...+++.+.|+|+...+++... .....+|+|++ +.+|.+.+.... +- +...+
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-----l~------~~s~~-------- 84 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-----LK------DESLL-------- 84 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-----cc------hhhhc--------
Confidence 34567778889999999999999988754 34578899999 679998874321 11 11101
Q ss_pred hcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHH
Q 046892 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLE 275 (519)
Q Consensus 196 ~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~e 275 (519)
.++ +.|- || ++++| -++.. | | ....+|+|||++|.++.+
T Consensus 85 ~~~---~~~~-----~~-------~~~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AHG---VLHL-----NI-------IYITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILE 123 (725)
T ss_pred ccc---ccee-----hh-------hhccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHH
Confidence 112 2222 12 22333 11100 0 0 111249999999999999
Q ss_pred HHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHH
Q 046892 276 LITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349 (519)
Q Consensus 276 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 349 (519)
+..|...+... ...............+........ ...+.-.+...+.++...|+-..|..||...+.
T Consensus 124 l~L~~~l~~~~---~~s~~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 124 LYLGISLEAEL---TESEYLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHhhHHHHHH---HHHHHHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 99987655432 222222333333322211111110 111223345567788888999999988865544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.049 Score=54.97 Aligned_cols=30 Identities=17% Similarity=0.186 Sum_probs=27.7
Q ss_pred CeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 201 ~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
.++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.034 Score=56.44 Aligned_cols=141 Identities=17% Similarity=0.150 Sum_probs=90.5
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---------c-------------ChH----HHHHHHHHHHhcCC
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---------Q-------------GNK----EFLVEVLMLSLLHH 133 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---------~-------------~~~----~~~~E~~~l~~l~H 133 (519)
.+..+|..|--+.||.|... +|..+|||+++..-. . ..+ ....|+.-|..|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 34457778889999999875 588899998742210 0 001 12345666666654
Q ss_pred CCeeeeeeEEecCCceEEEEEecCCCC-HHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046892 134 PNLVNLIGYCADGDQRLLVYEFMSGGS-VDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNI 212 (519)
Q Consensus 134 pnIv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NI 212 (519)
-.|.----.. - ..-.|||+|+.... ..-.| ....++...+..+-.+++.-+.-|-..+. +||.||.--|+
T Consensus 226 aGIP~PePIl-L-k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPIL-L-KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred cCCCCCCcee-e-ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 4322111111 1 12369999994221 11122 22346677788888888888888887775 99999999999
Q ss_pred eeCCCCCcEEeeecccccC
Q 046892 213 LLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 213 Ll~~~~~vkL~DFGla~~~ 231 (519)
|+- +|.+.|+|-+-+...
T Consensus 297 Lyh-dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVEH 314 (520)
T ss_pred eEE-CCEEEEEEccccccC
Confidence 984 568999998876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.046 Score=55.78 Aligned_cols=143 Identities=16% Similarity=0.217 Sum_probs=80.3
Q ss_pred eeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.|..|=...+|++..... +..|++|+...... ..-.-..|..+++.+..-++ .++++++..+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 3455577778998875432 23788998754322 22234568888887765444 4566665322 58999977
Q ss_pred CCHHH--------------HHhhhccCC-----CCCCHHHHHHHHHHH----------------------HHHHHH---H
Q 046892 159 GSVDD--------------HLLDVNETK-----KPLDWTTRMKIASGA----------------------AQGLEY---L 194 (519)
Q Consensus 159 gsL~~--------------~l~~~~~~~-----~~l~~~~~~~i~~qi----------------------~~aL~~---L 194 (519)
.+|.. .+...+... .+-.+..+..++.++ ..-+.. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 111111111 011233333332221 111111 1
Q ss_pred H-hcC-CCCeEecCCCCCCeeeCC-CCCcEEeeeccccc
Q 046892 195 H-DKA-NPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKL 230 (519)
Q Consensus 195 H-~~~-~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~ 230 (519)
. ..+ ...++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 111 234899999999999975 57899999998864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.031 Score=56.60 Aligned_cols=103 Identities=18% Similarity=0.172 Sum_probs=72.3
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
...|++|++- |+.|.. .....+.++..++++.+..|.-+...- +.-|||+.-.||||+ .|.|.|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 3456777776 545432 233568899999999988888887765 489999999999999 9999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHH
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSF 269 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSl 269 (519)
+++........ --...--|-++.| .-+..-|||-+
T Consensus 367 lsRl~~~q~~i-------sy~rldhp~lF~G-~dd~QFeIYrl 401 (488)
T COG5072 367 LSRLSYSQGII-------SYNRLDHPDLFNG-VDDYQFEIYRL 401 (488)
T ss_pred eeecccCCcee-------eccccCchhhhcC-ccceeeeHHHH
Confidence 99954333211 1122345556663 33677788874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.049 Score=56.46 Aligned_cols=75 Identities=20% Similarity=0.167 Sum_probs=50.1
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEecc------CCCcChHHHHHHHHHHHhcC--CC-CeeeeeeEEecCCceEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR------NGMQGNKEFLVEVLMLSLLH--HP-NLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~~~~~~~lV 152 (519)
.+.||.|.-..||++.+...++.|+||.-.. .-.-...+...|...|+... -| .+.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4688999999999999854456899997431 11223455666777777553 34 45556543 55567789
Q ss_pred EEecCC
Q 046892 153 YEFMSG 158 (519)
Q Consensus 153 ~E~~~~ 158 (519)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.066 Score=54.45 Aligned_cols=141 Identities=20% Similarity=0.295 Sum_probs=80.4
Q ss_pred eeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC---CC---eeeeee----EEecCCceEEEE
Q 046892 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH---PN---LVNLIG----YCADGDQRLLVY 153 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---pn---Iv~l~~----~~~~~~~~~lV~ 153 (519)
.|.. .-..||+....+ |. +++|+.... ....++..|+..+..+.- +- |..+-| ....+...+-|+
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred cccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 3444 556789887763 44 499988765 445666677777766632 11 222222 122223778899
Q ss_pred EecCCCCHHH------------HHh---hhcc--------CCCCCCHHH----H---------HHHHHHHHHHHHHHHhc
Q 046892 154 EFMSGGSVDD------------HLL---DVNE--------TKKPLDWTT----R---------MKIASGAAQGLEYLHDK 197 (519)
Q Consensus 154 E~~~~gsL~~------------~l~---~~~~--------~~~~l~~~~----~---------~~i~~qi~~aL~~LH~~ 197 (519)
+|++|..+.. ++- .... ......|.. . .....++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999877662 110 0000 001123321 0 01223344444444443
Q ss_pred C----C---CCeEecCCCCCCeeeCCCCC-cEEeeecccc
Q 046892 198 A----N---PPVIYRDLKSSNILLGANLD-PKLSDFGLAK 229 (519)
Q Consensus 198 ~----~---~~IvHrDikp~NILl~~~~~-vkL~DFGla~ 229 (519)
- . ..|||+|+.|.|||++.+.. +.++|||-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 1 22999999999999998885 8999999775
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.061 Score=50.95 Aligned_cols=152 Identities=14% Similarity=0.111 Sum_probs=89.4
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCCCHHHHHh
Q 046892 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLL 166 (519)
Q Consensus 88 G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 166 (519)
|+.++.-.+...- |- ..+|++....-. ...-|..+..++..+. .|++|..- +...+.+|.|+|.....
T Consensus 73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----- 141 (308)
T ss_pred CCceEEEEecccc-ch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence 4444544444332 33 445555433222 3445677778877664 57777732 44456799999953211
Q ss_pred hhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccc
Q 046892 167 DVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT 246 (519)
Q Consensus 167 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt 246 (519)
.. . .++..=+.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|-+.... . +
T Consensus 142 --------~~---~-N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~ 194 (308)
T PF07387_consen 142 --------NF---S-NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------Q 194 (308)
T ss_pred --------ch---h-HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h------------e
Confidence 11 1 12222246788889543 2399999999999999999999999774321 0 1
Q ss_pred cccCchhhhccCCCCchhHHHHHHHHHHHHHhCC
Q 046892 247 YGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280 (519)
Q Consensus 247 ~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~ 280 (519)
..|.--| ....|.++.+-+|=.-+++++...
T Consensus 195 V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 195 VNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred eeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 1122211 134577777777777777776643
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.4 Score=48.82 Aligned_cols=71 Identities=18% Similarity=0.179 Sum_probs=42.5
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eee---eee--EEecCCceEEEEEecCCCC
Q 046892 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVN---LIG--YCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 88 G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~---l~~--~~~~~~~~~lV~E~~~~gs 160 (519)
+.-..||+.... ++..+++|+.+.. ......+..|+..+..+.... ++. .-| +...++..+.|+++++|..
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 556679998764 3677999987533 234556667777766553211 222 112 1223456788999998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.12 Score=48.91 Aligned_cols=30 Identities=33% Similarity=0.407 Sum_probs=21.4
Q ss_pred CeEecCCCCCCeee-CCCCCcEEeeeccccc
Q 046892 201 PVIYRDLKSSNILL-GANLDPKLSDFGLAKL 230 (519)
Q Consensus 201 ~IvHrDikp~NILl-~~~~~vkL~DFGla~~ 230 (519)
.++|+||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 39999999999999 8899999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.27 Score=52.17 Aligned_cols=76 Identities=9% Similarity=0.108 Sum_probs=46.7
Q ss_pred cceeeeccCcEEEEEEEEcCC--------CeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEE
Q 046892 81 QECLLGEGGFGRVYKGTLQSN--------GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLL 151 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~l 151 (519)
..+.|..|=...+|++..... ++.|.+++....... .-.-..|..++..+..-+| .++++.+. -+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~-lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~ 183 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDE-LYNPISEFEVYKTMSKYRIAPQLLNTFS----GGR 183 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccc-eeCHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence 345666677778999876421 467889987543221 1233457777766654444 35566553 356
Q ss_pred EEEecCCCCH
Q 046892 152 VYEFMSGGSV 161 (519)
Q Consensus 152 V~E~~~~gsL 161 (519)
|.+|++|.+|
T Consensus 184 I~efi~g~~l 193 (442)
T PTZ00296 184 IEEWLYGDPL 193 (442)
T ss_pred EEEeeCCccC
Confidence 8999988744
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.66 E-value=0.35 Score=56.81 Aligned_cols=30 Identities=40% Similarity=0.390 Sum_probs=25.5
Q ss_pred CeEecCCCCCCeeeCCCC--CcE-Eeeeccccc
Q 046892 201 PVIYRDLKSSNILLGANL--DPK-LSDFGLAKL 230 (519)
Q Consensus 201 ~IvHrDikp~NILl~~~~--~vk-L~DFGla~~ 230 (519)
.+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999999875 554 999998864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.5 Score=49.25 Aligned_cols=76 Identities=20% Similarity=0.253 Sum_probs=45.5
Q ss_pred ceeeeccCcEEEEEEEEcCCC-e-----EEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNG-Q-----VVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~-~-----~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E 154 (519)
.+.|..|-...+|++...... . .|.++.... .....-.-..|+.++..+...++ .++++.+.. ++|+|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 345655888899999764321 1 244444321 11111223568888888865544 556666642 69999
Q ss_pred ecCCCCHH
Q 046892 155 FMSGGSVD 162 (519)
Q Consensus 155 ~~~~gsL~ 162 (519)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 519 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-49 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-44 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-44 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-43 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-23 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-23 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-23 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-23 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-23 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-23 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-21 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-19 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 520 bits (1341), Expect = 0.0
Identities = 117/312 (37%), Positives = 168/312 (53%), Gaps = 20/312 (6%)
Query: 58 ETKNINAQTFTFRELAAATKNFRQEC------LLGEGGFGRVYKGTLQSNGQVVAVKQL- 110
E + +F+F EL T NF + +GEGGFG VYKG + N VAVK+L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLA 63
Query: 111 ---DRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD 167
D + ++F E+ +++ H NLV L+G+ +DGD LVY +M GS+ D L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 168 VNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227
++ PL W R KIA GAA G+ +LH+ I+RD+KS+NILL K+SDFGL
Sbjct: 124 LDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTR 287
A+ + + +TSR++GT Y APE R GE+T KSD+YSFGV+LLE+ITG +D R
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 288 PVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMS 347
Q L+ + I + K D D + + ++A+ CL E+ RP +
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 348 DVVTALSFLSNS 359
V L ++ S
Sbjct: 296 KVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 500 bits (1290), Expect = e-177
Identities = 114/318 (35%), Positives = 172/318 (54%), Gaps = 5/318 (1%)
Query: 46 ATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVV 105
AT N+ + +L AT NF + L+G G FG+VYKG L +G V
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKV 66
Query: 106 AVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL 165
A+K+ QG +EF E+ LS HP+LV+LIG+C + ++ +L+Y++M G++ HL
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 166 LDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225
+ + W R++I GAA+GL YLH +I+RD+KS NILL N PK++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183
Query: 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDT 285
G++K G + ++ ++++ V GT GY PEY G LT KSDVYSFGV+L E++ R I
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 286 TRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL 345
+ P + NL WA + + + DP L + + L + A CL + RP
Sbjct: 244 SLPREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 346 MSDVVTALSFLSNSKEPI 363
M DV+ L + +E +
Sbjct: 303 MGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 494 bits (1275), Expect = e-175
Identities = 120/294 (40%), Positives = 183/294 (62%), Gaps = 6/294 (2%)
Query: 63 NAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK-EF 121
+ F+ REL A+ NF + +LG GGFG+VYKG L ++G +VAVK+L QG + +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQF 74
Query: 122 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRM 181
EV M+S+ H NL+ L G+C +RLLVY +M+ GSV L + E++ PLDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 182 KIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241
+IA G+A+GL YLHD +P +I+RD+K++NILL + + DFGLAKL +VT+
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTT 193
Query: 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ--NLIAWAQ 299
V GT G+ APEY +G+ + K+DV+ +GV+LLELITG+R D R ++ L+ W +
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
+ ++ K+ + D L+ + ++ + + + +A +C Q RP MS+VV L
Sbjct: 254 GLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 8e-93
Identities = 77/314 (24%), Positives = 115/314 (36%), Gaps = 29/314 (9%)
Query: 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVL 126
L + + + G FG V+K L + VAVK Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 127 MLSLLHHPNLVNLIGYCADGD----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK 182
L + H N++ IG G L+ F GS+ D L + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCH 125
Query: 183 IASGAAQGLEYLH-------DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235
IA A+GL YLH D P + +RD+KS N+LL NL ++DFGLA G+
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 236 KMNVTSRVMGTYGYCAPEYARSG-----ELTVKSDVYSFGVILLELITGRRVIDTTRPVD 290
T +GT Y APE + ++ D+Y+ G++L EL + D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 291 EQNLIA--WAQPIFRDPKRF--PDMADPLLRKQFPE-KGLNEAVAIAAMCLQEEAGARPL 345
P D + P+LR + + G+ C +A AR
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 346 MSDVVTALSFLSNS 359
V ++ +
Sbjct: 306 AGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 3e-75
Identities = 82/336 (24%), Positives = 132/336 (39%), Gaps = 48/336 (14%)
Query: 67 FTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFL--VE 124
E + N + L+G G +G VYKG+L + + VAVK Q F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ---NFINEKN 57
Query: 125 VLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTT 179
+ + L+ H N+ I + LLV E+ GS+ +L + DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVS 112
Query: 180 RMKIASGAAQGLEYLH------DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK---- 229
++A +GL YLH D P + +RDL S N+L+ + +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 230 --LGPQGEKMNVTSRVMGTYGYCAPEYARS-------GELTVKSDVYSFGVILLELITGR 280
L GE+ N +GT Y APE + D+Y+ G+I E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 281 RVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL----LRKQFPEKGLNEAVAIAAM-- 334
+ V E + A+ + P F DM + R +FPE ++A+ ++
Sbjct: 233 TDLFPGESVPEYQM-AFQTEVGNHPT-FEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 335 ----CLQEEAGARPLMSDVVTALSFLSNSKEPIPDP 366
C ++A AR ++ L E
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 1e-73
Identities = 88/285 (30%), Positives = 129/285 (45%), Gaps = 28/285 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLIGY 142
+G G FG V++ +G VAVK L EFL EV ++ L HPN+V +G
Sbjct: 45 IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
+V E++S GS+ L + ++ LD R+ +A A+G+ YLH++ NPP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTV 262
++R+LKS N+L+ K+ DFGL++L + GT + APE R
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 263 KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR--FPDMADPLLRKQF 320
KSDVYSFGVIL EL T + +P N + KR P +P +
Sbjct: 219 KSDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA-- 270
Query: 321 PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPD 365
I C E RP + ++ L L S P P+
Sbjct: 271 ----------IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 7e-71
Identities = 88/287 (30%), Positives = 141/287 (49%), Gaps = 47/287 (16%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN-------KEFLVEVLMLSLLHHPNLV 137
+G+GGFG V+KG L + VVA+K L +G +EF EV ++S L+HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
L G + +V EF+ G + LLD P+ W+ ++++ A G+EY+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 198 ANPPVIYRDLKSSNILL-----GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
NPP+++RDL+S NI L A + K++DFGL++ + ++ S ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 253 E--YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL--IAWAQPIFRDPKR- 307
E A T K+D YSF +IL ++TG P DE + I + I + R
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFINMIREEGLRP 249
Query: 308 -FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
P+ P LR + +C + RP S +V L
Sbjct: 250 TIPEDCPPRLRN------------VIELCWSGDPKKRPHFSYIVKEL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-69
Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 43/283 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN----KEFLVEVLMLSLLHHPNLVNLI 140
+G GGFG+VY+ G VAVK + + + E + ++L HPN++ L
Sbjct: 15 IGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
G C LV EF GG ++ L + K + + A A+G+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 201 PVIYRDLKSSNILLGANLDP--------KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
P+I+RDLKSSNIL+ ++ K++DFGLA+ + KM+ G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183
Query: 253 EYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR--FPD 310
E R+ + SDV+S+GV+L EL+TG P + +A A + + P
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVAMNKLALPIPS 237
Query: 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
K + C + +RP ++++ L
Sbjct: 238 TCPEPFAK------------LMEDCWNPDPHSRPSFTNILDQL 268
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-68
Identities = 81/310 (26%), Positives = 128/310 (41%), Gaps = 30/310 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G G FG V K + VA+KQ++ + K F+VE+ LS ++HPN+V L G C
Sbjct: 16 VGRGAFGVVCKAKW--RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ LV E+ GGS+ + +L E M +QG+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 205 RDLKSSNILLGANLD-PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK 263
RDLK N+LL A K+ DFG A + + G+ + APE + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 264 SDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEK 323
DV+S+G+IL E+IT R +P DE A+ R +
Sbjct: 184 CDVFSWGIILWEVITRR------KPFDEIGGPAFR---------IMWAVHNGTRPPLIKN 228
Query: 324 GLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPSDEDEYSEGYSSDG 383
++ C ++ RP M ++V ++ L +P+ + G DG
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG--EDG 286
Query: 384 HQKNENTYDN 393
+ +
Sbjct: 287 RVEPYVDFAE 296
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 2e-68
Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 34/295 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG+G FG+ K T + G+V+ +K+L R + + FL EV ++ L HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ + E++ GG++ + W+ R+ A A G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR------------VMGTYGYCAP 252
RDL S N L+ N + ++DFGLA+L + R V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 253 EYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312
E K DV+SFG++L E+I P F D P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR--TMDFGLNVRGFLDRYC-PPNC 248
Query: 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL-SFLSNSKEPIPDP 366
P I C + RP + L + + +P
Sbjct: 249 PPSFFP------------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-65
Identities = 57/278 (20%), Positives = 106/278 (38%), Gaps = 39/278 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLIGY 142
L E G ++KG Q G + VK L ++F E L + HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 143 CADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
C + +M GS+ + L + T +D + +K A A+G+ +LH P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE---YARS 257
+ L S ++++ ++ ++S + + M + APE
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 258 GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR--FPDMADPL 315
+D++SF V+L EL+T P + + + + + R P P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
+ K + +C+ E+ RP +V L
Sbjct: 240 VSK------------LMKICMNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-62
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 42/297 (14%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLIGY 142
+G+G FG+VY G +G+V A++ +D + K F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRW--HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
C ++ G ++ + D K LD +IA +G+ YLH +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKL---GPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+++DLKS N+ N ++DFGL + G + + G + APE R
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 260 L---------TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310
+ SDV++ G I EL P Q A +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAEAIIWQMGTG------ 258
Query: 311 MADPLLRKQFPEKGLNEAVA-IAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDP 366
++ + G+ + ++ I C E RP + ++ L L + P
Sbjct: 259 -----MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-62
Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 27/274 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLIGY 142
+G G FG VYKG +G V AVK L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW--HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
Q +V ++ G S+ HL ++ + + IA A+G++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL-- 260
I+RDLKS+NI L + K+ DFGLA + + ++ G+ + APE R +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 261 -TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ 319
+ +SDVY+FG++L EL+TG+ D+ I + R PD+ +R
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM--VGRGSLS-PDL--SKVRSN 253
Query: 320 FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
P+ + A CL+++ RP ++ +
Sbjct: 254 CPK----RMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 9e-62
Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 45/307 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFL--VEVLMLSLLHHPNLVNLIG 141
+G+G +G V+ G G+ VAVK + E+ L+ H N++ I
Sbjct: 44 QIGKGRYGEVWMGKW--RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 142 YCADGD----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH-- 195
G Q L+ ++ GS+ D+L LD + +K+A + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 196 ---DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK---MNVTSRVMGTYGY 249
+ P + +RDLKS NIL+ N ++D GLA + +RV GT Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRY 212
Query: 250 CAPE------YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303
PE + + +D+YSFG+IL E+ + + +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVPS 268
Query: 304 DPKRFPDMADPLLRKQ----FPEKGLNEAV--AIAAM---CLQEEAGARPLMSDVVTALS 354
DP + DM + + K+ FP + ++ + + C +R V L+
Sbjct: 269 DPS-YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 355 FLSNSKE 361
+S S++
Sbjct: 328 KMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-61
Identities = 70/300 (23%), Positives = 118/300 (39%), Gaps = 45/300 (15%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFL--VEVLMLSLLHHPNLVNLIG 141
+G+G +G V++G+ G+ VAVK + K + E+ +L H N++ I
Sbjct: 15 CVGKGRYGEVWRGSW--QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 142 YCADGD----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH-- 195
Q L+ + GS+ D+L LD + ++I A GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 196 ---DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM---NVTSRVMGTYGY 249
+ P + +RDLKS NIL+ N ++D GLA + Q RV GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 250 CAPE------YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303
APE + + D+++FG++L E+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK----PPFYDVVPN 239
Query: 304 DPKRFPDMADPLLRKQ----FPEKGLNEAV--AIAAM---CLQEEAGARPLMSDVVTALS 354
DP F DM + Q P + ++ ++A + C + AR + L+
Sbjct: 240 DPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 4e-59
Identities = 72/306 (23%), Positives = 117/306 (38%), Gaps = 45/306 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFL--VEVLMLSLLHHPNLVNLIG 141
+G+G FG V++G G+ VAVK + + + E+ +L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKW--RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 142 YCADGD----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH-- 195
+ Q LV ++ GS+ D+L + + +K+A A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 196 ---DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM---NVTSRVMGTYGY 249
+ P + +RDLKS NIL+ N ++D GLA RV GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRY 217
Query: 250 CAPE------YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303
APE + E ++D+Y+ G++ E+ + + + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----LPYYDLVPS 273
Query: 304 DPKRFPDMADPL----LRKQFPEK-----GLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354
DP +M + LR P + L I C AR + LS
Sbjct: 274 DPS-VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 355 FLSNSK 360
LS +
Sbjct: 333 QLSQQE 338
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 17/208 (8%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPN 135
++ +G G FG V+ G L+++ +VAVK +FL E +L HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V LIG C +V E + GG L L T +++ AA G+EYL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC----- 250
K I+RDL + N L+ K+SDFG+++ G G
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWT 282
Query: 251 APEYARSGELTVKSDVYSFGVILLELIT 278
APE G + +SDV+SFG++L E +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 6e-45
Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 38/276 (13%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNL 136
+ + +G G F VYKG VA +L + + + F E ML L HPN+
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 137 VNLIGYCAD---GDQRLLVY-EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
V G + +++ E M+ G++ +L + K + +GL+
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQ 143
Query: 193 YLHDKANPPVIYRDLKSSNILL-GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
+LH + PP+I+RDLK NI + G K+ D GLA L ++ + V+GT + A
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMA 198
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRP-VDEQNLIAWAQPIFRD--PKRF 308
PE DVY+FG+ +LE+ T P + QN + + P F
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASF 251
Query: 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
+A P + K+ E C+++ R
Sbjct: 252 DKVAIPEV-KEIIEG-----------CIRQNKDERY 275
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 68/310 (21%), Positives = 111/310 (35%), Gaps = 40/310 (12%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
K++ LGEGGF V +G A+K++ + Q +E E M L +HPN+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 137 VNLIGYCADGDQR----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
+ L+ YC L+ F G++ + + + + L + + G +GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM-------G 245
+H +RDLK +NILLG P L D G + + + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 246 TYGYCAPE------YARSGELTVKSDVYSFGVILLELITGRRVID-TTRPVDEQNLIAWA 298
T Y APE + E ++DV+S G +L ++ G D + D L
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
Q R LL + + RP + +++ L L
Sbjct: 263 QLSIPQSPRHSSALWQLLNS----------------MMTVDPHQRPHIPLLLSQLEALQP 306
Query: 359 SKEPIPDPII 368
I
Sbjct: 307 PAPGQHTTQI 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 85 LGEGGFGRVYKGTLQ----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
LG+G FG V + G+VVAVK+L + + ++F E+ +L L H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 141 GYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G C +R L+ E++ GS+ D+L + K+ +D ++ S +G+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG-----YCAPE 253
I+RDL + NIL+ K+ DFGL K+ PQ ++ G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 254 YARSGELTVKSDVYSFGVILLELIT 278
+ +V SDV+SFGV+L EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQ----VVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNL 139
LG G FG VYKG G+ VA+K+L E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+G C L+ + M G + D++ E K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+++RDL + N+L+ K++DFGLAKL EK + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 260 LTVKSDVYSFGVILLELIT-GRR 281
T +SDV+S+GV + EL+T G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-42
Identities = 64/194 (32%), Positives = 107/194 (55%), Gaps = 7/194 (3%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G +G VY+G + VAVK L + M+ +EFL E ++ + HPNLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
++ EFM+ G++ D+L + N ++ + + +A+ + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
R+L + N L+G N K++DFGL++L G+ + + APE + ++KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 265 DVYSFGVILLELIT 278
DV++FGV+L E+ T
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-42
Identities = 68/202 (33%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 85 LGEGGFGRVYKGTLQ----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
LG+G FG V + G+VVAVK+L + + ++F E+ +L L H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 141 GYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G C +R L+ E++ GS+ D+L + K+ +D ++ S +G+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYAR 256
I+RDL + NIL+ K+ DFGL K+ PQ ++ + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-YKVKEPGESPIFWYAPESLT 221
Query: 257 SGELTVKSDVYSFGVILLELIT 278
+ +V SDV+SFGV+L EL T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 51/361 (14%), Positives = 100/361 (27%), Gaps = 79/361 (21%)
Query: 38 QKQPPAPPATIHRNEGTKQDETKNINA----QTFTFR-ELAAATKNFRQECLLGEGGFGR 92
+ P A T + D + + Q F EL + + +LG+
Sbjct: 29 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 88
Query: 93 VYKGTLQSNGQVVAVKQLDRNGMQGNKE----------------------------FLVE 124
+ T Q G+ V + F+
Sbjct: 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148
Query: 125 VLMLSLLHHPNLVNLIGYCADGD--QRLLVYEFMSG--GSVDDHLLDVNETKKPLDWTTR 180
++ ++ + D R +Y M + + LL + T K L R
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 208
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240
+++ + L LH +++ L+ +I+L L+ F +
Sbjct: 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGAR 259
Query: 241 SRVMGTYGYCAPEY-----------ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV 289
+ G+ PE R +T D ++ G+++ + P+
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD------LPI 313
Query: 290 DEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
+ + ++ IFR K P LL L+ R L
Sbjct: 314 TKDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPKEDRLLPLQA 357
Query: 350 V 350
+
Sbjct: 358 M 358
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G +G VY+G + VAVK L + +EFL E ++ + HPNLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
++ EFM+ G++ D+L + N ++ + + +A+ + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKL-------GPQGEKMNVTSRVMGTYGYCAPEYARS 257
RDL + N L+G N K++DFGL++L G K + + APE
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI--KWT------APESLAY 186
Query: 258 GELTVKSDVYSFGVILLELIT-GRR 281
+ ++KSDV++FGV+L E+ T G
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-41
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G G FG V+ G + +V A+K + R G ++F+ E ++ L HP LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ LV EFM G + D+L + T + + +G+ YL + VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT---YGYCAPEYARSGELT 261
RDL + N L+G N K+SDFG+ + + + GT + +PE +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 262 VKSDVYSFGVILLELIT-GRR 281
KSDV+SFGV++ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 20/238 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK---EFLVEVLMLSLLHHPNLVNLI 140
LG+G FG VY + + ++A+K L + ++ + EV + S L HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
GY D + L+ E+ G+V L + K + T I A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITE-LANALSYCHSKR-- 129
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
VI+RD+K N+LLG+ + K++DFG + P + GT Y PE
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DL--CGTLDYLPPEMIEGRMH 184
Query: 261 TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318
K D++S GV+ E + G+ P + + I R FPD R
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G+G FG V G G VAVK + + + FL E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 145 DGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ L +V E+M+ GS+ D+L + + L +K + + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAK---LGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
+RDL + N+L+ + K+SDFGL K K+ V + APE R +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------APEALREKKF 363
Query: 261 TVKSDVYSFGVILLELIT-GRR 281
+ KSDV+SFG++L E+ + GR
Sbjct: 364 STKSDVWSFGILLWEIYSFGRV 385
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 85 LGEGGFGRVYKGTLQ----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
LG+G FG V + G +VAVKQL +G ++F E+ +L LH +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 141 GYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
G ++ LV E++ G + D L + LD + + +S +G+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG-----YCAPE 253
++RDL + NIL+ + K++DFGLAKL P + V+ G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREPGQSPIFWYAPE 200
Query: 254 YARSGELTVKSDVYSFGVILLELIT 278
+ +SDV+SFGV+L EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 27/280 (9%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLV-EVLMLSLLHHP 134
+++ +G G +GR K +S+G+++ K+LD M + K+ LV EV +L L HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 135 NLVNLIGYCADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
N+V D L V E+ GG + + + ++ LD +++ + L+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 193 YLHDKANPP--VIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
H +++ V++RDLK +N+ L + KL DFGLA++ T +GT Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 251 APEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR-DPKRFP 309
+PE KSD++S G +L EL P + A I +R P
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIREGKFRRIP 237
Query: 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
L + I L + RP + ++
Sbjct: 238 YRYSDELNE------------IITRMLNLKDYHRPSVEEI 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 85 LGEGGFGRVYKGTL----QSNGQVVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V + G+ VAVK L +G + E+ +L L+H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 140 IGYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
G C + L+ EF+ GS+ ++L K ++ ++K A +G++YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYA 255
++RDL + N+L+ + K+ DFGL K ++ T + + APE
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-YTVKDDRDSPVFWYAPECL 201
Query: 256 RSGELTVKSDVYSFGVILLELIT 278
+ + SDV+SFGV L EL+T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G+G FG V G G VAVK + + + FL E +++ L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 145 DGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ L +V E+M+ GS+ D+L + + L +K + + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAK---LGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
+RDL + N+L+ + K+SDFGL K K+ V + APE R +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------APEALREKKF 191
Query: 261 TVKSDVYSFGVILLELIT-GRR 281
+ KSDV+SFG++L E+ + GR
Sbjct: 192 STKSDVWSFGILLWEIYSFGRV 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQV-VAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
LG G FG V G GQ VAVK + + G EF E + L HP LV G C
Sbjct: 16 LGSGQFGVVKLGKW--KGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ +V E++S G + ++L K L+ + +++ +G+ +L I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FI 126
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT---YGYCAPEYARSGEL 260
+RDL + N L+ +L K+SDFG+ + + +GT + APE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY----VLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 261 TVKSDVYSFGVILLELIT-GRR 281
+ KSDV++FG+++ E+ + G+
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-40
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQV-------VAVKQLDRNGMQGNKEFLVEVLMLS 129
++ LG+G F +++KG + G V +K LD+ ++ F M+S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 130 LLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ 189
L H +LV G C GD+ +LV EF+ GS+D +L + K ++ ++++A A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAA 124
Query: 190 GLEYLHDKANPPVIYRDLKSSNILL--------GANLDPKLSDFGLAKLGPQGEKMNVTS 241
+ +L + +I+ ++ + NILL G KLSD G+ S
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI-------------S 168
Query: 242 RVMGTYGYC-------APE-YARSGELTVKSDVYSFGVILLELIT-GRR 281
+ PE L + +D +SFG L E+ + G +
Sbjct: 169 ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 81 QECLLGEGGFGRVYKGTLQSNGQV--VAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNL 136
++ LG G FG V KG Q V VAVK L E L E ++ L +P +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V +IG C + + +LV E G ++ +L + + +++ + G++YL +
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEY 254
++RDL + N+LL K+SDFGL+K E ++ G + + APE
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPEC 191
Query: 255 ARSGELTVKSDVYSFGVILLELIT-GRR 281
+ + KSDV+SFGV++ E + G++
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-40
Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQV-VAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
LG G FG V G GQ VA+K + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKW--RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
++ E+M+ G + ++L E + +++ + +EYL K +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FL 142
Query: 204 YRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT---YGYCAPEYARSGEL 260
+RDL + N L+ K+SDFGL++ + + +G+ + PE +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY----VLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 261 TVKSDVYSFGVILLELIT-GRR 281
+ KSD+++FGV++ E+ + G+
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKM 220
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-40
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 82 ECLLGEGGFGRVYKGTLQSNGQV--VAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVN 138
+ LG G FG V +G + + VA+K L + + + E + E ++ L +P +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
LIG C + +LV E GG + L+ ++ + + ++ + G++YL +K
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY--GYCAPEYAR 256
++RDL + N+LL K+SDFGL+K + T+R G + + APE
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECIN 186
Query: 257 SGELTVKSDVYSFGVILLELIT-GRR 281
+ + +SDV+S+GV + E ++ G++
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 7e-40
Identities = 70/194 (36%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG+G FG V+ GT +V A+K L + G + FL E ++ L H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 248
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ +V E+MS GS+ D L ET K L + +A+ A G+ Y+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
RDL+++NIL+G NL K++DFGLA+L + + + APE A G T+KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 265 DVYSFGVILLELIT 278
DV+SFG++L EL T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQ----VVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LG G FG V+KG G+ V +K + D++G Q + +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+G C G LV +++ GS+ DH+ + + L + A+G+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+++R+L + N+LL + +++DFG+A L P +K + S + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 260 LTVKSDVYSFGVILLELIT-GRR 281
T +SDV+S+GV + EL+T G
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 81/365 (22%), Positives = 134/365 (36%), Gaps = 58/365 (15%)
Query: 40 QPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQ 99
P + R++ +T + R + L EGGF VY+
Sbjct: 3 GPGSLGGASGRDQSDFVGQTVELGELRLRVRRV------------LAEGGFAFVYEAQDV 50
Query: 100 SNGQVVAVKQLDRNGMQGNKEFLVEV-LMLSLLHHPNLVNLIGYCADGDQR--------L 150
+G+ A+K+L N + N+ + EV M L HPN+V + G + L
Sbjct: 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110
Query: 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSS 210
L+ E G V+ L E++ PL T +KI + ++++H + PP+I+RDLK
Sbjct: 111 LLTELCKGQLVEF--LKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVE 167
Query: 211 NILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM----------GTYGYCAPE---YARS 257
N+LL KL DFG A + +++ T Y PE +
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 258 GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317
+ K D+++ G IL L P ++ + + P
Sbjct: 228 FPIGEKQDIWALGCILYLLCFR------QHPFEDGAKLRIVNGKYSIPP-HDTQYTVF-- 278
Query: 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKE-PIPDPIIPSDEDEYS 376
L I AM LQ R +++VV L ++ ++ PI E
Sbjct: 279 -----HSL-----IRAM-LQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGG 327
Query: 377 EGYSS 381
G ++
Sbjct: 328 YGSAT 332
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 85 LGEGGFGRVYKGTLQ----SNGQVVAVKQL-DRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V G++VAVK L G Q + E+ +L L+H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 140 IGYCADGDQR--LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
G C D LV E++ GS+ D+L + + + A +G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG-----YCAP 252
I+RDL + N+LL + K+ DFGLAK P+G + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVREDGDSPVFWYAP 206
Query: 253 EYARSGELTVKSDVYSFGVILLELIT 278
E + + SDV+SFGV L EL+T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGMQGNK---EFLVEVLMLSLLHHPNLVN 138
LG+G FG V +G + VAVK L + + + +F+ EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L G +V E GS+ D L + + T + A A+G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT---YGYCAPEYA 255
I+RDL + N+LL K+ DFGL + PQ + V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 256 RSGELTVKSDVYSFGVILLELIT-GRR 281
++ + SD + FGV L E+ T G+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-39
Identities = 61/244 (25%), Positives = 102/244 (41%), Gaps = 28/244 (11%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVK-----QLDRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
LG+G FG VY + N ++A+K QL++ G++ + E+ + S L HPN++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILR 78
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
+ Y D + L+ EF G + L + + + + A L Y H++
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSATFMEE-LADALHYCHERK 134
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
VI+RD+K N+L+G + K++DFG + P + GT Y PE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRTMCGTLDYLPPEMIEGK 187
Query: 259 ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP---- 314
K D++ GV+ E + G P D + + I +FP
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGM------PPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241
Query: 315 LLRK 318
L+ K
Sbjct: 242 LISK 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 85 LGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLI 140
+G G G V G L+ GQ VA+K L + + +FL E ++ HPN++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
G G ++V E+M GS+D L + + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMG--TYGY--------- 249
++RDL + N+L+ +NL K+SDFGL SRV+
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGL-------------SRVLEDDPDAAYTTTGGKIP 217
Query: 250 ---CAPEYARSGELTVKSDVYSFGVILLELIT-GRR 281
APE + SDV+SFGV++ E++ G R
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-39
Identities = 61/269 (22%), Positives = 98/269 (36%), Gaps = 23/269 (8%)
Query: 16 NKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAA 75
+ ++ + E +S Q QP +E + ++F
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFF------- 55
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEV-LMLSLL 131
++F++ LG G +G V+K + +G++ AVK+ G K+ L EV +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVG 114
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
HP V L +G L E G S+ H L L
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLAL 170
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
+LH + +++ D+K +NI LG KL DFGL V G Y A
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMA 224
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGR 280
PE + +DV+S G+ +LE+
Sbjct: 225 PELLQGS-YGTAADVFSLGLTILEVACNM 252
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 13/203 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQ----VVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNL 139
LG G FG VYKG G+ VA+K+L E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+G C L+ + M G + D++ E K + + A+G+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+++RDL + N+L+ K++DFGLAKL EK + A E
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 260 LTVKSDVYSFGVILLELIT-GRR 281
T +SDV+S+GV + EL+T G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 67/273 (24%), Positives = 116/273 (42%), Gaps = 26/273 (9%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHH 133
NFR E +G G F VY+ +G VA+K++ + K + E+ +L L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
PN++ + ++ +V E G + + + K+ + T K LE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
+H + V++RD+K +N+ + A KL D GL + K ++GT Y +PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPE 206
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRP--VDEQNLIAWAQPIFRDPKRFPDM 311
KSD++S G +L E+ + P D+ NL + + I + +P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ------SPFYGDKMNLYSLCKKIEQC--DYP-- 256
Query: 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
PL + E E + MC+ + RP
Sbjct: 257 --PLPSDHYSE----ELRQLVNMCINPDPEKRP 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-39
Identities = 63/299 (21%), Positives = 111/299 (37%), Gaps = 57/299 (19%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN 135
+F + +LG+G FG+V K + + A+K++ + L EV++L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 136 LVNLIGYCADGDQRL-------------LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK 182
+V + + + E+ G++ D + + R +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQ---RDE 117
Query: 183 IASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ------ 233
Q L Y+H + +I+RDLK NI + + + K+ DFGLAK +
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 234 -------GEKMNVTSRVMGTYGYCAPE-YARSGELTVKSDVYSFGVILLELITGRRVIDT 285
G N+TS + GT Y A E +G K D+YS G+I E+I
Sbjct: 175 LDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------ 227
Query: 286 TRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
+ + + FP F + + I + + + RP
Sbjct: 228 --FSTGMERVNILKKLRSVSIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRP 276
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 69/301 (22%), Positives = 119/301 (39%), Gaps = 50/301 (16%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
+F++ L+G GGFG+V+K + +G+ +K++ N N++ EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 137 VNLIGYCADGDQRL----------------LVYEFMSGGSVDDHLLDVNETKKPLDWTTR 180
V+ G D + EF G+++ + + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLA 124
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240
+++ +G++Y+H K +I RDLK SNI L K+ DFGL K
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT-- 179
Query: 241 SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300
R GT Y +PE S + + D+Y+ G+IL EL+ + +
Sbjct: 180 -RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-----TAFETSKFFTDLRD 233
Query: 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360
D+ D + + L ++ RP S+++ L+ S
Sbjct: 234 G-----IISDIFDKKEKT------------LLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
Query: 361 E 361
E
Sbjct: 277 E 277
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-39
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 33/295 (11%)
Query: 33 PESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGR 92
P + P A E + + R + + LG+GGF +
Sbjct: 4 PADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR-------RYVRGRFLGKGGFAK 56
Query: 93 VYKGTLQSNGQVVAVKQLDRNGMQGNK---EFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149
++ + +V A K + ++ + + +E+ + L H ++V G+ D D
Sbjct: 57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116
Query: 150 LLVYEFMSGGSVDDHLLDVNETKKPLD-WTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208
+V E S+ + + +K L R G +YLH VI+RDLK
Sbjct: 117 FVVLELCRRRSLLELH----KRRKALTEPEAR-YYLRQIVLGCQYLHRNR---VIHRDLK 168
Query: 209 SSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVY 267
N+ L +L+ K+ DFGLA K+ GE+ V GT Y APE + + DV+
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFEVDVW 225
Query: 268 SFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRFPDMADPLLRK 318
S G I+ L+ G+ P + L I + PK +A L++K
Sbjct: 226 SIGCIMYTLLVGK------PPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 85 LGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLI 140
+G G FG V G L+ + VA+K L + + +FL E ++ HPN++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
G ++V E+M GS+D L + + + G A G++YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY--CAPEYARSG 258
++RDL + NIL+ +NL K+SDFGL ++ + + + G +PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRV-LEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 259 ELTVKSDVYSFGVILLELIT-GRR 281
+ T SDV+S+G++L E+++ G R
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGER 249
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-38
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV----EVLMLSLLHHPNLVNL 139
LG GG VY VA+K + + +E L EV S L H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
I + D LV E++ G ++ +++ E+ PL T + + G+++ HD
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+++RD+K NIL+ +N K+ DFG+AK + T+ V+GT Y +PE A+
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 260 LTVKSDVYSFGVILLELITGRR 281
+D+YS G++L E++ G
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEP 210
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-38
Identities = 67/224 (29%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 85 LGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V+ + +VAVK L + K+F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHL------------LDVNETKKPLDWTTRMKIASGA 187
G C DGD ++V+E+M G ++ L + K L + + IAS
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
A G+ YL + ++RDL + N L+GANL K+ DFG++ R + +
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-------------RDVYST 186
Query: 248 GYC-------------APEYARSGELTVKSDVYSFGVILLELIT 278
Y PE + T +SDV+SFGVIL E+ T
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQV----VAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNL 139
+G G FG VYKG L+++ VA+K L + +FL E ++ H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G + +++ E+M G++D L E + + G A G++YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMN- 167
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKL---------GPQGEKMNVTSRVMGTYGYC 250
++RDL + NIL+ +NL K+SDFGL+++ G K+ + R
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI--RWT------ 217
Query: 251 APEYARSGELTVKSDVYSFGVILLELIT-GRR 281
APE + T SDV+SFG+++ E++T G R
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 22/219 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPN 135
+ +LG+G V++G + G + A+K + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 136 LVNLIGYCADGDQRL--LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
+V L + R L+ EF GS+ L + L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
L + +++R++K NI+ D KL+DFG A+ E+ S GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLY-GTEEY 181
Query: 250 CAPEYARSGEL--------TVKSDVYSFGVILLELITGR 280
P+ L D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 85 LGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLI 140
LGEG FG VY+G ++ VAVK ++ NK +F+ E +++ L HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
G + + ++ E G + +L K L T + + + + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY----------- 249
++RD+ NIL+ + KL DFGL SR + Y
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGL-------------SRYIEDEDYYKASVTRLPIK 179
Query: 250 -CAPEYARSGELTVKSDVYSFGVILLELIT-GRR 281
+PE T SDV+ F V + E+++ G++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 44/328 (13%), Positives = 89/328 (27%), Gaps = 73/328 (22%)
Query: 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE--------- 120
EL + + +LG+ + T Q G+ V +
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 121 -------------------FLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEFMSG- 158
F+ ++ ++ + D R +Y M
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 159 -GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN 217
+ + LL + T K L R+++ + L LH +++ L+ +I+L
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR 247
Query: 218 LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY----------ARSGELTVKSDVY 267
L+ F + ++ G+ PE +T D +
Sbjct: 248 GGVFLTGFEHLV------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 268 SFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNE 327
+ G+ + + P + + ++ IFR K P LL
Sbjct: 302 TLGLAIYWIWCAD------LPNTDDAALGGSEWIFRSCKNIPQPVRALLEG--------- 346
Query: 328 AVAIAAMCLQEEAGARPLMSDVVTALSF 355
L+ R L + +
Sbjct: 347 -------FLRYPKEDRLLPLQAMETPEY 367
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLI 140
+G G FG VY GTL N AVK L+R G +FL E +++ HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 141 GYCADGD-QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G C + L+V +M G + + + + A+G++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLA----------KLGPQGEKMNVTSRVMGTYGY 249
++RDL + N +L K++DFGLA G K+ V + M
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV--KWM----- 199
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELIT 278
A E ++ + T KSDV+SFGV+L EL+T
Sbjct: 200 -ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-38
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 20/287 (6%)
Query: 2 NCFPCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAP-PATIHRNEGTKQDETK 60
P + S + +L EP P P P E D +
Sbjct: 265 AAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEE 324
Query: 61 NINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQ-SNGQV-VAVKQLDRNGMQGN 118
+ + F R+ + LG G FG V +G + Q+ VA+K L + + +
Sbjct: 325 LKDKKLFLKRD-----NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD 379
Query: 119 K-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
E + E ++ L +P +V LIG C + +LV E GG + L+ ++ +
Sbjct: 380 TEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPV 435
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237
+ ++ + G++YL +K ++R+L + N+LL K+SDFGL+K +
Sbjct: 436 SNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492
Query: 238 NVTSRVMGTYGY--CAPEYARSGELTVKSDVYSFGVILLELIT-GRR 281
T+R G + APE + + +SDV+S+GV + E ++ G++
Sbjct: 493 -YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 71/343 (20%), Positives = 123/343 (35%), Gaps = 47/343 (13%)
Query: 31 KEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGF 90
K S K P T ++ K ++ E + +G G F
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY------EYREEVHWMTHQPRVGRGSF 71
Query: 91 GRVYKGTLQSNGQVVAVKQ--LDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148
G V++ + G AVK+ L+ ++ E++ + L P +V L G +G
Sbjct: 72 GEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPW 124
Query: 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208
+ E + GGS+ + + L + A +GLEYLH + +++ D+K
Sbjct: 125 VNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVK 177
Query: 209 SSNILLGAN-LDPKLSDFGLAK-LGPQGEKMNVTSR--VMGTYGYCAPEYARSGELTVKS 264
+ N+LL ++ L DFG A L P G ++ + + GT + APE K
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 265 DVYSFGVILLELITGRRVIDTTRP-VDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEK 323
D++S ++L ++ G P + P + ++ P
Sbjct: 238 DIWSSCCMMLHMLNGC------HPWTQYFRGPL----CLKIASEPPPI------REIPPS 281
Query: 324 GLNEAVAIAAMCLQEEAGARP----LMSDVVTALSFLSNSKEP 362
L++E R L V AL + K P
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 60/352 (17%), Positives = 132/352 (37%), Gaps = 32/352 (9%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHP 134
+ + + +GEG FG+ +G+ +K+++ + M +E EV +L+ + HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
N+V + +V ++ GG + + + + L+++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHV 141
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
HD+ +++RD+KS NI L + +L DFG+A++ + + +GT Y +PE
Sbjct: 142 HDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR-DPKRFPDMAD 313
+ KSD+++ G +L EL T + + ++ I
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVLKIISGSFPPVSLHYS 250
Query: 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPSDE- 372
LR + + + RP ++ ++ F++ E P + ++E
Sbjct: 251 YDLRS------------LVSQLFKRNPRDRPSVNSIL-EKGFIAKRIEKFLSPQLIAEEF 297
Query: 373 --DEYSEGYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERIASSR 422
+S+ S K + N + + ++ + +
Sbjct: 298 CLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDK 349
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-38
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVNLI 140
+GEG FG V++G S VA+K + +FL E L + HP++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
G + ++ E + G + L K LD + + A + L YL K
Sbjct: 83 GVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESKR-- 136
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKL-------GPQGEKMNVTSRVMGTYGYCAPE 253
++RD+ + N+L+ +N KL DFGL++ K+ + + APE
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK--------WMAPE 187
Query: 254 YARSGELTVKSDVYSFGVILLELIT-GRR 281
T SDV+ FGV + E++ G +
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 85 LGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVN 138
LG+G FG VY+G + VA+K ++ + EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL------LDVNETKKPLDWTTRMKIASGAAQGLE 192
L+G + G L++ E M+ G + +L + N P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE--KMNVTSRV----MGT 246
YL+ ++RDL + N ++ + K+ DFG+ + + + + + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 247 YGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+PE + G T SDV+SFGV+L E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-38
Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 48/280 (17%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHP 134
+ F + +G+G FG V+KG +VVA+K +D + E + E+ +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
+ G + ++ E++ GGS D L PLD T I +GL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYL 135
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPE 253
H + I+RD+K++N+LL + + KL+DFG+ +L K N +GT + APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPE 189
Query: 254 YARSGELTVKSDVYSFGVILLELITGR---------RVIDTTRPVDEQNLIAWAQPIFRD 304
+ K+D++S G+ +EL G +V +F
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------------------LFLI 231
Query: 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
PK P P L + K L E V CL +E RP
Sbjct: 232 PKNNP----PTLEGNYS-KPLKEFV---EACLNKEPSFRP 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN 135
K + + +G+G G VY + GQ VA++Q++ + + E+L++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+VN + GD+ +V E+++GGS+ D + T+ +D + Q LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH 133
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEY 254
VI+RD+KS NILLG + KL+DFG A++ P+ K + ++GT + APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEV 187
Query: 255 ARSGELTVKSDVYSFGVILLELITG 279
K D++S G++ +E+I G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 36/328 (10%), Positives = 72/328 (21%), Gaps = 49/328 (14%)
Query: 31 KEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGF 90
+E E + A E NA+T L+ + + L G
Sbjct: 17 REEELIGYCREEALKEPAAMVEAVTATVWPQ-NAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 91 GRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLIGYC---- 143
V+ + A+K E + L +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 144 ----------------------ADGDQRLLVYEFMSG--GSVDDHLLDVNETKKPLDWTT 179
LL+ S + L V +
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 180 RMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239
+ + + L K +++ N+ + + L D G +
Sbjct: 196 LHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPA 250
Query: 240 TSRVMGTYGYCAPEYARSGELTV--KSDVYSFGVILLELITGR-------RVIDTTRPVD 290
+S Y E+ + T + + G+ + + I +
Sbjct: 251 SS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307
Query: 291 EQNLIAWAQPIFRDPKRFPDMADPLLRK 318
+ F PD L+ +
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 70/194 (36%), Positives = 103/194 (53%), Gaps = 9/194 (4%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG+G FG V+ GT +V A+K L + G + FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ +V E+MS GS+ D L ET K L + +A+ A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
RDL+++NIL+G NL K++DFGLA+L + + + APE A G T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 265 DVYSFGVILLELIT 278
DV+SFG++L EL T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 32/216 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQV--VAVKQLDRNGMQGNK-EFLVEV-LMLSLLHHPNLVNL 139
++GEG FG+V K ++ +G A+K++ + + +F E+ ++ L HHPN++NL
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHL------------LDVNETKKPLDWTTRMKIASGA 187
+G C L E+ G++ D L N T L + A+
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-----LGPQGEKMNVTSR 242
A+G++YL K I+RDL + NIL+G N K++DFGL++ + ++ V R
Sbjct: 152 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV--R 206
Query: 243 VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
M A E T SDV+S+GV+L E+++
Sbjct: 207 WM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 47/220 (21%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-----------------EVLM 127
L +G F ++ + + + A+K+ +++ ++ ++F E+ +
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 128 LSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL-----LDVNETKKPLDWTTRMK 182
++ + + + G + D+ ++YE+M S+ LD N T +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-C 155
Query: 183 IASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR 242
I Y+H++ N + +RD+K SNIL+ N KLSDFG ++ + S
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS- 210
Query: 243 VMGTYGYCAPE--YARSGELTVKSDVYSFGVILLELITGR 280
GTY + PE S K D++S G+ L +
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 68/249 (27%), Positives = 108/249 (43%), Gaps = 21/249 (8%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK---EFLVEVLMLSLLHH 133
++F+ LLG+G F VY+ G VA+K +D+ M EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P+++ L Y D + LV E G ++ +L N K + R + G+ Y
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQ-IITGMLY 127
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
LH +++RDL SN+LL N++ K++DFGLA + + T GT Y +PE
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPE 182
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRFP 309
A ++SDV+S G + L+ GR P D + + + P
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKNTLNKVVLADYEMPSFLS 236
Query: 310 DMADPLLRK 318
A L+ +
Sbjct: 237 IEAKDLIHQ 245
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-38
Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 26/251 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK---EFLVEVLMLSLLHH 133
+ + + LG+GGF + ++ + +V A K + ++ + + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD-WTTRMKIASGAAQGLE 192
++V G+ D D +V E S LL++++ +K L R G +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEAR-YYLRQIVLGCQ 129
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA-KLGPQGEKMNVTSRVMGTYGYCA 251
YLH VI+RDLK N+ L +L+ K+ DFGLA K+ GE+ V GT Y A
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 183
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKR 307
PE + + DV+S G I+ L+ G+ P + L I + PK
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKKNEYSIPKH 237
Query: 308 FPDMADPLLRK 318
+A L++K
Sbjct: 238 INPVAASLIQK 248
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNL 139
LG+G FG V + L+ VAVK L + + + +EFL E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 140 IGYCADGDQR------LLVYEFMSGGSVDDHLLD--VNETKKPLDWTTRMKIASGAAQGL 191
+G + +++ FM G + LL + E L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE--KMNVTSRV----MG 245
EYL + I+RDL + N +L ++ ++DFGL++ G+ + S++ +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 246 TYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
A E TV SDV++FGV + E++T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 85 LGEGGFGRVYKGTLQSNG-----QVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNL 139
LGEG FG+V+ + +VAVK L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHL-----------LDVNETKKPLDWTTRMKIASGAA 188
G C +G L+V+E+M G ++ L + PL + +AS A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE--KMNVTSRV--- 243
G+ YL ++RDL + N L+G L K+ DFG+++ + ++ + +
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 244 -MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
M PE + T +SDV+SFGV+L E+ T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 69/310 (22%), Positives = 121/310 (39%), Gaps = 49/310 (15%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPN 135
+F LG GGFG V++ + + A+K++ + +E + EV L+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 136 LVNLIGYCADGD---------QRLLVY---EFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
+V + + ++ +Y + ++ D ++ T + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHI 123
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-----------LGP 232
A+ +E+LH K +++RDLK SNI + K+ DFGL L P
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292
T +V GT Y +PE + K D++S G+IL EL+ P Q
Sbjct: 181 MPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFSTQ 230
Query: 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352
R+ K FP PL +++P + L RP +++
Sbjct: 231 MERVRTLTDVRNLK-FP----PLFTQKYP-----CEYVMVQDMLSPSPMERPEAINII-E 279
Query: 353 LSFLSNSKEP 362
+ + P
Sbjct: 280 NAVFEDLDFP 289
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 85 LGEGGFGRVYKGTLQSNG-----QVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVN 138
LGE FG+VYKG L Q VA+K L + EF E ++ + L HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL------------LDVNETKKPLDWTTRMKIASG 186
L+G +++ + S G + + L D K L+ + + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 187 AAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT 246
A G+EYL V+++DL + N+L+ L+ K+SD GL R +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLF-------------REVYA 180
Query: 247 YGYC-------------APEYARSGELTVKSDVYSFGVILLELIT 278
Y APE G+ ++ SD++S+GV+L E+ +
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN 135
+ + LG+G FG+VYK + G + A K ++ + ++++VE+ +L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V L+G + ++ EF GG+VD + E + L + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPE- 253
K +I+RDLK+ N+L+ D +L+DFG+ AK +K + +GT + APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEV 188
Query: 254 ----YARSGELTVKSDVYSFGVILLELITG 279
+ K+D++S G+ L+E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 59/247 (23%), Positives = 103/247 (41%), Gaps = 16/247 (6%)
Query: 38 QKQPPAPPATIHRNEGTKQDETKNINAQTF-TFRELAAA---TKNFRQECLLGEGGFGRV 93
E + Q R + +GEG G V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIV 61
Query: 94 YKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153
+ +G+ VAVK +D Q + EV+++ H N+V + G++ ++
Sbjct: 62 CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121
Query: 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213
EF+ GG++ D + ++ L+ + Q L YLH + VI+RD+KS +IL
Sbjct: 122 EFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173
Query: 214 LGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVI 272
L + KLSDFG A++ K ++GT + APE + D++S G++
Sbjct: 174 LTLDGRVKLSDFGFCAQISKDVPKRKS---LVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 273 LLELITG 279
++E++ G
Sbjct: 231 VIEMVDG 237
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 58/344 (16%), Positives = 119/344 (34%), Gaps = 49/344 (14%)
Query: 48 IHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAV 107
+H + ++ + F+ ++ + + +G GG +V++ L Q+ A+
Sbjct: 1 MHHHH--HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAI 57
Query: 108 KQLDRNGMQGN--KEFLVEVLMLSLLHHPNL--VNLIGYCADGDQRLLVYEFMSGGSVDD 163
K ++ + E+ L+ L + + L Y +V E ++
Sbjct: 58 KYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNS 116
Query: 164 HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223
L + KK +D R + + +H +++ DLK +N L+ + KL
Sbjct: 117 WL----KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLI 168
Query: 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-----------YARSGELTVKSDVYSFGVI 272
DFG+A V +GT Y PE +++ KSDV+S G I
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 273 LLELITGRR-VIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAI 331
L + G+ + + + I P +L+
Sbjct: 229 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC------------- 275
Query: 332 AAMCLQEEAGARPLMSDVVTALS--FLSNSKEPIPDPIIPSDED 373
CL+ + R + ++ L+ ++ P+ + E+
Sbjct: 276 ---CLKRDPKQRISIPEL---LAHPYVQIQTHPVNQMAKGTTEE 313
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQ---VVAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+G+G FG VY G Q A+K L R MQ + FL E L++ L+HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 141 GYCADGD-QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G + ++ +M G + + ++ + A+G+EYL ++
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK- 144
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKL----------GPQGEKMNVTSRVMGTYGY 249
++RDL + N +L + K++DFGLA+ + ++ V +
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV--KWT----- 195
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELIT 278
A E ++ T KSDV+SFGV+L EL+T
Sbjct: 196 -ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN 135
+ F LGEG +G VYK + GQ+VA+KQ+ +E + E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V G +V E+ GSV D + K L I +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTYGYCAPEY 254
I+RD+K+ NILL KL+DFG+ +L K N V+GT + APE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPEV 196
Query: 255 ARSGELTVKSDVYSFGVILLELITG 279
+ +D++S G+ +E+ G
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG 221
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 24/205 (11%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ T + +V AVK + + G + FL E ++ L H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ ++ EFM+ GS+ D L ++ + ++ A+G+ ++ + I+
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKL-------GPQGEKMNVTSRVMGTYGYCAPEYARS 257
RDL+++NIL+ A+L K++DFGLA++ +G K + + APE
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK--------WTAPEAINF 359
Query: 258 GELTVKSDVYSFGVILLELIT-GRR 281
G T+KSDV+SFG++L+E++T GR
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V+ G + +V AVK L + M FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
+ ++ E+M GS+ D L + L + +A+ A+G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT---YGYCAPEYARSGELT 261
RDL+++NIL+ L K++DFGLA+L + N + G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 262 VKSDVYSFGVILLELIT-GRR 281
+KSDV+SFG++L E++T GR
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNL 139
LGEG FG V +G L+ VAVK + + +EFL E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 140 IGYCADGDQR-----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTR--MKIASGAAQGLE 192
+G C + + +++ FM G + +LL P + +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE--KMNVTSRV----MGT 246
YL ++ ++RDL + N +L ++ ++DFGL+K G+ + +++ +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 247 YGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
A E T KSDV++FGV + E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 79/306 (25%), Positives = 134/306 (43%), Gaps = 43/306 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV----EVLMLSLLHHPNLVNL 139
+LG GG V+ + + VAVK L R + + F + E + L+HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 140 --IGYCADGDQRLLVY---EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
G A+ L Y E++ G ++ D + T+ P+ +++ + A Q L +
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALNFS 132
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPE 253
H +I+RD+K +NI++ A K+ DFG+A+ + G + T+ V+GT Y +PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
AR + +SDVYS G +L E++TG PV +A+ R+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----VAYQH--VREDPIPPSARH 243
Query: 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSNSKEPIPDPII 368
L L+ V A L + R + +D+V + EP P +
Sbjct: 244 EGL----SA-DLDAVVLKA---LAKNPENRYQTAAEMRADLVRVH-----NGEPPEAPKV 290
Query: 369 PSDEDE 374
+D +
Sbjct: 291 LTDAER 296
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 22/219 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPN 135
+ +LG+G V++G + G + A+K + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 136 LVNLIGYCADGDQRL--LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
+V L + R L+ EF GS+ L + L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
L + +++R++K NI+ D KL+DFG A+ E+ S GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLY-GTEEY 181
Query: 250 CAPEYARSGEL--------TVKSDVYSFGVILLELITGR 280
P+ L D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 13/202 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV----EVLMLSLLHHPNLVNL 139
L+G GG G VY+ ++VA+K + + + F E L P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
+ Q + ++G + L + PL + I L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+RD+K NIL+ A+ L DFG+A EK+ +GT Y APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 260 LTVKSDVYSFGVILLELITGRR 281
T ++D+Y+ +L E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGSP 233
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 73/315 (23%), Positives = 123/315 (39%), Gaps = 53/315 (16%)
Query: 85 LGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVN 138
LG G FG VY+G + + VAVK L + ++ +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLD---VNETKKPLDWTTRMKIASGAAQGLEYLH 195
IG R ++ E M+GG + L + L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 196 DKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
+ I+RD+ + N LL G K+ DFG+A+ + M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 253 EYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311
E G T K+D +SFGV+L E+ + G P +P
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGY------------------MP-------YPSK 249
Query: 312 ADPLLRKQF--------PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKE-- 361
++ + + P+ I C Q + RP + ++ + + + +
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309
Query: 362 --PIPDPIIPSDEDE 374
+P P E+E
Sbjct: 310 NTALPIEYGPLVEEE 324
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-36
Identities = 62/260 (23%), Positives = 96/260 (36%), Gaps = 47/260 (18%)
Query: 84 LLGEGGFGRVYKGT-LQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPNLVNLIG 141
+ GG G +Y NG+ V +K L +G + + E L+ + HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 142 YCADGDQRL-----LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ D+ +V E++ G S+ + L + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
++Y DLK NI+L KL D G ++N + GT G+ APE R
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVR 250
Query: 257 SGELTVKSDVYSFGVILLELITGRR---------------VIDTTRPVDEQNLIAWAQPI 301
TV +D+Y+ G L L V+ T L+ A I
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYG--RLLRRA--I 305
Query: 302 FRDP-KRFPD---MADPLLR 317
DP +RF M+ L
Sbjct: 306 DPDPRQRFTTAEEMSAQLTG 325
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 61/360 (16%), Positives = 122/360 (33%), Gaps = 48/360 (13%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHP 134
+ + +G GG +V++ L Q+ A+K ++ + E+ L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 135 NL--VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
+ + L Y +V E ++ L + KK +D R + +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVH 122
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
+H +++ DLK +N L+ + KL DFG+A V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 253 E-----------YARSGELTVKSDVYSFGVILLELITGRR-VIDTTRPVDEQNLIAWAQP 300
E +++ KSDV+S G IL + G+ + + + I
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238
Query: 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS--FLSN 358
P +L+ CL+ + R + ++ L+ ++
Sbjct: 239 EIEFPDIPEKDLQDVLKC----------------CLKRDPKQRISIPEL---LAHPYVQI 279
Query: 359 SKEPIPDPIIPS-DEDEYSEGYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPER 417
P+ + +E +Y G + N +S++S + ++
Sbjct: 280 QTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKK 339
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-36
Identities = 50/286 (17%), Positives = 98/286 (34%), Gaps = 37/286 (12%)
Query: 10 QKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTF 69
+ V R ++ ++ P + +E ++ + ++
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60
Query: 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLM 127
+ +G GG +V++ L Q+ A+K ++ + E+
Sbjct: 61 LKQ------------IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 107
Query: 128 LSLLHHPNL--VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIAS 185
L+ L + + L Y +V E ++ L + KK +D R
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWK 162
Query: 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMG 245
+ + +H +++ DLK +N L+ + KL DFG+A V +G
Sbjct: 163 NMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 246 TYGYCAPE-----------YARSGELTVKSDVYSFGVILLELITGR 280
Y PE +++ KSDV+S G IL + G+
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPN 135
++ + ++G G V + VA+K+++ Q + + L+ E+ +S HHPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDD----HLLDVNETKKPLDWTTRMKIASGAAQGL 191
+V+ D+ LV + +SGGSV D + LD +T I +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSR--VMGTYG 248
EYLH I+RD+K+ NILLG + +++DFG+ A L G+ R +GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 249 YCAPE-YARSGELTVKSDVYSFGVILLELITGR---------RVIDTTRPVDEQNLIAWA 298
+ APE + K+D++SFG+ +EL TG +V+ L
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---------LTLQN 242
Query: 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
P P + D + K++ K + + ++CLQ++ RP
Sbjct: 243 DP----PSLETGVQDKEMLKKYG-KSFRKMI---SLCLQKDPEKRP 280
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQV---VAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+G G FG VY GTL N AVK L+R + +FL E +++ HPN+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 141 GYCADGD-QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
G C + L+V +M G + + + + A+G+++L K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMG------TYGYCAPE 253
++RDL + N +L K++DFGLA+ E +V ++ A E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALE 266
Query: 254 YARSGELTVKSDVYSFGVILLELIT 278
++ + T KSDV+SFGV+L EL+T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 85 LGEGGFGRVYKGTLQ-------SNGQVVAVKQLDRNGMQGNK-EFLVEV-LMLSLLHHPN 135
LGEG FG+V VAVK L + + + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD------------VNETKKPLDWTTRMKI 183
++NL+G C ++ E+ S G++ ++L ++ + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS-- 241
A+G+EYL + I+RDL + N+L+ N K++DFGLA+ + T+
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 242 ----RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ M APE T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-36
Identities = 64/273 (23%), Positives = 112/273 (41%), Gaps = 29/273 (10%)
Query: 25 PPRDECKEPESKKQKQP-PAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQEC 83
P ++ + S + H ++ D+ I + T+ + ++E
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRER 391
Query: 84 L-----LGEGGFGRVYKGTLQSNGQV---VAVKQLDRNGMQGNK-EFLVEVLMLSLLHHP 134
+ +GEG FG V++G S VA+K + +FL E L + HP
Sbjct: 392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
++V LIG + ++ E + G + L K LD + + A + L YL
Sbjct: 452 HIVKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYL 507
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG-----Y 249
K ++RD+ + N+L+ +N KL DFGL++ M ++ + G +
Sbjct: 508 ESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKW 558
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELIT-GRR 281
APE T SDV+ FGV + E++ G +
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 41/226 (18%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVN 138
LGEG FG+V K T ++ VAVK L N + L E +L ++HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL--------------------LDVNETKKPLDWT 178
L G C+ LL+ E+ GS+ L + ++ L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
+ A +QG++YL + +++RDL + NIL+ K+SDFGL++ + +
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 239 VTS------RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
S + M A E T +SDV+SFGV+L E++T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 79/379 (20%), Positives = 139/379 (36%), Gaps = 58/379 (15%)
Query: 26 PRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECL- 84
P E + + +P + + + N N + K ++ +
Sbjct: 15 PTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNIT 74
Query: 85 ----LGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHP 134
LG G FG VY+G + + VAVK L + ++ +FL+E L++S +H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD---VNETKKPLDWTTRMKIASGAAQGL 191
N+V IG R ++ E M+GG + L + L + +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 192 EYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
+YL + I+RD+ + N LL G K+ DFG+A+ + M
Sbjct: 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307
+ PE G T K+D +SFGV+L E+ + G P
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------------------MP------- 286
Query: 308 FPDMADPLLRKQF--------PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
+P ++ + + P+ I C Q + RP + ++ + + +
Sbjct: 287 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
Query: 360 KE----PIPDPIIPSDEDE 374
+ +P P E+E
Sbjct: 347 PDVINTALPIEYGPLVEEE 365
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 50/228 (21%)
Query: 85 LGEGGFGRVYKGTLQ-------SNGQVVAVKQLDRNGMQGNK-EFLVEV-LMLSLLHHPN 135
LGEG FG+V VAVK L + + + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD------------VNETKKPLDWTTRMKI 183
++NL+G C ++ E+ S G++ ++L ++ + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV 243
A+G+EYL + I+RDL + N+L+ N K++DFGLA R
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA-------------RD 252
Query: 244 MGTYGYC-------------APEYARSGELTVKSDVYSFGVILLELIT 278
+ Y APE T +SDV+SFGV++ E+ T
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQG-NKEFLVEV-LMLSLLHHPNLV 137
LG G FG+V + T + VAVK L + + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHL----------LDVNETKKPLDWTTRMKIASGA 187
NL+G C G L++ E+ G + + L + +S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
AQG+ +L K I+RD+ + N+LL K+ DFGLA+ +M
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218
Query: 248 GYC------------APEYARSGELTVKSDVYSFGVILLELIT 278
Y APE TV+SDV+S+G++L E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 36/221 (16%)
Query: 85 LGEGGFGRVYKGTLQ-------SNGQVVAVKQLDRNGMQGNK-EFLVEV-LMLSLLHHPN 135
LGEG FG+V + VAVK L + + + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHL------------LDVNETKKPLDWTTRMKI 183
++NL+G C ++ E+ S G++ ++L + ++ L +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS-- 241
A A+G+EYL K I+RDL + N+L+ + K++DFGLA+ + T+
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 242 ----RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ M APE T +SDV+SFGV+L E+ T
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
+LG+G +G VY G SN +A+K++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
++ + E + GGS+ LL + T +GL+YLHD ++
Sbjct: 89 SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 204 YRDLKSSNILLGA-NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL-- 260
+RD+K N+L+ + K+SDFG +K T GT Y APE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY 202
Query: 261 TVKSDVYSFGVILLELITGRR 281
+D++S G ++E+ TG+
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 85 LGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGNK-EFLVEV-LMLSLLHHPNLV 137
LG G FG+V + T VAVK L + + + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHL--------------LDVNETKKPLDWTTRMKI 183
NL+G C G L++ E+ G + + L + + + LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS-- 241
+ A+G+ +L K I+RDL + NILL K+ DFGLA+ V
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 242 ----RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ M APE + T +SDV+S+G+ L EL +
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-35
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEV-LMLSLLHHPNL 136
LG G +G V K +GQ++AVK++ Q K L+++ + + + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V G + E M S+D V + + + KIA + LE+LH
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE--- 253
K + VI+RD+K SN+L+ A K+ DFG++ G + + G Y APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDIDA-GCKPYMAPERIN 182
Query: 254 -YARSGELTVKSDVYSFGVILLELITGR 280
+VKSD++S G+ ++EL R
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 71/214 (33%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNL 136
+ + LG GGFG V + Q G+ VA+KQ + N+E E+ ++ L+HPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 137 VNLI------GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
V+ A D LL E+ GG + +L E L + S +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSA 133
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDP---KLSDFGLAKLGPQGEKMNVTSRVMGTY 247
L YLH+ +I+RDLK NI+L K+ D G AK QGE T V GT
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFV-GTL 187
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRR 281
Y APE + TV D +SFG + E ITG R
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 45/216 (20%), Positives = 86/216 (39%), Gaps = 16/216 (7%)
Query: 76 TKNFRQECLLGEG--GFGRVYKGTLQSNGQVVAVKQ--LDRNGMQGNKEFLVEVLMLSLL 131
+ ++G+G V + G+ V V++ L+ + E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
+HPN+V ++ +V FM+ GS D L+ + ++ I G + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFM-DGMNELAIAYILQGVLKAL 141
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG-LAKLGPQGEKMNV----TSRVMGT 246
+Y+H ++R +K+S+IL+ + LS + G++ V +
Sbjct: 142 DYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 247 YGYCAPEYARSGEL--TVKSDVYSFGVILLELITGR 280
+ +PE + KSD+YS G+ EL G
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 85 LGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNK-EFLVEV-LMLSLLHHPNLV 137
LG G FG+V + + + VAVK L + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 138 NLIGYCADGDQ-RLLVYEFMSGGSVDDHL------------LDVNETKKPLDWTTRMKIA 184
NL+G C +++ EF G++ +L + K L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 185 SGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS--- 241
A+G+E+L + I+RDL + NILL K+ DFGLA+ +
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 242 ---RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ M APE T++SDV+SFGV+L E+ +
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 66/273 (24%), Positives = 112/273 (41%), Gaps = 23/273 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEV-LMLSLLHHPN 135
+ + +G G +G V K + +GQ++AVK++ + K+ L+++ +++ P
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V G + E MS + + + KI + L +L
Sbjct: 83 IVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-- 253
+ +I+RD+K SNILL + + KL DFG++ G + + T G Y APE
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDA-GCRPYMAPERI 197
Query: 254 --YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311
A V+SDV+S G+ L EL TGR V +Q + + K P
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--------LTQVVKGDP-- 247
Query: 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
P L + + +CL ++ RP
Sbjct: 248 --PQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 19/264 (7%)
Query: 25 PPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFR---- 80
R E + + + F R + A
Sbjct: 31 DSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT 90
Query: 81 --QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
+ +LG G FG+V+K + G +A K + GM+ +E E+ +++ L H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L + +LV E++ GG + D ++D + LD MK +G+ ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ---ICEGIRHMHQMY 207
Query: 199 NPPVIYRDLKSSNILLGANLDP---KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+++ DLK NIL N D K+ DFGLA+ EK+ V GT + APE
Sbjct: 208 ---ILHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVV 260
Query: 256 RSGELTVKSDVYSFGVILLELITG 279
++ +D++S GVI L++G
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 41/226 (18%)
Query: 85 LGEGGFGRVYKGTLQSNG-----QVVAVKQLDRNGMQGNK-EFLVEVLMLSLLHHPNLVN 138
+GEG FGRV++ +VAVK L + +F E +++ +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHL--------------------LDVNETKKPLDWT 178
L+G CA G L++E+M+ G +++ L + PL
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE--K 236
++ IA A G+ YL ++ ++RDL + N L+G N+ K++DFGL++ + K
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 237 MNVTSRV----MGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
+ + M PE T +SDV+++GV+L E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 72/258 (27%), Positives = 99/258 (38%), Gaps = 22/258 (8%)
Query: 31 KEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAA---TKNFRQECLLGE 87
P + + + EL K F +G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPNLVNLIGYCA 144
G FG VY N +VVA+K++ +G Q N ++ + EV L L HPN + G
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIY 204
LV E+ G + D + KKPL + GA QGL YLH +I+
Sbjct: 125 REHTAWLVMEYCLGSASD----LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIH 177
Query: 205 RDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE---YARSGELT 261
RD+K+ NILL KL DFG A N +GT + APE G+
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSAS---IMAPANS---FVGTPYWMAPEVILAMDEGQYD 231
Query: 262 VKSDVYSFGVILLELITG 279
K DV+S G+ +EL
Sbjct: 232 GKVDVWSLGITCIELAER 249
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 44/232 (18%), Positives = 84/232 (36%), Gaps = 40/232 (17%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEV-LMLSLLH 132
T F + +G G FG V+K + +G + A+K+ + + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
H ++V A+ D L+ E+ +GGS+ D + + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDP-------------------KLSDFGLAKLGPQ 233
Y+H + +++ D+K SNI + P K+ D G
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182
Query: 234 GEKMNVTSRVMGTYGYCAPE-----YARSGELTVKSDVYSFGVILLELITGR 280
+++ G + A E Y K+D+++ + ++
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLP----KADIFALALTVVCAAGAE 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLV 137
F + LG G G V+K + + +G V+A K + + + E+ +L + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
G + + E M GGS+D L + + K++ +GL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN-VTSRVMGTYGYCAPEYAR 256
+++RD+K SNIL+ + + KL DFG++ G+ ++ + + +GT Y +PE +
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQ 203
Query: 257 SGELTVKSDVYSFGVILLELITGR 280
+V+SD++S G+ L+E+ GR
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 70/217 (32%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLS-LLHHP 134
F L+G G +G+VYKG GQ+ A+K +D G +E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 135 NLVNLIG-----YCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
N+ G D +L LV EF GSV D L+ + L I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTK-GNTLKEEWIAYICREIL 139
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL-AKLGPQGEKMNVTSRVMGTY 247
+GL +LH VI+RD+K N+LL N + KL DFG+ A+L + N +GT
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTP 193
Query: 248 GYCAPEYARSGELT-----VKSDVYSFGVILLELITG 279
+ APE E KSD++S G+ +E+ G
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 85 LGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNK-EFLVEV-LMLSLLHHPNLV 137
LG G FG+V T VAVK L + + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHL-------------------LDVNETKKPLDWT 178
NL+G C L++E+ G + ++L L+ E L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 179 TRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238
+ A A+G+E+L K+ ++RDL + N+L+ K+ DFGLA+
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD-------- 221
Query: 239 VTSRVMGTYGYC------------APEYARSGELTVKSDVYSFGVILLELIT 278
+M Y APE G T+KSDV+S+G++L E+ +
Sbjct: 222 ----IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-33
Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 16/243 (6%)
Query: 44 PPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQ 103
E F + ++ +++ LG G +G V +
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 104 VVAVKQLDRNGMQGNKEFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSV 161
A+K + + + + + EV +L LL HPN++ L + D LV E GG
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE- 122
Query: 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANL 218
L D + + I G+ YLH +++RDLK N+LL +
Sbjct: 123 ---LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176
Query: 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT 278
K+ DFGL+ + +KM +GT Y APE R + K DV+S GVIL L+
Sbjct: 177 LIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232
Query: 279 GRR 281
G
Sbjct: 233 GYP 235
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 39/303 (12%)
Query: 51 NEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL 110
KQ I Q + + +G G G+V+K + G V+AVKQ+
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
Query: 111 DRNG-MQGNKEFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDV 168
R+G + NK L+++ ++L P +V G + E M +
Sbjct: 59 RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA----EKLK 114
Query: 169 NETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228
+ P+ K+ + L YL +K VI+RD+K SNILL KL DFG++
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 229 KLGPQGEKMNVTSRVMGTYGYCAPE-----YARSGELTVKSDVYSFGVILLELITGRRVI 283
G + G Y APE + +++DV+S G+ L+EL TG+
Sbjct: 173 --GRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229
Query: 284 DTTRPVDEQ-NLIAWAQ-PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAG 341
+ E + + P+ F + F + CL ++
Sbjct: 230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDF-----QSFVKD-----------CLTKDHR 273
Query: 342 ARP 344
RP
Sbjct: 274 KRP 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 50/287 (17%), Positives = 89/287 (31%), Gaps = 29/287 (10%)
Query: 44 PPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQS--- 100
P + + N Q + I +T E +K LLGEG F +VY+ T
Sbjct: 36 KPVSSYPNTFEWQCKLPAIKPKT----EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 101 --NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158
N Q +K + L + + +LV E S
Sbjct: 92 AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 159 GSVDDHL-LDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN 217
G++ + + L N +K + + A +E +HD +I+ D+K N +LG
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNG 208
Query: 218 LDP-----------KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDV 266
L D G + K + + T G+ E + + D
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268
Query: 267 YSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
+ + ++ G V + + +FR +
Sbjct: 269 FGVAATVYCMLFGT-----YMKVKNEGGECKPEGLFRRLPHLDMWNE 310
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 66/289 (22%), Positives = 111/289 (38%), Gaps = 40/289 (13%)
Query: 40 QPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQ 99
+P ++ + Q K +F+ +LGEG F V
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPE--------------DFKFGKILGEGSFSTVVLAREL 52
Query: 100 SNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156
+ + A+K L++ + + E ++S L HP V L D ++ +
Sbjct: 53 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 112
Query: 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKANPPVIYRDLKSSNIL 213
G + ++ + + TR A+ LEYLH K +I+RDLK NIL
Sbjct: 113 KNGELLKYI---RKIGSFDETCTRFY----TAEIVSALEYLHGKG---IIHRDLKPENIL 162
Query: 214 LGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273
L ++ +++DFG AK+ K + +GT Y +PE SD+++ G I+
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 222
Query: 274 LELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP----LLRK 318
+L+ G P N Q I + FP+ P L+ K
Sbjct: 223 YQLVAGL------PPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 17/226 (7%)
Query: 61 NINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE 120
+ F A + ++ + +LG+G FG V + GQ AVK + + ++ +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 121 ---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
L EV +L L HPN++ L + D LV E +GG L D ++K
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSE 125
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQG 234
+I G+ Y+H +++RDLK N+LL + + ++ DFGL+
Sbjct: 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
+KM +GT Y APE G K DV+S GVIL L++G
Sbjct: 183 KKMK---DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 58/266 (21%), Positives = 96/266 (36%), Gaps = 40/266 (15%)
Query: 32 EPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFG 91
++ + + I +++ LG G +G
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIG-ESYFKVRK------------LGSGAYG 50
Query: 92 RVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-------------EVLMLSLLHHPNLVN 138
V ++ A+K + ++ + E+ +L L HPN++
Sbjct: 51 EVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L D LV EF GG L + + D I G+ YLH
Sbjct: 111 LFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSGICYLHKHN 166
Query: 199 NPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+++RD+K NILL + L+ K+ DFGL+ + K+ +GT Y APE
Sbjct: 167 ---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPEVL 220
Query: 256 RSGELTVKSDVYSFGVILLELITGRR 281
+ + K DV+S GVI+ L+ G
Sbjct: 221 K-KKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-31
Identities = 57/255 (22%), Positives = 102/255 (40%), Gaps = 15/255 (5%)
Query: 31 KEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQ----ECLLG 86
++ + D + + + + + LG
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 87 EGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG 146
G FG V++ T ++ G A K + + E+ +S+L HP LVNL D
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRD 206
++ +++YEFMSGG + + + D + + M+ +GL ++H+ ++ D
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ---VCKGLCHMHENN---YVHLD 280
Query: 207 LKSSNILLGANLDP--KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
LK NI+ KL DFGL + + V GT + APE A + +
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYT 337
Query: 265 DVYSFGVILLELITG 279
D++S GV+ L++G
Sbjct: 338 DMWSVGVLSYILLSG 352
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 50/243 (20%), Positives = 99/243 (40%), Gaps = 33/243 (13%)
Query: 47 TIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVA 106
++ +++G ++ + +F +++ LG G G + + + + VA
Sbjct: 6 SLEQDDGDEETSVVIVGKISFCPKDV------------LGHGAEGTIVYRGM-FDNRDVA 52
Query: 107 VKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL 165
VK++ ++E V++L HPN++ D + + E ++ +++
Sbjct: 53 VKRILPECFSFADRE--VQLLR-ESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYV 108
Query: 166 LDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL-----GANLDP 220
+ L+ + + GL +LH +++RDLK NIL+ +
Sbjct: 109 EQKDFAHLGLE---PITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKA 162
Query: 221 KLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEY---ARSGELTVKSDVYSFGVILLEL 276
+SDFGL K L + S V GT G+ APE T D++S G + +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 277 ITG 279
I+
Sbjct: 223 ISE 225
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 56/255 (21%), Positives = 108/255 (42%), Gaps = 12/255 (4%)
Query: 27 RDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLG 86
R + + I+ + +D K Q ++ + + LG
Sbjct: 2 RGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELG 60
Query: 87 EGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG 146
G FG V++ ++ G+V K ++ E+ +++ LHHP L+NL D
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRD 206
+ +L+ EF+SGG + D + + + M+ A +GL+++H+ + +++ D
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ---ACEGLKHMHEHS---IVHLD 174
Query: 207 LKSSNILLGANLDP--KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS 264
+K NI+ K+ DFGLA E + V T + APE + +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYT 231
Query: 265 DVYSFGVILLELITG 279
D+++ GV+ L++G
Sbjct: 232 DMWAIGVLGYVLLSG 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 70/221 (31%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 70 RELAAATKNFRQ----ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-- 123
RE F + C+LG+G FG V K + Q AVK +++ + +
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 124 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
EV +L L HPN++ L D +V E +GG L D +K +I
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARI 126
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVT 240
G+ Y+H +++RDLK NILL + D K+ DFGL+ Q KM
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-- 181
Query: 241 SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRR 281
+GT Y APE R G K DV+S GVIL L++G
Sbjct: 182 -DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 66/246 (26%), Positives = 110/246 (44%), Gaps = 33/246 (13%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EVLMLSLLHHPNLVNLIGY 142
+G+G F +V G+ VA+K +D+ + + EV ++ +L+HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
L+ E+ SGG V D+L+ + ++Y H K +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE------YAR 256
++RDLK+ N+LL A+++ K++DFG + G K++ G Y APE Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD-AF--CGAPPYAAPELFQGKKYDG 192
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRFPDMA 312
+ DV+S GVIL L++G P D QNL + + +R P
Sbjct: 193 P-----EVDVWSLGVILYTLVSGS------LPFDGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 313 DPLLRK 318
+ LL++
Sbjct: 242 ENLLKR 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 17/202 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPNLVNLIGYC 143
LG G FG V+ +S+G +K ++++ Q E E+ +L L HPN++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKANP 200
D +V E GG + + ++ K L + +A Q L Y H +
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL---SEGYVAELMKQMMNALAYFHSQH-- 144
Query: 201 PVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
V+++DLK NIL + K+ DFGLA+L E GT Y APE +
Sbjct: 145 -VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAPEVFK- 199
Query: 258 GELTVKSDVYSFGVILLELITG 279
++T K D++S GV++ L+TG
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTG 221
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 57/250 (22%), Positives = 98/250 (39%), Gaps = 30/250 (12%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV----EVLMLSLLHHPNLVNL 139
LLGEG +G+V + AVK L + ++ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 140 --IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK---IASGAAQGLEYL 194
+ Y + + +V E+ G + +LD K+ + G LEYL
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDG----LEYL 125
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H + ++++D+K N+LL K+S G+A+ + G+ + PE
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 255 ARSGEL--TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRF 308
A + K D++S GV L + TG P + N+ + I + P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL------YPFEGDNIYKLFENIGKGSYAIPGDC 236
Query: 309 PDMADPLLRK 318
LL+
Sbjct: 237 GPPLSDLLKG 246
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 65/300 (21%), Positives = 114/300 (38%), Gaps = 51/300 (17%)
Query: 8 QSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTF 67
++ R LP + + + + + E K ++ + +
Sbjct: 13 NKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENL 72
Query: 68 TFRELA--------AATKNFRQE----CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM 115
F+ + AA K F Q+ ++G G V + ++ G AVK ++
Sbjct: 73 YFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAE 132
Query: 116 QGNKEFLVEVL---------MLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLL 166
+ + E L EV + + HP+++ LI LV++ M G + D+L
Sbjct: 133 RLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT 192
Query: 167 DV---NETKKPLDWTTRMKIASGAAQ----GLEYLHDKANPPVIYRDLKSSNILLGANLD 219
+ +E K + + +LH +++RDLK NILL N+
Sbjct: 193 EKVALSE-----------KETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238
Query: 220 PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE------YARSGELTVKSDVYSFGVIL 273
+LSDFG + GEK+ + GT GY APE + D+++ GVIL
Sbjct: 239 IRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 69/251 (27%), Positives = 113/251 (45%), Gaps = 18/251 (7%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHH 133
F +LG GGFG V+ +++ G++ A K+L++ ++ K + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 134 PNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGL 191
+V+L Y + L LV M+GG + H+ +V+E R + GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
E+LH + +IYRDLK N+LL + + ++SD GLA G+ T GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMA 357
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGR---RVIDTTRPVDE-QNLIAWAQPIFRDPKR 307
PE E D ++ GV L E+I R R E + + + P +
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--PDK 415
Query: 308 FPDMADPLLRK 318
F +
Sbjct: 416 FSPASKDFCEA 426
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EV-LMLSLLHHPNLVNLIG 141
LG G F V + +S GQ A K L + + + E+ ++ P ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKA 198
+ + +L+ E+ +GG + L + + + + Q G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLP-----ELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 199 NPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
+++ DLK NILL +++ P K+ DFG+++ ++ +MGT Y APE
Sbjct: 152 ---IVHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEI 204
Query: 255 ARSGELTVKSDVYSFGVILLELITG 279
+T +D+++ G+I L+T
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 38/200 (19%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G FG V++ S+ + K + G E+ +L++ H N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK-IASGAAQGLEYLHDKANPPVI 203
++ ++++EF+SG + + + + + + + L++LH +
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE----ALQFLHSHN---IG 124
Query: 204 YRDLKSSNILL----GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
+ D++ NI+ + + K+ +FG A+ G+ + + Y APE +
Sbjct: 125 HFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDV 179
Query: 260 LTVKSDVYSFGVILLELITG 279
++ +D++S G ++ L++G
Sbjct: 180 VSTATDMWSLGTLVYVLLSG 199
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 6e-29
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK------EFLVEVLMLSLLHHPNLVN 138
LG G F V K + G+ A K + + + ++ E EV +L + HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLH 195
L + +L+ E +SGG + D L + K+ L T + Q G+ YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAE----KESL---TEDEATQFLKQILDGVHYLH 125
Query: 196 DKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
K + + DLK NI+L P KL DFG+A G + + GT + A
Sbjct: 126 SKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVA 179
Query: 252 PEYARSGELTVKSDVYSFGVILLELITG 279
PE L +++D++S GVI L++G
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 37/215 (17%)
Query: 81 QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEV-LMLSLLHHPNLVNL 139
QE +LGEG RV Q AVK +++ EV ++ H N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDV---NETKKPLDWTTRMKIASGA----AQGLE 192
I + + D+ LV+E M GGS+ H+ NE + AS A L+
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE-----------ASVVVQDVASALD 125
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAK-LGPQGEKMNVTSRVM--- 244
+LH+K + +RDLK NIL + + K+ DF L + G+ +++ +
Sbjct: 126 FLHNKG---IAHRDLKPENILC-EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 245 -GTYGYCAPEYARSGELTVKS-----DVYSFGVIL 273
G+ Y APE + D++S GVIL
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 58/258 (22%), Positives = 104/258 (40%), Gaps = 47/258 (18%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-------------------- 123
+G+G +G V +++ A+K L + + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 124 ------EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL 175
E+ +L L HPN+V L + + D +V+E ++ G +++V T KPL
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEV-PTLKPL 134
Query: 176 DWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235
+G+EYLH + +I+RD+K SN+L+G + K++DFG++ +
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 236 KMNVTSRVMGTYGYCAPEYARSGELTV---KSDVYSFGVILLELITGRRVIDTTRPVDEQ 292
+ + GT + APE DV++ GV L + G+ P ++
Sbjct: 192 ALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ------CPFMDE 243
Query: 293 NLIAWAQPIFRDPKRFPD 310
++ I FPD
Sbjct: 244 RIMCLHSKIKSQALEFPD 261
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 49/195 (25%), Positives = 76/195 (38%), Gaps = 20/195 (10%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G G +G V + A K++ + ++ F E+ ++ L HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKANPP 201
D LV E +GG L + K+ A + Y H
Sbjct: 77 DNTDIYLVMELCTGGE----LFERVVHKRVF---RESDAARIMKDVLSAVAYCHKLN--- 126
Query: 202 VIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
V +RDLK N L + KL DFGLA G+ M +GT Y +P+ G
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---TKVGTPYYVSPQVLE-G 182
Query: 259 ELTVKSDVYSFGVIL 273
+ D +S GV++
Sbjct: 183 LYGPECDEWSAGVMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 64/194 (32%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EVLMLSLLHHPNLVNLIGY 142
LG+G FG V K + Q AVK +++ + + EV +L L HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
D +V E +GG L D +K +I G+ Y+H +
Sbjct: 90 LEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 203 IYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++RDLK NILL + D K+ DFGL+ Q KM +GT Y APE R G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPEVLR-GT 198
Query: 260 LTVKSDVYSFGVIL 273
K DV+S GVIL
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 27/211 (12%)
Query: 76 TKNFRQE----CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EVLMLS 129
+ F LG+G F V + ++ G A K ++ + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 130 LLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL---DWTTRMK-IAS 185
L HPN+V L + LV++ ++GG L + ++ D + ++ I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP---KLSDFGLAKLGPQGEKMNVTSR 242
+ Y H +++R+LK N+LL + KL+DFGLA E
Sbjct: 117 S----IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGF 167
Query: 243 VMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273
GT GY +PE + + D+++ GVIL
Sbjct: 168 A-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 47/297 (15%)
Query: 35 SKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVY 94
+K + PPAPP T G K E +R LLG+GGFG V+
Sbjct: 4 TKPLQGPPAPPGTPTPPPGGKDREAF---------------EAEYRLGPLLGKGGFGTVF 48
Query: 95 KGTLQSNGQVVAVKQLDRN------GMQGNKEFLVEVLMLSLLH----HPNLVNLIGYCA 144
G ++ VA+K + RN + + +EV +L + HP ++ L+ +
Sbjct: 49 AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108
Query: 145 DGDQRLLVYEF-MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
+ +LV E + + D++ K PL +++ H + V+
Sbjct: 109 TQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VV 161
Query: 204 YRDLKSSNILL-GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELT- 261
+RD+K NIL+ KL DFG L E GT Y PE+ +
Sbjct: 162 HRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDFD---GTRVYSPPEWISRHQYHA 217
Query: 262 VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRK 318
+ + V+S G++L +++ G P + I A+ P L+R+
Sbjct: 218 LPATVWSLGILLYDMVCGD------IPFERDQEILEAE--LHFPAHVSPDCCALIRR 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 28/200 (14%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
+LG G F V+ + G++ A+K + ++ + E+ +L + H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDV---NETKKPLDWTTRMKIASGA----AQGLEYLHD 196
LV + +SGG + D +L+ E K AS ++YLH+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTE-----------KDASLVIQQVLSAVKYLHE 124
Query: 197 KANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
+++RDLK N+L N ++DFGL+K+ G + S GT GY APE
Sbjct: 125 NG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPE 177
Query: 254 YARSGELTVKSDVYSFGVIL 273
+ D +S GVI
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 76/265 (28%), Positives = 124/265 (46%), Gaps = 32/265 (12%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHH 133
FRQ +LG+GGFG V +++ G++ A K+L++ ++ K L E +L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 134 PNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGL 191
+V+L Y + L LV M+GG + H+ + + P R A+ GL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGL 299
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
E LH + ++YRDLK NILL + ++SD GLA P+G+ + RV GT GY A
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMA 353
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGR---RVIDTTRPVDEQNLIAWAQPIFRDPKRF 308
PE ++ T D ++ G +L E+I G+ + +E + + P+ +
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-----ERLVKEVPEEY 408
Query: 309 PDMADP--------LLRKQFPEKGL 325
+ P LL K P + L
Sbjct: 409 SERFSPQARSLCSQLLCKD-PAERL 432
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK------EFLVEVLMLSLLHHPNLVN 138
LG G F V K +S G A K + + + ++ E EV +L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLH 195
L + +L+ E +SGG + D L + + + S Q G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLH 132
Query: 196 DKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
K + + DLK NI+L P KL DFGLA G + + GT + A
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 252 PEYARSGELTVKSDVYSFGVILLELITG 279
PE L +++D++S GVI L++G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGY 142
LGEG +G V + + VAVK +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD-WTTRMK---IASGAAQGLEYLHDKA 198
+G+ + L E+ SGG + D + E + + + +G + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAG----VVYLHGIG 125
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARS 257
+ +RD+K N+LL + K+SDFGLA + + + +++ GT Y APE R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 258 GELTVKSDVYSFGVILLELITGR 280
DV+S G++L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK------EFLVEVLMLSLLHHPNLVN 138
LG G F V K +S G A K + + + ++ E EV +L + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLH 195
L + +L+ E +SGG + D L K+ L + + S Q G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESL---SEEEATSFIKQILDGVNYLH 132
Query: 196 DKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
K + + DLK NI+L P KL DFGLA G + + GT + A
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 252 PEYARSGELTVKSDVYSFGVILLELITG 279
PE L +++D++S GVI L++G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-28
Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 38/250 (15%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-----EVLMLSLLHHPNLVN 138
LG G FG+V G Q G VAVK L+R + +V E+ L L HP+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L + +V E++SGG + D++ ++ ++ ++Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE----- 253
V++RDLK N+LL A+++ K++DFGL+ + GE + TS G+ Y APE
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TS--CGSPNYAAPEVISGR 185
Query: 254 -YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRF 308
YA + D++S GVIL L+ G P D++++ + I F P+
Sbjct: 186 LYAGP-----EVDIWSCGVILYALLCGT------LPFDDEHVPTLFKKIRGGVFYIPEYL 234
Query: 309 PDMADPLLRK 318
LL
Sbjct: 235 NRSVATLLMH 244
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 56/253 (22%), Positives = 91/253 (35%), Gaps = 30/253 (11%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--------EVLML 128
+ + LG G FG V+ + + V VK + + + + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 129 SLLHHPNLVNLIGYCADGDQRLLVYEF-MSGGSVDDHLLDVNETKKPLDWTTRMKIASGA 187
S + H N++ ++ + LV E SG + + + LD I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQL 139
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
+ YL K +I+RD+K NI++ + KL DFG A +G+ GT
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTI 193
Query: 248 GYCAPEYARSGELTV--KSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305
YCAPE G + +++S GV L L+ P E A P
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE------NPFCELEETVEAA--IHPP 244
Query: 306 KRFPDMADPLLRK 318
L+
Sbjct: 245 YLVSKELMSLVSG 257
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK------EFLVEVLMLSLLHHPNLVN 138
LG G F V K +S G A K + + + ++ + EV +L + HPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLH 195
L + +L+ E ++GG + D L + K+ L T + Q G+ YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAE----KESL---TEEEATEFLKQILNGVYYLH 131
Query: 196 DKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
+ + DLK NI+L P K+ DFGLA G + + GT + A
Sbjct: 132 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 185
Query: 252 PEYARSGELTVKSDVYSFGVILLELITG 279
PE L +++D++S GVI L++G
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGY 142
LGEG +G V + + VAVK +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLD-WTTRMK---IASGAAQGLEYLHDKA 198
+G+ + L E+ SGG + D + E + + + +G + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAG----VVYLHGIG 125
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARS 257
+ +RD+K N+LL + K+SDFGLA + + + +++ GT Y APE R
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 258 GELTVKSDVYSFGVILLELITGR 280
DV+S G++L ++ G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 89/425 (20%), Positives = 168/425 (39%), Gaps = 59/425 (13%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV---EVLMLSLLHHPNLVNLI 140
LG G FG+V G + G VAVK L+R ++ E+ L L HP+++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK---IASGAAQGLEYLHDK 197
+ +V E++SGG + D++ + +R I SG ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEK-ESRRLFQQILSG----VDYCHRH 135
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YAR 256
V++RDLK N+LL A+++ K++DFGL+ + GE + TS G+ Y APE +
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TS--CGSPNYAAPEVISG 189
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRFPDMA 312
+ D++S GVIL L+ G P D+ ++ + I F P+
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGT------LPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243
Query: 313 ----------DPLLRKQFPE--------KGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354
DP+ R + + L + + + + + + +
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPE----DPSYSSTMIDDEALKEVC 299
Query: 355 -FLSNSKEPIPDPIIPSDE-DEYSEGYS--SDGHQKNENTYDNDNARSVRESENLESSNN 410
S+E + + + D + Y D + D A S L+ +
Sbjct: 300 EKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATS-PPDSFLDDHHL 358
Query: 411 SGSNPERI--ASSRGQVSGNLINSKEIGPSRKKSSKKSHHCLSQKVSPNENERRSSRSKS 468
+ +PER+ + + + ++ S+ + +K+ L + N+ + ++
Sbjct: 359 TRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRA 418
Query: 469 LSALN 473
+ L+
Sbjct: 419 IKQLD 423
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 54/203 (26%), Positives = 83/203 (40%), Gaps = 25/203 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-----EVLMLSLLHHPNLVNL 139
+G+G F V + + GQ AVK +D + E + +L HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA----AQGLEYLH 195
+ + +V+EFM G L + + +AS + L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 196 DKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAK-LGPQGEKMNVTSRVMGTYGYC 250
D +I+RD+K +LL A+ + KL FG+A LG G +GT +
Sbjct: 148 DNN---IIHRDVKPHCVLL-ASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPHFM 200
Query: 251 APEYARSGELTVKSDVYSFGVIL 273
APE + DV+ GVIL
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 69 FRELAAATKNFRQE----CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVE 124
++L + F +G G + + ++ AVK +D++ +E +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IE 67
Query: 125 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDV---NETKKPLDWTTRM 181
+ +L HPN++ L DG +V E M GG + D +L +E +
Sbjct: 68 I-LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE--------- 117
Query: 182 KIASGA----AQGLEYLHDKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQ 233
AS + +EYLH + V++RDLK SNIL ++ DFG AK
Sbjct: 118 --ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273
+ +T T + APE D++S GV+L
Sbjct: 173 ENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 78/325 (24%), Positives = 133/325 (40%), Gaps = 38/325 (11%)
Query: 1 MNCFPCFQSQKSKKANKNYVERSLPPRDECKEP------ESKKQKQPPAPPATIHRNEGT 54
M SK A ++ V+ L + + E + + I ++ T
Sbjct: 114 MKELLACSHPFSKSAIEH-VQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFT 172
Query: 55 KQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG 114
+ + KN+ +F ++G GGFG VY G++ A+K LD+
Sbjct: 173 RFCQWKNVELNI------HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226
Query: 115 MQGNKEF---LVEVLMLSLLH---HPNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLD 167
++ + L E +MLSL+ P +V + Y +L + + M+GG + HL
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS- 284
Query: 168 VNETKKPLDWTTRMKI-ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226
M+ A+ GLE++H++ V+YRDLK +NILL + ++SD G
Sbjct: 285 -QHGVFSEA---DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG 337
Query: 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKS-DVYSFGVILLELITGRRVIDT 285
LA + + +GT+GY APE + G S D +S G +L +L+ G
Sbjct: 338 LACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 286 TRPVDEQNLIAWAQPIFRDPKRFPD 310
+ D+ + + PD
Sbjct: 394 HKTKDKHEID---RMTLTMAVELPD 415
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 59/236 (25%), Positives = 93/236 (39%), Gaps = 34/236 (14%)
Query: 67 FTFRELAAA-----TKNFRQE----CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG 117
F F +L K R E LG G G V + + VA++ + +
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 118 NKEFLV--------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVN 169
E+ +L L+HP ++ + + D + +V E M GG L D
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGE----LFDKV 230
Query: 170 ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP---KLSDFG 226
K L T ++YLH+ +I+RDLK N+LL + + K++DFG
Sbjct: 231 VGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 227 LAKLGPQGEKMNVTSRVMGTYGYCAPE---YARSGELTVKSDVYSFGVILLELITG 279
+K+ + M + GT Y APE + D +S GVIL ++G
Sbjct: 288 HSKILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 49/226 (21%), Positives = 83/226 (36%), Gaps = 35/226 (15%)
Query: 65 QTFTFRELAAATKNFRQ-----ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNK 119
F+ + +LG G G+V + + GQ A+K L +
Sbjct: 12 LEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ- 70
Query: 120 EFLVEV-LMLSLLHHPNLVNLIGYCADGDQR----LLVYEFMSGGSVDDHLLDVNETKKP 174
EV P++V ++ + L++ E M GG L + +
Sbjct: 71 ----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE----LFSRIQERGD 122
Query: 175 LDWTTRMKIASGA----AQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGL 227
+T R A+ +++LH + +RD+K N+L + KL+DFG
Sbjct: 123 QAFTERE--AAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273
AK Q + + T Y APE + D++S GVI+
Sbjct: 178 AKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 57/261 (21%), Positives = 91/261 (34%), Gaps = 33/261 (12%)
Query: 26 PRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLL 85
P P P PPA + + + + K Q L
Sbjct: 13 PFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQV--L 70
Query: 86 GEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEV-LMLSLLHHPNLVNLIGYCA 144
G G G+V + + + A+K L EV L P++V ++
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVYE 125
Query: 145 DGDQR----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA----AQGLEYLHD 196
+ L+V E + GG L + + +T R AS + ++YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTERE--ASEIMKSIGEAIQYLHS 179
Query: 197 KANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
+ +RD+K N+L + P KL+DFG AK + + T Y AP
Sbjct: 180 IN---IAHRDVKPENLLY-TSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAP 232
Query: 253 EYARSGELTVKSDVYSFGVIL 273
E + D++S GVI+
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/260 (23%), Positives = 99/260 (38%), Gaps = 36/260 (13%)
Query: 25 PPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECL 84
Q + I+ A + F E
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDG-----SNRDALSDFFEVESE 60
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
LG G VY+ + + A+K L + K E+ +L L HPN++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 145 DGDQRLLVYEFMSGGSVDDHLLDV---NETKKPLDWTTRMKIASGA----AQGLEYLHDK 197
+ LV E ++GG + D +++ +E + A+ A + + YLH+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSE-----------RDAADAVKQILEAVAYLHEN 167
Query: 198 ANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
+++RDLK N+L A P K++DFGL+K+ M V GT GYCAPE
Sbjct: 168 G---IVHRDLKPENLLY-ATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPE 220
Query: 254 YARSGELTVKSDVYSFGVIL 273
R + D++S G+I
Sbjct: 221 ILRGCAYGPEVDMWSVGIIT 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 57/252 (22%), Positives = 97/252 (38%), Gaps = 28/252 (11%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV------EVLMLSL 130
++ LLG GGFG VY G S+ VA+K ++++ + E EV++L
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 131 LHH--PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
+ ++ L+ + D +L+ E L D + L
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ---DLFDFITERGALQEELARSFFWQVL 159
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
+ + + H+ V++RD+K NIL+ N + KL DFG L + GT
Sbjct: 160 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFD---GTR 212
Query: 248 GYCAPEYARSGELT-VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306
Y PE+ R + V+S G++L +++ G P + I Q +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQ--VFFRQ 264
Query: 307 RFPDMADPLLRK 318
R L+R
Sbjct: 265 RVSSECQHLIRW 276
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 56/244 (22%), Positives = 88/244 (36%), Gaps = 52/244 (21%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLLHHPNLVNL 139
+G+G +G V + A+K +++N ++ EV ++ LHHPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA----------- 188
D LV E GG + D L + +K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 189 -------------------------QGLEYLHDKANPPVIYRDLKSSNILLGA--NLDPK 221
L YLH++ + +RD+K N L + + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 222 LSDFGLAKL---GPQGEKMNVTSRVMGTYGYCAPEYARSGEL--TVKSDVYSFGVILLEL 276
L DFGL+K GE +T++ GT + APE + K D +S GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 277 ITGR 280
+ G
Sbjct: 270 LMGA 273
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 25/199 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EVLMLSLLHHPNLVNLIGY 142
LG+G F V + ++ G A K ++ + + E + L HPN+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL---DWTTRMKIASGAAQGLEYLHDKAN 199
+ LV++ ++GG L + ++ D + ++ + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQI---LESIAYCHSNG- 148
Query: 200 PPVIYRDLKSSNILL-----GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
+++R+LK N+LL GA + KL+DFGLA E GT GY +PE
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAV--KLADFGLAIEVNDSEAW---HGFAGTPGYLSPEV 201
Query: 255 ARSGELTVKSDVYSFGVIL 273
+ + D+++ GVIL
Sbjct: 202 LKKDPYSKPVDIWACGVIL 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 54/233 (23%), Positives = 85/233 (36%), Gaps = 42/233 (18%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPN 135
E +LG G G V G+ VAVK++ + E +++L S HPN
Sbjct: 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALME--IKLLTESD-DHPN 70
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA------- 188
++ + E + L D+ E+K D +++
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILL-------------GANLDPKLSDFGLAKL--GPQ 233
G+ +LH +I+RDLK NIL+ NL +SDFGL K Q
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 234 GEKMNVTSRVMGTYGYCAPE-------YARSGELTVKSDVYSFGVILLELITG 279
+ GT G+ APE LT D++S G + +++
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 29/245 (11%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-----EVLMLSLLHHPNLVN 138
LGEG FG+V T Q VA+K + R + K + E+ L LL HP+++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L ++V E+ +GG + D+++ KK + + +EY H
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARS 257
+++RDLK N+LL NL+ K++DFGL+ + G + TS G+ Y APE
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-TS--CGSPNYAAPEVINGK 182
Query: 258 GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----FRDPKRFPDMAD 313
+ DV+S G++L ++ GR P D++ + + + + P A
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR------LPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 314 PLLRK 318
L+R+
Sbjct: 237 SLIRR 241
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 34/202 (16%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEV-LMLSLLHHPNLVNLIGYC 143
LGEG F K + + Q AVK + + ++ E+ + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDV---NETKKPLDWTTRMKIASGA----AQGLEYLHD 196
D LV E ++GG + + + +E AS + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSE-----------TEASYIMRKLVSAVSHMHD 124
Query: 197 KANPPVIYRDLKSSNILLGANLDP----KLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCA 251
V++RDLK N+L + + K+ DFG A+ P + + + T Y A
Sbjct: 125 VG---VVHRDLKPENLLF-TDENDNLEIKIIDFGFARLKPPDNQPL--KTPC-FTLHYAA 177
Query: 252 PEYARSGELTVKSDVYSFGVIL 273
PE D++S GVIL
Sbjct: 178 PELLNQNGYDESCDLWSLGVIL 199
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 38/223 (17%)
Query: 75 ATKNFRQE----CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVL---- 126
+T F + +LG G V + + + AVK +D G V+ L
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 127 ------MLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPL---DW 177
+ + HPN++ L LV++ M G L D K L +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKET 126
Query: 178 TTRMK-IASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236
M+ + + LH +++RDLK NILL +++ KL+DFG + GEK
Sbjct: 127 RKIMRALLEV----ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 237 MNVTSRVMGTYGYCAPE------YARSGELTVKSDVYSFGVIL 273
+ V GT Y APE + D++S GVI+
Sbjct: 180 L---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 69/248 (27%), Positives = 99/248 (39%), Gaps = 25/248 (10%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHP 134
F + LG G FGRV + +G A+K LD+ + K+ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
LV L D +V E+++GG + HL + +P R A EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYAAQ-IVLTFEYL 157
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H +IYRDLK N+L+ +++DFG AK T + GT APE
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
S D ++ GV++ E+ G P I + I RFP
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSS 263
Query: 315 ----LLRK 318
LLR
Sbjct: 264 DLKDLLRN 271
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 25/246 (10%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
+G+G FG+V ++ A+K +++ E E+ ++ L HP LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 141 GYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
Y ++ + +V + + GG + HL + T ++ I L+YL ++
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQ--QNVHFKEE-TVKLFICE-LVMALDYLQNQR- 135
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE--YARS 257
+I+RD+K NILL + ++DF +A + P+ + + + GT Y APE +R
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRK 190
Query: 258 GELTVKS-DVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP-- 314
G + D +S GV EL+ GRR + ++ +P
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFETTVVTYPSAWSQEM 247
Query: 315 --LLRK 318
LL+K
Sbjct: 248 VSLLKK 253
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 24/199 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--EVLMLSLLHHPNLVNLIGY 142
LG+G F V + GQ A ++ + + E + LL HPN+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKAN 199
++ L+++ ++GG L + ++ + + Q + + H
Sbjct: 79 ISEEGHHYLIFDLVTGGE----LFEDIVAREYY---SEADASHCIQQILEAVLHCHQMG- 130
Query: 200 PPVIYRDLKSSNILL-----GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
V++R+LK N+LL GA + KL+DFGLA ++ GT GY +PE
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAV--KLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEV 184
Query: 255 ARSGELTVKSDVYSFGVIL 273
R D+++ GVIL
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 54/203 (26%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV--------EVLMLSLLHHPNL 136
LG G G V + + VA+K + + E+ +L L+HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ + + D + +V E M GG L D K L T ++YLH+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 197 KANPPVIYRDLKSSNILLGANLDP---KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
+I+RDLK N+LL + + K++DFG +K+ + M T + GT Y APE
Sbjct: 133 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR-T--LCGTPTYLAPE 186
Query: 254 ---YARSGELTVKSDVYSFGVIL 273
+ D +S GVIL
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 76/251 (30%), Positives = 115/251 (45%), Gaps = 43/251 (17%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHPNLVNLI 140
LG G FGRV+ + NG+ A+K L + + K+ E LMLS++ HP ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDK 197
G D Q ++ +++ GG + L + P + AA+ LEYLH K
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNP-VAKFY----AAEVCLALEYLHSK 125
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE---- 253
+IYRDLK NILL N K++DFG AK +VT + GT Y APE
Sbjct: 126 D---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVST 177
Query: 254 --YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311
Y +S + D +SFG+++ E++ G P + N + + I RFP
Sbjct: 178 KPYNKS----I--DWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELRFPPF 225
Query: 312 ADP----LLRK 318
+ LL +
Sbjct: 226 FNEDVKDLLSR 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 37/265 (13%)
Query: 28 DECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGE 87
DEC +++K N + K ++ +++ ++F ++G
Sbjct: 39 DECNNSPLRREK-----------NILEYLEWAKPFTSKV---KQMRLHREDFEILKVIGR 84
Query: 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLIGYCA 144
G FG V L++ +V A+K L++ M E F E +L + L + A
Sbjct: 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL--HYA 142
Query: 145 --DGDQRLLVYEFMSGGSVDD--HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
D + LV ++ GG D LL E + P + R +A ++ +H
Sbjct: 143 FQDDNNLYLVMDYYVGG---DLLTLLSKFEDRLPEEM-ARFYLAE-MVIAIDSVHQLH-- 195
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
++RD+K NIL+ N +L+DFG + + +S +GT Y +PE ++ E
Sbjct: 196 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 261 TVKS-----DVYSFGVILLELITGR 280
D +S GV + E++ G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 59/268 (22%), Positives = 95/268 (35%), Gaps = 41/268 (15%)
Query: 28 DECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGE 87
E E + K D + +E+ +F ++G
Sbjct: 26 QELGASELAQDKY--------------VADFLQWAEPIVVRLKEVRLQRDDFEILKVIGR 71
Query: 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLIGYCA 144
G F V ++ GQV A+K +++ M E F E +L + L + A
Sbjct: 72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL--HFA 129
Query: 145 --DGDQRLLVYEFMSGGSVDD--HLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
D + LV E+ GG D LL + P + R +A ++ +H
Sbjct: 130 FQDENYLYLVMEYYVGG---DLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVHRLG-- 182
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM-GTYGYCAPEYARSGE 259
++RD+K NILL +L+DFG V S V GT Y +PE ++
Sbjct: 183 -YVHRDIKPDNILLDRCGHIRLADFGSCLKL--RADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 260 LTVKSDVY-------SFGVILLELITGR 280
+ Y + GV E+ G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 80/334 (23%), Positives = 129/334 (38%), Gaps = 42/334 (12%)
Query: 5 PCFQSQKSKKANKNYVERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINA 64
++ + ++ ++ + E + P+ + E + +
Sbjct: 88 FHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM 147
Query: 65 QTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF--- 121
F + L LLG+G FG+V ++ G+ A+K L + + E
Sbjct: 148 NEFEY--LK----------LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT 195
Query: 122 LVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTR 180
L E +L HP L L Y RL V E+ +GG + HL E D R
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSED---R 249
Query: 181 MKI-ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV 239
+ + L+YLH + N V+YRDLK N++L + K++DFGL K G +
Sbjct: 250 ARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 305
Query: 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299
GT Y APE + D + GV++ E++ GR P Q+ +
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFE 359
Query: 300 PIFRDPKRFPDMADP--------LLRKQFPEKGL 325
I + RFP P LL+K P++ L
Sbjct: 360 LILMEEIRFPRTLGPEAKSLLSGLLKKD-PKQRL 392
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQL----DRNGMQGNKEFLVEVLMLSLLHHPNLVNLI 140
+GEG +G V+K + GQ+VA+K+ D + K L E+ ML L HPNLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 141 GYCADGDQRLLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ LV+E+ DH LD ++ + I Q + + H
Sbjct: 69 EVFRRKRRLHLVFEYC------DHTVLHELD--RYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPE-- 253
I+RD+K NIL+ + KL DFG A+ L + V T Y +PE
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVA-TRWYRSPELL 174
Query: 254 -----YARSGELTVKSDVYSFGVILLELITGR 280
Y V DV++ G + EL++G
Sbjct: 175 VGDTQYGPP----V--DVWAIGCVFAELLSGV 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 31/268 (11%)
Query: 26 PRDECKEPESKKQKQPPA--PPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQEC 83
PR K +QP A +G+K Q + ++
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQ----EVSYTDTK 60
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY- 142
++G G FG VY+ L +G++VA+K++ +Q + E+ ++ L H N+V L +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 143 CADGDQRL-----LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYL 194
+ G+++ LV +++ +V + K+ L + + Q L Y+
Sbjct: 117 YSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTL---PVIYVKLYMYQLFRSLAYI 172
Query: 195 HDKANPPVIYRDLKSSNILLGANLDP-KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
H + +RD+K N+LL + KL DFG AK +GE S + Y Y APE
Sbjct: 173 H-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY-YRAPE 226
Query: 254 Y-ARSGELTVKSDVYSFGVILLELITGR 280
+ + T DV+S G +L EL+ G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 78/358 (21%), Positives = 126/358 (35%), Gaps = 63/358 (17%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLV-EVLMLSLLHHPNLVNLIGY 142
+G G FG + ++VAVK ++R E + E++ L HPN+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK---IASGAAQGLEYLHDKAN 199
++ E+ SGG + + + N + D R + S G+ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI--CNAGRFSED-EARFFFQQLLS----GVSYCHSMQ- 136
Query: 200 PPVIYRDLKSSNILLGANLDP--KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YAR 256
+ +RDLK N LL + P K+ DFG +K + T GT Y APE R
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLR 191
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA----WAQPIFRDPKRFPD-- 310
+DV+S GV L ++ G P ++ Q I PD
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGA------YPFEDPEEPRDYRKTIQRILSVKYSIPDDI 245
Query: 311 --------------MADPLLRKQFPE--------KGLNEAVAIAAMCLQEEAGARPLMSD 348
+ADP R PE K L L E+ +
Sbjct: 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPAD-------LMNESNTGSQFQE 298
Query: 349 VVTALSFLSNSKEPIPDPIIPSDEDEYSEGYSSDGHQKNENTYDNDNARSVRESENLE 406
+ L + I + IP+ + + + +D +++ D D+ + + E
Sbjct: 299 PEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGE 356
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL----DRNGMQGNKEFLVEVLMLSLLHH 133
+ L+GEG +G V K + G++VA+K+ D + K + E+ +L L H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRH 83
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDH-LLDVNET-KKPLDWTTRMKIASGAAQGL 191
NLVNL+ C + LV+EF+ DH +LD E LD+ K G+
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV------DHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYC 250
+ H +I+RD+K NIL+ + KL DFG A+ L GE V T Y
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVA-TRWYR 191
Query: 251 APE-------YARSGELTVKSDVYSFGVILLELITGR 280
APE Y ++ V DV++ G ++ E+ G
Sbjct: 192 APELLVGDVKYGKA----V--DVWAIGCLVTEMFMGE 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 76/313 (24%), Positives = 119/313 (38%), Gaps = 48/313 (15%)
Query: 32 EPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFG 91
E E A + T +NF +LG G +G
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYG 68
Query: 92 RVY---KGTLQSNGQVVAVKQLDRNGMQGNKEFLVE-------------VLMLSLLHHPN 135
+V+ K + G++ A+K L K +V+ VL P
Sbjct: 69 KVFLVRKISGHDTGKLYAMKVL-------KKATIVQKAKTTEHTRTERQVLEHIR-QSPF 120
Query: 136 LVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEY 193
LV L Y + +L L+ ++++GG + HL + ++I LE+
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHL--SQRERFTEH---EVQIYVGEIVLALEH 174
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
LH +IYRD+K NILL +N L+DFGL+K E GT Y AP+
Sbjct: 175 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPD 230
Query: 254 ---YARSG-ELTVKSDVYSFGVILLELITGR---RVIDTTRPVDE-QNLIAWAQPIFRDP 305
SG + V D +S GV++ EL+TG V E I ++P + P
Sbjct: 231 IVRGGDSGHDKAV--DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--P 286
Query: 306 KRFPDMADPLLRK 318
+ +A L+++
Sbjct: 287 QEMSALAKDLIQR 299
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 76/267 (28%), Positives = 113/267 (42%), Gaps = 43/267 (16%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVEVLMLSLLHHP 134
+F LLG+G FG+V ++ G+ A+K L + + E + E +L HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 135 NLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLE 192
L L Y RL V E+ +GG + HL E + R + + LE
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEE---RARFYGAEIVSALE 119
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YLH + V+YRD+K N++L + K++DFGL K G GT Y AP
Sbjct: 120 YLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAP 174
Query: 253 E------YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306
E Y R+ V D + GV++ E++ GR P Q+ + I +
Sbjct: 175 EVLEDNDYGRA----V--DWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEI 222
Query: 307 RFPDMADP--------LLRKQFPEKGL 325
RFP P LL+K P++ L
Sbjct: 223 RFPRTLSPEAKSLLAGLLKKD-PKQRL 248
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-23
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 78 NFRQECLLGEGGFGRVY---KGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM----LSL 130
F +LG+G FG+V+ K + Q+ A+K L + ++ V M L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVE 82
Query: 131 LHHPNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAA 188
++HP +V L Y + +L L+ +F+ GG + L E + +K + A
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEE---DVKFYLAELA 136
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
L++LH +IYRDLK NILL KL+DFGL+K EK GT
Sbjct: 137 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 191
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGR 280
Y APE T +D +SFGV++ E++TG
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 5e-23
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLS 129
+++ F+Q LG G + VYKG ++ G VA+K++ + + + + E+ ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-K--LDSEEGTPSTAIREISLMK 58
Query: 130 LLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIAS 185
L H N+V L ++ LV+EFM D+ +D +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 186 GAAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL-GPQGEKMNVTS 241
Q GL + H+ +++RDLK N+L+ KL DFGLA+ G +S
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SS 167
Query: 242 RVMGTYGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
V+ T Y AP+ Y+ S D++S G IL E+ITG+
Sbjct: 168 EVV-TLWYRAPDVLMGSRTYSTS------IDIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-23
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLL 131
+ + + +GEG +G V+K + ++VA+K++ R + + E L E+ +L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-R--LDDDDEGVPSSALREICLLKEL 58
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIASGA 187
H N+V L + LV+EF D D LD
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFD--SCNGDLDPEIVKSFLFQL 110
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL-GPQGEKMNVTSRVMGT 246
+GL + H + V++RDLK N+L+ N + KL++FGLA+ G ++ V+ T
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVV-T 164
Query: 247 YGYCAPE-------YARSGELTVKSDVYSFGVILLELITGRR 281
Y P+ Y+ S D++S G I EL R
Sbjct: 165 LWYRPPDVLFGAKLYSTS------IDMWSAGCIFAELANAGR 200
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 16/167 (9%)
Query: 124 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
++ + N V + + + + ++ D ++ + + + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHI 169
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-----------LGP 232
A+ +E+LH K +++RDLK SNI + K+ DFGL L P
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG 279
T +V GT Y +PE + K D++S G+IL EL+
Sbjct: 227 MPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 69/254 (27%), Positives = 102/254 (40%), Gaps = 31/254 (12%)
Query: 34 ESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRV 93
E + PAPP + + F F L ++G+G FG+V
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHF--LK----------VIGKGSFGKV 54
Query: 94 YKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVE--VLMLSLLHHPNLVNLIGYCADGDQ 148
++ AVK L + + KE + E VL+ ++ HP LV L +
Sbjct: 55 LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLH-FSFQTAD 112
Query: 149 RL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHDKANPPVIYRD 206
+L V ++++GG + HL E R + A+ A L YLH ++YRD
Sbjct: 113 KLYFVLDYINGGELFYHLQ--RERCFLEP---RARFYAAEIASALGYLHSLN---IVYRD 164
Query: 207 LKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDV 266
LK NILL + L+DFGL K + TS GT Y APE D
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 267 YSFGVILLELITGR 280
+ G +L E++ G
Sbjct: 223 WCLGAVLYEMLYGL 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 33/217 (15%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPN 135
+ + + LGEG + VYKG + +VA+K++ +G + EV +L L H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIASGAAQGL 191
+V L LV+E++ D LD + ++ +GL
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL------DKDLKQYLD--DCGNIINMHNVKLFLFQLLRGL 113
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL-GPQGEKMNVTSRVMGTYGYC 250
Y H + V++RDLK N+L+ + KL+DFGLA+ + + V+ T Y
Sbjct: 114 AYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVV-TLWYR 167
Query: 251 APE-------YARSGELTVKSDVYSFGVILLELITGR 280
P+ Y + + D++ G I E+ TGR
Sbjct: 168 PPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 34/219 (15%)
Query: 78 NFRQECLLGEGGFGRVY---KGTLQSNGQVVAVKQLDRNGMQGNKEFLV----------- 123
F +LG+GG+G+V+ K T + G++ A+K L K +V
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-------KKAMIVRNAKDTAHTKA 70
Query: 124 EVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMK 182
E +L + HP +V+LI Y +L L+ E++SGG + L E D
Sbjct: 71 ERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMED---TAC 124
Query: 183 I-ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241
+ + L +LH K +IYRDLK NI+L KL+DFGL K + T
Sbjct: 125 FYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--TH 179
Query: 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
GT Y APE D +S G ++ +++TG
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 34/262 (12%)
Query: 28 DECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGE 87
+ P +K K + R+L +++ ++G
Sbjct: 34 YDLDFPALRKNK--------------NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGR 79
Query: 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHPNLVNLIGYCA 144
G FG V +S +V A+K L + M + F E +++ + P +V L + A
Sbjct: 80 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYA 137
Query: 145 --DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202
D +V E+M GG + + + + P W R A L+ +H
Sbjct: 138 FQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKW-ARFYTAE-VVLALDAIHSMG---F 189
Query: 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS----G 258
I+RD+K N+LL + KL+DFG + + + V GT Y +PE +S G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 248
Query: 259 ELTVKSDVYSFGVILLELITGR 280
+ D +S GV L E++ G
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGD 270
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 3e-22
Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 41/287 (14%)
Query: 30 CKEPESK----------KQKQPPAPPATIHRNEGTKQDE--TKNINAQTFTFRELAAATK 77
C EP KQ + ++ ++ + + TFT K
Sbjct: 9 CSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTV------LK 62
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGMQGNKEFLVEVLMLSLLHHP 134
++ +G G G V + VA+K+L R N K E++++ ++H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 121
Query: 135 NLVNLIG-YCADGDQRL-----LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
N+++L+ + LV E M + + + LD +
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQV----IQMELDHERMSYLLYQML 174
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
G+++LH A +I+RDLK SNI++ ++ K+ DFGLA+ M T V+ T
Sbjct: 175 CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVV-TRY 228
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI 295
Y APE D++S G I+ E++ + + +D+ N +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 275
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 43/269 (15%), Positives = 80/269 (29%), Gaps = 52/269 (19%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHHPN 135
+R G + ++ + + VA+ +D G+ + +E L L LS + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+ ++ L+V E++ GGS+ + ++ A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
V S + +S G L
Sbjct: 147 RA---GVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDANP 181
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315
+ D+ G L L+ R P+ E + + P RD P
Sbjct: 182 Q-------DDIRGIGASLYALLVNR------WPLPEAGVRSGLAPAERDTAGQPIEPAD- 227
Query: 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARP 344
+ + P + A+AA +Q + G R
Sbjct: 228 IDRDIPF----QISAVAARSVQGDGGIRS 252
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 3e-22
Identities = 77/322 (23%), Positives = 121/322 (37%), Gaps = 48/322 (14%)
Query: 20 VERSLPPRDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNF 79
E + R + + + + + P ++ + F F L
Sbjct: 296 SEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF--LM------ 347
Query: 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM------LSLLHH 133
+LG+G FG+V + ++ AVK L ++ + + + VE M
Sbjct: 348 ----VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPGKP 401
Query: 134 PNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGL 191
P L L C RL V E+++GG + H+ V K+P A+ A GL
Sbjct: 402 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGL 455
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
+L K +IYRDLK N++L + K++DFG+ K T GT Y A
Sbjct: 456 FFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIA 510
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311
PE D ++FGV+L E++ G+ + DE L Q I +P
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELF---QSIMEHNVAYPKS 564
Query: 312 ADP--------LLRKQFPEKGL 325
L+ K P K L
Sbjct: 565 MSKEAVAICKGLMTKH-PGKRL 585
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 37/221 (16%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLL 131
K + + LGEG F VYK ++ Q+VA+K++ K+ L E+ +L L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIASGA 187
HPN++ L+ LV++FM + ++ + L +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFM------ETDLEVIIK--DNSLVLTPSHIKAYMLMT 121
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL-GPQGEKMNVTSRVMGT 246
QGLEYLH +++RDLK +N+LL N KL+DFGLAK G T +V+ T
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVV-T 175
Query: 247 YGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
Y APE Y V D+++ G IL EL+
Sbjct: 176 RWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 54/226 (23%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-F----LVEVLMLSLLHHPNLVNL 139
+G+G FG V+K + GQ VA+K++ M+ KE F L E+ +L LL H N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 140 IGYCADGDQRL--------LVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIASGA 187
I C LV++F +H LL K L +I
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLS-----EIKRVM 130
Query: 188 AQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK---LGPQGEKMNVTS 241
GL Y+H +++RD+K++N+L+ + KL+DFGLA+ L + T+
Sbjct: 131 QMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 242 RVMGTYGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
RV+ T Y PE Y D++ G I+ E+ T
Sbjct: 188 RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 62/232 (26%), Positives = 93/232 (40%), Gaps = 54/232 (23%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEV-----------L 126
+ +G G +G VYK +G VA+K + R + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-R--VPNGGGGGGGLPISTVREVALLR 66
Query: 127 MLSLLHHPNLVNLI----GYCADGDQRL-LVYEFMSGGSVDDH----LLDVNETKKPLDW 177
L HPN+V L+ D + ++ LV+E + D LD K P
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQDLRTYLD----KAPPPG 116
Query: 178 TTRMKIASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234
I Q GL++LH +++RDLK NIL+ + KL+DFGLA+
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYS 171
Query: 235 EKMNVTSRVMGTYGYCAPE------YARSGELTVKSDVYSFGVILLELITGR 280
+M +T V+ T Y APE YA V D++S G I E+ +
Sbjct: 172 YQMALTPVVV-TLWYRAPEVLLQSTYATP----V--DMWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 74/268 (27%), Positives = 118/268 (44%), Gaps = 44/268 (16%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVE--VLMLSLLH 132
+F +LG+G FG+V+ + Q A+K L ++ + + + +VE VL L+
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-E 76
Query: 133 HPNLVNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
HP L ++ + L V E+++GG + H+ ++ A GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAE-IILGL 131
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
++LH K ++YRDLK NILL + K++DFG+ K G+ T+ GT Y A
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIA 186
Query: 252 PE------YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305
PE Y S D +SFGV+L E++ G+ DE+ L I D
Sbjct: 187 PEILLGQKYNHSV------DWWSFGVLLYEMLIGQSPFHGQ---DEEELF---HSIRMDN 234
Query: 306 KRFPDMADP--------LLRKQFPEKGL 325
+P + L ++ PEK L
Sbjct: 235 PFYPRWLEKEAKDLLVKLFVRE-PEKRL 261
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 62/256 (24%), Positives = 109/256 (42%), Gaps = 50/256 (19%)
Query: 49 HRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVK 108
H + GT + +T+ + + + A + +R+ LGEG +G VYK + VA+K
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65
Query: 109 QLDRNGMQGNKE-----FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDD 163
++ R ++ +E + EV +L L H N++ L + L++E+ +
Sbjct: 66 RI-R--LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA------E 116
Query: 164 HLLDVNETKKPLDWTTRMK---IASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGAN 217
+ L KK +D + I S Q G+ + H + ++RDLK N+LL +
Sbjct: 117 NDL-----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVS 168
Query: 218 LDP-----KLSDFGLAKL-GPQGEKMNVTSRVMGTYGYCAPE-------YARSGELTVKS 264
K+ DFGLA+ G + T ++ T Y PE Y+ S
Sbjct: 169 DASETPVLKIGDFGLARAFGIPIRQF--THEII-TLWYRPPEILLGSRHYSTS------V 219
Query: 265 DVYSFGVILLELITGR 280
D++S I E++
Sbjct: 220 DIWSIACIWAEMLMKT 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 9e-22
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLL 131
+ +++ +GEG +G VYK S G++VA+K++ R + E + E+ +L L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRI-R--LDAEDEGIPSTAIREISLLKEL 76
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIASGA 187
HHPN+V+LI LV+EFM + +LD E K L +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFM------EKDLKKVLD--ENKTGLQDSQIKIYLYQL 128
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL-GPQGEKMNVTSRVMGT 246
+G+ + H +++RDLK N+L+ ++ KL+DFGLA+ G T V+ T
Sbjct: 129 LRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVV-T 182
Query: 247 YGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
Y AP+ Y+ S D++S G I E+ITG+
Sbjct: 183 LWYRAPDVLMGSKKYSTS------VDIWSIGCIFAEMITGK 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 61/237 (25%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN 135
F+ E + G+G FG V G +S G VA+K++ ++ N+E L + L++LHHPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 136 LVNLI------GYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
+V L G D L +V E++ P +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-----------------PDTLHRCCRNYYRRQ 123
Query: 189 Q----------------GLEYLHDK-ANPPVIYRDLKSSNILL-GANLDPKLSDFGLAKL 230
+ LH N V +RD+K N+L+ A+ KL DFG AK
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 231 GPQGEKMNVTSRVMGTYGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
E + + Y Y APE Y T D++S G I E++ G
Sbjct: 182 LSPSEPN--VAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 27/295 (9%)
Query: 28 DECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAAT-KNFRQECLLG 86
P G+ +E K + + ++ ++F ++G
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61
Query: 87 EGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVE--VLMLSLLHHPNLVNLIG 141
G + +V L+ ++ A++ + + + +++ E V + +HP LV L
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLH- 119
Query: 142 YCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
C + RL V E+++GG + H+ + K P + R A + L YLH++
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEE-HARFYSAE-ISLALNYLHERG-- 173
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL 260
+IYRDLK N+LL + KL+D+G+ K G + TS GT Y APE R +
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDY 230
Query: 261 TVKSDVYSFGVILLELITGR------RVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
D ++ GV++ E++ GR D E L Q I R P
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---QVILEKQIRIP 282
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVE--VLMLSLLHHPNLVN 138
++G G + +V L+ ++ A+K + + + +++ E V + +HP LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVG 74
Query: 139 LIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
L C + RL V E+++GG + H+ + K P + R A + L YLH++
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHA-RFYSAE-ISLALNYLHER 129
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE---- 253
+IYRDLK N+LL + KL+D+G+ K G + TS GT Y APE
Sbjct: 130 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRG 184
Query: 254 --YARSGELTVKSDVYSFGVILLELITGR---RVIDTTRPVDEQNLIAWAQPIFRDPKRF 308
Y S V D ++ GV++ E++ GR ++ ++ D+ Q I R
Sbjct: 185 EDYGFS----V--DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238
Query: 309 P 309
P
Sbjct: 239 P 239
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 52/230 (22%)
Query: 78 NFRQECLLGEGGFGRVYKGT-LQSNGQVVAVKQLDRNGMQGNKE-----FLVEV---LML 128
+ +GEG +G+V+K L++ G+ VA+K++ R +Q +E + EV L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-R--VQTGEEGMPLSTIREVAVLRHL 68
Query: 129 SLLHHPNLVNLI----GYCADGDQRL-LVYEFMSGGSVDDH----LLDVNETKKPLDWTT 179
HPN+V L D + +L LV+E + D LD K P
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLD----KVPEPGVP 118
Query: 180 RMKIASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236
I Q GL++LH V++RDLK NIL+ ++ KL+DFGLA+ +
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQ 173
Query: 237 MNVTSRVMGTYGYCAPE------YARSGELTVKSDVYSFGVILLELITGR 280
M +TS V+ T Y APE YA V D++S G I E+ +
Sbjct: 174 MALTSVVV-TLWYRAPEVLLQSSYATP----V--DLWSVGCIFAEMFRRK 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 58/254 (22%), Positives = 104/254 (40%), Gaps = 24/254 (9%)
Query: 35 SKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVY 94
S P ++ + D K I + + ++G G FG V+
Sbjct: 2 SFTMSNAPLNGVKLNPLD----DPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 95 KGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGY-----CADGDQR 149
+ L + +V A+K++ +Q + E+ ++ ++ HPN+V+L + +
Sbjct: 58 QAKLVESDEV-AIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 150 L-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208
L LV E++ +V + K+ + + L Y+H + +RD+K
Sbjct: 113 LNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIK 168
Query: 209 SSNILLGANLDP-KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-YARSGELTVKSDV 266
N+LL KL DFG AK+ GE S + Y Y APE + T D+
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSYICSRY-YRAPELIFGATNYTTNIDI 225
Query: 267 YSFGVILLELITGR 280
+S G ++ EL+ G+
Sbjct: 226 WSTGCVMAELMQGQ 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 45/223 (20%)
Query: 85 LGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIG- 141
+G G +G VYK + + + A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 142 YCADGDQRL-LVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMK---IASGAAQ---G 190
+ + D+++ L++++ +H ++ + K ++ + S Q G
Sbjct: 87 FLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKL--GPQGEKMNVTSRVM 244
+ YLH V++RDLK +NIL+ K++D G A+L P ++ V+
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 245 GTYGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
T+ Y APE Y T D+++ G I EL+T
Sbjct: 198 -TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 23/232 (9%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF---LVE--VLMLSLLHHPNLVN 138
+LG+G FG+V + ++ AVK L ++ + + + +VE VL L P L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQ 85
Query: 139 LIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
L C RL V E+++GG + H+ V K+P A A GL +L K
Sbjct: 86 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAE-IAIGLFFLQSK 140
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS 257
+IYRDLK N++L + K++DFG+ K T GT Y APE
Sbjct: 141 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAY 195
Query: 258 GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
D ++FGV+L E++ G+ + DE L Q I +P
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELF---QSIMEHNVAYP 241
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLL 131
+ + +GEG +G VYK + G+ A+K++ R ++ E + E+ +L L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKI-R--LEKEDEGIPSTTIREISILKEL 57
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDH----LLDVNETKKPLDWTTRMKIASGA 187
H N+V L + +LV+E + D LLD + L+ T
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHL------DQDLKKLLD--VCEGGLESVTAKSFLLQL 109
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL-GPQGEKMNVTSRVMGT 246
G+ Y HD+ V++RDLK N+L+ + K++DFGLA+ G K T ++ T
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIV-T 163
Query: 247 YGYCAPE-------YARSGELTVKSDVYSFGVILLELITGR 280
Y AP+ Y+ + D++S G I E++ G
Sbjct: 164 LWYRAPDVLMGSKKYSTT------IDIWSVGCIFAEMVNGT 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 62/259 (23%), Positives = 108/259 (41%), Gaps = 35/259 (13%)
Query: 49 HRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVK 108
R++ + I TFT K ++ +G G G V + VA+K
Sbjct: 3 SRSKRDNNFYSVEIGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK 56
Query: 109 QLDR---NGMQGNKEFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-----LVYEFMSGG 159
+L R N K E++++ ++H N++ L+ + +V E M
Sbjct: 57 KLSRPFQNQTHA-KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-- 113
Query: 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGA 216
+ + + L +++ Q G+++LH A +I+RDLK SNI++ +
Sbjct: 114 -ANLCQV----IQMEL---DHERMSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKS 162
Query: 217 NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLEL 276
+ K+ DFGLA+ M T V+ T Y APE D++S G I+ E+
Sbjct: 163 DCTLKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 277 ITGRRVIDTTRPVDEQNLI 295
I G + T +D+ N +
Sbjct: 220 IKGGVLFPGTDHIDQWNKV 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 49/279 (17%)
Query: 44 PPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQ 103
P + G + + + F F + +LG+G FG+V ++ G
Sbjct: 2 PKESSKEGNGIGVNSSNRLGIDNFEF--IR----------VLGKGSFGKVMLARVKETGD 49
Query: 104 VVAVKQLDRNGMQGNKEF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEFMS 157
+ AVK L ++ + + + + E +L L+ +HP L L C RL V EF++
Sbjct: 50 LYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLF-CCFQTPDRLFFVMEFVN 107
Query: 158 GGSVDDHLLDVNETKKPLDWTTRMKI-ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA 216
GG + H+ + R + A+ L +LHDK +IYRDLK N+LL
Sbjct: 108 GGDLMFHI--QKSRRFDEA---RARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDH 159
Query: 217 NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE------YARSGELTVKSDVYSFG 270
KL+DFG+ K G T+ GT Y APE Y + V D ++ G
Sbjct: 160 EGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPA----V--DWWAMG 211
Query: 271 VILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
V+L E++ G P + +N + I D +P
Sbjct: 212 VLLYEMLCGH------APFEAENEDDLFEAILNDEVVYP 244
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 56/264 (21%), Positives = 95/264 (35%), Gaps = 73/264 (27%)
Query: 85 LGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQG-NKEFLVEV-LMLSLLHHPNLV 137
LG G FG+V + + + VAVK L ++ + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 138 NLIG--------------YCADGD------------------------------------ 147
NL+G +C G+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 148 -QRLLVYEFMSGGSVDDHLLD------------VNETKKPLDWTTRMKIASGAAQGLEYL 194
+RL + + + + K L + + A+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
+ I+RDL + NILL K+ DFGLA+ + + APE
Sbjct: 210 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 255 ARSGELTVKSDVYSFGVILLELIT 278
T++SDV+SFGV+L E+ +
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 65/358 (18%), Positives = 124/358 (34%), Gaps = 87/358 (24%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN 135
+K + LG G FG V + +G+ A+K++ +Q + E+ ++ +L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVN 61
Query: 136 LVNL--IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTR------------- 180
++ L Y ++ + VN K +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 181 ------MKIASGAAQ----------------GLEYLHDKANPPVIYRDLKSSNILLGANL 218
+K + + + ++H + +RD+K N+L+ +
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLVNSKD 178
Query: 219 DP-KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE-------YARSGELTVKSDVYSFG 270
+ KL DFG AK E + + + Y APE Y T D++S G
Sbjct: 179 NTLKLCDFGSAKKLIPSEPS--VAYICSRF-YRAPELMLGATEY------TPSIDLWSIG 229
Query: 271 VILLELITGR----------------RVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
+ ELI G+ +++ T P EQ + P + + + FP +
Sbjct: 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGT--PTKEQ--MIRMNPHYTEVR-FPTLKAK 284
Query: 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS--FLSNSKEPIPDPIIPS 370
RK PE + A+ + L+ E R + A++ F + + + +
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFFDHLRNSYESEVKNN 339
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 46/202 (22%), Positives = 73/202 (36%), Gaps = 52/202 (25%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEV-LMLSLLHHPNLVNLIGYC 143
LG G G+V + + + A+K L EV L P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 144 ADGDQR----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA----AQGLEYLH 195
+ L+V E + GG L + + +T R AS + ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTERE--ASEIMKSIGEAIQYLH 134
Query: 196 DKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
+ +RD+K N+L + P KL+DFG AK T Y
Sbjct: 135 SIN---IAHRDVKPENLLY-TSKRPNAILKLTDFGFAK--------ETTGE---KYDK-- 177
Query: 252 PEYARSGELTVKSDVYSFGVIL 273
D++S GVI+
Sbjct: 178 -----------SCDMWSLGVIM 188
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 38/250 (15%)
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGM 115
+++N + K + +G G +G V + +G+ VA+K+L R + +
Sbjct: 12 KQDVNKTAWEL------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65
Query: 116 QGNKEFLVEVLMLSLLHHPNLVNLI-----GYCADGDQRL-LVYEFMSGGSVDDHLLDVN 169
K E+L+L + H N++ L+ LV FM D +
Sbjct: 66 FA-KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQKI--- 118
Query: 170 ETKKPLDWTTRMKIASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226
+ KI Q GL+Y+H A V++RDLK N+ + + + K+ DFG
Sbjct: 119 -MGLKF---SEEKIQYLVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFG 171
Query: 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYA-RSGELTVKSDVYSFGVILLELITGRRVIDT 285
LA+ +M T V+ T Y APE D++S G I+ E++TG+ +
Sbjct: 172 LAR--HADAEM--TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226
Query: 286 TRPVDEQNLI 295
+D+ I
Sbjct: 227 KDYLDQLTQI 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 61/270 (22%), Positives = 99/270 (36%), Gaps = 68/270 (25%)
Query: 37 KQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKG 96
A A + + Q F + +GEG +G V
Sbjct: 2 HHHHHMAAAAAAGP---------EMVRGQVFDV------GPRYTNLSYIGEGAYGMVCSA 46
Query: 97 TLQSNGQVVAVKQLD--RNGMQGNKEFLVEVLMLSLLHHPNLVNLIG----YCADGDQRL 150
N VA+K++ + + L E+ +L H N++ + + + +
Sbjct: 47 YDNLNKVRVAIKKISPFEHQTYC-QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105
Query: 151 -LVYEFM---------SGGSVDDH-------LLDVNETKKPLDWTTRMKIASGAAQGLEY 193
+V + M + +DH +L +GL+Y
Sbjct: 106 YIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL----------------------RGLKY 143
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL--GPQGEKMNVTSRVMGTYGYCA 251
+H AN V++RDLK SN+LL D K+ DFGLA++ +T V T Y A
Sbjct: 144 IHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRA 199
Query: 252 PEYA-RSGELTVKSDVYSFGVILLELITGR 280
PE S T D++S G IL E+++ R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 40/242 (16%)
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN 118
+++ A+ + + + G +G V G + S G VA+K++ G
Sbjct: 10 MRDLIAELHAM------QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGR 62
Query: 119 -----------KEFLVEVLMLSLLHHPNLVNL----IGYCADGDQRL-LVYEFMSGGSVD 162
K L E+ +L+ HHPN++ L + + +L LV E M D
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR---TD 119
Query: 163 DHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGANLD 219
+ +++ + + + I GL LH+ A V++RDL NILL N D
Sbjct: 120 LAQV-IHDQRIVI---SPQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNND 172
Query: 220 PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY-ARSGELTVKSDVYSFGVILLELIT 278
+ DF LA+ T V Y APE + T D++S G ++ E+
Sbjct: 173 ITICDFNLAREDTADANK--THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
Query: 279 GR 280
+
Sbjct: 230 RK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 43/213 (20%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLML-SLLHHPNLVNLIGYC 143
LG G + V++ +N + V VK L K+ E+ +L +L PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNET--KKPLDWTTRMKIASGAAQ---GLEYLHDKA 198
D R F VN T K+ T I + L+Y H
Sbjct: 101 KDPVSRTPALVFE----------HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 199 NPPVIYRDLKSSNILL-GANLDPKLSDFGLAKLGPQGEKMN--VTSRVMGTYGYCAPE-- 253
+++RD+K N+++ + +L D+GLA+ G++ N V SR + PE
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELL 202
Query: 254 -----YARSGELTVKSDVYSFGVILLELITGRR 281
Y S D++S G +L +I +
Sbjct: 203 VDYQMYDYS------LDMWSLGCMLASMIFRKE 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 70/243 (28%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLD--RNGMQGNKEFLVEVLMLSLLHH 133
+ +F+ + LLGEG +G V T + G++VA+K+++ + L E+ +L H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLREIKILKHFKH 68
Query: 134 PNLVNLIG-YCADGDQRL----LVYEFM---------SGGSVDDH-------LLDVNETK 172
N++ + D + ++ E M + DDH L
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL------ 122
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA---- 228
+ ++ LH +N VI+RDLK SN+L+ +N D K+ DFGLA
Sbjct: 123 ----------------RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163
Query: 229 KLGPQGEKMNVTSRVMGTY----GYCAPE-------YARSGELTVKSDVYSFGVILLELI 277
+ + M + Y APE Y + DV+S G IL EL
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELF 217
Query: 278 TGR 280
R
Sbjct: 218 LRR 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGM 115
+ + + +R +G G +G V G VA+K+L R + +
Sbjct: 13 RQEVTKTAWE------VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 66
Query: 116 QGNKEFLVEVLMLSLLHHPNLVNLIG-YCADGDQRL-----LVYEFMSGGSVDDHLLDVN 169
K E+ +L + H N++ L+ + D LV FM D+
Sbjct: 67 FA-KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--------DLG 117
Query: 170 ETKK--PLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227
+ K L + +GL Y+H A +I+RDLK N+ + + + K+ DFGL
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYA-RSGELTVKSDVYSFGVILLELITGR 280
A+ +T V+ T Y APE T D++S G I+ E+ITG+
Sbjct: 175 AR----QADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 64/263 (24%), Positives = 105/263 (39%), Gaps = 63/263 (23%)
Query: 59 TKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGM 115
+ +N + + ++ +G G +G V G VAVK+L R + +
Sbjct: 17 RQELNKTIWEV------PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 116 QGNKEFLVEVLMLSLLHHPNLVNLI-----GYCADGDQRL-LVYEFM---------SGGS 160
K E+ +L + H N++ L+ + + LV M
Sbjct: 71 HA-KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 161 VDDH-------LLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213
DDH +L +GL+Y+H A+ +I+RDLK SN+
Sbjct: 130 TDDHVQFLIYQIL----------------------RGLKYIHS-AD--IIHRDLKPSNLA 164
Query: 214 LGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA-RSGELTVKSDVYSFGVI 272
+ + + K+ DFGLA+ ++M T V T Y APE D++S G I
Sbjct: 165 VNEDCELKILDFGLAR--HTADEM--TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 273 LLELITGRRVIDTTRPVDEQNLI 295
+ EL+TGR + T +D+ LI
Sbjct: 220 MAELLTGRTLFPGTDHIDQLKLI 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 58/253 (22%), Positives = 99/253 (39%), Gaps = 66/253 (26%)
Query: 62 INAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF 121
+N F + LG GG G V+ + VA+K++ Q K
Sbjct: 2 MNIHGFDL------GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA 55
Query: 122 LVEVLMLSLLHHPNLVNLIG-YCADGDQRL-------------LVYEFM---------SG 158
L E+ ++ L H N+V + G Q +V E+M G
Sbjct: 56 LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115
Query: 159 GSVDDH-------LLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSN 211
+++H LL +GL+Y+H AN V++RDLK +N
Sbjct: 116 PLLEEHARLFMYQLL----------------------RGLKYIHS-AN--VLHRDLKPAN 150
Query: 212 ILLGA-NLDPKLSDFGLAKL--GPQGEKMNVTSRVMGTYGYCAPE-YARSGELTVKSDVY 267
+ + +L K+ DFGLA++ K +++ ++ T Y +P T D++
Sbjct: 151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMW 209
Query: 268 SFGVILLELITGR 280
+ G I E++TG+
Sbjct: 210 AAGCIFAEMLTGK 222
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 26/217 (11%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
+++ +GEG FG +++GT N Q VA+K R L L +
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIP 69
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
N+ + +G +LV + + G S++D L + + T A ++ +H+K
Sbjct: 70 NVYYFGQEGLHNVLVIDLL-GPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 198 ANPPVIYRDLKSSNILLGANLDPK-----LSDFGLAKL---------GPQGEKMNVTSRV 243
+ ++YRD+K N L+G + DFG+ K P EK N++
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS--- 179
Query: 244 MGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
GT Y + E + + D+ + G + + + G
Sbjct: 180 -GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 60/296 (20%), Positives = 101/296 (34%), Gaps = 63/296 (21%)
Query: 27 RDECKEPESKKQKQPPAPPATIHRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLG 86
E + + + KQ + A + L+G
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 87 EGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLLHHPNLVNL--- 139
G +G V + + +VVA+K++ R + + L E+ +L+ L+H ++V +
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 140 -IGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYL 194
I + L +V E D + T L T + I + G++Y+
Sbjct: 121 VIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYL---TELHIKTLLYNLLVGVKYV 172
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG------ 248
H A +++RDLK +N L+ + K+ DFGLA+ E N +
Sbjct: 173 HS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 249 -------------------YCAPE-------YARSGELTVKSDVYSFGVILLELIT 278
Y APE Y T DV+S G I EL+
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENY------TEAIDVWSIGCIFAELLN 279
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH-PNL 136
+R +G G FG +Y GT + G+ VA+K E + ++ +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGI 67
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
+ A+GD ++V E + G S++D N + T + +A +EY+H
Sbjct: 68 PTIRWCGAEGDYNVMVMELL-GPSLEDLF---NFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 197 KANPPVIYRDLKSSNILLGANLDPK---LSDFGLAKL---------GPQGEKMNVTSRVM 244
K I+RD+K N L+G + DFGLAK P E N+T
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT---- 176
Query: 245 GTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
GT Y + E + + D+ S G +L+ G
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 60/310 (19%), Positives = 109/310 (35%), Gaps = 58/310 (18%)
Query: 49 HRNEGTKQDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVK 108
H + + ++ + N+ + L+G G +G VY ++ + VA+K
Sbjct: 4 HHHHSSGRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK 57
Query: 109 QLDR---NGMQGNKEFLVEVLMLSLLHHPNLVNL----IGYCADGDQRL-LVYEFMSGGS 160
+++R + + K L E+ +L+ L ++ L I L +V E
Sbjct: 58 KVNRMFEDLIDC-KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA---- 112
Query: 161 VDDHLLDVNETKKPLDWTTRMKIASGAAQ---GLEYLHDKANPPVIYRDLKSSNILLGAN 217
D L + +T L T I + G ++H+ + +I+RDLK +N LL +
Sbjct: 113 -DSDLKKLFKTPIFL---TEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQD 165
Query: 218 LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELT---------------- 261
K+ DFGLA+ + N+ + + +LT
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 262 -----VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
D++S G I EL+ N P+F FP D
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNML--------QSHINDPTNRFPLFPGSSCFPLSPDRNS 277
Query: 317 RKQFPEKGLN 326
+K + +
Sbjct: 278 KKVHEKSNRD 287
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 38/157 (24%), Positives = 59/157 (37%), Gaps = 13/157 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
NFR +G G FG + G + VA+K L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIP 68
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
+ + G +V E + G S++D + + T + IA +EY+H K
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLEDLF---DLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 198 ANPPVIYRDLKSSNILLGANLDPK-----LSDFGLAK 229
+IYRD+K N L+G + + DF LAK
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 59/247 (23%), Positives = 102/247 (41%), Gaps = 68/247 (27%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDR---NGMQGNKEFLVEVLMLSLLH 132
+ + LG+G +G V+K + G+VVAVK++ N + E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA-QRTFREIMILTELS 66
Query: 133 -HPNLVNLIG-YCADGDQRL-LVYEFM---------SGGSVDDH-------LLDVNETKK 173
H N+VNL+ AD D+ + LV+++M + H L+
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------- 119
Query: 174 PLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233
+ ++YLH +++RD+K SNILL A K++DFGL++
Sbjct: 120 ---------------KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 234 GEKMNVTSRVMGTYG-------------------YCAPEYA-RSGELTVKSDVYSFGVIL 273
++ + Y APE S + T D++S G IL
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 274 LELITGR 280
E++ G+
Sbjct: 222 GEILCGK 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 26/216 (12%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNL 136
FR +G G FG +Y GT + VA+K + + + L E + +L +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGI 65
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
N+ + +GD +LV + + G S++D N + L T + +A +E++H
Sbjct: 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLF---NFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 197 KANPPVIYRDLKSSNILLGANLDPK---LSDFGLAKL---------GPQGEKMNVTSRVM 244
K+ ++RD+K N L+G + DFGLAK P E N+T
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---- 174
Query: 245 GTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
GT Y + E + + D+ S G +L+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 46/224 (20%), Positives = 91/224 (40%), Gaps = 44/224 (19%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH----------- 132
LG G F V+ N VA+K + R + E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 133 HPNLVNLIGY----CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
+++ L+ + +G ++V+E + G ++ + PL + +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV--KQISKQLL 141
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDP------KLSDFGLAKLGPQGEKMNVTSR 242
GL+Y+H + +I+ D+K N+L+ P K++D G A + + T+
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTNS 195
Query: 243 VMGTYGYCAPE------YARSGELTVKSDVYSFGVILLELITGR 280
+ T Y +PE + +D++S ++ ELITG
Sbjct: 196 IQ-TREYRSPEVLLGAPW------GCGADIWSTACLIFELITGD 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 29/174 (16%), Positives = 61/174 (35%), Gaps = 27/174 (15%)
Query: 77 KNFRQECLLGEGGFGRVYKGT--------LQSNGQVVAVKQLDRNG---------MQGNK 119
+ ++ + G +Y+ Q ++K ++G + K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 120 EFLVEVLM-LSLLHHPNLVNLIGY-CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
V L + +G+ R LV + G S+ LDV+ K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSP-KHVLSE 158
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK--LSDFGLAK 229
+ +++A LE+LH+ ++ ++ + NI + + L+ +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 7e-12
Identities = 46/265 (17%), Positives = 75/265 (28%), Gaps = 70/265 (26%)
Query: 65 QTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL--------DRNGMQ 116
F T+ ++ +GEG FG V++ + VA+K + + + +
Sbjct: 9 GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQK 65
Query: 117 GNKEFLVEVLMLSLLH---------HPNLVNLIG-YCADG-------------------- 146
+E L E+++ L + L +C G
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 147 ---------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
DQ +V EF GG + + K T I L
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEAS 180
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP--EYA 255
+RDL N+LL KL K S + + G +Y
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYT 227
Query: 256 RSGELTVKSDVYSFGVILLELITGR 280
S V+ + +L TG
Sbjct: 228 LSRLERDGIVVFCDVSMDEDLFTGD 252
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 40/239 (16%), Positives = 80/239 (33%), Gaps = 53/239 (22%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
+ +G GGFG +Y + + A + + Q N E+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 137 VN---------------LIGY----CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
+ G R +V E + G + +
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS---GQNGT-FKK 150
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK--LSDFGLAKL----- 230
+T +++ LEY+H+ ++ D+K++N+LLG + L+D+GL+
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 231 ----GPQGEKMNVTSRVMGTYGYCAPEYA-----RSGELTVKSDVYSFGVILLELITGR 280
+ + GT E+ + L+ +SDV G +L + G+
Sbjct: 208 NHKQYQENPRKGHN----GT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 40/240 (16%), Positives = 78/240 (32%), Gaps = 52/240 (21%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQV-----VAVKQLDRNGMQ-----------GNKE 120
++ +G+GGFG +Y + S+ V VK + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 121 FLVEVLMLSLLHHPNLVNLIGYCADGDQ----RLLVYEFMSGGSVDDHLLDVNETKKPLD 176
+ + + L + + G R ++ + G + K
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY---EANAKRFS 150
Query: 177 WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK--LSDFGLAKL---- 230
T ++++ LEY+H+ ++ D+K+SN+LL + L D+GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 231 -----GPQGEKMNVTSRVMGTYGYCAPEYA-----RSGELTVKSDVYSFGVILLELITGR 280
K GT E+ + + D+ G +++ +TG
Sbjct: 208 GVHKAYAADPKRCHD----GT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL------HHPNLV 137
++G+G FG+V K Q VA+K + RN + +++ E+ +L L + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 138 NLIGY-------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
+++ C + +E +S ++ + + + K A Q
Sbjct: 163 HMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKF--QGFSLPLVRKFAHSILQC 212
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDP--KLSDFGLAKLGPQGEKMN--VTSRVMGT 246
L+ LH +I+ DLK NILL K+ DFG + + +++ + SR
Sbjct: 213 LDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQSRF--- 264
Query: 247 YGYCAPEYARSGELTVKSDVYSFGVILLELITGR 280
Y APE + D++S G IL EL+TG
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 56/229 (24%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL------- 131
+ + L+G+G FG+V K + + VA+K + +N + +EV +L L+
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 132 -HHPNLVNLIGY-------CADGDQRLLVYEFMSGGSVDDHLLDV--NETKKPLDWTTRM 181
++ +V+L + C LV+E +S +L D+ N + +
Sbjct: 115 KYY--IVHLKRHFMFRNHLC-------LVFEMLS-----YNLYDLLRNTNFRGVSLNLTR 160
Query: 182 KIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP--KLSDFGLAKLGPQGEKMN- 238
K A L +L +I+ DLK NILL K+ DFG + G+++
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQ 217
Query: 239 -VTSRVMGTYGYCAPE------YARSGELTVKSDVYSFGVILLELITGR 280
+ SR Y +PE Y + D++S G IL+E+ TG
Sbjct: 218 YIQSRF-----YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 49/262 (18%), Positives = 87/262 (33%), Gaps = 72/262 (27%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-----HHPNLVNL 139
LG G F V+ + VA+K + ++ + L E+ +L + + PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 140 IGYC-------ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
+ +G +V+E + G + + + + L KI QGL+
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLK-WIIKSNYQ-GLPLPCVKKIIQQVLQGLD 160
Query: 193 YLHDKANPPVIYRDLKSSNILLGAN----------------------------------- 217
YLH K +I+ D+K NILL N
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 218 --------------LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVK 263
L K++D G A + ++ +R Y + E
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 264 SDVYSFGVILLELITGRRVIDT 285
+D++S + EL TG + +
Sbjct: 274 ADIWSTACMAFELATGDYLFEP 295
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 52/238 (21%), Positives = 82/238 (34%), Gaps = 66/238 (27%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLL-----HHP 134
+G+G FGRV N + AVK + RN K++ +E +L + ++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RN----IKKYTRSAKIEADILKKIQNDDINNN 96
Query: 135 NLVNLIGY-------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA 187
N+V G C L++E + G S+ + + N
Sbjct: 97 NIVKYHGKFMYYDHMC-------LIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEI 146
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRV---- 243
+ L YL + + + DLK NILL K + ++ T
Sbjct: 147 LKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 244 ------------MGTY----GYCAPE------YARSGELTVKSDVYSFGVILLELITG 279
G+ Y APE + V SD++SFG +L EL TG
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 55/243 (22%), Positives = 87/243 (35%), Gaps = 80/243 (32%)
Query: 84 LLGEGGFGRVYKGT-LQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLL------- 131
LGEG FG+V + ++ G+ VAVK + +N + E+ +L L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-KN----VDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 132 -HHPNLVNLIGY-------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
V ++ + C +V+E + G S D + N P K+
Sbjct: 76 TFR--CVQMLEWFEHHGHIC-------IVFELL-GLSTYD-FIKENG-FLPFRLDHIRKM 123
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP-------------------KLSD 224
A + + +LH + + DLK NIL + K+ D
Sbjct: 124 AYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 225 FGLAKLGPQGEKMN--VTSRVMGTYGYCAPE------YARSGELTVKSDVYSFGVILLEL 276
FG A E + V++R Y APE + + DV+S G IL+E
Sbjct: 181 FGSATY--DDEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEY 227
Query: 277 ITG 279
G
Sbjct: 228 YLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 49/243 (20%), Positives = 80/243 (32%), Gaps = 80/243 (32%)
Query: 84 LLGEGGFGRVYKGT-LQSNGQVVAVKQLDRNGMQGNKEF----LVEVLMLSLL------- 131
LGEG FG+V + VA+K + RN ++ +E+ +L +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-RN----VGKYREAARLEINVLKKIKEKDKEN 80
Query: 132 -HHPNLVNLIGY-------CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
V + + C + +E + G + + L + N +P +
Sbjct: 81 KFL--CVLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENN--FQPYPLPHVRHM 128
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP-------------------KLSD 224
A L +LH+ + + DLK NIL + +++D
Sbjct: 129 AYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 225 FGLAKLGPQGEKMN--VTSRVMGTYGYCAPE------YARSGELTVKSDVYSFGVILLEL 276
FG A E V +R Y PE + DV+S G IL E
Sbjct: 186 FGSATF--DHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEY 232
Query: 277 ITG 279
G
Sbjct: 233 YRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 519 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.51 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.09 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.54 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.26 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.0 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.42 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.96 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.49 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.97 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.73 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=459.93 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=220.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
..|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998766666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
+||+|.+++.. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.......
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999998843 45999999999999999999999999 99999999999999999999999999987654322
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.....+||+.|||||++.+..|+.++|||||||+||||++|..||...........+... . ...+
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~--~~~~-------- 290 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---L--PPRL-------- 290 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---S--CCCC--------
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---C--CCCC--------
Confidence 245678999999999999999999999999999999999999999865433322222110 0 0000
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..+..++.++.+||.+||+.||.+|||+.++++|.|+-..
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 1123455688999999999999999999999999887543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=452.85 Aligned_cols=248 Identities=25% Similarity=0.323 Sum_probs=213.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999997532 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||+||+|.++|.. .+.+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999954 356999999999999999999999999 99999999999999999999999999997755
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
........+.+||+.|||||++.+..|+.++|||||||+||||++|..||........ ...+......
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~~~~------ 252 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI------FAKIIKLEYD------ 252 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCC------
Confidence 4444445668999999999999999999999999999999999999999976432221 1112222211
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHH
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 349 (519)
++...+.++.+||.+||+.||.+|||+.++
T Consensus 253 ------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 253 ------FPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp ------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred ------CCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 334455688999999999999999999885
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=454.25 Aligned_cols=263 Identities=29% Similarity=0.459 Sum_probs=212.3
Q ss_pred cCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
++|.+.+.||+|+||+||+|++. .+++.||||++........+.|.+|+.+|+.++|||||+++|+|.+.+.+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999875 3588999999987655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhcc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 152 VYEFMSGGSVDDHLLDVNE-----------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
|||||++|+|.++|..... ...+++|..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975422 2356999999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 299 (519)
||+|||+++..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||....... ++..+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHHHH
Confidence 9999999987655444444556789999999999999999999999999999999999 899998654322 222111
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.. .+...|..++.++.+|+.+||+.||.+||||.+|+++|+.+.+.
T Consensus 275 ---~g-----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 ---QG-----------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HT-----------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---cC-----------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11 01123455667899999999999999999999999999988654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=459.65 Aligned_cols=259 Identities=20% Similarity=0.322 Sum_probs=213.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999999765432 3456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||+||+|.++|... ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999999642 3456899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.......... .+.... ++
T Consensus 178 ~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~~~--~~---- 243 (350)
T 4b9d_A 178 TV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------KIISGS--FP---- 243 (350)
T ss_dssp HH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHTC--CC----
T ss_pred Cc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHcCC--CC----
Confidence 21 22345789999999999999999999999999999999999999998654322211 111111 11
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.++...+.++.+||.+||+.||.+|||+.++++|.|+...
T Consensus 244 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 -----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 1233455689999999999999999999999999877543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-57 Score=451.34 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=218.4
Q ss_pred cCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
++|.+.+.||+|+||+||+|++. .++..||||++........+.|.+|+.+|+.++|||||+++|+|.+.+.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57889999999999999999875 3578999999987655556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhc---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEE
Q 046892 152 VYEFMSGGSVDDHLLDVN---------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKL 222 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL 222 (519)
|||||++|+|.++|.... .....++|..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 23457999999999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchh
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~-- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECIT-- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH--
Confidence 99999986554443333445679999999999999999999999999999999998 89999865432 2222111
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
... +...|..++.++.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 245 -~~~-----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 -QGR-----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -HTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCC-----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 110 112345566789999999999999999999999999887654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=462.10 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=220.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+.|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
+||+|.+++.. ..+++..++.|+.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.......
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999843 35999999999999999999999999 99999999999999999999999999987644322
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.....+||+.|||||++.+..|+.++|||||||+||||++|..||...........+... . ...+
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---~--~~~~-------- 367 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---L--PPRL-------- 367 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---C--CCCC--------
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---C--CCCC--------
Confidence 234678999999999999999999999999999999999999999865443322222110 0 0000
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.....++.++.+||.+||+.||.+|||+.++++|.|+-..
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 1123345688999999999999999999999999887543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-56 Score=448.58 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=215.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.+.|.+.+.||+|+||.||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3568889999999999999999999999999999975432 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeecccccCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKLGPQG 234 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~~~~~ 234 (519)
|+||+|.++|... +.+++..++.|+.||+.||+|||+++ ||||||||+||||+.+| .+||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999543 46999999999999999999999999 99999999999999988 5999999999876543
Q ss_pred Cc---cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 235 EK---MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 235 ~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.. ......++||+.|||||++.+..|+.++|||||||+||||++|+.||...........+.. ...
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~----- 273 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------EPP----- 273 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------SCC-----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------CCC-----
Confidence 21 1123346899999999999999999999999999999999999999987554433222211 110
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPI 363 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~ 363 (519)
....++..++.++.+||.+||+.||.+|||+.||+++|.........+
T Consensus 274 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l 321 (336)
T 4g3f_A 274 ----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321 (336)
T ss_dssp ----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSS
T ss_pred ----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhc
Confidence 011245566778999999999999999999999999988765443333
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-56 Score=444.30 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=215.4
Q ss_pred cCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.++++.+.||+|+||+||+|.+. .+++.||||++..... ...+.|.+|+.++..++|||||+++|+|.+.+.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 35677889999999999999874 3578999999975432 34578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 046892 151 LVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL 218 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~ 218 (519)
||||||++|+|.++|..... ....++|..++.|+.||+.||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 1246999999999999999999999999 99999999999999999
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAW 297 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 297 (519)
.+||+|||+++..............+||+.|||||++.++.|+.++|||||||+||||+| |..||...... .+...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~ 259 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEM 259 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHH
Confidence 999999999986654433334456789999999999999999999999999999999998 89999865432 22222
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
+. . .. +...|..++.++.+|+.+||+.||.+||||.+|+++|..+
T Consensus 260 i~---~-~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IR---N-RQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH---T-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH---c-CC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21 1 10 1124556677899999999999999999999999999754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=440.45 Aligned_cols=262 Identities=30% Similarity=0.474 Sum_probs=207.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|.+.+.||+|+||+||+|++.. .||||+++.... ...+.|.+|+.+|+.++|||||++++++.+ +.++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3578888999999999999998753 599999865432 234678999999999999999999998865 5689999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||++|+|.++|.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999954 3457999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCccceecccccccccCchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||......... ........ ..+.
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~~~~~----~~p~ 258 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMVGRGY----ASPD 258 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHTTC----CCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCC----CCCC
Confidence 433334456789999999999964 46999999999999999999999999865433221 11111111 1111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
. ..++..++..+.+|+.+||+.||.+||||.+|+++|+.++..
T Consensus 259 ~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 259 L------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp S------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred c------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 0 123445667899999999999999999999999999988653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=433.03 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=200.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||+||+|++..+|+.||||++.+... .....+.+|+.+|+.++|||||++++++.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 589999999999999999999999999999999976432 23457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||| +|+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 7899999854 457999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.. .....+||+.|||||++.+..| +.++|||||||+||+|++|+.||...... .+. ..+......
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~---~~i~~~~~~----- 230 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLF---KNISNGVYT----- 230 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCCC-----
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHcCCCC-----
Confidence 32 2345789999999999998776 58999999999999999999999764322 111 111122111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
++...+.++.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 231 -------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 231 -------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp -------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred -------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 2334556889999999999999999999999998874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=435.82 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=205.5
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec----CCceEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 152 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 152 (519)
|+..+.||+|+||+||+|.+..++..||||++..... ...+.|.+|+.+|+.++|||||+++++|.+ ...+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4667789999999999999999999999999975432 234568999999999999999999999865 3458999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCcEEeeecccccC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDPKLSDFGLAKLG 231 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~vkL~DFGla~~~ 231 (519)
||||+||+|.++|.. ...+++..++.|+.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999954 356999999999999999999999986 3499999999999998 4799999999999864
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .+.... .... .+
T Consensus 183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i---~~~~--~~-- 248 (290)
T 3fpq_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV---TSGV--KP-- 248 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH---TTTC--CC--
T ss_pred CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHH---HcCC--CC--
Confidence 332 2345789999999999874 69999999999999999999999997543221 111111 1110 00
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..++...+.++.+||.+||+.||.+|||+.++++|.|+
T Consensus 249 ------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 249 ------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp ------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 01222334578999999999999999999999999876
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=443.38 Aligned_cols=266 Identities=26% Similarity=0.356 Sum_probs=211.8
Q ss_pred cCcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
++|++.+.||+|+||+||+|++. .+++.||||++.+... .....+.+|+.+|+.++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999984 4578999999975432 233468889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|||||+||+|.++|.. .+.+++..++.|+.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999954 356999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......... .+.....
T Consensus 177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~~~~----- 243 (304)
T 3ubd_A 177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT------MILKAKL----- 243 (304)
T ss_dssp ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCC-----
T ss_pred cCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH------HHHcCCC-----
Confidence 43322 2345789999999999999999999999999999999999999998654322211 1112211
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhhc-----CCCCCCCCCCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLSN-----SKEPIPDPIIP 369 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~~-----~~~~~~~p~~p 369 (519)
.+|..++.++.+||.+||+.||.+||| +.++++|.|+-.- ....+++|+.|
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 133445668899999999999999998 5799998876321 22445566554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=436.89 Aligned_cols=266 Identities=27% Similarity=0.369 Sum_probs=219.0
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCC-----CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCC-CCeeeeeeEEec
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSN-----GQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHH-PNLVNLIGYCAD 145 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~ 145 (519)
....++|++.+.||+|+||+||+|.+..+ ++.||||.+...... ..+.|..|+.+|..+.| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 34457899999999999999999998653 468999999765433 34568999999999975 899999999866
Q ss_pred -CCceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046892 146 -GDQRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNI 212 (519)
Q Consensus 146 -~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NI 212 (519)
++.++||||||++|+|.++|..... ....+++..++.|+.||+.||+|||+++ ||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 4578999999999999999975432 1345899999999999999999999999 99999999999
Q ss_pred eeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcch
Q 046892 213 LLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDE 291 (519)
Q Consensus 213 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~ 291 (519)
||++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..||........
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999997665544444556789999999999999999999999999999999998 8999986543221
Q ss_pred hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 292 QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+..... . ..+...|..++.++.+|+..||+.||.+|||+.+|+++|..+.
T Consensus 297 --~~~~i~----~----------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 297 --FCRRLK----E----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp --HHHHHH----H----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHH----c----------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111111 0 1112244556678999999999999999999999999998664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=419.58 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=194.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC-------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------- 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------- 147 (519)
..+|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35699999999999999999999999999999999765432 3456889999999999999999999987644
Q ss_pred -----ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEE
Q 046892 148 -----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKL 222 (519)
Q Consensus 148 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL 222 (519)
.+|||||||.+|+|.+++.... .....++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 3689999999999999996432 2233567788999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCcc----------ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh
Q 046892 223 SDFGLAKLGPQGEKM----------NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292 (519)
Q Consensus 223 ~DFGla~~~~~~~~~----------~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~ 292 (519)
+|||+|+........ ......+||+.|||||++.+..|+.++|||||||+||||++ ||... .
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~ 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----M 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----H
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----c
Confidence 999999876543221 11234689999999999999999999999999999999996 66431 1
Q ss_pred hHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
........+... .++ +. .......+.+|+.+||+.||.+|||+.++++|.++
T Consensus 232 ~~~~~~~~~~~~--~~p----~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 232 ERVRTLTDVRNL--KFP----PL-----FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HHHHHHHHHHTT--CCC----HH-----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHhcC--CCC----CC-----CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 111111111110 111 11 11223456789999999999999999999998765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=452.42 Aligned_cols=310 Identities=25% Similarity=0.333 Sum_probs=236.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHH---HHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVE---VLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|++.++||+|+||.||+|+++.+|+.||||++.+.. ......+..| +.++..++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999999999999999996532 1222334444 5666778999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
|||||||+||+|.++|.. .+.+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999954 356999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
...... ..+.+||+.|||||++.+ ..|+.++|||||||+||||++|..||......+...+... +.....
T Consensus 341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~~~~-- 411 (689)
T 3v5w_A 341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAV-- 411 (689)
T ss_dssp ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHHCCC--
T ss_pred ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcCCCC--
Confidence 765432 345789999999999964 5799999999999999999999999976544333322221 111111
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCC
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEG 378 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~ 378 (519)
.++...+.++.+||.+||+.||.+|++ +.+|++|.||-.- ....+++|+.|......+.+
T Consensus 412 ----------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~ 481 (689)
T 3v5w_A 412 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAAD 481 (689)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTB
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCC
Confidence 234455668999999999999999998 7999999876432 23456788888766555544
Q ss_pred ccCCCCCCCCCCCCCCCcccccccccccCCCCCCCCC
Q 046892 379 YSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNP 415 (519)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 415 (519)
+++...-.++.+. .......++..+.+|+++.+
T Consensus 482 ~fD~~~fd~e~~~----~~~~~~~d~~~f~~Fs~~~~ 514 (689)
T 3v5w_A 482 AFDIGSFDEEDTK----GIKLLDSDQELYRNFPLTIS 514 (689)
T ss_dssp CCC---------C----CCCCCHHHHTTTTTCCEECH
T ss_pred CCCCccCCccccC----CCCCCchHHHHHhCCCccCc
Confidence 4443221111110 01122235566777776543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=431.97 Aligned_cols=273 Identities=22% Similarity=0.277 Sum_probs=212.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec------CC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD------GD 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~ 147 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4689999999999999999999999999999999975432 233567899999999999999999998754 36
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
.+|||||||. |+|.+++. ..+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 68999883 4567999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC--ccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 228 AKLGPQGE--KMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 228 a~~~~~~~--~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|+...... ........+||+.|||||++.+. .|+.++|||||||+||||++|++||.+....+....+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98654321 12234467899999999998875 5799999999999999999999999876544443333211100000
Q ss_pred C--CC------------CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 305 P--KR------------FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 305 ~--~~------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
. .. ++......+.. +....+.++.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWET-VYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHH-hCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0 00 00000000000 11234568899999999999999999999999987643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=419.37 Aligned_cols=269 Identities=24% Similarity=0.351 Sum_probs=199.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHH--HHHHHHHhcCCCCeeeeeeEEecCC----ce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFL--VEVLMLSLLHHPNLVNLIGYCADGD----QR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~--~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 149 (519)
.++|.+.+.||+|+||+||+|++. |+.||||++... ....+. .|+..+..++|||||+++++|.+++ .+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 356888999999999999999984 899999998643 223333 4555567889999999999997654 57
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA-----NPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
|||||||++|+|.++|.. ..++|..++.|+.|++.||+|||++. .++||||||||+||||+.++.+||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999999999954 45899999999999999999999871 12399999999999999999999999
Q ss_pred ecccccCCCCCcc--ceecccccccccCchhhhccC------CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch-----
Q 046892 225 FGLAKLGPQGEKM--NVTSRVMGTYGYCAPEYARSG------ELTVKSDVYSFGVILLELITGRRVIDTTRPVDE----- 291 (519)
Q Consensus 225 FGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~------~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~----- 291 (519)
||+++........ ......+||+.|||||++.+. .++.++|||||||+||||+||.+||........
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 9999865443321 122346899999999999754 467899999999999999999887754322110
Q ss_pred ----hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 292 ----QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 292 ----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.........+.... .-+.+.+ ...+.+....+.+|+.+||+.||.+||||.+|++.|..+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~rp~~p~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQK-LRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCSSCCHHHHHHHHTTSC-CCCCCCG----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccchHHHHHHHHhccc-CCCCCCc----cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 00001111111110 0000000 011234567889999999999999999999999999887653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=415.40 Aligned_cols=272 Identities=22% Similarity=0.262 Sum_probs=206.7
Q ss_pred HHHhccCcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCC
Q 046892 72 LAAATKNFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGD 147 (519)
Q Consensus 72 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 147 (519)
+....++|++.+.||+|+||+||+|+++ .+++.||||++... .....+.+|+.+|..+ +|||||+++++|.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3445688999999999999999999875 35789999998654 3446788999999988 6999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CCcEEeeec
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFG 226 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-~~vkL~DFG 226 (519)
.+|||||||++|+|.+++ ..+++..++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 999999999999999998 24899999999999999999999999 9999999999999876 799999999
Q ss_pred ccccCCCCCcc--------------------------ceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhC
Q 046892 227 LAKLGPQGEKM--------------------------NVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITG 279 (519)
Q Consensus 227 la~~~~~~~~~--------------------------~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG 279 (519)
+|+........ ......+||+.|||||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99754432110 112346899999999999875 589999999999999999999
Q ss_pred CCCCCCCCCc-chhhHHHh----------hch----hccC------------------CCCCCcccch----HhhccCCh
Q 046892 280 RRVIDTTRPV-DEQNLIAW----------AQP----IFRD------------------PKRFPDMADP----LLRKQFPE 322 (519)
Q Consensus 280 ~~pf~~~~~~-~~~~~~~~----------~~~----~~~~------------------~~~~~~~~d~----~l~~~~~~ 322 (519)
+.||...... +....+.. ... .... ....+..... ........
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 9999654321 11111100 000 0000 0000000000 00001123
Q ss_pred hhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 323 KGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 323 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+.++.+|+.+||+.||.+|||+.|+++|.|+
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 455788999999999999999999999999876
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=417.83 Aligned_cols=322 Identities=22% Similarity=0.328 Sum_probs=261.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.++||+|+||.||+|++..+++.||||++.+... .....+..|..++..+ +||||++++++|.+.+.+||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999999999999999976432 2334578899988776 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++|+|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999998542 46999999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh---hHHHhhchhccCCCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ---NLIAWAQPIFRDPKRF 308 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~ 308 (519)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|..||......+.. ........+.....
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 279 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 279 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence 3222 2244578999999999999999999999999999999999999999754322110 00111111111111
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH------HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCC
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM------SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSE 377 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~ 377 (519)
.++...+.++.+||.+||+.||.+||++ .+|++|.+|-.- ....+.+|+.|...+..+.
T Consensus 280 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~ 349 (396)
T 4dc2_A 280 ----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 349 (396)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTG
T ss_pred ----------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccch
Confidence 2344556688999999999999999985 789988876432 2456778999999999999
Q ss_pred CccCCCCCCCCCCCCCCCcccccccccccCCCCCCCCCCCC
Q 046892 378 GYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERI 418 (519)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~ 418 (519)
.+++..++.+....++.+........+..|.+|++++|..+
T Consensus 350 ~~fd~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 390 (396)
T 4dc2_A 350 DNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPLLM 390 (396)
T ss_dssp GGSCHHHHTSCCCCCCCCHHHHTTSCGGGGTTCCEECC---
T ss_pred hhcChhhccCCCccCCCcchhhccccccccCCcEeECcccc
Confidence 99999888888888887776666777889999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=413.87 Aligned_cols=314 Identities=26% Similarity=0.331 Sum_probs=253.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|++..+++.||||++.+.. ......+..|+.++..+ +||||+++++++.+.+.+||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 578999999999999999999999999999999997532 23445678899999887 79999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+|+|..++... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999998543 46999999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......+... .+.....
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~~~----- 241 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE------AILNDEV----- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCC-----
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH------HHHcCCC-----
Confidence 3322 22345789999999999999899999999999999999999999998654322211 1112211
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH------HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCcc
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM------SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYS 380 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~ 380 (519)
.++...+..+.+|+..||+.||.+||++ .++++|.++-.- ....+.+|+.|...+..+..++
T Consensus 242 -------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f 314 (353)
T 3txo_A 242 -------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNF 314 (353)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTS
T ss_pred -------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCccccccc
Confidence 1233445678999999999999999998 889998876432 2456778888888888888888
Q ss_pred CCCCCCCCCCCCCCCcccccccccccCCCCCCCCCC
Q 046892 381 SDGHQKNENTYDNDNARSVRESENLESSNNSGSNPE 416 (519)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 416 (519)
+..++.+....++.+........+..|.+|+|.+|.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 350 (353)
T 3txo_A 315 DPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPE 350 (353)
T ss_dssp CHHHHTSCCCCCCCCTTSGGGSCGGGGTTCCEECC-
T ss_pred CcccccCCCcCCCccccccCcccccccCCceeeCcc
Confidence 888877777777766555555667789999998865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=437.50 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=218.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999999999999999999876555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--CCcEEeeecccccCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN--LDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~--~~vkL~DFGla~~~~~ 233 (519)
|.||+|.++|.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999843 3457999999999999999999999999 9999999999999854 8999999999998755
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
... ....+||+.|||||++.+..|+.++|||||||+||||++|..||...........+ ......++.
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~~~~~~~~~--- 377 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDWNMDD--- 377 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTCCCCCS---
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------HhCCCCCCc---
Confidence 432 34568999999999999999999999999999999999999999865433222221 111111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
......+.++.+||.+||+.||.+|||+.++++|.|+-
T Consensus 378 -----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 378 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp -----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 11123456889999999999999999999999997754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=403.42 Aligned_cols=313 Identities=25% Similarity=0.317 Sum_probs=246.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|++..+|+.||||++.+. .......+..|+.++..++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999753 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++|+|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999854 346899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... +.. .+.....
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~i~~~~~------ 222 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILMEEI------ 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCC------
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHH---HHHcCCC------
Confidence 3221 2345789999999999999999999999999999999999999997643221 111 1111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSD 382 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~ 382 (519)
.++...+.++.+||.+||+.||.+|| ++.++++|.++... ....+.+|+.|...+..+..+++.
T Consensus 223 ------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~ 296 (337)
T 1o6l_A 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCH
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccc
Confidence 13344556889999999999999999 89999999887432 235567888888888788888876
Q ss_pred CCCCCCCCCCCCCcc-c---cc---ccccccCCCCCCCCC
Q 046892 383 GHQKNENTYDNDNAR-S---VR---ESENLESSNNSGSNP 415 (519)
Q Consensus 383 ~~~~~~~~~~~~~~~-~---~~---~~~~~~~~~~s~~~~ 415 (519)
.++.+....++.+.. . .. ..++..|.+|+|.++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 297 EFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp HHHTSCCC--------------------CCTTTTCCEECC
T ss_pred hhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 665554444332211 1 11 114567888887653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=405.28 Aligned_cols=316 Identities=24% Similarity=0.347 Sum_probs=225.8
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 150 (519)
..++|.+.+.||+|+||.||+|++..+++.||||++.+.. ......+..|..++..+ +||||+++++++.+.+.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999999999999999997542 23445678898888866 8999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 95 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999998542 46899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........... +.....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~~~~~---- 235 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS------IRMDNP---- 235 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCC----
T ss_pred cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH------HHhCCC----
Confidence 433221 23457899999999999999999999999999999999999999976533221111 111111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCC
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMS-DVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGH 384 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~ 384 (519)
.++...+.++.+|+.+||+.||.+||++. ++++|.++-.- ....+.+|+.|...+..+..+++..+
T Consensus 236 --------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~ 307 (345)
T 1xjd_A 236 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEF 307 (345)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC-------------------
T ss_pred --------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhh
Confidence 12334456889999999999999999998 88888776432 23556788888887777888888776
Q ss_pred CCCCCCCCCCCcccccccccccCCCCCCCCCCC
Q 046892 385 QKNENTYDNDNARSVRESENLESSNNSGSNPER 417 (519)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 417 (519)
+.+....+..+........+..|.+|++.++..
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 340 (345)
T 1xjd_A 308 LNEKPRLSFADRALINSMDQNMFRNFSFMNPGM 340 (345)
T ss_dssp -------------------CCTTTTCCC-----
T ss_pred cccCccCCcccccccccccccccCCCeeeChhh
Confidence 666555444433333445667899999988653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=410.46 Aligned_cols=324 Identities=20% Similarity=0.237 Sum_probs=251.4
Q ss_pred HHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 71 ELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 71 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
++....++|++.+.||+|+||.||+|++..+++.||+|++.+.. ......+..|+.++..++|||||+++++|.+..
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999999999999999986521 223345788999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
.+||||||++||+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999853 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE----LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~----~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 303 (519)
++....... ......+||+.|+|||++.+.. ++.++|||||||+||||++|..||...........+....
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---- 289 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK---- 289 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc----
Confidence 987654322 2234578999999999998655 7899999999999999999999998654322221111000
Q ss_pred CCCCCCcccchHhhccCC--hhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCC
Q 046892 304 DPKRFPDMADPLLRKQFP--EKGLNEAVAIAAMCLQEEAGA--RPLMSDVVTALSFLSN-----SKEPIPDPIIPSDEDE 374 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~ 374 (519)
....++ ...+.++.+||.+||+.+|.+ ||++.+|++|.||-.. ....+.+|+.|...+.
T Consensus 290 ------------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~ 357 (410)
T 3v8s_A 290 ------------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSD 357 (410)
T ss_dssp ------------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSST
T ss_pred ------------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCc
Confidence 001112 134568899999999999988 9999999999887432 2344568889988888
Q ss_pred cCCCccCCCCCCCCCCCCCCCcccccccccccCCCCCCCCCCCCcc
Q 046892 375 YSEGYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERIAS 420 (519)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~ 420 (519)
.+..+++................. ....+.+|.+|+|.++.....
T Consensus 358 ~d~~~fd~~~~~~~~~~~~~~~~~-~~~~~~~f~~f~~~~~~~~~~ 402 (410)
T 3v8s_A 358 IDTSNFDDLEEDKGEEETFPIPKA-FVGNQLPFVGFTYYSNRRYLS 402 (410)
T ss_dssp TCCTTSCCCCSCCSCCCCCCCCSS-CCCTTGGGTTCCEECC-----
T ss_pred cchhhcCCccccccccccCCCchh-hcccccccccceEeCcccccc
Confidence 888888876554332222111111 123578899999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=397.73 Aligned_cols=320 Identities=23% Similarity=0.331 Sum_probs=250.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|++..+++.||||++.+..... ...+..|+.++..+ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999999999999999997653322 34577899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999998542 46899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch---hhHHHhhchhccCCCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE---QNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 308 (519)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......+. .........+.....
T Consensus 161 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 161 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred cCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 3222 123457899999999999999999999999999999999999999975322111 000011111111111
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH------HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCC
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM------SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSE 377 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~ 377 (519)
.++...+..+.+|+.+||+.||.+||++ .+++.|.++-.- ....+.+|+.|...+..+.
T Consensus 237 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~ 306 (345)
T 3a8x_A 237 ----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 306 (345)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCG
T ss_pred ----------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchh
Confidence 2344456688999999999999999995 789988876432 2345667888887777777
Q ss_pred CccCCCCCCCCCCCCCCCcccccccccccCCCCCCCCCC
Q 046892 378 GYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPE 416 (519)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 416 (519)
.+++..++.+....++.+...........|.+|++.+|.
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 345 (345)
T 3a8x_A 307 DNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL 345 (345)
T ss_dssp GGSCHHHHTSCSSCCCCCHHHHTTSCGGGGTTCCEECCC
T ss_pred hhcCcccccCcccCCCccccccccccccccCCCEeeCCC
Confidence 777766655555555544433344566789999988763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=401.46 Aligned_cols=315 Identities=25% Similarity=0.329 Sum_probs=248.8
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 150 (519)
..++|++.+.||+|+||.||+|++..+++.||||++.+.. ......+..|..++..+ +||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999997542 23456678899999877 7999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
|||||++||+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999643 45899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||....... +. ..+.....
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~---~~i~~~~~---- 238 (353)
T 2i0e_A 171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF---QSIMEHNV---- 238 (353)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCC----
T ss_pred cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HH---HHHHhCCC----
Confidence 43222 12345789999999999999999999999999999999999999997643221 11 11111111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCcc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYS 380 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~ 380 (519)
.++...+.++.+||.+||+.||.+||+ +.++++|.++-.- ....+.+|+.|...+. +..++
T Consensus 239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f 309 (353)
T 2i0e_A 239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENF 309 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHH
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhc
Confidence 133445568899999999999999995 6899988776422 2356677888876665 66666
Q ss_pred CCCCCCCCCCCCCCCcccccccccccCCCCCCCCCCC
Q 046892 381 SDGHQKNENTYDNDNARSVRESENLESSNNSGSNPER 417 (519)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 417 (519)
+..++......++.+...........|.+|++.+|..
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 346 (353)
T 2i0e_A 310 DRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEF 346 (353)
T ss_dssp HHHHHHSCCCCCCCCHHHHHHSCTTTTCSCCEECTTC
T ss_pred cchhccCCcccCCccccccccccccccCCCeeeCccc
Confidence 6555554444444443333334667899999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=402.28 Aligned_cols=344 Identities=22% Similarity=0.297 Sum_probs=249.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++..++|||||+++++|.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999999999999999986532 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+||||+.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999843 456999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
... .....+||+.|+|||++.+ ..++.++|||||||+||||++|..||..........+...... ..
T Consensus 167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~~---- 236 (384)
T 4fr4_A 167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---TV---- 236 (384)
T ss_dssp TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---CC----
T ss_pred CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---cc----
Confidence 432 2345789999999999863 4689999999999999999999999987655444333332211 11
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDG 383 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~ 383 (519)
..++...+..+.+||.+||+.||.+||+ +.+|+.|.++-.- ....+.+|+.|.... .+.+..
T Consensus 237 --------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~----~~~~~~ 304 (384)
T 4fr4_A 237 --------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGR----LNCDPT 304 (384)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCS----SCCCCC
T ss_pred --------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCC----CCCCCc
Confidence 1234445568999999999999999999 7777777665321 234455666654221 111111
Q ss_pred CCCCCCCCCCCCcccccccccccCCCCCCCCCCCCccccCccCCccccCcccccccccccccccccccccccCC----cc
Q 046892 384 HQKNENTYDNDNARSVRESENLESSNNSGSNPERIASSRGQVSGNLINSKEIGPSRKKSSKKSHHCLSQKVSPN----EN 459 (519)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 459 (519)
++. ..+.......++++|+..+ .....++...+ ..
T Consensus 305 ~~~----------------------------------------~~~~~~~~~l~~k~~~~~~-~~~~~~~~~~~~~~~~~ 343 (384)
T 4fr4_A 305 FEL----------------------------------------EEMILESKPLHKKKKRLAK-KEKDMRKCDSSQTCLLQ 343 (384)
T ss_dssp CCS----------------------------------------TTSCTTCCC-----------CCSTTCCCCSHHHHHHH
T ss_pred cCh----------------------------------------hhhhhccccccHHHHHHHh-hhhhcccCcccchhHHH
Confidence 111 1222222333444444433 23333343333 22
Q ss_pred cccccccchhhhhhhcccCCcccccccccc
Q 046892 460 ERRSSRSKSLSALNKKKSKNTSRKTSKKLA 489 (519)
Q Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 489 (519)
.+.+..++.+.+.+|+|.++.+-.++.-+.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (384)
T 4fr4_A 344 EHLDSVQKEFIIFNREKVNRDFNKRQPNLA 373 (384)
T ss_dssp HHHHHHHHHCCCEEHHHHHHTTCC------
T ss_pred HHHHHHHhhceecchhhhccccccccCCCC
Confidence 446778888999999999887765555443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=393.33 Aligned_cols=288 Identities=39% Similarity=0.689 Sum_probs=242.3
Q ss_pred cHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 68 TFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 68 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
.+.++...+++|++.+.||+|+||.||+|.+. ++..||||++..........+.+|+.++..++||||+++++++.+.+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33344556789999999999999999999975 58999999987766566678999999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..++||||+.+|+|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999998654444456999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
+................||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|....... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN-GQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT-TC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc-cc
Confidence 98654333333334456899999999999999999999999999999999999999877665555555554433222 24
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
+...+++.+...++...+..+.+++.+||+.||.+|||+.+|+++|+.+...+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 44555555566677888899999999999999999999999999999876544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=427.02 Aligned_cols=316 Identities=25% Similarity=0.326 Sum_probs=262.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 150 (519)
..++|++.+.||+|+||.||+|++..+++.||||++.+. .......+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 356899999999999999999999999999999998753 223456678899999877 6999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
|||||+++|+|.+++... ..+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999653 46999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||........ ...+.....
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~---- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEHNV---- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHSSCC----
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HHHHHhCCC----
Confidence 433221 24457899999999999999999999999999999999999999986533221 122222221
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCcc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM-----SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYS 380 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~ 380 (519)
.++...+.++.+||..||+.||.+||++ .+|++|.+|-.- ....+.+|+.|.... .+..++
T Consensus 560 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f 630 (674)
T 3pfq_A 560 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENF 630 (674)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHH
T ss_pred --------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-Cchhhc
Confidence 2344556689999999999999999998 889888776321 345677888888776 777888
Q ss_pred CCCCCCCCCCCCCCCcccccccccccCCCCCCCCCCCC
Q 046892 381 SDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERI 418 (519)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~ 418 (519)
+..++.....+++.+........+.+|.+|+|.+|..+
T Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 668 (674)
T 3pfq_A 631 DRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFL 668 (674)
T ss_dssp TTTTTSSCSSCCCCCHHHHTTCCGGGGTTCCEECSSCC
T ss_pred CchhccCCCccCCCchhhhhcccccccCCCcccChhhh
Confidence 88888888888887766666667889999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=403.02 Aligned_cols=330 Identities=18% Similarity=0.186 Sum_probs=247.3
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEec
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD 145 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 145 (519)
+.++....++|++.++||+|+||+||+|++..+++.||||++.+.. ......+..|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4455556789999999999999999999999999999999986521 1223347889999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.+.+|||||||++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999954 2456999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
|+++....... ......+||+.|+|||++. ...++.++|||||||+||||++|..||......+....+.....
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 99976544332 2234468999999999987 46789999999999999999999999986543322222111000
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCC--CCCHHHHHHHHhhhhcCC---CCCCCCCCCCCCCCc
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGA--RPLMSDVVTALSFLSNSK---EPIPDPIIPSDEDEY 375 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~l~~~~~~~---~~~~~p~~p~~~~~~ 375 (519)
.+ .++. .....+.++.+||.+||..+|.+ ||++.++++|.|+-.-.+ ....+|+.|...+..
T Consensus 299 ~~----~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~ 365 (437)
T 4aw2_A 299 RF----QFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPT 365 (437)
T ss_dssp HC----CCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTT
T ss_pred cc----cCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCCCcCCCcc
Confidence 00 1110 01224568899999999888888 999999999988754322 344577888777777
Q ss_pred CCCccCCCCCCCCCCCCCC-CcccccccccccCCCCCCCCCCCC
Q 046892 376 SEGYSSDGHQKNENTYDND-NARSVRESENLESSNNSGSNPERI 418 (519)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~~~ 418 (519)
+..+++...+......... ............|.+|+|..++..
T Consensus 366 d~~~fd~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 409 (437)
T 4aw2_A 366 DTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVL 409 (437)
T ss_dssp CCTTSCCC------------------CCTTGGGTTCCEESSCTT
T ss_pred chhhcCCcccccccccCCCCCccccccccCccccCCCcCCchhh
Confidence 7777765443222211111 111112234567899999877643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=386.85 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=214.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4789999999999999999999999999999999865432 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999883 3456999999999999999999999999 999999999999999999999999999865433
Q ss_pred CccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
..........||+.|+|||++.+..+ +.++|||||||+||+|++|..||......... ...+..... .. .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~----~~----~ 229 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKT----YL----N 229 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCT----TS----T
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcccc----cC----C
Confidence 33333445789999999999987765 78899999999999999999999765433221 111111100 00 0
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.....+..+.+|+.+||+.||.+|||+.+++++.|+.....
T Consensus 230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 01234457889999999999999999999999988754433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=380.07 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=218.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999999999999999999776666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+|+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999854 35899999999999999999999999 9999999999999999999999999998655433
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .. .
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~--~-------- 235 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TP--E-------- 235 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC---SC--C--------
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---CC--C--------
Confidence 2 2344679999999999999999999999999999999999999997654332221111110 00 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+...+..+.+|+.+||+.||.+|||+.+++++.++-.
T Consensus 236 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 236 --LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 0123345567899999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=384.21 Aligned_cols=286 Identities=42% Similarity=0.743 Sum_probs=240.1
Q ss_pred CccccHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeE
Q 046892 64 AQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGY 142 (519)
Q Consensus 64 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~ 142 (519)
...|++.++....++|.+.+.||+|+||.||+|.+. +++.||||++..... .....+..|+.++..++||||++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 456888999999999999999999999999999865 589999999876432 233468999999999999999999999
Q ss_pred EecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc---CCCCeEecCCCCCCeeeCCCCC
Q 046892 143 CADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK---ANPPVIYRDLKSSNILLGANLD 219 (519)
Q Consensus 143 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~~~~IvHrDikp~NILl~~~~~ 219 (519)
+.+....++||||+.+|+|.+++.........+++..++.|+.||+.||+|||+. + |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999977655666799999999999999999999999 7 999999999999999999
Q ss_pred cEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--CcchhhHHHh
Q 046892 220 PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTR--PVDEQNLIAW 297 (519)
Q Consensus 220 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~--~~~~~~~~~~ 297 (519)
+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... .........|
T Consensus 173 ~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 99999999987654332 23445679999999999999999999999999999999999999996321 1122233444
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....... ..+..+.+..+...++......+.+++.+||+.||.+|||+.+|+++|+.
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 252 VKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 4443333 24455566666667788889999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=395.81 Aligned_cols=327 Identities=19% Similarity=0.160 Sum_probs=240.0
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEec
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD 145 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 145 (519)
+.++....++|++.+.||+|+||.||+|++..+|+.||||++.+.. ......+..|+.++..++||||++++++|.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4445556789999999999999999999999999999999996532 1223457889999999999999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.+.+||||||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999653 246899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhc-------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR-------SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-------~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
|+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...........+...
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99987654332 1223468999999999987 357899999999999999999999999865432222111110
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCC---CCHHHHHHHHhhhhcC---CCCCCCCCCCCCC
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR---PLMSDVVTALSFLSNS---KEPIPDPIIPSDE 372 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~l~~~~~~---~~~~~~p~~p~~~ 372 (519)
.... .++ .++...+.++.+||.+||+ +|.+| |++.++++|.+|-.-. .....+|+.|...
T Consensus 286 ~~~~----~~p---------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~ 351 (412)
T 2vd5_A 286 KEHL----SLP---------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFE 351 (412)
T ss_dssp HHHC----CCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC--
T ss_pred ccCc----CCC---------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCC
Confidence 0000 001 0122345689999999999 99998 6999999998874322 2334577888777
Q ss_pred CCcCCCccCCCCCCCCC-------CCCCCCcccccccccccCCCCCCCCCCC
Q 046892 373 DEYSEGYSSDGHQKNEN-------TYDNDNARSVRESENLESSNNSGSNPER 417 (519)
Q Consensus 373 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 417 (519)
+..+..+++........ ..... ...........|.+|+|.++..
T Consensus 352 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~f~g~~~~~~~~ 402 (412)
T 2vd5_A 352 GATDTCNFDLVEDGLTAMVSGGGETLSDI-REGAPLGVHLPFVGYSYSCMAL 402 (412)
T ss_dssp ---CCSSCC--CCCCCTTSSSSSCCTTTC------CCTTGGGTTCCBSCCCC
T ss_pred CcccccccCcccccccccccccCCCcccc-cCCCccccCCCCCCCcccCccc
Confidence 76676776643221111 01100 0011122456788899887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=383.38 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=215.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 5689999999999999999999999999999999976432 23456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999998543 46999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCccceecccccccccCchhhhccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELT-VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~-~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... ....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.......... .+......
T Consensus 167 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~~~~----- 232 (328)
T 3fe3_A 167 GGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE------RVLRGKYR----- 232 (328)
T ss_dssp SCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCC-----
T ss_pred CCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCCC-----
Confidence 332 3456899999999999887775 89999999999999999999998654222111 11111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
++...+.++.+|+.+||+.||.+|||+.++++|.|+-..
T Consensus 233 -------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 233 -------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp -------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred -------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 233345678899999999999999999999999887543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=383.40 Aligned_cols=276 Identities=25% Similarity=0.320 Sum_probs=230.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.++..++||||+++++++.+...+|||
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999999999999999986532 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 9999999999999653 45899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.. ....+||+.|+|||++.+..++.++|||||||+||||++|..||.......... .+.....
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~~~~~------ 255 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------KIVSGKV------ 255 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCC------
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH------HHHcCCC------
Confidence 32 234679999999999999999999999999999999999999997653322111 1111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSS 381 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~ 381 (519)
.++...+..+.+||.+||+.||.+||+ +.+|++|.++-.. ....+.+|+.|...+..+..+++
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~ 328 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc
Confidence 133345568899999999999999998 9999999876432 23456778888777666666665
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=392.61 Aligned_cols=315 Identities=23% Similarity=0.284 Sum_probs=214.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHH-HHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|++..+++.||||++.+... .....+..|..+ +..++||||+++++++.+.+.+||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999999999999999999976532 223445667665 567899999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999854 246899999999999999999999999 999999999999999999999999999863
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... ..+.....
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~~~----- 256 (373)
T 2r5t_A 190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNILNKPL----- 256 (373)
T ss_dssp BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------HHHHHSCC-----
T ss_pred ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHhccc-----
Confidence 3222 1234578999999999999999999999999999999999999999764322111 11111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH----HHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM----SDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSD 382 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~ 382 (519)
.++...+..+.+||.+||+.||.+||++ .+++.|.++-.- ....+.+|+.|...+..+..+++.
T Consensus 257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~ 329 (373)
T 2r5t_A 257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDP 329 (373)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC---------
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCc
Confidence 1233445688999999999999999997 577777665321 235667888888777777777776
Q ss_pred CCCCCCCCCCC---CCccccc---ccccccCCCCCCCCCCC
Q 046892 383 GHQKNENTYDN---DNARSVR---ESENLESSNNSGSNPER 417 (519)
Q Consensus 383 ~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~s~~~~~~ 417 (519)
.++.+...... ....... ......|.+|+|.++..
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 370 (373)
T 2r5t_A 330 EFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTD 370 (373)
T ss_dssp -----------------------------------------
T ss_pred ccccccccccccCCccccccccccccccccCCCCcccCchh
Confidence 66554422111 1000000 12345688999888764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=400.98 Aligned_cols=285 Identities=25% Similarity=0.345 Sum_probs=222.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+..|+.++..++||||++++++|.+.+.++||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999998753 223345677899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999854 3468999999999999999999998 88 999999999999999999999999999864
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|..||...........+ .....
T Consensus 300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~~----- 366 (446)
T 4ejn_A 300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEI----- 366 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC-----
T ss_pred cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhCCC-----
Confidence 3322 1234578999999999999999999999999999999999999999765332221111 11111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSS 381 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~ 381 (519)
.++...+.++.+||.+||+.||.+|| ++.++++|.++-.. ....+.+|+.|...+..+..+++
T Consensus 367 -------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~ 439 (446)
T 4ejn_A 367 -------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFD 439 (446)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-
T ss_pred -------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcc
Confidence 12334456889999999999999999 99999999887432 24566788888888888888888
Q ss_pred CCCCCC
Q 046892 382 DGHQKN 387 (519)
Q Consensus 382 ~~~~~~ 387 (519)
..++.+
T Consensus 440 ~~~~~~ 445 (446)
T 4ejn_A 440 EEFTAQ 445 (446)
T ss_dssp ------
T ss_pred hhhhcC
Confidence 877654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=374.79 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=219.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|.+.+.||+|+||+||+|.+..++..||+|++..........+.+|+.++..++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46799999999999999999999999999999998765555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999964 2456999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccc------------eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc
Q 046892 236 KMN------------VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303 (519)
Q Consensus 236 ~~~------------~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 303 (519)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~----------- 231 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD----------- 231 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-----------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-----------
Confidence 211 011467999999999999999999999999999999999999998764332111
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
........+...++..++..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 232 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 232 ----FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ----SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011112223333455556688999999999999999999999999987764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=384.53 Aligned_cols=258 Identities=26% Similarity=0.308 Sum_probs=215.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
..++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 356899999999999999999999999999999999765332 24678999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----CcEEee
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL----DPKLSD 224 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~----~vkL~D 224 (519)
.++||||+.+|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999984 3457999999999999999999999999 99999999999998877 799999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........... +...
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~------i~~~ 233 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------ITAV 233 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HHTT
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhc
Confidence 999987654322 2346799999999999999999999999999999999999999976532221111 1111
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...+ +... ....+..+.+||..||..||.+|||+.++++|.|+-
T Consensus 234 ~~~~----~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 234 SYDF----DEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp CCCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CCCC----Cchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 1111 1111 123456789999999999999999999999987753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.97 Aligned_cols=269 Identities=24% Similarity=0.349 Sum_probs=222.8
Q ss_pred ccccHHHHHHhccC----------cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC
Q 046892 65 QTFTFRELAAATKN----------FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHP 134 (519)
Q Consensus 65 ~~~~~~~~~~~~~~----------y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp 134 (519)
..|+++++..+++. |...+.||+|+||.||+|++..+|+.||||++........+.+.+|+.++..++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777766653 77788999999999999999989999999999877666677899999999999999
Q ss_pred CeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 135 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
||+++++++...+..++||||+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999883 246999999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL 294 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~ 294 (519)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~-- 250 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-- 250 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 9999999999999986544322 233467999999999999999999999999999999999999999765432221
Q ss_pred HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 295 IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.... ... .+.. ......+..+.+++.+||+.||.+|||+.+++++.++...
T Consensus 251 -~~~~---~~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 251 -KRLR---DSP--PPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -HHHH---HSS--CCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -HHHh---cCC--CCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 1111 100 0000 0112344578899999999999999999999999887653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=376.52 Aligned_cols=276 Identities=27% Similarity=0.388 Sum_probs=221.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+.. ......+..|+.++..++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999999999999999987532 23456678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999954 356899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||......... ..+......
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~~----- 221 (318)
T 1fot_A 158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKILNAELR----- 221 (318)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHCCCC-----
T ss_pred Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCCC-----
Confidence 32 23468999999999999999999999999999999999999999764322111 111111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCC-CcCCCccC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDED-EYSEGYSS 381 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~-~~~~~~~~ 381 (519)
++...+.++.+|+.+||+.||.+|| ++.++++|.|+-.. ....+.+|+.|.... ..+..+++
T Consensus 222 -------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~ 294 (318)
T 1fot_A 222 -------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFD 294 (318)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------
T ss_pred -------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcC
Confidence 2334456889999999999999999 89999999886432 234455666666542 33444443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=377.65 Aligned_cols=283 Identities=25% Similarity=0.340 Sum_probs=210.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCC----cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGM----QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||+|++. .+++.||||++..... .....+..|+.++..++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 5799999999976432 233557789999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999854 246899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+.....
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~~~~~-- 238 (327)
T 3a62_A 169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---ID---KILKCKL-- 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHHHTCC--
T ss_pred cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhCCC--
Confidence 7543222 123456799999999999999999999999999999999999999976432211 11 1111111
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCC
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEG 378 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~ 378 (519)
.++...+..+.+|+.+||+.||.+|| ++.++++|.++-.. ......+|+.|......+..
T Consensus 239 ----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~ 308 (327)
T 3a62_A 239 ----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVS 308 (327)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC--------
T ss_pred ----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhh
Confidence 12334456889999999999999999 88999999886432 23445566776655555555
Q ss_pred ccCCCCC
Q 046892 379 YSSDGHQ 385 (519)
Q Consensus 379 ~~~~~~~ 385 (519)
+++..++
T Consensus 309 ~~~~~~~ 315 (327)
T 3a62_A 309 QFDSKFT 315 (327)
T ss_dssp -------
T ss_pred hcchhhh
Confidence 5544443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=380.44 Aligned_cols=262 Identities=26% Similarity=0.371 Sum_probs=215.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEc-------CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ-------SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 146 (519)
.++|.+.+.||+|+||.||+|.+. .++..||||++..... .....+..|+.++..+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999974 3456899999976532 2345688999999999 899999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
+.+|+||||+.+|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 1245899999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986654433223334567899999999999999999999999999999999 999997654332222
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+... .....+..++.++.+|+..||+.||.+||++.+++++|..+.
T Consensus 317 ~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 LLKEG-----------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHTT-----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcC-----------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100 011233455668999999999999999999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=374.51 Aligned_cols=257 Identities=23% Similarity=0.300 Sum_probs=213.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.++..++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45799999999999999999999999999999998764322 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----CcEEeee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL----DPKLSDF 225 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~----~vkL~DF 225 (519)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999984 3457999999999999999999999999 99999999999999887 7999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ...
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------AVN 233 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------HTC
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------hcC
Confidence 99987654322 234679999999999999999999999999999999999999997643222111111 000
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..++ .. +....+..+.+|+.+||+.||.+|||+.++++|.|+.
T Consensus 234 ~~~~----~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 234 YEFE----DE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp CCCC----HH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred CCcC----cc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 0110 11 1123345788999999999999999999999997753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=377.19 Aligned_cols=261 Identities=22% Similarity=0.302 Sum_probs=215.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC-----CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN-----GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++..++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999999999999999998642 1224567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC---cEEeeecc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD---PKLSDFGL 227 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~---vkL~DFGl 227 (519)
+|||||++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999988766555667999999999999999999999999 999999999999986654 99999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
+........ .....+||+.|+|||++.+..++.++|||||||+||+|++|..||.... ..+.. .+......
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~---~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFE---GIIKGKYK 250 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHH---HHHHTCCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHH---HHHcCCCC
Confidence 987654322 2344679999999999999999999999999999999999999997632 11111 11111101
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
+ ..... ...+..+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 251 ~----~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 251 M----NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp C----CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred C----Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 0 11111 12345789999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.70 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=215.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999999999999999986442 334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCCcEEeeecccccCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA--NLDPKLSDFGLAKLGP 232 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~--~~~vkL~DFGla~~~~ 232 (519)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999843 3346999999999999999999999999 999999999999987 7899999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. .+......++
T Consensus 156 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~---~i~~~~~~~~--- 223 (321)
T 1tki_A 156 PGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IE---NIMNAEYTFD--- 223 (321)
T ss_dssp TTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHHTCCCCC---
T ss_pred CCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HH---HHHcCCCCCC---
Confidence 4432 3346799999999999988899999999999999999999999976432211 11 1111111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... ....+.++.+|+.+||+.||.+|||+.++++|.|+..
T Consensus 224 -~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 224 -EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -hhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 111 1133567899999999999999999999999988753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=364.24 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=210.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||+||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999999999999999997654332 3668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 66666543 3467999999999999999999999999 999999999999999999999999999865432
Q ss_pred CccceecccccccccCchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC--CCCCcc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP--KRFPDM 311 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 311 (519)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ............. ..++.+
T Consensus 155 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTG
T ss_pred c--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhh
Confidence 2 2234467899999999997765 8999999999999999999988864432221 1111111110000 000000
Q ss_pred ------------cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 ------------ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 ------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.............+..+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 287 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence 000001112234567889999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=364.10 Aligned_cols=285 Identities=39% Similarity=0.622 Sum_probs=228.8
Q ss_pred CCccccHHHHHHhccCcccc------eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC----CcChHHHHHHHHHHHhcC
Q 046892 63 NAQTFTFRELAAATKNFRQE------CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG----MQGNKEFLVEVLMLSLLH 132 (519)
Q Consensus 63 ~~~~~~~~~~~~~~~~y~~~------~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~ 132 (519)
....|++.++..++++|... +.||+|+||.||+|.+ +++.||||++.... ......+.+|+.++..++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 45678999999999988877 8999999999999986 48899999986532 123466889999999999
Q ss_pred CCCeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046892 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNI 212 (519)
Q Consensus 133 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NI 212 (519)
||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999986532 3456999999999999999999999999 99999999999
Q ss_pred eeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh
Q 046892 213 LLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ 292 (519)
Q Consensus 213 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~ 292 (519)
|++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 999999999999999987654433333445679999999998874 5899999999999999999999999875433221
Q ss_pred hHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+ ..........+...++..+ ...+...+..+.+++..||+.||.+|||+.+|+++|..+.
T Consensus 244 ~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111 1111111111111122111 2245567788999999999999999999999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=368.39 Aligned_cols=277 Identities=25% Similarity=0.308 Sum_probs=204.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999999999999999975432 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 155 FMSGGSVDDHLLDVNE--TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|+. |+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 699999865432 2345899999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh-hchhc--------
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQPIF-------- 302 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~~~~~-------- 302 (519)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.. .....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3221 2234578999999999976 4689999999999999999999999986544332222111 00000
Q ss_pred cCC-------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 303 RDP-------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 303 ~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
... ...+..+...+........+.++.+|+.+||+.||.+|||+.+++++.|+-..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 000 00011111222223334456789999999999999999999999999887543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=376.41 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=213.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456899999999999999999999999999999999765332 335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CCcEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN---LDPKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~---~~vkL~DFGla~ 229 (519)
|||+.+|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999884 3456899999999999999999999999 9999999999999865 459999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... +... +......++
T Consensus 180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~---i~~~~~~~~ 250 (362)
T 2bdw_A 180 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQ---IKAGAYDYP 250 (362)
T ss_dssp CCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHTCCCCC
T ss_pred EecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhCCCCCC
Confidence 7654322 234679999999999999999999999999999999999999997643221 1111 111111111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.. ....++.++.+|+.+||+.||.+||++.+++++.|+.
T Consensus 251 ~~--------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 251 SP--------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp TT--------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred cc--------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 00 0123456789999999999999999999999998864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=371.78 Aligned_cols=264 Identities=28% Similarity=0.429 Sum_probs=213.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC---eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG---QVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|.+.+.||+|+||.||+|.+..++ ..||||++..... .....+.+|+.++..++||||+++++++.+.+..+|
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999997544 4699999975432 234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+++|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999854 3356999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 232 PQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 232 ~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||........ ........
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~~~~~------- 271 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---ISSVEEGY------- 271 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHHHTTC-------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHcCC-------
Confidence 543221 12233456888999999999999999999999999999999 9999976533222 21111100
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEP 362 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~ 362 (519)
....+..++..+.+|+..||+.||.+|||+.+|++.|..+......
T Consensus 272 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 272 -------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred -------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 1112344556889999999999999999999999999988765443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=376.76 Aligned_cols=272 Identities=26% Similarity=0.357 Sum_probs=217.9
Q ss_pred cHHHHHHhccCcccceeeeccCcEEEEEEE-----EcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeee
Q 046892 68 TFRELAAATKNFRQECLLGEGGFGRVYKGT-----LQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLI 140 (519)
Q Consensus 68 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~ 140 (519)
.........++|.+.+.||+|+||.||+|. ...+++.||||++..... .....+.+|+.++..+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 334444567899999999999999999999 445678999999976433 2335689999999999 789999999
Q ss_pred eEEecCC-ceEEEEEecCCCCHHHHHhhhccC------------------------------------------------
Q 046892 141 GYCADGD-QRLLVYEFMSGGSVDDHLLDVNET------------------------------------------------ 171 (519)
Q Consensus 141 ~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------ 171 (519)
+++.+.+ ..++||||+.+|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 489999999999999999754321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc
Q 046892 172 --------------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 172 --------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
...+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122899999999999999999999999 999999999999999999999999999876554443
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||......... ....... .
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~~--------------~ 313 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEG--------------T 313 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHHT--------------C
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHHcC--------------C
Confidence 34455678999999999999999999999999999999998 99999765432211 1111100 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+...+.++.+|+..||+.||.+|||+.+|+++|..+..
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111233445678999999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=364.58 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=204.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--------------------------ChHHHHHHHHHHH
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--------------------------GNKEFLVEVLMLS 129 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~ 129 (519)
.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999998654321 1256889999999
Q ss_pred hcCCCCeeeeeeEEec--CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046892 130 LLHHPNLVNLIGYCAD--GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDL 207 (519)
Q Consensus 130 ~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDi 207 (519)
.++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.||+.||+|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999987 56889999999999988764 3357999999999999999999999999 999999
Q ss_pred CCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCC---CCchhHHHHHHHHHHHHHhCCCCCC
Q 046892 208 KSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE---LTVKSDVYSFGVILLELITGRRVID 284 (519)
Q Consensus 208 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~---~~~~sDvwSlGvll~elltG~~pf~ 284 (519)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987544322 234467999999999997655 4788999999999999999999997
Q ss_pred CCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 285 TTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...... +.. .+......++ .....+..+.+|+.+||+.||.+|||+.++++|.|+
T Consensus 242 ~~~~~~---~~~---~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 242 DERIMC---LHS---KIKSQALEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp CSSHHH---HHH---HHHHCCCCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred CccHHH---HHH---HHhcccCCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 643211 111 1111111111 012344578999999999999999999999999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=383.07 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=213.3
Q ss_pred ccCcccceeeeccCcEEEEEEEE-----cCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||.||+|.+ ..++..||||++.... ......+..|+.++..++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46799999999999999999994 4567899999986542 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---CcEEe
Q 046892 150 LLVYEFMSGGSVDDHLLDVNE---TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL---DPKLS 223 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~---~vkL~ 223 (519)
++||||+.+|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976542 2246899999999999999999999999 99999999999999555 59999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|||+++...............||+.|+|||++.+..++.++|||||||+||||++ |..||....... +.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~--- 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVT--- 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH---
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---
Confidence 9999975322222222334568999999999999999999999999999999998 999997654322 222111
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
... ....+..++..+.+|+..||+.||.+||++.+|+++|+.+...
T Consensus 301 ~~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 SGG-----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp TTC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cCC-----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 100 0112334456789999999999999999999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=385.96 Aligned_cols=259 Identities=22% Similarity=0.276 Sum_probs=212.8
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999999999999999999765432 345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCCcEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG---ANLDPKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~---~~~~vkL~DFGla~ 229 (519)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999854 356999999999999999999999999 99999999999998 56789999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~~~~~ 233 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK------AGAYDFP 233 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HTCCCCC
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------hCCCCCC
Confidence 6654322 2334689999999999999999999999999999999999999997643222211111 1111111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. ......+.++.+|+..||+.||.+|||+.++++|.|+-
T Consensus 234 ~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 234 S--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred c--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 0 01123456789999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=365.26 Aligned_cols=265 Identities=31% Similarity=0.468 Sum_probs=206.4
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
....+|++.+.||+|+||+||+|.+. +..||||++...... ....+.+|+.++..++||||+++++++.+....++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34568999999999999999999874 899999998765432 23568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+|+|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999995421 1123899999999999999999999986 34999999999999999999999999999754
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~----~------- 256 (309)
T 3p86_A 190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC----K------- 256 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC----C-------
T ss_pred cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----C-------
Confidence 3322 12334679999999999999999999999999999999999999997654322221111110 0
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
...++...+..+.+|+.+||+.||.+|||+.+|++.|..+....
T Consensus 257 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 -----RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 01233445568899999999999999999999999998776543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=378.72 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=214.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46899999999999999999999999999999999766544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--CCCcEEeeecccccCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA--NLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~--~~~vkL~DFGla~~~~~ 233 (519)
+.+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999998843 2346899999999999999999999999 999999999999974 57799999999987654
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. .....++
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~------~~~~~~~---- 270 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK------RCDWEFD---- 270 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------HCCCCCC----
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCC----
Confidence 332 234579999999999999999999999999999999999999998654322211111 1111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.......+.++.+||.+||+.||.+|||+.+++++.|+-
T Consensus 271 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 271 ----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp ----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred ----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 011223456889999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=362.01 Aligned_cols=262 Identities=25% Similarity=0.358 Sum_probs=210.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|.+..++..||+|++....... .+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999999999999999986543332 35678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999543 46999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... . ..+
T Consensus 163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~----~--~~~--- 230 (294)
T 4eqm_A 163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQ----D--SVP--- 230 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHS----S--CCC---
T ss_pred cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhh----c--cCC---
Confidence 3321 223346799999999999999999999999999999999999999976542211 111111 1 011
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHhhhhc
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-LMSDVVTALSFLSN 358 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~~~~~ 358 (519)
.....++...+..+.+++.+||+.||.+|| ++.++++.|..+..
T Consensus 231 --~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 231 --NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp --CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred --CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 111223445567899999999999999998 88888888876544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=364.62 Aligned_cols=269 Identities=24% Similarity=0.326 Sum_probs=209.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||+||+|.+. +++.||||++...... ....+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 578999999999999999999996 4899999998754322 2356889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9997 488887743 3456999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh-hchhccCCCCCCcc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQPIFRDPKRFPDM 311 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 311 (519)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.. ..... ...++..
T Consensus 172 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 247 (311)
T 3niz_A 172 PVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN--PREWPQV 247 (311)
T ss_dssp CCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC--TTTSGGG
T ss_pred Ccc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC--hHHhhhh
Confidence 221 2334578999999999876 5689999999999999999999999987655443322211 11000 0000000
Q ss_pred cc-------------hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 AD-------------PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 ~d-------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.+ ......+....+.++.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 00 0000111233456889999999999999999999999997764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=380.73 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=201.0
Q ss_pred ccCcccc-eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHH-HhcCCCCeeeeeeEEec----CCce
Q 046892 76 TKNFRQE-CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLML-SLLHHPNLVNLIGYCAD----GDQR 149 (519)
Q Consensus 76 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~ 149 (519)
.++|.+. ++||+|+||+||+|.+..+++.||||++.. ...+.+|+.++ +..+||||++++++|.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567776 789999999999999999999999999863 24677888876 45689999999999875 5678
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeeec
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDFG 226 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DFG 226 (519)
|||||||.+|+|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999642 2346999999999999999999999999 999999999999987 7889999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHhhchhccCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ-NLIAWAQPIFRDP 305 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~ 305 (519)
+++...... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||......... ...... ....
T Consensus 210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~~ 283 (400)
T 1nxk_A 210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQ 283 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHTC
T ss_pred cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcCc
Confidence 998654322 234568999999999999999999999999999999999999999765432210 010000 0000
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..++. .....++.++.+||..||+.||.+|||+.++++|.|+...
T Consensus 284 ~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 284 YEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 01110 0012345688999999999999999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=373.34 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=212.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986431 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+ +|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 78999988543 46999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ..+...
T Consensus 160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------~~i~~~------- 223 (336)
T 3h4j_B 160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------KKVNSC------- 223 (336)
T ss_dssp TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------CCCCSS-------
T ss_pred CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------HHHHcC-------
Confidence 4332 234679999999999987776 78999999999999999999999764321110 000000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...++...+..+.+|+.+||+.||.+|||+.+++++.|+-..
T Consensus 224 -----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 224 -----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 012344456688999999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=380.51 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=213.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 4678999999999999999999998899999999875422 223457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999653 235899999999999999999999999 999999999999999999999999999864432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
..........+++.|+|||++.++.++.++|||||||+||||++ |..||....... ....... ..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~~----~~------- 332 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVEK----GG------- 332 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHHT----TC-------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CC-------
Confidence 21111122345778999999999999999999999999999998 999997654322 2221111 00
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+...+..++..+.+|+..||+.||.+|||+.+|++.|..+..
T Consensus 333 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 333 ---RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 112334455688999999999999999999999999987653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=387.45 Aligned_cols=277 Identities=26% Similarity=0.408 Sum_probs=226.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.++||+|+||.||+|++..+|+.||||++.+.. ......+..|+.++..++||||+++++++.+...+|||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999999999999999996532 23346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||++||+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999765544567999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc-hhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVD-EQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|..||....... ...+.. .+.....
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~~~~----- 410 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLEQAV----- 410 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHHCCC-----
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhhccc-----
Confidence 4332 1334689999999999999999999999999999999999999998754321 111111 1111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHhhhhc-----CCCCCCCCCCCCCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM-----SDVVTALSFLSN-----SKEPIPDPIIPSDE 372 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~l~~~~~-----~~~~~~~p~~p~~~ 372 (519)
.++...+..+.+||.+||+.||.+||++ .+|+.|.++-.- ....+.+|+.|...
T Consensus 411 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~ 474 (543)
T 3c4z_A 411 -------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSR 474 (543)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSS
T ss_pred -------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCcc
Confidence 2344456688999999999999999964 788888776432 13345677777643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=361.99 Aligned_cols=274 Identities=19% Similarity=0.246 Sum_probs=216.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC--ceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.... ..+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999999999999999997543 234567889999999999999999999998765 77999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCCcEEeeeccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL----GANLDPKLSDFGLA 228 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl----~~~~~vkL~DFGla 228 (519)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999996543 2334999999999999999999999999 9999999999999 78888999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhc--------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHH-hh
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYAR--------SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE-QNLIA-WA 298 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~--------~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~-~~~~~-~~ 298 (519)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|..||........ ..+.. ..
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 87654332 23457999999999986 57889999999999999999999999976443221 11111 11
Q ss_pred chhccCC-------CCCC-ccc-chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 QPIFRDP-------KRFP-DMA-DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 ~~~~~~~-------~~~~-~~~-d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
....... .... .+. .-.....+.......+.+|+.+||+.||.+|||+.++++++...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1100000 0000 000 00111234567788999999999999999999999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=372.47 Aligned_cols=280 Identities=23% Similarity=0.272 Sum_probs=217.1
Q ss_pred CccccHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----CCCeee
Q 046892 64 AQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-----HPNLVN 138 (519)
Q Consensus 64 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~ 138 (519)
...|++.+.....++|.+.+.||+|+||.||+|++..+++.||||++... ......+..|+.++..+. ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 33455556666778999999999999999999999999999999998642 233456778999999886 999999
Q ss_pred eeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--
Q 046892 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-- 216 (519)
Q Consensus 139 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-- 216 (519)
+++++...+..+|||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 999999999999999999 99999999653 2345899999999999999999999999 999999999999975
Q ss_pred -----------------------CCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHH
Q 046892 217 -----------------------NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVIL 273 (519)
Q Consensus 217 -----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll 273 (519)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999864432 2346789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcchhhHHHhhchhcc-----------------CC---CCCCcccch-----HhhccCC---hhhH
Q 046892 274 LELITGRRVIDTTRPVDEQNLIAWAQPIFR-----------------DP---KRFPDMADP-----LLRKQFP---EKGL 325 (519)
Q Consensus 274 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~-----------------~~---~~~~~~~d~-----~l~~~~~---~~~~ 325 (519)
|+|++|..||......+....+........ .. ..++..... .+....+ ....
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 999999999987543332222211100000 00 000000000 0000000 1112
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 326 NEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 326 ~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+.+|+.+||+.||.+|||+.++++|.|+
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f 359 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcCccc
Confidence 578899999999999999999999998765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=375.39 Aligned_cols=267 Identities=27% Similarity=0.364 Sum_probs=208.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC----ceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~~l 151 (519)
.++|++.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++..++||||+++++++.+.. .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 468999999999999999999886 8999999986542 22344566888899999999999999998754 3699
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCCeeeCCCCCcE
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK----------ANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~~IvHrDikp~NILl~~~~~vk 221 (519)
||||+++|+|.+++.. ..+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999954 3589999999999999999999999 8 99999999999999999999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhccC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-----ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI- 295 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-----~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~- 295 (519)
|+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999876544433334456799999999999863 4567899999999999999999999764332211110
Q ss_pred ---------HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 296 ---------AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 296 ---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+...... ....+.+ ... .-.......+.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 252 ~~~~~~~~~~~~~~~~~-~~~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVVH-KKKRPVL-RDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHCSSCCHHHHHHHHTT-SCCCCCC-CGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhhc-ccCCCCc-ccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000000 0001100 000 0122455679999999999999999999999999987764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=368.25 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=206.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeE----EEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQV----VAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.++|++.+.||+|+||.||+|++..++.. ||+|.+.... ......+.+|+.++..++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35799999999999999999999877765 4777775432 244577899999999999999999999998754 78
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+|+||+.+|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999865 3456999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---------- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---------- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC----------
Confidence 654443333344567889999999999999999999999999999999 999998765433322222110
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+..++..+.+|+.+||+.||.+||++.+|+++|..+..
T Consensus 237 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111233455688999999999999999999999999987754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=363.82 Aligned_cols=263 Identities=29% Similarity=0.417 Sum_probs=216.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||.||+|.+. .++..||||++..... .....+..|+.++..++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 568999999999999999999983 4568999999875432 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhcc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046892 150 LLVYEFMSGGSVDDHLLDVNE--------------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKS 209 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp 209 (519)
++||||+.+++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 1234899999999999999999999999 99999999
Q ss_pred CCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 046892 210 SNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRP 288 (519)
Q Consensus 210 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~ 288 (519)
+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333344567899999999999999999999999999999999 9999986654
Q ss_pred cchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 289 VDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
......+.... ....+...+..+.+|+.+||+.||.+||++.+|+++|..+..
T Consensus 259 ~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ERLFNLLKTGH-----------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GGHHHHHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCC-----------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 33222221110 011233455688999999999999999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=388.86 Aligned_cols=274 Identities=26% Similarity=0.410 Sum_probs=224.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|++..+|+.||||++.+.. ......+..|+.+|..++||||+++++++.+.+.+|||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999986532 23446688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||++||+|.+++... ....+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999998543 2345999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE-QNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ....+||+.|+|||++.+..++.++|||||||+||||++|..||........ ..+.... ....
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i---~~~~------ 405 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV---KEVP------ 405 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH---HHCC------
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh---hccc------
Confidence 4332 2346899999999999998999999999999999999999999987543222 1121111 1111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhcC-----CCCCCCCCCCCCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSNS-----KEPIPDPIIPSDE 372 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~~-----~~~~~~p~~p~~~ 372 (519)
..++...+.++.+||.+||+.||.+|| ++.+|++|.|+-... ...+.+|+.|...
T Consensus 406 ------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 406 ------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCcc
Confidence 123344556899999999999999999 789999998775321 2345567766543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.94 Aligned_cols=266 Identities=24% Similarity=0.372 Sum_probs=199.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCe---EEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
..++|.+.+.||+|+||.||+|.+..++. .||||++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35689999999999999999999877664 89999987542 23456789999999999999999999999877655
Q ss_pred ------EEEEEecCCCCHHHHHhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcE
Q 046892 150 ------LLVYEFMSGGSVDDHLLDVNE--TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 150 ------~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vk 221 (519)
++||||+.+|+|.+++..... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999965432 2236899999999999999999999999 99999999999999999999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhch
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 300 (519)
|+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~- 256 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN- 256 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-
Confidence 999999987654443333344567889999999999999999999999999999999 899998755433222211100
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
....+...+..+.+|+.+||+.||.+|||+.++++.|..+....
T Consensus 257 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 257 ----------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01123345568899999999999999999999999888776544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=369.51 Aligned_cols=265 Identities=25% Similarity=0.425 Sum_probs=215.5
Q ss_pred HhccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
...++|.+.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.++..++||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999997 3458999999975432 23456889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNET--------------------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDL 207 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDi 207 (519)
..++||||+++|+|.+++...... ...+++..++.|+.||+.||.|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 999999999999999999764221 257999999999999999999999999 999999
Q ss_pred CCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCC
Q 046892 208 KSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTT 286 (519)
Q Consensus 208 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~ 286 (519)
||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999976543322222344578999999999999999999999999999999999 99999764
Q ss_pred CCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 287 RPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
... .+.... .... . ..++..++..+.+|+..||+.||.+||++.+|+++|..+..
T Consensus 281 ~~~---~~~~~~---~~~~--~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 281 AHE---EVIYYV---RDGN--I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CHH---HHHHHH---HTTC--C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ChH---HHHHHH---hCCC--c---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 322 111111 1110 0 11234455688999999999999999999999999987654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=369.83 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=204.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|.+.+.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457999999999999999999999999999999997643 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC--cEEeeecccccCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD--PKLSDFGLAKLGPQ 233 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~--vkL~DFGla~~~~~ 233 (519)
+.+|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999854 246999999999999999999999999 999999999999987765 99999999974332
Q ss_pred CCccceecccccccccCchhhhccCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHHhhchhccCCCCCCcc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVK-SDVYSFGVILLELITGRRVIDTTRPVDE-QNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~-sDvwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 311 (519)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ...+. .+......++.
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~- 243 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RILSVKYSIPD- 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHHTTCCCCCT-
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHhcCCCCCCC-
Confidence 22 2234579999999999988887665 8999999999999999999986543222 22221 11111111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
....+..+.+||.+||+.||.+|||+.++++|.|+.....
T Consensus 244 ---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 244 ---------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp ---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred ---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 1123457889999999999999999999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=372.47 Aligned_cols=264 Identities=27% Similarity=0.365 Sum_probs=217.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-------CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-------NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 146 (519)
.++|.+.+.||+|+||.||+|.+.. .+..||||++..... .....+.+|+.++..+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999999753 346899999976532 2335688999999999 899999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
+..++||||+.+|+|.+++..... ....+++..++.|+.||+.||+|||+.+ |+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976432 1246999999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--- 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987655443333445568899999999999999999999999999999999 999997653222
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
+........ ....+..++.++.+|+..||+.||.+|||+.+|+++|..+...
T Consensus 302 ~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 302 LFKLLKEGH--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHHTTC--------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCC--------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 222111100 1112334556889999999999999999999999999887653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.75 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=209.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+..|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357999999999999999999999999999999987653 2345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl---~~~~~vkL~DFGla~~~ 231 (519)
|+++|+|.+++.........+++..++.|+.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999776555678999999999999999999999999 9999999999999 45688999999999865
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||................. ....
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------~~~~- 246 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP------NYAV- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------CCCC-
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc------cccc-
Confidence 4432 233467999999999986 5789999999999999999999999976543222211111110 0000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.....+..+.+|+.+||+.||.+|||+.+++++.|+-
T Consensus 247 --------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 247 --------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp ----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred --------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 0011345788999999999999999999999987764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=358.72 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=206.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||.||+|.+ .+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 5689999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9975 89988854 2356899999999999999999999999 999999999999999999999999999765432
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-HhhchhccCCCCCCcc-
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQPIFRDPKRFPDM- 311 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~- 311 (519)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+ ........ ..++..
T Consensus 154 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 229 (288)
T 1ob3_A 154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS--KNWPNVT 229 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT--TTSTTGG
T ss_pred cc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCCh--hhchhhh
Confidence 11 1234578999999999876 45899999999999999999999999865432222111 11100000 000000
Q ss_pred -----------cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 -----------ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 -----------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
..+.....+....+..+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 000001122334567889999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.05 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=211.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.++..++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999999999999999986432 12345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998553 45899999999999999999999999 9999999999999999999999999986543
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. ...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~------- 223 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------RVE------- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTC-------
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH------hCC-------
Confidence 322 234578999999999999999999999999999999999999997643322221111 111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
..++...+..+.+|+..||+.||.+|||+.++++|.|+-...
T Consensus 224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 122334456788999999999999999999999998876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.71 Aligned_cols=267 Identities=28% Similarity=0.430 Sum_probs=209.6
Q ss_pred ccCcccceeeeccCcEEEEEEE----EcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--Cce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGT----LQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 149 (519)
.++|++.+.||+|+||.||+|+ +..+++.||||++..........+.+|+.++..++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4689999999999999999998 4567999999999866555557789999999999999999999998653 558
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999653 235899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc---------chhhHHHhhc
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV---------DEQNLIAWAQ 299 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~---------~~~~~~~~~~ 299 (519)
........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76443221 1223345788899999999999999999999999999999999988642110 0000000000
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...... .....+..++.++.+|+..||+.||.+|||+.+|++.|..+..
T Consensus 243 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 243 ELLKNN----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHTT----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcc----------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000010 0112344566789999999999999999999999999987764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=361.00 Aligned_cols=272 Identities=25% Similarity=0.322 Sum_probs=208.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... ...+.+|+.++..++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999999999999999986553322 355788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999988873 3456999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-ch-----------
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QP----------- 300 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~----------- 300 (519)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+... ..
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 PSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred ccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 221 2334578999999999876 67899999999999999999999999876543332222111 00
Q ss_pred -hccCCCCCCcccch-HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 301 -IFRDPKRFPDMADP-LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 301 -~~~~~~~~~~~~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.......++...+. .+... ....+..+.+|+..||+.||.+|||+.++++|.|+-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELK-FPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHH-CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred ccccccCcCCCccccchhhhh-cccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 00000011100000 00000 1234567899999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.02 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=210.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ...|+.++..+ +||||+++++++.+....|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356799999999999999999999999999999999765432 34577777776 7999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-C---CcEEeeecccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-L---DPKLSDFGLAK 229 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-~---~vkL~DFGla~ 229 (519)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+... + .+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999853 456999999999999999999999999 9999999999998433 3 49999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+..... .....++
T Consensus 169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~~~~~~~ 243 (342)
T 2qr7_A 169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---SGKFSLS 243 (342)
T ss_dssp ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---HCCCCCC
T ss_pred cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---cCCcccC
Confidence 6543322 2345689999999999988889999999999999999999999998644333333322211 1111111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+....+.++.+|+.+||+.||.+||++.++++|.|+..
T Consensus 244 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 244 --------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp --------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred --------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 1122345568899999999999999999999999998853
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=366.88 Aligned_cols=265 Identities=26% Similarity=0.361 Sum_probs=214.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCC
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGD 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 147 (519)
..++|.+.+.||+|+||.||+|.+. .++..||||++.... ......+.+|+.++..+ .||||+++++++.+.+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3578999999999999999999973 356789999997542 23456789999999999 8999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNET-------------------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDik 208 (519)
..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999653211 134899999999999999999999999 9999999
Q ss_pred CCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 046892 209 SSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTR 287 (519)
Q Consensus 209 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~ 287 (519)
|+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||+||+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986654443334455678899999999999999999999999999999998 999997754
Q ss_pred CcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 288 PVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..... ....... .....+...+..+.+|+.+||+.||.+|||+.+|+++|..+..
T Consensus 280 ~~~~~--~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDANF--YKLIQNG--------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHHH--HHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHHH--HHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 32211 1111110 0111233445688999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=366.46 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=203.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCce---
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR--- 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~--- 149 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999999999999999997654333 24678899999999999999999998765543
Q ss_pred -EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 150 -LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 150 -~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
|+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999854 246899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCc-cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 229 KLGPQGEK-MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 229 ~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... . ......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~--~----~~~~~~- 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY--Q----HVREDP- 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H----HHHCCC-
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--H----HhcCCC-
Confidence 86543321 122334679999999999999999999999999999999999999997654322111 1 111100
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
. ... ......+.++.+|+.+||+.||.+||++.+++.+.++-.
T Consensus 237 ~----~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 I----PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp C----CHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C----Ccc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 000 112234567899999999999999999888887766543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=362.79 Aligned_cols=262 Identities=20% Similarity=0.224 Sum_probs=214.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4689999999999999999999999999999999875432 34688999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC-----cEEeeecccc
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD-----PKLSDFGLAK 229 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~-----vkL~DFGla~ 229 (519)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999998653 457999999999999999999999999 999999999999998887 9999999998
Q ss_pred cCCCCCccc-----eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-cc
Q 046892 230 LGPQGEKMN-----VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI-FR 303 (519)
Q Consensus 230 ~~~~~~~~~-----~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~-~~ 303 (519)
......... ......||+.|+|||++.+..++.++|||||||+||||++|..||.................. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 654332211 124568999999999999999999999999999999999999999876544433322221100 00
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.. ... .....+ ++.+|+..||+.||.+||++.+|++.|..+..
T Consensus 239 ~~-------~~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 239 TP-------IEV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp SC-------HHH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CC-------HHH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 00 000 111233 89999999999999999999999999886654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=368.89 Aligned_cols=274 Identities=20% Similarity=0.281 Sum_probs=206.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..++|++.+.||+|+||+||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..+||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 356899999999999999999999999999999999754322 234577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-----CCCCcEEeeecc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-----ANLDPKLSDFGL 227 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-----~~~~vkL~DFGl 227 (519)
|||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+ ..+.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99997 599999854 346999999999999999999999999 99999999999994 455699999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC--
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD-- 304 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-- 304 (519)
+....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.........
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 98654322 123345789999999999874 5899999999999999999999999875433322211111000000
Q ss_pred ----------CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 305 ----------PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 305 ----------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...++.+....+...++...+.++.+|+.+||+.||.+|||+.++++|.|+-..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 001111122222222233355788999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=370.12 Aligned_cols=268 Identities=23% Similarity=0.268 Sum_probs=209.6
Q ss_pred HHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC-----CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC
Q 046892 72 LAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN-----GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG 146 (519)
Q Consensus 72 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 146 (519)
+....++|.+.+.||+|+||.||+|.+..++..||+|++... .......+..|+.++..++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345677899999999999999999999999999999998643 233456789999999999999999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhccC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNET------------------------------------KKPLDWTTRMKIASGAAQG 190 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~a 190 (519)
+..++||||+++|+|.+++...... ...+++..++.|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521111 1234678889999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCCeeeCCCC--CcEEeeecccccCCCCC--ccceecccccccccCchhhhcc--CCCCchh
Q 046892 191 LEYLHDKANPPVIYRDLKSSNILLGANL--DPKLSDFGLAKLGPQGE--KMNVTSRVMGTYGYCAPEYARS--GELTVKS 264 (519)
Q Consensus 191 L~~LH~~~~~~IvHrDikp~NILl~~~~--~vkL~DFGla~~~~~~~--~~~~~~~~~Gt~~y~APE~l~~--~~~~~~s 264 (519)
|+|||+.+ |+||||||+||||+.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 89999999997543211 1112334679999999999975 6789999
Q ss_pred HHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC
Q 046892 265 DVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP 344 (519)
Q Consensus 265 DvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 344 (519)
|||||||+||+|++|..||......+.... +......++ .+ .....+..+.+|+.+||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~------~~~~~~~~~---~~-----~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQ------VLNKKLCFE---NP-----NYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCCCTT---SG-----GGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHH------HHhcccccC---Cc-----ccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999976543222111 111111111 00 1112346789999999999999999
Q ss_pred CHHHHHHHHhhh
Q 046892 345 LMSDVVTALSFL 356 (519)
Q Consensus 345 s~~evl~~l~~~ 356 (519)
++.+++++.|+-
T Consensus 324 s~~~~l~hp~~~ 335 (345)
T 3hko_A 324 DAMRALQHPWIS 335 (345)
T ss_dssp CHHHHHHSHHHH
T ss_pred CHHHHhcChhhc
Confidence 999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=353.49 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=213.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++..++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4679999999999999999999874 7889999997543 3456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999854 3456899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ..
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~------~~---------- 223 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TG---------- 223 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TT----------
T ss_pred c-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh------cC----------
Confidence 1 12233557888999999999999999999999999999999 999997654322211111 10
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.....+...+..+.+|+..||+.||.+||++.+++++|..+..
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 0011223345678999999999999999999999999987754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=373.18 Aligned_cols=277 Identities=19% Similarity=0.229 Sum_probs=212.3
Q ss_pred ccCcccceeeecc--CcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEG--GFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+| +||.||+|++..+++.||||++..... .....+.+|+.+++.++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5689999999999 999999999999999999999975432 223567789999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+|+|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999998653 2356999999999999999999999999 999999999999999999999999988643
Q ss_pred CCCC-----ccceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh-hchhcc
Q 046892 232 PQGE-----KMNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQPIFR 303 (519)
Q Consensus 232 ~~~~-----~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~~~~~~ 303 (519)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.............. ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 2211 1111223478999999999987 5799999999999999999999999977544332211000 000000
Q ss_pred CCCC------------------CCccc---------chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 304 DPKR------------------FPDMA---------DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 304 ~~~~------------------~~~~~---------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.... +.... .......++...+..+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 0000 00000 00001123344567899999999999999999999999998775
Q ss_pred h
Q 046892 357 S 357 (519)
Q Consensus 357 ~ 357 (519)
.
T Consensus 339 ~ 339 (389)
T 3gni_B 339 Q 339 (389)
T ss_dssp G
T ss_pred H
Confidence 4
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=361.24 Aligned_cols=273 Identities=23% Similarity=0.288 Sum_probs=208.5
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-----cChHHHHHHHHHHHhc---CCCCeeeeeeEEecC
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-----QGNKEFLVEVLMLSLL---HHPNLVNLIGYCADG 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~ 146 (519)
..++|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+++.+ .||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46789999999999999999999999999999999864321 2234677787777666 499999999999775
Q ss_pred C-----ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcE
Q 046892 147 D-----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 147 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vk 221 (519)
. ..++||||+. ++|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 4799999996 6999998652 2334999999999999999999999999 99999999999999999999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999986543322 34567999999999999999999999999999999999999999875443322222111100
Q ss_pred ccCCCCCCccc---chHh-------hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 FRDPKRFPDMA---DPLL-------RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 ~~~~~~~~~~~---d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... ..++... ...+ ........+..+.+|+.+||+.||.+|||+.++++|.|+-.
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 238 PPE-DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCT-TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CCh-hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 000 0011000 0000 00112345568899999999999999999999999977654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=367.54 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=197.8
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+..|+.++..++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999999999999999997543 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DFGla~~~ 231 (519)
|+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999984 3456899999999999999999999999 999999999999975 889999999999865
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ......||+.|+|||++.+..++.++|||||||+||||++|..||........ +... +......+.
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~---i~~~~~~~~-- 271 (349)
T 2w4o_A 202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRR---ILNCEYYFI-- 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHH---HHTTCCCCC--
T ss_pred Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHH---HHhCCCccC--
Confidence 4322 22346799999999999999999999999999999999999999976433211 1111 111111100
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.......+..+.+|+.+||+.||.+|||+.+++++.|+.
T Consensus 272 ------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 272 ------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp ------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred ------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 011233456889999999999999999999999987764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=356.18 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=217.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986432 22346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999998653 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||........... +....
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------~~~~~------- 228 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR------IVNVD------- 228 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTTC-------
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH------Hhccc-------
Confidence 322 2345789999999999999999999999999999999999999976432221111 11111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCCCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPD 365 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~~~ 365 (519)
..++...+..+.+|+.+||+.||.+||++.+++++.|+-.......++
T Consensus 229 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 229 -----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred -----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 112334456788999999999999999999999998876655444433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=363.93 Aligned_cols=256 Identities=25% Similarity=0.305 Sum_probs=212.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.++..++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999999999999999998764322 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----CcEEeee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL----DPKLSDF 225 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~----~vkL~DF 225 (519)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999843 456899999999999999999999999 99999999999999888 7999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ .... ....
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i---~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANI---TSVS 234 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH---HTTC
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH---Hhcc
Confidence 99987654322 2345799999999999999999999999999999999999999976432211 1111 1111
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..+ +... ....+..+.+|+.+||+.||.+|||+.+++++.|+
T Consensus 235 ~~~----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 235 YDF----DEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp CCC----CHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred ccc----Chhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 011 1111 12234578999999999999999999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.25 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=209.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeE----EEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQV----VAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~----vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.++|++.+.||+|+||.||+|.+..++.. ||+|.+.... ......+..|+.++..++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35799999999999999999999887775 7778775432 233456778999999999999999999986 56789
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+.+|+|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999998542 346889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---------- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------
Confidence 765544434455678889999999999999999999999999999999 999998765433332222111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+..++..+.+|+.+||+.||.+||++.+++++|..+..
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 011122233467889999999999999999999999987754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.84 Aligned_cols=271 Identities=24% Similarity=0.337 Sum_probs=201.2
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCC--c
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGD--Q 148 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~--~ 148 (519)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999999999999999986432 233456788999999997 999999999997544 6
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
+|+|||||. ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999996 689988853 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC-------------------ccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 046892 229 KLGPQGE-------------------KMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRP 288 (519)
Q Consensus 229 ~~~~~~~-------------------~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~ 288 (519)
+...... ........+||+.|+|||++.+ ..++.++|||||||+||||++|++||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8653211 1112334689999999999976 6799999999999999999999999987544
Q ss_pred cchhhHHHhhchhccCC----------------------------CCCCcccch----HhhccCChhhHHHHHHHHHHhh
Q 046892 289 VDEQNLIAWAQPIFRDP----------------------------KRFPDMADP----LLRKQFPEKGLNEAVAIAAMCL 336 (519)
Q Consensus 289 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~d~----~l~~~~~~~~~~~l~~li~~cl 336 (519)
.+....+. .....+ ......... ..........+.++.+|+.+||
T Consensus 237 ~~~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 MNQLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHHHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HHHHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 33322221 000000 000000000 0000111244568999999999
Q ss_pred hhCCCCCCCHHHHHHHHhhh
Q 046892 337 QEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 337 ~~dP~~RPs~~evl~~l~~~ 356 (519)
+.||.+|||+.++++|.++-
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVS 333 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTT
T ss_pred ccCcccCCCHHHHhCCHHHH
Confidence 99999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=353.25 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=214.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..++|.+.+.||+|+||.||+|.+..++..||+|++..........+.+|+.++..++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35679999999999999999999999999999999987666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl---~~~~~vkL~DFGla~~~ 231 (519)
|+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998854 345899999999999999999999999 9999999999999 78899999999999876
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+ ......++
T Consensus 160 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~~~~-- 227 (277)
T 3f3z_A 160 KPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI------REGTFTFP-- 227 (277)
T ss_dssp CTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCCC--
T ss_pred cCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhCCCCCC--
Confidence 54332 234579999999999875 4899999999999999999999999764322111111 11111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.... ...+..+.+|+.+||+.||.+|||+.+++++.|+-.
T Consensus 228 --~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 228 --EKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp --HHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred --chhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0000 123457899999999999999999999999988754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=381.07 Aligned_cols=255 Identities=27% Similarity=0.383 Sum_probs=214.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999986532 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999984 3457999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........... +.....
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~------i~~~~~----- 233 (476)
T 2y94_A 168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK------ICDGIF----- 233 (476)
T ss_dssp TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH------HHTTCC-----
T ss_pred cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH------HhcCCc-----
Confidence 4332 334689999999999988765 7899999999999999999999986543222111 111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..+...+..+.+|+.+||+.||.+|||+.++++|.|+...
T Consensus 234 -------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1223344578999999999999999999999999887654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=359.54 Aligned_cols=263 Identities=27% Similarity=0.376 Sum_probs=216.3
Q ss_pred ccCcccceeeeccCcEEEEEEEE-----cCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
.++|.+.+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 34678999999975533 2346788999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE--------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975432 1235899999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~- 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence 9999999999999987665544334445667899999999999999999999999999999999 99999765432211
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
....... .....+...+..+.+|+.+||+.||.+|||+.+++++|..+.
T Consensus 258 -~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 -YKMIKEG--------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp -HHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHhccC--------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1111110 011123344568899999999999999999999999998654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=352.12 Aligned_cols=253 Identities=32% Similarity=0.483 Sum_probs=199.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC----cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM----QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|.+. +..||||++..... ...+.+..|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999985 89999999865432 224678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC--------CCCcEEe
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA--------NLDPKLS 223 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~--------~~~vkL~ 223 (519)
||||+++++|.+++. ...+++..++.++.||+.||.|||+.+..+|+||||||+|||++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999883 357999999999999999999999998556889999999999986 7789999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR 303 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 303 (519)
|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||............. .
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~ 228 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA------M 228 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------T
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh------c
Confidence 999998654332 224578999999999999999999999999999999999999997643221111111 0
Q ss_pred CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 304 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.. ....++...+..+.+++.+||+.||.+|||+.+++++|..
T Consensus 229 ~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NK----------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC----------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 00 0112234455688999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=352.40 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=213.5
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35789999999999999999999999999999999865432 2335678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC---cEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD---PKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~---vkL~DFGla~ 229 (519)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999888543 46899999999999999999999999 999999999999976655 9999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.. .....+
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~------~~~~~~ 227 (284)
T 3kk8_A 157 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA------GAYDYP 227 (284)
T ss_dssp ECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------TCCCCC
T ss_pred EcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh------ccccCC
Confidence 6554332 2346799999999999999999999999999999999999999976433222111111 111111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. ......+.++.+|+..||+.||.+|||+.+++++.|+...
T Consensus 228 ~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 228 S--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred c--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 0 0112334578899999999999999999999999887543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=370.12 Aligned_cols=279 Identities=25% Similarity=0.361 Sum_probs=219.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCC----CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNG----MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGD 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 147 (519)
.++|++.+.||+|+||.||+|++. .+++.||||++.... ......+..|+.++..+ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 478999999986532 12345567799999988 6999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..+|||||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999643 46899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
++....... ......+||+.|+|||++.+ ..++.++|||||||+||||++|..||...........+ ...+....
T Consensus 206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~ 282 (355)
T 1vzo_A 206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE 282 (355)
T ss_dssp EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCC
T ss_pred CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhccC
Confidence 986543222 12334679999999999985 35789999999999999999999999765433221111 11111111
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCc
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEY 375 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~ 375 (519)
..++...+..+.+||.+||+.||.+|| ++.++++++++... ....+++|+.|...+..
T Consensus 283 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~ 350 (355)
T 1vzo_A 283 ------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL 350 (355)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-C
T ss_pred ------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCcccccc
Confidence 123344556788999999999999999 99999999887543 23455666666655444
Q ss_pred C
Q 046892 376 S 376 (519)
Q Consensus 376 ~ 376 (519)
+
T Consensus 351 d 351 (355)
T 1vzo_A 351 D 351 (355)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=373.24 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=205.8
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 159 (519)
...+.||+|+||.||+|.+..+|+.||+|++........+.+.+|+.++..++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33678999999999999999999999999998765556678899999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--CCCCCcEEeeecccccCCCCCcc
Q 046892 160 SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL--GANLDPKLSDFGLAKLGPQGEKM 237 (519)
Q Consensus 160 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl--~~~~~vkL~DFGla~~~~~~~~~ 237 (519)
+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 172 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999988542 345899999999999999999999999 9999999999999 6678899999999987654332
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
....+||+.|+|||++.+..++.++|||||||+||||++|..||...........+ . .....++ ..
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i--~----~~~~~~~---~~--- 310 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI--L----ACRWDLE---DE--- 310 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--H----HTCCCSC---SG---
T ss_pred --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----hccCCCC---hh---
Confidence 23357999999999999999999999999999999999999999765432211111 1 1111111 00
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.....+.++.+||.+||+.||.+|||+.+++++.|+-
T Consensus 311 --~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 311 --EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp --GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred --hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 0123346889999999999999999999999998864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=364.73 Aligned_cols=274 Identities=23% Similarity=0.318 Sum_probs=207.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999986543221 12345799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 96 589988854 3456899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+....... ....++.....
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 --KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGC
T ss_pred --cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcc
Confidence 12334578999999999876 578999999999999999999999998754333222221110000 00011111110
Q ss_pred H-h-h-----------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 315 L-L-R-----------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 315 ~-l-~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
. . . .......+..+.+|+.+||+.||.+|||+.++++|.|+.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0 0 0 0012234567899999999999999999999999998866543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=351.08 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=213.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+. ++..||||++.... .....+.+|+.++..++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 468999999999999999999887 47789999997553 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999653 245899999999999999999999999 9999999999999999999999999998765443
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ...
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~--------- 222 (268)
T 3sxs_A 159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS------QGH--------- 222 (268)
T ss_dssp EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------TTC---------
T ss_pred hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH------cCC---------
Confidence 22 2233456788999999998899999999999999999999 999997654322211111 000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+...+..+.+++..||+.||.+|||+.+++++|..+...
T Consensus 223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 --RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0011223345788999999999999999999999999887654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=367.50 Aligned_cols=250 Identities=23% Similarity=0.266 Sum_probs=199.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHh-cCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||+||+|.+..+++.||||++...... ....+..|+..+.. ..||||++++++|.+.+..+||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 35799999999999999999999999999999998654322 22344555555544 4899999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 77999988653 356999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..++... ........ . ..
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~~~~~~~----~------~~ 269 (311)
T 3p1a_A 209 TAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EGWQQLRQ----G------YL 269 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HHHHHHTT----T------CC
T ss_pred cCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHhc----c------CC
Confidence 432 2334569999999999875 7999999999999999999997766432 11111110 0 01
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
... ++...+.++.+|+.+||+.||.+|||+.+++++.|+
T Consensus 270 ~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 270 PPE----FTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred Ccc----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 111 122345689999999999999999999999998775
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.48 Aligned_cols=264 Identities=19% Similarity=0.235 Sum_probs=215.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+ +|+||+++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 468999999999999999999999999999999986543 334678899999988 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC-----cEEeeecccc
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD-----PKLSDFGLAK 229 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~-----vkL~DFGla~ 229 (519)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999642 346999999999999999999999999 999999999999987776 9999999998
Q ss_pred cCCCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 230 LGPQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 230 ~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 65443221 1234567999999999999999999999999999999999999999876544433332221110000
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. ....+....+..+.+|+..||+.||.+||++.+|++.|..+..
T Consensus 240 ~----------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 240 T----------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp S----------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred c----------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0 0001122345688999999999999999999999999987764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=370.99 Aligned_cols=272 Identities=22% Similarity=0.279 Sum_probs=215.6
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec--------
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-------- 145 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-------- 145 (519)
...++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+|+.+++.++||||++++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999999999999999999998654322 2369999999999999999999844
Q ss_pred ------------------------------CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046892 146 ------------------------------GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195 (519)
Q Consensus 146 ------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 195 (519)
....++||||++ |+|.+.+.........+++..++.++.||+.||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334889999997 5998888776666778999999999999999999999
Q ss_pred hcCCCCeEecCCCCCCeeeC-CCCCcEEeeecccccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHH
Q 046892 196 DKANPPVIYRDLKSSNILLG-ANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVIL 273 (519)
Q Consensus 196 ~~~~~~IvHrDikp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll 273 (519)
+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 99999999999997 688999999999987644332 2345789999999998764 489999999999999
Q ss_pred HHHHhCCCCCCCCCCcchhhHH-Hhhchh----------ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCC
Q 046892 274 LELITGRRVIDTTRPVDEQNLI-AWAQPI----------FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGA 342 (519)
Q Consensus 274 ~elltG~~pf~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~ 342 (519)
|||++|..||......+....+ ...... ......++..........++...+..+.+|+.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999875443322211 110000 00111233333334445566667788999999999999999
Q ss_pred CCCHHHHHHHHhhh
Q 046892 343 RPLMSDVVTALSFL 356 (519)
Q Consensus 343 RPs~~evl~~l~~~ 356 (519)
|||+.++++|.++-
T Consensus 313 R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 313 RINPYEAMAHPFFD 326 (383)
T ss_dssp SCCHHHHHTSGGGH
T ss_pred CCCHHHHhcCHHHH
Confidence 99999999998864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=368.33 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=202.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCC--CCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.++..++| +||+++++++.+....+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999885 5889999998755332 23568899999999986 999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|||+ .+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++..
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 58899999954 356899999999999999999999999 99999999999997 578999999999876
Q ss_pred CCCCccceecccccccccCchhhhcc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS-----------GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~-----------~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
.............||+.|+|||++.+ ..++.++|||||||+||+|++|..||....... ..+.....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~- 235 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIID- 235 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHC-
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHHHHhc-
Confidence 54443333445689999999999865 678999999999999999999999997543211 11111111
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
. .....++...+..+.+|+..||+.||.+|||+.++++++|+-.
T Consensus 236 ---~----------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 236 ---P----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp ---T----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---C----------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 0 1111233334457889999999999999999999999988753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=353.01 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=213.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3468999999999999999999999999999999986543 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999998883 3456999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
...........||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+... .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~----~~~~~--- 229 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK----KTYLN--- 229 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTT----CTTST---
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhc----ccccC---
Confidence 332223345679999999999987665 78899999999999999999999875432221 1111110 00000
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.....+..+.+|+..||+.||.+|||+.+++++.|+-.
T Consensus 230 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (276)
T 2yex_A 230 -------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (276)
T ss_dssp -------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence 01234457889999999999999999999999877643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=364.49 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=203.6
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 147 (519)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||++++++|.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34679999999999999999999999999999999975433 23467899999999999999999999986543
Q ss_pred ---------------------------------------------------ceEEEEEecCCCCHHHHHhhhccCCCCCC
Q 046892 148 ---------------------------------------------------QRLLVYEFMSGGSVDDHLLDVNETKKPLD 176 (519)
Q Consensus 148 ---------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~ 176 (519)
..++|||||.+++|.+++.... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 2799999999999999996532 233467
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc----------ceecccccc
Q 046892 177 WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM----------NVTSRVMGT 246 (519)
Q Consensus 177 ~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~Gt 246 (519)
+..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7789999999999999999999 999999999999999999999999999876543211 122345799
Q ss_pred cccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHH
Q 046892 247 YGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLN 326 (519)
Q Consensus 247 ~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 326 (519)
+.|+|||++.+..++.++|||||||++|||++|..|+.. ....... .... .++ . .......
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~---~~~~--~~~-----~----~~~~~~~ 300 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITD---VRNL--KFP-----L----LFTQKYP 300 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHH---HHTT--CCC-----H----HHHHHCH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHH---hhcc--CCC-----c----ccccCCh
Confidence 999999999999999999999999999999998665321 1111111 1000 010 0 0122335
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 327 EAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 327 ~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.+.+|+.+||+.||.+|||+.+++++.++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~~~~f 329 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIENAIF 329 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhhchhh
Confidence 67899999999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=366.00 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=187.5
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
+.||+|+||.||+|.+..+++.||||++... ....+..|+.++..+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 7899999999999999999999999998643 3466788999999997 99999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---CcEEeeecccccCCCCCccc
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL---DPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~---~vkL~DFGla~~~~~~~~~~ 238 (519)
.+++.. ...+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++........
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 999954 357999999999999999999999999 99999999999997665 799999999986544322
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHHhhchhccCCCCCCcccchHhh
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE-QNLIAWAQPIFRDPKRFPDMADPLLR 317 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~ 317 (519)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .........+......++ ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~---~~~-- 239 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE---GEA-- 239 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC---SHH--
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC---ccc--
Confidence 23346789999999999999999999999999999999999999976543211 111111111211111111 000
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
....+.++.+|+..||+.||.+|||+.+++++.|+-.
T Consensus 240 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 240 ---WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp ---HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred ---ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 1234568899999999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=363.29 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=213.7
Q ss_pred HHHHHHhccCcccc-eeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcC-CCCeeeeeeEEe
Q 046892 69 FRELAAATKNFRQE-CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLH-HPNLVNLIGYCA 144 (519)
Q Consensus 69 ~~~~~~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 144 (519)
+.......++|.+. +.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..+. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445566778887 89999999999999999999999999987542 234567889999999885 699999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcE
Q 046892 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPK 221 (519)
Q Consensus 145 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vk 221 (519)
+.+..++||||+.+|+|.+++.. .....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999998843 23457999999999999999999999999 999999999999988 78999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-- 249 (327)
T 3lm5_A 175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN-- 249 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--
T ss_pred EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc--
Confidence 999999987644322 234679999999999999999999999999999999999999997654322211111110
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...+ .......+..+.+|+.+||+.||.+|||+.+++++.|+-..
T Consensus 250 ----~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 250 ----VDYS--------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp ----CCCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred ----cccC--------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 0000 01122345678999999999999999999999999876443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=358.25 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=211.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.++..++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 34679999999999999999999999999999999986654455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl---~~~~~vkL~DFGla~~~ 231 (519)
|+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999998542 46899999999999999999999999 9999999999999 78899999999999764
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ......++
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~~~~~-- 227 (304)
T 2jam_A 160 QNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI------KEGYYEFE-- 227 (304)
T ss_dssp CCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHCCCCCC--
T ss_pred CCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HcCCCCCC--
Confidence 3321 23456899999999999999999999999999999999999999764322111111 11111110
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+....+..+.+|+.+||+.||.+||++.+++++.++-.
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 228 ------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp ------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred ------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 1122334568899999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=363.16 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=206.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEE----EEEEeccC-CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVV----AVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v----AvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.++|++.+.||+|+||.||+|.+..+++.| |+|.+... .......+.+|+.++..++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999998877754 67766543 2345577899999999999999999999998764 88
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+|++|+.+|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999865 2456999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---------- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---------- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC----------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 654433333344567889999999999999999999999999999999 999998765433322222110
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+...+..+.+|+..||+.||.+||++.++++.|..+...
T Consensus 237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1112334556789999999999999999999999999887653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=371.16 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=201.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEc---CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ---SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
..+|.+.+.||+|+||.||+|++. .++..||||++..... .....+.+|+.++..++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999986 4577899999875432 234568999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999954 3356999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCccc-eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 232 PQGEKMN-VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 232 ~~~~~~~-~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... ......+++.|+|||++.+..++.++|||||||+||||++ |..||...... .+........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~~~~------- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVDEGY------- 267 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHHTTE-------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC-------
Confidence 4432111 1122345788999999999999999999999999999998 99999765322 2222111111
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+..++..+.+|+..||+.||.+||++.+|++.|..+...
T Consensus 268 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 -------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1112334556889999999999999999999999999887543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=359.83 Aligned_cols=266 Identities=25% Similarity=0.276 Sum_probs=206.8
Q ss_pred ccCcccc-eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHh-cCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQE-CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.+.|.+. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.. +.||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4578874 789999999999999998999999999987665667789999999988 47999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC---cEEeeeccccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD---PKLSDFGLAKL 230 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~---vkL~DFGla~~ 230 (519)
||+++++|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999653 46899999999999999999999999 999999999999988776 99999999875
Q ss_pred CCCCCc-----cceecccccccccCchhhhcc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh--------
Q 046892 231 GPQGEK-----MNVTSRVMGTYGYCAPEYARS-----GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ-------- 292 (519)
Q Consensus 231 ~~~~~~-----~~~~~~~~Gt~~y~APE~l~~-----~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~-------- 292 (519)
...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 432211 111223569999999999875 56889999999999999999999999875433210
Q ss_pred -hHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 293 -NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 293 -~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
........+......++ . ... ...+..+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 244 ~~~~~~~~~i~~~~~~~~---~-~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFP---D-KDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp HHHHHHHHHHHHCCCCCC---H-HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred hHHHHHHHHHhccCcccC---c-hhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 00001111111111111 0 000 12345789999999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=379.82 Aligned_cols=273 Identities=22% Similarity=0.280 Sum_probs=193.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec-----CCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-----GDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~~ 148 (519)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+|..++|||||++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999999999999999865422 234568899999999999999999999844 356
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
+|+||||+ +++|.+++. ....+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 578998884 3457999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-------------------------ceecccccccccCchhhh-ccCCCCchhHHHHHHHHHHHHHh----
Q 046892 229 KLGPQGEKM-------------------------NVTSRVMGTYGYCAPEYA-RSGELTVKSDVYSFGVILLELIT---- 278 (519)
Q Consensus 229 ~~~~~~~~~-------------------------~~~~~~~Gt~~y~APE~l-~~~~~~~~sDvwSlGvll~ellt---- 278 (519)
+........ ......+||+.|+|||++ .+..|+.++||||||||||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 875432110 123456789999999976 55679999999999999999999
Q ss_pred -------CCCCCCCCCCcc-----------------hhhHHHhhchhccCCC-----------------CCCcccchHhh
Q 046892 279 -------GRRVIDTTRPVD-----------------EQNLIAWAQPIFRDPK-----------------RFPDMADPLLR 317 (519)
Q Consensus 279 -------G~~pf~~~~~~~-----------------~~~~~~~~~~~~~~~~-----------------~~~~~~d~~l~ 317 (519)
|+++|.+..... ..+.+.....++..+. .++......+.
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 666665433110 0011111100100000 00000000011
Q ss_pred ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 318 KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 318 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.. ....+.++.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 364 ~~-~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 364 ER-FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp GG-STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HH-CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 11 1234678999999999999999999999999988754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=380.27 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=204.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC--CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN--GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------ 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 146 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999754 223346688999999999999999999999654
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
...||||||+.+ +|.+.+. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 356999999965 5666662 24899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh-hc------
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-AQ------ 299 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~~------ 299 (519)
+++...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||......+....+.. ..
T Consensus 210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 210 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998654432 23456899999999999999999999999999999999999999987654332221110 00
Q ss_pred ---------hhccCCCCCCcccchHhhccCC-----------hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 300 ---------PIFRDPKRFPDMADPLLRKQFP-----------EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 300 ---------~~~~~~~~~~~~~d~~l~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
............. +...++ ...+.++.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLT---FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCC---HHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHcchhhhhHhhcccccCCCC---hHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0000000011000 011111 11256899999999999999999999999998874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=350.43 Aligned_cols=255 Identities=32% Similarity=0.553 Sum_probs=207.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh-------HHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN-------KEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~-------~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++........ ..+.+|+.++..++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4679999999999999999999999999999999865433222 57889999999999999999999996654
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC-----cEEe
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD-----PKLS 223 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~-----vkL~ 223 (519)
++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999988854 3457999999999999999999999986 34999999999999988776 9999
Q ss_pred eecccccCCCCCccceecccccccccCchhhh--ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA--RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l--~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||.................
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~- 245 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE- 245 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-
Confidence 9999975432 23346799999999998 345678999999999999999999999986544322111111110
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.....++..++..+.+|+..||+.||.+|||+.++++.|..
T Consensus 246 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 -------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 01112344556689999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=366.47 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=209.6
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--------ChHHHHHHHHHHHhcCCCCeeeeeeEEecC
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--------GNKEFLVEVLMLSLLHHPNLVNLIGYCADG 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 146 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.++..++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999999999999999999765321 223567899999999999999999999999
Q ss_pred CceEEEEEecCCC-CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 147 DQRLLVYEFMSGG-SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 147 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
+..++||||+.+| +|.+++. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999998766 9999884 3456999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...
T Consensus 175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~~ 239 (335)
T 3dls_A 175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VEA 239 (335)
T ss_dssp TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TTT
T ss_pred ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hhh
Confidence 99987654332 234679999999999988776 88999999999999999999999652110 000
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.. ..+...+.++.+|+..||+.||.+|||+.+++++.|+-
T Consensus 240 ~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~ 279 (335)
T 3dls_A 240 AI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279 (335)
T ss_dssp CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred cc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence 00 11222455789999999999999999999999997753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=364.45 Aligned_cols=272 Identities=25% Similarity=0.381 Sum_probs=209.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 468999999999999999999999999999999986543322 345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999988888763 3456999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHh-h------------c
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW-A------------Q 299 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~-~------------~ 299 (519)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.. . .
T Consensus 177 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Ccc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 221 23345789999999999875 789999999999999999999999987543322211110 0 0
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
........++.+.............+..+.+|+.+||+.||.+|||+.+++++.|+-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~ 311 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence 000011112222111111111234567899999999999999999999999998864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=381.45 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=217.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
..+|.+.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+|+.++||||++++++|.+....+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 457899999999999999999999889999999997543 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+|+|.+++... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999999653 3356899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
........+++.|+|||++.+..++.++|||||||+||||++ |..||...........+ ...
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~---~~~------------- 435 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EKD------------- 435 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HTT-------------
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcC-------------
Confidence 122233456789999999999999999999999999999999 99999765433222211 110
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+...+..++..+.+|+.+||+.||.+|||+.+|++.|..+.
T Consensus 436 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111234455678999999999999999999999999997653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=354.63 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=203.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHh--cCCCCeeeeeeEEec----CCc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSL--LHHPNLVNLIGYCAD----GDQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~----~~~ 148 (519)
..++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.+ ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 357899999999999999999988 4899999998643 34556667777666 789999999998654 345
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH--------DKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
.++||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCE
Confidence 899999999999999993 346999999999999999999999 888 9999999999999999999
Q ss_pred EEeeecccccCCCCCccc--eecccccccccCchhhhccC------CCCchhHHHHHHHHHHHHHhC----------CCC
Q 046892 221 KLSDFGLAKLGPQGEKMN--VTSRVMGTYGYCAPEYARSG------ELTVKSDVYSFGVILLELITG----------RRV 282 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~------~~~~~sDvwSlGvll~elltG----------~~p 282 (519)
||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997644332211 12335799999999999876 455799999999999999999 777
Q ss_pred CCCCCCcch--hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 283 IDTTRPVDE--QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 283 f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
|........ ........ .....+... ...++...+..+.+|+.+||+.||.+|||+.+|++.|..+
T Consensus 233 f~~~~~~~~~~~~~~~~~~----~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 233 FYDVVPNDPSFEDMRKVVC----VDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTSCSSCCHHHHHHHHT----TSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCCCCcchhhhhHHHh----ccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 765433221 11111111 001111111 1122345677899999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=372.47 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=211.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC-ceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ..+.+..|+.+|..++||||+++++++.+.. ..+||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467899999999999999999986 7899999997653 4578999999999999999999999987655 7899999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999753 2334799999999999999999999999 999999999999999999999999999854332
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. ....+++.|+|||++.+..++.++|||||||+||||++ |..||......+....+.. .
T Consensus 343 ~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-------~-------- 402 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------G-------- 402 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-------T--------
T ss_pred c-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------C--------
Confidence 1 22357889999999999999999999999999999998 9999986544332222110 0
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.+...+..++..+.+|+..||+.||.+|||+.+|++.|..+...
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01123445567899999999999999999999999999887654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=371.67 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=202.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcC--CCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~l 151 (519)
.++|.+.+.||+|+||.||+|.+.. ++.||||++..... .....+.+|+.+|..+. ||||+++++++...+.+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999875 89999999876533 23466889999999996 5999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||| +.+++|.+++.. ...+++..++.|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++..
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 558899999854 346899999999999999999999999 99999999999995 589999999999876
Q ss_pred CCCCccceecccccccccCchhhhcc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS-----------GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~-----------~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
............+||+.|+|||++.+ ..++.++|||||||+||||++|..||....... ..+..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~---- 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHA---- 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHH----
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHH----
Confidence 54433333445689999999999875 468999999999999999999999997543211 11111
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+.... ....++...+..+.+|+.+||+.||.+|||+.+++++.|+-.
T Consensus 280 ~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 280 IIDPN----------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHCTT----------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HhCcc----------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 11110 011123333457889999999999999999999999988753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=352.28 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=210.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+. ++..||||++.... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 468999999999999999999887 57889999997543 3457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999542 345999999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
........||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.. .
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------~---------- 237 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ------G---------- 237 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------T----------
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc------c----------
Confidence 111223456888999999999999999999999999999998 9999986543322221110 0
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.....+...+..+.+|+.+||+.||.+|||+.+++++|..+..
T Consensus 238 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 0011223334578899999999999999999999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=355.77 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=207.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC-------eEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG-------QVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.++..++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999998766 5799999977665666789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC--------c
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD--------P 220 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~--------v 220 (519)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999652 234899999999999999999999999 999999999999998887 9
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~ 299 (519)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+...... ........
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~~ 232 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFYE 232 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHH
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHhh
Confidence 9999999875432 123468999999999987 77999999999999999999965544332221 11111111
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.... ++...+.++.+|+..||+.||.+|||+.+++++|..+..
T Consensus 233 ----~~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 ----DRHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ----TTCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ----ccCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 122223467889999999999999999999999986654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.55 Aligned_cols=261 Identities=22% Similarity=0.266 Sum_probs=209.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC----CcChHHHHHHHHHHHhcCCCCeeeeeeEEe--cCCc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG----MQGNKEFLVEVLMLSLLHHPNLVNLIGYCA--DGDQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~ 148 (519)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++..++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999999999999999986532 233467889999999999999999999984 4568
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++||||+.++ |.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 77777543 3456999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGE--LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~--~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
................||+.|+|||++.+.. ++.++||||||+++|+|++|..||........ .. .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~i~~~~~ 230 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---FE---NIGKGSY 230 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHHHCCC
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HH---HHhcCCC
Confidence 8765433333344567999999999997644 37899999999999999999999976432211 11 1111111
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.++...+..+.+|+.+||+.||.+|||+.+++++.++....
T Consensus 231 ------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 ------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 12334456788999999999999999999999998876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=353.95 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=207.9
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 151 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+..|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 35689999999999999999999998999999999876432 3345678899999888 89999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--------------
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-------------- 217 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-------------- 217 (519)
||||+++++|.+++.........+++..++.|+.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999775554567999999999999999999999999 9999999999999844
Q ss_pred -----CCcEEeeecccccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch
Q 046892 218 -----LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDE 291 (519)
Q Consensus 218 -----~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~ 291 (519)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998754432 24589999999999765 66789999999999999999987764321
Q ss_pred hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 292 QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
....... . .. ..++...+..+.+|+.+||+.||.+|||+.+++++.++..
T Consensus 236 -~~~~~~~----~--~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 236 -QWHEIRQ----G--RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp -HHHHHHT----T--CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred -HHHHHHc----C--CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 1111111 0 00 1123344568899999999999999999999999987654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=370.43 Aligned_cols=271 Identities=25% Similarity=0.302 Sum_probs=210.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC------Cce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------DQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~ 149 (519)
..+|.+.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.++|||||+++++|... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3469999999999999999999999999999999865432 234699999999999999999998542 236
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-CCcEEeeeccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLA 228 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-~~vkL~DFGla 228 (519)
++||||+.+ +|.+++.........+++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999965 777777665556678999999999999999999999999 9999999999999965 56899999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH-HHhhc-------
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL-IAWAQ------- 299 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~-~~~~~------- 299 (519)
+....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+.... +....
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 87544332 2345789999999998764 799999999999999999999999987543322211 11100
Q ss_pred -hhcc--CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 300 -PIFR--DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 300 -~~~~--~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.... ....++.+....+...++...+.++.+||.+||+.||.+||++.++++|.++-.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 0000 011222222222333345556778999999999999999999999999988743
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.17 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=213.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEc-------CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ-------SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 146 (519)
.++|.+.+.||+|+||.||+|.+. .++..||||++..... .....+..|+.++..+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999985 3577899999875432 2345688999999999 899999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNET------------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
+..++||||+.+|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999654321 234899999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 9999999999999987655433333344567899999999998999999999999999999999 999997653222
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+........ ....+..++..+.+|+.+||+.||.+||++.+++++|..+..
T Consensus 268 ~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 LFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCC--------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111100 011233455688999999999999999999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=361.47 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=214.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.++..++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999999999999999999875432 2345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998854 246899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ .....
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~~~~------ 258 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------KKNEY------ 258 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCC------
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------hcCCC------
Confidence 3221 123467999999999999989999999999999999999999999764322111111 11111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.++......+.+|+.+||+.||.+||++.+++++.++-..
T Consensus 259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 1223344578899999999999999999999999877543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=351.67 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=218.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+..|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4568999999999999999999999999999999987543 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999653 3456899999999999999999999999 999999999999999999999999999876543
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.. .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------------- 228 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------------- 228 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---------------
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc---------------
Confidence 32 23344567889999999999999999999999999999999 99999765443322222110
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.....+...+..+.+|+..||+.||.+|||+.++++.|..+.
T Consensus 229 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 011123344568899999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=361.93 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=214.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCe-----EEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQ-----VVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
.++|.+.+.||+|+||.||+|.+..++. .||+|++..... .....+..|+.++..+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4689999999999999999999976554 799999875532 2345688999999999 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE----------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL 218 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~ 218 (519)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 9999999999999999975421 1346899999999999999999999999 99999999999999999
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAW 297 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~ 297 (519)
.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......... ...
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~~ 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--YKL 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--HHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--HHH
Confidence 999999999986544333333444567889999999999999999999999999999998 89999765433221 111
Q ss_pred hchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 298 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..... ....+...+..+.+|+..||+.||.+|||+.+|+++|..+.
T Consensus 280 ~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 280 VKDGY--------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCC--------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11100 01122334567899999999999999999999999997654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.20 Aligned_cols=260 Identities=25% Similarity=0.312 Sum_probs=198.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChH-HHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNK-EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~-~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ... .+..+..+++.+.||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46899999999999999999999999999999998754322 122 2344555578889999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||++ |+|.+++.........+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 599888876666677899999999999999999999998 8 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhh----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYA----RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l----~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
.... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ..+..... ......
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~---~~~~~~ 234 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQLKQVVE---EPSPQL 234 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHHHHHHH---SCCCCC
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHHHHHhc---cCCCCc
Confidence 4322 2334789999999996 56678999999999999999999999997643221 11111111 100000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.....+..+.+|+.+||+.||.+|||+.++++|.|+-.
T Consensus 235 -----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 -----------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -----------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -----------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 11234457899999999999999999999999988754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=369.73 Aligned_cols=274 Identities=21% Similarity=0.269 Sum_probs=204.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----Cc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 148 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 5789999999999999999999999999999999975422 2345788999999999999999999999776 57
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.|+||||+. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999995 69999884 3456999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc--------------------ceecccccccccCchhhh-ccCCCCchhHHHHHHHHHHHHHhCCCCC----
Q 046892 229 KLGPQGEKM--------------------NVTSRVMGTYGYCAPEYA-RSGELTVKSDVYSFGVILLELITGRRVI---- 283 (519)
Q Consensus 229 ~~~~~~~~~--------------------~~~~~~~Gt~~y~APE~l-~~~~~~~~sDvwSlGvll~elltG~~pf---- 283 (519)
+........ ......+||+.|+|||++ ....++.++|||||||+||||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 875443211 123457899999999986 5567999999999999999999854443
Q ss_pred -------CCCCCcc--------------hhhHHHhhchhccCCC-----------------CCCcccchHhhccCChhhH
Q 046892 284 -------DTTRPVD--------------EQNLIAWAQPIFRDPK-----------------RFPDMADPLLRKQFPEKGL 325 (519)
Q Consensus 284 -------~~~~~~~--------------~~~~~~~~~~~~~~~~-----------------~~~~~~d~~l~~~~~~~~~ 325 (519)
.+..... ..+.+.....++..+. .++......+... ....+
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s 335 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK-YPSIS 335 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH-STTSC
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH-CCCCC
Confidence 3322110 0011111000000000 0000000000000 12346
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 326 NEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 326 ~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.++.+|+.+||+.||.+|||+.++++|.++-.-
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 688999999999999999999999999877543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=353.25 Aligned_cols=266 Identities=22% Similarity=0.352 Sum_probs=206.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..+|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.++..++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 3579999999999999999999998999999999975332 2345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999776556677999999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...+..... .. .++..
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~---~~--~~~~~- 258 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE---QC--DYPPL- 258 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHH---TT--CSCCC-
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhh---cc--cCCCC-
Confidence 3221 123457899999999999999999999999999999999999999754322 111111111 10 01100
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.....+.++.+|+..||+.||.+|||+.+|+++|..+....
T Consensus 259 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 259 -------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11234557899999999999999999999999999886543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=351.90 Aligned_cols=258 Identities=24% Similarity=0.328 Sum_probs=210.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++..++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 35799999999999999999999999999999998754321 356789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----CcEEeee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL----DPKLSDF 225 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~----~vkL~DF 225 (519)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999854 346899999999999999999999999 99999999999998877 7999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. ...
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS------AVN 227 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TTC
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH------hcc
Confidence 99986544322 234578999999999999999999999999999999999999997643222111111 110
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+ .... ....+..+.+|+.+||+.||.+||++.+++++.++-.
T Consensus 228 ~~~----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 228 YDF----DEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CCC----CHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred cCC----cchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 000 1111 1223457899999999999999999999999887643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=353.33 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=215.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.+.|.+.+.||+|+||.||+|.+..+++.||||++.... ......+..|+.++..+.||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356999999999999999999999999999999997654 2345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999983 356999999999999999999999999 999999999999999999999999999765433
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ...... ..
T Consensus 173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~--~~--------- 236 (303)
T 3a7i_A 173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIPKN--NP--------- 236 (303)
T ss_dssp BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHS--CC---------
T ss_pred cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhhcC--CC---------
Confidence 21 123467899999999999999999999999999999999999999764332211 111100 00
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
..++...+..+.+|+..||+.||.+|||+.++++++++....
T Consensus 237 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 237 ---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp ---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 112233445789999999999999999999999999886643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=352.18 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=214.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 4679999999999999999999999999999999875432 2345678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998854 246899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........... +.....
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~~------ 232 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEY------ 232 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTTCC------
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HhhccC------
Confidence 3221 12346789999999999988899999999999999999999999976432211111 111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.++...+..+.+|+.+||+.||.+|||+.+++++.++...
T Consensus 233 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 233 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 1233344578899999999999999999999999877543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=360.09 Aligned_cols=275 Identities=26% Similarity=0.306 Sum_probs=206.6
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-----ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-----GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
...++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.++..++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999999999999999998753221 13467899999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999975 88888743 3356889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhchhc----
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPIF---- 302 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~~~---- 302 (519)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......+....+. ......
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 87543321 23346789999999998754 58999999999999999999999997654332221111 100000
Q ss_pred cCCCCCCcccchHh-----hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 303 RDPKRFPDMADPLL-----RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 303 ~~~~~~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.....+++...... ...+....+..+.+|+.+||+.||.+|||+.+++++.|+-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 00000111000000 00111344578999999999999999999999999987743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=356.79 Aligned_cols=271 Identities=26% Similarity=0.359 Sum_probs=216.8
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEE-----cCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCeeeeee
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLL-HHPNLVNLIG 141 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~ 141 (519)
........++|.+.+.||+|+||.||+|.+ ..+++.||||++...... ....+..|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444567899999999999999999985 346789999999765332 335688999999999 6999999999
Q ss_pred EEecCC-ceEEEEEecCCCCHHHHHhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046892 142 YCADGD-QRLLVYEFMSGGSVDDHLLDVNET------------KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208 (519)
Q Consensus 142 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDik 208 (519)
++...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 987754 589999999999999999653221 223889999999999999999999999 9999999
Q ss_pred CCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 046892 209 SSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTR 287 (519)
Q Consensus 209 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~ 287 (519)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987655443334445678999999999999999999999999999999998 999997654
Q ss_pred CcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 288 PVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..... ........ ....+...+..+.+++..||+.||.+|||+.+|+++|..+..
T Consensus 256 ~~~~~--~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 256 IDEEF--CRRLKEGT--------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp CSHHH--HHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHH--HHHhccCc--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 32211 11111000 011233345678999999999999999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=353.44 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=212.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 151 (519)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4689999999999999999999999999999999976532 234568899999999999999999998854 567899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA--NPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
||||+++++|.+++.........+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999876656667999999999999999999999986 2349999999999999999999999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... +..... ... .
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~---~~~--~- 233 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIR---EGK--F- 233 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HTC--C-
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHh---hcc--c-
Confidence 6543321 1234578999999999999999999999999999999999999998653221 111111 100 0
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..++...+.++.+|+.+||+.||.+||++.+|++++++..
T Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1123345568899999999999999999999999886543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=360.83 Aligned_cols=253 Identities=30% Similarity=0.394 Sum_probs=208.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
+.|...+.||+|+||.||+|++..+++.||||++....... ...+.+|+.++..++||||+++++++.+.+..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45899999999999999999999999999999997553322 246789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+. |+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 6888887542 356999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
. ....||+.|+|||++. ...++.++|||||||++|||++|..||.......... ... ... .+.
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~~----~~~--~~~ 272 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA----QNE--SPA 272 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHH----HSC--CCC
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHH----hcC--CCC
Confidence 2 2457999999999985 5678999999999999999999999997653322111 111 110 000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..+...+..+.+|+..||+.||.+|||+.+++++.++...
T Consensus 273 --------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 --------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0112334578899999999999999999999999887654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=357.17 Aligned_cols=264 Identities=27% Similarity=0.390 Sum_probs=203.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEcC---CCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC--
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQS---NGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD-- 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 147 (519)
..++|.+.+.||+|+||.||+|.+.. ++..||||++...... ....+..|+.++..++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998865 4568999998754322 3356889999999999999999999998755
Q ss_pred ---ceEEEEEecCCCCHHHHHhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEE
Q 046892 148 ---QRLLVYEFMSGGSVDDHLLDVN--ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKL 222 (519)
Q Consensus 148 ---~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL 222 (519)
..++||||+.+++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 3599999999999999985432 23457999999999999999999999999 999999999999999999999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchh
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---- 264 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH---- 264 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc----
Confidence 99999986654432223334567889999999999999999999999999999999 8889876543322221110
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.. ....+...+..+.+|+..||+.||.+||++.+++++|..+..
T Consensus 265 --~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 265 --GH-----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp --TC-----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CC-----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 011233455688999999999999999999999999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=355.42 Aligned_cols=265 Identities=18% Similarity=0.246 Sum_probs=209.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEec--CCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.++..+. ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999999999999999998643 3567899999999997 9999999999987 6678999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeecccccC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKLG 231 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~~ 231 (519)
|||+.+++|.+++. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999873 3889999999999999999999999 99999999999999776 8999999999876
Q ss_pred CCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc---------hh
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ---------PI 301 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~---------~~ 301 (519)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .+..... .+
T Consensus 182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHH
T ss_pred CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHH
Confidence 54332 234578999999999877 6799999999999999999999999965432211 1110000 00
Q ss_pred ccCCCCCCc------------ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 FRDPKRFPD------------MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 ~~~~~~~~~------------~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
......+.. ..........+...+.++.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 000000000 00001111122235678999999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=351.86 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=191.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999998899999999986432 12346788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999853 3356899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ......
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~------- 228 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVVLAD------- 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSC-------
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHhhcc-------
Confidence 3221 1224578999999999998899999999999999999999999997643321110 000000
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..++...+.++.+|+.+||+.||.+|||+.+++++.++..
T Consensus 229 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 229 -----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred -----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 0123344568899999999999999999999999877643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=364.70 Aligned_cols=277 Identities=27% Similarity=0.379 Sum_probs=213.8
Q ss_pred ccCcccceeeeccCcEEEEEEEE----cCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEe--cCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA--DGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~ 149 (519)
.++|++.+.||+|+||.||+|++ ..++..||||++........+.+.+|+.++..++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36799999999999999999994 5678999999998765555667899999999999999999999986 45668
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++++|.+++.... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999999999996532 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... ........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~-~~~~~~~~ 250 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMG-CERDVPAL 250 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC-----CCHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcc-cccccccH
Confidence 76543322 1223456889999999999999999999999999999999999998642110 000000 00000000
Q ss_pred Cc---ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCC
Q 046892 309 PD---MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPI 363 (519)
Q Consensus 309 ~~---~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~ 363 (519)
.. ..........+..++..+.+|+..||+.||.+|||+.+|+++|..+.......
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 00 00000112234556678999999999999999999999999998876544333
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=379.41 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=214.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999986543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCCcEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl---~~~~~vkL~DFGla~ 229 (519)
|||+.+|+|.+++.. ...+++..++.|+.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998843 456999999999999999999999999 9999999999999 567899999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+. .....++
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE------KGKYTFE 247 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCCCCC
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------cCCCCCC
Confidence 7654332 234679999999999875 79999999999999999999999998654322221111 1111110
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+ .....+..+.+|+.+||+.||.+|||+.++++|.|+-..
T Consensus 248 ---~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 248 ---LP-----QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp ---SG-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ---Cc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 00 112345688999999999999999999999999887543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.17 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=200.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|.+..+ +..||+|++..... ...+.+.+|+.++..++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 46899999999999999999998653 56799999875432 23456889999999999999999999984 567899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999954 2346899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+....
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~----------- 234 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----------- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----------
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-----------
Confidence 443211 1223457889999999999999999999999999999996 999998654433222211100
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...++..++..+.+|+..||+.||.+|||+.+++++|..+.
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01123445568899999999999999999999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=380.58 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=207.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||+||+|++..++..||||++.... ......+.+|+.+++.++||||++++++|.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999999999999999997643 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeeeccccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDFGLAKL 230 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DFGla~~ 230 (519)
|||.+|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988543 46899999999999999999999999 999999999999976 45599999999987
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||...........+. .....++
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~~~~- 257 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------KGKYTFD- 257 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCCCCC-
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCC-
Confidence 65432 233467999999999986 579999999999999999999999998654322221111 1111110
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+. ....+..+.+|+.+||+.||.+|||+.++++|.|+-.
T Consensus 258 --~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 258 --SPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --SGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --chh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 000 1134457899999999999999999999999988743
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=359.98 Aligned_cols=264 Identities=22% Similarity=0.404 Sum_probs=214.1
Q ss_pred HhccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD 147 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 147 (519)
...++|.+.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34578999999999999999999876 3578899999875432 23456889999999999999999999999999
Q ss_pred ceEEEEEecCCCCHHHHHhhhcc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcE
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNE------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vk 221 (519)
..++||||+.+|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEE
Confidence 99999999999999999965321 1245799999999999999999999999 99999999999999999999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhch
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~ 300 (519)
|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...... .......
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~- 254 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLRFVM- 254 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHHHHH-
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHHHHH-
Confidence 999999976543332222334567899999999999999999999999999999999 88888764322 1211111
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... . ...+..++..+.+|+.+||+.||.+|||+.+++++|..+.
T Consensus 255 --~~~--~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 255 --EGG--L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp --TTC--C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred --cCC--c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 100 0 1123345567899999999999999999999999997653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=358.22 Aligned_cols=264 Identities=23% Similarity=0.308 Sum_probs=210.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEe----cCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|.+..+++.||||++..........+.+|+.++..++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999999899999999987665555677899999999999999999999987 3457899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+|+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999876666678999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCcc-------ceecccccccccCchhhhccCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 232 PQGEKM-------NVTSRVMGTYGYCAPEYARSGE---LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 232 ~~~~~~-------~~~~~~~Gt~~y~APE~l~~~~---~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQN- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHHC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhhc-
Confidence 321110 0012345799999999987544 689999999999999999999998532110000 0000000
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... ...+...+..+.+|+.+||+.||.+||++.+|+++|..+.
T Consensus 263 ---~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 ---QLS----------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp ---C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred ---cCC----------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000 1112234568899999999999999999999999998764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.11 Aligned_cols=261 Identities=24% Similarity=0.353 Sum_probs=209.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|....+||+|+||.||+|.+..++..||||.+..........+..|+.++..++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34556669999999999999999999999999998766556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeeecccccCCCCC
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DFGla~~~~~~~ 235 (519)
++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999996532 2345679999999999999999999999 999999999999987 8999999999998654322
Q ss_pred ccceecccccccccCchhhhccCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGE--LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~--~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||......... ... ......
T Consensus 178 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~~~~~~--------- 243 (295)
T 2clq_A 178 P--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--VGMFKV--------- 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--HHHHCC---------
T ss_pred C--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--hccccc---------
Confidence 1 123457899999999997654 889999999999999999999999653322111 111 001111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...++...+.++.+|+.+||+.||.+||++.+++++.++-..
T Consensus 244 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 ---HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ---CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ---cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 112334455688999999999999999999999999776543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.19 Aligned_cols=261 Identities=29% Similarity=0.445 Sum_probs=197.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||.||+|.+. ..||||++...... ..+.+.+|+.+++.++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 467999999999999999999865 35999998754332 335688999999999999999999965 556789999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999843 3456999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...........||+.|+|||++. +..++.++|||||||++|+|++|..||......+. +.......... ..+
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~-~~~-- 247 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLS-PDL-- 247 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSCC-CCT--
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcccccC-cch--
Confidence 33233334567999999999986 67789999999999999999999999976543222 11211110000 000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
......++..+.+|+..||+.||.+|||+.++++.|..+..
T Consensus 248 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 -------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11223445689999999999999999999999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=363.36 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=213.1
Q ss_pred HHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhc-CCCCeeee
Q 046892 69 FRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--------NKEFLVEVLMLSLL-HHPNLVNL 139 (519)
Q Consensus 69 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~~l~~l-~HpnIv~l 139 (519)
+.......++|.+.+.||+|+||.||+|.+..+|+.||||++....... ...+..|+.++..+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344556678999999999999999999999889999999987653211 34577899999998 79999999
Q ss_pred eeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC
Q 046892 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD 219 (519)
Q Consensus 140 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~ 219 (519)
++++......++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999864 246899999999999999999999999 999999999999999999
Q ss_pred cEEeeecccccCCCCCccceecccccccccCchhhhcc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 046892 220 PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS------GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN 293 (519)
Q Consensus 220 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~------~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~ 293 (519)
+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 315 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315 (365)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 99999999987654332 234679999999999864 358899999999999999999999997643221111
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.+. .....+ ..+. . ...+..+.+|+.+||+.||.+|||+.+++++.|+
T Consensus 316 ~i~------~~~~~~---~~~~-~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 316 MIM------EGQYQF---SSPE-W----DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp HHH------HTCCCC---CHHH-H----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHH------hCCCCC---CCcc-c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 111 110000 0000 0 1234578899999999999999999999999876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=350.83 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=209.1
Q ss_pred cCcccceeeeccCcEEEEEEE----EcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecC--Cce
Q 046892 77 KNFRQECLLGEGGFGRVYKGT----LQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 149 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 149 (519)
+.|++.+.||+|+||.||+|+ +..+++.||||++.... ......+.+|+.++..++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 468999999999999999999 45679999999997543 23446789999999999999999999999876 668
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999998543 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------Ccc-hhhHHHhhc
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTR--------PVD-EQNLIAWAQ 299 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~--------~~~-~~~~~~~~~ 299 (519)
........ .......||..|+|||++.+..++.++|||||||++|+|++|..|+.... +.. .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 76544321 22334678899999999999999999999999999999999998864321 000 000001010
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.. .. ......+...+..+.+|+.+||+.||.+|||+.++++.|..+
T Consensus 255 ~~-~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TL-KE----------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HH-HT----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-hc----------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 00 00 001123445567899999999999999999999999999765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=372.84 Aligned_cols=249 Identities=16% Similarity=0.155 Sum_probs=196.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHH---HHHHhcCCCCeeeee-------eE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEV---LMLSLLHHPNLVNLI-------GY 142 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~---~~l~~l~HpnIv~l~-------~~ 142 (519)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+ .++..++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467999999999999999999998889999999997432 23346788999 455556899999998 66
Q ss_pred EecCCc-----------------eEEEEEecCCCCHHHHHhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046892 143 CADGDQ-----------------RLLVYEFMSGGSVDDHLLDVNET---KKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202 (519)
Q Consensus 143 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~I 202 (519)
+.+.+. .||||||+ +|+|.+++...... ...+++..++.|+.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 68999999754221 123446888999999999999999999 9
Q ss_pred EecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccC-----------CCCchhHHHHHHH
Q 046892 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-----------ELTVKSDVYSFGV 271 (519)
Q Consensus 203 vHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-----------~~~~~sDvwSlGv 271 (519)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986332 2344678 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 046892 272 ILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVT 351 (519)
Q Consensus 272 ll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 351 (519)
+||||++|..||.......... .+.. .....+..+.+|+.+||+.||.+|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~------~~~~----------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE------WIFR----------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSG------GGGS----------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchh------hhhh----------------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999997543221110 0000 11233457899999999999999999999999
Q ss_pred HHhhh
Q 046892 352 ALSFL 356 (519)
Q Consensus 352 ~l~~~ 356 (519)
+.++-
T Consensus 360 hp~f~ 364 (377)
T 3byv_A 360 TPEYE 364 (377)
T ss_dssp SHHHH
T ss_pred ChHHH
Confidence 87763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=361.00 Aligned_cols=265 Identities=26% Similarity=0.410 Sum_probs=208.3
Q ss_pred ccCcccceeeeccCcEEEEEEE-----EcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGT-----LQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||.||+|+ ...++..||||++.... ......+..|+.++..++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4689999999999999999999 45568899999986442 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEe
Q 046892 150 LLVYEFMSGGSVDDHLLDVNET---KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLS 223 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~ 223 (519)
++||||+++++|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999764321 245899999999999999999999999 999999999999984 4469999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...... .+......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~-- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVTS-- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHT--
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHHhc--
Confidence 9999975433322222334568999999999999999999999999999999998 98998764322 22221111
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.. ....+..++..+.+|+..||+.||.+||++.+|+++|+.+....
T Consensus 261 -~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 261 -GG-----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp -TC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -CC-----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00 01123344567899999999999999999999999999887543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=377.85 Aligned_cols=258 Identities=28% Similarity=0.376 Sum_probs=211.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999999999999999986432 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCCcEEeeeccccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG---ANLDPKLSDFGLAKL 230 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~---~~~~vkL~DFGla~~ 230 (519)
|||.+|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988543 46899999999999999999999999 99999999999995 556799999999986
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+. .....+.
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~~~~- 242 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE------TGKYAFD- 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCCCSC-
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCCC-
Confidence 644322 234679999999999875 69999999999999999999999997654322221111 1110100
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+ .....+..+.+||.+||+.||.+|||+.++++|.|+-..
T Consensus 243 --~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 243 --LP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp --SG-----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred --Cc-----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 00 012345688999999999999999999999999887553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.14 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=199.9
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--------cChHHHHHHHHHHHhcCCCCeeeeeeEEec
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--------QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD 145 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 145 (519)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|..++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456789999999999999999999999999999999865321 112347889999999999999999999864
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CCcEE
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN---LDPKL 222 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~---~~vkL 222 (519)
+..++||||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 55899999999999998873 4467999999999999999999999999 9999999999999654 45999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHHhh
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPVDE-QNLIAWA 298 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~ 298 (519)
+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||........ ...+..
T Consensus 284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~- 359 (419)
T 3i6u_A 284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 359 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-
T ss_pred eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-
Confidence 9999998764432 2345689999999999853 6788999999999999999999999976433221 111110
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.... .. +.. ....+..+.+|+.+||+.||.+|||+.++++|.|+
T Consensus 360 -----~~~~---~~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 360 -----GKYN---FI-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp -----TCCC---CC-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred -----CCCC---CC-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 0000 00 011 11245678999999999999999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=343.65 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=212.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 467999999999999999999987 57889999997653 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999954 2356899999999999999999999999 9999999999999999999999999998654321
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
........|++.|+|||++.+..++.++||||||+++|+|++ |..||....... ...... ...
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~---~~~--------- 222 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIS---TGF--------- 222 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TTC---------
T ss_pred -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHh---cCC---------
Confidence 111233467889999999999999999999999999999999 899987643221 111111 100
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+...+..+.+|+.+||+.||.+||++.+++++|..+..
T Consensus 223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 223 --RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011223345678999999999999999999999999987754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=373.97 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=212.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++. .+..+||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 35679999999999999999999864 7889999997643 45678999999999999999999999986 567899999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+|+|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999996432 235889999999999999999999999 999999999999999999999999999875432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. ........+++.|+|||++....++.++|||||||+||||++ |..||...... .+........
T Consensus 338 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~~----------- 402 (454)
T 1qcf_A 338 E-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGY----------- 402 (454)
T ss_dssp H-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHHTC-----------
T ss_pred c-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC-----------
Confidence 1 111223456789999999999999999999999999999999 99999765332 2222111100
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+...+..++..+.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 403 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 111234456689999999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.48 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=209.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec---------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--------- 145 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------- 145 (519)
...+|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.++..++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999999899999999987542 457789999999999999999999864
Q ss_pred -------CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC
Q 046892 146 -------GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL 218 (519)
Q Consensus 146 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~ 218 (519)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 44579999999999999999653 2356899999999999999999999999 99999999999999999
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|+... .....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~-- 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFT-- 229 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHH--
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHH--
Confidence 999999999987654322 23456899999999999999999999999999999999998876421 11111
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.+. ...++...+..+.+|+.+||+.||.+|||+.+++++|+.+....
T Consensus 230 -~~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 230 -DLR--------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -HHH--------------TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -Hhh--------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 110 11122334457889999999999999999999999999887544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=358.31 Aligned_cols=273 Identities=23% Similarity=0.309 Sum_probs=209.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec--------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-------- 145 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-------- 145 (519)
.++|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.++..++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999999999999999865432 234578899999999999999999999977
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.+..++||||+.+ +|.+.+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999964 77777743 3356999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCc--cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc
Q 046892 226 GLAKLGPQGEK--MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 226 Gla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99986543221 122344678999999999876 468999999999999999999999998754433322222111100
Q ss_pred cCCCCCCcccchHhhc--------------cC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 RDPKRFPDMADPLLRK--------------QF-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~--------------~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.. ..++......+.. .+ .......+.+|+.+||+.||.+|||+.++++|.|+.
T Consensus 249 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 249 TP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp CT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred Ch-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 00 0011110000000 00 001134688999999999999999999999998774
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=356.63 Aligned_cols=280 Identities=21% Similarity=0.227 Sum_probs=205.0
Q ss_pred HHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc--
Q 046892 71 ELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ-- 148 (519)
Q Consensus 71 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 148 (519)
......++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+..++..+..++||||++++++|.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556789999999999999999999999999999999986543 333456778888888999999999999966433
Q ss_pred -----eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCeeeCC-CCCc
Q 046892 149 -----RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH--DKANPPVIYRDLKSSNILLGA-NLDP 220 (519)
Q Consensus 149 -----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~IvHrDikp~NILl~~-~~~v 220 (519)
.++||||+.+ +|...+.........+++..++.++.||+.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999975 666666555556678999999999999999999999 888 999999999999996 8999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hh
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WA 298 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~ 298 (519)
||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. ..
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999987654332 2345789999999998664 48999999999999999999999998754332221111 00
Q ss_pred c--------hhccCCCC-----CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 299 Q--------PIFRDPKR-----FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 299 ~--------~~~~~~~~-----~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. ........ ........+........+.++.+|+.+||+.||.+|||+.++++|.|+-..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 0 00000000 000001111122333467789999999999999999999999999887543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=363.99 Aligned_cols=272 Identities=22% Similarity=0.323 Sum_probs=211.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4679999999999999999999999999999999876532 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|+++++|.+++... ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999543 4589999999999999999999996 8 99999999999999999999999999864322
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc--hhcc-------C
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ--PIFR-------D 304 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~--~~~~-------~ 304 (519)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||................ .... .
T Consensus 185 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp H----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred c----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 1 1234579999999999999999999999999999999999999997643322111110000 0000 0
Q ss_pred C-------------CCCCcccchHhhcc---C-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 305 P-------------KRFPDMADPLLRKQ---F-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 305 ~-------------~~~~~~~d~~l~~~---~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. .......+...... . ....+.++.+|+.+||+.||.+|||+.++++|.|+-..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0 00000000001110 1 12345689999999999999999999999999887543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=346.14 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=204.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999999899999999986432 23446788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999553 45899999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....... .... +.....
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~---~~~~~~----- 228 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKK---IRGGVF----- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCCC-----
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHH---hhcCcc-----
Confidence 4321 234578999999999987765 689999999999999999999997643211 1111 111111
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.++...+..+.+++.+||+.||.+|||+.+++++.++-.
T Consensus 229 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 229 -------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred -------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 123334457889999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=358.58 Aligned_cols=266 Identities=17% Similarity=0.177 Sum_probs=201.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC---CCeEEEEEEeccCCCc-----------ChHHHHHHHHHHHhcCCCCeeeeee
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS---NGQVVAVKQLDRNGMQ-----------GNKEFLVEVLMLSLLHHPNLVNLIG 141 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~HpnIv~l~~ 141 (519)
.++|.+.+.||+|+||.||+|.+.. ++..||||++...... ....+..|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999986 7889999998755321 1234567888899999999999999
Q ss_pred EEec----CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC
Q 046892 142 YCAD----GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN 217 (519)
Q Consensus 142 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~ 217 (519)
++.+ ....++||||+ +++|.+++... ..+++..++.|+.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 77899999999 99999998542 37999999999999999999999999 9999999999999887
Q ss_pred C--CcEEeeecccccCCCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc
Q 046892 218 L--DPKLSDFGLAKLGPQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVD 290 (519)
Q Consensus 218 ~--~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~ 290 (519)
+ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999765432111 11234679999999999999999999999999999999999999996432211
Q ss_pred hhhHHHhhchhccCCCCCCcccchHhhccC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 291 EQNLIAWAQPIFRDPKRFPDMADPLLRKQF-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
. ........... .+ ...+.... ....+.++.+|+..||+.||.+||++.+|++.|..+.
T Consensus 268 ~-~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 V-AVQTAKTNLLD---EL----PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp H-HHHHHHHHHHH---TT----THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred H-HHHHHHHhhcc---cc----cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1 11111111100 00 11111111 1145568999999999999999999999999986543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.21 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=207.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCe---EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce-EEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLV 152 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-~lV 152 (519)
.|...+.||+|+||.||+|.+..++. .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999999765444 799999875433 2346688999999999999999999999876655 999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999854 3456899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCc--cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCC-CCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 233 QGEK--MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRV-IDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 233 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
.... ........||+.|+|||.+.+..++.++|||||||++|+|++|..| |...........+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---------- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---------- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC----------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC----------
Confidence 3221 1122345688999999999999999999999999999999996555 44333322222221110
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+...+..+.+|+..||+.||.+|||+.++++.|..+...
T Consensus 246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0112333456789999999999999999999999999877553
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=350.32 Aligned_cols=254 Identities=31% Similarity=0.481 Sum_probs=200.4
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||+|+||.||+|.+. ++.||||++... ...+.+..|+.++..++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 57899999999999999999986 789999998643 345678999999999999999999998864 589999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCCCeEecCCCCCCeeeCCCCC-cEEeeecccccCC
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD---KANPPVIYRDLKSSNILLGANLD-PKLSDFGLAKLGP 232 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~~~~IvHrDikp~NILl~~~~~-vkL~DFGla~~~~ 232 (519)
++|+|.+++.... ....+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++. +||+|||++....
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999996432 22347899999999999999999999 66 999999999999998887 7999999997543
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .. +. .... .
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~-~~--~~~~--~----- 221 (307)
T 2eva_A 158 TH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM-WA--VHNG--T----- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH-HH--HHTT--C-----
T ss_pred cc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH-HH--HhcC--C-----
Confidence 22 22346899999999999999999999999999999999999999764332211 11 11 1000 0
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
...++...+..+.+|+.+||+.||.+|||+.+++++|..+....
T Consensus 222 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 222 ----RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ----CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ----CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 01122334557889999999999999999999999998876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=362.33 Aligned_cols=269 Identities=23% Similarity=0.332 Sum_probs=208.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc------e
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ------R 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~------~ 149 (519)
..+|.+.+.||+|+||.||+|.+..++. ||+|++...... ..+|+.+++.++||||++++++|..... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3579999999999999999999987655 888887543322 2369999999999999999999965433 7
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCcEEeeeccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDPKLSDFGLA 228 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~vkL~DFGla 228 (519)
++||||+.+ +|...+.........+++..++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999975 555555444445678999999999999999999999999 99999999999999 7999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHH-Hhh--------
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWA-------- 298 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~-~~~-------- 298 (519)
+....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+....+ ...
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 87644332 2345789999999998764 5899999999999999999999999875433322111 110
Q ss_pred ---chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 299 ---QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 299 ---~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...+. ...++......+...++...+.++.+|+.+||+.||.+|||+.++++|.++-.
T Consensus 267 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 267 KTMNPNYM-EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHCGGGS-SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HhhChhhh-hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 00010 11222222223334455556779999999999999999999999999987643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=377.01 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=210.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-------------cChHHHHHHHHHHHhcCCCCeeeeee
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-------------QGNKEFLVEVLMLSLLHHPNLVNLIG 141 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l~~ 141 (519)
..++|.+.+.||+|+||+||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46789999999999999999999999999999999875432 23467889999999999999999999
Q ss_pred EEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC---
Q 046892 142 YCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL--- 218 (519)
Q Consensus 142 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~--- 218 (519)
++.+....+||||||.+|+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999998543 46999999999999999999999999 99999999999998776
Q ss_pred CcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 219 DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|..||...........+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-- 260 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-- 260 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence 699999999987654322 23467999999999987 569999999999999999999999998654322221111
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.....++ ... ....+.++.+|+.+||+.||.+|||+.++++|.|+-..
T Consensus 261 ----~~~~~~~----~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 261 ----KGKYYFD----FND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp ----HCCCCCC----HHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ----cCCCCCC----ccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 1110000 000 01234678999999999999999999999999887543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=356.38 Aligned_cols=274 Identities=22% Similarity=0.293 Sum_probs=208.5
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----Cc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~ 148 (519)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.++..++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35789999999999999999999999999999999964332 2235678899999999999999999988654 67
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++||||+. ++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999996 689998853 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccc--------eecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 046892 229 KLGPQGEKMN--------VTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 229 ~~~~~~~~~~--------~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~ 299 (519)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8654322111 1223578999999998764 778999999999999999999999998654322221111100
Q ss_pred hhccCCCCCCcccchHhh--------------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 300 PIFRDPKRFPDMADPLLR--------------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~--------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.................. .......+..+.+|+.+||+.||.+|||+.+++++.|+-.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000000000000000000 0111245568899999999999999999999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=364.80 Aligned_cols=268 Identities=20% Similarity=0.251 Sum_probs=210.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC--------CCCeeeeeeEEe---
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH--------HPNLVNLIGYCA--- 144 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~~--- 144 (519)
.++|.+.+.||+|+||+||+|++..+++.||||++... ......+.+|+.++..+. |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999999999999998643 233456788999998885 788999999987
Q ss_pred -cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCC----
Q 046892 145 -DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANL---- 218 (519)
Q Consensus 145 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~---- 218 (519)
.....+|||||+ +++|.+++... ....+++..++.|+.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 566899999999 66777777542 335699999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CcEEeeecccccCCCCCccceecccccccccCchh
Q 046892 219 ---------------------------------------------DPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253 (519)
Q Consensus 219 ---------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE 253 (519)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999865432 23457899999999
Q ss_pred hhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch---hhHHHhhchhc------------------cCCCCCCccc
Q 046892 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE---QNLIAWAQPIF------------------RDPKRFPDMA 312 (519)
Q Consensus 254 ~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~---~~~~~~~~~~~------------------~~~~~~~~~~ 312 (519)
++.+..++.++|||||||+||||++|..||........ ........... .....+..+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999999987543321 11111111100 0000000000
Q ss_pred c-------hHhh--ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 313 D-------PLLR--KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 313 d-------~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
+ ..+. ..++......+.+|+.+||+.||.+|||+.++++|.|+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 0 0111 12456777889999999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=360.93 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=204.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 147 (519)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 57899999999999999999999999999999998654322 2356789999999999999999999997653
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999853 46899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-----
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----- 301 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~----- 301 (519)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9875432 234678999999999887 68999999999999999999999999875443322211110000
Q ss_pred ccCC---------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 FRDP---------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 ~~~~---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...- ..++......+ ..+....+..+.+|+.+||+.||.+|||+.++++|.++-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 0000 00000000001 1122345678999999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=362.82 Aligned_cols=268 Identities=17% Similarity=0.213 Sum_probs=204.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC-----CeEEEEEEeccCCCcC-----------hHHHHHHHHHHHhcCCCCeeee
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN-----GQVVAVKQLDRNGMQG-----------NKEFLVEVLMLSLLHHPNLVNL 139 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~HpnIv~l 139 (519)
.++|.+.+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 46899999999999999999999764 5789999987543211 1223445566777889999999
Q ss_pred eeEEecC----CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 046892 140 IGYCADG----DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG 215 (519)
Q Consensus 140 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~ 215 (519)
++++... ...+|||||+ +++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998765 4589999999 9999999854 3457999999999999999999999999 99999999999999
Q ss_pred --CCCCcEEeeecccccCCCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 046892 216 --ANLDPKLSDFGLAKLGPQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRP 288 (519)
Q Consensus 216 --~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~ 288 (519)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999765432211 111335699999999999999999999999999999999999999985332
Q ss_pred cchhhHHHhhchhccCCCCCCcccchHhhccC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 289 VDEQNLIAWAQPIFRDPKRFPDMADPLLRKQF-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
... ........... .+ ...+...+ ....+.++.+|+..||+.||.+||++.+|++.|..+..
T Consensus 267 ~~~--~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 DPK--YVRDSKIRYRE--NI----ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp CHH--HHHHHHHHHHH--CH----HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHH--HHHHHHHHhhh--hH----HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 211 11111100000 00 11111111 13345689999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=355.20 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=211.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEE--EEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVV--AVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~v--AvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|.+.+.||+|+||.||+|++..++..+ |+|.+.... ......+..|+.++..+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999998888865 999886532 23446688999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHHhhhc------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 153 YEFMSGGSVDDHLLDVN------------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
|||+++++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 23357999999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~ 299 (519)
||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .+.....
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~ 255 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP 255 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHGG
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHHhh
Confidence 999999997432211 1223457889999999998899999999999999999998 99999765322 1111111
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.. .....+...+..+.+|+.+||+.||.+|||+.+++++|..+....
T Consensus 256 ---~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 256 ---QG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ---GT-----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---cC-----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 10 011123345568899999999999999999999999999876544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=367.67 Aligned_cols=271 Identities=20% Similarity=0.231 Sum_probs=209.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc------CCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL------HHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~~~~~ 149 (519)
..+|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 46799999999999999999999999999999999643 22335667788887776 578999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC--cEEeeecc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD--PKLSDFGL 227 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~--vkL~DFGl 227 (519)
++||||+. ++|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999995 6999988653 2345899999999999999999999999 999999999999999887 99999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-ch----hc
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QP----IF 302 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~----~~ 302 (519)
+...... ....+||+.|+|||++.+..++.++|||||||+||||++|.+||......+....+... .. ..
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 9764432 23457899999999999999999999999999999999999999876443322111100 00 00
Q ss_pred ---------cCCCCCCcc---------------------------cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 046892 303 ---------RDPKRFPDM---------------------------ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLM 346 (519)
Q Consensus 303 ---------~~~~~~~~~---------------------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 346 (519)
-.....+.. ....+...++......+.+||.+||+.||.+|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 000000000 00001111222335678999999999999999999
Q ss_pred HHHHHHHhhhhc
Q 046892 347 SDVVTALSFLSN 358 (519)
Q Consensus 347 ~evl~~l~~~~~ 358 (519)
.++++|.|+...
T Consensus 404 ~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 404 GQALRHPWLRRR 415 (429)
T ss_dssp HHHHTSTTTC--
T ss_pred HHHhCChhhccC
Confidence 999999887543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=342.92 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=207.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecC--CceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 151 (519)
.++|.+.+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++..++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 357999999999999999999986 89999999976532 2345688999999999999999999999887 78899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999542 2336899999999999999999999875 34999999999999999999999999987643
Q ss_pred CCCCccceecccccccccCchhhhccCCCC---chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELT---VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~---~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
.. ....||+.|+|||++.+..++ .++|||||||++|+|++|..||............ ....
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~--- 227 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV------ALEG--- 227 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH------HHSC---
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH------HhcC---
Confidence 22 234689999999999875544 4899999999999999999999765332211111 1010
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....++...+..+.+++..||+.||.+|||+.++++.|..+..
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 -------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0112334455688999999999999999999999999987653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=354.78 Aligned_cols=272 Identities=28% Similarity=0.417 Sum_probs=195.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999998889999999986543 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 154 EFMSGGSVDDHLLDVNE----TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
||+++++|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999865322 2456899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCc---cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 230 LGPQGEK---MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 230 ~~~~~~~---~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ .. ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~---~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQ---NDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HT---SSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hc---cCC
Confidence 6543221 112234579999999999876 57899999999999999999999999875443322111 11 111
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... .............+..+.+|+.+||+.||.+||++.+++++.++-.
T Consensus 245 ~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 245 PSL---ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp CCT---TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred Ccc---ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 011 1111111223344567899999999999999999999999876643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=349.85 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=209.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .....+..|+.++..++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 356899999999999999999999999999999998754 245678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999853 2456899999999999999999999999 999999999999999999999999999765433
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+. .. ....+
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~--~~~~~------ 245 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP---TN--PPPTF------ 245 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HS--CCCCC------
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh---cC--CCccc------
Confidence 21 2234578999999999999999999999999999999999999997643322111110 00 00000
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+...+..+.+|+..||+.||.+|||+.+++++.++-.
T Consensus 246 ----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 246 ----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp ----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred ----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 012234567899999999999999999999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=343.19 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=207.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEE-ecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~ 153 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..++|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999999999999999998765432 23578899999999988877666655 6677889999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCCcEEeeeccccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKL 230 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl---~~~~~vkL~DFGla~~ 230 (519)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999854 2356999999999999999999999999 9999999999999 7899999999999986
Q ss_pred CCCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chhccC
Q 046892 231 GPQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPIFRD 304 (519)
Q Consensus 231 ~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~ 304 (519)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 5443221 1223467999999999999999999999999999999999999999875443322221111 100000
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+ ........+..+.+|+..||+.||.+|||+.+|++.|..+..
T Consensus 238 ~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 P-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp C-----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred h-----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 000112334689999999999999999999999999987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=364.55 Aligned_cols=273 Identities=18% Similarity=0.241 Sum_probs=216.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC--ceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999999999999999997543 234567889999999999999999999998765 77999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCCcEEeeeccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL----GANLDPKLSDFGLA 228 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl----~~~~~vkL~DFGla 228 (519)
|||+.+|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999996543 2334999999999999999999999999 9999999999999 77888999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhcc--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc-hhhHHH-hh
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARS--------GELTVKSDVYSFGVILLELITGRRVIDTTRPVD-EQNLIA-WA 298 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--------~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~-~~~~~~-~~ 298 (519)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ...... ..
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87644322 234679999999999865 567889999999999999999999997643322 111111 11
Q ss_pred chhccCCCCCCccc------------chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 299 QPIFRDPKRFPDMA------------DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 299 ~~~~~~~~~~~~~~------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.. .+....... +......+.......+.+++..||+.||.+||++.++++.+..+..
T Consensus 241 ~~---~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 241 TG---KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HS---CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cC---CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 10 000000000 0001123456777889999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=346.44 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=210.3
Q ss_pred ccCcccce-eeeccCcEEEEEEEEc--CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQEC-LLGEGGFGRVYKGTLQ--SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~-~LG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|.+.. .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.++..++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566666 9999999999999864 4578999999976432 3346688999999999999999999999 4567899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999853 3456999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 232 PQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 232 ~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. . .
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~---~---~----- 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---Q---G----- 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---T---T-----
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh---c---C-----
Confidence 443321 11223457899999999998899999999999999999998 999997654332221111 0 0
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....++...+..+.+|+..||+.||.+||++.+++++|+.+..
T Consensus 230 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 230 ------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0112344556689999999999999999999999999987653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=347.84 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=205.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec----CCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 150 (519)
..|.+.+.||+|+||.||+|.+..++..||+|++..... .....+..|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458888999999999999999999999999999875432 234568899999999999999999999865 45689
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCcEEeeecccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDPKLSDFGLAK 229 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~vkL~DFGla~ 229 (519)
+||||+++++|.+++... ..+++..++.|+.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999542 46899999999999999999999986 3499999999999997 78999999999997
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
...... .....||+.|+|||++. +.++.++|||||||++|+|++|..||........ ...... ... .
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~---~~~--~- 247 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT---SGV--K- 247 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT---TTC--C-
T ss_pred cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHHh---ccC--C-
Confidence 654332 23457999999999887 5699999999999999999999999976433221 111111 000 0
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
. ..++...+.++.+|+..||+.||.+|||+.+++++.|+
T Consensus 248 ---~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 248 ---P----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp ---C----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ---c----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 0 01122233578999999999999999999999998775
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=342.38 Aligned_cols=265 Identities=21% Similarity=0.291 Sum_probs=211.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEE-ecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~ 153 (519)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 3578999999999999999999999999999999986543 235688999999999988866666555 6677889999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCCcEEeeeccccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKL 230 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl---~~~~~vkL~DFGla~~ 230 (519)
||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 9999999853 2356999999999999999999999999 9999999999999 4889999999999986
Q ss_pred CCCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chhccC
Q 046892 231 GPQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPIFRD 304 (519)
Q Consensus 231 ~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~ 304 (519)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 5443221 1123467999999999999999999999999999999999999999875433222111111 100000
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
+ ...+....+..+.+|+..||+.||.+||++.+|++.|..+...
T Consensus 238 ~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 238 P-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp C-----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred c-----------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0 0011133456889999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=370.37 Aligned_cols=258 Identities=31% Similarity=0.446 Sum_probs=207.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+ +..+|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 4678999999999999999999975 5679999987543 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999642 2245899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. .......+++.|+|||++.+..++.++|||||||+||||++ |..||....... +...... .
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~----~--------- 397 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER----G--------- 397 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT----T---------
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C---------
Confidence 1 12233457889999999999999999999999999999999 999997653322 2221111 0
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.+...+..++..+.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 01123445566889999999999999999999999999876543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.01 Aligned_cols=258 Identities=24% Similarity=0.420 Sum_probs=206.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+..++..||+|++..........+..|+.++..++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 56899999999999999999999999999999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999988542 356899999999999999999999999 999999999999999999999999987532111
Q ss_pred ccceecccccccccCchhhh-----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 236 KMNVTSRVMGTYGYCAPEYA-----RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l-----~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
........||+.|+|||++ .+..++.++|||||||++|+|++|..||......... .... ... .+.
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~----~~~--~~~ 241 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIA----KSD--PPT 241 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHH----HSC--CCC
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHHh----ccC--Ccc
Confidence 1112335789999999998 3677899999999999999999999999765432211 1111 110 000
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. ..+...+..+.+|+..||+.||.+|||+.+++++.++-
T Consensus 242 ~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 280 (302)
T 2j7t_A 242 L-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280 (302)
T ss_dssp C-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred c-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence 0 11233456789999999999999999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.40 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=200.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 147 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 5789999999999999999999999999999999975432 23356789999999999999999999997655
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..++||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 6899999996 57888773 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh---------
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA--------- 298 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~--------- 298 (519)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 223467999999999999999999999999999999999999999875432221111000
Q ss_pred -------chhccCCCCCCccc-chHhhc-cC------ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 -------QPIFRDPKRFPDMA-DPLLRK-QF------PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 -------~~~~~~~~~~~~~~-d~~l~~-~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.........+.... ...... .+ ....+..+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 00000000000000 000000 00 112367899999999999999999999999998874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=349.50 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=206.2
Q ss_pred ccCcccce-eeeccCcEEEEEEEE--cCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQEC-LLGEGGFGRVYKGTL--QSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~-~LG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
.++|.+.+ .||+|+||.||+|.+ ..+++.||||++...... ....+..|+.++..++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788887 999999999999955 556789999999765332 246788999999999999999999999 567789
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999954 346899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 231 GPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 231 ~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
....... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||....... +........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~------ 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGE------ 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTC------
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC------
Confidence 6543321 11222456789999999998889999999999999999999 999998654322 222111100
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...++..++..+.+++..||+.||.+||++.+|++.|..+-
T Consensus 238 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 238 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01223445568999999999999999999999999987653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.19 Aligned_cols=273 Identities=21% Similarity=0.270 Sum_probs=210.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----Cce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----DQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~~~ 149 (519)
..+|++.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.++..++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 56899999999999999999999999999999999754322 235688999999999999999999999765 368
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+. |+|.+++.. ..+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999996 599998843 45999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chhccCC-
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPIFRDP- 305 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~~- 305 (519)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+... .......
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 65433211 11234689999999998754 55899999999999999999999999876554433222110 0000000
Q ss_pred CCCCcccchHh-----------hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 306 KRFPDMADPLL-----------RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 306 ~~~~~~~d~~l-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
........... ...+....+..+.+|+.+||+.||.+|||+.++++|.|+-.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 00000000000 00112334567899999999999999999999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.12 Aligned_cols=267 Identities=26% Similarity=0.355 Sum_probs=203.8
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHh--cCCCCeeeeeeEEecC----
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSL--LHHPNLVNLIGYCADG---- 146 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~---- 146 (519)
....++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|.+++.. ++||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 445678999999999999999999986 899999998543 23445556666654 4899999999999887
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeEecCCCCCCeeeCCCC
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK--------ANPPVIYRDLKSSNILLGANL 218 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~~~~IvHrDikp~NILl~~~~ 218 (519)
...++||||+.+|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG 179 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence 678999999999999999943 3589999999999999999999998 7 99999999999999999
Q ss_pred CcEEeeecccccCCCCCccc--eecccccccccCchhhhccCCCCch------hHHHHHHHHHHHHHhC----------C
Q 046892 219 DPKLSDFGLAKLGPQGEKMN--VTSRVMGTYGYCAPEYARSGELTVK------SDVYSFGVILLELITG----------R 280 (519)
Q Consensus 219 ~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~------sDvwSlGvll~elltG----------~ 280 (519)
.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++| .
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997654332211 1224579999999999987766654 9999999999999999 5
Q ss_pred CCCCCCCCcch--hhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 281 RVIDTTRPVDE--QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 281 ~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.||........ ........ .......++ ....+..++..+.+|+.+||+.||.+|||+.+|+++|..+..
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDMREIVC-IKKLRPSFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CTTTTTSCSSCCHHHHHHHHT-TSCCCCCCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHhhhcCCCCchhhhHHHHh-hhccCcccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 55554322211 11111110 000000010 001123567789999999999999999999999999998775
Q ss_pred CC
Q 046892 359 SK 360 (519)
Q Consensus 359 ~~ 360 (519)
..
T Consensus 332 ~~ 333 (337)
T 3mdy_A 332 SQ 333 (337)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=353.86 Aligned_cols=262 Identities=29% Similarity=0.424 Sum_probs=205.9
Q ss_pred HHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEec----
Q 046892 71 ELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCAD---- 145 (519)
Q Consensus 71 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---- 145 (519)
++....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.++..+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33445678999999999999999999999899999999987543 3457788999999988 79999999999976
Q ss_pred --CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 146 --GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 146 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
....++||||+.+++|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999999653 2356899999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||...........+
T Consensus 172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--- 246 (326)
T 2x7f_A 172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 246 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---
T ss_pred eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---
Confidence 9999986543221 123457899999999987 567899999999999999999999999764432211111
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.... .+.. .+...+..+.+|+.+||..||.+||++.+++++.++.
T Consensus 247 ---~~~~--~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 247 ---PRNP--APRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp ---HHSC--CCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred ---hcCc--cccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 0110 0000 1123345788999999999999999999999987764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=346.10 Aligned_cols=259 Identities=25% Similarity=0.305 Sum_probs=211.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---------cChHHHHHHHHHHHhcC-CCCeeeeeeEEe
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---------QGNKEFLVEVLMLSLLH-HPNLVNLIGYCA 144 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 144 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.++..+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45789999999999999999999999999999999975431 11345778999999995 999999999999
Q ss_pred cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 145 DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 145 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999954 246899999999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhc------cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR------SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~------~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|..||...........+
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--- 241 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--- 241 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH---
Confidence 999987654332 23457899999999985 456889999999999999999999999764322211111
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
......++. ......+..+.+|+.+||+.||.+|||+.+++++.++..
T Consensus 242 ---~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (298)
T 1phk_A 242 ---MSGNYQFGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289 (298)
T ss_dssp ---HHTCCCCCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ---hcCCcccCc--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence 111111100 011234567899999999999999999999999877643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=353.24 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=204.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC----eEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG----QVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
..+|.+.+.||+|+||.||+|.+..++ ..||||++..... .....+..|+.++..++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 357888999999999999999987543 4699999875432 23456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
|||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999854 3456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 231 GPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 231 ~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...... ...
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~----~~~- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAIND----GFR- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHT----TCC-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHC----CCc-
Confidence 5433211 11223456889999999999999999999999999999999 99999754322 22221111 000
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...+..++..+.+|+.+||+.||.+||++.+|+++|..+..
T Consensus 269 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 ---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11233445688999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=344.81 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=207.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC---CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS---NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.++..++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4689999999999999999998754 245699999876532 345678899999999999999999999865 45789
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999652 346899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~----------- 231 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD----------- 231 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-----------
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-----------
Confidence 443211 1233467889999999999999999999999999999998 999997654433322221110
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+...+..+.+|+.+||+.||.+||++.+++++|..+..
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 011223345678999999999999999999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=352.46 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=204.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--------cChHHHHHHHHHHHhcCCCCeeeeeeEEecC
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--------QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 146 (519)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.++..++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 35689999999999999999999999999999999865421 1223478899999999999999999999765
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC---cEEe
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD---PKLS 223 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~---vkL~ 223 (519)
. .++||||+.+++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 899999999999999884 3457999999999999999999999999 999999999999987654 9999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHHhhc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE-QNLIAWAQ 299 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~~ 299 (519)
|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...+..
T Consensus 160 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 234 (322)
T 2ycf_A 160 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-- 234 (322)
T ss_dssp CCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH--
T ss_pred cCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh--
Confidence 999998764332 123457899999999974 46789999999999999999999999976543211 111110
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.... . .+.. ....+..+.+|+.+||+.||.+||++.+++++.|+
T Consensus 235 ----~~~~---~-~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 235 ----GKYN---F-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp ----TCCC---C-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred ----Cccc---c-Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 0000 0 0111 12234678999999999999999999999998775
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=354.65 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=193.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEe--------cC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCA--------DG 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~--------~~ 146 (519)
..+|++.+.||+|+||.||+|.+..+++.||||++..........+..|+.++..+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999999899999999987665555667889999999996 999999999984 34
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
...++||||+. |+|.+++.... ....+++..++.|+.||+.||.|||+.+ ++|+||||||+||||+.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 45799999995 79999886543 3456999999999999999999999886 349999999999999999999999999
Q ss_pred ccccCCCCCccc----------eecccccccccCchhhh---ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 046892 227 LAKLGPQGEKMN----------VTSRVMGTYGYCAPEYA---RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQN 293 (519)
Q Consensus 227 la~~~~~~~~~~----------~~~~~~Gt~~y~APE~l---~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~ 293 (519)
++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998754432211 11135689999999998 56778999999999999999999999996532211
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
... ... ...........+.+|+..||+.||.+||++.+++++|+.+...
T Consensus 261 ~~~---~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 261 IVN---GKY--------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------C--------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhc---Ccc--------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000 000 0011112223577899999999999999999999999988654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=344.33 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=205.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEE-ecCCceE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRL 150 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~~ 150 (519)
..+|.+.+.||+|+||.||+|.+..+ ...||+|.+..... .....+.+|+.+++.++||||+++++++ ...+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 35688999999999999999997543 34689999875432 2346688999999999999999999986 4566889
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999953 3456899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCc--cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 231 GPQGEK--MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 231 ~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
...... ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-------- 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------- 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC--------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC--------
Confidence 544321 112334567889999999999999999999999999999999 556665544333222111100
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+...+..+.+++..||+.||.+|||+.++++.|..+..
T Consensus 250 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 ---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011123344578999999999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=350.87 Aligned_cols=260 Identities=21% Similarity=0.239 Sum_probs=203.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++..++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999999999999999987543322 35688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999998643 46899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .+..... .....
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~----~~~~~---- 253 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHIN----QAIPR---- 253 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHH----SCCCC----
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhc----cCCCC----
Confidence 3321 1223457899999999999999999999999999999999999999764321 1111111 10000
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHhhhhc
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-LMSDVVTALSFLSN 358 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~~~~~ 358 (519)
...++...+..+.+|+.+||+.||.+|| ++.++++.|..+..
T Consensus 254 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 254 ----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp ----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred ----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0112334455788999999999999999 99999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.35 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=210.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+..|+.++..++||||+++++++.+ +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 468999999999999999999986 47789999987543 345778999999999999999999999864 568999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999999985421 125899999999999999999999999 9999999999999999999999999998764432
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. .......|++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~~------------ 227 (279)
T 1qpc_A 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERGY------------ 227 (279)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTC------------
T ss_pred c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHhccc------------
Confidence 1 12233457889999999998999999999999999999999 89999764322 1221111100
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....+...+..+.+|+..||+.||.+|||+.++++.|..+..
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 228 --RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 011233445688999999999999999999999999987654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=359.31 Aligned_cols=254 Identities=18% Similarity=0.175 Sum_probs=204.8
Q ss_pred hccCcccceeeeccCcEEEEEEE-----EcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCeeeeeeEEecC
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGT-----LQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH---HPNLVNLIGYCADG 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 146 (519)
..++|.+.+.||+|+||.||+|. +..+++.||||++... ....+..|+.++..+. |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45779999999999999999994 5667899999998654 3456778888888777 99999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---------
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNE-TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA--------- 216 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~--------- 216 (519)
+..+|||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+.+ ||||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999976433 3457999999999999999999999999 999999999999998
Q ss_pred --CCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 046892 217 --NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNL 294 (519)
Q Consensus 217 --~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~ 294 (519)
++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999754332233344567899999999999999999999999999999999999999854321100
Q ss_pred HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCC-CCHHHHHHHHhhh
Q 046892 295 IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR-PLMSDVVTALSFL 356 (519)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~l~~~ 356 (519)
.....+. .+ .....+.+++..||+.+|.+| |++.++.+.|..+
T Consensus 294 --------~~~~~~~---------~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 --------KPEGLFR---------RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp --------EECSCCT---------TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred --------eechhcc---------cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0000000 01 124567889999999999999 5677777666543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=364.97 Aligned_cols=260 Identities=11% Similarity=0.042 Sum_probs=188.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc---ChHHHHHHHHHHHhc--CCCCeeeee-------eEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ---GNKEFLVEVLMLSLL--HHPNLVNLI-------GYC 143 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l--~HpnIv~l~-------~~~ 143 (519)
...|.+.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34589999999999999999999999999999999875432 234566775444444 699988755 444
Q ss_pred ecC-----------------CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 046892 144 ADG-----------------DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTR------MKIASGAAQGLEYLHDKANP 200 (519)
Q Consensus 144 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~ 200 (519)
... ...+|||||+. |+|.+++..... .+.+..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 33799999998 899999976422 3444555 678899999999999999
Q ss_pred CeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHh
Q 046892 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELIT 278 (519)
Q Consensus 201 ~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~ellt 278 (519)
|+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999999865321 113567799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 279 GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 279 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
|+.||....+..... +.... ........+........+..+.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 289 g~~Pf~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS---WKRPS------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp SSCSTTBCCTTCTTC---CCBCC------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred CCCCCCCcCcccccc---hhhhh------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 999998754321110 00000 0000000011111234566899999999999999999999999988764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=380.43 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=205.4
Q ss_pred cCcccce-eeeccCcEEEEEEEEcC--CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQEC-LLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~-~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|.+.. .||+|+||.||+|.+.. ++..||||++..... ...+.+.+|+.+|..++|||||++++++.+ +..+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3445555 79999999999998753 466899999976532 356789999999999999999999999976 568999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+|+|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999853 3456999999999999999999999999 9999999999999999999999999998764
Q ss_pred CCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 233 QGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 233 ~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..... .......+++.|+|||++.+..++.++|||||||+||||++ |..||......+....+.. .
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-------~----- 555 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------G----- 555 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-------T-----
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------C-----
Confidence 33221 11222345789999999999999999999999999999998 9999987554322221111 0
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+..++..++.++.+|+..||+.||.+||++.+|++.|..+.
T Consensus 556 -----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 556 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011234456678999999999999999999999999887654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.27 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=193.6
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecC------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------ 146 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 146 (519)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 35789999999999999999999999999999999865422 2345678999999999999999999998654
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
...|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 7899988732 56999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chh---
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPI--- 301 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~--- 301 (519)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+... ...
T Consensus 178 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 178 LARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99864332 234678999999999877 67899999999999999999999999875543322221110 000
Q ss_pred -ccCCC---------CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 302 -FRDPK---------RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 302 -~~~~~---------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+..-. .++......+.. .....+..+.+|+.+||+.||.+|||+.++++|.++-.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHH-HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHH-HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 00000 000000000000 11233567899999999999999999999999987643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=352.56 Aligned_cols=277 Identities=22% Similarity=0.266 Sum_probs=206.2
Q ss_pred cHHHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-----------hHHHHHHHHHHHhcCCCCe
Q 046892 68 TFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-----------NKEFLVEVLMLSLLHHPNL 136 (519)
Q Consensus 68 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~HpnI 136 (519)
.+.++....++|.+.+.||+|+||.||+|.+.. |..||||++....... .+.+.+|+.++..++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 456788889999999999999999999999865 8999999986533221 2678899999999999999
Q ss_pred eeeeeEEec-----CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046892 137 VNLIGYCAD-----GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSN 211 (519)
Q Consensus 137 v~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~N 211 (519)
+++++++.. ....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999854 346799999997 688888753 3457999999999999999999999999 9999999999
Q ss_pred eeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcc
Q 046892 212 ILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVD 290 (519)
Q Consensus 212 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~ 290 (519)
||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999997543322 2334678999999999876 678999999999999999999999998754332
Q ss_pred hhhHH-Hhhchhc-------c-------CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 291 EQNLI-AWAQPIF-------R-------DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 291 ~~~~~-~~~~~~~-------~-------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+ ....... . ............ ........+..+.+|+.+||+.||.+|||+.++++|.++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 22111 1000000 0 000000000000 011223345678999999999999999999999999876
Q ss_pred h
Q 046892 356 L 356 (519)
Q Consensus 356 ~ 356 (519)
-
T Consensus 321 ~ 321 (362)
T 3pg1_A 321 E 321 (362)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=347.28 Aligned_cols=269 Identities=23% Similarity=0.291 Sum_probs=209.6
Q ss_pred ccCcccceeeeccCcEEEEEEEE-cCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC------CeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTL-QSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHP------NLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||+|.+ ..+++.||||++... ......+..|+.++..++|+ +|+++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999998 567899999998643 22345678899888888655 59999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA------------ 216 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~------------ 216 (519)
.++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 88999998653 2346899999999999999999999999 999999999999987
Q ss_pred -------CCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 046892 217 -------NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV 289 (519)
Q Consensus 217 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~ 289 (519)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999864432 23457899999999999999999999999999999999999999865433
Q ss_pred chhhHHHhhchhcc---------------CCCCCCcccc----------hHh-hccCChhhHHHHHHHHHHhhhhCCCCC
Q 046892 290 DEQNLIAWAQPIFR---------------DPKRFPDMAD----------PLL-RKQFPEKGLNEAVAIAAMCLQEEAGAR 343 (519)
Q Consensus 290 ~~~~~~~~~~~~~~---------------~~~~~~~~~d----------~~l-~~~~~~~~~~~l~~li~~cl~~dP~~R 343 (519)
+....+........ ....+..... ... ....+...+..+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 22222211100000 0000000000 000 011234556789999999999999999
Q ss_pred CCHHHHHHHHhhh
Q 046892 344 PLMSDVVTALSFL 356 (519)
Q Consensus 344 Ps~~evl~~l~~~ 356 (519)
||+.+++++.|+-
T Consensus 321 pt~~ell~hp~f~ 333 (339)
T 1z57_A 321 ITLREALKHPFFD 333 (339)
T ss_dssp CCHHHHTTSGGGG
T ss_pred cCHHHHhcCHHHH
Confidence 9999999997764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=358.50 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=199.3
Q ss_pred CcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEec-CCceEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLV 152 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV 152 (519)
.|.+.+.||+|+||.||+|.+..+ +..||||.+.... ......+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 477889999999999999998543 2468999986532 2334678999999999999999999998754 5678999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999953 3456899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCcc--ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 233 QGEKM--NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 233 ~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||......+....+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~---------- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---------- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC----------
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC----------
Confidence 32211 11233567889999999999999999999999999999999 677777654443322221110
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
....+..++..+.+|+.+||+.||.+||++.+++++|..+...
T Consensus 314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0112334456789999999999999999999999999877643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=348.28 Aligned_cols=267 Identities=28% Similarity=0.434 Sum_probs=211.8
Q ss_pred ccCcccceeeeccCcEEEEEEEE----cCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCC--ce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD--QR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~ 149 (519)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..........+.+|+.++..++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35789999999999999999984 5579999999998765555677899999999999999999999987654 78
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999642 346899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc---------chhhHHHhhc
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV---------DEQNLIAWAQ 299 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~---------~~~~~~~~~~ 299 (519)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ..........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 76543321 1122345788899999999889999999999999999999999887642100 0000000000
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
....... ....+..++.++.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 274 ~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 274 ELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111100 112234556789999999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=351.19 Aligned_cols=262 Identities=28% Similarity=0.417 Sum_probs=207.8
Q ss_pred CcccceeeeccCcEEEEEEEE----cCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceE
Q 046892 78 NFRQECLLGEGGFGRVYKGTL----QSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRL 150 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~ 150 (519)
.|++.+.||+|+||.||++.+ ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+ ....+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 349999999999999988865 34688999999976532 234568899999999999999999999987 46789
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999843 34899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc---------chhhHHHhhch
Q 046892 231 GPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV---------DEQNLIAWAQP 300 (519)
Q Consensus 231 ~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~---------~~~~~~~~~~~ 300 (519)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT-E 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH-H
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH-H
Confidence 6544321 2233456888999999999999999999999999999999999998653110 000000000 0
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.... ......+..++..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 263 ~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 263 LLER----------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhc----------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0000 11122344556789999999999999999999999999987754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.09 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=201.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC-CceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.+. |+.||||++... ...+.+.+|+.++..++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 468999999999999999999885 899999998754 2456789999999999999999999997554 57899999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 999999999996532 223789999999999999999999999 999999999999999999999999999754432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+.. ..... .
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~~----~-------- 230 (278)
T 1byg_A 171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEK----G-------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHTT----T--------
T ss_pred c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhc----C--------
Confidence 2 22457899999999999999999999999999999998 99999765432221 11110 0
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.....+...+..+.+++..||+.||.+||++.++++.|..+..
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 231 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 0112234455688999999999999999999999999987764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=346.78 Aligned_cols=272 Identities=23% Similarity=0.293 Sum_probs=202.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEe-----------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA----------- 144 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~----------- 144 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 578999999999999999999999999999999987665555677889999999999999999999874
Q ss_pred ---cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCc
Q 046892 145 ---DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDP 220 (519)
Q Consensus 145 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~v 220 (519)
+....++||||+. |+|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 69999883 356899999999999999999999999 99999999999997 56789
Q ss_pred EEeeecccccCCCCCc-cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 221 KLSDFGLAKLGPQGEK-MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 221 kL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986543211 112234567999999998865 67899999999999999999999999875432222111100
Q ss_pred chhccCC------CCCCcccchHhh------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 QPIFRDP------KRFPDMADPLLR------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 ~~~~~~~------~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
....... ..++........ ..+....+.++.+|+.+||+.||.+|||+.+++++.++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 0000000 000000000000 011233567899999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=374.35 Aligned_cols=257 Identities=31% Similarity=0.442 Sum_probs=211.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|+.++|+||+++++++.+ +..+|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 4678999999999999999999975 5679999997653 345789999999999999999999999876 678999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+|+|.++|... ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999999643 2245899999999999999999999999 9999999999999999999999999998654321
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
........++..|+|||++.+..++.++|||||||+||||++ |..||...... .+...... ..
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i~~----~~-------- 481 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVER----GY-------- 481 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHHHT----TC--------
T ss_pred -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----CC--------
Confidence 111223456789999999999999999999999999999999 89999764322 22221111 00
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+...+..++..+.+||.+||+.||.+|||+.+|++.|..+..
T Consensus 482 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 112334556688999999999999999999999999976643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.24 Aligned_cols=265 Identities=19% Similarity=0.270 Sum_probs=210.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcCh-----------------HHHHHHHHHHHhcCCCCeee
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN-----------------KEFLVEVLMLSLLHHPNLVN 138 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~-----------------~~~~~E~~~l~~l~HpnIv~ 138 (519)
.++|.+.+.||+|+||.||+|.+ +++.||||++........ ..+.+|+.++..++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 699999999865322111 78899999999999999999
Q ss_pred eeeEEecCCceEEEEEecCCCCHHHH------HhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCC
Q 046892 139 LIGYCADGDQRLLVYEFMSGGSVDDH------LLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSN 211 (519)
Q Consensus 139 l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~N 211 (519)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999988 422 125679999999999999999999999 88 9999999999
Q ss_pred eeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 046892 212 ILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTV-KSDVYSFGVILLELITGRRVIDTTRPV 289 (519)
Q Consensus 212 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~-~sDvwSlGvll~elltG~~pf~~~~~~ 289 (519)
||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999865433 23456799999999999877 6666 999999999999999999999865442
Q ss_pred chhhHHHhhchhccCCCCCCcc----cch---HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 290 DEQNLIAWAQPIFRDPKRFPDM----ADP---LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~----~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
........ .....++.. ... ..........+..+.+|+.+||+.||.+|||+.+++++.++-
T Consensus 259 --~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~ 327 (348)
T 2pml_X 259 --VELFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327 (348)
T ss_dssp --HHHHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred --HHHHHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 11111111 111111110 000 000111234556889999999999999999999999987764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=345.05 Aligned_cols=273 Identities=24% Similarity=0.324 Sum_probs=209.4
Q ss_pred hccCcccceeeeccCcEEEEEEEEc-CCCeEEEEEEeccCCC--cChHHHHHHHHHHHhc---CCCCeeeeeeEEe----
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQ-SNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLL---HHPNLVNLIGYCA---- 144 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~---- 144 (519)
..++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999864322 2234566777777665 8999999999987
Q ss_pred -cCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 145 -DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 145 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
.....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5677899999997 6999998653 2345899999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhch--
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQP-- 300 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~-- 300 (519)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. ....
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999998654322 2334678999999999999999999999999999999999999998654332221111 1000
Q ss_pred --hccCCCCCCcc----cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 301 --IFRDPKRFPDM----ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 301 --~~~~~~~~~~~----~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.+......+.. ........+....+..+.+|+.+||+.||.+|||+.+++++.++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 301 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence 00000000000 000001123344567889999999999999999999999987764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=353.57 Aligned_cols=270 Identities=18% Similarity=0.261 Sum_probs=207.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----------CCCeeeeeeEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-----------HPNLVNLIGYCA 144 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~ 144 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.++..+. |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 368999999999999999999999999999999986432 23456788998888776 899999999997
Q ss_pred cCC----ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeC----
Q 046892 145 DGD----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLG---- 215 (519)
Q Consensus 145 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~---- 215 (519)
..+ ..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 89999998653 234589999999999999999999998 8 99999999999994
Q ss_pred --CCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcch--
Q 046892 216 --ANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE-- 291 (519)
Q Consensus 216 --~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~-- 291 (519)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||||++|..||........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4457999999999865432 2335789999999999999999999999999999999999999986542211
Q ss_pred --hhHHHhhchh-----------------ccCCCCCCcc-------cchHh--hccCChhhHHHHHHHHHHhhhhCCCCC
Q 046892 292 --QNLIAWAQPI-----------------FRDPKRFPDM-------ADPLL--RKQFPEKGLNEAVAIAAMCLQEEAGAR 343 (519)
Q Consensus 292 --~~~~~~~~~~-----------------~~~~~~~~~~-------~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~R 343 (519)
..+....... +.....+..+ ....+ ...++...+..+.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111111000 0000000000 00111 123566778899999999999999999
Q ss_pred CCHHHHHHHHhhhh
Q 046892 344 PLMSDVVTALSFLS 357 (519)
Q Consensus 344 Ps~~evl~~l~~~~ 357 (519)
||+.++++|.++..
T Consensus 326 pt~~ell~hp~f~~ 339 (373)
T 1q8y_A 326 ADAGGLVNHPWLKD 339 (373)
T ss_dssp BCHHHHHTCGGGTT
T ss_pred CCHHHHhhChhhhc
Confidence 99999999988754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=347.23 Aligned_cols=267 Identities=25% Similarity=0.339 Sum_probs=209.2
Q ss_pred HHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHh--cCCCCeeeeeeEEecCC--
Q 046892 72 LAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSL--LHHPNLVNLIGYCADGD-- 147 (519)
Q Consensus 72 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~-- 147 (519)
.....++|.+.+.||+|+||.||+|.+. ++.||||++... ....+..|+.++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 3455678999999999999999999984 899999998643 34567888888887 78999999999998876
Q ss_pred --ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeeeCCC
Q 046892 148 --QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH--------DKANPPVIYRDLKSSNILLGAN 217 (519)
Q Consensus 148 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~IvHrDikp~NILl~~~ 217 (519)
..++||||+.+|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+||||+.+
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN 183 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred cceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence 78999999999999999954 35899999999999999999999 788 9999999999999999
Q ss_pred CCcEEeeecccccCCCCCccc--eecccccccccCchhhhccCC------CCchhHHHHHHHHHHHHHhC----------
Q 046892 218 LDPKLSDFGLAKLGPQGEKMN--VTSRVMGTYGYCAPEYARSGE------LTVKSDVYSFGVILLELITG---------- 279 (519)
Q Consensus 218 ~~vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~------~~~~sDvwSlGvll~elltG---------- 279 (519)
+.+||+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 999999999997654432211 123457999999999997652 34789999999999999999
Q ss_pred CCCCCCCCCcc--hhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 280 RRVIDTTRPVD--EQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 280 ~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..||......+ ...+.... .... ..+.+.. ......+...+.+|+.+||+.||.+|||+.+|+++|..+.
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVV---CEQK-LRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHH---TTSC-CCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHHH---HHHH-hCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 66776543221 11111111 1110 0010100 0112356678999999999999999999999999999876
Q ss_pred cC
Q 046892 358 NS 359 (519)
Q Consensus 358 ~~ 359 (519)
..
T Consensus 336 ~~ 337 (342)
T 1b6c_B 336 QQ 337 (342)
T ss_dssp HT
T ss_pred HH
Confidence 53
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.33 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=205.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce---
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR--- 149 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~--- 149 (519)
..++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 357899999999999999999999999999999999764322 235678999999999999999999999887665
Q ss_pred ---EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 150 ---LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 150 ---~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
++||||+. ++|.+++ ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999996 6888776 234899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.. ....+
T Consensus 190 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~~~~ 261 (371)
T 4exu_A 190 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK---VTGVP 261 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---HHCCC
T ss_pred cccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---HhCCC
Confidence 99865332 234678999999999987 6899999999999999999999999986543322211110 00000
Q ss_pred C-----CCC------------cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 306 K-----RFP------------DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 306 ~-----~~~------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. .+. ......+ ..+....+..+.+|+.+||+.||.+|||+.+++++.|+-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhH-HHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0 000 0000000 011233456899999999999999999999999998874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.88 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=211.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC-CCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 5789999999999999999999999999999998865433 3457889999999987 556666667778888999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---CCCCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL---GANLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl---~~~~~vkL~DFGla~~~ 231 (519)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 99999999542 356999999999999999999999999 9999999999999 68899999999999875
Q ss_pred CCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch-hccCC
Q 046892 232 PQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP-IFRDP 305 (519)
Q Consensus 232 ~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~-~~~~~ 305 (519)
...... .......||+.|+|||++.+..++.++|||||||+||||++|..||...........+..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT- 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-
Confidence 543221 122356899999999999999999999999999999999999999987655443333222111 0000
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. ...+ ...++.++.+|+..||+.+|.+||++.+|++.|..+
T Consensus 236 -----~-~~~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 -----S-IEAL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -----C-HHHH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -----c-HHHH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 0011 123345889999999999999999999999988765
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=357.97 Aligned_cols=274 Identities=23% Similarity=0.326 Sum_probs=191.9
Q ss_pred cCccc-ceeeeccCcEEEEEEEEc--CCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEe--cCCceEE
Q 046892 77 KNFRQ-ECLLGEGGFGRVYKGTLQ--SNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLL 151 (519)
Q Consensus 77 ~~y~~-~~~LG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~~l 151 (519)
+.|.+ .++||+|+||.||+|.+. .+++.||||++.... ....+.+|+.+|+.++||||+++++++. .....+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999976 468899999987542 3457889999999999999999999995 4678999
Q ss_pred EEEecCCCCHHHHHhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----CCCCCcEE
Q 046892 152 VYEFMSGGSVDDHLLDVNE-----TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL----GANLDPKL 222 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl----~~~~~vkL 222 (519)
||||+. ++|.+++..... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 588888754321 2235999999999999999999999999 9999999999999 77899999
Q ss_pred eeecccccCCCCCc-cceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc-------chhh
Q 046892 223 SDFGLAKLGPQGEK-MNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPV-------DEQN 293 (519)
Q Consensus 223 ~DFGla~~~~~~~~-~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~-------~~~~ 293 (519)
+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||...... ....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987543221 122345689999999999987 45899999999999999999999999764331 1111
Q ss_pred HHHhhchhccCC--CCCCccc---c-hHh-----h------------ccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHH
Q 046892 294 LIAWAQPIFRDP--KRFPDMA---D-PLL-----R------------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVV 350 (519)
Q Consensus 294 ~~~~~~~~~~~~--~~~~~~~---d-~~l-----~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 350 (519)
+..... .+..+ ..+..+. . ..+ . ..........+.+||.+||+.||.+|||+.+++
T Consensus 254 l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 254 LDRIFN-VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHH-HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHH-hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111111 11000 0000000 0 000 0 001111245788999999999999999999999
Q ss_pred HHHhhhh
Q 046892 351 TALSFLS 357 (519)
Q Consensus 351 ~~l~~~~ 357 (519)
+|.|+..
T Consensus 333 ~hp~f~~ 339 (405)
T 3rgf_A 333 QDPYFLE 339 (405)
T ss_dssp TSGGGTS
T ss_pred cChhhcc
Confidence 9988754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=347.49 Aligned_cols=269 Identities=26% Similarity=0.348 Sum_probs=197.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHH--HHhcCCCCeeeeeeEEec-----CCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLM--LSLLHHPNLVNLIGYCAD-----GDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~HpnIv~l~~~~~~-----~~~ 148 (519)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|..+ +..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46899999999999999999977 4899999998643 23445555554 445899999999986532 335
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCCeeeCCCCC
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK---------ANPPVIYRDLKSSNILLGANLD 219 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~~IvHrDikp~NILl~~~~~ 219 (519)
++|||||+++|+|.+++.. ..+++..++.++.||+.||+|||+. + |+||||||+||||+.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 7899999999999999954 3358999999999999999999999 8 999999999999999999
Q ss_pred cEEeeecccccCCCCCc------cceecccccccccCchhhhcc-------CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Q 046892 220 PKLSDFGLAKLGPQGEK------MNVTSRVMGTYGYCAPEYARS-------GELTVKSDVYSFGVILLELITGRRVIDTT 286 (519)
Q Consensus 220 vkL~DFGla~~~~~~~~------~~~~~~~~Gt~~y~APE~l~~-------~~~~~~sDvwSlGvll~elltG~~pf~~~ 286 (519)
+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999986543221 112234579999999999976 35667899999999999999998776443
Q ss_pred CCcchh-h--HH--------HhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 287 RPVDEQ-N--LI--------AWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 287 ~~~~~~-~--~~--------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...... . .. .............+.+... .......+..+.+||.+||+.||.+|||+.++++.|..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 221110 0 00 0000000000000000000 00123456689999999999999999999999999988
Q ss_pred hhcCC
Q 046892 356 LSNSK 360 (519)
Q Consensus 356 ~~~~~ 360 (519)
+....
T Consensus 316 ll~~~ 320 (336)
T 3g2f_A 316 LMMIW 320 (336)
T ss_dssp HHHCC
T ss_pred HHHHH
Confidence 76543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=353.61 Aligned_cols=266 Identities=17% Similarity=0.217 Sum_probs=208.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC--------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeee---------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS--------NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVN--------- 138 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~--------- 138 (519)
.++|.+.+.||+|+||.||+|++.. +++.||||++... ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999987 3889999998744 46888999999999999987
Q ss_pred ------eeeEEec-CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 046892 139 ------LIGYCAD-GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSN 211 (519)
Q Consensus 139 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~N 211 (519)
+++++.. ....+|||||+ +++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6677765 67889999999 99999999653 2356999999999999999999999999 9999999999
Q ss_pred eeeCCCC--CcEEeeecccccCCCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 046892 212 ILLGANL--DPKLSDFGLAKLGPQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVID 284 (519)
Q Consensus 212 ILl~~~~--~vkL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~ 284 (519)
||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999765432211 11234579999999999999999999999999999999999999998
Q ss_pred CCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 285 TTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
...... ..+............. +..... .....+..+.+|+..||+.||.+||++.+|++.|..+...
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDKPGP---FVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHSCCC---EECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCcCH-HHHHHHHHhccCChhh---hhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 654222 1122222111111111 110000 0112346889999999999999999999999999877643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=378.75 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=200.5
Q ss_pred eeeeccCcEEEEEEEE--cCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTL--QSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.+|..++|||||++++++.. +..+|||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 34578999999975432 234679999999999999999999999965 568899999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc-c
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK-M 237 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 237 (519)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999953 456899999999999999999999999 99999999999999999999999999987654332 1
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.......||+.|+|||++.+..++.++|||||||+||||++ |..||...........+. .. .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~~--------------~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KG--------------E 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TT--------------C
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC--------------C
Confidence 12233457889999999999999999999999999999998 999997654322221111 10 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...++..++.++.+||..||+.||.+||++.+|++.|..+
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1123445567899999999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=339.42 Aligned_cols=258 Identities=28% Similarity=0.371 Sum_probs=210.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4578999999999999999999999899999999986542 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC---CCcEEeeecccc
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN---LDPKLSDFGLAK 229 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~---~~vkL~DFGla~ 229 (519)
|||+.+++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999988543 46899999999999999999999999 9999999999999754 469999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||........ .... .......+
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~---~~~~~~~~ 242 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRV---ETGKYAFD 242 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HHCCCCCC
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHH---HcCCCCCC
Confidence 6544322 223468999999999875 589999999999999999999999976533221 1111 11110000
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+ .....+..+.+|+.+||+.||.+|||+.+++++.++-.
T Consensus 243 ---~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 243 ---LP-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp ---SG-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred ---ch-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 00 01223457899999999999999999999999887643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=355.29 Aligned_cols=272 Identities=22% Similarity=0.263 Sum_probs=207.8
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CC-----CeeeeeeEEecC
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HP-----NLVNLIGYCADG 146 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~~~ 146 (519)
....++|.+.+.||+|+||+||+|.+..+++.||||++... ......+..|+.++..+. |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34467999999999999999999999999999999999643 222355677888888775 44 499999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeEecCCCCCCeeeC--CCCCcEE
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD--KANPPVIYRDLKSSNILLG--ANLDPKL 222 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~~~~IvHrDikp~NILl~--~~~~vkL 222 (519)
+..+|||||+. ++|.+++... ....+++..++.++.||+.||.|||. .+ |+||||||+||||+ .++.+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 99999999995 5999998653 23458999999999999999999994 56 99999999999994 5788999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI- 301 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~- 301 (519)
+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|..||......+....+......
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999999876432 23467899999999999999999999999999999999999999875443322211110000
Q ss_pred ----ccCCCC-------CC--------------cc-------cchHhh-------------ccCChhhHHHHHHHHHHhh
Q 046892 302 ----FRDPKR-------FP--------------DM-------ADPLLR-------------KQFPEKGLNEAVAIAAMCL 336 (519)
Q Consensus 302 ----~~~~~~-------~~--------------~~-------~d~~l~-------------~~~~~~~~~~l~~li~~cl 336 (519)
...... ++ .+ +...+. ..........+.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 000000 00 00 000000 0011223457899999999
Q ss_pred hhCCCCCCCHHHHHHHHhhh
Q 046892 337 QEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 337 ~~dP~~RPs~~evl~~l~~~ 356 (519)
+.||.+|||+.++++|.|+-
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~ 377 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFK 377 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGC
T ss_pred CCChhhCCCHHHHhcCcccc
Confidence 99999999999999998764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.93 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=199.3
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhc----CCCCeeeeeeEE
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLL----HHPNLVNLIGYC 143 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~HpnIv~l~~~~ 143 (519)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.++..+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999999989999999999755332 223355788888888 899999999999
Q ss_pred ecCCceEEEEEe-cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCcE
Q 046892 144 ADGDQRLLVYEF-MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDPK 221 (519)
Q Consensus 144 ~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~vk 221 (519)
.+.+..++|||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 999999999999 789999999965 246899999999999999999999999 99999999999999 889999
Q ss_pred EeeecccccCCCCCccceecccccccccCchhhhccCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 222 LSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELT-VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 222 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~-~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
|+|||++....... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||.... ....
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~---- 247 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE---- 247 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH----
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh----
Confidence 99999998765432 2345789999999999877664 58999999999999999999986421 1111
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.. ..++...+..+.+|+.+||+.||.+|||+.+++++.++..
T Consensus 248 ---~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~ 289 (312)
T 2iwi_A 248 ---AE------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289 (312)
T ss_dssp ---TC------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC
T ss_pred ---hc------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcC
Confidence 00 1123344567889999999999999999999999977643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=339.66 Aligned_cols=259 Identities=22% Similarity=0.379 Sum_probs=199.9
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec---------
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD--------- 145 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--------- 145 (519)
..++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.++..++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356899999999999999999999989999999998643 2334568899999999999999999998865
Q ss_pred ----CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcE
Q 046892 146 ----GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPK 221 (519)
Q Consensus 146 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vk 221 (519)
....++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 4568999999999999999964 2345788999999999999999999999 99999999999999999999
Q ss_pred EeeecccccCCCCCc------------cceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Q 046892 222 LSDFGLAKLGPQGEK------------MNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRP 288 (519)
Q Consensus 222 L~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~ 288 (519)
|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 999999986542210 1122345789999999999764 78999999999999999998 44321
Q ss_pred cchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 289 VDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.+..... ..+......++ ..++...+..+.+|+.+||+.||.+|||+.+++++.|+-
T Consensus 232 ~~~~~~~---~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (303)
T 1zy4_A 232 MERVNIL---KKLRSVSIEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288 (303)
T ss_dssp HHHHHHH---HHHHSTTCCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred hhHHHHH---HhccccccccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence 1111111 11111111111 123344556789999999999999999999999987763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=349.13 Aligned_cols=260 Identities=20% Similarity=0.246 Sum_probs=181.6
Q ss_pred ccCcccc-eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec----CCceE
Q 046892 76 TKNFRQE-CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRL 150 (519)
Q Consensus 76 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 150 (519)
.++|.+. ++||+|+||.||+|.+..+++.||||++... ..........+..+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 5688885 4699999999999999999999999998643 2222223344667899999999999876 45589
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeeecc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDFGL 227 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DFGl 227 (519)
+||||+.+|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999653 2346999999999999999999999999 999999999999976 45599999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ...+......
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~ 251 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLGQYG 251 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------C
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhccccc
Confidence 98654322 23457899999999998888999999999999999999999999764332111000 0000000000
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
++ .......+..+.+|+..||+.||.+|||+.+++++.|+-..
T Consensus 252 ~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 252 FP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00 01112345688999999999999999999999999887543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=348.34 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=201.0
Q ss_pred HhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcC--CCCeeeeeeEEecCCce
Q 046892 74 AATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLH--HPNLVNLIGYCADGDQR 149 (519)
Q Consensus 74 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~ 149 (519)
...++|.+.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.++..++ |+||+++++++.+....
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 34678999999999999999999986 488999999875432 23466889999999997 59999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 558899999854 346899999999999999999999999 999999999999964 889999999998
Q ss_pred cCCCCCccceecccccccccCchhhhcc-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARS-----------GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA 298 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~-----------~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~ 298 (519)
...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .+....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~ 253 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAII 253 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHHH
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-HHHHHH
Confidence 7654333223345679999999999875 4788999999999999999999999975432111 111111
Q ss_pred chhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 299 QPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 299 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. . .....++...+..+.+|+.+||+.||.+||++.+++++.|+-
T Consensus 254 ~----~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 254 D----P----------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp C----T----------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred h----c----------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 1 0 011122333345788999999999999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.28 Aligned_cols=270 Identities=19% Similarity=0.257 Sum_probs=208.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC-eEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC------eeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG-QVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN------LVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||+|.+..++ ..||||++... ......+..|+.++..+.|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999998776 79999998643 233456788999998887655 9999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL-------------- 214 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl-------------- 214 (519)
.+|||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 67777777542 3356999999999999999999999999 9999999999999
Q ss_pred -----CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCc
Q 046892 215 -----GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV 289 (519)
Q Consensus 215 -----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~ 289 (519)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999864432 23457999999999999999999999999999999999999999865433
Q ss_pred chhhHHHhhc-hhc--------------cCCCCCCcccch--Hh---------hccCChhhHHHHHHHHHHhhhhCCCCC
Q 046892 290 DEQNLIAWAQ-PIF--------------RDPKRFPDMADP--LL---------RKQFPEKGLNEAVAIAAMCLQEEAGAR 343 (519)
Q Consensus 290 ~~~~~~~~~~-~~~--------------~~~~~~~~~~d~--~l---------~~~~~~~~~~~l~~li~~cl~~dP~~R 343 (519)
.....+.... ... .....+...... .+ ...........+.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 2221111110 000 000000000000 00 001123446689999999999999999
Q ss_pred CCHHHHHHHHhhhh
Q 046892 344 PLMSDVVTALSFLS 357 (519)
Q Consensus 344 Ps~~evl~~l~~~~ 357 (519)
||+.++++|.|+-.
T Consensus 326 pt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 326 ITLAEALLHPFFAG 339 (355)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcChhhcC
Confidence 99999999987653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=345.71 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=188.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHH-HHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4689999999999999999999999999999999976432 22334555665 677889999999999999999999999
Q ss_pred EecCCCCHHHHHhhhc-cCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 154 EFMSGGSVDDHLLDVN-ETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||+.+ +|.+++.... .....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 8888775422 2356799999999999999999999998 9 999999999999999999999999999865
Q ss_pred CCCCccceecccccccccCchhhh----ccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYA----RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l----~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
..... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||....... ..........
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-- 246 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVKGD-- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSC--
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhcCC--
Confidence 43321 2234789999999998 45678999999999999999999999997643211 1111111100
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+ .+........+..+.+|+.+||+.||.+||++.+++++.++..
T Consensus 247 ~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 247 PP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00 0111112234568999999999999999999999999988754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=341.17 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=199.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-CCe--EEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-NGQ--VVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~--~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|++.+.||+|+||.||+|.+.. ++. .||||++..... ...+.+.+|+.++..++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4579999999999999999998743 333 699999875422 23467889999999999999999999998765 8
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999999653 245899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...... ...... ......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~---~~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHH---HccCCC
Confidence 76543322 12234567889999999998889999999999999999999 99999765322 121111 111111
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. ..+...+..+.+++.+||+.||.+|||+.+++++|..+..
T Consensus 244 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 L----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred C----------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1 1223445688999999999999999999999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=343.59 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=204.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc-----
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 148 (519)
.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.++..++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 57899999999999999999999999999999999754322 23567899999999999999999999987654
Q ss_pred -eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 149 -RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 149 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 68877762 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh-----
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI----- 301 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~----- 301 (519)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+......
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9864332 234578999999999877 67899999999999999999999999865433221111100000
Q ss_pred ccCC---------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 302 FRDP---------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 302 ~~~~---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...- ..++......+ .......+..+.+|+.+||+.||.+|||+.++++|.++-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 0000 00000000000 012234567899999999999999999999999998764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=348.84 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=206.7
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcC--CCCeeeeeeEEe
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLH--HPNLVNLIGYCA 144 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~ 144 (519)
....++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.++..+. |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33467899999999999999999999999999999998754322 2245677999999886 599999999999
Q ss_pred cCCceEEEEEecCC-CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCcEE
Q 046892 145 DGDQRLLVYEFMSG-GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDPKL 222 (519)
Q Consensus 145 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~vkL 222 (519)
+.+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 899999854 346899999999999999999999999 99999999999999 7899999
Q ss_pred eeecccccCCCCCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchh
Q 046892 223 SDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301 (519)
Q Consensus 223 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~ 301 (519)
+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|..||.... ....
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~----- 257 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR----- 257 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-----
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhc-----
Confidence 9999998765332 234579999999999987766 688999999999999999999986421 1111
Q ss_pred ccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 302 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.. ..++...+.++.+|+.+||+.||.+|||+.+|+++.++-
T Consensus 258 --~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~ 298 (320)
T 3a99_A 258 --GQ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298 (320)
T ss_dssp --CC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred --cc------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence 00 012233445788999999999999999999999987753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=340.24 Aligned_cols=262 Identities=25% Similarity=0.337 Sum_probs=200.1
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
..++|++.+.||+|+||.||+|.+.. .||+|++..... ...+.+.+|+.++..++||||+++++++.+....++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35789999999999999999999863 399999865422 2335577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||+.+++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++....
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999843 3346899999999999999999999999 99999999999998 6799999999987543
Q ss_pred CCC---ccceecccccccccCchhhhcc---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhch
Q 046892 233 QGE---KMNVTSRVMGTYGYCAPEYARS---------GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300 (519)
Q Consensus 233 ~~~---~~~~~~~~~Gt~~y~APE~l~~---------~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~ 300 (519)
... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~- 256 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---IWQMG- 256 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---HHHHH-
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhc-
Confidence 211 1112233568999999999864 4578999999999999999999999976432211 11111
Q ss_pred hccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCC
Q 046892 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEP 362 (519)
Q Consensus 301 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~ 362 (519)
... .+.. .+...+..+.+|+..||+.||.+|||+.++++.|..+......
T Consensus 257 --~~~--~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 257 --TGM--KPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp --TTC--CCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred --cCC--CCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 000 0000 0112334688999999999999999999999999887665433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.99 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=186.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-hHH-HHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-NKE-FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-~~~-~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||.||+|.+..+|+.||||++....... ... +..+..++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999999899999999997653322 222 334455678889999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||+ ++.+..++.. ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555555432 235689999999999999999999995 8 9999999999999999999999999997654
Q ss_pred CCCccceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... ........ ......
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~--~~~~~~ 249 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVL--QEEPPL 249 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHH--HSCCCC
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHh--ccCCCC
Confidence 332 123457899999999984 567899999999999999999999999764321 11111110 001101
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
++ .....+..+.+|+.+||+.||.+||++.+++++.++.
T Consensus 250 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (318)
T 2dyl_A 250 LP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288 (318)
T ss_dssp CC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred CC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence 11 0112345788999999999999999999999988764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=366.54 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=207.0
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
..++|++.+.||+|+||.||+|.+..+ +..||||.+..... ...+.+..|+.++..++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 456799999999999999999998643 56899999865432 22367889999999999999999999985 46789
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999954 2346899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||......+ ....... ..
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~---~~---- 609 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN---GE---- 609 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHH---TC----
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc---CC----
Confidence 6443221 2233457889999999999999999999999999999997 999997654322 2211110 00
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
...++..++..+.+|+.+||+.||.+|||+.+|++.|..+.
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01133445568899999999999999999999999998664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=351.80 Aligned_cols=258 Identities=24% Similarity=0.321 Sum_probs=191.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEEe
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
+.|.+.+.||+|+||+||.+.. .+|+.||||++... ....+..|+.++..+ +||||+++++++.+.+..+|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4566778999999999987544 46999999998643 235678899999876 899999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC-------------CC
Q 046892 156 MSGGSVDDHLLDVNETKKP---LDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN-------------LD 219 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~-------------~~ 219 (519)
|. |+|.+++......... ..+..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999653222111 133456789999999999999999 9999999999999754 47
Q ss_pred cEEeeecccccCCCCCccc--eecccccccccCchhhhcc-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCc
Q 046892 220 PKLSDFGLAKLGPQGEKMN--VTSRVMGTYGYCAPEYARS-------GELTVKSDVYSFGVILLELIT-GRRVIDTTRPV 289 (519)
Q Consensus 220 vkL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~APE~l~~-------~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~ 289 (519)
+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998765433211 1234679999999999975 678999999999999999999 99999754322
Q ss_pred chhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 290 DEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
. ..+.. ... ..+.. ....+...+.++.+|+.+||+.||.+|||+.+|++|.++
T Consensus 247 ~-~~i~~---~~~----~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 247 E-SNIIR---GIF----SLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp H-HHHHH---TCC----CCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred H-HHHhc---CCC----Ccccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 1 11111 111 11110 111234566789999999999999999999999998876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.10 Aligned_cols=254 Identities=21% Similarity=0.252 Sum_probs=189.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
..+|.+.++||+|+||+||... ..+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+....|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3468899999999999976433 34689999999865432 2356799999988 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----CCCcEEeeecccc
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-----NLDPKLSDFGLAK 229 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-----~~~vkL~DFGla~ 229 (519)
||. |+|.+++... ...+.+..++.++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 995 6999998542 233455567789999999999999999 999999999999953 3357899999998
Q ss_pred cCCCCCc-cceecccccccccCchhhhc---cCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccC
Q 046892 230 LGPQGEK-MNVTSRVMGTYGYCAPEYAR---SGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 230 ~~~~~~~-~~~~~~~~Gt~~y~APE~l~---~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
....... ........||+.|+|||++. ...++.++|||||||++|||++ |..||........ .... .
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~~~~---~- 243 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----NILL---G- 243 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----HHHT---T-
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----HHHh---c-
Confidence 7654321 12234567999999999997 4677889999999999999999 8898864322111 1110 0
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...... ..........+.+||.+||+.||.+|||+.+|++|.++
T Consensus 244 ~~~~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 244 ACSLDC-------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp CCCCTT-------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred cCCccc-------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 000000 00122345568899999999999999999999998876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=322.13 Aligned_cols=240 Identities=19% Similarity=0.237 Sum_probs=188.0
Q ss_pred ccCcccc-eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHH-HhcCCCCeeeeeeEEec----CCce
Q 046892 76 TKNFRQE-CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLML-SLLHHPNLVNLIGYCAD----GDQR 149 (519)
Q Consensus 76 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~~~~ 149 (519)
.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+..|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567776 789999999999999999999999999863 35677888887 66789999999999877 6778
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeeec
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDFG 226 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DFG 226 (519)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999652 3346999999999999999999999999 999999999999998 7889999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
++.... +..++.++|||||||++|+|++|..||......... ........
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------~~~~~~~~ 215 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------PGMKTRIR 215 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------CCSCCSSC
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------HHHHHHHh
Confidence 986432 234678999999999999999999999754321100 00000000
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.......... ....+.++.+|+.+||+.||.+|||+.++++|.++....
T Consensus 216 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 216 MGQYEFPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TTCCSSCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hccccCCchh----cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000000000 023456899999999999999999999999998876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=360.94 Aligned_cols=266 Identities=26% Similarity=0.347 Sum_probs=206.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEec------CCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD------GDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~~ 148 (519)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+..|+.++..++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999999999999999986542 2234568899999999999999999999765 677
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCC---cEEeee
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLD---PKLSDF 225 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~---vkL~DF 225 (519)
.++||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999996532 2346899999999999999999999999 999999999999997765 899999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhcc--
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFR-- 303 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~-- 303 (519)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...|......
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC---
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhccc
Confidence 99987654332 2346799999999999999999999999999999999999999975321 1111111100
Q ss_pred -----------CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 304 -----------DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 304 -----------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+.... .....+....+..+.+|+..||..||.+|||+.+++++.++
T Consensus 241 ~~~~~~~~~l~g~~~~~~~l--p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F 301 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVL--PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSS--CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred chhhhhhhhhcccccccccc--CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence 000010000 01123455678899999999999999999999997666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.27 Aligned_cols=248 Identities=18% Similarity=0.171 Sum_probs=188.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHHHHHHHhcCC-CCeee---------ee--
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHH-PNLVN---------LI-- 140 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H-pnIv~---------l~-- 140 (519)
...|...++||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++..+.| .|+.. .+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4458888999999999999999999999999999874332 235678899999999887 22111 11
Q ss_pred ----------eEEec-----CCceEEEEEecCCCCHHHHHhhh---ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046892 141 ----------GYCAD-----GDQRLLVYEFMSGGSVDDHLLDV---NETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202 (519)
Q Consensus 141 ----------~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~I 202 (519)
.++.. ....+++|+++ +++|.+++... ......+++..++.|+.||+.||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 22356777766 68999988532 223445788899999999999999999999 9
Q ss_pred EecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhh----------ccCCCCchhHHHHHHHH
Q 046892 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA----------RSGELTVKSDVYSFGVI 272 (519)
Q Consensus 203 vHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l----------~~~~~~~~sDvwSlGvl 272 (519)
|||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998864322 344678 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 273 LLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 273 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
||||++|+.||......... ..++.. ....+..+.+|+..||+.||.+||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~------~~~~~~----------------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS------EWIFRS----------------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS------GGGGSS----------------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhH------HHHHhh----------------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999999999764322110 111110 01234578999999999999999999999887
Q ss_pred Hhh
Q 046892 353 LSF 355 (519)
Q Consensus 353 l~~ 355 (519)
.++
T Consensus 365 ~~~ 367 (413)
T 3dzo_A 365 PEY 367 (413)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=318.23 Aligned_cols=235 Identities=16% Similarity=0.138 Sum_probs=188.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|++..+++.||||++....... ...+..|+.++..++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999999999999999997654332 26688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
|||++|++|.+++.. . .....+..|+.||+.||+|||+.| |+||||||+||||+.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999832 2 355678889999999999999999 9999999999999999999997443
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
|++ .++.++|||||||+||||++|+.||.......... ......... ..
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~-----~~ 223 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQ-----PI 223 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSC-----BC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccC-----CC
Confidence 443 36899999999999999999999998754322110 000000000 00
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
. ...+....+..+.+|+.+||+.||.+| |+.++++.|..+....
T Consensus 224 ~---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 224 E---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp C---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred C---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0 011223455688999999999999999 9999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=357.76 Aligned_cols=236 Identities=24% Similarity=0.382 Sum_probs=191.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc-----
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 148 (519)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+..|+.++..++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999976 789999999865432 233567899999999999999999999987665
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.||||||+++++|.+++. ..+++..++.|+.||+.||.|||+++ ||||||||+||||+.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 799999999999998762 26999999999999999999999999 9999999999999985 8999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
+..... ....||+.|+|||++.++. +.++|||||||+||+|++|..||...... .+
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~~ 284 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------GL 284 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------SC
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------cc
Confidence 875432 3457999999999997654 89999999999999999998887642110 00
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
+.. ... ......+.+||.+||+.||.+||+..+.+.+
T Consensus 285 ~~~-~~~------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 285 PED-DPV------LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp CTT-CHH------HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ccc-ccc------cccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 000 000 1123578899999999999999975554443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=328.78 Aligned_cols=247 Identities=18% Similarity=0.183 Sum_probs=187.3
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--------cChHHHHHHHHHHHhcC---------CCCeee
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--------QGNKEFLVEVLMLSLLH---------HPNLVN 138 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---------HpnIv~ 138 (519)
.++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+|+.+++.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 589999999976532 22367889999988885 666666
Q ss_pred eeeEE-----------------ec-------------CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHH
Q 046892 139 LIGYC-----------------AD-------------GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188 (519)
Q Consensus 139 l~~~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~ 188 (519)
+++++ .+ ....||||||+++|++.+.+. ...+++..++.|+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 66653 32 678999999999997766662 25689999999999999
Q ss_pred HHHHHHH-hcCCCCeEecCCCCCCeeeCCCC--------------------CcEEeeecccccCCCCCccceeccccccc
Q 046892 189 QGLEYLH-DKANPPVIYRDLKSSNILLGANL--------------------DPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247 (519)
Q Consensus 189 ~aL~~LH-~~~~~~IvHrDikp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~ 247 (519)
.||+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ..+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999 899 99999999999999887 8999999999865432 347999
Q ss_pred ccCchhhhccCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHH
Q 046892 248 GYCAPEYARSGELTVKSDVYSFGVI-LLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLN 326 (519)
Q Consensus 248 ~y~APE~l~~~~~~~~sDvwSlGvl-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 326 (519)
.|+|||++.+.. +.++||||||++ .+++++|..||..... ..... ..+.... ....... .......+.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~---~~~~~~~-~~~~~~~----~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLT---DKMLKQM-TFKTKCN----TPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHH---HHHHHTC-CCSSCCC----SHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHH---Hhhhhhh-ccCcccc----hhhhhhcCH
Confidence 999999998666 999999998777 7778889888742100 00011 1111000 0000000 112235678
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHH-HHHhh
Q 046892 327 EAVAIAAMCLQEEAGARPLMSDVV-TALSF 355 (519)
Q Consensus 327 ~l~~li~~cl~~dP~~RPs~~evl-~~l~~ 355 (519)
++.+||.+||+.| |+.+++ +|.|+
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~Hp~f 335 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQHSLF 335 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHCGGG
T ss_pred HHHHHHHHHhccC-----CHHHHHhcCCCc
Confidence 8999999999977 999999 88764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=296.02 Aligned_cols=186 Identities=16% Similarity=0.094 Sum_probs=133.6
Q ss_pred eeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc----------ChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEE
Q 046892 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ----------GNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 84 ~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~----------~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++.|++|.+..++....|+.||||++...... ..++|.+|+.+|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467788888887777777999999999764321 234688999999999 699999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||||+|++|.++|.. .++++.. .|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999953 4567654 48899999999999999 9999999999999999999999999998765
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCC
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRV 282 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~p 282 (519)
.... .....+||+.|||||++.+ .+..++|+|++|+++++|.++..+
T Consensus 391 ~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 2345789999999999875 567889999999999988776443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=263.50 Aligned_cols=185 Identities=21% Similarity=0.244 Sum_probs=145.4
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC--------hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG--------NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
...+.||+|+||.||+|.. .+..+++|+........ .+.+.+|+.++..++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4467899999999999954 37889999865432211 2347899999999999999966666667778899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++++|.+++.. ++.|+.||+.||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999843 5579999999999999999 999999999999998 9999999999976
Q ss_pred CCCCccc-----eecccccccccCchhhhcc--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 046892 232 PQGEKMN-----VTSRVMGTYGYCAPEYARS--GELTVKSDVYSFGVILLELITGRRVI 283 (519)
Q Consensus 232 ~~~~~~~-----~~~~~~Gt~~y~APE~l~~--~~~~~~sDvwSlGvll~elltG~~pf 283 (519)
....... ......||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 5432211 1235789999999999986 66788899999999999988877654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=217.81 Aligned_cols=151 Identities=14% Similarity=0.061 Sum_probs=122.3
Q ss_pred HHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------------------ChHHHHHHHHHHHhcC
Q 046892 71 ELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------------------GNKEFLVEVLMLSLLH 132 (519)
Q Consensus 71 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------------------~~~~~~~E~~~l~~l~ 132 (519)
.+......|.+.+.||+|+||.||+|.+ .+|+.||||++...... ....+.+|+.++..++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 3444456678889999999999999999 78999999998643211 2345889999999998
Q ss_pred CCCeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 046892 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNI 212 (519)
Q Consensus 133 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NI 212 (519)
| +++++++.. +..++||||++|++|.+ +. . .....++.||+.||.|||+.+ |+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 5 677776544 56799999999999987 41 1 234569999999999999999 99999999999
Q ss_pred eeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhc
Q 046892 213 LLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256 (519)
Q Consensus 213 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~ 256 (519)
|++ ++.+||+|||+++. +..|+|||++.
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999 99999999999863 45589999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=9.8e-21 Score=184.94 Aligned_cols=138 Identities=16% Similarity=0.082 Sum_probs=107.9
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeE--EEEEEeccCCCcC------------------------hHHHHHHHHHHHhc
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQV--VAVKQLDRNGMQG------------------------NKEFLVEVLMLSLL 131 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~~~~~------------------------~~~~~~E~~~l~~l 131 (519)
-|.+.+.||+|+||.||+|.+..+|+. ||||++....... ...+..|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999999667999 9999875432110 12578899999999
Q ss_pred CCCCe--eeeeeEEecCCceEEEEEecCC-C----CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 046892 132 HHPNL--VNLIGYCADGDQRLLVYEFMSG-G----SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH-DKANPPVI 203 (519)
Q Consensus 132 ~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~Iv 203 (519)
.|++| ..++++ +..+|||||+.+ | +|.+++.. .++..+..++.||+.||.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88764 444442 367899999942 3 67766532 224467789999999999999 999 99
Q ss_pred ecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 204 YRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 204 HrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-17 Score=171.07 Aligned_cols=135 Identities=13% Similarity=0.148 Sum_probs=96.7
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--------------cChHHH--------HHHHHHHHhcCCCC
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--------------QGNKEF--------LVEVLMLSLLHHPN 135 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~Hpn 135 (519)
-|.+...||.|+||.||+|.+. +|+.||||+++.... ...... ..|...|..+.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999986 599999998753211 001111 23445555554333
Q ss_pred ee--eeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 046892 136 LV--NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNIL 213 (519)
Q Consensus 136 Iv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NIL 213 (519)
+. ..+++ ...+|||||+.|++|..+.. . .....++.||+.+|.|||..| ||||||||.|||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL 237 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence 21 22221 23479999999988765431 1 234568899999999999999 999999999999
Q ss_pred eCCCCC----------cEEeeeccccc
Q 046892 214 LGANLD----------PKLSDFGLAKL 230 (519)
Q Consensus 214 l~~~~~----------vkL~DFGla~~ 230 (519)
|++++. +.|+||+-+..
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EeCCCCcccccccccceEEEEeCCccc
Confidence 987763 88999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=3e-13 Score=131.52 Aligned_cols=146 Identities=16% Similarity=0.074 Sum_probs=114.3
Q ss_pred HHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEE
Q 046892 73 AAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 73 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 151 (519)
......|.+...++.|+++.||++... +..+++|+...........+..|+.++..+. +..+.++++++.+.+..|+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344567988889999999999999754 6789999986532233346888999998885 6778899999988889999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA--------------------------------- 198 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------- 198 (519)
||||++|.+|.+.+. +......++.+++.+|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999887631 11223468889999999999811
Q ss_pred -----------------------CCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 199 -----------------------NPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 199 -----------------------~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
...++|+|++|.|||++.+..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1339999999999999876666799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=117.07 Aligned_cols=138 Identities=16% Similarity=0.069 Sum_probs=99.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E 154 (519)
..|.+..+.+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455544444666799999965 45778999987543 2245778998888876444 5668998888888999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA------------------------------------ 198 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------ 198 (519)
|++|.+|. .. ... ...++.+++..|+.||...
T Consensus 96 ~i~G~~l~--~~-------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SS-------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TS-------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cC-------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998874 21 011 1246777778888888643
Q ss_pred -------------------CCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 199 -------------------NPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 199 -------------------~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
...++|+|++|.|||++.++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=9.9e-11 Score=119.19 Aligned_cols=144 Identities=15% Similarity=0.226 Sum_probs=107.2
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEec--cCC-CcChHHHHHHHHHHHhcC--CCCeeeeeeEEecC---CceEE
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLD--RNG-MQGNKEFLVEVLMLSLLH--HPNLVNLIGYCADG---DQRLL 151 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~l 151 (519)
...+.|+.|.++.||++... +..+++|+.. ... ......+..|+.++..+. +..+.+++.++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34578899999999998765 4678888775 322 122346788999998887 45588899988776 45899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA--------------------------------- 198 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------- 198 (519)
||||++|..+.+.. ...++......++.+++..|+.||...
T Consensus 119 vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 99999987764321 234678888899999999999999831
Q ss_pred ----------------------CCCeEecCCCCCCeeeCCCCC--cEEeeecccccC
Q 046892 199 ----------------------NPPVIYRDLKSSNILLGANLD--PKLSDFGLAKLG 231 (519)
Q Consensus 199 ----------------------~~~IvHrDikp~NILl~~~~~--vkL~DFGla~~~ 231 (519)
...++|+|+++.|||++.++. +.|+||+.+...
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 234999999999999987753 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=7.4e-11 Score=117.33 Aligned_cols=187 Identities=20% Similarity=0.216 Sum_probs=122.2
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCC--eeeeeeEEecCC---ceEEEEEe
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPN--LVNLIGYCADGD---QRLLVYEF 155 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~ 155 (519)
.+.++.|....||++. ..+++|+.... .....+..|+.+|..+. +.. +..++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999863 45889986432 23456888999998773 322 345555443333 34899999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA------------------------------------- 198 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------- 198 (519)
++|.+|..... ..++......++.+++..|+.||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988875432 23677777888888888888888621
Q ss_pred ------------------CCCeEecCCCCCCeeeCC--CCCcEEeeecccccCCCCCccceecc------------cccc
Q 046892 199 ------------------NPPVIYRDLKSSNILLGA--NLDPKLSDFGLAKLGPQGEKMNVTSR------------VMGT 246 (519)
Q Consensus 199 ------------------~~~IvHrDikp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~------------~~Gt 246 (519)
...++|+|++|.|||++. +..+.|+||+.+.............. +...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 134899999999999988 55678999999876433211100000 0000
Q ss_pred cccCc-hhhhccCCCCchhHHHHHHHHHHHHHhCCCCC
Q 046892 247 YGYCA-PEYARSGELTVKSDVYSFGVILLELITGRRVI 283 (519)
Q Consensus 247 ~~y~A-PE~l~~~~~~~~sDvwSlGvll~elltG~~pf 283 (519)
.++.. |+.... .....+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11122 222211 122368999999999999997654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=1.7e-07 Score=90.82 Aligned_cols=136 Identities=17% Similarity=0.132 Sum_probs=98.7
Q ss_pred eeeccCcE-EEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEEecCCCCH
Q 046892 84 LLGEGGFG-RVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEFMSGGSV 161 (519)
Q Consensus 84 ~LG~G~~g-~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 161 (519)
.+..|..| .||+......+..+++|+.... ....+..|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445444 6999887777788999986532 3456788998888774 33367889999889999999999999888
Q ss_pred HHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 046892 162 DDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA------------------------------------------- 198 (519)
Q Consensus 162 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------------- 198 (519)
.+..... ......++.+++..|+.||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7765321 1223346666777777777531
Q ss_pred ------------CCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 199 ------------NPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 199 ------------~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877778999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=4e-07 Score=90.41 Aligned_cols=137 Identities=20% Similarity=0.165 Sum_probs=93.9
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCC---CeeeeeeEEe-cCCceEEEEEecC
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHP---NLVNLIGYCA-DGDQRLLVYEFMS 157 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~ 157 (519)
.+.++.|....||+. +..+++|+... ......+..|+.+|..+.+. .+.+++.+.. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 457888999999988 45688887532 12345688999999988752 3556666664 4556789999999
Q ss_pred CCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 046892 158 GGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK---------------------------------------- 197 (519)
Q Consensus 158 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------------------------------------- 197 (519)
|.+|..... ..++......++.+++..|+.||+.
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 1234444445555555555555542
Q ss_pred -----------------CCCCeEecCCCCCCeeeCC---CCCc-EEeeecccccC
Q 046892 198 -----------------ANPPVIYRDLKSSNILLGA---NLDP-KLSDFGLAKLG 231 (519)
Q Consensus 198 -----------------~~~~IvHrDikp~NILl~~---~~~v-kL~DFGla~~~ 231 (519)
....++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1224799999999999987 4554 89999988754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.5e-06 Score=89.38 Aligned_cols=76 Identities=17% Similarity=0.101 Sum_probs=49.7
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-------cChHHHHHHHHHHHhcCC--CC-eeeeeeEEecCCceEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-------QGNKEFLVEVLMLSLLHH--PN-LVNLIGYCADGDQRLL 151 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--pn-Iv~l~~~~~~~~~~~l 151 (519)
.+.||.|..+.||++....++..|+||....... .....+..|..++..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4689999999999997655578899998653211 123456778888876642 33 4456544 3456789
Q ss_pred EEEecCCC
Q 046892 152 VYEFMSGG 159 (519)
Q Consensus 152 V~E~~~~g 159 (519)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-06 Score=88.85 Aligned_cols=81 Identities=9% Similarity=0.027 Sum_probs=55.2
Q ss_pred ceee-eccCcEEEEEEEEc--C----CCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCC---CCeeeeeeEEecC--
Q 046892 82 ECLL-GEGGFGRVYKGTLQ--S----NGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHH---PNLVNLIGYCADG-- 146 (519)
Q Consensus 82 ~~~L-G~G~~g~Vy~~~~~--~----~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~~-- 146 (519)
.+.| +.|....+|++... . ++..+++|+..... ......+..|+.++..+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88889999998754 1 15678999865432 1122456778888877642 3467788877665
Q ss_pred -CceEEEEEecCCCCHH
Q 046892 147 -DQRLLVYEFMSGGSVD 162 (519)
Q Consensus 147 -~~~~lV~E~~~~gsL~ 162 (519)
+..++||||++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=7.1e-06 Score=81.91 Aligned_cols=143 Identities=17% Similarity=0.281 Sum_probs=79.8
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--CCeeeeee------EEecCCceEEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH--PNLVNLIG------YCADGDQRLLVY 153 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~------~~~~~~~~~lV~ 153 (519)
.+.|+.|..+.||++... +..+++|+.... ...+..|+.++..+.. -.+.+++. +....+..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778899999764 345999988642 2344445555554421 12333433 123456789999
Q ss_pred EecCCCCHH-----------HH---HhhhccCC----------CCCCHHHH-----------------------------
Q 046892 154 EFMSGGSVD-----------DH---LLDVNETK----------KPLDWTTR----------------------------- 180 (519)
Q Consensus 154 E~~~~gsL~-----------~~---l~~~~~~~----------~~l~~~~~----------------------------- 180 (519)
+|++|.++. .. ++...... ....|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 11 11111100 00122211
Q ss_pred --HHHHHHHHHHHHHHHh--------c--CCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 181 --MKIASGAAQGLEYLHD--------K--ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 181 --~~i~~qi~~aL~~LH~--------~--~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
..+...+..++.+|+. . ....++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 1 233499999999999998888999999997753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.09 E-value=4.2e-06 Score=86.81 Aligned_cols=77 Identities=13% Similarity=0.115 Sum_probs=47.8
Q ss_pred CeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccC---CCCchhHHHHHHHHHHHHH
Q 046892 201 PVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG---ELTVKSDVYSFGVILLELI 277 (519)
Q Consensus 201 ~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~sDvwSlGvll~ell 277 (519)
.++|+|++|.|||++.++ ++|+||+.+............-. .-...|++|+..... .-....++..+...+|+++
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 399999999999998876 99999999876432211110000 001346666654311 1122355668888888887
Q ss_pred hC
Q 046892 278 TG 279 (519)
Q Consensus 278 tG 279 (519)
.+
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.00 E-value=4.9e-05 Score=74.34 Aligned_cols=80 Identities=20% Similarity=0.242 Sum_probs=58.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC---CCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH---PNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~~~~~~lV~ 153 (519)
........+|.|..+.||+++.. +|+.|++|+...........+..|+..|+.+.- --+.+++++. ..++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence 45666788999999999999875 589999998765544444567889998887742 2345555542 347899
Q ss_pred EecCCCCH
Q 046892 154 EFMSGGSV 161 (519)
Q Consensus 154 E~~~~gsL 161 (519)
||+.++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=3.7e-05 Score=76.40 Aligned_cols=140 Identities=16% Similarity=0.187 Sum_probs=91.2
Q ss_pred cceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC---CCCeeeeeeEEecCCceEEEEEecC
Q 046892 81 QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEFMS 157 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~ 157 (519)
..+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.+....+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 456789999999999875 3678889987543 3456788988888774 3568888988888888999999999
Q ss_pred CCCHH--------HHHhhhccCCC---------------------CCCHHHHH---HHH----------------HHHHH
Q 046892 158 GGSVD--------DHLLDVNETKK---------------------PLDWTTRM---KIA----------------SGAAQ 189 (519)
Q Consensus 158 ~gsL~--------~~l~~~~~~~~---------------------~l~~~~~~---~i~----------------~qi~~ 189 (519)
+..+. ..|........ .-+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 12211111100 01344322 011 11222
Q ss_pred HH-HHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeec
Q 046892 190 GL-EYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFG 226 (519)
Q Consensus 190 aL-~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFG 226 (519)
.+ ..|.. ...+.+||+|+.+.||+++.++ +.|+||+
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22 23432 1235599999999999999887 8899974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00066 Score=67.09 Aligned_cols=159 Identities=14% Similarity=0.110 Sum_probs=85.6
Q ss_pred ccHHHHHHhccCccc-----ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eeee
Q 046892 67 FTFRELAAATKNFRQ-----ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVNL 139 (519)
Q Consensus 67 ~~~~~~~~~~~~y~~-----~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l 139 (519)
++..++......|.+ .+.|+.|....||++.... | .+++|+.... .....+..|+.++..+...+ +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 344555555555654 3456778889999987652 4 6889988652 12234566777766553212 2333
Q ss_pred eeE------EecCCceEEEEEecCCCCHH-----------HH---HhhhccC-CCC----C---CHHHHHH---------
Q 046892 140 IGY------CADGDQRLLVYEFMSGGSVD-----------DH---LLDVNET-KKP----L---DWTTRMK--------- 182 (519)
Q Consensus 140 ~~~------~~~~~~~~lV~E~~~~gsL~-----------~~---l~~~~~~-~~~----l---~~~~~~~--------- 182 (519)
+.. ....+..++||+|++|..+. .. ++..... ..+ . .|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 12245678999999886531 11 1111000 000 1 1222110
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 183 ---IASGAAQGLEYLHDK----ANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 183 ---i~~qi~~aL~~LH~~----~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
+...+...+++|... ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134455555532 12349999999999999887666899999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00042 Score=68.06 Aligned_cols=142 Identities=6% Similarity=0.010 Sum_probs=76.8
Q ss_pred ccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEEEec-C
Q 046892 80 RQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEFM-S 157 (519)
Q Consensus 80 ~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~-~ 157 (519)
.-.+.|+.|....+|++ ..+++|+....... ......|+.++..+...++ .+++++. .+..++|+||+ +
T Consensus 21 ~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 21 TGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred cceeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 33678999999999998 34889987643211 1123457777666542222 4555543 44467899999 6
Q ss_pred CCCHHH---------------HHhhhccCCCCC----C-HHHHHHHHHH--------------HHHHHH----HHHh-cC
Q 046892 158 GGSVDD---------------HLLDVNETKKPL----D-WTTRMKIASG--------------AAQGLE----YLHD-KA 198 (519)
Q Consensus 158 ~gsL~~---------------~l~~~~~~~~~l----~-~~~~~~i~~q--------------i~~aL~----~LH~-~~ 198 (519)
|.+|.. .|...+.....+ . +..+..+... +...+. .|.. ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 654432 111111111111 1 1111111110 111111 1111 12
Q ss_pred CCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 199 ~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
...++|+|+.+.||| ..++.+.|+||..+...
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 234899999999999 56677899999988754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00045 Score=70.38 Aligned_cols=143 Identities=15% Similarity=0.190 Sum_probs=84.1
Q ss_pred eeeeccCcEEEEEEEEcC-------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEEE
Q 046892 83 CLLGEGGFGRVYKGTLQS-------NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 154 (519)
+.|..|-...+|++.... ++..|++|+... .......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467678888899998742 357899998633 2234566778988887774 3233667776644 29999
Q ss_pred ecCCCCHH--------------HHHhhhccC----CCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 046892 155 FMSGGSVD--------------DHLLDVNET----KKPL--DWTTRMKIASGAAQ-------------------GLEYLH 195 (519)
Q Consensus 155 ~~~~gsL~--------------~~l~~~~~~----~~~l--~~~~~~~i~~qi~~-------------------aL~~LH 195 (519)
|++|.+|. +.|...+.. .... -+..+..++.++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99886543 111111111 1112 24555555544322 223332
Q ss_pred ----hc-CCCCeEecCCCCCCeeeCCC----CCcEEeeeccccc
Q 046892 196 ----DK-ANPPVIYRDLKSSNILLGAN----LDPKLSDFGLAKL 230 (519)
Q Consensus 196 ----~~-~~~~IvHrDikp~NILl~~~----~~vkL~DFGla~~ 230 (519)
.. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 12349999999999999876 7899999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0011 Score=68.84 Aligned_cols=73 Identities=14% Similarity=0.193 Sum_probs=50.1
Q ss_pred ceeeeccCcEEEEEEEEcC-------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQS-------NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 153 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~ 153 (519)
.+.|+.|-...||++.... ++..|++|+.... .....+..|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578888889999998753 2578999987432 112556688888887753333 667776643 3899
Q ss_pred EecCCCC
Q 046892 154 EFMSGGS 160 (519)
Q Consensus 154 E~~~~gs 160 (519)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998644
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00093 Score=62.03 Aligned_cols=100 Identities=12% Similarity=0.069 Sum_probs=66.1
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCccc
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN 238 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 238 (519)
-+|.+.|.. .+.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 378898865 35789999999999999999877622111 11333457899999999988764 1110
Q ss_pred eecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhC
Q 046892 239 VTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG 279 (519)
Q Consensus 239 ~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG 279 (519)
.....+.+||.+. ...+.+.=|||||++||..+--
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0123466888763 4557889999999999998863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0014 Score=65.17 Aligned_cols=34 Identities=29% Similarity=0.351 Sum_probs=28.4
Q ss_pred CCeEecCCCCCCeeeCCC----CCcEEeeecccccCCC
Q 046892 200 PPVIYRDLKSSNILLGAN----LDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 200 ~~IvHrDikp~NILl~~~----~~vkL~DFGla~~~~~ 233 (519)
..++|+|+.+.|||++.+ +.+.|+||+.+.....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 349999999999999874 6789999999876443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0029 Score=66.13 Aligned_cols=75 Identities=13% Similarity=0.063 Sum_probs=48.6
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEEEecCCCC
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
.+.|+.|-...+|++.....+..|++|+..... ........|..++..+...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 457888888999999886435789999875432 111123578888888765444 56777763 2 35999998754
Q ss_pred H
Q 046892 161 V 161 (519)
Q Consensus 161 L 161 (519)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0019 Score=63.87 Aligned_cols=144 Identities=14% Similarity=0.139 Sum_probs=80.1
Q ss_pred eeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC--eeeeeeE-----EecCCceEEEEEe
Q 046892 83 CLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN--LVNLIGY-----CADGDQRLLVYEF 155 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~E~ 155 (519)
..|+ |....||++... +|..+++|+..... .....+..|..++..+.... +++++.. ....+..++||+|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4577 888899987654 46679999986332 23456677887777664212 3444443 1224456789999
Q ss_pred cCCCCHH-----------HH---HhhhccC-----CCCCCHHHH----------------------HHHHHHHHHHHHHH
Q 046892 156 MSGGSVD-----------DH---LLDVNET-----KKPLDWTTR----------------------MKIASGAAQGLEYL 194 (519)
Q Consensus 156 ~~~gsL~-----------~~---l~~~~~~-----~~~l~~~~~----------------------~~i~~qi~~aL~~L 194 (519)
++|..+. .. ++..... ...+++... ..++..++..+.-+
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875432 11 1111110 111222211 01111222222222
Q ss_pred Hh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 195 HD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 195 H~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
-. .....++|+|+++.|||++ + .+.|+||+.+...
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 11 1223489999999999999 4 8999999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0011 Score=66.99 Aligned_cols=75 Identities=9% Similarity=0.054 Sum_probs=44.1
Q ss_pred ceeeeccCcEEEEEEEEcC--------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCC-eeeeeeEEecCCceEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQS--------NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLV 152 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV 152 (519)
...|+.|....+|++.... .+..+++|+..... ........|..++..+...+ +.++++.+ . .++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888888999998753 12678899865431 11112356777777664333 44666554 1 3789
Q ss_pred EEecCCCCH
Q 046892 153 YEFMSGGSV 161 (519)
Q Consensus 153 ~E~~~~gsL 161 (519)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.017 Score=57.60 Aligned_cols=32 Identities=19% Similarity=0.271 Sum_probs=28.0
Q ss_pred CCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 200 ~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 34999999999999998888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.96 E-value=0.036 Score=57.14 Aligned_cols=143 Identities=13% Similarity=0.162 Sum_probs=84.2
Q ss_pred ceeeeccCcEEEEEEEEcCC-------CeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSN-------GQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.+.|..|-...+|++..... +..|++++..... .......+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 45677788889999987531 5779999864432 22223456777777664 223455665442 37899
Q ss_pred EecCCCCHHH--------------HH---hhhcc---------CCCCCCHHHHHHHHHHH-------------------H
Q 046892 154 EFMSGGSVDD--------------HL---LDVNE---------TKKPLDWTTRMKIASGA-------------------A 188 (519)
Q Consensus 154 E~~~~gsL~~--------------~l---~~~~~---------~~~~l~~~~~~~i~~qi-------------------~ 188 (519)
||++|.+|.. .| +.... ...+..+..+..+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9998865321 11 11111 11122344444444322 1
Q ss_pred HHHHHHHh---------------------cCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 189 QGLEYLHD---------------------KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 189 ~aL~~LH~---------------------~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
..+.+|.. .....++|+|+.+.||| +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11234999999999999 8888999999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.49 E-value=0.22 Score=50.74 Aligned_cols=29 Identities=28% Similarity=0.334 Sum_probs=24.9
Q ss_pred eEecCCCCCCeee------CCCCCcEEeeeccccc
Q 046892 202 VIYRDLKSSNILL------GANLDPKLSDFGLAKL 230 (519)
Q Consensus 202 IvHrDikp~NILl------~~~~~vkL~DFGla~~ 230 (519)
++|+|+.+.|||+ +++..+.|+||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.97 E-value=0.84 Score=42.03 Aligned_cols=122 Identities=11% Similarity=0.157 Sum_probs=80.3
Q ss_pred HHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCCC-CHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046892 124 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGG-SVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPV 202 (519)
Q Consensus 124 E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~I 202 (519)
|+.+|. ..||+++.. .+-.+++.+.+.++.-..+ ++.. + ..++....+.++..|+....+++. -
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r 100 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----R 100 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----S
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----c
Confidence 344433 368888877 4556666666666554322 2222 2 347888999999999988755543 3
Q ss_pred EecCCCCCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCC
Q 046892 203 IYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRV 282 (519)
Q Consensus 203 vHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~p 282 (519)
+|--|.|+||+++.++.++|.--|+-..+. |. .++...=+-.+=|++..+++++..
T Consensus 101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~ 156 (215)
T 4ann_A 101 YTFVLAPDELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQS 156 (215)
T ss_dssp EECCCSGGGEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCC
T ss_pred eEEEEecceEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCC
Confidence 788999999999999999998777643321 11 112222234677889999999877
Q ss_pred CC
Q 046892 283 ID 284 (519)
Q Consensus 283 f~ 284 (519)
|.
T Consensus 157 Fe 158 (215)
T 4ann_A 157 FD 158 (215)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.73 E-value=2.1 Score=39.54 Aligned_cols=115 Identities=13% Similarity=0.108 Sum_probs=75.4
Q ss_pred CCCCeeeeeeEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 046892 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE-YLHDKANPPVIYRDLKSS 210 (519)
Q Consensus 132 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~IvHrDikp~ 210 (519)
.||++ -..+-.+++.+.+.++.-.++.=...+ ..++....+.++..|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57887 333346667777777765443323333 24788899999988887766 4443 478889999
Q ss_pred CeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 046892 211 NILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVID 284 (519)
Q Consensus 211 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~ 284 (519)
||++|.++.++|.-.|+-..+ +|.- .+..-=+-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764332 2221 1111122366778888888877654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 519 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-79 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-68 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-67 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-65 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-65 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-64 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-64 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-61 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-57 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-57 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-54 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-54 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-53 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-52 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-51 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-50 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-50 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-43 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 3e-79
Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 27/287 (9%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPN 135
+G G FG VYKG + VAVK L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
++ +GY Q +V ++ G S+ HL + + + + IA AQG++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHL---HIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
K +I+RDLKS+NI L +L K+ DFGLA + + + ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 256 R---SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312
R + +SDVY+FG++L EL+TG+ P N + PD+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLSPDL- 231
Query: 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
+R P+ + A CL+++ RPL ++ ++ L+ S
Sbjct: 232 -SKVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 2e-69
Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 26/285 (9%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
+ + LG G FG V+ G VAVK L + M FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRL 70
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V L + ++ E+M GS+ D L + L + +A+ A+G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
+ I+RDL+++NIL+ L K++DFGLA+L E + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAIN 183
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
G T+KSDV+SFG++L E++T R P Q + R
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGR-----IPYPGMTNPEVIQNLERGY----------- 227
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL-SFLSNSK 360
R P+ E + +C +E RP + + L F + ++
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 221 bits (564), Expect = 6e-69
Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 38/304 (12%)
Query: 66 TFTFRELAAATKNFRQEC---------LLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRN 113
FTF + A + F +E ++G G FG V G L+ G+ VA+K L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 114 GMQGN-KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETK 172
+ ++FL E ++ HPN+++L G +++ EFM GS+D + +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQND 122
Query: 173 KPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232
+ + G A G++YL + ++RDL + NIL+ +NL K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 233 QGEKMNVTSRV---MGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPV 289
+ + APE + + T SDV+S+G+++ E+++ RP
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPY 234
Query: 290 DEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
+ I +D + P P + + C Q++ RP +
Sbjct: 235 WDMTNQDVINAIEQDYRLPP-----------PMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 350 VTAL 353
V L
Sbjct: 284 VNTL 287
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-68
Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 25/277 (9%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
K+ LG G FG V G + VA+K + M EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKL 61
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V L G C ++ E+M+ G + ++L E + +++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
K ++RDL + N L+ K+SDFGL++ E + + PE
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLM 174
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
+ + KSD+++FGV++ E+ + + P + A+ I + L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHIAQG-----------L 218
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
R P + I C E+A RP +++ +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 3e-68
Identities = 76/296 (25%), Positives = 131/296 (44%), Gaps = 30/296 (10%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
+ LG+G FG+VYK + + A K +D + ++++VE+ +L+ HPN+V
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
L+ + ++ EF +GG+VD + E ++PL + + L YLHD
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 198 ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA-- 255
+I+RDLK+ NIL + D KL+DFG++ + + +GT + APE
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMC 184
Query: 256 ---RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ-PIFRDPKRFPDM 311
+ K+DV+S G+ L+E+ P+ IA ++ P P R+
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPI 367
L+K CL++ AR S ++ +S +PI + I
Sbjct: 245 FKDFLKK----------------CLEKNVDARWTTSQLLQHPFVTVDSNKPIRELI 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 5e-68
Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 37/299 (12%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN-KEFLVEVLMLSLLHHPNL 136
+F + LG G G V+K + + +G V+A K + + + E+ +L + P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V G + + E M GGS+D L + + K++ +GL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
K +++RD+K SNIL+ + + KL DFG++ ++ + +GT Y +PE +
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 176
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI--------------------- 295
+V+SD++S G+ L+E+ GR I + + +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 296 -AWAQPIFRDPKRFPDMADPLLRKQFPEKGLN----EAVAIAAMCLQEEAGARPLMSDV 349
+ R P ++ D ++ + P+ E CL + R + +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 9e-68
Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 25/279 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPN 135
++ +G G +GR K +S+G+++ K+LD M + + EV +L L HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 136 LVNLIGYCADGDQRLL--VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
+V D L V E+ GG + + + ++ LD +++ + L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 194 LHDK--ANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
H + V++RDLK +N+ L + KL DFGLA++ +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311
PE KSD++S G +L EL + I + R P R+ D
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDE 241
Query: 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVV 350
+ ++ + L + RP + +++
Sbjct: 242 LNEIITR----------------MLNLKDYHRPSVEEIL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-67
Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 31/285 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
K + +G+G FG V G G VAVK + + + FL E +++ L H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 137 VNLIGYCADGDQRL-LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
V L+G + L +V E+M+ GS+ D+L + + L +K + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
++RDL + N+L+ + K+SDFGL K + + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEAL 172
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315
R + + KSDV+SFG++L E+ + R P L + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKG----------- 216
Query: 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360
+ P+ + C +A RP + L + +
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 3e-67
Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 32/286 (11%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLHH 133
++F LG+G FG VY + + ++A+K L + ++ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
PN++ L GY D + L+ E+ G+V L + D + A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 121
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
H K VI+RD+K N+LLG+ + K++DFG + P + + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPE 174
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
K D++S GV+ E + G+ P + + I R FPD
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVT 228
Query: 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
A + + L+ RP++ +V+ +NS
Sbjct: 229 E------------GARDLISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 3e-67
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPN 135
+++ LGEG +G V + + VAVK +D E E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V G+ +G+ + L E+ SGG + D + E + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+ +RD+K N+LL + K+SDFGLA + + + +++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 256 RSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP-KRFPDMAD 313
+ E DV+S G++L ++ G D ++ + + +P K+
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
LL K L E AR + D+
Sbjct: 238 ALLHK----------------ILVENPSARITIPDI 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 7e-67
Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 25/283 (8%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
+G G FG V+ G N VA+K + R G ++F+ E ++ L HP L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V L G C + LV+EFM G + D+ + + T + + +G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
VI+RDL + N L+G N K+SDFG+ + + ++ + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFS 175
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
+ KSDV+SFGV++ E+ + ++ R E + D +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYK--- 223
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
P I C +E RP S ++ L+ ++ S
Sbjct: 224 ----PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (547), Expect = 2e-66
Identities = 80/308 (25%), Positives = 120/308 (38%), Gaps = 35/308 (11%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLH 132
K F +G G FG VY N +VVA+K++ +G Q N ++ + EV L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
HPN + G LV E+ G + D + KKPL + GA QGL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLA 129
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAP 252
YLH +I+RD+K+ NILL KL DFG A + M + +GT + AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAP 180
Query: 253 EYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
E + G+ K DV+S G+ +EL + + + IA + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIP 369
+ + CLQ+ RP ++ L + +I
Sbjct: 241 EYFRNFVDS----------------CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284
Query: 370 SDEDEYSE 377
+D E
Sbjct: 285 RTKDAVRE 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 6e-66
Identities = 74/292 (25%), Positives = 133/292 (45%), Gaps = 23/292 (7%)
Query: 62 INAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEF 121
++ + + + + + LG G +G VY+G + VAVK L + M+ +EF
Sbjct: 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEF 60
Query: 122 LVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRM 181
L E ++ + HPNLV L+G C ++ EFM+ G++ D+L + N ++ + +
Sbjct: 61 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLL 118
Query: 182 KIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTS 241
+A+ + +EYL K I+RDL + N L+G N K++DFGL++L G+ +
Sbjct: 119 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHA 174
Query: 242 RVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301
+ APE + ++KSDV++FGV+L E+ T
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--------------- 219
Query: 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
D + ++ + R + PE + + C Q RP +++ A
Sbjct: 220 -IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 7e-66
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 28/289 (9%)
Query: 70 RELAAATKNFR-QECLLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGMQGN-KEFLVEV 125
++L N + LG G FG V +G + VA+K L + + + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 126 LMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIAS 185
++ L +P +V LIG C + +LV E GG + L+ ++ + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 186 GAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVM 244
+ G++YL +K ++RDL + N+LL K+SDFGL+K LG S
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 245 GTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304
+ APE + + +SDV+S+GV + E ++ + +P + I +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQG 228
Query: 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
R + P + E A+ + C + RP V +
Sbjct: 229 K-----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-65
Identities = 67/297 (22%), Positives = 112/297 (37%), Gaps = 29/297 (9%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCA 144
+G+G FG V++G G+ VAVK + + E+ +L H N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 145 DGD----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA-- 198
+ Q LV ++ GS+ D+L + + +K+A A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 199 ---NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMN--VTSRVMGTYGYCAPE 253
P + +RDLKS NIL+ N ++D GLA + +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 254 YARS------GELTVKSDVYSFGVILLELITGRRVI----DTTRPVDEQNLIAWAQPIFR 303
E ++D+Y+ G++ E+ + D P + + R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 304 DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360
+ + + + L I C AR + LS LS +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-65
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 44/302 (14%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQ-----VVAVKQLDRNGMQGNKE-FLVEV-LMLSL 130
N +LG G FG+V T + VAVK L +E + E+ +M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 131 LHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL-------------------LDVNET 171
H N+VNL+G C L++E+ G + ++L L+ E
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 172 KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231
L + + A A+G+E+L K ++RDL + N+L+ K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE 291
V + APE G T+KSDV+S+G++L E+ + P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYPG 269
Query: 292 QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVT 351
+ A + ++ + P E I C ++ RP ++ +
Sbjct: 270 IPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 352 AL 353
L
Sbjct: 320 FL 321
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-65
Identities = 66/274 (24%), Positives = 109/274 (39%), Gaps = 29/274 (10%)
Query: 85 LGEGGFGRVYKGTLQSN--GQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPNLVNLI 140
LG G FG V KG Q + VAVK L E L E ++ L +P +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANP 200
G C + + +LV E G ++ +L + + +++ + G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 201 PVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++RDL + N+LL K+SDFGL+K L + + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ 319
+ KSDV+SFGV++ E + + +P + + R
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGE-----------RMG 230
Query: 320 FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
P E + +C + RP + V L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 5e-65
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 32/281 (11%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHP 134
+ + + +G G F VYKG VA +L + + + F E ML L HP
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 135 NLVNLIGYCADGDQR----LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
N+V + +LV E M+ G++ +L + K + +G
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKG 124
Query: 191 LEYLHDKANPPVIYRDLKSSNILL-GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
L++LH + PP+I+RDLK NI + G K+ D GLA L + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEF 179
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
APE + DVY+FG+ +LE+ T P E A +
Sbjct: 180 MAPEMYE-EKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPA 232
Query: 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVV 350
F + + E I C+++ R + D++
Sbjct: 233 S---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (535), Expect = 8e-65
Identities = 68/302 (22%), Positives = 115/302 (38%), Gaps = 45/302 (14%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGMQGN-KEFLVEVLMLSLL 131
N +GEG FGRV++ +VAVK L +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNE--------------------T 171
+PN+V L+G CA G L++E+M+ G +++ L ++
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 172 KKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231
PL ++ IA A G+ YL ++RDL + N L+G N+ K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDE 291
+ + PE T +SDV+++GV+L E+ + +P
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-----QPYYG 245
Query: 292 QNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVT 351
+ RD PE E + +C + RP +
Sbjct: 246 MAHEEVIYYV-RDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 352 AL 353
L
Sbjct: 295 IL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 2e-64
Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 29/283 (10%)
Query: 84 LLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGMQGN-KEFLVEVLMLSLLHHPNLVNL 139
++G G FG VY GTL N AVK L+R G +FL E +++ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 140 IGYCADGDQR-LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
+G C + L+V +M G + + + + A+G+++L
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLA--- 147
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKL--GPQGEKMNVTSRVMGTYGYCAPEYAR 256
+ ++RDL + N +L K++DFGLA+ + + ++ + + A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
+ + T KSDV+SFGV+L EL+T P + N + +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGR----------- 251
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
R PE + + C +A RP S++V+ +S + ++
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-64
Identities = 76/291 (26%), Positives = 114/291 (39%), Gaps = 39/291 (13%)
Query: 84 LLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLS-LLHHPNL 136
LG G FG+V + T VAVK L + +E + E+ +LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHL--------------LDVNETKKPLDWTTRMK 182
VNL+G C G L++ E+ G + + L + + + LD +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 183 IASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSR 242
+ A+G+ +L K I+RDL + NILL K+ DFGLA+ V
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 243 VMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302
+ APE + T +SDV+S+G+ L EL + PVD +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------- 256
Query: 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
F M R PE E I C + RP +V +
Sbjct: 257 -----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-64
Identities = 71/321 (22%), Positives = 134/321 (41%), Gaps = 38/321 (11%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNG--QVVAVKQLDRNGM-QGNKEFLVEV-LMLSLLH 132
+ + + ++GEG FG+V K ++ +G A+K++ +++F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLD------------VNETKKPLDWTTR 180
HPN++NL+G C L E+ G++ D L N T L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 181 MKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVT 240
+ A+ A+G++YL K I+RDL + NIL+G N K++DFGL++ K
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 241 SRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQP 300
+ + A E T SDV+S+GV+L E+++ P +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 301 IFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360
+ + R + P +E + C +E+ RP + ++ +L+ + +
Sbjct: 239 LPQGY-----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 361 EPIPDPIIPSDEDEYSEGYSS 381
+ + + S+
Sbjct: 288 KTYVNTTLYEKFTYAGIDCSA 308
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-64
Identities = 86/290 (29%), Positives = 128/290 (44%), Gaps = 25/290 (8%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL 136
++ R E LG+G FG V+ GT VA+K L + G + FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 137 VNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD 196
V L + +V E+MS GS+ D ET K L + +A+ A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDF--LKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 197 KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYAR 256
++RDL+++NIL+G NL K++DFGLA+L E + APE A
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAAL 187
Query: 257 SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316
G T+KSDV+SFG++L EL T RV + ++ + +R P
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRMP----------- 234
Query: 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDP 366
P + + C ++E RP + L S EP P
Sbjct: 235 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-63
Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 29/297 (9%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPN 135
K + + +G+G G VY + GQ VA++Q++ + + E+L++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+VN + GD+ +V E+++GGS+ D + T+ +D + Q LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH 133
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
VI+RD+KS NILLG + KL+DFG + S ++GT + APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVV 188
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPIFRDPKRFPDMADP 314
K D++S G++ +E+I G P+ LIA P ++P++ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKE-PIPDPIIPS 370
L + CL + R +++ FL +K P+I +
Sbjct: 249 FLNR----------------CLDMDVEKRGSAKELL-QHQFLKIAKPLSSLTPLIAA 288
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-62
Identities = 73/284 (25%), Positives = 114/284 (40%), Gaps = 29/284 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQS---NGQVVAVKQLDRNGM---QGNKEFLVEVLMLSL 130
K+ R LG+G FG V +G + VAVK L + + + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 131 LHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
L H NL+ L G ++ V E GS+ D + + + T + A A+G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEG 123
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNV-TSRVMGTYGY 249
+ YL K I+RDL + N+LL K+ DFGL + PQ + V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
CAPE ++ + SD + FGV L E+ T + P N I ++ +R P
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLP 235
Query: 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
PE + + C + RP + L
Sbjct: 236 ----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-61
Identities = 76/285 (26%), Positives = 128/285 (44%), Gaps = 28/285 (9%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRNGMQGNK-EFLVEVLMLSLLH 132
++ ++G G FG VYKG L+++ VA+K L + + +FL E ++
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 133 HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLE 192
H N++ L G + +++ E+M G++D + E + + G A G++
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 193 YLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCA 251
YL N ++RDL + NIL+ +NL K+SDFGL++ L E TS + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 252 PEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311
PE + T SDV+SFG+++ E++T RP E + + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE-----RPYWELSNHEVMKAI---------- 226
Query: 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356
+ R P + + C Q+E RP +D+V+ L L
Sbjct: 227 -NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-61
Identities = 80/332 (24%), Positives = 137/332 (41%), Gaps = 31/332 (9%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQV----VAVKQLDRNGM-QGNKEFLVEVLMLSLLHH 133
F++ +LG G FG VYKG G+ VA+K+L + NKE L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P++ L+G C +L + + M G + D+ V E K + + A+G+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDY---VREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
L D+ +++RDL + N+L+ K++DFGLAKL EK + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
T +SDV+S+GV + EL+T +P D + +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIP-----------ASEISSILE 227
Query: 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPSDED 373
R P + I C +A +RP +++ S ++ + I +
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV-IQGDERM 286
Query: 374 EYSEGYSSDGHQKNENTYDNDNARSVRESENL 405
S+ ++ + D D+ V E L
Sbjct: 287 HLPSPTDSNFYRALMDEEDMDDV--VDADEYL 316
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-59
Identities = 71/304 (23%), Positives = 119/304 (39%), Gaps = 40/304 (13%)
Query: 78 NFRQECLLGEGGFGRVYKGTL-----QSNGQVVAVKQLDRNGMQG-NKEFLVEV-LMLSL 130
+ LG G FG+V + + + VAVK L ++ + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 131 LHHPNLVNLIGYCA-DGDQRLLVYEFMSGGSVDDHL------------LDVNETKKPLDW 177
HH N+VNL+G C G +++ EF G++ +L + K L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237
+ + A+G+E+L + I+RDL + NILL K+ DFGLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297
+ APE T++SDV+SFGV+L E+ + P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE 245
Query: 298 AQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL- 356
++ R P+ E C E RP S++V L L
Sbjct: 246 FCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
Query: 357 -SNS 359
+N+
Sbjct: 296 QANA 299
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-58
Identities = 63/283 (22%), Positives = 106/283 (37%), Gaps = 28/283 (9%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHP 134
+F+ +LGEG F V + + A+K L++ + E ++S L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
V L D ++ + G + ++ D T + LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 124
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H +I+RDLK NILL ++ +++DFG AK+ K + +GT Y +PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
SD+++ G I+ +L+ G P N Q I + FP+ P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357
+A + L +A R ++ +
Sbjct: 236 ------------KARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-57
Identities = 60/289 (20%), Positives = 119/289 (41%), Gaps = 31/289 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGMQGNK-EFLVEVLMLSL 130
+ LG+G FG VY+G + VA+K ++ + EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 131 LHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL------LDVNETKKPLDWTTRMKIA 184
+ ++V L+G + G L++ E M+ G + +L + N P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 185 SGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVM 244
A G+ YL+ ++RDL + N ++ + K+ DFG+ + + + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 245 GTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304
+ +PE + G T SDV+SFGV+L E+ T +P + + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVLRFVMEG 251
Query: 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
P+ + + MC Q RP ++++++
Sbjct: 252 G-----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 192 bits (489), Expect = 2e-57
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 26/295 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
++ LG G FG V++ T ++ G A K + + E+ +S+L HP LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
NL D ++ +++YEFMSGG + + + + + ++ +GL ++H+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 198 ANPPVIYRDLKSSNILLGANLDP--KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
++ DLK NI+ KL DFGL + + VT GT + APE A
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 197
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315
+ +D++S GV+ L++G P +N + + D A
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPS 370
+ + + L + R + + +L+ P D IPS
Sbjct: 252 ISE--------DGKDFIRKLLLADPNTRMTIHQAL-EHPWLTPGNAPGRDSQIPS 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-57
Identities = 64/277 (23%), Positives = 105/277 (37%), Gaps = 28/277 (10%)
Query: 84 LLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHPNLVNL 139
+GEG FG V++G S VA+K +E FL E L + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 140 IGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKAN 199
IG + + ++ E + G + + K LD + + A + L YL K
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 200 PPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGE 259
++RD+ + N+L+ +N KL DFGL++ S+ + APE
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRR 185
Query: 260 LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQ 319
T SDV+ FGV + E++ +P I R
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGE-----------RLP 229
Query: 320 FPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356
P ++ C + RP +++ LS +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 191 bits (487), Expect = 7e-57
Identities = 88/381 (23%), Positives = 146/381 (38%), Gaps = 35/381 (9%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVEVLMLSLLH-- 132
+F ++G GGFG VY G++ A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 133 -HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
P +V + D+ + + M+GG + HL A+ GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGL 120
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA 251
E++H++ V+YRDLK +NILL + ++SD GLA + + +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 252 PEYARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI-AWAQPIFRDPKRFP 309
PE + G +D +S G +L +L+ G + D+ + P F
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 310 DMADPLLRKQF---PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDP 366
LL + L A + P + + FL P P
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE-----SPFFRSLDWQMVFLQK----YPPP 284
Query: 367 IIPSDEDEYSEGYSSDGHQKNENTYDNDNARSVRESENLESSNNSGSNPERIASSRGQVS 426
+IP + + G E+T + +S+ N + ER +
Sbjct: 285 LIPPRGEVNAADAFDIGSFDEEDTKGI----KLLDSDQELYRNFPLTISERWQQEVAETV 340
Query: 427 GNLINSKEIGPSRKKSSKKSH 447
+ IN++ +K +K
Sbjct: 341 FDTINAETDRLEARKKTKNKQ 361
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-56
Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 40/298 (13%)
Query: 78 NFRQECLLGEGGFGRVYKGTL-------QSNGQVVAVKQLDRNGMQGN-KEFLVEV-LML 128
LGEG FG+V + VAVK L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 129 SLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHL------------LDVNETKKPLD 176
+ H N++NL+G C ++ E+ S G++ ++L + ++ L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 177 WTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236
+ A A+G+EYL K I+RDL + N+L+ + K++DFGLA+ +
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA 296
T+ + APE T +SDV+SFGV+L E+ T PV+E +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 297 WAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354
P + E + C RP +V L
Sbjct: 251 KEGHRMDKPSNCTN----------------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 187 bits (475), Expect = 2e-55
Identities = 66/302 (21%), Positives = 122/302 (40%), Gaps = 26/302 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
+ LG G FG V++ ++ G+V K ++ E+ +++ LHHP L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 138 NLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
NL D + +L+ EF+SGG + D + + + A +GL+++H+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 198 ANPPVIYRDLKSSNILLGANLDP--KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+++ D+K NI+ K+ DFGLA E + VT T + APE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIV 200
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315
+ +D+++ GV+ L++G P ++ + Q + R F + A
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPSDEDEY 375
+ EA LQ+E R + D + +L + I S ++
Sbjct: 255 VSP--------EAKDFIKNLLQKEPRKRLTVHDAL-EHPWLKGDHSNLTSRIPSSRYNKI 305
Query: 376 SE 377
+
Sbjct: 306 RQ 307
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (468), Expect = 4e-55
Identities = 68/287 (23%), Positives = 121/287 (42%), Gaps = 30/287 (10%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN---KEFLVEVLMLSLLH 132
+ + +LG GG V+ + VAVK L + + F E + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 133 HPNLVNLIGYCAD----GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
HP +V + G +V E++ G ++ D + T+ P+ +++ + A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADAC 121
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTY 247
Q L + H +I+RD+K +NI++ A K+ DFG+A+ + G + T+ V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 248 GYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307
Y +PE AR + +SDVYS G +L E++TG P + ++ A R+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVREDPI 232
Query: 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-MSDVVTAL 353
P L + A+ L + R +++ L
Sbjct: 233 PPSARHEGLSA--------DLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-54
Identities = 57/334 (17%), Positives = 125/334 (37%), Gaps = 38/334 (11%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
LG G FG V++ S+ + K + G E+ +L++ H N+++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 144 ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVI 203
++ ++++EF+SG + + + N + L+ + + L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 204 YRDLKSSNILLGANLDP--KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELT 261
+ D++ NI+ K+ +FG A+ G+ + Y APE + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQHDVVS 181
Query: 262 VKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFP 321
+D++S G ++ L++G P + + I F + A +
Sbjct: 182 TATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFDEEAFKEISI--- 232
Query: 322 EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPSDEDEYSEGYSS 381
EA+ L +E +R S+ + +L E + +I + +
Sbjct: 233 -----EAMDFVDRLLVKERKSRMTASEAL-QHPWLKQKIERVSTKVIRTLK--------- 277
Query: 382 DGHQKNENTYDNDNARSVRESENLESSNNSGSNP 415
H++ +T + V + + S
Sbjct: 278 --HRRYYHTLIKKDLNMVVSAARISCGGAIRSQK 309
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-54
Identities = 77/337 (22%), Positives = 133/337 (39%), Gaps = 38/337 (11%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSL-LHH 133
+F +LG+G FG+V+ + Q A+K L ++ + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P L ++ + V E+++GG + H+ ++ D + A+ GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQF 118
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
LH K ++YRDLK NILL + K++DFG+ K G+ + GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
+ D +SFGV+L E++ G+ P Q+ I D +P +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN------SKEPIPDPI 367
EA + E R + + ++ I P
Sbjct: 228 K------------EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPF 275
Query: 368 IPSDEDEYSEGYSSDGHQKNENTYDNDNARSVRESEN 404
P + + D NE + R++ S +
Sbjct: 276 RPKVKSPFDCSN-FDKEFLNEKPRLSFADRALINSMD 311
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 179 bits (456), Expect = 2e-53
Identities = 64/288 (22%), Positives = 108/288 (37%), Gaps = 40/288 (13%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---------QGNKEFLVEV-LM 127
N+ + +LG G V + + + AVK +D G + + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 128 LSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA 187
+ HPN++ L LV++ M G + D+L K L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTY 247
+ + LH +++RDLK NILL +++ KL+DFG + GEK+ V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTP 173
Query: 248 GYCAPEYARSGEL------TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPI 301
Y APE + D++S GVI+ L+ G P + + + I
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRMI 227
Query: 302 FRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
+F + + + + L + R +
Sbjct: 228 MSGNYQFG----SPEWDDYSD----TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (456), Expect = 5e-53
Identities = 55/275 (20%), Positives = 100/275 (36%), Gaps = 22/275 (8%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-FLVEVLMLSLLHHP 134
+ +LG G F V + ++VA+K + + ++G + E+ +L + HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
N+V L G L+ + +SGG + D +++ K ++ ++YL
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYL 123
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
HD + L + +SDFGL+K+ G ++ GT GY APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPEV 180
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
+ D +S GVI L+ G P ++N + I + F
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFD----S 230
Query: 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
+ A ++++ R
Sbjct: 231 PYWDDISD----SAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (455), Expect = 9e-53
Identities = 82/306 (26%), Positives = 128/306 (41%), Gaps = 26/306 (8%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHH 133
++F+ LG G FGRV+ + NG+ A+K L + + K+ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P ++ + G D Q ++ +++ G L + + A+ LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
LH K +IYRDLK NILL N K++DFG AK P +VT + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
+ D +SFG+++ E++ G + + I A+ F P F +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF--PPFFNEDVK 229
Query: 314 PLLRKQF---PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPS 370
LL + + L P +VV LS + E +P I
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKN-----HPWFKEVVWE-KLLSRNIETPYEPPIQQ 283
Query: 371 DEDEYS 376
+ + S
Sbjct: 284 GQGDTS 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 8e-52
Identities = 78/302 (25%), Positives = 123/302 (40%), Gaps = 26/302 (8%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE-----FLVEVLMLSLLHHPNLVN 138
LGEG F VYK ++ Q+VA+K++ K+ L E+ +L L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 139 LIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
L+ LV++FM D + + + L + QGLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 199 NPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSG 258
+++RDLK +N+LL N KL+DFGLAK G + + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 259 EL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLI--AWAQPIFRDPKRFPDMADPL 315
+ V D+++ G IL EL+ + +D+ I P + D +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 316 LRKQFPEKGLN--------EAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPI 367
K FP L+ + + + AR + + + + SN P P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL-KMKYFSNRPGPTPGCQ 294
Query: 368 IP 369
+P
Sbjct: 295 LP 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 3e-51
Identities = 57/284 (20%), Positives = 98/284 (34%), Gaps = 28/284 (9%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVN 138
+R +G G FG +Y GT + G+ VA+K + +E + ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 139 LIGYC-ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDK 197
I +C A+GD ++V E + D N + T + +A +EY+H K
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLF----NFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 198 ANPPVIYRDLKSSNIL---LGANLDPKLSDFGLAKLGPQGE-----KMNVTSRVMGTYGY 249
I+RD+K N L + DFGLAK + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 250 CAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309
+ E + + D+ S G +L+ G + ++ R ++
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------YERISEKKM 233
Query: 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTAL 353
+L K +P E C +P S +
Sbjct: 234 STPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 172 bits (437), Expect = 2e-50
Identities = 54/300 (18%), Positives = 97/300 (32%), Gaps = 30/300 (10%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLL-HHPN 135
+++ +GEG FG +++GT N Q VA+K R + E LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+ N+ + +G +LV + + ++ + T A ++ +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 196 DKANPPVIYRDLKSSNILLGANLDP-----KLSDFGLAKL-----GPQGEKMNVTSRVMG 245
+K ++YRD+K N L+G + DFG+ K Q + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 246 TYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305
T Y + E + + D+ + G + + + G + Q R
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------KQKYERIG 229
Query: 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPD 365
++ L FPE E A P + S + D
Sbjct: 230 EKKQSTPLRELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 8e-50
Identities = 67/292 (22%), Positives = 110/292 (37%), Gaps = 47/292 (16%)
Query: 79 FRQECL---------LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN------KEFLV 123
FRQE + LG G F V K +S G A K + + + + ++
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 124 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKI 183
EV +L + HPN++ L + +L+ E ++GG L D K+ L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEF 118
Query: 184 ASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP----KLSDFGLAKLGPQGEKMNV 239
G+ YLH + + DLK NI+L P K+ DFGLA G +
Sbjct: 119 LKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK- 174
Query: 240 TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299
+ GT + APE L +++D++S GVI L++G + ++
Sbjct: 175 --NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232
Query: 300 PIFRD--PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
F D +A +R+ L ++ R + D
Sbjct: 233 YEFEDEYFSNTSALAKDFIRR----------------LLVKDPKKRMTIQDS 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-49
Identities = 65/300 (21%), Positives = 117/300 (39%), Gaps = 21/300 (7%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPN 135
NF++ +GEG +G VYK + G+VVA+K++ + + E+ +L L+HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V L+ ++ LV+EF+ D + QGL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLH---QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
V++RDLK N+L+ KL+DFGLA+ + T V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILL 175
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315
+ D++S G I E++T R + +D+ I + + P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 316 LRKQFPEKGLN-----------EAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIP 364
+ FP+ + ++ + L + R + A F + +P+P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL-AHPFFQDVTKPVP 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 7e-49
Identities = 67/319 (21%), Positives = 118/319 (36%), Gaps = 23/319 (7%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN-KEFLVEVLMLSLLHHP 134
+ +GEG +G V N VA+K++ Q + L E+ +L H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
N++ + + ++ + L + + + L +GL+Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYI 125
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK-LGPQGEKMNVTSRVMGTYGYCAPE 253
H V++RDLK SN+LL D K+ DFGLA+ P + + + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 254 YARSGELTVKS-DVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ------------- 299
+ + KS D++S G IL E+++ R + +D+ N I
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 300 -PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358
P + FP ++A+ + L R + + A +L
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNAD-SKALDLLDKMLTFNPHKRIEVEQAL-AHPYLEQ 300
Query: 359 SKEPIPDPIIPSDEDEYSE 377
+P +PI + E
Sbjct: 301 YYDPSDEPIAEAPFKFDME 319
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 7e-48
Identities = 62/281 (22%), Positives = 106/281 (37%), Gaps = 44/281 (15%)
Query: 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE------FLVEVLMLSLLH 132
++ LLG GGFG VY G S+ VA+K ++++ + E +EV++L +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 133 --HPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQG 190
++ L+ + D +L+ E + + L +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEA 122
Query: 191 LEYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGY 249
+ + H+ V++RD+K NIL+ N + KL DFG L K V + GT Y
Sbjct: 123 VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 250 CAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308
PE+ R + V+S G++L +++ G P + I Q F +R
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFF--RQRV 227
Query: 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
L+R CL RP ++
Sbjct: 228 SSECQHLIRW----------------CLALRPSDRPTFEEI 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-47
Identities = 66/292 (22%), Positives = 112/292 (38%), Gaps = 23/292 (7%)
Query: 75 ATKNFRQECLLGEGGFGRVYKGT-LQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLL 131
A + + +GEG +G+V+K L++ G+ VA+K++ + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 132 ---HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDV--NETKKPLDWTTRMKIASG 186
HPN+V L C + VD L + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 187 AAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGT 246
+GL++LH V++RDLK NIL+ ++ KL+DFGLA++ + V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVT 178
Query: 247 YGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306
Y APE D++S G I E+ + + + VD+ I + +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 307 RFPDMADPLLR---------KQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
D+A P ++F + CL R
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 5e-47
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 29/307 (9%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLV 137
++ ++G G FG VY+ L +G++VA+K++ ++ N+ E+ ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 138 NLIGYCADGDQR------LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
L + ++ LV +++ + K+ L + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 192 EYLHDKANPPVIYRDLKSSNILLGAN-LDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
Y+H + +RD+K N+LL + KL DFG AK +GE S + Y
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190
Query: 251 APEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP----- 305
+ + T DV+S G +L EL+ G+ + VD+ I
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 306 ------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359
+FP + K F + EA+A+ + L+ AR + A SF
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC-AHSFFDEL 309
Query: 360 KEPIPDP 366
++P
Sbjct: 310 RDPNVKL 316
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 6e-47
Identities = 70/312 (22%), Positives = 115/312 (36%), Gaps = 26/312 (8%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHH 133
+F LLG+G FG+V ++ G+ A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 134 PNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEY 193
P L L D+ V E+ +GG + HL T + A+ +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFYGAEIVSA 117
Query: 194 LHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
L + V+YRD+K N++L + K++DFGL K G GT Y APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPE 175
Query: 254 YARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313
+ D + GV++ E++ GR LI + F P+ A
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAK 233
Query: 314 PLLRKQF---PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPS 370
LL P++ L + A ++ + ++ ++ + P P
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVME-----HRFFLSI----NWQDVVQKKLLPPFKPQ 284
Query: 371 DEDEYSEGYSSD 382
E Y D
Sbjct: 285 VTSEVDTRYFDD 296
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-46
Identities = 61/335 (18%), Positives = 115/335 (34%), Gaps = 31/335 (9%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEV-LMLSLLHHPNLVNLIGY 142
+LG G G+V + + + A+K L + EV L P++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 143 C----ADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA 198
A L+V E + GG + + D + +I + ++YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 199 NPPVIYRDLKSSNILLGANLDP---KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
+ +RD+K N+L + KL+DFG AK + T Y APE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315
+ D++S GVI+ L+ G P + +A + + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPSDEDEY 375
+ E E + L+ E R +++ + + ++K P E
Sbjct: 240 EWSEVSE----EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295
Query: 376 SEGYSSDGHQKNENTYDNDNARSVRESENLESSNN 410
E + + + + +E ++N
Sbjct: 296 KERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (390), Expect = 8e-44
Identities = 57/285 (20%), Positives = 110/285 (38%), Gaps = 22/285 (7%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQL--DRNGMQGNKEFLVEVLMLSLLHHPN 135
+ +GEG +G VYK G+ A+K++ ++ + E+ +L L H N
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 136 LVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH 195
+V L + +LV+E + D ++ + L+ T G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 196 DKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYA 255
D+ V++RDLK N+L+ + K++DFGLA+ + ++ +
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLM 173
Query: 256 RSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA---------QPIFRDPK 306
S + + D++S G I E++ G + D+ I + PK
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 307 RFPDMA--DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDV 349
P+ +PL + F + + + + L+ + R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 59/334 (17%), Positives = 112/334 (33%), Gaps = 31/334 (9%)
Query: 60 KNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN- 118
+ + + R +R +G G +G V G VA+K+L R
Sbjct: 7 QEVTKTAWEVRA------VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 119 -KEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDW 177
K E+ +L + H N++ L+ + +F L + L
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120
Query: 178 TTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM 237
+ +GL Y+H +RDLK N+ + + + K+ DFGLA+
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS---- 173
Query: 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAW 297
+T V+ + T D++S G I+ E+ITG+ + + +D+ I
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 298 AQPIFRD--------------PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGAR 343
K P++ AV + L +A R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS-PLAVNLLEKMLVLDAEQR 292
Query: 344 PLMSDVVTALSFLSNSKEPIPDPIIPSDEDEYSE 377
+ + A + + + +P + +D + +
Sbjct: 293 VTAGEAL-AHPYFESLHDTEDEPQVQKYDDSFDD 325
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-43
Identities = 58/287 (20%), Positives = 107/287 (37%), Gaps = 22/287 (7%)
Query: 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHP 134
+ + + +GEG +G V+K + ++VA+K++ + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
N+V L + LV+EF D + LD +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC----DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H + V++RDLK N+L+ N + KL++FGLA+ + ++ V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVL 173
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
+ + D++S G I EL R + VD+Q + +++P M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 315 LLRKQFPEKGLN------------EAVAIAAMCLQEEAGARPLMSDV 349
K +P + L+ R +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 6e-43
Identities = 71/311 (22%), Positives = 109/311 (35%), Gaps = 29/311 (9%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKE---FLVEVLMLSLLHHP 134
F + LG G FGRV + +G A+K LD+ + K+ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 135 NLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
LV L D +V E+++GG + HL A+ EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL 157
Query: 195 HDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEY 254
H +IYRDLK N+L+ +++DFG AK T + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 255 ARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314
S D ++ GV++ E+ G +P+ I + F P F
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF--PSHFSSDLKD 267
Query: 315 LLRKQF---PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIPDPIIPSD 371
LLR K + +++ + + P IP
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKN-----HKWFATT----DWIAIYQRKVEAPFIPKF 318
Query: 372 EDEYSEGYSSD 382
+ D
Sbjct: 319 KGPGDTSNFDD 329
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-43
Identities = 62/317 (19%), Positives = 115/317 (36%), Gaps = 37/317 (11%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHHPN 135
+ + +G+G FG V+K + GQ VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 136 LVNLIGYCADGDQR--------LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGA 187
+VNLI C LV++F L T +I
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVM 123
Query: 188 AQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK--MNVTSRVMG 245
L L+ +++RD+K++N+L+ + KL+DFGLA+ + N + +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 246 TYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-------- 296
T Y PE + D++ G I+ E+ T ++ + LI+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 297 -----WAQPIFRDPKRFPDMADPLLRKQFPEKGLN-EAVAIAAMCLQEEAGARPLMSDVV 350
+ ++ + + A+ + L + R D +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 351 TALSFLSNSKEPIPDPI 367
F + +P+P +
Sbjct: 304 -NHDFFWS--DPMPSDL 317
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 73/313 (23%), Positives = 125/313 (39%), Gaps = 31/313 (9%)
Query: 77 KNFRQECLLGEGGFGRVYKG---TLQSNGQVVAVKQLDRNGM----QGNKEFLVEVLMLS 129
+NF +LG G +G+V+ + G++ A+K L + + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 130 LL-HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
+ P LV L + L+ ++++GG + HL ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIV 139
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
LE+LH +IYRD+K NILL +N L+DFGL+K ++ GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 249 YCAPEYARSGE--LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA--QPIFRD 304
Y AP+ R G+ D +S GV++ EL+TG + Q I+ +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 305 PKRFPDMADPLLRKQF---PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKE 361
P+ +A L+++ P+K L A + + L+ K
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE-----HLFFQKIN--WDDLAAKKV 308
Query: 362 PIP-DPIIPSDED 373
P P P+I + D
Sbjct: 309 PAPFKPVIRDELD 321
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 63/324 (19%), Positives = 112/324 (34%), Gaps = 39/324 (12%)
Query: 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGN--KEFLVEVLMLSLLHH 133
+ ++ +G G +G V G VAVK+L R K E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 134 PNLVNLIGYCADGD-----QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAA 188
N++ L+ + + + G +++ + L +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-----VKCQKLTDDHVQFLIYQIL 131
Query: 189 QGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYG 248
+GL+Y+H +RDLK SN+ + + + K+ DFGLA + +T V +
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA----RHTDDEMTGYVATRWY 184
Query: 249 YCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP--- 305
D++S G I+ EL+TGR + T +D+ LI
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 306 -----------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354
+ M F AV + L ++ R + + A +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQAL-AHA 302
Query: 355 FLSN----SKEPIPDPIIPSDEDE 374
+ + EP+ DP S E
Sbjct: 303 YFAQYHDPDDEPVADPYDQSFESR 326
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (346), Expect = 4e-37
Identities = 47/250 (18%), Positives = 97/250 (38%), Gaps = 21/250 (8%)
Query: 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEV-LMLSLLHHPNL 136
+++ LG G + V++ +N + V VK L K+ E+ ++ +L PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNI 92
Query: 137 VNLIGYCADGDQRL--LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYL 194
+ L D R LV+E ++ + L + L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 145
Query: 195 HDKANPPVIYRDLKSSNILLGA-NLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPE 253
H +++RD+K N+++ + +L D+GLA+ G++ N + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPE 199
Query: 254 YARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312
++ D++S G +L +I + +Q + D + D
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 313 DPLLRKQFPE 322
+ L +F +
Sbjct: 260 NIELDPRFND 269
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 72/361 (19%), Positives = 128/361 (35%), Gaps = 59/361 (16%)
Query: 56 QDETKNINAQTFTFRELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM 115
Q + + TFT K ++ +G G G V + VA+K+L R
Sbjct: 2 QFYSVEVGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 55
Query: 116 --QGNKEFLVEVLMLSLLHHPNLVNLIGYCA------DGDQRLLVYEFMSGGSVDDHLLD 167
K E++++ ++H N+++L+ + LV E M
Sbjct: 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--- 112
Query: 168 VNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227
+ LD + G+++LH + +I+RDLK SNI++ ++ K+ DFGL
Sbjct: 113 ----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR------- 280
A+ M + T Y APE D++S G I+ E++ +
Sbjct: 166 ARTAGTSFMMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222
Query: 281 ---------RVIDTTRPVDEQNLIAWAQPIFRD---------PKRFPDMADPLLRKQFPE 322
+ T P + L + + PK FPD P +
Sbjct: 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282
Query: 323 KGLNEAVAIAAMCLQEEAGARPLMSDV-----VTALSFLSNSKEPIPDPIIPS-DEDEYS 376
K ++A + + L + R + D + + + P P DE E++
Sbjct: 283 KA-SQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHT 341
Query: 377 E 377
Sbjct: 342 I 342
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (312), Expect = 3e-32
Identities = 43/240 (17%), Positives = 81/240 (33%), Gaps = 16/240 (6%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYC 143
LG G F V+ N VA+K + + + + E+ +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 144 ADGDQRLLVYE------------FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
A+ +LL + + L + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 192 EYLHDKANPPVIYRDLKSSNILLGANLDP-KLSDFGLAKLGPQGEKMNVTSRVMGTYGYC 250
+Y+H + +I+ D+K N+L+ P L +A LG + + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 251 APEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310
+PE +D++S ++ ELITG + + I P
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 1e-19
Identities = 20/160 (12%), Positives = 45/160 (28%), Gaps = 30/160 (18%)
Query: 84 LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG----------MQGNKEFLVEVLMLSLLHH 133
L+GEG V+ + VK G+ F V + +
Sbjct: 7 LMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 134 PNLVNLIGYCA----DGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQ 189
L L G + ++ E + + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELI-----------DAKELYRVRVENPDEVLDMILE 114
Query: 190 GLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229
+ + + +++ DL N+L+ + DF +
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 39.0 bits (90), Expect = 0.001
Identities = 21/136 (15%), Positives = 42/136 (30%), Gaps = 22/136 (16%)
Query: 85 LGEGGFGRVYKGTLQSNGQVVAVKQ-------------LDRNGMQGNKEFLVEVLMLSLL 131
+G+G V+ Q + + + +KQ L + + L+
Sbjct: 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPH 93
Query: 132 HHPNLVNLIGYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGL 191
P + + +D + + V E +S + L + I + L
Sbjct: 94 LVPRV-----FYSDTEMAVTVMEDLSHLKIARKGL----IEGENYPHLSQHIGEFLGKTL 144
Query: 192 EYLHDKANPPVIYRDL 207
Y D A P + + L
Sbjct: 145 FYSSDYALEPKVKKQL 160
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 519 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.77 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.98 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.69 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.59 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-56 Score=434.89 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=214.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+.+..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4689999999999999999999999999999999976532 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
||++|+|.++|. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999883 3457999999999999999999999999 999999999999999999999999999876544
Q ss_pred CccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.........+||+.|||||++.+..+ +.++|||||||+||||++|+.||............ +.. .. ..
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~----~~-~~----- 225 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKE----KK-TY----- 225 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHT----TC-TT-----
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-Hhc----CC-CC-----
Confidence 43334556789999999999988776 57899999999999999999999765433222111 111 00 00
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.......+.++.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~ 264 (271)
T d1nvra_ 226 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264 (271)
T ss_dssp ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 001123456788999999999999999999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=429.60 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=215.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||+||+|+++.+++.||||++.+.. ......+.+|+.+++.++|||||++++++.+.+..||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||++|+|.+++.. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999854 346999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.. .....||+.|||||++.+..|+.++|||||||+||||++|+.||........... +.....
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~~~------- 221 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR------ISRVEF------- 221 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTTCC-------
T ss_pred Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH------HHcCCC-------
Confidence 32 2346899999999999999999999999999999999999999976433222111 111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.++...+.++.+|+.+||+.||.+|||+.++++|.|+-.
T Consensus 222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 133445568899999999999999999999999987754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=433.74 Aligned_cols=255 Identities=28% Similarity=0.403 Sum_probs=217.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||+|+||+||+|++..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998766566778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++|+|.+++.. ..+++..++.|+.||+.||+|||++| ||||||||+||||+.++.+||+|||+++.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998743 35999999999999999999999999 99999999999999999999999999987654332
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.....+||+.|+|||++.+..|+.++|||||||+||+|++|..||...........+... ....
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-----~~~~--------- 235 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-----GTPE--------- 235 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-----CSCC---------
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC-----CCCC---------
Confidence 234568999999999999999999999999999999999999999765433222111100 0000
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
...+...+.++.+||.+||+.||.+|||+.++++|.|+-
T Consensus 236 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred -CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 012334566889999999999999999999999997763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=429.98 Aligned_cols=260 Identities=25% Similarity=0.381 Sum_probs=205.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEec--CCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 151 (519)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+ .+.+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999999999999999999765432 23568899999999999999999999865 456899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA--NPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
|||||++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999999776666778999999999999999999999865 1249999999999999999999999999998
Q ss_pred cCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFP 309 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (519)
....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+ +... +.... +
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~---i~~~~--~- 231 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGK---IREGK--F- 231 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH---HHHTC--C-
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHH---HHcCC--C-
Confidence 7654322 2345789999999999999999999999999999999999999997653322 2111 11110 0
Q ss_pred cccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 310 DMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 310 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
..++...+.++.+|+.+||+.||.+|||+.++++|+|
T Consensus 232 --------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 232 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 1123345568999999999999999999999998865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=436.73 Aligned_cols=283 Identities=26% Similarity=0.348 Sum_probs=233.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+. .......+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999999999999999999754 223456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||||+||+|.+++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999854 356899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... .....+||+.|||||++.+..|+.++|||||||+||||++|++||.......... .+.....
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~i~~~~~------ 222 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------LILMEEI------ 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCC------
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH------HHhcCCC------
Confidence 3322 2345789999999999999999999999999999999999999998754322111 1111111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSD 382 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~ 382 (519)
.+|...+.++.+||.+||+.||.+||+ +.++++|.|+... ....+.+|+.|......+..+++.
T Consensus 223 ------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~ 296 (337)
T d1o6la_ 223 ------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296 (337)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCH
T ss_pred ------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCc
Confidence 234455668899999999999999994 8999999876432 234456777776666666666554
Q ss_pred CCC
Q 046892 383 GHQ 385 (519)
Q Consensus 383 ~~~ 385 (519)
.++
T Consensus 297 ~~~ 299 (337)
T d1o6la_ 297 EFT 299 (337)
T ss_dssp HHH
T ss_pred hhh
Confidence 433
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=429.04 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=215.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
+.|++.+.||+|+||+||+|++..+++.||||++........+.+.+|+.+|+.++|||||++++++.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999999999999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++|+|.+++... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-- 163 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 163 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence 999999988542 356999999999999999999999999 999999999999999999999999999754321
Q ss_pred cceecccccccccCchhhhc-----cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 237 MNVTSRVMGTYGYCAPEYAR-----SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~-----~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
........||+.|||||++. +..|+.++|||||||+||||++|+.||...........+... ....
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-----~~~~---- 234 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-----EPPT---- 234 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-----CCCC----
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----CCCC----
Confidence 11233568999999999984 456899999999999999999999999876544332211110 0000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+...+.++.+|+.+||+.||.+|||+.++++|.|+
T Consensus 235 ------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 235 ------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp ------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred ------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 01233456689999999999999999999999998765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=434.96 Aligned_cols=309 Identities=24% Similarity=0.343 Sum_probs=222.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHH-hcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+.+..|..++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999997532 233456677777654 68999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||||++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999854 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCccc
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMA 312 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (519)
.... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+. ....
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~~~------ 220 (320)
T d1xjda_ 155 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------MDNP------ 220 (320)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCC------
T ss_pred cccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------cCCC------
Confidence 4332 2345689999999999999999999999999999999999999998654332222111 1111
Q ss_pred chHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHH-HHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCccCCCCCC
Q 046892 313 DPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMS-DVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYSSDGHQK 386 (519)
Q Consensus 313 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~~~~~~~ 386 (519)
.++..++.++.+|+.+||+.||.+||++. ++++|.|+-.- ....+.+|..|...+..+..+++.....
T Consensus 221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~ 294 (320)
T d1xjda_ 221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLN 294 (320)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHTTCSCC---------------------
T ss_pred ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhh
Confidence 12334556889999999999999999995 78888765321 2345566777776666666666665555
Q ss_pred CCCCCCCCCcccccccccccCCCCCC
Q 046892 387 NENTYDNDNARSVRESENLESSNNSG 412 (519)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~s~ 412 (519)
+....+........+.++..+.|||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 295 EKPRLSFADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp -----------------CCTTTTCCC
T ss_pred CCccCCCCcccccCchhhcccCcCcC
Confidence 55555555555556666777777775
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=428.05 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=208.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ......+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986532 234467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||++|+|.+++.. .+.+++..++.++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998854 356999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
..........+||+.|||||++.+..|+.++|||||||+||||++|..||......... ..+.....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i~~~~~------- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF------QKIIKLEY------- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHTTCC-------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH------HHHHcCCC-------
Confidence 44333445578999999999999999999999999999999999999999865332211 11122111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTA 352 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 352 (519)
.++...+.++.+||.+||+.||.+|||+.|++.+
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1334455688999999999999999999986433
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=419.50 Aligned_cols=261 Identities=30% Similarity=0.458 Sum_probs=206.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.++|++.+.||+|+||+||+|++. ..||||++.... ....+.|.+|+.+|..++|||||++++++.+ +.++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 467899999999999999999864 359999987543 2344678899999999999999999998754 5689999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999854 3456999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCccceecccccccccCchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
...........||+.|||||++.+ +.|+.++|||||||+||||+||+.||.......... ........ .+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~----~p- 229 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYL----SP- 229 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTSC----CC-
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCCC----CC-
Confidence 443334456789999999999864 458999999999999999999999998654432221 11111100 00
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
. ....+..++.++.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus 230 ----~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 ----D-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ----C-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----c-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 112344556789999999999999999999999999998865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-54 Score=430.61 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=199.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
..+.|++.+.||+|+||+||+|++..+|+.||||++...... ....+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 356799999999999999999999999999999999765432 3356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCCcEEeeeccccc
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG---ANLDPKLSDFGLAKL 230 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~---~~~~vkL~DFGla~~ 230 (519)
|||+||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+|||+. .++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999943 467999999999999999999999999 99999999999994 578999999999986
Q ss_pred CCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..... .....+||+.|||||++.+..|+.++|||||||+||||++|..||........... +......++
T Consensus 160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~~~~~~~- 229 (307)
T d1a06a_ 160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------ILKAEYEFD- 229 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHTTCCCCC-
T ss_pred ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------HhccCCCCC-
Confidence 54433 23456899999999999999999999999999999999999999976433222111 111111111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.......+.++.+|+.+||+.||.+|||+.++++|.|+
T Consensus 230 -------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 230 -------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp -------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred -------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 11223455689999999999999999999999998765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=432.81 Aligned_cols=269 Identities=24% Similarity=0.353 Sum_probs=212.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||+||+|++..+|+.||+|++...... ....+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999999999999999999765332 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||++|+|.+++... ..+++..++.++.||+.||.|||+ ++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999643 469999999999999999999997 48 99999999999999999999999999986432
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC-------
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK------- 306 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 306 (519)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||............ .........
T Consensus 158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPR 231 (322)
T ss_dssp H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhcCCcccCCcccc
Confidence 2 233568999999999999999999999999999999999999999765432211100 000000000
Q ss_pred ------------CCCcc-----cchHhhc---cCC-hhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 307 ------------RFPDM-----ADPLLRK---QFP-EKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 307 ------------~~~~~-----~d~~l~~---~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..+.. .+..... .++ ...+.++.+|+.+||+.||.+|||+.++++|.|+-.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00000 0000000 011 123568999999999999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.1e-53 Score=428.64 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=216.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45899999999999999999999999999999999776555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCCcEEeeecccccCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG--ANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~--~~~~vkL~DFGla~~~~~ 233 (519)
|+||+|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999843 3456999999999999999999999999 99999999999995 468899999999987654
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
... .....||+.|||||++.+..|+.++|||||||++|+|++|+.||......+....+ ......++.
T Consensus 179 ~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~~~~--- 246 (350)
T d1koaa2 179 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDWNMDD--- 246 (350)
T ss_dssp TSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCCSCC---
T ss_pred ccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCCc---
Confidence 432 34568999999999999999999999999999999999999999765332222111 111111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.....++.++.+||.+||+.||.+|||+.++++|.|+-
T Consensus 247 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 247 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp -----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11123456889999999999999999999999987653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-53 Score=422.17 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=202.0
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe---EEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ---VVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|++.+.||+|+||+||+|++..+++ .||||.+..... ...+.|.+|+.+|+.++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467888999999999999999976654 689998865433 2345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998853 3456999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCccce---ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 233 QGEKMNV---TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 233 ~~~~~~~---~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
....... .....||+.|||||++.++.++.++|||||||+||||+| |..||...... .+...... . .
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~---~-~-- 250 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQ---D-Y-- 250 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHT---T-C--
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc---C-C--
Confidence 4322211 223467999999999999999999999999999999998 89999765432 22222211 1 0
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+...+..++..+.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 251 --------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 --------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 112344566789999999999999999999999999976544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-53 Score=419.94 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=217.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 457889999999999999999999999999999987553 4467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
|++|+|.+++... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999998652 3457999999999999999999999999 9999999999999999999999999998765433
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
........||+.|+|||++.+..|+.++|||||||++|||++|..||..... ...+...... .
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i~~----~---------- 232 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEK----D---------- 232 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHT----T----------
T ss_pred -ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHHhc----C----------
Confidence 2233445689999999999999999999999999999999998776644322 2222222211 0
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+..++..++.++.+|+..||+.||.+|||+.+|++.|..+.
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112234455678999999999999999999999999887653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=412.27 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=202.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.|.+|+.++..++|||||+++|+|.+.+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 57899999999999999999987 47889999997643 44578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++|+|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999854 3456899999999999999999999999 99999999999999999999999999987654332
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR-RVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. ......||+.|+|||++.+..|+.++|||||||+||||+|+. +||.... ...+.......
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~~-------------- 218 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTG-------------- 218 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHHT--------------
T ss_pred e-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHHHhc--------------
Confidence 2 233467899999999999999999999999999999999965 4444322 22222221111
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+...|..++.++.+|+..||+.||.+||||++|+++|..+.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 011223445568899999999999999999999999998765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.7e-53 Score=428.74 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=216.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||+|+||.||+|++..+|+.||||++..........+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999999999999998765555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC--CCCCcEEeeecccccCCCC
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG--ANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~--~~~~vkL~DFGla~~~~~~ 234 (519)
+||+|.+++.. ....+++..++.|+.||+.||.|||+.| ||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988743 3456999999999999999999999999 99999999999997 6789999999999876554
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. .....||+.|||||++.+..|+.++|||||||+||+|++|..||...........+ ......++
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~~~~~----- 248 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRCDWEFD----- 248 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHCCCCCC-----
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCC-----
Confidence 32 34467999999999999999999999999999999999999999765433222111 11111111
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.......+.++.+||.+||+.||.+|||+.++++|.|+
T Consensus 249 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 249 ---EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp ---SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 11223445688999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=414.28 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=204.5
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEec----CCceEEE
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 152 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 152 (519)
|+..+.||+|+||+||+|++..++..||+|++..... ...+.+.+|+.+|+.++|||||+++++|.+ ...+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 4667789999999999999999999999999875432 234568899999999999999999999865 3467999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC-CCCCcEEeeecccccC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG-ANLDPKLSDFGLAKLG 231 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~-~~~~vkL~DFGla~~~ 231 (519)
||||++|+|.+++.. ...+++..++.|+.||+.||+|||+++ .+|+||||||+||||+ .++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999954 346899999999999999999999975 3499999999999996 5789999999999864
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.... ....+||+.|||||++.+ .++.++|||||||+||||++|+.||....... .+..... ... .+
T Consensus 166 ~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~---~~~--~~-- 231 (270)
T d1t4ha_ 166 RASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT---SGV--KP-- 231 (270)
T ss_dssp CTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT---TTC--CC--
T ss_pred cCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHH---cCC--CC--
Confidence 4322 345789999999999875 69999999999999999999999997543322 1111111 110 00
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..++...+.++.+|+.+||+.||++|||+.|+++|.|+
T Consensus 232 ------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f 269 (270)
T d1t4ha_ 232 ------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269 (270)
T ss_dssp ------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence 11222344578899999999999999999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-52 Score=423.47 Aligned_cols=274 Identities=25% Similarity=0.321 Sum_probs=226.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC---CcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG---MQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999999999999999986432 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
||+.+|+|..++... +.+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998543 46999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. .....||+.|||||++.+..|+.++|||||||+||||++|..||........... +.....
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~~------- 255 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IVSGKV------- 255 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCC-------
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH------HhcCCC-------
Confidence 2 2346899999999999999999999999999999999999999976533222111 111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCCcCCCcc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDEYSEGYS 380 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~~~~~~~ 380 (519)
.++...+.++.+||.+||+.||.+|+ |+.++++|.||-.. ....+.+|+.|...+..+.+++
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~ 327 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNF 327 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTS
T ss_pred -----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhc
Confidence 12334556889999999999999994 99999999876432 2344566777765554444443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=417.20 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=214.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC------cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM------QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999875432 2346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC----CcEEeee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL----DPKLSDF 225 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~----~vkL~DF 225 (519)
|||||||++|+|.+++... ..+++..++.++.||+.||+|||+.+ ||||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 9999999999999998543 46999999999999999999999999 99999999999998776 4999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP 305 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 305 (519)
|++........ .....||+.|+|||++.+..++.++|||||||+||||++|..||...........+ ....
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------SAVN 232 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HTTC
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH------HhcC
Confidence 99987654332 34467999999999999999999999999999999999999999865432221111 1111
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
..++ .. ++...+..+.+||.+||+.||.+|||+.++++|.|+
T Consensus 233 ~~~~----~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 233 YEFE----DE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp CCCC----HH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCCC----ch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1111 11 122345688999999999999999999999998765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=421.50 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=212.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC-----eEEEEEEeccCC-CcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG-----QVVAVKQLDRNG-MQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||+||+|++..++ ..||+|.+.... ......+.+|+.+|..+ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 367999999999999999999987544 369999986542 33456788999999887 89999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE-------------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKS 209 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp 209 (519)
.+||||||++|+|.++|..... ....+++..++.|+.||+.||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999965321 1245899999999999999999999999 99999999
Q ss_pred CCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCC
Q 046892 210 SNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRP 288 (519)
Q Consensus 210 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~ 288 (519)
+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |..||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655444444456778999999999999999999999999999999997 8999976543
Q ss_pred cchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 289 VDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
... +..... .. .+...+..++.++.+||.+||+.||.+|||+.+|+++|.
T Consensus 273 ~~~--~~~~~~----~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN--FYKLIQ----NG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH--HHHHHH----TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HHHHHh----cC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 222 111111 11 111234456678999999999999999999999999984
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-52 Score=418.72 Aligned_cols=251 Identities=29% Similarity=0.394 Sum_probs=209.4
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
.|+..+.||+|+||+||+|++..+++.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4999999999999999999999999999999997654332 2458899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
||.+|+|..++. ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999876653 2457999999999999999999999999 99999999999999999999999999986533
Q ss_pred CccceecccccccccCchhhhcc---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS---GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDM 311 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~---~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (519)
.....||+.|||||++.+ +.|+.++|||||||++|||++|..||...........+ .... .+..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i------~~~~--~~~~ 234 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQNE--SPAL 234 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHSC--CCCC
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhCC--CCCC
Confidence 234679999999999864 46899999999999999999999999765432211111 1110 0000
Q ss_pred cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 312 ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 312 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
.+...+.++.+|+.+||+.||.+|||+.++++|.|+..
T Consensus 235 --------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 235 --------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 12234568899999999999999999999999987754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-52 Score=417.04 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=213.6
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccC---CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN---GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 153 (519)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999999999999999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~ 233 (519)
|||.||+|..++.. ...+++..++.++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998843 456889999999999999999999999 99999999999999999999999999987643
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......... .+.....
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~~------- 218 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNAEL------- 218 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHCCC-------
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------HHHcCCC-------
Confidence 3 235789999999999999999999999999999999999999998654322211 1112111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSF 355 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~ 355 (519)
.++...+.++.+++.+||+.||.+|+ |+.++++|.|+
T Consensus 219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 12334456789999999999999996 99999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=407.26 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=208.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||.||+|.++ ++..||||++.... ...+.|.+|+.++..++|||||++++++.+ +..+|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 457899999999999999999986 47889999997543 445789999999999999999999998854 567999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+++|+|.+++.... ...+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999875432 235899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchH
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPL 315 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 315 (519)
. .......||+.|||||++.++.++.++|||||||+||||+||..|+..... ...+.......
T Consensus 164 ~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~~~-------------- 226 (272)
T d1qpca_ 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERG-------------- 226 (272)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT--------------
T ss_pred c-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhc--------------
Confidence 2 223456789999999999999999999999999999999997655543222 22222221110
Q ss_pred hhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 316 LRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 316 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.+...+..++.++.+|+.+||+.||.+||||.+|++.|..
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1112334456689999999999999999999999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=402.40 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=213.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||+||+|+++ ++..||||++..... ..+.|.+|+.++..++|||||+++|+|.+.+.+++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 368899999999999999999986 688999999986543 457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.+|+|..++.. ....+++..++.|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999754 3356899999999999999999999999 9999999999999999999999999998665443
Q ss_pred ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 236 KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +..... ..
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~---~~---------- 217 (258)
T d1k2pa_ 155 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIA---QG---------- 217 (258)
T ss_dssp CC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH---TT----------
T ss_pred ce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHH---hC----------
Confidence 22 2334679999999999999999999999999999999998 899997654322 222111 11
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
.+...|...+.++.+|+.+||+.||.+|||+.+|+++|.
T Consensus 218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 011233445568999999999999999999999999984
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=421.88 Aligned_cols=271 Identities=27% Similarity=0.390 Sum_probs=217.6
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC---cChHHHHHH---HHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM---QGNKEFLVE---VLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|++.+.||+|+||.||+|++..+|+.||||++.+... .....+..| +.+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 3689999999999999999999999999999999864321 222334444 6677778899999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
|||||||++|+|.++|.. ...+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999954 356899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 230 LGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 230 ~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
...... ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+...+.... .....
T Consensus 156 ~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~~~-- 226 (364)
T d1omwa3 156 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTMAV-- 226 (364)
T ss_dssp ECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---SSCCC--
T ss_pred ecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccCCC--
Confidence 765432 234689999999999974 56899999999999999999999999876554443333221 11111
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHhhhhc-----CCCCCCCCCCCCCC
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPL-----MSDVVTALSFLSN-----SKEPIPDPIIPSDE 372 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~l~~~~~-----~~~~~~~p~~p~~~ 372 (519)
.++...+.++.+||.+||+.||.+||| +.++++|.|+-.- .....++|+.|...
T Consensus 227 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~ 290 (364)
T d1omwa3 227 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 290 (364)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCC
Confidence 123344568899999999999999999 6999998776321 12344556665443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=408.34 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=209.3
Q ss_pred cCccccee-eeccCcEEEEEEEEcC--CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECL-LGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~-LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|.+... ||+|+||+||+|.++. ++..||||++..... ...+.|.+|+.+|+.++|||||++++++.+ +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 56777775 9999999999998754 355899999976533 334678999999999999999999999875 468999
Q ss_pred EEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCC
Q 046892 153 YEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGP 232 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~ 232 (519)
||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998743 3457999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCcc-ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 233 QGEKM-NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 233 ~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..... .......||+.|||||++.++.++.++|||||||+||||+| |..||......+....+. . .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~------~-~----- 228 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------Q-G----- 228 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH------T-T-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH------c-C-----
Confidence 44322 22334578999999999999999999999999999999998 899998654332221111 1 1
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.+..++..++.++.+|+.+||+.||.+|||+.+|++.|..+
T Consensus 229 -----~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 229 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01123455667899999999999999999999998887643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=406.27 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=205.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCC----eEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNG----QVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
..|+..++||+|+||.||+|.+..++ ..||||++...... ....|.+|+.++..++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46888999999999999999987654 47999998754332 33568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
|||||.+++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999988754 3457999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCc-cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEK-MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..... ........||+.|||||++.++.++.++|||||||+||||++|..|+..... ...+......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~---------- 228 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAIND---------- 228 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHT----------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHHHHhc----------
Confidence 44322 2223345789999999999999999999999999999999997666544322 2222222111
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
..+...+..++..+.+|+.+||+.||.+||||.+|++.|..+...
T Consensus 229 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 229 ----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 111233445667899999999999999999999999999876543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=404.57 Aligned_cols=247 Identities=27% Similarity=0.411 Sum_probs=199.6
Q ss_pred eeeeccCcEEEEEEEEcC--CCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEecCC
Q 046892 83 CLLGEGGFGRVYKGTLQS--NGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMSG 158 (519)
Q Consensus 83 ~~LG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 158 (519)
+.||+|+||+||+|.+.. +++.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+ +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998754 4578999999654322 24578999999999999999999999965 467899999999
Q ss_pred CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCcc-
Q 046892 159 GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEKM- 237 (519)
Q Consensus 159 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~~- 237 (519)
|+|.+++.. ...+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999853 456999999999999999999999999 999999999999999999999999999876543322
Q ss_pred ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 238 NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 238 ~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.......||+.|||||++.+..++.++|||||||++|||++ |..||...... .+..... . . .
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~---~-~----------~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLE---K-G----------E 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH---T-T----------C
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHH---c-C----------C
Confidence 22334679999999999999999999999999999999998 89999865432 2222111 1 1 0
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALS 354 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~ 354 (519)
+..++..++.++.+|+.+||+.||.+|||+.+|++.|.
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 11234455678999999999999999999999987765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=406.73 Aligned_cols=273 Identities=27% Similarity=0.315 Sum_probs=207.7
Q ss_pred cceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC-----hHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 81 QECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG-----NKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 81 ~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.+++||+|+||+||+|++..+|+.||||++....... ...+.+|+.+|+.++|||||++++++.+.+..||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4578999999999999999999999999986543221 34688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGE 235 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~ 235 (519)
+.++++..++ .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9887766554 34567899999999999999999999999 9999999999999999999999999998755433
Q ss_pred ccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chh----ccCCC---
Q 046892 236 KMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPI----FRDPK--- 306 (519)
Q Consensus 236 ~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~----~~~~~--- 306 (519)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||......+....+... ... +....
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred c--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2 2334679999999999865 46899999999999999999999999876544332222111 000 00000
Q ss_pred ---CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCCC
Q 046892 307 ---RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPIP 364 (519)
Q Consensus 307 ---~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~~ 364 (519)
.+.......+. ......+.++.+|+.+||+.||.+|||+.|+++|.|+ ++.+.+.+
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f-~~~p~p~~ 291 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLH-HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPGPTP 291 (299)
T ss_dssp TCCCCCCCCCCCHH-HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG-TSSSCCCC
T ss_pred hhhhhccCCCCChH-HhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh-CCCCCCCC
Confidence 00000000011 1112345689999999999999999999999998764 44444433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.4e-51 Score=401.22 Aligned_cols=256 Identities=25% Similarity=0.313 Sum_probs=213.0
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---------hHHHHHHHHHHHhcC-CCCeeeeeeEEec
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---------NKEFLVEVLMLSLLH-HPNLVNLIGYCAD 145 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 145 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++.+..... .+.+.+|+.+++.++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999997654321 135788999999997 9999999999999
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.+..|||||||++|+|.++|.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999954 346999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhcc------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARS------GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~------~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~ 299 (519)
|+++....... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||...........+.
T Consensus 155 G~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~--- 228 (277)
T d1phka_ 155 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--- 228 (277)
T ss_dssp TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred hheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH---
Confidence 99987655432 234679999999999863 357889999999999999999999998754322222111
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.....++ .......+.++.+|+.+||+.||.+|||+.+|++|.|+
T Consensus 229 ---~~~~~~~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 229 ---SGNYQFG--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp ---HTCCCCC--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred ---hCCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 1111111 01122455689999999999999999999999998765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=408.53 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=208.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe----EEEEEEeccC-CCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ----VVAVKQLDRN-GMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.+|++.+.||+|+||+||+|.+..+|+ .||+|.+... .....+.+.+|+.+++.++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 479999999999999999999987776 5888888653 234567899999999999999999999999875 5678
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
++||+.+|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998754 3567999999999999999999999999 999999999999999999999999999977
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
.............||+.|||||++.++.|+.++|||||||+||||+| |..||...........+...
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~------------ 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------------ 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT------------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------
Confidence 65544444445678999999999999999999999999999999998 78888765433322222211
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
.+...+..++..+.+|+.+||+.||.+|||+.+|+++|..+..
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112344566789999999999999999999999999987653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=408.37 Aligned_cols=257 Identities=18% Similarity=0.242 Sum_probs=214.2
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEe
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEF 155 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 155 (519)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|..++|||||+++++|.+.+.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999999999999999997653 3345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCC--CCcEEeeecccccCCC
Q 046892 156 MSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGAN--LDPKLSDFGLAKLGPQ 233 (519)
Q Consensus 156 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~--~~vkL~DFGla~~~~~ 233 (519)
|+||+|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999843 3346999999999999999999999999 9999999999999854 5799999999987654
Q ss_pred CCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 234 GEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 234 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.. ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||......+.... +......++
T Consensus 157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~------i~~~~~~~~---- 223 (321)
T d1tkia_ 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNAEYTFD---- 223 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCCCC----
T ss_pred CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCCCCC----
Confidence 33 23446789999999999999999999999999999999999999986543222111 111111111
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
... ....+.++.+|+.+||+.||.+|||+.++++|.|+-
T Consensus 224 ~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 224 EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred hhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 111 112355789999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-50 Score=399.00 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=206.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcC---hHHHHHHHHHHHhcCCCCeeeeeeEEecCC----c
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQG---NKEFLVEVLMLSLLHHPNLVNLIGYCADGD----Q 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~ 148 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++....... ...+.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999997654433 346889999999999999999999987654 3
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
+|||||||+|++|.+++.. .+.+++..++.|+.||+.||+|||+.+ ||||||||+||||+.++.++|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998854 356999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC-ccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCC
Q 046892 229 KLGPQGE-KMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKR 307 (519)
Q Consensus 229 ~~~~~~~-~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 307 (519)
....... ........+||+.|||||++.+..++.++|||||||+||||+||..||....+.... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCC
Confidence 7554322 122234568999999999999999999999999999999999999999765432211 111111111
Q ss_pred CCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-CHHHHHHHHhhhhc
Q 046892 308 FPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-LMSDVVTALSFLSN 358 (519)
Q Consensus 308 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~l~~~~~ 358 (519)
.+ .......+.++.+||.+||+.||.+|| |+.+++..|..+.+
T Consensus 233 ~~--------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 PP--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CG--------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred CC--------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 10 112234556889999999999999999 89999888776543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-51 Score=405.47 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=214.3
Q ss_pred hccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCc
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 148 (519)
..++|++.+.||+|+||+||+|++. .+++.||||++...... ..+.+.+|+.+|+.++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999985 34679999998754333 34568999999999999999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE--------------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLK 208 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDik 208 (519)
.++||||+.+|+|.+++..... ....+++..++.|+.||+.||+|||+.+ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 9999999999999999964321 2235899999999999999999999999 9999999
Q ss_pred CCCeeeCCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCC
Q 046892 209 SSNILLGANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR-RVIDTTR 287 (519)
Q Consensus 209 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~-~pf~~~~ 287 (519)
|+||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||+||||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998665444444445678999999999999999999999999999999999996 5666543
Q ss_pred CcchhhHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 288 PVDEQNLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
... +...+ .... . ...+..++.++.+|+..||+.||.+||||.+|+++|..+.
T Consensus 248 ~~e---~~~~v---~~~~--~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEE---VIYYV---RDGN--I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHH---HHHHH---HTTC--C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHH---HHHHH---HcCC--C---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 322 22211 1110 1 1234455668999999999999999999999999987653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=409.66 Aligned_cols=261 Identities=21% Similarity=0.264 Sum_probs=207.8
Q ss_pred ccCcccce-eeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHH-hcCCCCeeeeeeEEec----CCce
Q 046892 76 TKNFRQEC-LLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLS-LLHHPNLVNLIGYCAD----GDQR 149 (519)
Q Consensus 76 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~----~~~~ 149 (519)
.++|.+.. +||+|+||+||+|++..+++.||||++.. ...+.+|+.++. ..+|||||+++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898764 69999999999999999999999999863 356788998865 5589999999999875 4678
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC---CCCcEEeeec
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA---NLDPKLSDFG 226 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~---~~~vkL~DFG 226 (519)
|||||||+||+|.++|... ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++. .+.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999642 2356999999999999999999999999 999999999999975 5679999999
Q ss_pred ccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 227 LAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 227 la~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
+++....... ....+||+.|||||++.+..|+.++|||||||+||+|+||+.||...........+ ...+.....
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--~~~i~~~~~ 234 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--KTRIRMGQY 234 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSCSS
T ss_pred eeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH--HHHHhcCCC
Confidence 9987654332 34568999999999999999999999999999999999999999765433221111 011111111
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcC
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNS 359 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~ 359 (519)
.++. ......+.++.+||.+||+.||.+|||+.++++|.|+....
T Consensus 235 ~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 235 EFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 1110 00123456899999999999999999999999998876443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=396.48 Aligned_cols=256 Identities=31% Similarity=0.436 Sum_probs=203.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFM 156 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 156 (519)
++|++.+.||+|+||+||+|++.. +..||||++.... ...+.|.+|+.++..++|||||++++++.+ +..++|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 579999999999999999999975 4679999996543 456789999999999999999999999854 5689999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++|+|..++.... ...++|..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999886532 346999999999999999999999999 99999999999999999999999999987644332
Q ss_pred cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccchHh
Q 046892 237 MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADPLL 316 (519)
Q Consensus 237 ~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 316 (519)
.......||+.|+|||++..+.++.++|||||||+||||++|..|+..... ...+....... .
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~~--------------~ 231 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERG--------------Y 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT--------------C
T ss_pred -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHHHhc--------------C
Confidence 223346799999999999999999999999999999999997666544322 12222221110 1
Q ss_pred hccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 317 RKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 317 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+..++..++.++.+||.+||+.||++||++.+|+++|...-
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11234455678999999999999999999999998876533
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=398.67 Aligned_cols=277 Identities=24% Similarity=0.325 Sum_probs=211.1
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||+||+|++..+|+.||||++..... .....+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 689999999999999999999999999999999965432 235678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.+ .+..++.. .....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 44544433 23456999999999999999999999999 999999999999999999999999999865443
Q ss_pred CccceecccccccccCchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhchhcc--------C
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPIFR--------D 304 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~~~~--------~ 304 (519)
.. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+....+. ....... .
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 32 234467999999999887655 5789999999999999999999998654332221111 1000000 0
Q ss_pred ---CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCCCCC
Q 046892 305 ---PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSKEPI 363 (519)
Q Consensus 305 ---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~~~~ 363 (519)
...++......... .....+.++.+|+.+||+.||.+|||+.++++|.|+ ++...++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff-~~~~~p~ 293 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293 (298)
T ss_dssp TTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG-TTCCCCC
T ss_pred cccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh-ccCCCCC
Confidence 00000011100010 112345688999999999999999999999998664 4444433
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=394.50 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=201.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC---CeEEEEEEeccCCCc-ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN---GQVVAVKQLDRNGMQ-GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 151 (519)
.++|++.+.||+|+||.||+|++..+ +..||||.+...... ..+.+.+|+.+|+.++|||||++++++. .+.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 36799999999999999999998654 457999998654333 3456899999999999999999999996 467899
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccC
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLG 231 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~ 231 (519)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998754 3457999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCc
Q 046892 232 PQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPD 310 (519)
Q Consensus 232 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (519)
..... .......||+.|+|||++.+..++.++|||||||+||||++ |.+||...........+.. . .
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~------~-~---- 226 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------G-E---- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT------T-C----
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc------C-C----
Confidence 44322 22344678999999999999999999999999999999998 8899987654433222211 0 0
Q ss_pred ccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 311 MADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 311 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+..++..++..+.+||.+||+.||.+|||+.+|+++|..+.
T Consensus 227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11234456678999999999999999999999999997654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=398.43 Aligned_cols=263 Identities=27% Similarity=0.363 Sum_probs=201.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecC-C
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADG-D 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~-~ 147 (519)
.++|++.+.||+|+||.||+|++.. +++.||||++..... .....+..|..++..+ +|+|||.+++++.+. .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4689999999999999999999754 357899999875433 2345577777777665 689999999998654 5
Q ss_pred ceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG 215 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~ 215 (519)
.+++|||||++|+|.++|..... ....+++..++.++.||+.||.|||+++ ||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 68999999999999999975432 2345899999999999999999999999 99999999999999
Q ss_pred CCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCcchhhH
Q 046892 216 ANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR-RVIDTTRPVDEQNL 294 (519)
Q Consensus 216 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~-~pf~~~~~~~~~~~ 294 (519)
.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. +||........ +
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~ 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--H
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 99999999999998765544444445678999999999999999999999999999999999875 56765433221 1
Q ss_pred HHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 295 IAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..... . ..+..++...+.++.+|+.+||+.||.+|||+.+|+++|..+.
T Consensus 247 ~~~~~----~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 CRRLK----E----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHH----H----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh----c----------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111 0 0011234445668999999999999999999999999998653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=393.37 Aligned_cols=252 Identities=27% Similarity=0.426 Sum_probs=202.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEec-CCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+.+++.++|||||+++|+|.+ .+.++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 357889999999999999999985 789999999654 345779999999999999999999999865 466899999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999996532 235899999999999999999999999 999999999999999999999999999865432
Q ss_pred CccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCCCcccc
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMAD 313 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 313 (519)
.....+|+.|+|||++.++.++.++|||||||++|||+| |.+||......+ +......
T Consensus 157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~------------- 215 (262)
T d1byga_ 157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK------------- 215 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT-------------
T ss_pred -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc-------------
Confidence 223467999999999999999999999999999999998 677776543332 2222211
Q ss_pred hHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 314 PLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 314 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
..+..++...+.++.+|+.+||+.||.+|||+.+|+++|..++.
T Consensus 216 -~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 01123444556788999999999999999999999999987764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=396.89 Aligned_cols=245 Identities=22% Similarity=0.375 Sum_probs=203.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------ChHHHHHHHHHHHhcC--CCCeeeeeeEEecCC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------GNKEFLVEVLMLSLLH--HPNLVNLIGYCADGD 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~ 147 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.... ....+.+|+.+|+.++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999999999999999998754221 1234678999999886 899999999999999
Q ss_pred ceEEEEEecCC-CCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-CCCcEEeee
Q 046892 148 QRLLVYEFMSG-GSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-NLDPKLSDF 225 (519)
Q Consensus 148 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-~~~vkL~DF 225 (519)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 577777743 356999999999999999999999999 999999999999985 478999999
Q ss_pred cccccCCCCCccceecccccccccCchhhhccCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 226 GLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGEL-TVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 226 Gla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~-~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
|+++...... .....||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... .+.. .
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~-------~ 219 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR-------G 219 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-------C
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhh-------c
Confidence 9998654332 345689999999999987765 577999999999999999999996421 1111 1
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
.. .++...+.++.+||.+||+.||.+|||+.++++|.|+
T Consensus 220 ~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 220 QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 11 1233345688999999999999999999999998765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=395.33 Aligned_cols=262 Identities=27% Similarity=0.377 Sum_probs=209.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCC-------eEEEEEEeccCCCc-ChHHHHHHHHHHHhc-CCCCeeeeeeEEecC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNG-------QVVAVKQLDRNGMQ-GNKEFLVEVLMLSLL-HHPNLVNLIGYCADG 146 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~-------~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 146 (519)
.++|++.+.||+|+||.||+|++..++ ..||||++...... ....+..|+..+..+ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468999999999999999999976543 47999999765432 346678888888777 799999999999999
Q ss_pred CceEEEEEecCCCCHHHHHhhhcc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 147 DQRLLVYEFMSGGSVDDHLLDVNE------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 147 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
+..++|||||++|+|.++|..... ....+++..++.++.||+.||.|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999965431 2346899999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQN 293 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~ 293 (519)
+.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence 9999999999999987655444444555789999999999999999999999999999999998 67887654322 2
Q ss_pred HHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 294 LIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
+..... ... +..++...+.++.+||.+||+.||.+|||+.+|++.|..+.
T Consensus 246 ~~~~i~----~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 LFKLLK----EGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHH----TTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH----cCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 222211 111 11233445568999999999999999999999999997664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=394.88 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=210.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCe--EEEEEEeccC-CCcChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCceEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQ--VVAVKQLDRN-GMQGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 152 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lV 152 (519)
++|++.++||+|+||.||+|++..+|. .||||.+... .....+.+.+|+.+|..+ +|||||+++++|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578899999999999999999988876 4777877543 233456799999999998 799999999999999999999
Q ss_pred EEecCCCCHHHHHhhh------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 153 YEFMSGGSVDDHLLDV------------NETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 153 ~E~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
|||+++|+|.++|... ......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 234467999999999999999999999999 9999999999999999999
Q ss_pred EEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCC-CCCCCCCcchhhHHHhhc
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRR-VIDTTRPVDEQNLIAWAQ 299 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~-pf~~~~~~~~~~~~~~~~ 299 (519)
||+|||+++...... ......||+.|+|||.+.++.++.++|||||||++|||++|.. ||.... ...+...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGG
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---HHHHHHHHH
Confidence 999999998644322 1234568999999999999999999999999999999999765 565432 222222221
Q ss_pred hhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhcCC
Q 046892 300 PIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSNSK 360 (519)
Q Consensus 300 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~~~ 360 (519)
.. .+...+..++.++.+||.+||+.||++||||.+|+++|..+....
T Consensus 241 ---~~-----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 ---QG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---GT-----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---hc-----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 11 011234455678999999999999999999999999998776543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=394.37 Aligned_cols=261 Identities=27% Similarity=0.371 Sum_probs=215.1
Q ss_pred ccCcccceeeeccCcEEEEEEEEc-----CCCeEEEEEEeccCCC-cChHHHHHHHHHHHhc-CCCCeeeeeeEEecCCc
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQ-----SNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 148 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 148 (519)
.++|++.+.||+|+||.||+|++. .+++.||||++..... .....+.+|+.++..+ +|||||+++++|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 468999999999999999999873 4577999999976543 2345688999999988 69999999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNE--------------TKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILL 214 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl 214 (519)
.+||||||++|+|.+++..... ....+++..++.|+.||+.||+|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999975321 2346899999999999999999999999 9999999999999
Q ss_pred CCCCCcEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCCcchh-
Q 046892 215 GANLDPKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITG-RRVIDTTRPVDEQ- 292 (519)
Q Consensus 215 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG-~~pf~~~~~~~~~- 292 (519)
+.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+||.........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999987665555555667899999999999999999999999999999999995 5555444332221
Q ss_pred hHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 293 NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.++.. ..+...+...+..+.+||.+||+.||.+||||.+|+++|+.+
T Consensus 259 ~~i~~-----------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 KMIKE-----------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHH-----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhc-----------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111 111223344566899999999999999999999999999753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=390.47 Aligned_cols=256 Identities=28% Similarity=0.395 Sum_probs=198.5
Q ss_pred cCcccceeeeccCcEEEEEEEEcCC-C--eEEEEEEeccCCC---cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSN-G--QVVAVKQLDRNGM---QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 150 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~-~--~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 150 (519)
++|++.+.||+|+||.||+|++..+ + ..||||++..... ...+.|.+|+.+|+.++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999987533 2 4789999875432 234578999999999999999999999976 4678
Q ss_pred EEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccccc
Q 046892 151 LVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKL 230 (519)
Q Consensus 151 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~ 230 (519)
+||||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999988653 345999999999999999999999999 99999999999999999999999999997
Q ss_pred CCCCCccce-ecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHhhchhccCCCCC
Q 046892 231 GPQGEKMNV-TSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELIT-GRRVIDTTRPVDEQNLIAWAQPIFRDPKRF 308 (519)
Q Consensus 231 ~~~~~~~~~-~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (519)
......... .....|+..|+|||++.+..++.++|||||||++|||+| |..||...... ...... ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i---~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI---DKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH---HTSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH---HhCCCC-
Confidence 655433222 234568889999999999999999999999999999998 89999754332 222221 111111
Q ss_pred CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 309 PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 309 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+..++..+.+|+.+||+.||.+|||+.+|++.|..
T Consensus 234 ---------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11234455688999999999999999999999988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=390.27 Aligned_cols=271 Identities=24% Similarity=0.302 Sum_probs=206.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCC-CeEEEEEEeccCCC--cChHHHHHHHHHHHhc---CCCCeeeeeeEEec----
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSN-GQVVAVKQLDRNGM--QGNKEFLVEVLMLSLL---HHPNLVNLIGYCAD---- 145 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~---- 145 (519)
.++|++.+.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999654 67899999865322 2234566777776655 79999999999853
Q ss_pred -CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 146 -GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 146 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
....+++|||+.++.+..... .....+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 346899999998876654432 34567899999999999999999999999 99999999999999999999999
Q ss_pred ecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-chh--
Q 046892 225 FGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-QPI-- 301 (519)
Q Consensus 225 FGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~~~-- 301 (519)
||++....... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+....+... ...
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99998654322 234578999999999999999999999999999999999999999876543332222111 000
Q ss_pred --ccCCCCCCcc----cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 302 --FRDPKRFPDM----ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 302 --~~~~~~~~~~----~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
+......... ........+....+..+.+|+.+||+.||.+|||+.++++|.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 0000000000 00000112344556788999999999999999999999999765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-48 Score=386.70 Aligned_cols=269 Identities=22% Similarity=0.295 Sum_probs=207.9
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC--cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM--QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+.+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999986 689999999976432 235679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
|+.++.+..+. .....+++..++.++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 99876666555 34567999999999999999999999999 999999999999999999999999999875433
Q ss_pred CccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC-----CCC
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP-----KRF 308 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~ 308 (519)
.. ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.......... ...
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 22 2334568999999999875 457999999999999999999999998654433322211110000000 000
Q ss_pred Ccc------cchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 309 PDM------ADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 309 ~~~------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
... ........+....+..+.+|+.+||+.||.+|||+.|+++|.|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000 00011122334456789999999999999999999999998765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=389.80 Aligned_cols=261 Identities=22% Similarity=0.398 Sum_probs=212.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcC-----CCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCCce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQS-----NGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 149 (519)
.++|.+.+.||+|+||+||+|.+.. +++.||||++..... .....+.+|+.+++.++|||||+++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 3688999999999999999998852 357899999975432 2334688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHHhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEe
Q 046892 150 LLVYEFMSGGSVDDHLLDVN------ETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLS 223 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~ 223 (519)
++||||+.+|+|.+++.... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986432 22345799999999999999999999999 9999999999999999999999
Q ss_pred eecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCC-CCCCCCCCcchhhHHHhhchhc
Q 046892 224 DFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGR-RVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 224 DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~-~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|||+++...............||+.|+|||.+.++.++.++|||||||+||||+||. .||...... ...... .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~~~i---~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLRFV---M 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHHHH---H
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---H
Confidence 999998765544433444567899999999999999999999999999999999985 666543222 222211 1
Q ss_pred cCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 RDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.. .. ...+..++..+.+|+.+||+.||.+|||+.+|+++|...
T Consensus 250 ~~-~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EG-GL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TT-CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hC-CC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 00 112334556899999999999999999999999998654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=389.01 Aligned_cols=268 Identities=25% Similarity=0.303 Sum_probs=206.4
Q ss_pred CcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCeeeeeeEEecC------CceEE
Q 046892 78 NFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLL 151 (519)
Q Consensus 78 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~~l 151 (519)
+|...++||+|+||+||+|++..+|+.||||++...... +.+|+.+|+.++||||++++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 588889999999999999999999999999999765322 34699999999999999999998542 34789
Q ss_pred EEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeeccccc
Q 046892 152 VYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKL 230 (519)
Q Consensus 152 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~ 230 (519)
|||||+++ +...+.........+++..++.|+.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999754 55555444456678999999999999999999999999 99999999999999775 899999999987
Q ss_pred CCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhh-c--------h
Q 046892 231 GPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWA-Q--------P 300 (519)
Q Consensus 231 ~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~-~--------~ 300 (519)
...... ....+||+.|+|||.+.+ ..++.++|||||||++|||++|..||......+....+... . .
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 654432 234679999999998765 57899999999999999999999999765443322211100 0 0
Q ss_pred hcc--CCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 301 IFR--DPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 301 ~~~--~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
... ....++...............+.++.+|+.+||+.||.+|||+.|+++|.|+-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 000 00111111111112223344567899999999999999999999999997763
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=386.81 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=204.0
Q ss_pred ceeeeccCcEEEEEEEEcCCC---eEEEEEEeccCC-CcChHHHHHHHHHHHhcCCCCeeeeeeEEec-CCceEEEEEec
Q 046892 82 ECLLGEGGFGRVYKGTLQSNG---QVVAVKQLDRNG-MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEFM 156 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~ 156 (519)
.++||+|+||+||+|++..++ ..||||++.... ....+.|.+|+.+|..++|||||+++|++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986543 369999997532 2344679999999999999999999999865 56789999999
Q ss_pred CCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCCCc
Q 046892 157 SGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQGEK 236 (519)
Q Consensus 157 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~~~ 236 (519)
++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998853 4456789999999999999999999999 99999999999999999999999999987654332
Q ss_pred c--ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCCCCCcccch
Q 046892 237 M--NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPKRFPDMADP 314 (519)
Q Consensus 237 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 314 (519)
. .......||+.|+|||.+..+.++.++||||||++||||+||..||...... .++.... ....
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i---~~g~--------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYL---LQGR--------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH---HTTC---------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHH---HcCC---------
Confidence 1 1223457899999999999999999999999999999999988887653211 1111111 1110
Q ss_pred HhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 315 LLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 315 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
+...+..++.++.+|+.+||+.||.+||+|.+|+++|..+..
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111234455688999999999999999999999999987754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=382.50 Aligned_cols=273 Identities=22% Similarity=0.293 Sum_probs=205.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCC--CcChHHHHHHHHHHHhcCCCCeeeeeeEEec--------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNG--MQGNKEFLVEVLMLSLLHHPNLVNLIGYCAD-------- 145 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-------- 145 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999999999999999986542 2345678899999999999999999999855
Q ss_pred CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeee
Q 046892 146 GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDF 225 (519)
Q Consensus 146 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DF 225 (519)
.+..++||||+.++.+..+. .....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 34689999999877665443 34567899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCc--cceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc
Q 046892 226 GLAKLGPQGEK--MNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF 302 (519)
Q Consensus 226 Gla~~~~~~~~--~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~ 302 (519)
|++........ .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99976543221 1223345799999999998764 68999999999999999999999998654433332222111100
Q ss_pred cCCCCCCcccch--------------HhhccC-ChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 RDPKRFPDMADP--------------LLRKQF-PEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 ~~~~~~~~~~d~--------------~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
... ........ .+...+ .......+.+|+.+||+.||.+|||+.++++|.||-
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 242 TPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp CTT-TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred Chh-hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 000 00000000 000000 011234678999999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=383.16 Aligned_cols=269 Identities=24% Similarity=0.342 Sum_probs=198.5
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHH--HHHHHhcCCCCeeeeeeEEecCC----ce
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVE--VLMLSLLHHPNLVNLIGYCADGD----QR 149 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E--~~~l~~l~HpnIv~l~~~~~~~~----~~ 149 (519)
.++|.+.+.||+|+||.||+|++. |+.||||++... ....+..| +..+..++|||||++++++.+.+ .+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 357888999999999999999974 899999998643 23344444 44556789999999999997654 57
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeeCCCCCcEEee
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA-----NPPVIYRDLKSSNILLGANLDPKLSD 224 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~IvHrDikp~NILl~~~~~vkL~D 224 (519)
+||||||++|+|.++|.. ..++|..++.++.|++.||+|||+.. ..+||||||||+||||+.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 999999999999999954 35899999999999999999999741 11299999999999999999999999
Q ss_pred ecccccCCCCCcc--ceecccccccccCchhhhccCC------CCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh----
Q 046892 225 FGLAKLGPQGEKM--NVTSRVMGTYGYCAPEYARSGE------LTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ---- 292 (519)
Q Consensus 225 FGla~~~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~------~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~---- 292 (519)
||+++........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..||.........
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 9999865443321 1233568999999999987542 577899999999999999998887543221100
Q ss_pred ----hHHHhhchhccCCCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhhc
Q 046892 293 ----NLIAWAQPIFRDPKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLSN 358 (519)
Q Consensus 293 ----~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~~ 358 (519)
...............-+.+.+ ...+......+.+|+.+||+.||.+|||+.+|+++|..+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHhccccCCCCCc----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 000000011111000010000 01122345679999999999999999999999999987764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=385.04 Aligned_cols=276 Identities=26% Similarity=0.367 Sum_probs=220.7
Q ss_pred cCcccceeeeccCcEEEEEEEE---cCCCeEEEEEEeccCC----CcChHHHHHHHHHHHhcCC-CCeeeeeeEEecCCc
Q 046892 77 KNFRQECLLGEGGFGRVYKGTL---QSNGQVVAVKQLDRNG----MQGNKEFLVEVLMLSLLHH-PNLVNLIGYCADGDQ 148 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~---~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~ 148 (519)
++|++.+.||+|+||+||+|.+ ..+|+.||||++.+.. ....+.+.+|+.+++.++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999997 3468999999986532 1234567889999999976 899999999999999
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeeccc
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLA 228 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla 228 (519)
.++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998543 45788999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCccceecccccccccCchhhhccC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCCC
Q 046892 229 KLGPQGEKMNVTSRVMGTYGYCAPEYARSG--ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDPK 306 (519)
Q Consensus 229 ~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~--~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 306 (519)
+....... .......|++.|+|||.+.+. .++.++|||||||+||+|++|..||......+....+.... ....
T Consensus 177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~~- 252 (322)
T d1vzoa_ 177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSE- 252 (322)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCC-
T ss_pred hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccCC-
Confidence 86544322 223456799999999998754 46889999999999999999999998765544332222111 1111
Q ss_pred CCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHhhhhc-----CCCCCCCCCCCCCCCC
Q 046892 307 RFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARP-----LMSDVVTALSFLSN-----SKEPIPDPIIPSDEDE 374 (519)
Q Consensus 307 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~l~~~~~-----~~~~~~~p~~p~~~~~ 374 (519)
..++...+.++.+|+.+||+.||.+|| |+.|+++|.|+-.- ....+++|+.|...+.
T Consensus 253 -----------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~ 319 (322)
T d1vzoa_ 253 -----------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 319 (322)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-
T ss_pred -----------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCC
Confidence 123445667899999999999999999 58999998776321 3456677888765543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-46 Score=378.94 Aligned_cols=264 Identities=19% Similarity=0.247 Sum_probs=206.2
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEec--CCceEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLVY 153 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV~ 153 (519)
++|++.+.||+|+||+||+|++..+|+.||||++... ..+.+.+|+.+|..++ ||||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999998643 3567889999999985 9999999999974 45689999
Q ss_pred EecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCC-CcEEeeecccccCC
Q 046892 154 EFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANL-DPKLSDFGLAKLGP 232 (519)
Q Consensus 154 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~-~vkL~DFGla~~~~ 232 (519)
|||.+++|..+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.++ .+||+|||+++...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987653 45999999999999999999999999 99999999999998655 58999999998765
Q ss_pred CCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh-hHH-H---------hhch
Q 046892 233 QGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ-NLI-A---------WAQP 300 (519)
Q Consensus 233 ~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~-~~~-~---------~~~~ 300 (519)
.... ....+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||......... ..+ . +...
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 4432 3446789999999998764 5799999999999999999999999765432211 110 0 0000
Q ss_pred h-ccCCCC-------C-CcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 301 I-FRDPKR-------F-PDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 301 ~-~~~~~~-------~-~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
. ...... . ................+.++.+||.+||+.||.+|||+.++++|.||-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0 000000 0 000001111112234567899999999999999999999999998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=372.84 Aligned_cols=270 Identities=22% Similarity=0.249 Sum_probs=212.3
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCCceEEEEE
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 154 (519)
++|++.+.||+|+||+||+|++..+++.||||++...... ....+.+|+.+|+.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999999999999999999755432 34678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccccCCCC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAKLGPQG 234 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~~~~~~ 234 (519)
++.+++|..++. ..+.+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999988887763 3467899999999999999999999999 999999999999999999999999999876543
Q ss_pred CccceecccccccccCchhhhccCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHHhh-chhccC-------
Q 046892 235 EKMNVTSRVMGTYGYCAPEYARSGE-LTVKSDVYSFGVILLELITGRRVIDTTRPVDE-QNLIAWA-QPIFRD------- 304 (519)
Q Consensus 235 ~~~~~~~~~~Gt~~y~APE~l~~~~-~~~~sDvwSlGvll~elltG~~pf~~~~~~~~-~~~~~~~-~~~~~~------- 304 (519)
.. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||........ ...+... ......
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 32 233456789999999987654 69999999999999999999999754333221 1111111 100000
Q ss_pred ---CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 305 ---PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 305 ---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
....+...............+..+.+|+.+||+.||.+|||+.|+++|.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 000000000001112234456688999999999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=388.75 Aligned_cols=272 Identities=21% Similarity=0.273 Sum_probs=204.7
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCC-cChHHHHHHHHHHHhcCCCCeeeeeeEEecCC----ce
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGM-QGNKEFLVEVLMLSLLHHPNLVNLIGYCADGD----QR 149 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 149 (519)
.+.+|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+++|+.+|+.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35689999999999999999999999999999999975432 23457889999999999999999999997653 23
Q ss_pred EEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 150 LLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 150 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||+++ ||||||||+||||+.++.+||+|||++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 555666779999999853 35999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-ceecccccccccCchhhhc-cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccCC--
Q 046892 230 LGPQGEKM-NVTSRVMGTYGYCAPEYAR-SGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRDP-- 305 (519)
Q Consensus 230 ~~~~~~~~-~~~~~~~Gt~~y~APE~l~-~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-- 305 (519)
........ ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||......+...............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 65443221 1234467999999999984 4567899999999999999999999997754433222111110000000
Q ss_pred ------------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhh
Q 046892 306 ------------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSF 355 (519)
Q Consensus 306 ------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~ 355 (519)
...+........ ......+.++.+|+.+||+.||.+|||+.++++|.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWN-RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhhhhcccccCCccCCCCHH-HhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 000000000000 0112334578999999999999999999999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=383.72 Aligned_cols=266 Identities=24% Similarity=0.318 Sum_probs=202.4
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecCC------
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADGD------ 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 147 (519)
.++|++.+.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57899999999999999999999999999999999754332 2356889999999999999999999997654
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
.+||||||+ +.+|..++.. ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 6677776632 46999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhcc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc----
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARS-GELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF---- 302 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~-~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~---- 302 (519)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+............
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9876433 234679999999999876 457899999999999999999999998764333221111110000
Q ss_pred -cCC---------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 -RDP---------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 -~~~---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
... ..++......+ .......+..+.+||.+||+.||.+|||+.++++|.|+-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 000 00000000001 112234456889999999999999999999999997653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=366.48 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=201.7
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-eeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+..|+.+++.++|+|+ +.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4579999999999999999999999999999999876432 3457889999999987664 555666677888999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeC---CCCCcEEeeecccccC
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLG---ANLDPKLSDFGLAKLG 231 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~---~~~~vkL~DFGla~~~ 231 (519)
|+ +++|.+.+.. ....+++..++.++.||+.||+|||+++ ||||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 5677766643 3457999999999999999999999999 99999999999875 4567999999999876
Q ss_pred CCCCcc-----ceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhchhccCC
Q 046892 232 PQGEKM-----NVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQPIFRDP 305 (519)
Q Consensus 232 ~~~~~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~~~~~~~ 305 (519)
...... .......||+.|||||++.+..++.++|||||||++|||++|..||............. ........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 543221 12345689999999999999999999999999999999999999998754433222111 111000000
Q ss_pred CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 306 KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 306 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
.......++.++.+|+..||+.||.+||++.++.+.|..+
T Consensus 237 -----------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 -----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111223456889999999999999999999887766543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-45 Score=363.29 Aligned_cols=263 Identities=19% Similarity=0.236 Sum_probs=210.8
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC-CCeeeeeeEEecCCceEEEEE
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 154 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E 154 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+..|+..+..+.| +||+.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999999999999999986543 23457788899988875 899999999999999999999
Q ss_pred ecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCC-----CCCcEEeeecccc
Q 046892 155 FMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGA-----NLDPKLSDFGLAK 229 (519)
Q Consensus 155 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~-----~~~vkL~DFGla~ 229 (519)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+.| ||||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 7899998854 3456899999999999999999999999 999999999999974 5789999999998
Q ss_pred cCCCCCc-----cceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhccC
Q 046892 230 LGPQGEK-----MNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIFRD 304 (519)
Q Consensus 230 ~~~~~~~-----~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 304 (519)
....... .......+||+.|||||++.+..++.++|||||||++|||++|..||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7543221 11234568999999999999999999999999999999999999999876554443322211100000
Q ss_pred CCCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 305 PKRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 305 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
. . ...+...++.++.+|+..|+..+|++||++..+.+.+..+.
T Consensus 235 ~------~----~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 T------P----LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp S------C----HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred C------C----hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0 0 01112234457899999999999999999999888776543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=372.88 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=204.2
Q ss_pred hccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEecC-----C
Q 046892 75 ATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCADG-----D 147 (519)
Q Consensus 75 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-----~ 147 (519)
+.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 367899999999999999999999999999999999765332 335688999999999999999999998643 3
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
..++||+|+.+|+|.+++. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence 4467778888999999883 346999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHhhchhc----
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSG-ELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIAWAQPIF---- 302 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~-~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~~~~~~~---- 302 (519)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.......
T Consensus 168 a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 9764322 3346789999999987665 56899999999999999999999998754433322221110000
Q ss_pred -cCC---------CCCCcccchHhhccCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhh
Q 046892 303 -RDP---------KRFPDMADPLLRKQFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFL 356 (519)
Q Consensus 303 -~~~---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~ 356 (519)
... ..+.......+.. .....+.++.+||.+||+.||.+|||+.++++|.|+-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 000 0000000000000 0123456789999999999999999999999997764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=375.23 Aligned_cols=269 Identities=21% Similarity=0.248 Sum_probs=198.9
Q ss_pred ccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc--ChHHHHHHHHHHHhcCCCCeeeeeeEEec------CC
Q 046892 76 TKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ--GNKEFLVEVLMLSLLHHPNLVNLIGYCAD------GD 147 (519)
Q Consensus 76 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~~ 147 (519)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ....+.+|+.+++.++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 46899999999999999999999999999999999765332 23468899999999999999999999964 46
Q ss_pred ceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCcEEeeecc
Q 046892 148 QRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDPKLSDFGL 227 (519)
Q Consensus 148 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~vkL~DFGl 227 (519)
.+|+|||||.++. ...+ ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~iv~Ey~~~~l-~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANL-CQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEH-HHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHH-HHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence 7899999997654 4444 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH-hhc-------
Q 046892 228 AKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQNLIA-WAQ------- 299 (519)
Q Consensus 228 a~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~~~~~-~~~------- 299 (519)
++....... ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||...........+. ...
T Consensus 166 ~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 886554332 334678999999999999999999999999999999999999997654332221111 000
Q ss_pred --------hhccCCCCCCcccchH-----hhc---cCChhhHHHHHHHHHHhhhhCCCCCCCHHHHHHHHhhhh
Q 046892 300 --------PIFRDPKRFPDMADPL-----LRK---QFPEKGLNEAVAIAAMCLQEEAGARPLMSDVVTALSFLS 357 (519)
Q Consensus 300 --------~~~~~~~~~~~~~d~~-----l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~l~~~~ 357 (519)
..............+. ... ......+.++.+|+.+||+.||.+|||+.|+++|.|+-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000000000000000 000 012335678999999999999999999999999987754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-41 Score=344.11 Aligned_cols=270 Identities=18% Similarity=0.212 Sum_probs=198.7
Q ss_pred cCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-----------CCCeeeeeeEEec
Q 046892 77 KNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-----------HPNLVNLIGYCAD 145 (519)
Q Consensus 77 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~~~~~ 145 (519)
.+|++.+.||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 359999999999999999999999999999999975432 2356778888887765 5789999998854
Q ss_pred --CCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeeCCCCC---
Q 046892 146 --GDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHD-KANPPVIYRDLKSSNILLGANLD--- 219 (519)
Q Consensus 146 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~IvHrDikp~NILl~~~~~--- 219 (519)
....+++|+++..+........ ......+++..++.++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 3566777777655544333322 2345678999999999999999999998 77 999999999999986654
Q ss_pred ---cEEeeecccccCCCCCccceecccccccccCchhhhccCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCcchh----
Q 046892 220 ---PKLSDFGLAKLGPQGEKMNVTSRVMGTYGYCAPEYARSGELTVKSDVYSFGVILLELITGRRVIDTTRPVDEQ---- 292 (519)
Q Consensus 220 ---vkL~DFGla~~~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~sDvwSlGvll~elltG~~pf~~~~~~~~~---- 292 (519)
++|+|||.+...... ....+||+.|+|||++.+..++.++|||||||++++|++|+.||.........
T Consensus 168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 899999999865332 23467999999999999999999999999999999999999999764332111
Q ss_pred hHHHhhch-----------------hcc---CCCCCCccc----chH--hhccCChhhHHHHHHHHHHhhhhCCCCCCCH
Q 046892 293 NLIAWAQP-----------------IFR---DPKRFPDMA----DPL--LRKQFPEKGLNEAVAIAAMCLQEEAGARPLM 346 (519)
Q Consensus 293 ~~~~~~~~-----------------~~~---~~~~~~~~~----d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 346 (519)
.+...... ... ....+.... ... ....+....+.++.+|+.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11110000 000 000011000 001 1223456778899999999999999999999
Q ss_pred HHHHHHHhhh
Q 046892 347 SDVVTALSFL 356 (519)
Q Consensus 347 ~evl~~l~~~ 356 (519)
.++++|.|+-
T Consensus 323 ~e~L~Hp~f~ 332 (362)
T d1q8ya_ 323 GGLVNHPWLK 332 (362)
T ss_dssp HHHHTCGGGT
T ss_pred HHHhcCcccC
Confidence 9999988764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.2e-24 Score=196.39 Aligned_cols=164 Identities=13% Similarity=0.050 Sum_probs=119.9
Q ss_pred cccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCc------------------ChHHHHHHHHHHHhcCCCCeeeee
Q 046892 79 FRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQ------------------GNKEFLVEVLMLSLLHHPNLVNLI 140 (519)
Q Consensus 79 y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~------------------~~~~~~~E~~~l~~l~HpnIv~l~ 140 (519)
+.+.+.||+|+||+||+|++. +|+.||||+++..... .......|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 346789999999999999986 5899999987532110 012234578888899999999988
Q ss_pred eEEecCCceEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeeCCCCCc
Q 046892 141 GYCADGDQRLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKANPPVIYRDLKSSNILLGANLDP 220 (519)
Q Consensus 141 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~IvHrDikp~NILl~~~~~v 220 (519)
++. ..+++|||+++..+.. +++..+..++.||+.+|+|||+.+ |+||||||+|||+++++ +
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-I 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-E
T ss_pred Eec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-E
Confidence 764 2479999998765432 333456679999999999999999 99999999999999655 8
Q ss_pred EEeeecccccCCCCCccceecccccccccCc------hhhhccCCCCchhHHHHHHHHH
Q 046892 221 KLSDFGLAKLGPQGEKMNVTSRVMGTYGYCA------PEYARSGELTVKSDVYSFGVIL 273 (519)
Q Consensus 221 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~A------PE~l~~~~~~~~sDvwSlGvll 273 (519)
+|+|||+|......... .|.. .+.+ ...|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999999765432211 1111 1222 35678889999975444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.77 E-value=1.2e-08 Score=96.21 Aligned_cols=149 Identities=17% Similarity=0.086 Sum_probs=104.8
Q ss_pred HHHHHhccCcccceeeeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCc
Q 046892 70 RELAAATKNFRQECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 148 (519)
Q Consensus 70 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 148 (519)
.++......|+..+..+.++.+.||+... ++..+++|+...........+..|..++..+. +--+.+++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 35666677888777665566678998864 36678889876554444556778888877664 3346778888888889
Q ss_pred eEEEEEecCCCCHHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 046892 149 RLLVYEFMSGGSVDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLHDKA------------------------------ 198 (519)
Q Consensus 149 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------ 198 (519)
.++||++++|.++...... ......++.+++..|+.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999999887655421 0112234555666666666421
Q ss_pred --------------------------CCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 199 --------------------------NPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 199 --------------------------~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1228999999999999987767799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.98 E-value=7e-06 Score=76.20 Aligned_cols=130 Identities=18% Similarity=0.104 Sum_probs=82.6
Q ss_pred eeeccC-cEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC--CCeeeeeeEEecCCceEEEEEecCCCC
Q 046892 84 LLGEGG-FGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEFMSGGS 160 (519)
Q Consensus 84 ~LG~G~-~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gs 160 (519)
.+..|. .+.||+.... ++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 344444 4679998764 46678899765442 2346667777765542 336778888888889999999998866
Q ss_pred HHHHHhhhccCCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 046892 161 VDDHLLDVNETKKPLDWTTRMKIASGAAQGLEYLH--------------------------------------------- 195 (519)
Q Consensus 161 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------------------------------------------- 195 (519)
+.... +.. ..++.++...|+-||
T Consensus 93 ~~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 43210 010 011222233333333
Q ss_pred ------hcC----CCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 196 ------DKA----NPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 196 ------~~~----~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
... ...++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 1238999999999999987667899999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.91 E-value=1.9e-05 Score=78.59 Aligned_cols=77 Identities=17% Similarity=0.045 Sum_probs=49.2
Q ss_pred ceeeeccCcEEEEEEEEcCCCeEEEEEEeccC-------CCcChHHHHHHHHHHHhcC-C--CCeeeeeeEEecCCceEE
Q 046892 82 ECLLGEGGFGRVYKGTLQSNGQVVAVKQLDRN-------GMQGNKEFLVEVLMLSLLH-H--PNLVNLIGYCADGDQRLL 151 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~l 151 (519)
.+.||.|....||++....+++.|+||.-... ..........|...|..+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998777889999975421 1112344556777776553 2 345566654 4556789
Q ss_pred EEEecCCCC
Q 046892 152 VYEFMSGGS 160 (519)
Q Consensus 152 V~E~~~~gs 160 (519)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.97 E-value=0.0012 Score=65.22 Aligned_cols=74 Identities=12% Similarity=0.135 Sum_probs=51.0
Q ss_pred ceeeeccCcEEEEEEEEcC-------CCeEEEEEEeccCCCcChHHHHHHHHHHHhcC-CCCeeeeeeEEecCCceEEEE
Q 046892 82 ECLLGEGGFGRVYKGTLQS-------NGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 153 (519)
Q Consensus 82 ~~~LG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~ 153 (519)
.+.|+.|-.-.+|++.... ....|.+++... ........+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578888899999998753 245677887653 233445667888888775 4334578887743 6899
Q ss_pred EecCCCCH
Q 046892 154 EFMSGGSV 161 (519)
Q Consensus 154 E~~~~gsL 161 (519)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.69 E-value=0.002 Score=61.73 Aligned_cols=70 Identities=16% Similarity=0.083 Sum_probs=45.3
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCCCCe-----eeee--eEEecCCceEEEEEecCCC
Q 046892 88 GGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHHPNL-----VNLI--GYCADGDQRLLVYEFMSGG 159 (519)
Q Consensus 88 G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~--~~~~~~~~~~lV~E~~~~g 159 (519)
+.-..||+++.. +|..|++|+.+.. .....++..|...+..|....| +..- ..+...+..+.+++++.|.
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 445689999875 5888999987643 3455677888887776642222 1111 1234456778899999764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.59 E-value=0.0085 Score=56.52 Aligned_cols=159 Identities=15% Similarity=0.084 Sum_probs=80.5
Q ss_pred ccHHHHHHhccCccccee-----eeccCcEEEEEEEEcCCCeEEEEEEeccCCCcChHHHHHHHHHHHhcCC-----CCe
Q 046892 67 FTFRELAAATKNFRQECL-----LGEGGFGRVYKGTLQSNGQVVAVKQLDRNGMQGNKEFLVEVLMLSLLHH-----PNL 136 (519)
Q Consensus 67 ~~~~~~~~~~~~y~~~~~-----LG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-----pnI 136 (519)
.+..++.....+|.+.++ |..|---+.|+..... | .+++|++.... ....+..|+.++..+.. |..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 455677777888876443 3456667889988653 4 48999886432 23345556666655532 222
Q ss_pred eeee-e--EEecCCceEEEEEecCCCCHHH--------------HHhhhccC-C----CCCC------------------
Q 046892 137 VNLI-G--YCADGDQRLLVYEFMSGGSVDD--------------HLLDVNET-K----KPLD------------------ 176 (519)
Q Consensus 137 v~l~-~--~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~-~----~~l~------------------ 176 (519)
+... | +.........++.++.+..... .+...... . ....
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 1 1122345566677765543210 00000000 0 0000
Q ss_pred HHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCeeeCCCCCcEEeeecccc
Q 046892 177 WTTRMKIASGAAQGLEYLHDK-ANPPVIYRDLKSSNILLGANLDPKLSDFGLAK 229 (519)
Q Consensus 177 ~~~~~~i~~qi~~aL~~LH~~-~~~~IvHrDikp~NILl~~~~~vkL~DFGla~ 229 (519)
.......+..+...+...+.. -..+|||+|+.++|||++.+...-|+||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111222222223322221 12339999999999999988877899999875
|